Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.8689168794100655,-1.9457357413098522,0.0,0.06861189468735307,0.07,1/46,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.8835234324143552,-1.887481320123213,0.0,0.11320962623413258,0.22,1/41,0.01%,CD44
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.7930859990627627,-1.8630628200474086,0.0,0.11206609465601003,0.29,3/59,1.88%,CD44;IL10RB;CXCL13
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.9312429731903733,1.8438939475830813,0.0,1.0,0.56,1/20,0.00%,CPA1
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.8065591719122215,1.837735358969622,0.0,1.0,0.63,1/50,0.00%,CPA1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.9307916681929338,-1.8296596996645367,0.0,0.14236968147625764,0.37,2/23,0.87%,CD44;SIRPG
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.8737474520726759,-1.8271933202029507,0.0,0.12350141043723555,0.4,1/24,0.01%,CD44
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.9288146212788763,-1.8036947307496316,0.0,0.14408497884344146,0.5,1/20,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.859840806753181,-1.7982099369510915,0.0,0.14310480891933644,0.52,3/34,1.88%,CD44;SIRPG;CXCL13
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.9509316358267491,-1.788351561189418,0.0,0.15523441173013636,0.6,1/16,0.01%,CD44
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.819909596744246,-1.7772931335424023,0.019230769230769232,0.16085677532257223,0.65,1/46,0.01%,CD44
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.8483868155618243,-1.7758564984588985,0.0196078431372549,0.14751557357780912,0.65,1/33,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.9112509440037037,-1.7727002662523332,0.0,0.13909502286617942,0.66,1/17,0.01%,CD44
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.8629213355881729,1.772425708364091,0.0,1.0,0.88,4/32,1.92%,SGO1;ESPL1;TOP2A;NDC80
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.8229245702758148,-1.7702293401211897,0.02040816326530612,0.13608025779658361,0.68,1/46,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.8570717529983454,-1.7680494088555576,0.0,0.13194595132183284,0.71,1/29,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.8461108809186291,-1.7433740749435827,0.0,0.17349007656659277,0.84,1/14,0.61%,DDX11
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.822267544019244,-1.7425701547725259,0.0,0.16421113461839837,0.84,11/51,8.18%,CD44;IRF4;PRKCD;TRIM5;CAMK2A;CIITA;IRF5;HCK;HLA-DRB1;OAS3;OAS1
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.9260798502594885,1.7179877777367296,0.0196078431372549,1.0,0.99,3/10,1.41%,SULT2A1;HS3ST5;SULT6B1
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.9608007113613861,-1.7170565691470177,0.0,0.23027867154442877,0.9,1/15,0.01%,CD44
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.936705346471239,-1.71556721993502,0.0,0.2227868580436406,0.9,1/16,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.9414809562196416,-1.7154566359999683,0.0,0.21079098756725695,0.9,1/14,0.01%,CD44
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.7666745795717129,-1.7127557467407508,0.021739130434782608,0.2101690668844184,0.91,6/47,2.82%,ANXA8;EHF;DUOXA1;CD24;ENTPD2;C6ORF132
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.8669015460318372,-1.706893939947661,0.0,0.22024418194640338,0.94,2/17,0.08%,CYP1A2;UGT2B15
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.7552222025151377,-1.7006093669517002,0.0,0.22674597577630018,0.95,3/64,2.29%,CD44;TERF2IP;IL11
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.9696955450053015,-1.6931089726825377,0.0,0.23764665341710475,0.97,1/13,0.01%,CD44
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.9422215706837986,1.690791879352641,0.0,1.0,1.0,1/14,0.02%,CLEC2A
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.8813990645749197,-1.6904340745072803,0.0,0.23328044193700048,0.97,4/31,3.66%,CD44;CLDN4;WTIP;ZMYM6
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.7201264204317103,1.6895801375376713,0.024390243902439025,1.0,1.0,14/75,6.51%,IGF1;HEMGN;SMAD6;SMOC1;HGF;PPARG;WNT4;FBXO5;RORB;BMP2;CRIM1;ACVR2A;CCN4;WWTR1
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.829115699593761,-1.6758007097404797,0.0,0.2764487590111268,0.98,1/33,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.9118916663389176,-1.6738699999883564,0.0,0.27362423601316405,0.98,3/12,4.94%,CYP1A2;HSD11B1;CYP24A1
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.919400198366535,1.6733994549070874,0.0,1.0,1.0,1/15,0.05%,SGO1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.7303530897395386,-1.673161330769087,0.0,0.266003037864815,0.98,3/82,2.29%,CD44;TERF2IP;IL11
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.885652118883432,-1.6664625502929196,0.0,0.28207112260356265,0.98,1/23,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.7837364269212195,1.6610734250447974,0.0,1.0,1.0,3/33,4.32%,GATA4;TGFBR1;DAPK2
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.9177803828738362,-1.6591840603407602,0.0,0.3021373791053798,0.98,1/13,0.01%,CD44
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.8624898784630741,1.6582580293954705,0.0,1.0,1.0,6/19,6.41%,LGALS9;IGF1;FGF10;MYC;ZFP36L2;ITGAV
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.6420343358154675,1.657326662361343,0.0,1.0,1.0,38/117,16.62%,FGF10;PDZRN4;ZNF385D;LSAMP;PRKG1;RAB27A;ANGPT1;CADM2;RSPO2;SLC17A6;ROBO2;PENK;UNC5D;NRXN1;RAB3C;PDGFRA;NOVA1;OLFM3;PTPRD;PCDH18;FGF14;PABPC5;SCN3A;MAGI2;ADGRB3;MAGEL2;TMEM196;INTS6L;ZNF536;COL11A1;RUNX1T1;SEMA6D;NREP;FRZB;PDZRN3;MAPK10;PCSK2;CNTN4
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.9394461809847237,1.650981541993291,0.0,1.0,1.0,2/13,0.87%,CLEC2A;KLRD1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.8232655183559988,1.6468268746766328,0.03225806451612903,1.0,1.0,8/20,8.80%,FLT1;FGFR3;CCL5;FGFR1;FGF2;ESR1;PDGFRA;ABL2
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.7041891248023273,1.645989325569978,0.020833333333333332,1.0,1.0,17/62,14.65%,NPC1L1;SULT2A1;IL4;INSIG1;MSMO1;FDFT1;CEL;ABCA1;FDX1;CYP27A1;HMGCS1;ACAA2;MVD;SOAT2;IDI2;CH25H;SOAT1
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.8681656485985776,-1.6456434730115286,0.0,0.3463717718009825,1.0,2/22,2.60%,CD44;COL5A1
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.6563832678018136,1.6449976928878636,0.0,1.0,1.0,37/183,10.74%,CPA1;MXRA5;MITF;CFH;HGF;LSAMP;IL4;SOCS2;ADGRL4;RIN2;ALDH1A1;ROR1;IL2RA;ST6GALNAC3;HS3ST1;CXCL12;RIOK2;POSTN;PDGFRA;UNC13B;HPGDS;NEO1;ABCA1;HS2ST1;PLSCR4;CYBRD1;ACHE;RAMP3;CYP27A1;GRIK2;ESYT3;EXT1;GSN;MEDAG;GPM6A;STK32B;PCDH7
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.6836974461254349,-1.6448052143659988,0.0,0.3384853471242752,1.0,4/78,2.31%,CD44;SHCBP1;FGF1;NR4A1
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.8003015968242545,1.643588593523502,0.0,1.0,1.0,6/26,6.02%,MITF;C3;CCL5;SIRT1;ADIPOR2;PRKAB2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.8473347330529309,1.6423535771638382,0.022222222222222223,1.0,1.0,3/13,3.41%,SULT2A1;SULT6B1;ENPP1
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.8968827207426625,1.6408094050637883,0.018518518518518517,1.0,1.0,3/11,2.18%,IRS1;SIRT1;ZBTB7B
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.6504896071856597,1.6306264753240647,0.0,1.0,1.0,18/90,12.35%,STK26;DACH1;MITF;TMEFF2;CCDC125;NAV3;TP53INP1;DLC1;FOXO3;KANK1;ARID2;MAGI2;PTPRT;TMIGD3;PTPRK;SINHCAF;FRMD5;PTEN
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.9242639814146218,1.6292820487607302,0.0,1.0,1.0,2/13,4.04%,RAB27A;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.901536395771774,-1.6278180234832211,0.0,0.4081301090434809,1.0,1/10,0.61%,DDX11
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.6982775040928098,1.6265442069453795,0.021739130434782608,1.0,1.0,8/41,5.54%,HGF;TGFBR1;FGFR1;HIF1A;SNAI1;WNT4;BMP2;RBPJ
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.6012691109245439,1.621424207666913,0.018518518518518517,1.0,1.0,41/115,17.14%,CXXC4;PDZRN4;UNC5C;ESRRG;ERBB4;PCLO;SCGN;PLCXD3;PCDH17;PTGFR;NRXN1;PLPPR1;ADGRL2;PAX6;LIFR;NOVA1;PTPRD;FGF12;STOX2;FGF14;ANK2;MAGI1;GUCY1A2;PTPRT;PAK5;TMEM196;NOL4;CNTN1;PPP1R9A;PROX1;CNTN3;SEMA3E;ID4;SEMA6D;FRZB;CPE;MAPK10;CNTN4;PXK;HMGCLL1;FLRT3
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),0.797729006018899,1.613554525457599,0.0196078431372549,1.0,1.0,2/18,2.68%,SGO1;KASH5
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.9767778889800858,1.6115938324849197,0.0,1.0,1.0,2/10,0.15%,GATA4;STK26
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.6924348814323751,-1.603613641700339,0.0,0.544606914080865,1.0,10/69,3.27%,MS4A8;DUSP4;EHF;CAPN8;CLDN4;TMEM184A;FAM3D;C6ORF132;MUC5B;SPDEF
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.7156191985225203,-1.6025785214469657,0.01818181818181818,0.5353806933937398,1.0,8/66,2.39%,CD44;P2RY10;SIRPG;SELL;TRAF3IP3;CD53;NR4A1;CYTH4
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.6107379918057418,1.5964227892714848,0.0,1.0,1.0,31/139,12.26%,CRX;PCDH15;VWC2L;LSAMP;CDH20;CADM2;PCBP3;RNF152;SLC17A6;CNTNAP2;VSX2;SAG;ZDHHC22;NRXN1;RCVRN;RAB3C;FRMD3;SLC24A2;OLFM3;LIN7A;SYNPR;MAGI2;GRM5;ADGRB3;CTNNA2;QPCT;PAK5;TMEM196;HCN1;ZNF536;PROX1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.8598220828249835,1.5960236207196108,0.047619047619047616,1.0,1.0,2/14,4.06%,ESPL1;LLGL1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.8193049766475033,1.594178802702962,0.05405405405405406,1.0,1.0,4/18,4.79%,SULT2A1;SULT6B1;ENPP1;SLC35B2
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.8245233351634876,-1.5927435603036013,0.0,0.5874388983378966,1.0,3/22,6.32%,CYP1A2;HSD11B1;CYP4F2
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.8851895046213852,-1.5913465698512392,0.023809523809523808,0.5800645610853651,1.0,3/13,3.29%,CYP1A2;CYP2A6;CYP2E1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.9461104645564647,-1.5892621740768844,0.0,0.564657349521595,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.9461104645564647,-1.5892621740768844,0.0,0.564657349521595,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.721356856577798,1.5876216238322458,0.05660377358490566,1.0,1.0,10/49,11.97%,IRGM;SIRT1;IL4;FYCO1;PIP4K2A;GNAI3;GPSM1;STING1;EPM2A;BNIP3L
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.9275880461063284,1.5856101110893028,0.0,1.0,1.0,2/9,2.51%,NPC1L1;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.8002598412218479,1.5841983901149754,0.018518518518518517,1.0,1.0,4/28,5.62%,VAPB;TOP2A;CCL5;NR5A2
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.6966889263220979,-1.5825123188017984,0.0196078431372549,0.5924095433400144,1.0,11/74,8.18%,CD44;IRF4;PRKCD;TRIM5;CAMK2A;CIITA;IRF5;HCK;HLA-DRB1;OAS3;OAS1
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.7362172875306209,-1.5811597306923062,0.0,0.5847844562583632,1.0,1/42,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.8178348594918664,1.58014950366698,0.0,1.0,1.0,7/23,6.94%,IGF1;IRS1;PPP1R3B;PPP1R3A;ENPP1;PPP1R3D;DYRK2
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.6128519411509958,-1.5800786519300034,0.0,0.5782267424776681,1.0,3/169,0.25%,CD44;TRIP10;DUSP4
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.7615803936590332,1.5780220732583963,0.0,1.0,1.0,6/22,10.72%,CGNL1;NLGN1;PCLO;MARVELD3;DSP;MPP4
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.7123686753852424,-1.5777034464574011,0.03508771929824561,0.5798541831504351,1.0,7/40,11.17%,NARS1;TARS3;WARS1;SARS1;DARS2;SARS2;CARS1
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.8095413097594815,1.576931307925732,0.0,1.0,1.0,5/26,3.80%,GATA4;TGFBR1;HES6;BMP2;PCSK5
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.9853276218322649,1.5758399412887671,0.0,1.0,1.0,1/7,0.81%,IRGM
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.6732160164331413,1.5756460437415172,0.017241379310344827,1.0,1.0,10/70,8.94%,GATA4;IGF1;HGF;TGFBR1;IL4;URI1;RELA;ITGAV;PELI3;ACAA2
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.8367388657810205,-1.5755875276065683,0.045454545454545456,0.5691596008134615,1.0,8/17,11.61%,CLDN4;CLDN1;ALOXE3;FLG;HRNR;FLG2;STMN1;ALOX12B
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.8367388657810205,-1.5755875276065683,0.045454545454545456,0.5691596008134615,1.0,8/17,11.61%,CLDN4;CLDN1;ALOXE3;FLG;HRNR;FLG2;STMN1;ALOX12B
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.6287744884562826,-1.574296740482725,0.0196078431372549,0.5662040672949523,1.0,2/132,1.28%,CD44;GPX3
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.8308643213034165,-1.574246002826838,0.02,0.5540791673196468,1.0,1/18,0.17%,TERT
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.6736015482384012,-1.5737123767493444,0.019230769230769232,0.5448679375932627,1.0,5/74,3.41%,CYP1A2;ACOT1;AWAT1;CYP2E1;ALOX5
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.8136884639863039,1.5717717205455113,0.02,1.0,1.0,6/14,15.11%,STARD4;LDLR;NPC2;ABCA1;LRP6;STAR
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.7023662247313415,-1.5710794087306967,0.022222222222222223,0.5486031919895168,1.0,4/84,1.75%,CD44;GAB3;GYPB;ICAM3
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.6221908818604319,-1.5702715416757287,0.0,0.5417480851355586,1.0,11/181,5.72%,CD44;HK2;LDHC;XYLT2;COL5A1;BIK;AGRN;GPC1;TGFBI;IER3;GPC3
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.8852449687148015,-1.569999114902732,0.0,0.5323722930639111,1.0,3/12,3.29%,CYP1A2;CYP2A6;CYP2E1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.7164679700310194,-1.5689030499611698,0.041666666666666664,0.5277626939351199,1.0,4/40,5.39%,ANXA8;AHSG;TIMP4;SERPINI2
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.7869126357596218,1.5687849652238297,0.018518518518518517,1.0,1.0,6/20,7.75%,LGALS9;CCL5;IL4;CXCL12;MOSPD2;HMGB1
prerank,GO_Biological_Process_2021__regulation of NAD(P)H oxidase activity (GO:0033860),0.9893539198866182,1.5679628358266449,0.0,1.0,1.0,1/5,0.64%,DRD5
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.9007400212039924,-1.5665891167958286,0.0,0.5335583810392986,1.0,1/14,0.17%,TERT
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.8487801450132058,1.5644880096790208,0.022222222222222223,1.0,1.0,6/18,9.05%,F2;F2R;CALCR;SNCA;RAMP3;ANK2
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.7903627133562076,1.5644784798766198,0.05555555555555555,1.0,1.0,5/23,9.78%,PNP;AMPD1;SHMT2;ADA;GMPS
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.9854029817975473,-1.56234444359502,0.0,0.5521938062818705,1.0,1/8,0.01%,CD44
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),0.6678670881719302,1.5611859449669763,0.023255813953488372,1.0,1.0,15/42,16.53%,NPC1L1;STARD4;LDLR;NPC2;CEL;ABCA1;ABCG8;SOAT2;MSR1;ABCA8;ABCG5;LIPG;SOAT1;STAR;AKR1C1
prerank,GO_Biological_Process_2021__regulation of phospholipase A2 activity (GO:0032429),-0.977598604671198,-1.5599870310515809,0.0,0.5588633006892515,1.0,1/5,0.12%,ANXA8
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.9709593558437629,-1.559128522570847,0.023255813953488372,0.5543586972609658,1.0,1/6,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.8371341474448606,-1.5591138335769943,0.0,0.5345601723587884,1.0,1/16,0.17%,TERT
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.8371341474448606,-1.5591138335769943,0.0,0.5345601723587884,1.0,1/16,0.17%,TERT
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.8241763952989416,1.559015726336766,0.016666666666666666,1.0,1.0,4/13,8.08%,TIMELESS;SLFN11;FBXO5;GMNN
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.7149996978179978,1.5555018550110193,0.019230769230769232,1.0,1.0,8/37,7.75%,LGALS9;SYK;F2R;CD244;RELA;TLR2;F3;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.8960984539450794,1.5543376063976968,0.02,1.0,1.0,3/12,2.18%,IRS1;SIRT1;ZBTB7B
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),-0.9240834396397253,-1.552797884084614,0.0,0.5633397669066884,1.0,2/6,2.31%,NUPR1;NR4A1
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.7271822895219645,-1.55150380475616,0.0,0.5632090182870483,1.0,8/44,6.82%,CYP1A2;AWAT1;CYP2A6;CYP2E1;ALOX5;PTGES;CYP4F2;ALOXE3
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.6588351237430131,-1.5510997046000436,0.02,0.556105221008343,1.0,1/86,0.01%,CD44
prerank,GO_Biological_Process_2021__cellular response to monoamine stimulus (GO:0071868),0.9124299832230315,1.5499031951114528,0.0,1.0,1.0,1/7,0.64%,DRD5
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.7750437413397219,-1.5490049478401535,0.023809523809523808,0.5614740048581727,1.0,2/16,4.93%,TAFA3;DRD2
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.5480735535461616,-1.5483849113566117,0.0,0.5574435247057736,1.0,14/304,4.48%,CD44;ALB;NTRK1;APIP;MPO;TEK;NUPR1;TNFSF18;HMGN5;IL31RA;PLK3;ANGPT4;BCL2L2;PRAME
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.7664114074513526,1.547564747667158,0.018518518518518517,1.0,1.0,2/22,4.18%,MT4;GLRA1
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),0.8715699627153584,1.5471037855130663,0.017543859649122806,1.0,1.0,2/12,4.18%,MT4;GLRA1
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.6104690774670708,-1.5460354170369004,0.0,0.5633921868601848,1.0,9/134,3.15%,CD44;SELE;IL10RB;LTB4R;CXCL13;XCR1;NLRP3;PTGDR;MEFV
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.5976596594781617,1.5458913284705964,0.031746031746031744,1.0,1.0,6/93,9.35%,SGO1;ESPL1;NDC80;DLGAP5;CHMP6;RRS1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.6984356300372718,1.5458868084566368,0.041666666666666664,1.0,1.0,6/38,7.75%,VEGFC;LGALS9;CCL5;CXCL12;MOSPD2;HMGB1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.8259156464386206,1.5454442013589644,0.0196078431372549,1.0,1.0,6/15,7.75%,FLT1;FGFR1;FGF2;PPARG;SP1;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.7497018545735219,-1.5453617379539912,0.06,0.558261225662495,1.0,1/22,0.61%,DDX11
prerank,GO_Biological_Process_2021__negative regulation of macrophage migration (GO:1905522),-0.9329802474418036,-1.544485809664763,0.0,0.555220316540315,1.0,2/6,4.51%,CD200R1;C5
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.8485408164017716,1.5432949989868652,0.01818181818181818,1.0,1.0,4/13,4.70%,IRS1;SOCS2;STAT5A;IL7R
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.8485408164017716,1.5432949989868652,0.01818181818181818,1.0,1.0,4/13,4.70%,IRS1;SOCS2;STAT5A;IL7R
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.9349514434416593,-1.5431871873669196,0.0,0.538756982015171,1.0,1/10,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.9349514434416593,-1.5431871873669196,0.0,0.538756982015171,1.0,1/10,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.9349514434416593,-1.5431871873669196,0.0,0.538756982015171,1.0,1/10,0.04%,CYP1A2
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.6443112048532653,-1.5419118010806998,0.041666666666666664,0.5378970743798225,1.0,9/90,3.12%,CD44;RAB44;MPO;GAB3;GYPB;RAC2;ICAM3;CGA;STK10
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.6649913206268134,-1.541658006326363,0.0,0.5312947149485905,1.0,8/74,3.86%,CD44;BST1;IL11;ENPP2;PRKCD;TEC;ANGPT4;IL6R
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.9062145750125952,1.541369786509251,0.0,1.0,1.0,3/9,3.61%,PPP1R3B;PPP1R3A;PPP1R3D
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.855754696615248,-1.5400722944274288,0.044444444444444446,0.5335064896903754,1.0,4/9,9.83%,EPN1;ALOX5;ADAMTS9;CREB3L1
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.6397269122633269,-1.539591015881916,0.0,0.5283115890926187,1.0,7/99,3.15%,CD44;SELE;SELL;CD53;CYTH4;CD86;MEFV
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.9116007055081732,1.5383752533419515,0.0,1.0,1.0,3/11,5.37%,GATA4;SOX5;SOX6
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.9041872816665707,1.537970561017623,0.020833333333333332,1.0,1.0,1/9,0.23%,REP15
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.7141185138263572,-1.5376749084187675,0.0,0.5332668925978165,1.0,2/59,1.37%,CD44;IRF4
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.910113353182841,1.5372541676154945,0.0,1.0,1.0,3/10,2.58%,FGF10;TGFBR1;ZBTB1
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.9527366157564221,-1.534944862741534,0.0,0.5431618347920733,1.0,1/5,1.24%,RTF1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.8085603903759991,1.533332588672156,0.05555555555555555,1.0,1.0,7/14,11.92%,RUNX1;TGFBR1;ERBB4;FGF2;RBPJ;BMPR1A;MEF2C
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.8615968420833421,1.533309340719633,0.018867924528301886,1.0,1.0,1/8,0.09%,GATA4
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.875525284709364,1.5304968264887862,0.02,1.0,1.0,1/8,1.40%,LYPD1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.6964062784649563,-1.5294493302093004,0.05454545454545454,0.5685515381389852,1.0,1/68,0.01%,CD44
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.8308540571419063,1.528484842038901,0.022222222222222223,1.0,1.0,3/12,3.79%,GATA4;TGFBR1;BMP2
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.7910275553307006,-1.527493120415919,0.0,0.5747847124275193,1.0,5/20,7.27%,TEKT3;DNAH17;TEKT5;DRC1;RSPH9
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),-0.968933237619068,-1.5262091885432618,0.020833333333333332,0.5608582570853374,1.0,1/5,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),-0.968933237619068,-1.5262091885432618,0.020833333333333332,0.5608582570853374,1.0,1/5,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),-0.968933237619068,-1.5262091885432618,0.020833333333333332,0.5608582570853374,1.0,1/5,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.6017309957498186,1.5243745391040475,0.0425531914893617,1.0,1.0,50/129,23.78%,RUNX1;GPRIN3;PBX3;NRTN;NEDD4;EHD1;NPY;TENM3;CNTNAP2;NLGN1;TENM1;PRMT1;MANF;LGI1;UGDH;EPHA5;POU3F2;HMGB1;EPHA8;GPM6A;PPP1R9A;MEF2C;GPM6B;HDGFL3;MYT1L;PTPRM;LRP12;RP1L1;L1CAM;SLC44A4;CNTN4;FLRT3;ARL3;MICALL1;STMN4;PLP1;WNK1;LYN;RAPGEF2;CDK16;MAP2;TDP2;STX3;RYK;TENM4;SH3GL2;PBX1;BLK;RP1;CDNF
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.7843876450445703,-1.5224204123577316,0.06,0.5760793638749531,1.0,3/17,2.36%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.9175107162311602,1.5223719210698303,0.03773584905660377,1.0,1.0,1/8,0.48%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.9175107162311602,1.5223719210698303,0.03773584905660377,1.0,1.0,1/8,0.48%,IGF1
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),-0.9023764332647963,-1.5210245634019606,0.023255813953488372,0.5770260343206395,1.0,3/7,7.27%,TEKT3;TEKT5;RSPH9
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.9468326739130067,-1.5194728781416624,0.0,0.5794740389582499,1.0,1/6,1.24%,RTF1
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.8466062547387719,1.5186574566264832,0.017241379310344827,1.0,1.0,3/11,3.61%,PPP1R3B;PPP1R3A;PPP1R3D
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.8529090134318563,-1.516410363329016,0.022727272727272728,0.5902296403958398,1.0,1/10,1.10%,SCN5A
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.7210238099632907,-1.5163445031212404,0.023809523809523808,0.5840277541760837,1.0,6/48,5.72%,CD44;HGSNAT;AGRN;GPC2;GPC1;GPC3
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.7953073574784484,-1.5154808117014387,0.046511627906976744,0.5814041266483087,1.0,6/15,10.52%,TERF2IP;SLX4;ERCC1;RAD50;RTEL1;PARP1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.7112543524998978,1.51451550328215,0.03225806451612903,1.0,1.0,8/25,19.07%,FGF10;ANGPT1;ANK2;PTPRK;PTPRU;GGA1;CTNNB1;SMURF1
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.8446528158398768,-1.5115409941799107,0.06666666666666667,0.5990222005586439,1.0,1/7,0.61%,DDX11
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),-0.9000179064430498,-1.5114921368767664,0.023255813953488372,0.5922163886793278,1.0,2/5,6.37%,BFSP1;WNT7A
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.8961769298468392,1.511291122775631,0.0,1.0,1.0,4/10,6.19%,F2;F2R;F12;HPSE
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.8961769298468392,1.511291122775631,0.0,1.0,1.0,4/10,6.19%,F2;F2R;F12;HPSE
prerank,GO_Biological_Process_2021__response to catecholamine (GO:0071869),0.9284794834430943,1.5109903027112195,0.01818181818181818,1.0,1.0,1/6,0.64%,DRD5
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.6806114162691336,1.5087513225908435,0.023255813953488372,1.0,1.0,8/44,5.54%,HGF;TGFBR1;FGFR1;HIF1A;SNAI1;WNT4;BMP2;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.7349172983465164,-1.508500923261681,0.06,0.604809908456679,1.0,3/36,5.43%,EPN1;MVP;PTPN3
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.8634194268595067,-1.5081303871839762,0.041666666666666664,0.5998083020793263,1.0,1/11,0.33%,ALB
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.8416964477943435,1.5077373599429857,0.017241379310344827,1.0,1.0,3/14,2.71%,VEGFC;ITGA11;ITGA2
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.8511200162001952,-1.5076690592373816,0.022222222222222223,0.596229655631448,1.0,1/12,0.42%,NTRK1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.569239511837681,1.5054455249079752,0.0,1.0,1.0,22/221,7.59%,CPA1;CAPN13;MME;HGF;TMPRSS2;PRSS57;MMP23B;KLKB1;NAALAD2;MMP16;PCSK5;CTSF;TRHDE;ADGRV1;HGFAC;MMP15;F12;PRSS3;KLK14;F3;DPP4;HTRA2
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.8180691468509464,1.5054443846412688,0.07142857142857142,1.0,1.0,7/14,8.80%,FLT1;FGFR1;FGF2;ESR1;PDGFRA;BICD1;ABL2
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.9476047483341414,-1.505108231429203,0.0196078431372549,0.6058430300893277,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.8439789062656549,1.5049037195830413,0.0392156862745098,1.0,1.0,2/12,5.04%,ESPL1;DLGAP5
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.8439789062656549,1.5049037195830413,0.0392156862745098,1.0,1.0,2/12,5.04%,ESPL1;DLGAP5
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.8439789062656549,1.5049037195830413,0.0392156862745098,1.0,1.0,2/12,5.04%,ESPL1;DLGAP5
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.7332506866998173,1.5043998709713329,0.05263157894736842,1.0,1.0,5/26,7.57%,GATA4;CLMP;PCSK5;NPY;AGR2
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.5770510096966832,1.5043194720489719,0.01818181818181818,1.0,1.0,20/118,11.18%,STK26;DACH1;MITF;IL4;FGF2;TMEFF2;NAV3;TP53INP1;MARVELD3;DLC1;FOXO3;KANK1;ARID2;MAGI2;PTPRT;TMIGD3;CORO1C;BMPR1A;PTPRK;SINHCAF
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.7992016895403278,1.503286047843542,0.0,1.0,1.0,5/14,13.39%,SIRT1;SNAI1;LOXL2;HP1BP3;SETD7
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.7189586960035752,1.5031180085609797,0.03636363636363636,1.0,1.0,7/28,12.26%,GATA4;TGFBR1;ROBO2;BMPR1A;DAND5;SMAD4;PROX1
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.8536163402545192,-1.5019285057903302,0.0,0.6205229596449625,1.0,1/15,0.17%,TERT
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.87768930045976,-1.5015416044588887,0.041666666666666664,0.617059583307782,1.0,1/12,0.23%,RFX6
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),0.8994010547308049,1.500110998239764,0.02,1.0,1.0,2/8,2.71%,ITGA8;ITGA2
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.7661864098344047,-1.500036339205016,0.03508771929824561,0.6206056538817356,1.0,3/27,3.41%,CYP1A2;CYP2E1;ALOX5
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.8246180898227592,1.4991625932567554,0.018518518518518517,1.0,1.0,7/24,7.47%,FGF10;SMOC1;LRP4;KAT2B;RSPO2;PCSK5;CHD7
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.811366285864072,1.498335821377565,0.06,1.0,1.0,3/12,7.41%,STARD4;NPC2;ABCA1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.8186041637491571,1.498193335673732,0.02,1.0,1.0,1/13,1.92%,NDC80
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.598820884341165,1.4980976690843701,0.018518518518518517,1.0,1.0,17/101,12.78%,IGF1;RIT2;RAB38;CCNA2;RIN2;FGF2;RRAS;RRAD;KSR1;ARHGAP31;CDKN2A;RALA;SHOC2;RAPGEF6;RGL2;RRAGC;SOS1
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.8765582306220863,1.4975261391557702,0.0392156862745098,1.0,1.0,2/8,5.19%,VEGFC;CXCL12
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.6688608728409355,1.4968843193635417,0.03571428571428571,1.0,1.0,3/46,1.70%,CPA1;TMPRSS2;ACE2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.8049711523557391,1.494987502645176,0.057692307692307696,1.0,1.0,4/14,12.35%,PRKG1;PPARG;MEF2C;PTEN
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.8048506658934447,1.4947922901878241,0.02127659574468085,1.0,1.0,2/8,5.32%,UGDH;MAT2A
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.9132731317205275,1.494448996065067,0.0,1.0,1.0,1/11,2.73%,RAB27A
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.7277780403390574,1.4940422168968626,0.018867924528301886,1.0,1.0,7/31,9.95%,IRGM;SIRT1;PYHIN1;FBXL3;SNCA;RNF139;GSN
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.9159703493330609,1.4933251015630296,0.015625,1.0,1.0,3/10,2.18%,PNP;RUNX1;ZBTB7B
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.9646327174722884,-1.492959337880383,0.0,0.6631266630155348,1.0,2/5,3.43%,DDX11;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.7731822906532548,1.492538301653473,0.023255813953488372,1.0,1.0,3/27,5.04%,IGF1;ESPL1;DLGAP5
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.8290674599440414,1.4922780583406083,0.01818181818181818,1.0,1.0,2/13,2.55%,IGF1;STAT5A
prerank,GO_Biological_Process_2021__columnar/cuboidal epithelial cell differentiation (GO:0002065),0.9564545953501925,1.4921505114416478,0.019230769230769232,1.0,1.0,2/5,3.87%,GATA4;NPY
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.6698581867436271,1.492043040096546,0.0,1.0,1.0,6/55,6.78%,FGF10;ESPL1;CDC25A;FBXO5;DLGAP5;UBE2E2
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.7479786041689637,1.4914000120637099,0.023255813953488372,1.0,1.0,3/18,3.79%,GATA4;SMAD6;BMP2
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.7725733681886873,-1.4911956875976211,0.017857142857142856,0.6689298616781728,1.0,3/19,8.49%,ALB;NFE2L1;ALAS2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.6564485459785531,1.4910229500473504,0.0425531914893617,1.0,1.0,15/59,7.90%,VEGFC;SEMA5A;SIRT1;TGFBR1;FGFR1;HIF1A;STAT5A;FGF2;BMP2;SP1;NRARP;APELA;F3;HMGB1;AGGF1
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.801162919472511,1.4900531368990653,0.0,1.0,1.0,3/15,5.82%,SIRT1;ZBTB7B;NAPEPLD
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.7946669780301867,1.4890305633123455,0.038461538461538464,1.0,1.0,5/16,10.39%,SOX5;GDF6;BMP2;SOX6;LOXL2
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),0.9870354387705699,1.4890049677794468,0.0,1.0,1.0,1/5,0.81%,IRGM
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.7039756601865458,1.4883884813200603,0.07547169811320754,1.0,1.0,7/19,14.36%,NPC1L1;LDLR;NPC2;ABCG8;MSR1;ABCA8;ABCG5
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.7136408611647092,1.4882900292374222,0.06666666666666667,1.0,1.0,5/30,4.30%,GATA4;SMAD6;SNAI1;BMP2;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.931736276078229,-1.4879736452690313,0.021739130434782608,0.6820451156264692,1.0,1/6,0.60%,HK2
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.7997355618056362,1.4877300912753437,0.018867924528301886,1.0,1.0,3/25,1.32%,IGF1;IRS1;C3
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.7103524778190443,1.486475983305011,0.057692307692307696,1.0,1.0,4/26,4.30%,GATA4;SMAD6;SNAI1;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.7600956043494747,1.4844159137590305,0.037037037037037035,1.0,1.0,8/22,8.97%,ACE2;PPARG;CALCR;CBLB;CNRIP1;RAMP3;CRHBP;CHMP6
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.8280328259737924,-1.4839404729756667,0.02040816326530612,0.7034487553254911,1.0,3/11,2.36%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.9023917011696484,1.4838360497027274,0.0,1.0,1.0,2/7,2.87%,IGF1;PPARG
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.6340334735216534,1.4837415686652529,0.02,1.0,1.0,11/57,13.04%,VEGFC;FLT1;DOCK1;MAPKAPK2;ITGAV;MAPKAPK3;PIK3CA;PXN;NCK2;BCAR1;HSPB1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.6769791717148687,-1.4835004670300669,0.041666666666666664,0.6990011801617685,1.0,8/68,4.94%,CYP1A2;UGT2B15;AMACR;CYP2A6;CYP2E1;SLC22A24;HSD11B1;CYP24A1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),0.8001776926063142,1.4832668567832015,0.04918032786885246,0.9935982322760225,1.0,2/9,1.66%,LGALS9;TMPRSS2
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),0.8001776926063142,1.4832668567832015,0.04918032786885246,0.9935982322760225,1.0,2/9,1.66%,LGALS9;TMPRSS2
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.6729457615186252,1.48294925483334,0.0,0.9886097204141732,1.0,1/29,0.09%,GATA4
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8969307095064761,1.4822890161335205,0.0425531914893617,0.9865161712469621,1.0,4/8,7.75%,LGALS9;RUNX1;VSIR;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.7840641540454742,1.482021880796431,0.017543859649122806,0.9799444705501912,1.0,2/20,1.13%,IGF1;IRS1
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.873191536977517,1.481403442434303,0.0,0.9773918856662126,1.0,3/10,9.52%,SEMA5A;PLEKHH2;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.6903177284561718,1.4813894941928774,0.0196078431372549,0.9689698843717377,1.0,8/38,6.51%,IGF1;HGF;WNT4;FBXO5;BMP2;ACVR2A;CCN4;WWTR1
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.846526071627689,1.4804523477966274,0.0392156862745098,0.9699406841088513,1.0,4/16,6.01%,FGF10;SEMA5A;ANGPT1;SCRIB
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.6873635130995855,1.4804407026433655,0.04,0.9615064172905134,1.0,9/36,14.65%,SULT2A1;IL4;IDH1;ABCA1;FDX1;CYP27A1;SOAT2;CH25H;SOAT1
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.7568508914682932,1.4801739206306148,0.02040816326530612,0.9562091850877701,1.0,9/20,19.49%,THRSP;NPC2;PRKAB2;ABCD3;ABCD2;ACACA;ACACB;ABCD4;MID1IP1
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.6279892911616007,1.4797584615181658,0.06666666666666667,0.9516616253856859,1.0,22/64,18.76%,SLC12A7;GABRR1;SLC12A1;GABRR2;SLC1A3;SLC26A7;SLC26A6;SLC12A3;GLRA1;GABRG3;GABRA5;GLRB;GABRG1;GABRB2;PACC1;ANO5;ANO6;SLC4A1;SLC12A9;GABRE;GABRA4;GABRB1
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.8022925854490872,-1.4794735218372175,0.02127659574468085,0.720702113993722,1.0,2/18,1.07%,TERT;GINS3
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.6068270040041857,-1.478563538333232,0.057692307692307696,0.7198759990597086,1.0,11/70,3.29%,MS4A8;EHF;DUOXA1;CAPN8;CYP2B7P;DUOX1;FAM3D;ALS2CL;SFTPA2;MUC5B;CYP2E1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.550132030040137,1.4780798240732458,0.0,0.9601529352864943,1.0,43/157,20.81%,GPRIN3;NRTN;NEDD4;EHD1;NPY;CNTNAP2;NYAP2;NLGN1;PRMT1;WHRN;TNIK;ADGRV1;MANF;LGI1;NEFH;HMGB1;EPHA8;PLXNB1;GPM6A;VASH2;PPP1R9A;PTEN;GPM6B;HDGFL3;GRM7;DBN1;PTPRM;LRP12;L1CAM;SGK1;CNTN4;FLRT3;WASL;MICALL1;STMN4;PLP1;LYN;RAPGEF2;CDK16;MYO16;MAP2;CAMSAP2;DIP2A
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.827379543568201,1.4777444734340783,0.03636363636363636,0.955216635167808,1.0,7/15,12.47%,LGALS9;ITGB8;HIF1A;ITGAV;LTBP1;SMAD4;CD34
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.7498557756559053,-1.4775426003764167,0.06896551724137931,0.7195417708202415,1.0,3/21,8.49%,ALB;NFE2L1;ALAS2
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.7190063590229651,1.4760206757813694,0.07142857142857142,0.9664286938368543,1.0,8/28,13.60%,NPC1L1;INSIG1;MSMO1;FDFT1;HMGCS1;ACAA2;MVD;IDI2
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.8608379671510055,1.475889308415795,0.018518518518518517,0.9602474549193561,1.0,3/11,8.46%,GAS2L3;EPS8;GAS2
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.6424636218131075,1.475767877670687,0.0425531914893617,0.952903331096053,1.0,10/48,10.17%,FGF10;IL4;HIF1A;INSL3;DOCK1;GLUL;PLCG2;BMPER;MARVELD3;CORO1C
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.789895259180215,1.4756208421272758,0.04081632653061224,0.9463055931737108,1.0,2/14,9.57%,AASS;CTCFL
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),0.9549200329569874,1.4745392242710864,0.0,0.9512160096249526,1.0,2/6,3.42%,SLC26A3;SLC26A6
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.6974124450535697,1.4739120582737288,0.05263157894736842,0.9490558982987475,1.0,11/32,17.08%,NPC1L1;INSIG1;MSMO1;FDFT1;HMGCS1;ACAA2;MVD;IDI2;CH25H;SC5D;SQLE
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.6226496045045786,1.4736554380333293,0.0196078431372549,0.9436658535789213,1.0,20/44,15.72%,SMAD6;VWC2L;GREM2;PPARG;BMP2;CRIM1;ACVR2A;BMPER;UBE2D3;SMAD1;VWC2;BMPR1A;DAND5;SMAD4;GREM1;LRP2;SPART;BAMBI;SMAD5;FBN1
prerank,GO_Biological_Process_2021__leukocyte aggregation (GO:0070486),-0.9808237790389012,-1.4736050467212713,0.0,0.7404703301160614,1.0,2/5,1.71%,CD44;RAC2
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.6004181358479865,-1.4730157377481847,0.019230769230769232,0.7377444016140149,1.0,19/70,10.86%,MPO;CD24;SELL;DOCK8;BST1;CYTH4;NLRP3;LILRB3;MEFV;PRAM1;ARG2;HCK;SLC11A1;OAS3;TAGAP;LY86;CEACAM1;MMP9;SPI1
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.8695118887092737,-1.4729097811465208,0.08163265306122448,0.7311784892499367,1.0,4/17,2.60%,MPO;GPX3;DUOX1;PXDN
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.8420571675540381,1.472604968133369,0.0,0.9468618021176965,1.0,2/12,3.79%,GATA4;BMP2
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.8828430526757896,-1.4725897608923963,0.05555555555555555,0.7265672924082656,1.0,3/10,2.60%,MPO;GPX3;PXDN
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.8113857362668875,1.4720432290488341,0.07142857142857142,0.9440834443353897,1.0,4/11,7.75%,FGFR1;FGF2;SP1;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.7927575258466368,1.4719411749880529,0.06382978723404255,0.9380602184571195,1.0,5/21,8.32%,F2;F2R;CALCR;SNCA;RAMP3
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.694953270534747,1.4717574732951964,0.022222222222222223,0.9319319211355106,1.0,1/25,0.09%,GATA4
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.9346869179566571,1.4717416734661266,0.015873015873015872,0.9249160505138292,1.0,1/9,0.10%,TNFSF14
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.8652843746071223,1.470843706521558,0.017543859649122806,0.9274513927836979,1.0,1/8,0.09%,GATA4
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.7921656531622133,1.4689579571795341,0.04,0.937486382810644,1.0,1/10,0.09%,GATA4
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),0.9542846661627423,1.468544654346068,0.0,0.9347105610478177,1.0,1/5,0.81%,IRGM
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.8479232343996781,1.4679392293457176,0.04,0.9337847849719227,1.0,1/7,0.38%,LGALS9
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.8758070933609082,1.467009988036144,0.0,0.9352352831205392,1.0,2/10,9.37%,SIRT1;LEPR
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.510221893648265,1.4662419364080232,0.02040816326530612,0.9348820913384451,1.0,62/348,13.34%,STK26;DACH1;MITF;IGF1;FGF10;FAM83H;FLT1;SEMA5A;FERMT3;HGF;ITGAX;CCL5;TGFBR1;F2R;ERBB4;IL4;FGF2;SNAI1;TMEFF2;PRR5L;BMP2;TCAF2;CXCL12;ABI3;SEMA6C;CASS4;NAV3;PDGFRA;TP53INP1;VSIR;F3;FER;DLC1;FOXO3;PDGFC;KANK1;ARID2;MAGI2;FGF17;PTPRT;TMIGD3;PLXNB1;CTNNA2;CORO1C;PTPRK;WASHC1;SINHCAF;AMOTL1;HAS2;PLXNB2;NTNG2;CARMIL1;BCAR1;FRMD5;PTEN;PPP3CA;FAM89B;FGF5;IGF1R;CPNE3;SEMA3E;MGAT5
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.7620998315093231,1.4661103710451715,0.021739130434782608,0.9294114977471071,1.0,5/18,11.92%,TNFSF14;CD40;ELF4;FLT3;MEF2C
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.7080984154147206,1.4660369729652722,0.06896551724137931,0.923187417536526,1.0,10/29,17.08%,NPC1L1;INSIG1;MSMO1;FDFT1;HMGCS1;ACAA2;MVD;IDI2;SC5D;SQLE
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.631456311386726,1.4658831983880587,0.0196078431372549,0.9177867024543974,1.0,5/67,6.55%,SGO1;ESPL1;NDC80;NDE1;EPS8
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.5822116174336371,1.4651769911340182,0.021739130434782608,0.9177495893048215,1.0,42/128,20.67%,LRRC3B;LSAMP;GRM3;GRIN3A;LRRC4C;CDH20;PMP2;SLC1A3;GFAP;CADM2;HEPACAM;ZEB2;SEPTIN4;NRXN1;NTSR2;SYNPR;MAGI2;GRM5;LRRTM3;ADGRB3;CTNNA2;ATP1A2;ACSBG1;NPAS3;GPM6B;BAALC;GABRG1;SLC39A12;DLG2;GJB6;CNTN2;MAPK10;RFTN2;STMN4;TTC21B;PLP1;RBFOX1;KCNJ10;TRPM3;AMER2;DAO;ATP1B2
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.7422692371562941,1.4648641966109002,0.04,0.9151786302033551,1.0,3/30,3.41%,IGF1;IRS1;ENPP1
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.7189442329862114,1.464696645997967,0.10204081632653061,0.9107561442109956,1.0,12/33,12.26%,FGFR1;BRINP3;BMP2;ZEB1;ZC4H2;ADRA2C;NEUROD2;VWC2;TCF4;CPNE1;MEF2C;PROX1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.8148425998945159,1.4646209057173591,0.034482758620689655,0.9050562410419393,1.0,4/11,10.19%,VEGFC;GAB1;PIK3CA;NUS1
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.9401405058760474,1.463793039381518,0.017857142857142856,0.9053738694309604,1.0,2/6,3.87%,GATA4;NPY
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.7465406172565571,1.463369302143288,0.06521739130434782,0.9025179459993803,1.0,9/20,17.47%,HIF1A;BMP2;RBPJ;RELA;SMAD1;SMAD4;SMAD5;NFE2L2;VEGFA
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.7483203146014537,1.4633353288604782,0.018867924528301886,0.8967281060863306,1.0,4/27,2.54%,LGALS9;IRGM;CCL5;HIF1A
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.7456693371422498,1.4629103718250986,0.017857142857142856,0.8940560372486901,1.0,4/25,5.33%,ESPL1;FBXO5;DLGAP5;RIOK2
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.7664052859586383,1.4607250920250787,0.03773584905660377,0.9060841830813261,1.0,8/22,15.72%,SOX5;TGFBR1;GDF6;SOX6;WNT9A;LOXL2;GREM1;TRPS1
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.7557905358356811,-1.460394820994262,0.044444444444444446,0.808455249665132,1.0,1/15,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),0.8248330037912822,1.4603310646540257,0.08,0.9032139963856173,1.0,1/12,0.43%,AASS
prerank,GO_Biological_Process_2021__ADP transport (GO:0015866),-0.9366626566643445,-1.46025778934623,0.046511627906976744,0.8014125792547091,1.0,1/5,3.93%,SLC17A9
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.5900920446546176,1.460242390884395,0.0196078431372549,0.8977431567947962,1.0,13/108,6.94%,IGF1;IRS1;HGF;MYC;SIRT1;IL4;PRR16;FGF2;PRMT1;EIF3E;SAMD4A;TLR2;DYRK2
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.9454711344408594,1.4600771964751391,0.0,0.8931053271147583,1.0,1/6,1.94%,SIRT1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.7586173330291817,1.4600448746901213,0.058823529411764705,0.887268037395054,1.0,5/14,19.73%,SOCS2;STAT5A;PXN;PRLR;LYN
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.7639331926572374,-1.4600347228964405,0.08163265306122448,0.7952626830521166,1.0,9/22,9.93%,OR2M4;OR51M1;OR52A1;OR9G4;SLC24A4;DRD2;GNAL;SYT10;OR9Q1
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),-0.8890289258815595,-1.459442083285588,0.020833333333333332,0.7923100169079937,1.0,3/10,3.29%,CYP1A2;CYP2A6;CYP2E1
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.8766849651988989,-1.4592358153899978,0.0,0.7865418109159295,1.0,1/8,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.6969330200557313,1.4584950441147047,0.11320754716981132,0.8951105680634565,1.0,5/22,11.34%,MYC;MRAP2;COQ10A;LEPR;SLC25A13
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.7890380542200837,1.4581864770300306,0.018867924528301886,0.8917403916318395,1.0,6/13,11.92%,IGF1;ERBB4;FGF2;RBPJ;BMPR1A;MEF2C
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.7333037088080951,1.4581054158393545,0.03773584905660377,0.8865184482122228,1.0,4/17,9.33%,NPC2;PLA2G10;SLC29A2;SLC15A2
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.8735169208758509,1.4578247807797793,0.05454545454545454,0.8839008541390558,1.0,1/7,0.48%,IGF1
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.6505135560143017,1.457594562183646,0.04081632653061224,0.8804215741260049,1.0,28/67,19.55%,GSTM2;ANTXR2;STARD4;PPARG;LDLR;SCD;NFIL3;ANXA5;FDFT1;TP53INP1;ACSS2;ALCAM;HMGCS1;ETHE1;MVD;FASN;CBS;PLAUR;PLSCR1;ERRFI1;SC5D;CTNNB1;SQLE;ABCA2;DHCR7;STX5;JAG1;LGMN
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),0.897579101518211,1.4575761143397055,0.02564102564102564,0.8751268384968212,1.0,1/5,0.38%,LGALS9
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.5848105784992499,1.4571272398642123,0.0196078431372549,0.8734328262292017,1.0,20/85,10.31%,VEGFC;IL17RD;EFNA5;ROR1;GNG12;TENM3;CSRP2;ZNF462;FBLIM1;PDLIM4;WWTR1;CNN3;P3H2;ADGRL2;PCDH18;PTPN14;SERTAD4;GPR161;TNC;EFNB2
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.6619328294193314,-1.4569601154714718,0.0,0.7989886042601134,1.0,4/60,2.26%,SLC28A2;UGT2B15;RFX6;CLCA1
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.7339330952301474,1.456700269621613,0.0392156862745098,0.8716001946146548,1.0,9/35,7.44%,F2;RUNX1;CCL5;F2R;RAB27A;WNT4;ZBTB20;PLCG2;HDAC2
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.7949951567074371,1.4566336209565869,0.045454545454545456,0.8667753174125081,1.0,3/12,8.99%,ADRA1A;SLC8A1;MYH11
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.9051475922614224,1.4563003539073878,0.0,0.8642963480359267,1.0,3/8,2.43%,LGALS9;CCL5;IDO1
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.9076587256147558,1.4559834043261852,0.0,0.8616124965231705,1.0,2/6,7.41%,F2R;ABCA1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.8150921612564476,1.4557734644983389,0.0784313725490196,0.8533995769955874,1.0,1/15,0.59%,FHDC1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.8150921612564476,1.4557734644983389,0.0784313725490196,0.8533995769955874,1.0,1/15,0.59%,FHDC1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide metabolic process (GO:0010310),-0.8562673128765026,-1.4554108182752334,0.08888888888888889,0.8042906833484452,1.0,2/5,2.61%,RAC2;NOXA1
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.8145938404519125,-1.4551144546825499,0.08333333333333333,0.7994803693348478,1.0,1/8,2.60%,COL5A1
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.7901585372360114,1.4548521740947624,0.02,0.8566014353793816,1.0,5/14,14.05%,STK26;TNIK;RAPGEF6;RAP1A;ESPN
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.8138028386345825,-1.4544324709416783,0.05714285714285714,0.7975831828042131,1.0,2/21,0.33%,SLC28A2;ALB
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.8637585104275805,-1.454428431562119,0.10416666666666667,0.7907073393839047,1.0,1/8,0.17%,TERT
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.9079163855081451,1.454075042238774,0.044444444444444446,0.8579290521592821,1.0,1/5,1.69%,BOK
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),0.8641662128112344,1.4533582288958034,0.01639344262295082,0.8569593829958816,1.0,1/8,0.70%,TIMELESS
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.7559195543584292,1.452061449813959,0.10204081632653061,0.8627299770160447,1.0,6/20,8.14%,CCL5;MRAP2;KLK14;BICD1;SNCA;ADA
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.836827014511238,1.4519888970037398,0.06349206349206349,0.8579854243947878,1.0,2/7,2.98%,SIRT1;SASH3
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.8773271932653554,-1.4515391315899704,0.04,0.8040012797286125,1.0,3/10,2.36%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.6357143178053601,1.4512674490548483,0.024390243902439025,0.858825763998487,1.0,11/46,12.93%,LAMA4;ALDH1A1;RBPJ;MAP2K6;IL15;NOVA1;ARRDC3;BTN2A2;LNPEP;NR1H3;IL18R1
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.7672830016554173,1.4511016050119354,0.05263157894736842,0.8550501579356306,1.0,1/16,0.40%,CSTA
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.9040864946467596,1.451033977194983,0.02040816326530612,0.8504315448370412,1.0,1/8,2.20%,SHMT2
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.6475837202630402,1.4507790400982958,0.05,0.8477018401303313,1.0,10/41,12.93%,LAMA4;ALDH1A1;RBPJ;MAP2K6;IL15;NOVA1;ARRDC3;LNPEP;NR1H3;IL18R1
prerank,GO_Biological_Process_2021__exocrine system development (GO:0035272),0.9264110197993711,1.4507304190076187,0.03508771929824561,0.8431044354084876,1.0,1/5,0.53%,FGF10
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.8716087400384659,1.4502448090357425,0.03636363636363636,0.842770653577996,1.0,1/7,0.64%,DRD5
prerank,GO_Biological_Process_2021__positive regulation of neuroinflammatory response (GO:0150078),-0.8910229014061093,-1.4501849345982403,0.061224489795918366,0.8078610779598085,1.0,2/6,1.23%,TAFA3;NUPR1
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.7810749589459822,1.4501482204308225,0.01639344262295082,0.8389024725822952,1.0,6/13,14.59%,ABHD3;CYP4Z1;ACADM;GLYATL2;OXSM;OLAH
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.6519025702783597,1.448549437159048,0.047619047619047616,0.8470687362854854,1.0,13/45,17.57%,CSTA;F2;TM4SF20;HDAC2;RNF139;SPOP;SPOPL;DNAJC1;KNG1;PLAUR;ASPH;FADD;PERP
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.8355031270839202,-1.4477818004262268,0.06,0.8185166453507365,1.0,3/12,8.60%,TAFA3;SPACA3;TTBK1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.8547708809812382,1.4474792382340844,0.04,0.8493604723624353,1.0,2/11,1.13%,IGF1;IRS1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.6742696461385057,1.4472035926998132,0.08163265306122448,0.8473662656003239,1.0,11/32,25.08%,MYC;ACD;PARM1;GREM1;NEK7;CTNNB1;POT1;MAPK3;MAPK15;NAF1;HMBOX1
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.8301265882092965,-1.446791174610568,0.1111111111111111,0.8189031430625847,1.0,2/7,0.56%,SELP;SELE
prerank,GO_Biological_Process_2021__membrane depolarization during AV node cell action potential (GO:0086045),-0.9325717145170529,-1.446500263871363,0.05555555555555555,0.8138514241498198,1.0,2/5,4.62%,SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.8218137181993551,-1.4464038890865756,0.06666666666666667,0.8078058278644892,1.0,4/11,4.93%,DRD4;NMUR2;ABCC4;DRD2
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.7842509525601665,1.44630148927549,0.043478260869565216,0.8499842838036893,1.0,4/16,11.92%,IGF1;SIX4;ADGRB3;MEF2C
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.7593558229556877,1.4462717131793321,0.04918032786885246,0.8453395609413741,1.0,5/19,12.91%,RNF185;AUP1;KLHL15;RNF5;POMT2
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),0.835591669261285,1.4462316575591756,0.1,0.8410247344078942,1.0,3/9,7.98%,TMEM100;F2R;SPX
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.8763273778877748,-1.4461460714216023,0.06521739130434782,0.8029278856158524,1.0,3/8,3.86%,SIGIRR;AHSG;IL6R
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.7038365061439258,-1.4461017372817362,0.03508771929824561,0.7968462728527145,1.0,8/36,16.44%,NARS1;WARS1;SARS1;DARS2;SARS2;CARS1;PPA1;GARS1
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.6706340355096274,1.4459990223686587,0.043478260869565216,0.838771328816197,1.0,8/30,11.01%,MAFB;SCGN;LMO2;ELP4;PAX6;DPP4;FOXO1;GCK
prerank,GO_Biological_Process_2021__negative regulation of ruffle assembly (GO:1900028),0.8717189817007547,1.4454030159237614,0.04411764705882353,0.8394444142910844,1.0,3/6,9.16%,ARHGAP24;ABI3;KANK1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.7715105123063742,1.4448856976798308,0.0,0.83928551790879,1.0,8/25,15.78%,GATA4;SIRT1;HTRA2;PYCR1;FBXO7;HSPB1;GPR37;NFE2L2
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.669620158887003,1.4435289879950894,0.1016949152542373,0.8454180141048436,1.0,10/25,21.43%,SIRT1;KAT2B;AANAT;FOXO1;ESCO1;KAT6A;NAA16;GTF2B;NAA11;NAA50
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.8915033128879033,1.4432684115588632,0.03773584905660377,0.8426450179581606,1.0,4/7,5.20%,IGF1;SIRT1;CDKN2A;DIPK2A
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.822912049092709,-1.4421714133103822,0.1276595744680851,0.8172008650302561,1.0,3/7,6.12%,RAC2;NOXA1;JCHAIN
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.7325310748421672,1.4418182739058452,0.06521739130434782,0.8486952799834695,1.0,2/12,3.79%,GATA4;BMP2
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.6060088672817827,-1.4416891132991836,0.0,0.8137370709920074,1.0,15/70,10.63%,ANXA8;CLDN4;TMEM184A;C6ORF132;PTGES;PHLDA2;CYP24A1;IER3;LAMB3;MALL;ABCC3;ADAM19;VDR;PARP1;SERPINB5
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.6559069000192428,1.4412692253538302,0.057692307692307696,0.8484239849108166,1.0,10/50,9.98%,LGALS9;SYK;F2R;SSC5D;CD244;RELA;TLR2;F3;HMGB1;C5AR2
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.8272649123100955,-1.440948472999838,0.058823529411764705,0.8135410370071865,1.0,4/10,8.80%,CGA;DUOX1;TG;CPQ
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.5737854352330007,1.4402491662134242,0.037037037037037035,0.8514356752819842,1.0,26/123,16.17%,IRGM;RIT2;CDK11A;URI1;SOCS2;CD22;NEDD4;GFAP;MLLT3;ZFYVE16;NRG3;CHPT1;ABL2;LATS1;HIP1;PAK5;SNCAIP;BCAR1;HSPA8;PICALM;STON2;RAP1A;RAB33B;HCFC1;SGK1;BAP1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.666014783860076,-1.4396444827033197,0.018518518518518517,0.8166436221212827,1.0,1/38,0.17%,TERT
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.5825883792999121,-1.4395693981564475,0.06818181818181818,0.8106924181652562,1.0,4/116,1.08%,CYP1A2;ACOT1;AMACR;LDHC
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.8314720500313584,1.4394836112560518,0.06521739130434782,0.8527512769323015,1.0,3/14,3.24%,CTDNEP1;C3;LDLR
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.708631837535727,1.4390044369338264,0.0392156862745098,0.8514694913588242,1.0,5/21,6.19%,GATA4;C3;HIF1A;RORA;HPSE
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.811885364669024,1.4388819303552052,0.06896551724137931,0.8480916634309792,1.0,1/10,0.53%,FGF10
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.6723108477806772,-1.4379570519337963,0.061224489795918366,0.8168538593863323,1.0,8/57,2.28%,MS4A8;EHF;CAPN8;CLDN4;PGC;TMEM184A;GPR39;FAM3D
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.7604634347323744,1.4376888769867007,0.03773584905660377,0.8528141346274909,1.0,3/15,5.23%,IGF1;CCL5;CCN4
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.8260209908101488,1.437094113713444,0.08,0.853117381397728,1.0,2/11,7.89%,MT4;SNCA
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),-0.9715736733197538,-1.4368032180221457,0.0,0.8173787792484901,1.0,1/5,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.6298725156122167,1.4367858300451721,0.09090909090909091,0.851405247086683,1.0,6/34,6.54%,NEDD4;EHD1;PRR5L;MLC1;TENM1;PCM1
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.8363805727848236,1.4365423534152408,0.05454545454545454,0.8496457328707475,1.0,3/11,6.66%,F2;LDLR;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.9024127531164535,1.4362935417372336,0.0,0.8433017191105605,1.0,1/7,1.92%,NDC80
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.9024127531164535,1.4362935417372336,0.0,0.8433017191105605,1.0,1/7,1.92%,NDC80
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.6462840683684037,1.4354723361528092,0.07407407407407407,0.8463169297860802,1.0,13/43,25.08%,MYC;ACD;PARM1;GREM1;TERF1;NEK7;CTNNB1;TP53;POT1;MAPK3;MAPK15;NAF1;HMBOX1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.5906156354182496,1.4352980655956638,0.0,0.843794061225937,1.0,14/81,13.04%,LGALS9;IGF1;SYK;FZD5;IL4;MAPKAPK2;TLR2;PLCG2;VSIR;HMGB1;C5AR2;HLA-E;CD34;HSPB1
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),0.9014494492381118,1.4348114851897347,0.05660377358490566,0.8436900886733456,1.0,2/7,2.43%,CCL5;IDO1
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.8572168425802349,1.4343893698045749,0.018867924528301886,0.8433363427857499,1.0,2/7,7.89%,ACE2;SNCA
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.782925300322284,1.4343865040065387,0.10869565217391304,0.8393048696154076,1.0,1/10,0.93%,F2
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.8942021538519325,1.4343047864959004,0.0,0.8358090771402483,1.0,1/8,2.09%,SAMD9
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.6096161022169408,1.4341521131974706,0.05555555555555555,0.8329030318391648,1.0,23/95,9.35%,VEGFC;GATA4;FLT1;SEMA5A;RUNX1;ITGAX;ITGB8;SIRT1;RAPGEF3;HIF1A;FGF2;PIK3R6;RRAS;SP1;APELA;GAB1;F3;ANXA3;BMPER;CD40;AGGF1;SMAD1;TMIGD2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.8227632786754464,-1.433185637414315,0.06,0.8395791388078396,1.0,3/12,3.41%,SELP;SELE;ALOX5
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.8741679342881237,-1.4331177949977134,0.07017543859649122,0.8339463926999187,1.0,2/6,9.92%,DBH;LRTOMT
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.8351350974315341,-1.4328356585084199,0.04878048780487805,0.829739634700291,1.0,2/10,1.92%,DDX11;KDM4D
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.6432957496676038,1.432580224756986,0.0392156862745098,0.8413402406745972,1.0,14/32,26.29%,RAB31;RAB34;GGA1;GOLPH3L;GORASP2;MACF1;BLZF1;AFDN;VAMP4;GCC2;GOLGA4;RILPL2;ARFRP1;SPTBN1
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.6343390394016509,1.431682137509456,0.08888888888888889,0.8439439058480002,1.0,18/47,18.76%,SLC12A7;GABRR1;SLC12A1;GABRR2;SLC1A3;SLC12A3;GLRA1;GABRG3;GABRA5;GLRB;GABRG1;GABRB2;ANO5;ANO6;SLC12A9;GABRE;GABRA4;GABRB1
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.6450319511778362,-1.4311071129886535,0.04081632653061224,0.8367066948403259,1.0,6/38,7.59%,H1-3;H1-4;H1-2;ERN2;INCENP;NCAPD3
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.6573697623573234,1.4305595585439226,0.057692307692307696,0.8477411732183631,1.0,9/33,16.69%,LRRC4C;NLGN1;NRG3;CEL;GRIK2;NLGN4X;GRIK3;PXK;GRID2
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.7302989919876668,1.4302920578902214,0.0851063829787234,0.8456218231586224,1.0,3/16,6.56%,SLC1A3;SLC26A6;ABCC2
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.8456281249451041,-1.429760325311248,0.041666666666666664,0.8286013121184356,1.0,3/9,2.36%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.8456281249451041,-1.429760325311248,0.041666666666666664,0.8286013121184356,1.0,3/9,2.36%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.8456281249451041,-1.429760325311248,0.041666666666666664,0.8286013121184356,1.0,3/9,2.36%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.7936353051315513,1.4292236131242286,0.041666666666666664,0.8499186368914553,1.0,3/13,9.73%,STK26;TNIK;RAPGEF6
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.6352865363531283,1.428937643358867,0.08163265306122448,0.8493104222467995,1.0,9/54,6.66%,GATA4;IGF1;FGF10;TGFBR1;FGF2;NRG1;HPSE;MYOF;PDGFRA
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.6649599902089975,1.4286752158189093,0.0425531914893617,0.8471535648915034,1.0,9/31,10.67%,CFH;F2;C3;C6;CD59;C9;CPN1;C5AR2;C3AR1
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.8609725377055933,-1.428356768478263,0.08695652173913043,0.833137332808678,1.0,1/10,0.60%,HK2
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.8208874446515056,1.4283163774492287,0.058823529411764705,0.8461472549386178,1.0,1/11,0.61%,VAPB
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.870491857156117,1.426528723980931,0.018867924528301886,0.8561077353706666,1.0,4/8,9.95%,LGALS9;ST18;HTRA2;GSN
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.5795164302496544,-1.4265223259914444,0.0,0.8406684736836764,1.0,9/167,2.87%,CD44;SELP;HK2;AMACR;SELL;IRF4;CD86;SPRY4;ETV4
prerank,GO_Biological_Process_2021__omega-hydroxylase P450 pathway (GO:0097267),-0.9227425111479408,-1.4261368058961663,0.020833333333333332,0.8376042086439655,1.0,1/6,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.7352992894234173,-1.4260400605133805,0.1,0.8320530406092556,1.0,2/11,7.24%,ADSS1;LHPP
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.75420235344833,1.4259181774333354,0.03773584905660377,0.8573099919216659,1.0,4/25,2.81%,DACH1;HGF;MYC;FGF2
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),-0.8950912879398261,-1.4257528525257408,0.020833333333333332,0.8287060604104173,1.0,1/7,0.12%,ANXA8
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.8331168012582434,1.4256363679929374,0.08695652173913043,0.8550973126031324,1.0,3/10,7.89%,FGFR3;FGFR1;SNCA
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.7234418502616189,-1.4253317373280612,0.09090909090909091,0.8202456715574884,1.0,3/22,9.57%,HK2;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.7234418502616189,-1.4253317373280612,0.09090909090909091,0.8202456715574884,1.0,3/22,9.57%,HK2;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.8112381626564594,1.4246160267854209,0.10909090909090909,0.8595064498037017,1.0,5/9,17.62%,POGLUT2;GALNT3;GALNT1;POGLUT3;GALNT16
prerank,GO_Biological_Process_2021__positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),-0.8944541819506758,-1.4242128303516763,0.022222222222222223,0.8221124539986705,1.0,1/5,6.91%,PRKD2
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.6750793199397657,1.424175640511113,0.04081632653061224,0.8589322738888904,1.0,10/40,14.30%,SEMA5A;ERBB4;NRTN;NRG1;CDH2;SEMA6C;CORO1C;PHACTR4;SEMA3E;SEMA6D
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.7229612592245248,-1.4233742218592655,0.06896551724137931,0.8222148694862531,1.0,3/23,9.57%,HK2;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.7837263467168453,-1.422683048175201,0.06382978723404255,0.8204022264759219,1.0,3/10,8.13%,RAC2;BST1;OLFM4
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.7941422023218654,1.4225000807771628,0.09259259259259259,0.8696529535705082,1.0,3/10,9.81%,LGALS9;SCRIB;BTN2A2
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.8834978792297007,1.4220146270823433,0.08333333333333333,0.869326608133451,1.0,3/6,8.07%,NOX5;SLC39A8;CYBRD1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.9102256679754853,1.421265682721604,0.0,0.8708393007371205,1.0,3/6,6.82%,LGALS9;ZBTB7B;VSIR
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.6819505546352893,1.4209036813329583,0.03571428571428571,0.8700535925718204,1.0,16/29,26.67%,THRSP;PPARG;PRKAB2;SPX;ABCD3;ABCD2;ACACA;ACACB;ABCD4;MID1IP1;ACSL1;APOE;CPT2;SLC27A1;SLC27A6;CD36
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.6090325815616155,1.4208533366685978,0.05454545454545454,0.8664312823338082,1.0,24/53,27.98%,FAIM;RELA;TIFA;TLR2;TICAM1;TAB2;ZNF675;TANK;TAB3;BCL3;BIRC3;ERC1;TICAM2;RIPK2;IKBKB;IRAK1BP1;TAB1;TBKBP1;BCL10;REL;TRAF6;CHUK;NFKBIA;TRADD
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.8720860598864559,1.4201181844165638,0.08620689655172414,0.8676536352877519,1.0,1/6,1.34%,UHRF2
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.6116964444523549,1.4199773362765677,0.03508771929824561,0.8650883260684896,1.0,17/49,22.25%,REP15;SYK;NEDD4;RAB31;SNCA;RAMP3;PICALM;DNM3;CALCRL;CD81;ARRB2;SMURF1;MVB12A;LGMN;ITGB2;GRB2;MX2
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.8507366776831651,-1.4196554410221829,0.07692307692307693,0.8367405994675916,1.0,3/6,12.94%,APIP;BHMT2;BHMT
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.616550423050893,1.4189363385263885,0.05405405405405406,0.8691121713155379,1.0,20/83,7.90%,VEGFC;GATA4;FLT1;SEMA5A;RUNX1;ITGAX;ITGB8;SIRT1;RAPGEF3;HIF1A;FGF2;PIK3R6;RRAS;SP1;APELA;GAB1;F3;ANXA3;CD40;AGGF1
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.7870755532877952,1.4188376141132997,0.034482758620689655,0.8662834174612077,1.0,3/11,3.79%,TGFBR1;GDF6;BMP2
prerank,GO_Biological_Process_2021__prostaglandin transport (GO:0015732),-0.9121089527629189,-1.4186889707937635,0.021739130434782608,0.8373874529459836,1.0,2/5,4.05%,SLCO2A1;ABCC4
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.5500551557132143,-1.4186086526112875,0.0,0.8323080238207178,1.0,6/164,4.91%,CD44;ASS1;PTGES;TST;FOS;OLFM1
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.8687304363640465,1.4184848512074075,0.10909090909090909,0.8655934798671759,1.0,1/6,0.92%,SMYD1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.80346602872181,1.4184326435951644,0.09803921568627451,0.8623056758917232,1.0,3/14,10.39%,MT4;SNCA;LOXL2
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.8117462637475749,1.4183457303756524,0.04878048780487805,0.8590460934096221,1.0,5/15,7.05%,F2;F2R;F12;HPSE;F3
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.7820231424559064,1.4179831050816818,0.038461538461538464,0.858286076317484,1.0,5/19,6.46%,RGPD4;CBLB;RGPD3;RGPD2;RGPD5
prerank,GO_Biological_Process_2021__plasminogen activation (GO:0031639),0.8803037374798544,1.4178961657965805,0.06666666666666667,0.8555635772047271,1.0,1/6,2.49%,KLKB1
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.6597382263486099,1.4172703342470523,0.05172413793103448,0.8570032098507245,1.0,4/31,7.07%,SMOC1;C3;PBX3;PAX6
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.8217533571582827,-1.4171395072495383,0.0625,0.836610731777182,1.0,1/16,0.17%,TERT
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.8292242550576913,1.4171260541540478,0.05263157894736842,0.8541464037995983,1.0,2/12,2.87%,IRS1;PPARG
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.891620523531963,1.4169103435080022,0.01818181818181818,0.8520156520263742,1.0,1/7,0.19%,TEX101
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.8285601350936339,1.4168257792859709,0.058823529411764705,0.8488809545599967,1.0,1/10,1.43%,CD99
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.855562075396134,1.416781009826207,0.0784313725490196,0.8456117187013149,1.0,1/6,2.55%,STAT5A
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.6216615581185877,1.416506805545385,0.06,0.8443428755830578,1.0,8/49,12.35%,LRRC4C;LRP4;CDH2;ROBO2;CHODL;PLXNB1;PLXNB2;PTEN
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.578373579259,-1.416230316886251,0.04081632653061224,0.8373810910165046,1.0,9/99,4.67%,CD44;TNFSF18;IL11;ENPP2;IL31RA;TEC;ANGPT4;IL6R;CRLF1
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.7422597452323874,1.4161892233960356,0.13333333333333333,0.8440405173439385,1.0,8/14,16.70%,CDH2;SLC8A1;PIK3CA;GSN;NPPA;DMD;RYR2;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.786986367355198,1.4160513014706055,0.08888888888888889,0.8419423037420172,1.0,2/12,1.67%,LGALS9;SYK
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.7983136793723438,1.415839864827562,0.11538461538461539,0.8369054295863046,1.0,3/10,3.91%,SLC12A7;SLC12A1;SLC12A3
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.7983136793723438,1.415839864827562,0.11538461538461539,0.8369054295863046,1.0,3/10,3.91%,SLC12A7;SLC12A1;SLC12A3
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.7722758873476672,-1.4153570426005864,0.14285714285714285,0.8377377808198975,1.0,5/12,9.92%,DRD4;DRD2;PAH;DBH;LRTOMT
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.760336340686186,1.414807698762943,0.12698412698412698,0.8385066488647088,1.0,5/12,22.25%,STAT5A;IL15;PLCB1;IL2RB;GRB2
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.760336340686186,1.414807698762943,0.12698412698412698,0.8385066488647088,1.0,5/12,22.25%,STAT5A;IL15;PLCB1;IL2RB;GRB2
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.828139283637751,1.4146652928887564,0.06779661016949153,0.8363693997672161,1.0,2/8,7.89%,DRD5;SNCA
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.618003772009409,1.414661360053018,0.021739130434782608,0.8330104865151389,1.0,18/55,12.83%,SLC26A3;CD99;TMPRSS2;ACE2;HNF4G;GOLT1A;EFNA2;FLI1;PPP1R14D;APOBEC1;AGR2;MOGAT2;DSP;MUC13;CGN;ARHGEF16;HSD11B2;BCO1
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.6589090519631574,1.414432992201029,0.03773584905660377,0.8309637315386055,1.0,2/25,2.60%,DACH1;ACD
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.5807269084550194,-1.4144256952992786,0.058823529411764705,0.8392036677473913,1.0,6/118,2.64%,CD44;SELP;MPL;TEK;HMGB3;TIE1
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.6609477316625518,1.414195851771856,0.06382978723404255,0.828830872062321,1.0,17/60,16.62%,FGFR1;BRINP3;BMP2;NLGN1;ZEB1;MOSMO;ZC4H2;ADRA2C;NEUROD2;BIN1;VWC2;TCF4;CPNE1;MEF2C;NREP;GPRC5B;CNTN4
prerank,GO_Biological_Process_2021__AV node cell to bundle of His cell communication (GO:0086067),-0.867895429514531,-1.4137784867577141,0.022727272727272728,0.8398538567117096,1.0,2/5,4.62%,SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.701680436500776,1.4134309890330015,0.02040816326530612,0.8306932092335906,1.0,8/21,15.26%,TMTC2;DPY19L1;DPY19L3;POMT2;FKRP;CRPPA;SDF2L1;TMTC3
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.849776323427964,1.4133548293379576,0.04,0.828019459143115,1.0,4/9,10.39%,SOX5;GDF6;SOX6;LOXL2
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.8238606135781555,1.4127243560429472,0.038461538461538464,0.8294149101384761,1.0,4/10,6.92%,SULT2A1;ALDH1A1;ALDH1B1;ACSS2
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.8239141088715132,1.4125186231883593,0.043478260869565216,0.8278256151965367,1.0,4/18,6.82%,TNFRSF18;RUNX1;IL2RA;VSIR
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.7663063522758543,1.4122338908288636,0.10869565217391304,0.8272026605440269,1.0,6/18,12.19%,F2;C3;MRAP2;KLK14;KLK5;PDE6H
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.8812516831277772,1.4118495655493555,0.11764705882352941,0.8262344756247394,1.0,1/6,0.15%,STK26
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),0.8793296128453499,1.4116449936071924,0.05454545454545454,0.8244269015000992,1.0,2/6,10.05%,MME;HYAL3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.6694200763625264,1.41131078606982,0.0784313725490196,0.8233776601695839,1.0,7/34,12.35%,IGF1;PRKG1;FGF2;PPARG;BMPR1A;MEF2C;PTEN
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.8964828918282616,1.4111711459363139,0.0392156862745098,0.8212983735277622,1.0,1/5,3.25%,TOX
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),-0.7671492258075729,-1.4111009982204594,0.10869565217391304,0.8529865933118754,1.0,8/17,9.93%,OR2M4;OR51M1;OR52A1;OR9G4;SLC24A4;DRD2;SYT10;OR9Q1
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.5837415321527472,1.4110870806111315,0.02127659574468085,0.8187918177136271,1.0,23/61,15.60%,SMAD6;VWC2L;PPARG;BMP2;CRIM1;ACVR2A;RBPJ;ELAPOR2;BMPER;UBE2D3;SMAD1;SMAD2;VWC2;BMPR1A;DAND5;SMAD4;GREM1;FBXL15;LRP2;SPART;BAMBI;CRB2;SMAD5
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),0.9285233184633008,1.4109115389458136,0.0,0.8139825005491237,1.0,1/6,1.86%,RAB38
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),0.9285233184633008,1.4109115389458136,0.0,0.8139825005491237,1.0,1/6,1.86%,RAB38
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.8280246329528148,-1.4107407407277552,0.08163265306122448,0.8497823517169303,1.0,1/8,0.17%,TERT
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.8680030161156956,1.4105153431035233,0.07547169811320754,0.8136742849130678,1.0,1/6,0.26%,DACH1
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.7681871742465639,1.4104883743926273,0.07692307692307693,0.8107493200986254,1.0,4/12,7.41%,SYK;PPARG;LDLR;ABCA1
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.8855336623311708,-1.4099270486035467,0.045454545454545456,0.8495281618789167,1.0,2/5,7.19%,COL5A1;SLC11A1
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.8127836473172677,1.4097959080939244,0.08,0.8131131249323533,1.0,3/9,10.99%,TOP2A;HMGB1;TOP1MT
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.5865324306246723,1.4096661377026711,0.05263157894736842,0.8108379668431847,1.0,11/54,11.85%,SMAD6;TMEM100;GDF6;BMP2;ACVR2A;ZFYVE16;SMAD1;SMAD2;BMPR1A;SMAD4;GDF9
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.6136493724625233,1.4088709631180754,0.06,0.8129440082258367,1.0,15/54,15.61%,SULT2A1;IL4;INSIG1;CYP39A1;MSMO1;ABCA1;FDX1;CYP27A1;CYP7B1;SOAT2;FDXR;CH25H;SOAT1;SC5D;CYP4V2
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.7463534929502671,1.4088104164565147,0.1,0.8103519332036492,1.0,4/17,4.48%,IL4;CD22;SAMSN1;ZFP36L2
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),0.9694995430443765,1.408344885439483,0.0,0.8106352520027974,1.0,1/6,0.53%,FGF10
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.6842430210519541,1.4080191668288085,0.05454545454545454,0.8106793420710428,1.0,4/20,6.41%,BOK;IL4;DCC;ITGAV
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.7442118553507113,1.4079131681079962,0.10204081632653061,0.8085967140642011,1.0,3/11,12.66%,SIRT1;ZNF274;MYB
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.8146303938700086,1.4069716060847204,0.07894736842105263,0.8117081553705222,1.0,3/11,5.90%,F2;KLKB1;F12
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.8980285998869802,1.4063033597673498,0.05,0.8132958203525319,1.0,2/7,5.19%,FERMT3;CXCL12
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.849524775228778,1.4062534727449452,0.061224489795918366,0.8105253318377267,1.0,2/11,3.59%,RUNX1;MAFB
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.8563798904732287,1.4054212253732536,0.04081632653061224,0.8129905765942977,1.0,2/7,5.20%,IGF1;DIPK2A
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),0.9354782466760578,1.404921446196555,0.03508771929824561,0.8142780154595516,1.0,1/6,2.90%,PIK3R6
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.7649247888269387,-1.4047371551404528,0.15,0.8779733391879784,1.0,2/8,2.31%,CXCL13;NR4A1
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.7204397139190234,1.4045028855161574,0.02,0.8145390586016884,1.0,4/19,8.33%,DRD5;GRM3;ADGRV1;GNAI3
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.8778927027837935,1.403909944996673,0.05454545454545454,0.8153510420666173,1.0,1/6,3.01%,PADI2
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.7574739988230832,1.4031716424881928,0.08,0.8183146716342173,1.0,3/15,8.93%,CGNL1;SCRIB;DSP
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.847145696443211,1.4026357493264334,0.034482758620689655,0.819198919011702,1.0,1/10,0.97%,SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),0.8760033334180732,1.4025645537386409,0.057692307692307696,0.8169776215876502,1.0,2/7,2.47%,SYK;IL4
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),-0.818875767549893,-1.4025506754101378,0.10344827586206896,0.8874519753467326,1.0,1/8,0.17%,TERT
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.7491967393281814,1.401900872202789,0.07407407407407407,0.8191774229455392,1.0,4/17,9.37%,MYC;MRAP2;PHKA1;LEPR
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.79069396405713,-1.4015940791455688,0.0784313725490196,0.8881191834064834,1.0,2/8,7.78%,EGR1;CLU
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.6794396209399566,1.4015707949929632,0.11627906976744186,0.8183295416544886,1.0,8/22,14.96%,ACVR2A;RBPJ;ELAPOR2;SMAD2;BMPR1A;SMAD4;FBXL15;CRB2
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.8761339888501429,1.4015015412680814,0.031746031746031744,0.813011418381581,1.0,1/7,4.22%,THOC6
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.8761339888501429,1.4015015412680814,0.031746031746031744,0.813011418381581,1.0,1/7,4.22%,THOC6
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.8195865679383968,1.4014992956796912,0.10638297872340426,0.810223409501141,1.0,3/8,10.30%,IL4;NFKBIZ;NFKBID
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),0.8564278875291763,1.401099861896059,0.0847457627118644,0.8074626373263831,1.0,1/6,2.55%,STAT5A
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),0.8564278875291763,1.401099861896059,0.0847457627118644,0.8074626373263831,1.0,1/6,2.55%,STAT5A
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.5941550997477288,1.4005456471644353,0.06521739130434782,0.8091546276777484,1.0,14/66,15.75%,GSTM2;GSTT2;MME;PCSK5;TRHDE;NAALADL1;HPGDS;CPN1;LNPEP;ETHE1;BACE2;ANPEP;DMD;CPE
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.7937433414093853,1.400513183388524,0.09615384615384616,0.8066390352052186,1.0,3/9,7.57%,BOK;PPP1R15B;AGR2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.7280726687711416,-1.4004805987094193,0.08333333333333333,0.8905146282075838,1.0,8/14,16.85%,MYH7;DSG2;ADAMTS9;HOPX;TGFB1;ID2;TGFBR3;FGFR2
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.6624673699464277,1.4004063427369104,0.06,0.8046688729425805,1.0,8/33,14.30%,SEMA5A;ERBB4;NRTN;SEMA6C;CORO1C;PHACTR4;SEMA3E;SEMA6D
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.5437979586517232,1.4003555043958833,0.05555555555555555,0.8022296279423221,1.0,38/124,16.18%,MXRA5;LAMA4;MRGPRF;SEMA5A;COL9A1;PRRX1;PBX3;ADGRL4;PRG4;BMP2;BGN;COL6A2;CHODL;IL10RA;CXCL12;LTBP2;SOX6;EFS;POSTN;CCDC80;PDGFRA;PCDH18;MATN1;MEDAG;TNC;TCF4;HMCN1;HAS2;HTRA1;CREB3L2;COL11A1;CRTAC1;OLFML3;FRZB;FBN1;GAS1;PDZRN3;HAPLN1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.8193330012959019,-1.399985408639644,0.1276595744680851,0.8886292691685342,1.0,1/5,2.15%,FGF1
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.8278939625100751,1.3998594455968216,0.13559322033898305,0.8033917904421068,1.0,1/5,4.27%,FYCO1
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.5676702193112698,1.3998368155683694,0.03636363636363636,0.8009298427394952,1.0,24/92,17.87%,FZD5;CDH20;CDH7;CDH6;CDH2;NLGN1;FBLIM1;CDH12;SDK1;NRXN1;ACHE;DSCAM;GPM6A;PTEN;CDHR3;CDH10;CDH8;DNM3;RAB29;CDH24;PKP4;GJC1;FLRT3;FARP1
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.7013781924634205,1.3998182233953798,0.019230769230769232,0.7982674205332646,1.0,8/29,13.14%,ERBB4;NRG1;GAB1;NRG2;ERBIN;PIK3CA;SOS1;CPNE3
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.8988213951998202,1.3995058864593886,0.08,0.7977001585620019,1.0,1/6,0.32%,MITF
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.8832350262382159,1.3992856135529763,0.05263157894736842,0.7967916602363109,1.0,2/6,3.09%,FGF2;ANGPT1
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.7393908011018709,1.3991674731809036,0.1568627450980392,0.7946426394206149,1.0,3/15,6.02%,PPARG;ADIPOR2;PRKAB2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.6982681452374702,1.399111710663052,0.05357142857142857,0.7924651025113729,1.0,6/30,12.47%,LGALS9;IGF1;IL4;VSIR;C5AR2;CD34
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.6511755255277307,1.3988467599953538,0.041666666666666664,0.7914122489439762,1.0,1/28,0.09%,GATA4
prerank,PanglaoDB_Augmented_2021__Basophils,-0.5738549707717062,-1.3987734392723825,0.06666666666666667,0.8923311596259476,1.0,6/99,3.71%,CD44;H1-3;RNF39;CD86;LILRB3;TEC
prerank,GO_Biological_Process_2021__meiotic sister chromatid segregation (GO:0045144),0.9304713301578287,1.3979515613204032,0.0196078431372549,0.794707403376753,1.0,1/5,0.05%,SGO1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.8500791522717794,1.3979314656103958,0.057692307692307696,0.7922542815134009,1.0,3/7,7.69%,ADRA1A;ADGRV1;CD40
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.8196044108943012,-1.3977863637012262,0.14583333333333334,0.8926615413657021,1.0,2/7,4.34%,PM20D1;TST
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.8533453362646616,1.3972493465687843,0.034482758620689655,0.7939183787427064,1.0,1/11,0.64%,DRD5
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.5559443555212145,1.3972476788074886,0.037037037037037035,0.7913153676648615,1.0,31/127,16.03%,LRRC3B;NXPH1;RIT2;NGB;GRM3;KCNC2;CDH20;GFAP;CADM2;SLC17A6;NRXN1;RAB3C;OLFM3;SYNPR;GRM5;LRRTM3;ADGRB3;CTNNA2;PAK5;TMEM196;EMX1;KCND2;KCNB2;NR4A2;GABRG1;GRIN2D;SEZ6L;FEZF2;GRM1;CNTN2;CALB1
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.9179909870041691,1.396674651052104,0.0625,0.7934336880511537,1.0,1/6,0.40%,PNP
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.6562973780497803,-1.3962894228034752,0.09090909090909091,0.897121189270481,1.0,2/42,1.76%,TERT;TERF2IP
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.743155257534558,1.3962835745033455,0.07575757575757576,0.7935286391014669,1.0,4/16,8.00%,C3;SIRT1;ITGAV;PLA2G10
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.7906709918693002,-1.3962408608397605,0.1346153846153846,0.892077885836226,1.0,4/12,14.29%,KCNE2;KCNE1;KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.6351955540350714,1.396026320533479,0.043478260869565216,0.7924962609833613,1.0,8/30,13.34%,DERL3;OSTC;UBE2J1;MGAT2;MAGT1;LMAN1;FUT8;MGAT5
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.7744259820817208,1.3959611694723038,0.08620689655172414,0.7901811184499902,1.0,1/9,0.09%,GATA4
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.7025143693026398,1.3958208336407734,0.08620689655172414,0.7882540601499225,1.0,2/21,1.66%,LGALS9;TMPRSS2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.7777966816384394,-1.3952781256261648,0.11363636363636363,0.8941191728513219,1.0,2/15,1.76%,TERT;TERF2IP
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),0.8198911944021198,1.3949106288238031,0.07547169811320754,0.7924558726906914,1.0,7/10,16.53%,NPC1L1;LDLR;CEL;ABCG8;SOAT2;ABCG5;AKR1C1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.5647224217596444,1.394488670376913,0.05454545454545454,0.7925936312083255,1.0,16/104,9.33%,SLC5A8;SLC26A3;SLC12A7;SLC12A1;SLC1A3;SLC26A7;SLC26A6;SLC12A3;SLC17A6;GLRA1;SLC5A12;SLC8A1;SLC24A2;SLC15A1;SLC9A2;SLC15A2
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.9005216288105311,-1.3944169581080954,0.047619047619047616,0.894471753699268,1.0,1/9,0.17%,TERT
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.8007561854278048,1.3943833022878833,0.05263157894736842,0.7910469067402046,1.0,6/11,15.72%,GREM2;BMP2;LTBP1;DAND5;GREM1;FBN1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.8863435564489004,1.3942259087870374,0.05263157894736842,0.7897556302565039,1.0,4/6,10.28%,ADRA1A;ZDHHC12;NLGN1;HAP1
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.8467477699794042,-1.3936518765176515,0.06521739130434782,0.8938515480240052,1.0,2/7,1.92%,DDX11;KDM4D
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.8635642899154021,1.3927299184286288,0.018867924528301886,0.7966331045411248,1.0,5/8,12.14%,EFS;CASS4;MCU;GSN;BCAR1
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),0.8014074036931341,1.392610394851262,0.05172413793103448,0.7948849128312164,1.0,3/11,7.26%,RPP25;RPP25L;RPP40
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell apoptotic process (GO:0034392),0.8613016723338308,1.392331814840746,0.05357142857142857,0.7940802933181885,1.0,2/5,5.20%,IGF1;DIPK2A
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.7775713135092176,-1.392097443931593,0.0625,0.8997386704498277,1.0,2/14,1.88%,SELP;CXCL13
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),0.8564425998301552,1.3911760772055364,0.019230769230769232,0.7997475869821079,1.0,4/8,5.02%,SNAI1;WNT4;BMP2;DKKL1
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.6122601865818424,1.3909694159506754,0.06,0.7986104395923184,1.0,3/46,2.01%,LGALS9;MYC;IL26
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.5647248796165794,1.3909242114409741,0.09090909090909091,0.7963156080575808,1.0,18/96,10.79%,LGALS9;SYK;BOK;MYC;SIRT1;F2R;EGLN3;PPARG;ST18;F3;HTRA2;HMGB1;SNCA;DLC1;HIP1;GSN;TNFRSF10B;CASP10
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.6278446700830455,1.3908853354003419,0.10526315789473684,0.794155194816162,1.0,13/67,10.54%,ADRA1A;TSHZ3;ZDHHC12;CLSTN2;NLGN1;LGI1;SYT1;NRXN1;SLC24A2;GRIK2;RIMS2;HAP1;ZDHHC2
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.747771805260548,1.390873582163323,0.061224489795918366,0.7918086215685524,1.0,3/13,7.05%,VEGFC;CXCL12;F3
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.6769300916453842,1.3908144498996826,0.020833333333333332,0.7898744998486451,1.0,5/31,7.22%,LGALS9;GDF6;BMP2;PRMT1;RELL1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.5434737710995307,1.3901541561718431,0.04,0.7916018974355424,1.0,33/118,17.87%,F2R;FZD5;LRRC4C;LRP4;NEDD4;CDH2;NLGN1;CACNB4;SDK1;PPFIBP1;NRXN1;UNC13B;ZC4H2;SNCA;PTPRD;ACHE;NLGN4X;GPC4;DSCAM;GRM5;GPM6A;PTEN;LRFN5;SEMA3E;PPFIA3;L1CAM;DNM3;CNTN2;RAB29;PDZRN3;FLRT3;GPHN;FARP1
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.8524423731994677,1.3898566470947389,0.14285714285714285,0.7911040165667198,1.0,2/8,11.30%,PEX12;ZFAND6
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),-0.819766456987844,-1.3897634887276034,0.16363636363636364,0.912258964886673,1.0,4/6,13.81%,NLRP3;CD86;IL18;RARA
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.8401550773570001,1.389455288068285,0.1,0.7908063200850569,1.0,2/9,2.84%,SIRT1;KAT2B
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.8982084804532597,1.3891409028658581,0.015873015873015872,0.7900780848459485,1.0,1/5,4.55%,IDH1
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.5718974445033145,1.388437241688347,0.057692307692307696,0.7930377344295035,1.0,8/61,10.06%,MITF;RBM20;PCBP3;HNRNPH1;AFF2;NOVA1;FASTK;METTL18
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.6916872568972398,-1.3880705925322823,0.08163265306122448,0.9172180858002397,1.0,3/21,4.93%,DRD4;RHBDF1;DRD2
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),0.8499598429726749,1.3874141476427237,0.07142857142857142,0.7975420511517933,1.0,1/7,1.82%,CCL5
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.8489216164779216,1.3869470625372708,0.046511627906976744,0.7983579485262043,1.0,3/9,2.04%,HS3ST5;F2;F2R
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.8391671213254054,-1.3867224776756302,0.07317073170731707,0.9211738343627903,1.0,2/9,1.15%,PALM3;SIGIRR
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.7511278202770998,1.3865454734109253,0.09259259259259259,0.7987029509426332,1.0,6/15,16.11%,ITGA8;ITGA2;SNAI1;SMAD2;CRB2;MESP1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.7655724199135566,1.386398217712658,0.09615384615384616,0.7971489153473118,1.0,1/9,1.94%,SIRT1
prerank,GO_Biological_Process_2021__centromeric sister chromatid cohesion (GO:0070601),0.9140285740209477,1.3862857089070584,0.023809523809523808,0.795758602124278,1.0,1/5,0.05%,SGO1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.680983425224867,1.3861384388359703,0.03571428571428571,0.794453577421713,1.0,10/31,22.07%,IRGM;FYCO1;HTRA2;LMAN1;LIG4;SORBS3;ANXA2;STX18;ANXA1;AKT2
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.7292025274081616,1.3860644260905055,0.04081632653061224,0.7925808422832556,1.0,3/18,8.69%,TCIRG1;ATP6V0D2;ATP6V0A4
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.7178270423322854,-1.3858790672876327,0.1,0.9209284538921352,1.0,2/18,0.85%,ACTC1;MYH7
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.6412399119513585,1.3857688844344473,0.075,0.7919050846175074,1.0,13/44,13.04%,SIRT1;FGFR1;HIF1A;STAT5A;FGF2;PPARG;ANGPT1;SP1;CD40;HMGB1;NUS1;MEF2C;HSPB1
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.8159195546849952,1.3856992542099642,0.05660377358490566,0.790127304085791,1.0,5/11,11.28%,SLC22A3;SLC1A3;GLUL;SLC29A2;ATP1A2
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.7446426753505184,-1.3856439601159052,0.10416666666666667,0.9169823788840449,1.0,1/18,0.33%,ALB
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.6383511657924825,1.38495066026107,0.08196721311475409,0.7937217430454844,1.0,10/51,4.72%,FGF10;ITGA8;MME;TGFBR1;LRP4;GDF6;WNT4;PCSK5;ROBO2;KANK2
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.7901629079094629,1.3847985904236244,0.09803921568627451,0.7923661467889402,1.0,5/12,12.76%,AK3;EFL1;GNAI3;RAB23;ENTPD7
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.7472708829454251,1.3846346933267624,0.03636363636363636,0.7909429195121683,1.0,2/12,4.30%,SMAD6;ROBO2
prerank,GO_Biological_Process_2021__alditol phosphate metabolic process (GO:0052646),0.870439197517849,1.384391347488395,0.07407407407407407,0.789904956609315,1.0,1/5,9.78%,ACP6
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),0.9133323976759314,1.3842552603049227,0.03773584905660377,0.7884596672712504,1.0,1/6,0.38%,LGALS9
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.6678531010940358,1.384189050044517,0.10869565217391304,0.786535670273237,1.0,4/29,4.50%,SMAD6;PPARG;RORB;CRIM1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.8176057599455899,1.3838061724280524,0.03636363636363636,0.7869020018955944,1.0,2/10,4.27%,IRGM;FYCO1
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.5138631620168257,1.383380083083186,0.0,0.7876760114988308,1.0,31/168,13.16%,LAMA4;SMAD6;HS3ST5;IL17RD;F2R;IL4;LRP4;ALDH1A1;BMP2;RBPJ;MAP2K6;TNNT1;ELAPOR2;ZNF706;RPS6KA4;IL15;NOVA1;MARVELD3;SPX;CRHBP;ARRDC3;BTN2A2;LNPEP;CORO1C;LOXL2;NR1H3;MEF2C;PTEN;TBX18;IL18R1;KLF7
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.8466437303904722,1.3830979394788636,0.03636363636363636,0.7873682834131387,1.0,3/12,8.14%,PNP;AMPD1;ADA
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.5557551469351041,-1.3818603673069834,0.05263157894736842,0.9368818546319981,1.0,2/137,0.42%,CD44;NTRK1
prerank,GO_Biological_Process_2021__negative regulation of serine-type peptidase activity (GO:1902572),-0.9511626281649355,-1.38163794585881,0.02040816326530612,0.9335843198470177,1.0,1/5,0.12%,ANXA8
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),0.869363549101379,1.3811656090630549,0.057692307692307696,0.7992484792061648,1.0,1/7,0.05%,SGO1
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.7971395604469185,-1.3808715443884658,0.09803921568627451,0.9340417037661564,1.0,1/15,0.42%,NTRK1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.8152622623162605,-1.3805398846223045,0.14285714285714285,0.9311777640651935,1.0,2/7,8.71%,CD24;CDH3
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.5972803401076845,1.3804900630738923,0.08333333333333333,0.801088343937958,1.0,16/79,8.38%,VEGFC;LAMA4;MRGPRF;ITGA8;RSPO3;ADGRL4;GDF6;MSRB3;ACTG2;BGN;COL6A2;CXCL12;POSTN;PDGFRA;BMPER;PCDH18
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.6848706748145672,1.3804106223092363,0.11538461538461539,0.7994558605871757,1.0,11/26,20.59%,TICAM1;CD40;UBE2D3;TANK;IKBKE;BIRC3;FADD;IRF3;UBE2D1;TICAM2;IKBKB
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.7856595746092931,1.3799974179357084,0.08771929824561403,0.7998524423790829,1.0,3/10,11.28%,RNLS;SPX;ATP1A2
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.518082052481377,1.379917316281969,0.05555555555555555,0.7980863105652786,1.0,46/203,15.37%,IGF1;TMEM100;SMYD1;HGF;SOX5;TGFBR1;FGFR1;RIN2;PPARG;GDF6;SNAI1;RRAS;WNT4;BRINP3;FBXO5;BMP2;CDH2;ACVR2A;CCN4;SOX6;ZEB1;WWTR1;ZC4H2;ADRA2C;NEUROD2;PLA2G10;SMAD2;MEDAG;CTNNA2;EZH2;VWC2;LOXL2;TCF4;BMPR1A;CPNE1;SMAD4;MEF2C;CD34;MSR1;RAP1A;CREB1;RPS6KA1;BAMBI;CRB2;PLCB1;FRZB
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.7029095287745482,1.379741945635387,0.05454545454545454,0.7971700317816414,1.0,6/29,12.47%,LGALS9;IGF1;IL4;VSIR;C5AR2;CD34
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.8297224529535964,-1.3796574312208418,0.08333333333333333,0.9317950184032188,1.0,3/10,9.04%,NPTX2;BEGAIN;CACNG5
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.6899638498988973,1.379175266750411,0.06818181818181818,0.7991717760381993,1.0,8/31,13.08%,IGF1;IRS1;NYAP2;PIK3R5;PIK3C2B;PIK3CA;PTEN;IGF1R
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),0.8874748627609998,1.3790648704179855,0.06779661016949153,0.7978219171860625,1.0,1/7,1.11%,SLC12A7
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.678312049771878,1.378893751300439,0.08,0.7968055105732544,1.0,12/27,21.63%,TICAM1;CD40;UBE2D3;TANK;IKBKE;BIRC3;FADD;IRF3;UBE2D1;TICAM2;IKBKB;TNIP3
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.5765487435891967,1.3771184628710065,0.08333333333333333,0.8064092626785223,1.0,14/63,15.10%,DERL3;OSTC;UBE2J1;ALG6;MGAT2;GAL3ST1;SLC39A8;MAGT1;LMAN1;FUT8;ALG9;MGAT5;MGAT4C;MGAT4A
prerank,GO_Biological_Process_2021__granulocyte migration (GO:0097530),-0.8638101909554313,-1.3770527811588789,0.0851063829787234,0.9451853975831408,1.0,2/7,4.85%,UMODL1;UMOD
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.5867884742292935,1.3767296096318993,0.061224489795918366,0.8069586032206862,1.0,13/59,17.54%,IGF1;RAB27A;BMP2;UNC13B;SNCA;PLA2G10;ACHE;RAB9A;MYOM1;RAB27B;GOLPH3L;CD2AP;STXBP5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.7898153173704405,1.3762185292397011,0.09803921568627451,0.8082947159757318,1.0,3/10,3.50%,LGALS9;SIRT1;CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.8013726199966416,1.3761014872573254,0.10714285714285714,0.8066160285081793,1.0,4/12,11.01%,IGF1;IRS1;DYRK2;GCK
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.544747857044857,1.3759059276161623,0.11904761904761904,0.805696417814337,1.0,45/138,20.64%,IRS1;RUNX1;MYC;INSIG1;PPARG;LDLR;ADD3;MMP16;ACVR2A;PDLIM5;PTGFR;ADGRL2;F3;PHF3;AGGF1;DLC1;ATXN1;SPOP;INPP4B;MAGI2;LTBP1;BMPR1A;NR1D2;HAS2;PTEN;IGF1R;COL11A1;PTPRM;DYRK1A;NEK7;PIK3CD;NOTCH2;BCKDHB;TOGARAM1;VAV2;CITED2;RASA2;ADORA2B;KIT;NR3C1;ANXA2;AKT3;ATP2C1;PIK3R3;SFMBT1
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),0.8482938477481348,1.375775427506304,0.08163265306122448,0.8042478491591615,1.0,3/9,10.05%,MME;RELA;HYAL3
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.4799783461066595,-1.3755584765233166,0.0,0.9502934878391536,1.0,20/381,6.36%,CD44;ALB;NTRK1;APIP;MPO;TEK;NUPR1;TNFSF18;HMGN5;PRKCD;IL31RA;PLK3;ANGPT4;BCL2L2;PRAME;CRLF1;SFRP1;NIBAN2;RNF213;PAX2
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.8761427095101479,1.375101319162829,0.0784313725490196,0.8056832020029561,1.0,2/8,2.08%,FGFR3;FGFR1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.5953581600924954,-1.3750158948763707,0.07692307692307693,0.9482984205402589,1.0,16/72,7.72%,EHF;DUOXA1;CAPN8;PGC;ETV5;FAM3D;SFTPA2;RNASE1;CRLF1;NRN1;IFI27;MS4A4A;C2;LAMB3;SFTPA1;ADGRF5
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.7483660645587797,-1.3744107559453451,0.06818181818181818,0.9421224679112891,1.0,5/26,5.91%,ACTC1;MYH7;TMOD1;ACTN3;NEB
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.7483660645587797,-1.3744107559453451,0.06818181818181818,0.9421224679112891,1.0,5/26,5.91%,ACTC1;MYH7;TMOD1;ACTN3;NEB
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.7111361792685081,-1.3742575075039132,0.09803921568627451,0.9378548877558459,1.0,3/19,5.96%,TAFA3;SHCBP1;DLL4
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.724764086809539,1.3742542512010683,0.11627906976744186,0.8091288657749678,1.0,2/11,7.60%,PCBP3;NOVA1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.6877768176884199,1.3739552708373501,0.11764705882352941,0.8093423799046345,1.0,4/15,8.34%,FGF2;ITPKB;IP6K3;CYP27A1
prerank,GO_Biological_Process_2021__cellular response to vitamin D (GO:0071305),-0.8900260966273885,-1.3739470686909037,0.07692307692307693,0.9348370651151858,1.0,3/5,9.52%,CYP24A1;SFRP1;VDR
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7288828579582963,1.3722629594962843,0.14285714285714285,0.8165621790784091,1.0,6/15,15.49%,GSTM2;SLC8A1;ANK2;ATP1A2;DMD;RYR2
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),0.8815531530583779,1.3718751182749083,0.09433962264150944,0.8173512080803623,1.0,1/6,1.76%,MYC
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.7221672866432931,1.3714057033115257,0.11764705882352941,0.8180658943101234,1.0,2/13,2.90%,KAT2B;AANAT
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),0.8641976581597348,1.3713307891362647,0.057692307692307696,0.8164715621367666,1.0,1/5,1.32%,C3
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.7592222193385096,1.3711777549363924,0.07142857142857142,0.8153386824576789,1.0,4/12,7.24%,LGALS9;SYK;IL4;FER
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.7795632370772982,1.3710545143748618,0.08333333333333333,0.8138645515959032,1.0,5/10,11.92%,ERBB4;FGF2;RBPJ;BMPR1A;MEF2C
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.6481209274209131,1.370893153980789,0.045454545454545456,0.8125715867993565,1.0,8/29,13.34%,DERL3;OSTC;UBE2J1;MGAT2;MAGT1;LMAN1;FUT8;MGAT5
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.8062450805218464,-1.370877580525775,0.11320754716981132,0.9500024719964777,1.0,1/8,0.42%,NTRK1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.7251927002536703,1.3706283257059242,0.061224489795918366,0.8120802401011544,1.0,4/15,11.11%,KLRD1;NECTIN2;CADM1;HLA-E
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.7411223268316837,1.370618795196499,0.029850746268656716,0.8100064555676013,1.0,4/18,4.40%,FGF10;GDF6;ROBO2;SIX4
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.8314412668107294,1.369436304194724,0.1206896551724138,0.815469906414613,1.0,1/6,2.58%,ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.5201126170013644,1.369290374113665,0.03278688524590164,0.8142207266155668,1.0,34/220,9.40%,VEGFC;IGF1;FGF10;FLT1;IRGM;F2;C3;EPHA7;FGFR3;HGF;CCL5;SIRT1;FGFR1;ERBB4;HIF1A;FGF2;EFNA5;ANGPT1;ROR1;BMP2;PELI2;TNIK;ZBTB20;ACVR2A;FAM20A;PDGFRA;EPHA5;HDAC3;EPHA3;CD40;EPHA8;FGF17;LEPR;DSCAM
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.6957092246163248,1.3691852381331335,0.11764705882352941,0.8125679934209218,1.0,4/14,18.72%,DNASE2B;HMGB1;ENDOG;CASP3
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.6671745561395297,1.3690141478203044,0.12280701754385964,0.811605877892841,1.0,4/26,4.61%,FGF10;MYRF;CDH2;ADGRG6
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.6543685410642484,-1.368741626107322,0.08888888888888889,0.9592665107762353,1.0,11/45,10.96%,TEKT3;CFAP61;DNAH17;TEKT5;DNAAF1;DNHD1;RSPH9;DNAH11;CFAP73;ZBBX;CCDC40
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.8101576478266346,1.3686932301804686,0.05,0.8115669150442006,1.0,6/16,7.44%,F2;RUNX1;F2R;WNT4;VSIR;HDAC2
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.599213604317073,-1.3678473004424316,0.058823529411764705,0.9602073010434282,1.0,3/64,3.41%,CYP1A2;CYP2E1;ALOX5
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.8871319583031801,1.367841960134966,0.021739130434782608,0.8136646506559804,1.0,3/7,9.63%,WNT4;BMP2;H6PD
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.8185788151432394,-1.3677364582952791,0.1,0.9563140175667999,1.0,2/11,1.79%,APIP;NLRP1
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),0.8200433039270907,1.3676129863970918,0.09433962264150944,0.8131469482736566,1.0,7/9,16.53%,NPC1L1;LDLR;CEL;ABCG8;SOAT2;ABCG5;AKR1C1
prerank,GO_Biological_Process_2021__negative regulation of T-helper 17 type immune response (GO:2000317),0.8476082476339768,1.3675951896737126,0.13043478260869565,0.8111476425794504,1.0,1/5,2.47%,IL4
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.6595980485530125,1.3672469314401545,0.125,0.811581334868092,1.0,15/28,23.48%,TOX;NPY;MDGA2;ZC4H2;PROX1;NR4A2;LRP6;GRID2;CTNNB1;WNT2;MAP2;RYK;CBLN1;CEND1;SPOCK1
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.8272756629706555,1.3665686939182728,0.16666666666666666,0.8139591500229174,1.0,1/6,1.94%,SIRT1
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.5758412780520432,-1.3663896854362585,0.06666666666666667,0.9604598750094394,1.0,19/69,15.50%,LRP10;SIGIRR;PRKCD;STXBP2;PSD4;ST6GALNAC2;PRKD2;B3GALT4;FOXO4;DEF6;HLA-C;ARRDC2;CXCL16;NFKB2;DEDD2;RHBDF2;IFI35;SYTL1;MMP25
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.8347010406556625,1.3661357498869242,0.06,0.8124015169724648,1.0,2/6,5.88%,RELA;TLR2
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.8347010406556625,1.3661357498869242,0.06,0.8124015169724648,1.0,2/6,5.88%,RELA;TLR2
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7422927021123543,1.3659955658222729,0.0847457627118644,0.8111958847569203,1.0,3/17,5.37%,SOX5;BMP2;SOX6
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.6872434761992785,1.3656392512539195,0.061224489795918366,0.8113249451828277,1.0,5/22,6.19%,GATA4;C3;HIF1A;RORA;HPSE
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.7058506218177738,1.3654416638936595,0.06779661016949153,0.8104926877169448,1.0,9/23,17.67%,IGF1;MYC;BMI1;PDGFRA;PDGFC;LIG4;CD74;WNT2;CDK4
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.7608876513149946,-1.3651736615480679,0.1276595744680851,0.9635727168850179,1.0,4/15,8.08%,SCN5A;KCNE2;KCNE1;KCNQ1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.7210529440716933,1.3648951935053855,0.1509433962264151,0.8116471569776634,1.0,4/14,10.58%,IRS1;SCD;FOXO3;FOXO1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.7365290001487929,1.3648013781817483,0.08,0.8102580880202865,1.0,10/19,17.86%,ACSM2A;SCD;SLC25A1;SCD5;FASN;THEM5;ACACA;FAR2;DGAT2;ACSL4
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.8596797154727069,1.3645341363827561,0.045454545454545456,0.8079930303585259,1.0,3/9,4.16%,SYK;STAT5A;IL2RA
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.8596797154727069,1.3645341363827561,0.045454545454545456,0.8079930303585259,1.0,3/9,4.16%,SYK;STAT5A;IL2RA
prerank,GO_Biological_Process_2021__tryptophan catabolic process to kynurenine (GO:0019441),0.9110426251504795,1.3640673389462845,0.03571428571428571,0.8089785872320668,1.0,3/5,6.53%,IDO1;IDO2;TDO2
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.720443500405659,-1.3639556809787492,0.14,0.9677091997878317,1.0,2/13,7.24%,ADSS1;LHPP
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.7592370668741586,-1.3634285489002467,0.11627906976744186,0.9662375087552652,1.0,5/12,16.51%,RTP1;RTP5;TAS2R5;TAS2R8;AZGP1
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.7501534892739071,1.3632068775254151,0.14285714285714285,0.8125688610139189,1.0,4/18,17.28%,COX19;BCS1L;COX10;SCO2
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.5253658324716981,1.362812243876293,0.06666666666666667,0.812821987311008,1.0,26/157,7.90%,VEGFC;GATA4;FLT1;STAB1;SEMA5A;RUNX1;TSPAN12;ITGAX;ITGB8;SIRT1;RAPGEF3;HIF1A;FGF2;PPARG;PIK3R6;RRAS;SP1;GLUL;CCN6;APELA;GAB1;F3;ANXA3;BMPER;CD40;AGGF1
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.5473764767950658,1.3627711503641122,0.037037037037037035,0.8109966037265532,1.0,18/79,11.97%,IRGM;SIRT1;IL4;TFEB;RNF152;MID2;TP53INP1;TICAM1;HMGB1;FOXO3;GNAI3;GPSM1;STING1;EPM2A;TRIM65;FBXO7;FOXO1;BNIP3L
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.6562586062023037,1.362663495500629,0.13725490196078433,0.8099897906951227,1.0,7/28,10.84%,ADRA1A;SLC35G1;MCUB;SLC8A1;SMDT1;MCU;JPH1
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.6436466312629865,-1.3626579313452911,0.07142857142857142,0.9663132071576706,1.0,2/38,2.38%,ANXA8;ALS2CL
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.8503426042700669,-1.362372620344923,0.20833333333333334,0.9631308085557028,1.0,1/6,0.69%,CLDN4
prerank,GO_Biological_Process_2021__regulation of catecholamine uptake involved in synaptic transmission (GO:0051940),-0.8814784069870729,-1.36226837048266,0.06666666666666667,0.9588426086709996,1.0,1/5,4.93%,DRD2
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.5362903111692148,-1.3619874557771146,0.058823529411764705,0.955900916784203,1.0,6/166,4.91%,CD44;SYT12;CALB2;PTGES;FOS;OLFM1
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.817702979593496,1.3619454375857702,0.1320754716981132,0.812281988555603,1.0,2/8,4.29%,IGF1;LMOD3
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.859898404682287,1.3617890768853178,0.037037037037037035,0.811115937160156,1.0,5/9,8.41%,LRP4;NLGN1;NRXN1;CEL;NLGN4X
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.7888751175213516,-1.3614919098155815,0.12195121951219512,0.9542515004900276,1.0,4/18,7.45%,EIF2S3B;RBM4;EIF2S2;EIF2S3
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.7062054582983057,1.3614070709262702,0.05555555555555555,0.8114016638624041,1.0,3/20,5.37%,MYRF;PRDM8;SOX6
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.7666402474043095,1.3604128035412295,0.05660377358490566,0.815756575098056,1.0,2/17,2.87%,SLC5A8;PPARG
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.6831511228382153,1.3594159691923178,0.09615384615384616,0.8195782631058579,1.0,12/32,18.72%,IGF1;SP1;RELA;LRRTM3;BIN1;HAP1;RTN1;PICALM;EFNA1;ABCA2;RTN2;CASP3
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.7646273623298068,1.3590479501270467,0.058823529411764705,0.819649506621446,1.0,3/12,7.69%,ADRA1A;ADGRV1;CD40
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.8134453801534136,1.358943086690683,0.11904761904761904,0.8180660676836051,1.0,2/7,11.62%,SOCS2;PXN
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.7095631651317345,1.358524804543374,0.09615384615384616,0.8189658156941761,1.0,9/15,21.42%,EMB;CNTN6;DSCAML1;DSCAM;CNTN2;CNTN4;MYPN;BSG;ROBO3
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.651692064059745,1.3583426281262456,0.09090909090909091,0.8183732376660801,1.0,13/29,23.16%,SCRIB;LIN7A;ERBIN;ANK1;SYNE4;LRRC7;DLG2;CRB2;RAP2A;DLG3;PARD3;CRB1;DLG1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.6172735290704221,1.3582193835306364,0.06779661016949153,0.8172782990505929,1.0,4/59,5.62%,VAPB;CCL5;MDFIC;NR5A2
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.569209813831253,-1.3582018170726564,0.06,0.9723188600594899,1.0,6/118,4.08%,CD44;HAPLN3;INHA;RFLNB;AHSG;PHEX
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.5423772711206422,1.3575055844037363,0.043478260869565216,0.8194019452050778,1.0,26/91,15.60%,SMAD6;IL17RD;VWC2L;SIRT1;TGFBR1;PPARG;BMP2;CRIM1;ACVR2A;BMPER;UBE2D3;PPM1A;SMAD1;MAGI2;SMAD2;VWC2;BMPR1A;DAND5;SMAD4;GREM1;FAM89B;LRP2;SPART;BAMBI;VASN;SMAD5
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.8164876524258768,1.3573847693712786,0.06,0.8183098456352923,1.0,6/10,12.35%,LRP4;NLGN1;CEL;PTPRD;NLGN4X;PTEN
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.6501567387632924,1.3572444374861308,0.10638297872340426,0.8171917249178101,1.0,4/16,5.54%,TGFBR1;SNAI1;BMP2;RBPJ
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.8285328969493257,1.3571757479656203,0.0967741935483871,0.8156725067195405,1.0,3/9,11.01%,SIRT1;LEPR;GCK
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.7684193046815615,1.3566457774568947,0.05660377358490566,0.8169683290770255,1.0,4/13,11.11%,KLRD1;NECTIN2;CADM1;HLA-E
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.7138591532980223,1.3565865160479702,0.17647058823529413,0.8153014050282985,1.0,7/13,24.66%,SLC26A7;SLC26A6;SLC26A4;RACGAP1;SLC25A30;SLC25A14;SLC26A2
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.7621594371130325,1.3564643311855071,0.14035087719298245,0.8140771718583906,1.0,3/16,17.28%,COX19;BCS1L;SCO2
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.7187785563698362,1.3564492570530546,0.1320754716981132,0.812208452430023,1.0,2/17,0.64%,ADRA1A;DRD5
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.7823023784508696,1.3562691493049983,0.1276595744680851,0.8113682958353107,1.0,2/11,3.24%,CTDNEP1;LDLR
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.8558211491806044,1.356155289681221,0.08620689655172414,0.8101931242442949,1.0,2/5,13.72%,MTMR9;MTMR3
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.700225213437999,-1.3559750480966264,0.18181818181818182,0.9819612691387531,1.0,3/14,7.82%,ACTC1;NEB;MYLK3
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.7707577275263787,1.3557567600734588,0.09615384615384616,0.8104995031043678,1.0,3/11,12.69%,TGFBR1;WNT9A;GREM1
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.7574478291615571,1.3555118955352015,0.08,0.8104056431487875,1.0,3/15,11.34%,BOK;RNF185;RNFT1
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.8683485188805301,1.355309412226712,0.14285714285714285,0.80963898458991,1.0,3/5,11.05%,ABHD3;ACADM;GLYATL2
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.6565729017232967,1.355268180949688,0.09302325581395349,0.8078990279000803,1.0,7/28,8.51%,LPIN3;ABHD3;SLC44A5;CHPT1;PCYT1B;ACHE;CEPT1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.8916430596248006,1.3552289304821226,0.0196078431372549,0.8062586885620646,1.0,2/5,4.82%,RUNX1;HCLS1
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.604425439883686,1.3548633551786786,0.11764705882352941,0.8063276669110728,1.0,6/37,14.76%,TNFSF14;CD40;TNFRSF10B;MAPK8;MAP3K1;PIEZO1
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.6749762640332269,1.354150836797609,0.09259259259259259,0.8086698227847209,1.0,7/18,14.65%,NPC2;ABCA1;ABCG8;SOAT2;ABCA8;ABCG5;SOAT1
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.7639576442897276,1.353782738048638,0.06451612903225806,0.8091561919215247,1.0,3/11,8.97%,SYT1;UNC13B;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.7876082753861327,1.3536998909261804,0.14,0.8077395011309209,1.0,3/11,11.86%,SEMA5A;CRACD;CARMIL1
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.570569195251755,1.3535055322935357,0.09433962264150944,0.806871253047802,1.0,20/86,8.38%,MXRA5;LAMA4;MRGPRF;PRRX1;PRKG1;ITGA11;ADGRL4;ANGPT1;MSRB3;SSC5D;CPED1;BGN;COL6A2;CXCL12;POSTN;CCDC80;PDGFRA;CNRIP1;CYBRD1;PCDH18
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.8584895328829437,1.352559128426844,0.14583333333333334,0.8107518131609891,1.0,1/6,2.33%,PLOD2
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),0.9128363561174944,1.3517114076709926,0.05357142857142857,0.8143746015310793,1.0,1/5,1.70%,ACE2
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),0.8013214420430861,1.351005280987056,0.21428571428571427,0.8167550335424575,1.0,2/7,1.67%,LGALS9;SYK
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.5493279311121059,-1.350912593796681,0.021739130434782608,1.0,1.0,16/105,13.11%,TERT;DDX11;PRKCD;GOLGA2;PPP1CA;IFIT2;FLOT1;HFE;TMC8;LRPAP1;TTBK1;ZFPM1;GTF2F1;WNT3A;PRMT7;CAV1
prerank,GO_Biological_Process_2021__skeletal muscle cell differentiation (GO:0035914),0.8652934363807332,1.3506878912461924,0.1111111111111111,0.8167387359954958,1.0,2/5,6.50%,SIX4;MEGF10
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.7497713015742715,1.3505959370195832,0.19607843137254902,0.8152349132409656,1.0,5/10,19.49%,THRSP;PRKAB2;ACACA;ACACB;MID1IP1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.667178263704548,-1.3505474747665682,0.10256410256410256,1.0,1.0,5/26,10.00%,DDX11;HMGB3;RECQL5;RAD50;RTEL1
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.5729901372393942,1.350430879252305,0.038461538461538464,0.8144504357940466,1.0,16/55,20.89%,IGF1;TLR2;UNC13B;ACHE;MCU;GCK;MYRIP;MYOM1;GOLPH3L;CD2AP;PTPN23;ACSL4;IRS2;CAPN10;BAD;GLUD1
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.8080720268586757,1.3503720213769301,0.1111111111111111,0.8127515113294788,1.0,1/8,2.51%,INSIG1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.4876303247033454,1.3502667418355327,0.024390243902439025,0.8113558662807313,1.0,71/441,10.92%,TNFSF14;LGALS9;IGF1;ADRA1A;FGF10;FLT1;SEMA5A;IRS1;FGFR3;HGF;BOK;CCL5;RIT2;TNFRSF19;SIRT1;TGFBR1;IL26;F2R;FGFR1;ERBB4;FGF2;NRG1;NEDD4;ANGPT1;CALCR;ROR1;KSR1;CANT1;BMP2;NLGN1;PIK3R5;PELI2;SLC35B2;HCLS1;ADGRV1;LIN28A;SEPTIN4;MID2;RELA;PELI1;TIFA;TLR2;ESR1;HPSE;CASS4;ITGAV;PDGFRA;PLCG2;TICAM1;GAB1;HDAC3;F3;NRG2;CD40;ADRA2C;NEUROD2;HMGB1;PPM1A;PDGFC;RAMP3;EPHA8;TAB2;FGF17;TSPAN6;PIK3CA;HIP1;PLXNB1;FLT3;TNFRSF10B;CASP10;GPR62
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.6556919057553929,1.3502659982006786,0.09302325581395349,0.8094949583305462,1.0,7/25,20.46%,LRP4;DCC;PTEN;KIAA0319;DIP2B;MCF2;MAP2
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.5483058345252183,-1.350206243024515,0.07317073170731707,1.0,1.0,13/91,10.23%,LRP10;EHF;RAC2;FAM3D;MVP;IER3;LAMB3;OAS3;OAS1;ABCC3;VDR;MFGE8;HLA-C
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.8970040773714163,1.3502053414952777,0.08333333333333333,0.8081131527396853,1.0,3/7,6.66%,SOX5;SOX6;PDGFRA
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.7831882372489121,1.3501691896738366,0.06779661016949153,0.8066789678606764,1.0,4/17,3.48%,ZBTB7B;ERBB4;NRG1;WNT4
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.8368612948941405,-1.3496984257690414,0.14893617021276595,1.0,1.0,4/7,10.96%,DNAAF1;DRC1;DNAH11;CCDC40
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.9213661175590893,1.3493904792802671,0.038461538461538464,0.8097015131945128,1.0,2/5,4.27%,IRGM;FYCO1
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6053766454243035,-1.3491687433783228,0.14814814814814814,1.0,1.0,9/49,15.62%,DDX11;RECQL5;RAD50;XPC;RTEL1;PARP1;GTF2H2;SUPV3L1;MCM2
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.6259056087015603,1.3487379821152512,0.125,0.8119800429986914,1.0,13/36,17.85%,GRM3;GRIN3A;GRM8;GRIK2;GRM5;GRIN3B;GRIK3;GRM4;GRM7;PLCB1;GRM1;GRID2;FMR1
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),-0.8796686649252011,-1.3485386084944835,0.1282051282051282,0.9977476380773277,1.0,1/5,1.04%,CD24
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),-0.8796686649252011,-1.3485386084944835,0.1282051282051282,0.9977476380773277,1.0,1/5,1.04%,CD24
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.8182511279233574,1.3485000673991066,0.10344827586206896,0.8118583633366103,1.0,4/9,11.90%,PPARG;ITGAV;ABCA1;NR1H3
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7903211818832356,1.3484193861383342,0.03508771929824561,0.8104577630698511,1.0,2/10,2.18%,LGALS9;ZBTB7B
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.7668318938396697,1.3480282069227247,0.125,0.8112684930454712,1.0,5/13,11.28%,GSTM2;SLC8A1;PIK3CA;GSN;ATP1A2
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.6982418108966307,1.3474952369127446,0.12280701754385964,0.8127124249880839,1.0,5/25,10.26%,SMYD1;PRMT1;SMYD2;CTCFL;EZH2
prerank,GO_Biological_Process_2021__negative regulation of anion transmembrane transport (GO:1903960),0.8802353181603212,1.3466756891636111,0.03773584905660377,0.8149585872398706,1.0,1/5,4.02%,TCAF2
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.7696175389264678,1.3463851599632146,0.14285714285714285,0.8150333200036551,1.0,2/12,7.26%,SEMA5A;EPHA3
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.7259556573773708,1.3463535596638412,0.1111111111111111,0.8134400082308555,1.0,5/24,10.28%,F2;GSTM2;F2R;SNCA;HAP1
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),0.8105882663238584,1.3461899065649678,0.09259259259259259,0.8126571138129958,1.0,3/9,6.53%,IDO1;IDO2;TDO2
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.7075183106160223,1.3457052243948786,0.017543859649122806,0.8135952393740936,1.0,6/15,19.69%,SMAD6;ROBO2;NOTCH2;HEY2;JAG1;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.556823480409635,1.3453674731093965,0.0392156862745098,0.8138437091045055,1.0,27/87,20.73%,IGF1;TGFBR1;CDKN2AIP;LGI1;SYT1;RIMS2;EXOSC4;DBN1;ZNF639;RPS6KA1;DERL2;L1CAM;SLC44A4;CDKL5;MACF1;H3-3A;ADAM10;SMURF1;SYT3;BRAT1;SLC25A33;CPNE9;GOLGA4;NCBP1;EDN1;ADNP2;SYT17
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.8202971233321916,1.34507704093346,0.08620689655172414,0.8137490937444427,1.0,2/14,1.62%,IGF1;HGF
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.6459133009915586,-1.3449009227950974,0.10416666666666667,1.0,1.0,4/34,8.85%,DUSP4;DUSP6;UBASH3B;PGP
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.6380051409906893,1.3446065880172577,0.06779661016949153,0.8149060613430349,1.0,10/35,19.94%,KAT2B;ZDHHC12;GLUL;ZDHHC22;ZDHHC2;FOXO1;KAT6A;GTF2B;ZDHHC17;ZDHHC13
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),0.8591284789448596,1.3445231125795556,0.09615384615384616,0.8136746073310314,1.0,1/5,1.32%,C3
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),0.8795969439633899,1.3442579136189803,0.09615384615384616,0.8136376102248103,1.0,3/6,9.95%,PLEKHH2;PIK3CA;GSN
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.5796134551664628,-1.344076392414713,0.075,1.0,1.0,9/75,6.91%,LRP10;UMODL1;TMEM184A;UPK1A;PRKCD;STXBP2;ABHD11;PSD4;PRKD2
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),-0.7809510729274691,-1.3440341763570263,0.25,1.0,1.0,4/7,13.81%,NLRP3;CD86;IL18;RARA
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.8452489452602268,1.342571233544362,0.038461538461538464,0.8221881875835886,1.0,2/8,2.86%,CHRM2;HRH3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),0.7907147477578342,1.34165635906072,0.08333333333333333,0.826276041922904,1.0,2/11,2.47%,SYK;IL4
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.7216064575090361,-1.3415052841460313,0.14,1.0,1.0,2/10,4.76%,APOBEC3H;APOBEC3G
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.8542165242594407,1.341379624954923,0.03773584905660377,0.8258742201348093,1.0,3/6,7.79%,HS3ST5;HS3ST3B1;HS2ST1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.6901236818412035,1.3412860046589126,0.05357142857142857,0.8247725771702829,1.0,7/22,10.25%,LGALS9;SYK;TLR2;PLCG2;CD40;HMGB1;IL23R
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.8431191067742263,-1.3410931790538756,0.16,1.0,1.0,4/10,9.36%,KCNE2;KCNE1;KCNQ1;KCNA5
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.710865452401178,-1.3409895478290752,0.13725490196078433,1.0,1.0,4/16,8.78%,SIGIRR;TRIM5;TRIB1;LY86
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.5332103441316849,1.3407457338245679,0.07692307692307693,0.8261399011319281,1.0,28/133,10.29%,FGF10;SEMA5A;IRS1;FGFR3;HGF;TGFBR1;IL26;FGFR1;ERBB4;FGF2;NRG1;ANGPT1;CALCR;PIK3R5;HCLS1;LIN28A;ESR1;HPSE;CASS4;PDGFRA;GAB1;F3;NRG2;RAMP3;FGF17;PIK3CA;HIP1;FLT3
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.8020500617672199,1.3407221977033519,0.1111111111111111,0.8245674729937331,1.0,4/11,11.01%,IGF1;IRS1;DYRK2;GCK
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.7998582087391808,-1.3406866075335269,0.14285714285714285,1.0,1.0,3/8,4.93%,DRD4;NMUR2;DRD2
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.7998582087391808,-1.3406866075335269,0.14285714285714285,1.0,1.0,3/8,4.93%,DRD4;NMUR2;DRD2
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.7579680479477914,1.3405108397745937,0.16666666666666666,0.8245074088898567,1.0,5/12,17.81%,SIRT1;PPIF;PXK;VCPKMT;TP53
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.4788453001130249,-1.3399944926037308,0.018867924528301886,1.0,1.0,15/386,3.83%,CD44;TBC1D10C;RAB44;MPO;SELL;DNASE1L1;HGSNAT;CD53;BST1;LILRB3;STK10;ALOX5;PRKCD;AHSG;CRACR2A
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.808561358983757,1.3399530696452375,0.10526315789473684,0.8254491271176633,1.0,2/10,3.23%,ITGAX;MYRF
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.7853670416883046,-1.3398908577847426,0.11538461538461539,1.0,1.0,2/6,16.80%,LDB1;NUP133
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),-0.9099183944605536,-1.3398650731865738,0.075,1.0,1.0,2/5,3.29%,CYP1A2;CYP2E1
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.8390150462764976,1.3398198448452372,0.1320754716981132,0.8245823788948258,1.0,2/6,8.67%,SPR;GCH1
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.8093307704808272,1.3397248691391586,0.10714285714285714,0.8234423651536542,1.0,1/8,1.94%,SIRT1
prerank,GO_Biological_Process_2021__membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-0.8499407860408582,-1.3397082000433478,0.2222222222222222,0.9975613174881511,1.0,3/5,8.08%,KCNE2;KCNE1;KCNQ1
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.7714140503662953,1.3395047723790257,0.11290322580645161,0.8228047851372079,1.0,4/9,9.75%,TGFBR1;INSIG1;RORA;SMAD2
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.7961748361089314,1.3390458001656989,0.11320754716981132,0.8239903050347543,1.0,4/7,19.92%,ABCD3;ABCD2;ABCD4;ACOX1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.5393618018639053,1.3389424711936253,0.022222222222222223,0.8229139269562683,1.0,9/80,10.07%,MAP3K11;TNFRSF19;IL26;GDF6;BMP2;PRMT1;RELL1;HMGB1;MAP4K2
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.7219112145253211,1.3387071702221607,0.12,0.8223914167197958,1.0,5/16,8.41%,NCAM2;NLGN1;NRXN1;CEL;NLGN4X
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.7429454023837817,1.3383845402993526,0.1346153846153846,0.8227480895339025,1.0,5/12,20.09%,PRR5L;MOV10;ZC3HAV1;CNOT8;PNPT1
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),-0.8077172018753475,-1.3383112575202494,0.13333333333333333,1.0,1.0,1/8,0.23%,RFX6
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.6758435216721396,1.3381556194834348,0.11290322580645161,0.8221734625282913,1.0,6/24,16.12%,IRGM;RELA;MAP2K6;TAB2;IRAK1;TAB3
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.5920769067465581,1.3378473500118966,0.1590909090909091,0.8222016219076208,1.0,19/62,18.76%,SLC12A7;GABRR1;SLC12A1;GABRR2;SLC1A3;SLC12A3;GLRA1;GABRG3;GABRA5;GLRB;SLC37A4;GABRG1;GABRB2;ANO5;ANO6;SLC12A9;GABRE;GABRA4;GABRB1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.8019991407683236,1.3376534612898592,0.12280701754385964,0.82184843278167,1.0,3/8,11.90%,PPARG;ABCA1;NR1H3
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.7679431709939275,1.337114565038151,0.0851063829787234,0.8234803723364942,1.0,4/10,12.75%,SHMT2;PHGDH;SRR;CBS
prerank,GO_Biological_Process_2021__blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),0.8921065525653217,1.337079535209974,0.10526315789473684,0.8217973034906166,1.0,3/5,7.36%,SEMA5A;NRARP;BMPER
prerank,GO_Biological_Process_2021__positive regulation of epithelial tube formation (GO:1905278),0.8565997051042469,1.3369472595253553,0.04,0.8207977880764727,1.0,2/5,4.40%,FGF2;SIX4
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.7970854387332703,1.336812569940224,0.11320754716981132,0.8197484686527443,1.0,2/10,9.28%,CCL5;PAG1
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.47732095420318355,-1.3366198018627415,0.018518518518518517,1.0,1.0,15/391,3.83%,CD44;TBC1D10C;RAB44;MPO;SELL;DNASE1L1;HGSNAT;CD53;BST1;LILRB3;STK10;ALOX5;PRKCD;AHSG;CRACR2A
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.5416612460444201,-1.3364644935047696,0.08,1.0,1.0,7/89,3.34%,ANXA8;EHF;DUOXA1;CLDN4;SERINC2;CLDN1;EPAS1
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.8141060805933703,1.3360395994651026,0.16666666666666666,0.8227992222531847,1.0,3/6,18.53%,SNCA;PPIF;NDFIP2
prerank,GO_Biological_Process_2021__regulation of gap junction assembly (GO:1903596),0.8416120822709614,1.3354881524002058,0.16,0.8246809906986095,1.0,2/5,4.00%,ACE2;CNTNAP2
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.5426669443718728,1.3350067998723185,0.1276595744680851,0.8256425898193369,1.0,32/111,16.15%,LRRC3B;SLC35F1;LRRC4C;LRP4;SLC1A3;GFAP;NLGN1;OLIG2;PCDH17;EFS;MEGF10;TMEM200C;PAX6;NOVA1;PTPRD;ANK2;GUCY1A2;ADGRB3;MAGEL2;ATP1A2;NPAS3;ZNF536;GPM6B;ID4;RUNX1T1;SEMA6D;FAT3;CPE;GPRC5B;CNTN2;PDZRN3;MAPK10
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.5492868922472606,1.3344271107854595,0.038461538461538464,0.827483817068611,1.0,10/67,14.90%,CGNL1;TGFBR1;RAPGEF3;TMEFF2;DLC1;PPM1E;PXN;CARMIL1;SORBS3;PHLDB2
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.7241669574427854,-1.3340106495215136,0.14634146341463414,1.0,1.0,1/15,0.73%,AMACR
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.7309742663462065,1.3332515509626086,0.0967741935483871,0.8337798193378675,1.0,4/15,15.78%,SIRT1;HTRA2;HSPB1;NFE2L2
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.580108308194377,1.3331279543627137,0.037037037037037035,0.8325832997830285,1.0,24/81,15.24%,IL17RD;EPHA7;MYCN;FRAS1;CNTNAP2;SYT6;LIN28A;CXCL12;ZDHHC22;UNC5D;TMEM200C;ADAMTS19;IGDCC3;SPSB4;NLGN4X;EPHA8;VANGL2;MAGEL2;VASH2;CLDN6;GRM4;RIMS4;L1TD1;VRTN
prerank,GO_Biological_Process_2021__innate immune response in mucosa (GO:0002227),0.9079151805344208,1.3325711257828363,0.05357142857142857,0.8336270164466414,1.0,2/5,4.68%,IL4;H2BC21
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.8030547212706478,1.33245621374055,0.1320754716981132,0.8323560903482383,1.0,3/8,8.32%,CALCR;CXCL12;RAMP3
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.9099762048053748,1.3321826312023057,0.02,0.8320709333857567,1.0,3/5,7.75%,RUNX1;ZBTB7B;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6077373469038249,1.3320619276376766,0.08695652173913043,0.8310464553583725,1.0,10/41,10.19%,SIRT1;FGFR1;HIF1A;STAT5A;FGF2;ANGPT1;SP1;CD40;HMGB1;NUS1
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.8023389806322249,1.3318722829630587,0.09836065573770492,0.8303956716467759,1.0,2/7,5.19%,LGALS9;CXCL12
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.6684255428690768,1.331731493258913,0.10204081632653061,0.8295631901473847,1.0,4/30,9.35%,HELB;RPP40;PWP2;RRS1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.6605925562402641,1.3314842220081038,0.16666666666666666,0.8292860772095465,1.0,3/27,4.07%,ESPL1;NDC80;NDE1
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),-0.8201474523488548,-1.3312159761907183,0.22448979591836735,1.0,1.0,2/7,6.93%,KCNE2;KCNE1
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.7015596213793598,1.3311683226058917,0.13333333333333333,0.8298232360807476,1.0,2/16,3.37%,MYRF;PRDM8
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell chemotaxis (GO:2000510),0.9161703211100449,1.33109946382718,0.038461538461538464,0.8285258222504998,1.0,1/5,0.38%,LGALS9
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),0.8692517876485575,1.330710652750877,0.08771929824561403,0.8287488581559961,1.0,1/7,0.53%,FGF10
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),0.7143054340464984,1.330661404149243,0.14,0.8273024625557961,1.0,2/13,3.42%,NPC1L1;SLC26A6
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.7697457233133158,1.3303395218321725,0.12727272727272726,0.8273969821443032,1.0,3/13,3.30%,FGF10;NRG1;OPRK1
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.5112068082469333,-1.3303128938867472,0.05263157894736842,1.0,1.0,7/134,4.32%,CD44;TEK;COL4A2;COL5A1;COL4A1;BOC;CRYM
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.4994413625345871,1.3300541058091475,0.022222222222222223,0.8272833966888932,1.0,19/153,8.22%,MXRA5;PCOLCE2;LAMA4;SMAD6;MRGPRF;STAB1;SMOC1;TMTC2;ADGRL4;GNG12;DOCK1;BGN;CXCL12;LTBP2;POSTN;WWTR1;FAM114A1;PLSCR4;MARVELD1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.8323407809259358,1.3300367477407988,0.0967741935483871,0.8256154866149236,1.0,3/6,6.01%,GRIP1;GRIP2;SCRIB
prerank,GO_Biological_Process_2021__receptor guanylyl cyclase signaling pathway (GO:0007168),-0.8406098270051117,-1.3299377608901393,0.14545454545454545,1.0,1.0,2/6,2.25%,GUCY2C;GUCA1B
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.686276649087754,1.3295457202659113,0.21666666666666667,0.8273162060792499,1.0,2/13,1.94%,IRS1;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.6075326565425115,1.3291455474772857,0.15555555555555556,0.8281325901850062,1.0,6/38,7.23%,F2;SYK;ACE2;RAB27A;PLCG2;DCXR
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.7488091079071169,1.328796151674834,0.1896551724137931,0.8283532853705167,1.0,1/11,0.53%,FGF10
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.7649381569671729,-1.3282631787884087,0.11627906976744186,1.0,1.0,1/10,1.28%,INHA
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.5505943404024785,1.3276348387955539,0.034482758620689655,0.833894185829127,1.0,18/99,14.41%,IRGM;CCNG1;CDKN2C;SIRT1;CDC25A;CCNA2;KSR1;SLC8A1;CNPPD1;SNCA;TELO2;CCNB3;EZH2;CDK12;CCND3;SERTAD1;LRP6;CCNH
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.749622132868677,1.3274350981630867,0.14035087719298245,0.833281558028083,1.0,5/12,9.75%,CXXC4;SMAD6;FZD5;RIPPLY2;SMAD2
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.6871745686905157,1.3272996479019046,0.14285714285714285,0.8322617177578712,1.0,12/23,22.16%,SULT2A1;SULT6B1;ENPP1;MTARC2;TPST2;THAP4;GRHPR;PPA2;MINPP1;DAO;LIAS;LIPT2
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.7415169780138849,1.327296049290393,0.14285714285714285,0.8306582267472005,1.0,4/14,11.90%,PPARG;ITGAV;ABCA1;NR1H3
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.7431979669842708,1.3270623828344146,0.18,0.8306677075080047,1.0,2/7,5.54%,SNAI1;RBPJ
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.6881515811043161,1.3262569007995784,0.17307692307692307,0.8336040418399665,1.0,5/17,15.86%,SHMT2;MTHFD2L;MTHFD2;SLC19A1;PM20D2
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),0.8140321110343166,1.326065082624575,0.08695652173913043,0.8329980410804133,1.0,1/7,0.09%,GATA4
prerank,GO_Biological_Process_2021__regulation of blood vessel remodeling (GO:0060312),-0.8367346826167816,-1.3258593385736923,0.18,1.0,1.0,2/5,13.89%,CEACAM1;TGFB1
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),0.8610199019454401,1.3256444972414243,0.14893617021276595,0.8340168838356854,1.0,1/5,1.53%,TSPAN12
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.7125973212806738,1.3254800232785935,0.15555555555555556,0.8334630580739942,1.0,3/10,10.84%,BMP2;SMAD2;BMPR1A
prerank,GO_Biological_Process_2021__melanosome assembly (GO:1903232),0.8281959702573821,1.3254639229460858,0.08196721311475409,0.8318508573109711,1.0,1/5,1.86%,RAB38
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.8743416057842325,1.3249862102504701,0.08928571428571429,0.8330675698957841,1.0,1/5,2.00%,TGFBR1
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.8309056228010614,1.3245711027120841,0.1111111111111111,0.832750481252337,1.0,2/8,1.70%,MME;ACE2
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.8309056228010614,1.3245711027120841,0.1111111111111111,0.832750481252337,1.0,2/8,1.70%,MME;ACE2
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),0.6140201959586783,1.3244028583361684,0.09615384615384616,0.8323799023118129,1.0,4/35,8.54%,HELB;RIOK2;TSR3;PWP2
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.8186054504423035,1.324047650158029,0.09259259259259259,0.8326609104723744,1.0,2/9,5.13%,SLC22A3;ODC1
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.7929352406959489,1.3235289606757696,0.09090909090909091,0.8342635498514377,1.0,4/11,12.91%,RNF185;AUP1;RNF5;POMT2
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.5894698305044578,-1.3234657613468959,0.12,1.0,1.0,8/61,5.72%,CYP1A2;ABCA4;AGRN;GPC2;SCPEP1;RBP2;GPC1;GPC3
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6299692587395876,1.323422976001234,0.08620689655172414,0.8333192939055478,1.0,5/29,5.37%,RUNX1;FGFR3;SOX5;BMP2;SOX6
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.7890260240507123,1.322901764007721,0.07692307692307693,0.834640994737533,1.0,4/12,12.08%,IRGM;FYCO1;TMEM39A;UBQLN4
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.7253494941013655,1.3228079304983384,0.10344827586206896,0.8336252184401372,1.0,5/17,15.78%,SIRT1;HIF1A;HTRA2;HSPB1;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.613987186921632,1.3224731902761135,0.12280701754385964,0.8340744727104016,1.0,4/40,5.88%,TNFSF14;LGALS9;RELA;TLR2
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.5931883202597654,-1.3222735011585018,0.17647058823529413,1.0,1.0,7/36,10.00%,H1-3;H1-4;TERF2IP;H1-2;RAD50;RAD51AP1;RTEL1
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.7740716679713848,1.3219924001192582,0.11290322580645161,0.8357578519349411,1.0,5/12,11.28%,GSTM2;SLC8A1;PIK3CA;GSN;ATP1A2
prerank,MSigDB_Hallmark_2020__Androgen Response,0.5563577770547579,1.3217662951827185,0.06666666666666667,0.8357819048100906,1.0,27/96,17.09%,TMPRSS2;HERC3;INSIG1;SCD;STEAP4;UBE2J1;FKBP5;PDLIM5;ITGAV;MYL12A;UAP1;TSC22D1;LIFR;ELOVL5;GNAI3;HMGCS1;INPP4B;LMAN1;ZBTB10;CCND3;ANKH;ELL2;SGK1;GUCY1A1;DNAJB9;SMS;SELENOP
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.603429988762159,1.3214768203714562,0.08,0.8362983126433916,1.0,17/40,23.74%,SLC26A7;ENPP1;SLC26A6;GLRA1;SLC26A4;PACC1;RACGAP1;ANO5;ANO6;SLC4A1;SLC34A2;ENPP3;SLC25A30;SLC25A14;BEST1;CLCN2;CLIC4
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.6886704165224072,-1.3213195755957055,0.13636363636363635,1.0,1.0,3/15,16.24%,C2ORF49;CPSF4;CSTF2
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.728852522440492,1.3212995995439243,0.16666666666666666,0.8357068582358632,1.0,1/18,0.48%,IGF1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.6864329683273777,1.3207498816221648,0.15517241379310345,0.837742197656978,1.0,7/21,11.03%,ARHGAP24;EPS8L2;NLGN1;ABI3;EPS8;KANK1;DEF8
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.5519666477945275,1.3206913103921314,0.11538461538461539,0.8363668331419314,1.0,11/58,11.85%,SMAD6;TMEM100;GDF6;BMP2;ACVR2A;ZFYVE16;SMAD1;SMAD2;BMPR1A;SMAD4;GDF9
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.6843985077762478,-1.3202924928145046,0.17391304347826086,1.0,1.0,3/16,16.24%,C2ORF49;CPSF4;CSTF2
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),0.8249129222039867,1.3202462520315574,0.12698412698412698,0.8371958583637751,1.0,1/6,3.48%,WNT4
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.7214349124517402,1.3196114508901928,0.15555555555555556,0.8399728371438312,1.0,2/21,5.78%,SLC5A8;RNLS
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.6292957178894438,1.319082191821325,0.1,0.8413274288028915,1.0,7/38,9.16%,IRS1;SIRT1;ZBTB7B;VWA2;ENPP1;PIP4K2A;KANK1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell differentiation (GO:2001200),0.8477160262149206,1.3190086713814775,0.12244897959183673,0.8402715416658273,1.0,2/5,7.75%,LGALS9;HMGB1
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.6260624600994521,-1.3189790986843815,0.08695652173913043,1.0,1.0,2/43,2.38%,ANXA8;ALS2CL
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.7996747150853125,1.3189148035807439,0.11538461538461539,0.839243889706064,1.0,1/10,0.97%,SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.801726807369217,1.3185887775040164,0.06896551724137931,0.8392851295928381,1.0,5/15,7.44%,F2;RUNX1;F2R;WNT4;HDAC2
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.727789855020986,1.3182190529146751,0.08163265306122448,0.8399302026800034,1.0,2/12,5.82%,ZBTB7B;NAPEPLD
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.6410537044185486,1.3177956485056155,0.14893617021276595,0.8405969694323113,1.0,7/22,5.09%,F2;CCL5;IL26;F2R;ERBB4;IL4;IL10RA
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.6992870261543264,1.31768907655227,0.21153846153846154,0.8394801296472509,1.0,3/13,4.49%,INSIG1;MLC1;RORA
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.49417256036735624,1.3176489447564557,0.07894736842105263,0.8382473446866652,1.0,31/237,7.24%,IGF1;FGF10;FAM83H;FLT1;SEMA5A;TNFRSF18;FERMT3;HGF;ITGAX;CCL5;TGFBR1;F2R;IL4;HIF1A;SNAI1;FBXO5;BMP2;INSL3;TCAF2;DOCK1;CXCL12;CCN4;SEMA6C;CASS4;APELA;PDGFRA;PLCG2;VSIR;GAB1;F3;FER
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),0.824109432811258,1.3171976116187336,0.11864406779661017,0.8391772907755112,1.0,3/6,12.69%,GREM2;BMP2;GREM1
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),0.853455111882046,1.3171886222761322,0.18333333333333332,0.8376385115928663,1.0,2/6,8.44%,GSTM2;CRYZ
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.5157825307513229,1.3171032897508987,0.07547169811320754,0.8366549249034493,1.0,30/130,18.96%,IGF1;RIT2;RAPGEF3;CCNA2;FGF2;RRAS;KSR1;CDKN2A;EPS8L2;RALA;ARHGAP5;EPS8;SHOC2;RAPGEF6;PHACTR4;RGL2;SOS1;RAP1A;SGSM3;CNKSR1;ROPN1B;G3BP1;RRAS2;RHOG;TP53;FARP2;RHOD;RAP2A;RHOB;GNA13
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.8027678600058541,-1.31707391107127,0.2222222222222222,1.0,1.0,3/7,9.97%,COL4A2;UBASH3B;COL1A1
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.6470535161568541,1.3170094793996343,0.06,0.8356988336557281,1.0,8/27,9.99%,IGF1;SGCZ;SLC8A1;MYOF;MEGF10;MYH11;ANK2;BIN1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),0.8087356078455792,1.3169688620131494,0.12727272727272726,0.8328707077764981,1.0,2/5,10.08%,DPY19L1;DPY19L3
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),0.8087356078455792,1.3169688620131494,0.12727272727272726,0.8328707077764981,1.0,2/5,10.08%,DPY19L1;DPY19L3
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.6574729109712747,1.3169466000253405,0.11320754716981132,0.8314763286443857,1.0,9/27,13.84%,LGALS9;HS3ST5;TMPRSS2;MID2;NECTIN2;GSN;TRIM26;PTX3;CD74
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.8137436281028321,1.3163857012217317,0.07272727272727272,0.8316799009985374,1.0,2/10,3.95%,ASIC1;STEAP4
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.8137436281028321,1.3163857012217317,0.07272727272727272,0.8316799009985374,1.0,2/10,3.95%,ASIC1;STEAP4
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.572208170849615,1.3162304077358113,0.06896551724137931,0.8311207959646063,1.0,15/35,22.11%,ZEB2;KANK2;PRSS3;DPP4;KANK1;PIK3CA;LOXL2;PXN;ANLN;PKN2;FERMT1;KIT;ABL1;NANOS1;FAP
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.5625389428984889,1.3162152357820622,0.11320754716981132,0.8295985967045979,1.0,15/79,14.41%,CCNG1;CDKN2C;CDC25A;CCNA2;CDKN2A;CNPPD1;LATS1;CCNB3;PROX1;PTEN;HEXIM2;CCND3;NR2F2;SERTAD1;CCNH
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.7830213673103255,1.3161217449654887,0.18867924528301888,0.8285519034636486,1.0,2/7,9.78%,SHMT2;GMPS
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotactic protein-1 production (GO:0071639),0.8199845948258517,1.3160818795372413,0.13725490196078433,0.8272275805696677,1.0,2/5,1.67%,LGALS9;SYK
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.867667515159332,1.3159651158002137,0.07547169811320754,0.8262124306298336,1.0,1/6,1.81%,AMPD1
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.5064157298353323,1.3159480420064489,0.10638297872340426,0.8248037016264722,1.0,34/173,11.22%,GATA4;FGF10;SEMA5A;IRS1;FGFR3;HGF;SIRT1;TGFBR1;IL26;FGFR1;ERBB4;FGF2;NRG1;ANGPT1;CALCR;RRAS;PIK3R5;HCLS1;LIN28A;ESR1;HPSE;CASS4;PDGFRA;GAB1;F3;NRG2;RAMP3;MAGI2;FGF17;PIK3CA;HIP1;FLT3;BANK1;CPNE1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.7445586779956478,1.3159179487568724,0.16666666666666666,0.8234467388615815,1.0,3/12,7.59%,IRGM;PYHIN1;HTRA2
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7420012623124269,1.315909955590439,0.10714285714285714,0.8219782717072945,1.0,4/10,23.85%,STAT5A;PRLR;LYN;JAK2
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.5035592964592767,-1.315643788037276,0.05660377358490566,1.0,1.0,29/180,10.32%,CD44;COL23A1;COL24A1;COL4A2;ICAM3;COL27A1;COL5A1;PXDN;COL4A1;MFAP5;AGRN;MATN4;TGFBI;COL28A1;ITGA9;LAMB3;F11R;LAMB1;COL6A3;COL11A2;ADAM19;ADAMTS9;ADAMTS3;SPARC;COL1A1;MMP9;VIT;HRNR;ACAN
prerank,GO_Biological_Process_2021__negative regulation of T-helper 17 cell differentiation (GO:2000320),0.8128347505517435,1.315516521936538,0.16326530612244897,0.8226533867343341,1.0,1/6,2.47%,IL4
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta activation (GO:1901388),0.8716426931977812,1.315363364395372,0.07142857142857142,0.8219572571005884,1.0,3/5,9.80%,ITGB8;ITGAV;LTBP1
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.7231672449781783,1.315288778663072,0.18867924528301888,0.8207541529190435,1.0,1/10,3.04%,EHD1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.5104807501439892,1.3152780144673117,0.08695652173913043,0.8193473264013579,1.0,21/150,7.89%,IGF1;CTDNEP1;IRS1;HGF;MYC;CCL5;SIRT1;STARD4;PRR16;HIF1A;FGF2;LDLR;ZEB2;CD244;PRMT1;EIF3E;SAMD4A;SP1;DYRK2;ELOVL5;SNCA
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.6737622623963873,1.3145716428065441,0.16129032258064516,0.8221452322671094,1.0,8/19,16.07%,TOX;NFIL3;ULBP2;CD244;ELF4;IL21R;ULBP3;PIK3CD
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.7564315329793376,1.3145048574436773,0.125,0.8209252256978994,1.0,3/14,3.71%,SIRT1;SASH3;SAMSN1
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.7723734496140992,1.3143828620010929,0.19230769230769232,0.8201004584810296,1.0,4/7,15.90%,SIRT1;PLCG2;CD74;GPRC5B
prerank,GO_Biological_Process_2021__regulation of nephron tubule epithelial cell differentiation (GO:0072182),-0.7774080521147564,-1.314356891669189,0.125,1.0,1.0,2/6,6.36%,CD24;PAX2
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),0.7750968648803634,1.3141238854256643,0.18032786885245902,0.8198753772400715,1.0,4/7,15.11%,SIRT1;STARD4;PROX1;STAR
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.751988121026768,1.3138288071468718,0.13636363636363635,0.8197656516336204,1.0,2/14,5.78%,SLC5A8;RNLS
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.787105627725708,-1.3132043012414507,0.1568627450980392,1.0,1.0,1/9,6.80%,B3GALT5
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.7724205719849278,1.312995840720097,0.16326530612244897,0.8227666194965101,1.0,3/9,11.62%,SHMT2;MTHFD2L;MTHFD2
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.4719447718942627,-1.3129800577349282,0.0196078431372549,1.0,1.0,15/388,3.83%,CD44;TBC1D10C;RAB44;MPO;SELL;DNASE1L1;HGSNAT;CD53;BST1;LILRB3;STK10;ALOX5;PRKCD;AHSG;CRACR2A
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.6766328130155737,1.3123896626517573,0.06,0.8246611225617112,1.0,6/17,15.26%,TMTC2;POMT2;FKRP;CRPPA;SDF2L1;TMTC3
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.809951490213477,1.311953018756588,0.1509433962264151,0.8253866799521088,1.0,1/8,1.94%,SIRT1
prerank,GO_Biological_Process_2021__negative regulation of B cell differentiation (GO:0045578),-0.8680101187340923,-1.3119349311647903,0.14893617021276595,1.0,1.0,2/5,6.07%,INHA;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.8407046525234989,1.3117235555707045,0.11538461538461539,0.82535897041379,1.0,3/9,12.47%,LGALS9;BMPR1A;CD34
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.7195944891948948,1.31170894070505,0.14285714285714285,0.8239915720186792,1.0,5/11,17.81%,PHGDH;SRR;CBS;CTH;PSPH
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.7697431293203325,1.3100521372815552,0.08620689655172414,0.8316056043045511,1.0,1/9,7.50%,BICD1
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.6687868838521238,-1.3097753353873005,0.2,1.0,1.0,8/23,14.29%,KCNE2;KCNE1;SLC11A1;KCNQ1;KCNA5;ATP4A;SLC4A4;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.4729504024372138,1.3095425008259163,0.05,0.8326985068947993,1.0,49/378,10.31%,MITF;LGALS9;NOX5;IGF1;FGF10;RBM20;ITGAX;ITGB8;MYC;TGFBR1;IL26;ZBTB7B;IL4;PRR16;HIF1A;RAB27A;MYCN;FGF2;KAT2B;ANGPT1;CALCR;ACTG2;BMP2;SF3B1;EIF3E;SAMD4A;SP1;LIN28A;RBPJ;ZNF804A;MOV10;TLR2;PLCG2;VSIR;TICAM1;F3;PAX6;IL15;AGR2;CCDC88B;RAMP3;SMAD1;RIMS2;ANK2;TMIGD2;FGF17;CTCFL;GSN;CADM1
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),0.6459056844125872,1.3091616054966373,0.15555555555555556,0.8334035631054341,1.0,3/16,13.29%,AASS;SNCA;NOC2L
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.8695580142305335,1.3089964501437035,0.16071428571428573,0.8331816407723366,1.0,1/6,2.54%,HIF1A
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5649618264558438,-1.3089657429997001,0.07017543859649122,1.0,1.0,6/79,6.82%,SLC28A2;SLC6A6;ABCC4;SLC22A8;SLC13A3;SLC7A3
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.5798672169268384,1.3089421857842933,0.13043478260869565,0.8319700819735197,1.0,18/42,30.85%,PRR5L;ZFP36L2;MOV10;TOB1;ZC3HAV1;RIDA;CNOT8;PNPT1;ZFP36;NANOS1;YTHDF2;MEX3D;PUM1;PABPC1;RC3H1;YTHDF3;YTHDF1;CPEB3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.6902030282011331,1.3088207420187616,0.1724137931034483,0.8313469807440643,1.0,6/18,15.49%,GSTM2;SLC8A1;ANK2;ATP1A2;DMD;RYR2
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.7871511389812641,1.308616834525304,0.1836734693877551,0.831197101968465,1.0,1/6,3.70%,SLC38A3
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.7440557703637984,1.3084016737449733,0.09803921568627451,0.8310477454185647,1.0,4/13,13.89%,RPP25;RPP25L;RPP40;HSD17B10
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.586811015386338,-1.308382531498278,0.10204081632653061,1.0,1.0,7/39,2.96%,ANXA8;EHF;DUOXA1;NUPR1;C6ORF132;MGP;IL1RL2
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.5168612086852209,1.308100155961585,0.08,0.8313683175237957,1.0,46/163,17.14%,DACH1;EPHA7;PNOC;SLC35F1;EDIL3;NRG1;CADM2;CLSTN2;SLC17A6;CNTNAP2;NLGN1;ISOC1;KCNH7;RALGPS2;SYT1;ZDHHC22;FUT9;MEGF10;TMEM200C;CNRIP1;ELAVL2;LINGO2;NOVA1;OLFM3;ACHE;FAM171B;SMAD1;ANK2;ADGRB3;NHLH2;PAK5;LZTFL1;NOL4;ZNF536;MAPK8;GPM6B;TMEM170B;NBEA;RIMS4;FAT3;DNM3;CNTN2;GRID2;GNL3L;HMGCLL1;FLRT3
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.8094418354468944,1.308060919685408,0.10909090909090909,0.8300811678195302,1.0,1/10,0.15%,STK26
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.5672010607702055,-1.3078955078806054,0.19607843137254902,1.0,1.0,13/65,10.48%,EPN1;TEK;COL4A2;ALOX5;ANGPT4;NIBAN2;NAXE;SARS1;FOXO4;ADAMTS9;CREB3L1;SPARC;SPRED1
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.5397682504882938,1.307364021859901,0.09433962264150944,0.8327857650387688,1.0,25/93,13.44%,MXRA5;LAMA4;MRGPRF;ITGA8;PRRX1;PRKG1;ITGA11;ADGRL4;MSRB3;SSC5D;BGN;CXCL12;POSTN;CCDC80;PDGFRA;ABI3BP;DLC1;PCDH18;MYH11;MEDAG;HMCN1;SYNPO2;TBX18;RBMS3;ABCA8
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.7174810548431683,-1.30726795753121,0.20930232558139536,1.0,1.0,1/11,1.28%,INHA
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.8662780616446206,1.3072344846551471,0.17647058823529413,0.8320565367778862,1.0,2/5,10.13%,SEC22B;TAP1
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),0.7214900865140045,1.307193819740754,0.12727272727272726,0.8308192643952949,1.0,4/21,10.25%,ZDHHC11;IL4;STING1;IL23R
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 cell differentiation (GO:2000321),0.8536961759160013,1.3071429121229161,0.14545454545454545,0.8296305787095235,1.0,3/6,10.30%,NFKBIZ;IL23R;NFKBID
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.6903634346160374,1.3064862668503634,0.10526315789473684,0.831410330047053,1.0,4/14,18.05%,LIN28A;MRPL44;PRKRA;AGO3
prerank,GO_Biological_Process_2021__regulation of t-circle formation (GO:1904429),-0.8912493130829522,-1.3064576075465184,0.14814814814814814,1.0,1.0,3/5,10.00%,SLX4;ERCC1;RTEL1
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.723936201061236,1.306398185393672,0.1111111111111111,0.8304897212376787,1.0,3/15,14.62%,KCNC2;MAT2A;TMEM120A
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.7325159834191425,1.3050042796164234,0.1694915254237288,0.8371340790202365,1.0,3/11,3.79%,MYC;FGF2;BMP2
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.7953124976387189,1.3049981469333296,0.22641509433962265,0.8357226385933103,1.0,2/5,19.85%,PRPF39;SFSWAP
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.5011405084943922,1.3042940785501793,0.045454545454545456,0.8380730162838969,1.0,54/182,21.67%,LGALS9;TNFRSF19;SIRT1;F2R;ROR1;CANT1;RORA;PELI2;SLC35B2;MID2;RELA;PELI1;TIFA;ESR1;PLCG2;TICAM1;CD40;PPM1A;TAB2;TSPAN6;TNFRSF10B;CASP10;CPNE1;ZFAND6;IRAK1;HSPB1;TANK;CD74;IKBKE;TRIM52;GPRC5B;LGALS1;TAB3;EEF1D;BIRC3;FADD;ZDHHC17;RIOK3;NDFIP2;C18ORF32;TFG;GPR89A;PIM2;ZDHHC13;SLC20A1;ATP2C1;TICAM2;RIPK2;IKBKB;CARD16;ANKRD17;TMEM101;TNIP3;CARD9
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.7251802361395979,1.304217471934608,0.1864406779661017,0.8371253884972278,1.0,3/11,11.51%,TTLL2;TPGS1;TTLL9
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.7323941166067985,1.3040808420262486,0.23728813559322035,0.8363999480232098,1.0,6/8,22.72%,TOX;NFIL3;PIK3CD;AXL;PTPRC;PBX1
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.7775050396085346,1.3037538696626183,0.17307692307692307,0.8369447751057798,1.0,2/8,13.70%,DCUN1D1;UBA3
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.7394097877119006,-1.3035951391521297,0.17647058823529413,1.0,1.0,1/8,4.30%,ATG14
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.7336097563494153,1.3035237520182592,0.11538461538461539,0.8365930702500285,1.0,1/14,0.48%,IGF1
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),-0.8682967528385249,-1.3034479969895532,0.1111111111111111,1.0,1.0,3/5,10.80%,SLC6A6;SLC6A11;SLC6A12
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.5565261527453694,1.3032014787614852,0.13636363636363635,0.8373099993345818,1.0,6/65,2.93%,MME;MYC;SIRT1;CDC25A;ZBTB1;NEDD4
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),0.8400715934805472,1.3031026406246045,0.1346153846153846,0.8362846891064605,1.0,2/6,7.98%,RNLS;SPX
prerank,GO_Biological_Process_2021__regulation of immunoglobulin mediated immune response (GO:0002889),0.8108127836537886,1.3030304393870875,0.16981132075471697,0.8351759990500877,1.0,2/5,9.65%,IL4;NECTIN2
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.5289029809506296,1.3029509716222538,0.09259259259259259,0.8342227684675423,1.0,18/103,9.36%,MXRA5;LAMA4;TMEM100;PRRX1;PRKG1;LRP4;BGN;CXCL12;EFS;POSTN;PDGFRA;ADGRL2;LIFR;PCDH18;ANK2;GFRA1;MAGI1;GUCY1A2
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.689972885619502,-1.3027480730368106,0.15217391304347827,1.0,1.0,4/16,7.82%,SIGIRR;AHSG;IL6R;MYLK3
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),0.8139961004625269,1.3027237583736724,0.125,0.8342680874929894,1.0,1/7,0.93%,F2
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6458929749466881,1.3026183354812317,0.14,0.8334923986420144,1.0,7/29,10.19%,VEGFC;FLT1;RELA;MAPKAPK2;GAB1;PIK3CA;NUS1
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.8535699918520336,1.3025441231832975,0.1346153846153846,0.8326330519033226,1.0,2/7,11.30%,PEX12;ZFAND6
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.7081372627040297,1.3024151746357147,0.1568627450980392,0.8317765840481776,1.0,3/11,8.25%,FGF2;ITPKB;IP6K3
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.698209425864798,1.3021012738617326,0.13043478260869565,0.831933156011407,1.0,6/15,12.92%,BMP2;PPP1R15B;MAGI2;ITGA1;MEF2C;MTMR9
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.6859766442873346,-1.3018012207018295,0.18,1.0,1.0,3/21,2.68%,CLDN4;DUOX1;CLDN1
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.7519489841671034,1.3015367068958867,0.2,0.8336126672140987,1.0,4/11,11.70%,TMEM100;F2R;SPX;ATPSCKMT
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),-0.7603812333033575,-1.3014915685476358,0.17073170731707318,1.0,1.0,5/11,16.51%,RTP1;RTP5;TAS2R5;TAS2R8;AZGP1
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.6872479541545858,1.301223685620145,0.09433962264150944,0.833894185829127,1.0,3/22,7.97%,CGNL1;TMEFF2;DLC1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.6110503677192205,1.3012139464579782,0.10869565217391304,0.8325494463175819,1.0,6/24,16.70%,SIRT1;PAXIP1;AUTS2;SMAD4;MYB;CTNNB1
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.6835563936210399,1.3005827308593279,0.12962962962962962,0.8343263155344961,1.0,4/18,13.67%,SHMT2;MTHFD2L;MTHFD2;SLC19A1
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.6598876385389199,1.300494833382583,0.18518518518518517,0.833390302181372,1.0,7/24,7.10%,F2R;LRP4;NEDD4;CACNB4;PPFIBP1;UNC13B;ZC4H2
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.8412970503711129,-1.3002361430144909,0.18,1.0,1.0,1/6,0.36%,SELP
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.8012371466081579,1.300051732944267,0.18867924528301888,0.8330996447934194,1.0,2/6,11.90%,PPARG;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.8012371466081579,1.300051732944267,0.18867924528301888,0.8330996447934194,1.0,2/6,11.90%,PPARG;NR1H3
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.5214914070995093,-1.2999870431577614,0.045454545454545456,1.0,1.0,8/131,4.08%,CD44;TEK;COL4A2;NLRP3;COL5A1;COL4A1;SLC6A6;PHEX
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.5666962036282854,-1.2999546590446178,0.07272727272727272,1.0,1.0,6/77,6.82%,SLC28A2;SLC6A6;ABCC4;SLC22A8;SLC13A3;SLC7A3
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.6594144682957107,-1.2998250663605546,0.11363636363636363,1.0,1.0,7/28,7.57%,P2RY10;KLRC1;SIRPG;SELL;LTB;KLRB1;CD5
prerank,GO_Biological_Process_2021__lipoprotein metabolic process (GO:0042157),0.844963105045412,1.2995820750426428,0.11538461538461539,0.8339730846331969,1.0,2/5,7.72%,NPC1L1;MTTP
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),0.8288341149904369,1.2995604743911373,0.2037037037037037,0.8327685539460947,1.0,1/5,2.54%,HIF1A
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.8025270697839139,1.2995301140861049,0.12727272727272726,0.831589125119304,1.0,1/6,7.50%,BICD1
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.509082560138712,1.2992357323520989,0.10638297872340426,0.8322496938641755,1.0,18/125,10.58%,IGF1;IRGM;IRS1;HIF1A;TFEB;RNF152;PRR5L;ZBTB20;MID2;MOV10;TP53INP1;TICAM1;HMGB1;SNCA;FOXO3;ZC3HAV1;TRIM65;FOXO1
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.6214684258522445,-1.2992134010096525,0.1276595744680851,1.0,1.0,1/24,0.04%,CYP1A2
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),0.8227787329275513,1.2988458021515967,0.13793103448275862,0.8328448859753164,1.0,3/6,14.59%,ABHD3;OXSM;OLAH
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.6388930750591203,1.2988329496519098,0.07894736842105263,0.831523872642117,1.0,10/31,11.46%,CLSTN2;CDKN2AIP;LGI1;SYT1;SCRIB;SNCA;RAMP3;GRIK2;RIMS2;VAMP3
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.7628635692692203,-1.2985100564715084,0.13953488372093023,1.0,1.0,5/10,16.51%,RTP1;RTP5;TAS2R5;TAS2R8;AZGP1
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.5243886968713253,-1.2984505105553765,0.13793103448275862,1.0,1.0,17/89,9.52%,RFX6;NPAS4;CAMK1G;KIRREL2;KIF12;SLC22A8;UMOD;DLL4;PAX2;ARNT2;SPRED2;UCHL1;TTBK1;CYS1;SLC22A6;WWC1;VDR
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.5828741734664717,1.2983893703119878,0.12962962962962962,0.8328113525587214,1.0,10/51,10.84%,SMAD6;TGFBR1;BMP2;RAB31;LTBP2;WWTR1;UBE2D3;PPM1A;SMAD1;BMPR1A
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),0.8269751242822738,1.2983765049255414,0.18181818181818182,0.8314947039238633,1.0,2/6,7.29%,FER;IL15
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.6035694867987111,1.2978800211877006,0.08928571428571429,0.8331548318264609,1.0,6/41,7.47%,SMOC1;PBX3;MAFB;SIX4;PAX6;CHD7
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.7434958740067599,1.2977967890908184,0.14583333333333334,0.8320299972489349,1.0,1/12,0.64%,DRD5
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.7835117895772754,1.297551170918146,0.10416666666666667,0.8318477419010228,1.0,7/11,15.94%,LRP4;NLGN1;CEL;PTPRD;NLGN4X;PTEN;CNTN2
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.8059394494726815,-1.2975114945503494,0.13636363636363635,1.0,1.0,1/7,0.22%,TAFA3
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.5973252778854121,1.297068747838367,0.12244897959183673,0.8328742887460143,1.0,11/25,26.29%,RAB31;RAB34;GGA1;GOLPH3L;MACF1;BLZF1;VAMP4;GCC2;GOLGA4;ARFRP1;SPTBN1
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.6686797671795728,-1.2968867957770844,0.19047619047619047,1.0,1.0,2/16,6.07%,TEK;SFRP1
prerank,GO_Biological_Process_2021__response to morphine (GO:0043278),-0.8762899255519132,-1.296771885358941,0.24489795918367346,1.0,1.0,1/5,4.93%,DRD2
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.7447851288304971,1.2966394766731177,0.14814814814814814,0.8333983728622414,1.0,3/12,8.78%,TGFBR1;PDGFRA;DSCAML1
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.5677577141518666,1.2966143405138715,0.043478260869565216,0.8321765939370547,1.0,17/59,21.16%,LGALS9;MAP3K11;TNFRSF19;TAB2;MAP4K2;MAPK8;IRAK1;ARHGEF6;TAB3;MAPK10;MAP3K8;ADORA2B;GPS1;RIPK2;IKBKB;ZFP36;MAPK3
prerank,GO_Biological_Process_2021__protein sulfation (GO:0006477),0.8590866368437458,1.2965644013510966,0.1836734693877551,0.831062408409169,1.0,1/5,0.89%,HS3ST5
prerank,GO_Biological_Process_2021__maintenance of protein location in extracellular region (GO:0071694),0.8324630018909744,1.296560107749784,0.14035087719298245,0.8297448407139775,1.0,3/5,15.72%,LTBP1;DAND5;FBN1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.6621394958401896,-1.2961273121998145,0.06976744186046512,1.0,1.0,2/29,1.76%,TERT;TERF2IP
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.5720385863683641,1.2957847862328224,0.08928571428571429,0.8328328942092732,1.0,26/78,19.49%,THRSP;PPARG;SCD;NPC2;RORA;SP1;FDFT1;HDAC3;HMGCS1;SMARCD3;NCOA2;TBL1X;NR1D2;MVD;FASN;ACACA;CHD9;ACACB;SC5D;RORC;SQLE;CCDC3;IRS2;PLPP1;DHCR7;MID1IP1
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.7308677105552202,-1.2956597867610806,0.22448979591836735,1.0,1.0,3/10,13.64%,TNFSF18;SLC11A1;IFNK
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.6229052179564567,-1.2956501498736475,0.13725490196078433,1.0,1.0,3/39,5.43%,EPN1;MVP;PTPN3
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.6255518244166841,1.2953447194239263,0.16071428571428573,0.8339304957017815,1.0,6/30,10.88%,SLC26A3;RAPGEF3;AANAT;SLC26A6;CRHBP;HCN1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.7460629121488316,1.29507797759783,0.1702127659574468,0.8338711165758278,1.0,5/14,12.76%,AK3;EFL1;GNAI3;RAB23;ENTPD7
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.6406008203995246,-1.294495997781107,0.17073170731707318,1.0,1.0,3/31,1.10%,ACTC1;MYH7;SCN5A
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.6666771640226042,-1.2943906453647627,0.2,1.0,1.0,4/15,10.30%,TIE1;BTK;HCK;HES7
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.6271342117639743,1.2943872724365861,0.15555555555555556,0.8361562908954946,1.0,7/28,9.74%,SLC26A7;SLC26A6;CA13;SLC39A8;SLC4A7;CYB5R4;CA2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.7694072119116235,1.2943683721007397,0.16363636363636364,0.8349027049336504,1.0,1/12,0.52%,CTDNEP1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.5749546931892602,1.2940046338982467,0.06896551724137931,0.8352520392399957,1.0,5/57,5.73%,MITF;MED17;CDKN2A;RELA;MOV10
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.833973110342723,1.29399992437212,0.125,0.8339220200692314,1.0,2/7,3.50%,PPARG;CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.7612878368557928,-1.2938040810021882,0.21951219512195122,1.0,1.0,2/10,1.23%,IL10RB;NUPR1
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.7451038952939779,1.293182919815814,0.17391304347826086,0.8365399562077337,1.0,3/10,3.41%,MITF;LRMDA;ENPP1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.7611223018600414,1.2929058964137934,0.21818181818181817,0.8365382047378682,1.0,2/8,9.35%,RPP40;RRS1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.5892766438666683,1.2927175609245403,0.15217391304347827,0.8360476016519225,1.0,15/57,20.20%,IGF1;TGFBR1;FGFR1;IL4;RELA;ITGAV;PELI3;TNFRSF10B;PML;WWOX;PHIP;FADD;TNFRSF10A;DEPTOR;FEM1B
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.5488487360502359,1.2921289060275887,0.07407407407407407,0.8386497476163769,1.0,17/86,13.87%,SYK;RIT2;CD22;SEPTIN4;ZFYVE16;RALA;SYT1;ITGAV;RAB3C;RNF139;ABL2;RIMS2;HIP1;HAP1;PICALM;STON2;RAB33B
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),0.8000743804485367,1.29210922318031,0.11320754716981132,0.8374263899558082,1.0,1/7,0.53%,FGF10
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.6549185173517394,1.291419254078057,0.09615384615384616,0.8396329718754,1.0,6/27,9.73%,RUNX1;KANK2;ESR1;KCTD6;LATS1;UBA5
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.8080559694280358,1.2913604033179376,0.13793103448275862,0.8387560114996842,1.0,2/8,9.52%,DAPK2;PIK3CA
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.6625383688192334,-1.291350636696388,0.06818181818181818,1.0,1.0,2/28,1.76%,TERT;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.8019577462315091,1.2912636707335885,0.2,0.8378818088609991,1.0,1/8,0.93%,F2
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.7090479265154727,1.2911179039126726,0.14814814814814814,0.8373331860031643,1.0,5/14,13.37%,PPARG;EHD1;ABCA1;NR1H3;MSR1
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.7494384778593338,1.2908902538083464,0.19298245614035087,0.8373100676246286,1.0,4/8,23.10%,DNAJB2;SACS;DNAJB1;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.7240091400007069,1.290795621850772,0.14545454545454545,0.836482460120813,1.0,3/13,2.81%,SEMA5A;FGFR1;FGF2
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),0.8275167154979415,1.290746729219262,0.18604651162790697,0.8340730432358069,1.0,2/6,3.24%,STARD4;LDLR
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),0.8275167154979415,1.290746729219262,0.18604651162790697,0.8340730432358069,1.0,2/6,3.24%,STARD4;LDLR
prerank,MSigDB_Hallmark_2020__Apical Surface,0.6185850570778364,1.2906398975121,0.12244897959183673,0.8332343251045846,1.0,13/37,21.01%,EFNA5;ADIPOR2;ATP6V0A4;SCUBE1;HSPB1;PLAUR;GAS1;DCBLD2;IL2RB;ADAM10;LYN;EPHB4;ATP8B1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.7005759871673946,-1.2906287184786465,0.09615384615384616,1.0,1.0,5/19,9.36%,SCN5A;KCNE2;KCNE1;KCNQ1;KCNA5
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.4991335344267305,1.2906214931146778,0.1320754716981132,0.8320584042539892,1.0,44/178,20.71%,SIPA1;CDKN2C;SIRT1;TGFBR1;CDK11A;URI1;SOCS2;ENPP1;CDKN2A;CDKN2AIP;LGI1;NRG3;NAIF1;DNAJB2;CHPT1;SERTAD2;PAK5;DACT3;SMAD4;GNG4;EXOSC4;BCAR1;ACVR1B;RAB33B;PML;ZNF639;RPS6KA1;DERL2;FRZB;SLC44A4;SGK1;BAP1;SMARCA2;DCBLD2;TP53;H3-3A;ADAM10;BRAT1;SLC25A33;FBP1;BMPR2;ST7L;NCBP1;ADNP2
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.6174650145065731,-1.2904444077903199,0.14583333333333334,1.0,1.0,6/29,9.83%,EPN1;FGF1;ALOX5;CEACAM1;ADAMTS9;CREB3L1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.7630072731606605,-1.2904115741473168,0.22,1.0,1.0,5/10,16.18%,PLAAT4;ETV4;VDR;PRKCH;MED1
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.7669638890740553,1.2903668583738914,0.14,0.8323430600019276,1.0,2/6,14.89%,PRR5L;RICTOR
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.6790334990285384,1.2903173650671307,0.11764705882352941,0.8312518749429365,1.0,9/18,19.73%,CCL5;CXCL12;MOSPD2;HMGB1;GREM1;ANO6;PLA2G7;LGMN;LYN
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.5440995235992008,1.2900713446098915,0.15517241379310345,0.8311588723218425,1.0,11/55,16.98%,IGF1;PRR5L;TENM1;PCM1;UNC13B;ACHE;MYOM1;ZFAND1;GOLPH3L;RAB29;CD2AP
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),-0.6428261163602363,-1.2895203504373807,0.14285714285714285,1.0,1.0,1/29,0.17%,TERT
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.8177491590965028,1.2894424898212093,0.18032786885245902,0.833291074354709,1.0,1/7,2.84%,KAT2B
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.4829380039094279,1.2892448753728993,0.038461538461538464,0.833096038488791,1.0,43/195,18.55%,ESPL1;MAP3K11;TOP2A;SAC3D1;NDC80;PLEKHG2;FGD4;FBXO5;LLGL1;DLGAP5;PDLIM5;ARHGAP5;MYO1E;PCM1;LATS1;EPB41;RAPGEF6;GSN;BIN1;RASAL2;RANBP9;PXN;ANLN;NCK2;BCAR1;CNTRL;SOS1;RACGAP1;LMNB1;PCGF5;RICTOR;DOCK4;CNTROB;DST;KPTN;NOTCH2;CD2AP;WASL;FARP1;STK38L;SUN2;RASA2;SMC3
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.7502109266580994,1.288938044772878,0.14754098360655737,0.8335155311780121,1.0,1/8,3.93%,DCC
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6857389203408835,-1.2881051076759034,0.12244897959183673,1.0,1.0,3/13,8.89%,NTRK1;TEC;TXK
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.8277209206682035,1.2879014933083552,0.22580645161290322,0.8380664250686684,1.0,1/6,0.50%,ADRA1A
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.5988573870787942,1.2878507798924816,0.10909090909090909,0.837094964991949,1.0,18/40,24.14%,IGF1;MYC;BMI1;PDGFRA;PDGFC;LIG4;CD74;PEX2;CTNNB1;WNT2;CDK4;TP53;GAS6;MED25;B4GALT7;CDK6;DDR2;DHX9
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.6581430614525959,1.2876449218976411,0.14814814814814814,0.8368361525060014,1.0,3/21,8.93%,MITF;MED17;PAXIP1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.7110771900010919,1.2876258735225994,0.10204081632653061,0.8357317722223129,1.0,4/17,10.92%,IGF1;BIN1;HAP1;RTN1
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.8294111806728288,-1.2873613621384645,0.12195121951219512,1.0,1.0,2/7,9.13%,ERCC1;RAD50
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.6757623623127527,1.2872625300486695,0.1875,0.8364388181963189,1.0,4/16,9.16%,CCDC125;DLC1;ABL2;KANK1
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.5747837478717871,1.287227726040613,0.10416666666666667,0.8352991712797854,1.0,15/64,21.85%,SIRT1;LIN28A;HDAC3;TELO2;PIK3CA;EPM2A;RRAGC;RICTOR;PRKAA1;DYRK3;RRAGD;MLST8;DEPTOR;GAS6;GPAT3
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.7852945454875087,1.287116701575193,0.17543859649122806,0.8344568907340785,1.0,2/9,2.39%,ANTXR2;SLC22A3
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.8234230454774268,1.2869594617401545,0.16666666666666666,0.833910618721888,1.0,1/7,1.67%,SYK
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.8115977735992983,1.2869341327706922,0.24074074074074073,0.832780010012382,1.0,2/5,13.65%,HRH3;GRM7
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.8491800269384896,-1.2868650262372014,0.2222222222222222,1.0,1.0,1/5,3.41%,ALOX5
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.7562732370381178,1.2865991288313467,0.14285714285714285,0.833271631048136,1.0,7/11,19.55%,CCL5;CXCL12;MOSPD2;HMGB1;ANO6;PLA2G7;LGMN
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.702405097759429,1.2864199705890906,0.20754716981132076,0.8331191188384122,1.0,1/16,0.40%,PNP
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.6656404151624816,1.2863553893608366,0.15384615384615385,0.8322281739146176,1.0,6/22,17.32%,MT4;SLC39A8;SLC39A12;SLC30A10;MT1M;SLC30A1
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.8328124896941349,1.2859326750397493,0.1694915254237288,0.8329902136040336,1.0,2/7,2.31%,ZBTB7B;ERBB4
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.6222820616878789,1.2854240104030639,0.1509433962264151,0.8344866197625923,1.0,10/33,16.70%,MYC;TGFBR1;URI1;ACVR2A;HTRA2;BMPR1A;CPNE3;ACVR1B;LRP2;CTNNB1
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.7614567580128839,-1.2852151595156573,0.18181818181818182,1.0,1.0,2/6,13.10%,BUD23;EMG1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.6927475591386997,1.285012032421648,0.07272727272727272,0.835030038831715,1.0,5/23,12.91%,RNF185;AUP1;KLHL15;RNF5;POMT2
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.8325862002743172,1.2849692365199363,0.11627906976744186,0.8339676307988143,1.0,2/7,6.82%,LGALS9;VSIR
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.7113225153461653,1.2848490044654928,0.18181818181818182,0.8332364894339095,1.0,3/16,8.32%,CALCR;ADGRV1;RAMP3
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.7991275101499384,-1.2846186472228402,0.1320754716981132,1.0,1.0,1/9,0.33%,ALB
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.7991275101499384,-1.2846186472228402,0.1320754716981132,1.0,1.0,1/9,0.33%,ALB
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.7100858857331288,-1.284576310854881,0.17777777777777778,1.0,1.0,1/12,0.60%,HK2
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.774622339644354,-1.284264085573627,0.14285714285714285,1.0,1.0,2/10,4.09%,DNASE1L1;REXO4
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.6086135924182815,1.2840252116574737,0.15254237288135594,0.8358990022655525,1.0,12/38,24.21%,LIN28A;HDAC3;TELO2;PIK3CA;RRAGC;GPR137B;RICTOR;RRAGD;MLST8;GAS6;HTR6;PIP4P1
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.6712042742540215,-1.2839366383449604,0.21818181818181817,1.0,1.0,3/20,7.13%,DUSP4;DUSP6;PPP1CA
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.5387704330230878,1.2838046851010607,0.07407407407407407,0.8360522365252671,1.0,12/87,12.71%,CSTA;F2;SYNCRIP;TM4SF20;SAMD4A;LIN28A;TOB1;RNF139;PATL2;RIDA;DNAJC1;KNG1
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.7481379208880649,1.2835199264682497,0.16326530612244897,0.8363587091841482,1.0,3/11,11.62%,SHMT2;MTHFD2L;MTHFD2
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.5913798295493401,1.2834156449963665,0.1276595744680851,0.8358010145570521,1.0,14/34,20.26%,SOCS2;ITPKB;PIP4K2A;PIK3C2B;SOCS6;SMG1;IP6K3;PIK3CA;EFR3A;PI4K2B;PIK3CD;SOCS7;IP6K1;PIK3R3
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.6849810165587812,1.2834103113875395,0.1,0.834574564266647,1.0,5/19,14.46%,SMAD6;ROBO2;BMPR1A;SMAD4;LRP2
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.5984615295573527,1.2831079159034022,0.14545454545454545,0.8349774991320139,1.0,6/34,10.47%,NEDD4;UTRN;TCAF2;FGF12;ANK2;SCN2B
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.669900527084065,1.2828767081878947,0.17647058823529413,0.8348444960758381,1.0,4/24,7.75%,IGF1;PPARG;PYHIN1;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.8351459725832532,-1.2828426043267747,0.18,1.0,1.0,2/5,7.78%,EGR1;CLU
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),0.8588459541600947,1.282751887574659,0.2127659574468085,0.8342160796576968,1.0,3/6,9.74%,MYC;NGB;CA2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.7706863492057274,1.2825369340083652,0.18032786885245902,0.8342369290210009,1.0,3/8,10.30%,NFKBIZ;IL23R;NFKBID
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.7028664717253714,-1.2824732521695366,0.21568627450980393,1.0,1.0,2/22,5.36%,GFRA3;GPC1
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.8301121388925123,-1.282336148013841,0.14583333333333334,1.0,1.0,1/6,5.75%,KMT2B
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.5946926254699509,1.2823339293690896,0.14814814814814814,0.8339535067661821,1.0,9/34,12.41%,WNT4;FBXO5;BMP2;ADGRV1;ACVR2A;SLC8A1;BMPR1A;MEF2C;GPM6B
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.792818563022481,1.2822909739153239,0.13043478260869565,0.8318157365173432,1.0,4/8,13.52%,ABHD17B;ABHD17C;ABHD10;LYPLA1
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.792818563022481,1.2822909739153239,0.13043478260869565,0.8318157365173432,1.0,4/8,13.52%,ABHD17B;ABHD17C;ABHD10;LYPLA1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.6502269035762507,1.2821796802497112,0.125,0.8311774791153344,1.0,11/25,21.86%,SCD;SLC25A1;ELOVL5;SCD5;ACSBG1;FASN;ACACA;TECR;ACSL4;ELOVL6;ACSL1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.7571048508049378,1.2820271844441944,0.14893617021276595,0.830767914288542,1.0,5/7,22.11%,BOK;DLC1;TP53BP2;TP53;FAP
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.8310004848983521,1.281943225790806,0.11764705882352941,0.8299443347721135,1.0,2/5,14.60%,CEP120;CCP110
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.8299095872256858,1.2818878184659086,0.17307692307692307,0.8289535577949452,1.0,1/7,0.68%,SMAD6
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 methylation (GO:0051574),0.8427445015211132,1.281685148622891,0.1568627450980392,0.8288501401583799,1.0,2/6,12.66%,SIRT1;MYB
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.8244799025818703,-1.28168090367882,0.10869565217391304,1.0,1.0,4/8,15.76%,RGS8;DRD2;CAV2;VPS35
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.5307216881675694,1.2813722893966921,0.12,0.8293483287579577,1.0,12/75,7.90%,VEGFC;SEMA5A;SIRT1;TGFBR1;HIF1A;STAT5A;FGF2;ANGPT1;BMP2;NRARP;F3;AGGF1
prerank,GO_Biological_Process_2021__negative regulation of hormone secretion (GO:0046888),-0.819052177670106,-1.2812793501441262,0.11904761904761904,1.0,1.0,1/6,2.29%,IL11
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.7295408046978678,1.2807396978669188,0.13559322033898305,0.83098962491113,1.0,4/11,19.69%,PDGFRA;PIK3CA;ERRFI1;BMPR2
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.7263703082707192,1.280241029131397,0.25,0.8326448719059772,1.0,3/10,4.63%,DERL3;INSIG1;UBE2J1
prerank,GO_Biological_Process_2021__epithelial tube branching involved in lung morphogenesis (GO:0060441),0.9058884026842784,1.2802019530366537,0.06896551724137931,0.831638666221468,1.0,1/5,0.53%,FGF10
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.6788365624850112,1.28003783486072,0.08163265306122448,0.8310837414730856,1.0,3/16,4.78%,LGALS9;IL4;IRF8
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.5106870257336527,1.2797912280537755,0.06521739130434782,0.831295257228336,1.0,16/82,13.84%,GPR55;C3;ADAM28;ALDH1A1;CLIC6;TEX26;SLC8A1;FGL2;FAM20A;ABCA1;CYP27A1;ST3GAL6;APOL6;DNAJC3;MSR1;CD74
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.7418494120003843,1.2790941888183944,0.16981132075471697,0.8336669321910367,1.0,2/7,11.11%,VSIR;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.7762549820546267,1.2788305990820201,0.1568627450980392,0.8337624950658237,1.0,1/6,10.17%,CORO1C
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.46041300476105584,1.27863805410632,0.05172413793103448,0.8333748704582026,1.0,27/250,8.01%,GATA4;LGALS9;PNP;NOX5;C3;RUNX1;SYK;IL26;F2R;FZD5;ZBTB7B;IL4;HIF1A;LY9;CD244;RORA;RELA;TLR2;SCRIB;HPSE;PLCG2;TICAM1;F3;IL15;CD40;HMGB1;CCDC88B
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.7410502502185409,1.2786088830879743,0.2127659574468085,0.8323392297032229,1.0,7/14,15.92%,GRM3;GRM8;GRM5;GRIK3;GRM4;GRM7;GRM1
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.6629530529398084,1.2784967706904946,0.24528301886792453,0.831676973206767,1.0,4/27,4.40%,GATA4;LHFPL2;WNT4;SIX4
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7267911986820053,1.2783826246854277,0.18,0.8309056624582555,1.0,2/14,0.64%,ADRA1A;DRD5
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.676006703444259,1.2783823998733939,0.14814814814814814,0.8297118324834591,1.0,5/17,14.47%,C3;EHD1;PLA2G10;MSR1;IKBKE
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.5604045440698352,-1.2782707205248585,0.125,1.0,1.0,11/63,10.85%,DDX11;PRKCD;GOLGA2;PPP1CA;IFIT2;HFE;TMC8;LRPAP1;TTBK1;ZFPM1;GTF2F1
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.5047208256898432,1.2780009338377902,0.1111111111111111,0.8305314177980947,1.0,32/93,19.30%,LAMA4;IL17RD;FGF2;TENM3;CSRP2;ALDH7A1;ZNF462;PPFIBP1;WWTR1;ADGRL2;LIFR;PCDH18;ANK2;PTPN14;MAGI1;GUCY1A2;GPR161;BMPR1A;AMOTL1;FLRT2;FIGN;RBMS3;RUNX1T1;SEMA6D;FBN1;DIXDC1;GJC1;FARP1;PHLDB1;MPDZ;DZIP1;PYGO1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.7892858518000042,1.27769162281807,0.19642857142857142,0.830814652981223,1.0,1/7,2.54%,HIF1A
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.7690639102833751,1.2775679185653732,0.23636363636363636,0.8301593147382782,1.0,1/6,4.27%,FYCO1
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6900014071552188,1.2772173308169663,0.16326530612244897,0.8306442459204658,1.0,9/18,13.00%,LRP4;NLGN1;PCLO;CEL;PTPRD;NLGN4X;LRRTM3;PTEN;FZD1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.6034960801967615,1.2767960794066773,0.1956521739130435,0.8317328501947782,1.0,7/32,17.14%,SEMA5A;LLPH;ALCAM;AUTS2;CPNE1;CTNNB1;FLRT3
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.5703087232710385,1.276629141408409,0.10416666666666667,0.8314818010555532,1.0,6/50,7.75%,LGALS9;SYK;FZD5;TLR2;PLCG2;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.7799069360320936,1.276626633065526,0.1956521739130435,0.8302990388918896,1.0,2/8,6.83%,HIF1A;TICAM1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.6558232686081665,-1.2765371752813026,0.23636363636363636,1.0,1.0,2/33,0.59%,TERT;NOSTRIN
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.7138650405136346,1.2761358542562131,0.25,0.8320772574312956,1.0,4/15,6.53%,IDO1;HPD;IDO2;TDO2
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.7700114284276045,1.2760217501826367,0.20754716981132076,0.831516860711023,1.0,3/7,11.19%,HS2ST1;EXT1;CSGALNACT1
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.720111776362643,1.2757588536373734,0.1568627450980392,0.8314860022550612,1.0,3/13,6.81%,EGLN3;PLOD2;P3H2
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.7409994293428092,-1.2753538516897187,0.23214285714285715,1.0,1.0,5/11,18.46%,AQP7;AQP8;SLC5A1;UPK3A;AQP1
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.6537110832731963,1.2752204036869674,0.10909090909090909,0.8332731758874149,1.0,3/20,3.91%,SLC12A7;SLC12A1;SLC12A3
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.5946560013177448,1.2748252583219108,0.18181818181818182,0.8342746888641734,1.0,15/42,16.94%,TSHZ3;GRM3;CDH2;NLGN1;SYT1;NRXN1;GRM8;GRM5;GRIK3;ATP1A2;MEF2C;GRM4;GRM7;GRM1;DGKZ
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.770142135620355,1.2747684500549206,0.24,0.8332792784383463,1.0,1/7,2.00%,TGFBR1
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.8043276816072307,1.2746804926387918,0.18,0.832359082519044,1.0,2/6,10.59%,MYC;TCF4
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.6113891551495624,1.2746663189944734,0.13333333333333333,0.8312426261569718,1.0,6/34,7.29%,MYC;SIRT1;CDKN2A;CDKN2AIP;ABI3;IL15
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.6032760122831702,1.274539412012121,0.1276595744680851,0.8310860504221098,1.0,12/42,12.26%,FLT1;SYK;ITGB8;TGFBR1;CDH2;RBPJ;APELA;AGGF1;EFNB2;EGFL7;HAS2;PROX1
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.7287102764239369,1.2744598732836852,0.23076923076923078,0.8302268817466505,1.0,1/11,3.79%,BMP2
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.8016814345166892,1.2743333812573794,0.19642857142857142,0.8295681331048029,1.0,2/5,7.44%,SIRT1;HDAC2
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.7264677490565756,-1.2742106003870621,0.14583333333333334,1.0,1.0,6/15,15.90%,ALOX5;ALOXE3;ALOX12B;ALOX15;PON3;LTC4S
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.7628405079649205,1.2741118217965945,0.1875,0.8284177144790807,1.0,1/10,1.06%,GSTM2
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.7628405079649205,1.2741118217965945,0.1875,0.8284177144790807,1.0,1/10,1.06%,GSTM2
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.6024690606058233,1.2740184144899598,0.14545454545454545,0.8276029122611325,1.0,5/21,11.68%,FUT9;HS2ST1;EXT1;CSGALNACT1;HAS2
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.7432997324825725,-1.2734456258259201,0.13157894736842105,1.0,1.0,4/11,16.36%,ZWILCH;SPDL1;TTK;CDK1
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.7210872787507374,1.2733074746898447,0.20408163265306123,0.8301915569046566,1.0,7/11,14.28%,PADI2;CDCA4;SERTAD2;ELOF1;ARID1A;ARID1B;SERTAD1
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.6959140497842726,-1.2732209877461984,0.21428571428571427,1.0,1.0,1/7,2.93%,RIN3
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.6633459944203932,1.2732005785929779,0.10909090909090909,0.8293586780418057,1.0,4/28,10.25%,ZDHHC11;IL4;STING1;IL23R
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),0.8404046142636552,1.2729472559696338,0.17647058823529413,0.8292778634635757,1.0,1/5,1.43%,CD99
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.7011237703611045,1.2728500980378477,0.13793103448275862,0.8286803060392898,1.0,6/11,23.85%,IL7R;PTPRT;MGAT5;PTPRC;DOT1L;JAK2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.80492006708623,1.2722620850190474,0.11538461538461539,0.8305944518586073,1.0,1/5,7.75%,HMGB1
prerank,GO_Biological_Process_2021__spinal cord dorsal/ventral patterning (GO:0021513),-0.7853667890458769,-1.272218809458892,0.2127659574468085,1.0,1.0,2/5,9.67%,DLL4;RFX4
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.7767620303895363,1.2720823043814564,0.23529411764705882,0.8305122633798487,1.0,2/7,6.70%,CKMT1A;GAMT
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),-0.815605871151243,-1.271984050776341,0.21568627450980393,1.0,1.0,1/5,1.10%,SCN5A
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.7688537399453844,-1.2718098859337674,0.23809523809523808,1.0,1.0,5/9,15.40%,DRD4;CBARP;DRD2;GNB5;CALM1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.7195014601526417,-1.2717272927732133,0.19607843137254902,1.0,1.0,1/17,0.17%,TERT
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.8362419178385172,1.2717069512152654,0.1836734693877551,0.8315487146355646,1.0,2/7,3.79%,WNT4;BMP2
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.6453454198030305,1.2716825053811003,0.14545454545454545,0.830543575660291,1.0,6/23,9.87%,KCTD21;TULP3;ENPP1;MOSMO;KCTD6;GPR161
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.49276444884762044,-1.27166705154055,0.07547169811320754,1.0,1.0,28/180,10.32%,CD44;COL23A1;COL24A1;COL4A2;ICAM3;COL27A1;COL5A1;PXDN;COL4A1;MFAP5;AGRN;MATN4;TGFBI;COL28A1;ITGA9;LAMB3;F11R;LAMB1;COL6A3;COL11A2;ADAM19;ADAMTS9;ADAMTS3;SPARC;COL1A1;MMP9;VIT;ACAN
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.8422861694327455,1.2716437115507286,0.14285714285714285,0.8295589093401767,1.0,3/6,12.26%,SIX4;CHD7;PROX1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase A signaling (GO:0010739),0.8520868684280322,1.2715774663303072,0.08196721311475409,0.8288067831007763,1.0,3/5,8.32%,CALCR;ADGRV1;RAMP3
prerank,GO_Biological_Process_2021__positive regulation of plasminogen activation (GO:0010756),0.7812412999060503,1.2712985915063515,0.2037037037037037,0.8288865100593928,1.0,1/5,5.90%,F12
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.7874716940132767,-1.2711797310353783,0.2631578947368421,1.0,1.0,2/6,7.82%,ADCYAP1;OAS3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.8094191027954031,1.2710424424153954,0.17307692307692307,0.8290541724014925,1.0,2/8,7.75%,LGALS9;HMGB1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6895838687794935,1.2709253747040372,0.18,0.8284642885496456,1.0,3/19,6.94%,IGF1;PLCG2;DYRK2
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.7295249755810347,1.2708993262049344,0.15789473684210525,0.8274364539800451,1.0,4/9,19.73%,BIN1;PICALM;EFNA1;LYN
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.5884408394613367,1.2707727842851284,0.10810810810810811,0.8267625990047678,1.0,6/46,7.75%,LGALS9;SYK;F2R;TLR2;PLCG2;HMGB1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.7772493722216737,-1.2706511959935434,0.32075471698113206,1.0,1.0,4/7,17.76%,TIE1;SMAD3;TGFB1;RGCC
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.6944745617285741,1.2705767782694495,0.18461538461538463,0.8264588094777184,1.0,3/17,2.58%,SYK;IL4;ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.6543744190900711,1.2704963309069695,0.16363636363636364,0.8245946537149166,1.0,3/19,4.73%,IGF1;HIF1A;ZBTB20
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.6543744190900711,1.2704963309069695,0.16363636363636364,0.8245946537149166,1.0,3/19,4.73%,IGF1;HIF1A;ZBTB20
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.7002777206443258,1.2704286573526762,0.24,0.8237711538930478,1.0,3/18,4.73%,F2;PPARG;ZBTB20
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.6346518647729134,1.2699788229520537,0.13725490196078433,0.8247461514636576,1.0,4/24,12.77%,PLEKHH2;NAV3;PIK3CA;HDGFL3
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.6415318055366083,1.269914822070283,0.2,0.8239769255049066,1.0,6/23,8.97%,CLSTN2;CDKN2AIP;LGI1;SYT1;GRIK2;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.713310034880758,1.2698338094274755,0.15555555555555556,0.823227173594346,1.0,2/15,3.24%,CTDNEP1;LDLR
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.7041628493055966,1.2692583101503654,0.16363636363636364,0.8250673907221859,1.0,2/19,3.72%,BOK;SYVN1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5289014127447215,1.2690360885665792,0.11538461538461539,0.8249599670401395,1.0,12/59,15.72%,SMAD6;IL17RD;SIRT1;TGFBR1;PPM1A;SMAD2;LTBP1;DAND5;FAM89B;BAMBI;VASN;FBN1
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.6996833988963875,1.2690129897023996,0.16666666666666666,0.8239694146423319,1.0,6/17,14.88%,IRGM;PYHIN1;XAF1;HTRA2;IKBKE;PLSCR1
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.6465801451826776,1.2688922281974326,0.21951219512195122,0.8235177856164609,1.0,6/24,12.71%,F2;F2R;F12;HPSE;CD34;KNG1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),-0.7454044316770425,-1.2688777324409195,0.18867924528301888,1.0,1.0,1/11,0.17%,TERT
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.49114405867881866,1.2681389442843884,0.08333333333333333,0.8263496895209033,1.0,45/139,22.04%,LGALS9;TNFRSF19;F2R;ROR1;CANT1;PELI2;SLC35B2;MID2;RELA;PELI1;TIFA;TICAM1;CD40;PPM1A;TAB2;TSPAN6;TNFRSF10B;CASP10;IRAK1;CD74;IKBKE;TRIM52;GPRC5B;LGALS1;TAB3;EEF1D;BIRC3;FADD;ZDHHC17;NDFIP2;C18ORF32;TFG;GPR89A;PIM2;ZDHHC13;SLC20A1;ATP2C1;TICAM2;RIPK2;IKBKB;CARD16;ANKRD17;TMEM101;CARD9;MIER1
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.8319809658033879,1.2672692504676777,0.1951219512195122,0.8293120083914575,1.0,2/5,9.38%,LLPH;AUTS2
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.8503746250953519,1.2671819470492676,0.15384615384615385,0.828734430579342,1.0,2/5,6.72%,ST6GALNAC3;GAL3ST1
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.7473809235712687,1.2670605109312258,0.16,0.8282616350614649,1.0,1/9,0.93%,F2
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.5658385767488119,1.266847920828071,0.09615384615384616,0.8281509463011228,1.0,6/62,6.78%,FGF10;CDKN2C;SLFN11;CDKN2A;KANK2;UBE2E2
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.7927934756566847,-1.2663009807427685,0.19047619047619047,1.0,1.0,3/10,7.45%,EIF2S3B;EIF2S2;EIF2S3
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.8186556204146027,1.2662381538811247,0.14893617021276595,0.8300482777435408,1.0,2/6,7.75%,LGALS9;HMGB1
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.7386687568998613,1.2661349091851009,0.1694915254237288,0.829301427058017,1.0,5/17,7.44%,F2;RUNX1;F2R;WNT4;HDAC2
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.8149967103468918,-1.2659345418744377,0.14893617021276595,1.0,1.0,2/5,16.26%,SLX4;MUS81
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.5203766037665739,1.265664441669553,0.12244897959183673,0.8303193423911136,1.0,10/72,7.24%,IRS1;SIRT1;ZBTB7B;INSIG1;KAT2B;PPARG;LPIN3;ENPP1;RAB31;FER
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.6206567535333273,1.2655322053152445,0.16071428571428573,0.8298988576110866,1.0,1/22,0.48%,IGF1
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.7669368808328121,-1.265037656040681,0.2,1.0,1.0,2/11,8.96%,GUCA1B;SLC22A6
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.649720969986366,1.264975686817054,0.1509433962264151,0.83159603127963,1.0,3/25,7.97%,CGNL1;TMEFF2;DLC1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.6611405255299566,1.2648855422535092,0.16071428571428573,0.8309363211745867,1.0,4/24,8.90%,FBXO5;BMI1;DCUN1D1;ARRDC3
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.7063525474447512,-1.26480899010007,0.21951219512195122,1.0,1.0,5/15,16.36%,ZWILCH;SPDL1;CTCF;TTK;CDK1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.7025207253061729,1.2646687753248722,0.20754716981132076,0.8309933527217441,1.0,1/12,1.94%,SIRT1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.741743951818525,1.2646583167164815,0.2037037037037037,0.8299621597667962,1.0,5/12,10.72%,ZDHHC12;NLGN1;PCLO;NRXN1;MPP4
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.6885975454770958,1.2642931568045332,0.21428571428571427,0.8304447948023224,1.0,2/11,11.34%,RNF185;RNFT1
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.822792881576601,1.264270060614204,0.1568627450980392,0.8294340026567736,1.0,1/5,5.68%,SDC4
prerank,GO_Biological_Process_2021__establishment of protein localization to telomere (GO:0070200),-0.8158205920035406,-1.2640986275992911,0.19230769230769232,1.0,1.0,1/5,0.17%,TERT
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),0.7674490561088592,1.263900805208415,0.29508196721311475,0.8302039389727458,1.0,3/6,18.75%,LHFPL2;NR2F2;COL9A3
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.51919422290325,1.26291190368722,0.16071428571428573,0.8336608047741338,1.0,11/95,3.79%,VEGFC;IGF1;FGF10;SEMA5A;MYC;SIRT1;TGFBR1;HIF1A;STAT5A;FGF2;BMP2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.6783617510197475,1.2625803329608678,0.11764705882352941,0.8341191532724135,1.0,3/19,5.23%,IGF1;CCL5;CCN4
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.7732123971778063,1.2623144484071194,0.22580645161290322,0.8342726876610979,1.0,1/7,2.00%,TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.8197551909032312,-1.2622207869436242,0.3018867924528302,1.0,1.0,2/6,5.43%,TIMP4;PTPN3
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),0.5795563992899339,1.2621046709448902,0.10204081632653061,0.8343079033647964,1.0,10/43,10.25%,LGALS9;CCL5;SLC26A6;SYNCRIP;IRF8;TLR2;CD40;SNCA;GCH1;IL23R
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.6573748524299323,-1.2620982365862978,0.19148936170212766,1.0,1.0,3/14,10.00%,DDX11;RAD50;RTEL1
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.7052641859653555,1.2618704808747028,0.16666666666666666,0.8348140744612439,1.0,2/13,4.18%,GRIN3A;GLRA1
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),0.8113984375700745,1.2615786601678887,0.23214285714285715,0.8352349165502806,1.0,2/5,15.15%,SLC26A6;SLC2A5
prerank,GO_Biological_Process_2021__ventricular compact myocardium morphogenesis (GO:0003223),0.800390022245894,1.2613979067781953,0.25,0.8351848421436964,1.0,4/5,14.46%,TGFBR1;DSP;BMPR1A;LRP2
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.7065519857856408,-1.261389214227386,0.17647058823529413,1.0,1.0,5/14,16.18%,PLAAT4;ETV4;VDR;PRKCH;MED1
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.6859456676905286,1.2612419914389625,0.2,0.8349840823675628,1.0,5/16,15.30%,CASR;ANK2;EPB41;GRIN3B;SLC30A10
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.6580997325505193,1.261175787628141,0.2,0.8341478961215493,1.0,7/22,12.66%,SLC12A7;SLC12A1;SLC12A3;SCNN1B;ATP6V0A4;CYP4F12;SLC26A4
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.7572568560602599,1.2610309395224082,0.27450980392156865,0.8337651557198323,1.0,2/7,2.47%,SIRT1;IL4
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.7844424160350616,1.260949103420134,0.2222222222222222,0.8330161846005929,1.0,2/6,13.40%,SNX18;SPIRE2
prerank,GO_Biological_Process_2021__regulation of bile acid metabolic process (GO:1904251),0.8050832900635172,1.2609390892119405,0.15384615384615385,0.8319690893409172,1.0,1/5,1.94%,SIRT1
prerank,GO_Biological_Process_2021__phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),0.7414670518732185,1.260816968349779,0.1836734693877551,0.8314741169963491,1.0,1/7,0.64%,DRD5
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),0.7325716466624455,1.2607217972546627,0.22448979591836735,0.8308640345053675,1.0,2/11,11.63%,RAPGEF3;SMAD4
prerank,GO_Biological_Process_2021__membrane depolarization during SA node cell action potential (GO:0086046),-0.8190036745458615,-1.2607072296640032,0.10869565217391304,1.0,1.0,2/5,4.62%,SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.8134259010660333,1.2606593339386936,0.1568627450980392,0.8300562591573301,1.0,1/7,6.30%,CHCHD4
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.7778006556908025,1.2602422117961478,0.14035087719298245,0.8305607318823536,1.0,3/7,6.01%,GRIP1;GRIP2;SCRIB
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.6925180394353467,1.2600925791451119,0.21311475409836064,0.8300701258352559,1.0,3/11,10.84%,TGFBR1;SIX4;BMPR1A
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.4869462472230196,-1.2599685661272113,0.1111111111111111,1.0,1.0,12/139,5.72%,CYP1A2;ALB;CYP2A6;ASS1;CYP2E1;HABP2;AHSG;F7;HSD11B1;FGL1;PAH;GPC3
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.5742841974614573,-1.2597003806880984,0.13333333333333333,1.0,1.0,5/47,9.57%,HK2;LDHC;PDHX;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),0.6550583812740733,1.2594027211271561,0.1724137931034483,0.8319296983065912,1.0,2/21,4.11%,PNP;FHIT
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.8109958438282971,1.259314621272123,0.19298245614035087,0.8312238286857548,1.0,1/5,2.87%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of NLRP3 inflammasome complex assembly (GO:1900226),-0.8230631676737019,-1.2592773937678898,0.2222222222222222,1.0,1.0,2/5,12.20%,MEFV;PYDC1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.6489032707657753,-1.259102350557842,0.2,1.0,1.0,3/13,22.67%,RCC1L;MPV17L2;UQCC2
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.6630202637257212,1.2585260066052122,0.2,0.8343475835945005,1.0,1/13,1.82%,CCL5
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.6451775887076407,1.2583003169843165,0.10909090909090909,0.83429954556567,1.0,7/18,19.54%,SLC17A6;UNC13B;GRIK2;GRIK3;CDH8;GRID2;UNC13C
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.7856167066907964,1.2580823283675255,0.19607843137254902,0.8342022597352671,1.0,1/7,2.97%,SLC35G1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.5116876686849994,1.2580530926696434,0.14285714285714285,0.8333656074539353,1.0,26/123,12.15%,LRRC3B;NXPH1;LSAMP;RIT2;NEGR1;GRM3;LRRC4C;KCNC2;GFAP;CADM2;NPY;PENK;NRXN1;RAB3C;OLFM3;ATXN1;SYNPR;GRM5;TAC1;LRRTM3;ADGRB3;SCN2B;PAK5;TMEM196;DPF1;ZNF536
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.6906526537674971,1.2580283496056825,0.14,0.8323833580810392,1.0,5/19,13.21%,IGF1;BIN1;HAP1;RTN1;PICALM
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.8082203937321413,1.2573841051074148,0.18181818181818182,0.8347807715346374,1.0,2/5,18.05%,MOV10;AGO3
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),0.8741251053044526,1.2572824086529093,0.09090909090909091,0.8342904144235543,1.0,2/5,5.57%,IRGM;RELA
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.7048632052050765,-1.2571229599386247,0.18867924528301888,1.0,1.0,2/9,21.52%,PGP;GK5
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),0.7546842209095945,1.2570521014200646,0.1320754716981132,0.834308224837631,1.0,2/9,12.25%,FBXO5;BAG2
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.5996838854257637,1.2570488663051445,0.12280701754385964,0.8332644442084794,1.0,8/24,10.29%,FLT1;F2;IRS1;FGFR3;FGF2;PDGFRA;EPHA8;FLT3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.6463339094464857,-1.2568827745792879,0.13725490196078433,1.0,1.0,1/21,0.17%,TERT
prerank,GO_Biological_Process_2021__SA node cell to atrial cardiac muscle cell signaling (GO:0086018),-0.7723426458971082,-1.2568363482527944,0.2,1.0,1.0,2/5,4.62%,SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.7642409952889881,-1.2565981708649654,0.26666666666666666,1.0,1.0,1/9,0.22%,TAFA3
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.8277581703190505,1.2561585454301512,0.22641509433962265,0.836382553596526,1.0,1/5,3.06%,AK3
prerank,GO_Biological_Process_2021__negative regulation of T cell apoptotic process (GO:0070233),0.8137595626380207,1.2560491844410204,0.17543859649122806,0.8357786217814067,1.0,1/5,1.82%,CCL5
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.689418685034556,1.2554850233464623,0.11764705882352941,0.8375027510169888,1.0,1/13,2.54%,HIF1A
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.7463392830253817,1.25509548664979,0.2153846153846154,0.8384425743058653,1.0,4/9,18.14%,APELA;RYR2;MESP1;CITED2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.6930636428497088,-1.2549044462811678,0.1875,1.0,1.0,4/16,8.08%,SCN5A;KCNE2;KCNE1;KCNQ1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.5362745255180447,1.2547311254068199,0.18181818181818182,0.8392177405953346,1.0,15/49,27.74%,ACD;TERF1;TENT4B;NEK7;CTNNB1;GNL3L;POT1;MAPK3;MAPK15;HNRNPU;NAF1;HMBOX1;HNRNPC;CCT3;TNKS
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.7357327536222589,1.2544704742946418,0.1836734693877551,0.8394560909547624,1.0,2/9,2.04%,ADRA1A;F2R
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.7326238760142445,1.2539432905518646,0.20754716981132076,0.8409564654143316,1.0,3/14,5.84%,TMEM100;FGF2;VEZF1
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.7319312532670734,1.2539232738733488,0.16326530612244897,0.8399633270663652,1.0,2/7,14.22%,LIN28A;TENT4B
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.6013292556014789,1.253768342646284,0.2,0.8395378227837638,1.0,11/28,23.10%,IRGM;HIF1A;CPNE1;CD74;FADD;CSF1;TICAM2;AXL;EDN1;GAS6;HSPA1A
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.6328308438661355,-1.2537638909678521,0.12244897959183673,1.0,1.0,3/24,3.44%,CD24;DUSP6;SPAAR
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.6089448505168686,1.253411711781361,0.10869565217391304,0.8402261190250503,1.0,5/28,8.92%,FERMT3;SYK;DPP4;ADA;EPHA8
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),-0.800464662848739,-1.2533295249495182,0.14285714285714285,1.0,1.0,3/5,13.11%,RFTN1;FLOT1;CAV1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.816096622631117,1.2532128486503085,0.19672131147540983,0.8400268407980129,1.0,2/5,9.40%,SEMA5A;DSCAM
prerank,GO_Biological_Process_2021__hydrogen peroxide biosynthetic process (GO:0050665),-0.8225638466921814,-1.2526018057455028,0.2692307692307692,1.0,1.0,1/5,2.25%,DUOX1
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",0.8021887859930579,1.252388890353305,0.15873015873015872,0.842771835049935,1.0,2/6,11.11%,RUNX1;HLA-E
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.7962007344210636,1.2522695261664671,0.14545454545454545,0.8424092120022433,1.0,2/6,9.78%,SHMT2;GMPS
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),-0.8296760286105991,-1.2521597901239885,0.22916666666666666,1.0,1.0,2/5,13.11%,FLOT1;CAV1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.5496690090811055,1.2521165617567085,0.17307692307692307,0.8421116784987172,1.0,18/66,16.85%,LPIN3;ABHD3;ACADS;CEL;ECI1;PECR;ACADM;ACAA2;GLYATL2;ABCD3;ABCD2;BDH2;ECHDC1;HSD17B10;AIG1;AUH;PEX2;ABCD4
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.7790825801203142,1.2520153464679527,0.10526315789473684,0.841526418576852,1.0,5/11,14.00%,LGALS9;ST18;HTRA2;GSN;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.7004326415560859,1.25186720839645,0.16,0.8412787436904094,1.0,1/16,0.48%,IGF1
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),-0.7841632303359389,-1.2517469286670533,0.2727272727272727,1.0,1.0,1/5,2.15%,FGF1
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.5811656879056007,1.2515143343668225,0.1590909090909091,0.8419109235092066,1.0,7/54,5.99%,MYC;KAT2B;SNAI1;BMP2;DLGAP5;RBPJ;NRARP
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.8460858345228379,1.2514421880505593,0.16363636363636364,0.8412482625765076,1.0,1/7,0.40%,PNP
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.6731204538379614,1.2513967205983028,0.2,0.8404118345907285,1.0,7/13,25.90%,FOXO3;SLC25A33;PNPT1;TFB1M;TFB2M;MTERF2;MTERF1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.7724013893710436,-1.251352061250829,0.2553191489361702,1.0,1.0,2/6,13.11%,FLOT1;CAV1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.6974963983557352,1.2512188576491263,0.15217391304347827,0.8403738159491068,1.0,4/17,24.68%,PRDX6;PNPLA6;GPCPD1;GDPD3
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.6835697351966626,1.2508293522621174,0.2727272727272727,0.8410039861249164,1.0,9/11,25.89%,FUT8;CSGALNACT1;GFUS;GFPT1;B4GALNT2;EXTL2;GALT;GMDS;UGP2
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.7413812176853732,1.2508169777042677,0.1276595744680851,0.8399962009002756,1.0,4/8,19.07%,BMI1;RNF2;PCGF5;PCGF1
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.6478563677403821,1.2504425022348813,0.1509433962264151,0.8407204877339481,1.0,7/24,11.63%,SELPLG;ST18;RELA;FER;ST3GAL6;PTPRT;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.7512072687537961,1.2503668564750896,0.2391304347826087,0.8400008045109784,1.0,6/9,19.41%,SCRIB;SNCA;RAMP3;VAMP3;RAB29;ANXA2
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.7711189344535405,1.2502633136331271,0.12280701754385964,0.8394728377939065,1.0,1/11,0.87%,KLRD1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.4946507400490946,1.2502170399084573,0.07894736842105263,0.8386299861316054,1.0,34/112,20.67%,GPRIN3;NRTN;NEDD4;EHD1;NPY;CNTNAP2;TTC29;NLGN1;PRMT1;MANF;LGI1;HMGB1;EPHA8;GPM6A;CARMIL1;PPP1R9A;GPM6B;HDGFL3;FAM161B;PTPRM;LRP12;ROPN1B;L1CAM;MNS1;CNTN4;FLRT3;MICALL1;STMN4;PLP1;LYN;RAPGEF2;CDK16;MAP2;ATP1B2
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.5004661487533448,1.250182520872499,0.11904761904761904,0.8376313076958057,1.0,21/111,13.69%,IRS4;IRS1;TCIRG1;ATP6V0D2;INSIG1;KAT2B;PPARG;LPIN3;ENPP1;RAB31;GAB1;FER;ATP6V0A4;FOXO1;GCK;BCAR1;SOS1;ATP6V0B;IGF1R;SH2B2;CPEB1
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.8220499370369879,-1.2501529103619835,0.2765957446808511,1.0,1.0,2/7,4.76%,APOBEC3H;APOBEC3G
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.6830719537751714,1.2499201270571327,0.22448979591836735,0.8378651706012361,1.0,8/17,23.88%,PDE4DIP;RAB33B;STX5;STX18;CAMSAP2;MAPK3;USP6NL;AKAP9
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.598540260965291,1.2499077790895399,0.16071428571428573,0.8368541261148319,1.0,10/34,17.55%,SLC12A7;SLC1A3;GLUL;IL10RA;SLC29A2;ATP1A2;SLC19A1;LRP2;SLC1A6;SLC36A1
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.7359929070848418,1.2498574481860372,0.22413793103448276,0.8361129970186263,1.0,5/9,18.59%,GSTM2;SLC8A1;TRPM2;RYR2;RYR3
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.4825909438320347,1.2497285318061104,0.058823529411764705,0.8358607691678311,1.0,31/119,21.62%,SLC7A11;RAB38;SLC22A3;SLC38A3;LRP1B;SLC38A4;SLC7A2;ABCC2;TCN2;RAMP3;SLC7A9;ARRDC3;SLC25A48;SLC15A2;TOM1;SLC52A1;SLC22A5;LRP2;LMAN2L;SLC44A4;CALCRL;SLC3A2;SLC36A1;SLC19A2;SLC7A14;SLC7A6;EDN1;SCAMP4;SLC6A15;SLC18A2;SLC7A8
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),-0.710304885749026,-1.2497006727798858,0.13953488372093023,1.0,1.0,2/9,4.93%,DRD4;DRD2
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.6966952544884236,1.2494806191378933,0.12,0.835844557801933,1.0,9/23,16.76%,ACSM2A;SIRT1;RORA;NR1H3;PLA2G12B;MLXIPL;ANGPTL4;PNPLA8;DGAT2
prerank,GO_Biological_Process_2021__regulation of glomerular filtration (GO:0003093),0.8090239399199903,1.249450797109069,0.12727272727272726,0.8349663032524886,1.0,1/6,2.04%,F2R
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.8585859087186777,1.2493398568821796,0.17543859649122806,0.8344502563913389,1.0,3/5,11.71%,KANK2;KANK1;ANLN
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.5281817849154523,1.2491490852103961,0.14893617021276595,0.8344514562378124,1.0,11/86,9.05%,MT4;VAPB;DRD5;CCL5;CXCL12;SLC8A1;SLC39A8;SLC24A2;CD40;CASR;ANK2
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.7297555197130929,-1.2491437375416639,0.3181818181818182,1.0,1.0,1/9,3.43%,PRKCD
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.7297555197130929,-1.2491437375416639,0.3181818181818182,1.0,1.0,1/9,3.43%,PRKCD
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),-0.8028992296956922,-1.2491267124619319,0.3,1.0,1.0,1/5,3.22%,TICRR
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.5216578246538566,1.249106558480517,0.09615384615384616,0.8336405641962579,1.0,17/91,12.35%,FLT1;IRGM;SIRT1;FGFR1;FGF2;PIK3R6;TENM1;PIK3R5;DIPK2A;CD40;SNCA;PDGFC;TELO2;EZH2;FLT3;PROX1;IRAK1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.6342834025620444,1.2490872383162315,0.16981132075471697,0.8326912570537638,1.0,6/27,12.37%,CDKN2C;SLFN11;CDKN2A;KANK2;PTEN;CDK2AP2
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.6292154099628818,1.2488039797039314,0.20754716981132076,0.8328815354894997,1.0,5/27,9.71%,DRD5;LGR5;CALCR;RXFP2;TMIGD3
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.7822765437457788,1.2486149059087255,0.2631578947368421,0.8326667834543534,1.0,2/8,5.24%,C3;RAB31
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.8090722127864556,-1.2483511736307056,0.2857142857142857,1.0,1.0,1/5,4.30%,ATG14
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.676320847080536,1.2475917701112296,0.17543859649122806,0.8364001068807175,1.0,1/18,1.82%,CCL5
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.5544474312104538,1.247460449178839,0.16326530612244897,0.8359643050351188,1.0,8/51,12.23%,STK26;SIRT1;HIF1A;PDGFRA;FER;PTPRK;PXN;MAPK8
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.6468490505497247,1.2474299018566002,0.19444444444444445,0.8352349773505345,1.0,7/20,5.09%,F2;CCL5;IL26;F2R;ERBB4;IL7R;IL10RA
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.7735036570274713,1.2473339278191617,0.13725490196078433,0.8347087170893333,1.0,2/5,20.02%,TENT4B;ELAVL4
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.6240274739589047,1.2471290892656794,0.17857142857142858,0.8348642604227339,1.0,7/21,21.89%,SAMD4A;CNOT6L;CNOT4;CNOT8;CNOT2;ZFP36;PAN3
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.6443035074059311,1.24690900318769,0.1836734693877551,0.8347722592828278,1.0,5/25,8.14%,SOCS2;STAT5A;FER;IL15;SOCS6
prerank,GO_Biological_Process_2021__regulation of T-helper cell differentiation (GO:0045622),-0.7916724088732972,-1.2466593640308166,0.2978723404255319,1.0,1.0,2/6,7.55%,IRF4;HLA-DRB1
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.6982062567890633,1.2461632432310752,0.22641509433962265,0.8371492175108967,1.0,4/12,17.23%,NRG1;CDH2;HEY2;KLHL12
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.676569457403239,-1.245847041852341,0.23684210526315788,1.0,1.0,2/11,5.12%,PLK3;GOLGA2
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.6446095791372534,1.2456385362452902,0.21739130434782608,0.8382875864199274,1.0,6/12,22.98%,ZFP36L2;AKR1C3;NR3C1;ZFP36;ANXA1;HNRNPU
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),-0.8089298188425396,-1.2456377618026124,0.27450980392156865,1.0,1.0,1/6,0.81%,EIF5AL1
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.7075406833558551,1.245590860350235,0.2033898305084746,0.8374375757738589,1.0,1/14,0.52%,CTDNEP1
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.6190013537276204,1.2454915974679834,0.21568627450980393,0.8369432063051628,1.0,5/29,6.02%,C3;THRSP;ADIPOR2;ZBTB20;PRKAB2
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.8430487282722869,-1.2453729454664277,0.17391304347826086,1.0,1.0,2/6,6.34%,SIGIRR;TRIB1
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.7906839191359487,-1.2448845891553548,0.3018867924528302,1.0,1.0,1/6,6.01%,ST6GALNAC2
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.5328441965258903,-1.244608639533856,0.12244897959183673,1.0,1.0,6/57,2.28%,MS4A8;EHF;DUOXA1;CYP2B7P;DUOX1;FAM3D
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.7768871122766827,-1.2444112220136196,0.20454545454545456,1.0,1.0,2/9,1.56%,TERT;DND1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.5930310731805204,1.2442372044067345,0.2037037037037037,0.8420088458790296,1.0,5/29,14.30%,SEMA5A;ROBO2;SEMA6C;SEMA3E;SEMA6D
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.7315052114802293,1.2437057530907596,0.16326530612244897,0.843519420800444,1.0,3/10,9.99%,F2;BMP2;BIN1
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.7705734685284598,-1.243180484669024,0.16326530612244897,1.0,1.0,2/11,5.45%,SPTLC3;DEGS2
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.7570783326029721,1.2431235652539556,0.17307692307692307,0.8455012922781284,1.0,1/10,1.92%,NDC80
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),0.8060599652194094,1.2430529732248976,0.17857142857142858,0.8448007638276848,1.0,1/6,13.89%,HSD17B10
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),-0.7769588663903799,-1.2430450098815053,0.21428571428571427,1.0,1.0,1/5,3.84%,SLC6A6
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.4421975297304551,1.2428452278259234,0.11538461538461539,0.8446979321370703,1.0,66/341,13.12%,LGALS9;SELPLG;IRGM;GREM2;MME;HGF;ITGAX;SYK;MYC;CCL5;SIRT1;IL26;IL4;SOCS2;HIF1A;STAT5A;CSF3R;FGF2;PYHIN1;SLC26A6;CSF2RA;IL2RA;SYNCRIP;ZFP36L2;RORA;PTPN20;IRF8;HCLS1;IL10RA;CXCL12;RELA;ZEB1;TLR2;F3;NLRP7;FER;LIFR;HTRA2;CD40;SOCS6;FOXO3;CRHBP;ERBIN;ABL2;RHOU;PTPN14;LEPR;PIK3CA;ZNF675;ST3GAL6;RO60;PTPRT;HYAL3;IL23R;FLT3;FOXO1;IL13RA2;ZFAND6;HAS2;MAPK8;NPR2;IRAK1;SOS1;IL18R1;TANK;HSPA8
prerank,GO_Biological_Process_2021__negative regulation of histone deacetylation (GO:0031064),-0.8107320281214422,-1.2424158744869607,0.3125,1.0,1.0,1/5,14.78%,USP17L2
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.8115418762902799,1.2423835263089211,0.14754098360655737,0.8465186957492887,1.0,2/7,9.52%,CXCL12;PIK3CA
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.6435931055756586,1.2423426555497812,0.14893617021276595,0.845636494399126,1.0,8/18,19.49%,THRSP;PRKAB2;ABCD3;ABCD2;ACACA;ACACB;ABCD4;MID1IP1
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.70639617568799,1.2421381611297408,0.22448979591836735,0.8456700946892672,1.0,6/11,24.95%,BOK;DLC1;TP53BP2;TP53;FAP;FZD3
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.5761908638984619,-1.2420034885537725,0.16326530612244897,1.0,1.0,9/36,7.93%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;LTB;KLRB1;CD5;TAGAP
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.7124952943774439,-1.2416459130299498,0.20930232558139536,1.0,1.0,1/8,1.10%,SCN5A
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.49617756950894926,1.2416198472729534,0.13636363636363635,0.8471942441268124,1.0,16/122,6.66%,PCDH15;LHFPL3;TMEM100;LRRC3B;NXPH1;C1QL1;SLC35F1;LRRC4C;PMP2;GFAP;OLIG1;VCAN;OLIG2;GPR17;MEGF10;PDGFRA
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),0.7532419290105921,1.241478391246831,0.1746031746031746,0.8457855941030367,1.0,3/8,14.96%,LIN7A;ANK1;CRB2
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),0.7532419290105921,1.241478391246831,0.1746031746031746,0.8457855941030367,1.0,3/8,14.96%,LIN7A;ANK1;CRB2
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.7702627113358387,1.2414633178907357,0.1956521739130435,0.8448488321745908,1.0,4/9,9.70%,SELPLG;RELA;ST3GAL6;PTPRT
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.6698196019005963,1.241023647844485,0.13725490196078433,0.8458520476841327,1.0,10/21,16.11%,IGF1;SMYD1;NRG1;LMOD3;EFNB2;MEF2C;PROX1;GREM1;PIEZO1;MESP1
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.6977867402658318,1.2410221695229964,0.27586206896551724,0.8448720486512047,1.0,1/15,0.40%,PNP
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.8209547645271743,1.240886964324868,0.2711864406779661,0.8445891025019997,1.0,1/5,2.87%,PPARG
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.7144068389170676,1.2408137459591277,0.22950819672131148,0.843959853405972,1.0,6/12,19.39%,RENBP;NANP;UAP1;GNPNAT1;GNPDA2;GFPT1
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.514611377703557,1.2407748002828614,0.13725490196078433,0.8430307228378302,1.0,11/82,10.92%,IGF1;SYNCRIP;SAMD4A;LIN28A;TOB1;RNF139;BIN1;PATL2;HAP1;RIDA;RTN1
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.5534678284464963,1.2407576678104257,0.1694915254237288,0.8421790192130288,1.0,10/50,18.43%,GDAP1;IMMP2L;CHCHD4;TIMM22;FBXO7;DNAJC15;AIP;IMMP1L;MFF;TIMM10
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.6435567708046113,-1.2406491014120866,0.225,1.0,1.0,2/21,6.07%,TEK;SFRP1
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.8020339590128187,-1.239970412291283,0.25,1.0,1.0,4/6,18.30%,FLOT1;CAV2;CAV1;CAV3
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.6951882495721777,1.239936286774257,0.21739130434782608,0.8457789563333148,1.0,7/14,22.09%,SCRIB;SNCA;RAMP3;VAMP3;RAB29;ANXA2;AP1AR
prerank,GO_Biological_Process_2021__glucocorticoid metabolic process (GO:0008211),-0.7396267340855722,-1.239728349236019,0.2558139534883721,1.0,1.0,4/7,8.26%,HSD11B1;CYP21A2;HSD3B2;HSD3B1
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.4694511454193168,1.2396861593898594,0.08163265306122448,0.846097204822982,1.0,30/139,13.14%,SCN7A;LSAMP;CADM2;SLC17A6;NKAIN2;GDAP1;NEFH;PARM1;NRXN1;RAB3C;VAMP1;NOVA1;SCN10A;OLFM3;PTPRD;CLGN;SYNPR;ANK2;MAGI2;GRM5;TAC1;LRRTM3;ADGRB3;ZDHHC2;PAK5;TMEM196;ZNF536;LRFN5;SCN9A;CPNE3
prerank,GO_Biological_Process_2021__glycerol transport (GO:0015793),-0.7905029892682905,-1.239522595643722,0.28846153846153844,1.0,1.0,1/5,3.99%,AQP7
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.7265030058841246,1.2392513007327444,0.1568627450980392,0.8471945813490258,1.0,6/13,18.33%,FGFR1;NR5A2;STOX2;SCEL;RICTOR;RAI2
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.6897498493873185,1.23923983349461,0.17857142857142858,0.8462521151808868,1.0,3/12,15.08%,BOK;AGR2;ATF6
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.7430499027773594,-1.2391079827732916,0.20930232558139536,1.0,1.0,2/6,14.78%,KCNE1;USP17L2
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.7552803942132231,1.2388771844714597,0.19148936170212766,0.8469128410846107,1.0,4/11,7.59%,TMPRSS2;MYRF;F12;HTRA2
prerank,GO_Biological_Process_2021__regulation of response to wounding (GO:1903034),-0.8484848847816501,-1.2386416806029348,0.23404255319148937,1.0,1.0,1/5,3.41%,ALOX5
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.5179373427007156,1.2386003181705114,0.07317073170731707,0.8473478524566644,1.0,14/97,9.40%,GATA4;SMAD6;TSPAN12;PLOD2;LRP4;GNG12;TENM3;DOCK1;LRIG3;WWTR1;ADGRL2;LIFR;MAGI1;TSPAN6
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.6334023145816531,-1.2385712536259548,0.14285714285714285,1.0,1.0,3/33,8.69%,RFX6;HLA-DRB1;NNAT
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.6682142687933788,1.2385452528508036,0.19230769230769232,0.8464980591637501,1.0,5/13,24.21%,ELP4;CTU1;DPH3;TRMT9B;MTO1
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.7499194031595559,1.2381265506923131,0.25925925925925924,0.8478569947588702,1.0,3/7,7.10%,SOX6;MDGA2;ZC4H2
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.5316351926432912,1.2376788987526521,0.14285714285714285,0.8487659837004004,1.0,25/100,20.38%,SIPA1;CDKN2C;FGFR3;SIRT1;ENPP1;CDKN2A;CDKN2AIP;NAIF1;DNAJB2;SERTAD2;DACT3;SMAD4;GNG4;ACVR1B;PML;FRZB;MT1M;NOTCH2;SMARCA2;DCBLD2;TP53;FBP1;BMPR2;PNPT1;ST7L
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.6338625666125732,1.2372732743988635,0.1724137931034483,0.8498662565865547,1.0,3/20,14.22%,LIN28A;PRKRA;TENT4B
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.7599183166306701,1.237037167865605,0.23529411764705882,0.8500724569553815,1.0,3/8,3.12%,TMEM100;RIN2;RRAS
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.5719346650654409,1.23693298836206,0.17391304347826086,0.8495657818668055,1.0,12/39,17.36%,MME;FAIM;CLSTN2;NLGN1;NRXN1;PTPRD;LIG4;LRP2;RGS14;SPEN;GRID2;NUMB
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4517959540231003,1.2368653001051104,0.06,0.8488972057211699,1.0,61/354,13.08%,VEGFC;IGF1;FGF10;FLT1;IRS4;IRS1;TCIRG1;ATP6V0D2;EPHA7;FGFR3;HGF;SYK;FGFR1;ERBB4;SOCS2;FGF2;NRG1;EFNA5;ANGPT1;ROR1;HNRNPH1;BLNK;EFNA2;DOCK1;MAPKAPK2;EFS;CLNK;CASS4;ITGAV;MUC20;PDGFRA;EPHA5;GAB1;FER;EPHA3;GALNT3;PDGFC;ATP6V0A4;MTSS1;EPHA8;SHOC2;FGF17;MAPKAPK3;PIK3CA;PTPRT;FRK;NUS1;HAP1;FLT3;EFNB2;MPZL1;FOXO1;PXN;NCK2;BCAR1;FLRT2;TIAL1;SOS1;ATP6V0B;FGF5;IGF1R
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.5571591397515399,1.2367751750486808,0.20408163265306123,0.8484522818770552,1.0,4/39,5.23%,IGF1;CCL5;FGF2;CCN4
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.6248725607343197,1.2366584998676644,0.22641509433962265,0.8479048491259458,1.0,6/22,8.97%,RAPGEF3;KSR1;ADGRG6;EPHA5;PDE7A;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.5404531937431052,1.2365115063906655,0.11864406779661017,0.8476984633501159,1.0,5/59,7.50%,F2;NDC80;PYHIN1;WWTR1;BICD1
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),0.8225837766945628,1.2363645513462287,0.2631578947368421,0.8473597434115929,1.0,1/5,3.09%,ANGPT1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.5549293806328458,1.236164751688486,0.17647058823529413,0.8473165909430039,1.0,11/69,16.79%,SYK;RGPD4;CBLB;RGPD3;RGPD2;RGPD5;NXT1;RANBP17;PRICKLE1;KPNA4;RANBP2
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7304900101548851,1.2359984309181244,0.1702127659574468,0.8469643617749151,1.0,6/11,25.01%,BACE2;SOAT1;ABCA2;ITM2B;NECAB3;ABCA7
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),-0.8745851586443523,-1.2359470533500323,0.11764705882352941,1.0,1.0,3/5,10.48%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.6286858648660912,1.2358686768167237,0.208955223880597,0.8465688212215291,1.0,4/22,9.39%,PNP;REXO2;FHIT;AK1
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.5020344017704726,1.2358511871246718,0.14285714285714285,0.8456747589669631,1.0,21/113,15.60%,SMAD6;TMEM100;SIRT1;TGFBR1;GDF6;BMP2;ACVR2A;ZFYVE16;LTBP2;SMAD1;SMAD2;CGN;BMPR1A;PTPRK;PXN;SMAD4;GDF9;ACVR1B;BAMBI;HJV;SMAD5
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.5643069953401687,1.235713227387336,0.25,0.8453109380748846,1.0,11/32,20.58%,KLKB1;HGFAC;F12;PRSS3;VSIR;ASPH;FADD;PERP;LGMN;RIPK2;BAD
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.7944152216306882,1.2353117579423532,0.12903225806451613,0.8465014294171077,1.0,4/6,15.21%,PLSCR4;PLSCR2;PLSCR1;ANO6
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.7353752507808499,1.2352004558733178,0.2037037037037037,0.8460057465023373,1.0,1/10,3.41%,ENPP1
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.6742595477304093,-1.2348714180660396,0.21428571428571427,1.0,1.0,1/8,3.12%,STK10
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),-0.7930418135637511,-1.2347441741664364,0.28,1.0,1.0,2/7,4.62%,SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.7124266830348799,-1.2342374002081602,0.22448979591836735,1.0,1.0,3/14,1.10%,SELP;SELE;SELL
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.5941421426471952,1.2341584740444285,0.13333333333333333,0.8495761490723389,1.0,10/39,8.23%,PCDH15;MME;PNOC;OPRK1;TRPV2;WHRN;ADGRV1;PENK;SCN10A;NTSR2
prerank,GO_Biological_Process_2021__response to heparin (GO:0071503),-0.769502838851408,-1.233771013320398,0.3269230769230769,1.0,1.0,2/5,7.09%,SFRP1;EGR1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5832871003018661,1.233705422925558,0.10204081632653061,0.8507869461581604,1.0,11/43,10.29%,IGF1;TNFRSF18;FGFR3;CCL5;ERBB4;IL4;HCLS1;IL15;CD40;IL23R;FLT3
prerank,GO_Biological_Process_2021__skeletal muscle thin filament assembly (GO:0030240),-0.7596204612365363,-1.2335421849276114,0.2916666666666667,1.0,1.0,1/6,0.37%,ACTC1
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),0.8089177726543123,1.2333579629921938,0.23076923076923078,0.8513676694743244,1.0,2/7,5.24%,C3;RAB31
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.7151424912638162,1.2332545658889709,0.17857142857142858,0.8508395724464148,1.0,4/9,5.84%,TMEM100;APOLD1;ZEB1;VEZF1
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.6715384165431919,1.2330920250639317,0.23076923076923078,0.8505892338763376,1.0,5/16,14.32%,MYC;ARID2;SMARCD3;ARID1A;SMARCD2
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.5328497499042415,1.2329809235697142,0.1111111111111111,0.8500486727759831,1.0,16/59,22.45%,MED17;CDKN2A;RELA;MOV10;PAXIP1;PTEN;ATF7IP;HEY2;CTNNB1;CDK4;TP53;AGO3;MED30;TRIM28;CDK8;MED25
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.8192378484906327,-1.2329785655946963,0.1875,1.0,1.0,3/6,10.96%,DNAAF1;DNAH11;CCDC40
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.8349147021440201,-1.2327843116268737,0.20930232558139536,1.0,1.0,2/5,8.95%,CELA2A;CEACAM1
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),-0.7529803949127478,-1.232415608477436,0.2727272727272727,1.0,1.0,2/5,14.99%,RRM2;RRM1
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.5162862011300915,-1.2323736117853805,0.1346153846153846,1.0,1.0,7/116,4.02%,MS4A8;RFX6;EHF;TMEM179;NPTX2;MAPK4;IGSF21
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell development (GO:1901552),-0.7880727613833823,-1.2321465073439224,0.17391304347826086,1.0,1.0,2/5,16.11%,F11R;CLDN5
prerank,GO_Biological_Process_2021__positive regulation of establishment of endothelial barrier (GO:1903142),-0.7880727613833823,-1.2321465073439224,0.17391304347826086,1.0,1.0,2/5,16.11%,F11R;CLDN5
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.5193037446490693,1.2320945667753678,0.15217391304347827,0.8528641501183494,1.0,9/67,8.59%,ITGA10;FERMT3;SYK;ITGB8;ITGA11;ITGA2;DOCK1;ITGAV;ERBIN
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.511364009535043,1.231912007250443,0.1320754716981132,0.8528154668685567,1.0,14/89,8.38%,MXRA5;LAMA4;MRGPRF;PRRX1;PRKG1;ADGRL4;GFAP;BGN;CXCL12;POSTN;CCDC80;PDGFRA;PLSCR4;PCDH18
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.5339781053568041,1.2318963888913035,0.14545454545454545,0.8519119674456846,1.0,8/50,8.97%,TVP23B;PCSK5;LTBP2;RAB3C;ABCA1;MTTP;CYB5R4;RIMS2
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.7096510857611602,1.2318064499231571,0.16279069767441862,0.8513289298833325,1.0,2/11,5.90%,RUNX1;F12
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.7263243135563244,1.231302473111407,0.2641509433962264,0.8529013970000805,1.0,4/8,20.84%,RELA;RPS6KA1;RGS14;DDIT3
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.5870429233657743,1.2312209434755386,0.16981132075471697,0.8523185579158974,1.0,3/35,11.71%,CDC14A;ANAPC16;ANLN
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",0.7549666690267608,1.2310689592569413,0.22641509433962265,0.8522274845419359,1.0,2/8,5.24%,C3;RAB31
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.585810386123022,1.2309133467946134,0.25,0.85187725252698,1.0,13/36,24.67%,FGF10;DNAJB2;PLSCR1;RYR2;TOR1AIP2;DNAJB1;POT1;ATP1B2;DNAJB11;DNAJC9;HNRNPU;DHX9;SETMAR
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.8129997479415346,1.2305834221396146,0.19607843137254902,0.8524057724890022,1.0,2/6,10.44%,MSRB3;MSRB1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.7364317917996656,1.2305300311033667,0.25862068965517243,0.8516679506466532,1.0,2/6,16.66%,CNOT6L;CNOT2
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.7027058301350618,1.2303665703712943,0.2413793103448276,0.8514056822608727,1.0,1/9,2.04%,F2R
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.5387521342069976,1.230362631558777,0.12,0.8505128315873461,1.0,6/59,3.25%,FGF10;HGF;MYC;SIRT1;FGF2;TOX
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.7749042015420786,1.2303362429325748,0.20754716981132076,0.8497222727635564,1.0,3/7,16.47%,ZBTB1;HMGB1;CLC
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.7586113883230317,-1.230307137807768,0.16326530612244897,1.0,1.0,3/10,10.96%,DNAAF1;CFAP73;CCDC40
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.7648680327993985,-1.2303069621476195,0.21621621621621623,1.0,1.0,2/7,5.33%,ASS1;ARG2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),-0.771086080503694,-1.2301639777140683,0.3111111111111111,1.0,1.0,2/6,9.62%,CCBE1;ADAMTS3
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.6647621832956673,1.2301515223698636,0.2692307692307692,0.8495202983218977,1.0,3/15,14.62%,SYVN1;AUP1;DERL2
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.8255818099609725,-1.2301511510173435,0.1320754716981132,1.0,1.0,1/6,1.07%,GINS3
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.8255818099609725,-1.2301511510173435,0.1320754716981132,1.0,1.0,1/6,1.07%,GINS3
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.6675806876153698,-1.2300468699549985,0.21739130434782608,1.0,1.0,2/8,23.64%,MAN2B1;MAN2B2
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.5955605001755035,1.2299979178943197,0.23529411764705882,0.8492472889529943,1.0,4/32,10.96%,GSTM2;GSTT2;HPGDS;ETHE1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.6331539217189116,1.2299619772863064,0.15384615384615385,0.8484750524500945,1.0,2/20,2.81%,IGF1;FGF2
prerank,GO_Biological_Process_2021__diadenosine polyphosphate catabolic process (GO:0015961),0.7575053589287619,1.2298849859468755,0.20754716981132076,0.8478329161694625,1.0,3/6,14.06%,FHIT;NUDT4;NUDT4B
prerank,GO_Biological_Process_2021__G protein-coupled opioid receptor signaling pathway (GO:0038003),0.7677977394333121,1.229546150445792,0.2982456140350877,0.8484033942975436,1.0,1/5,3.30%,OPRK1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.4552448984284039,1.2289781473792645,0.13636363636363635,0.8499974224386959,1.0,45/264,13.62%,LGALS9;IGF1;FGF10;IRS1;IL17RD;FGFR3;HGF;MYC;CCL5;RIT2;FGFR1;ERBB4;NRTN;FGF2;NRG1;ANGPT1;KSR1;CSF2RA;IL2RA;ZFP36L2;TNIK;ABHD17B;SPTBN5;MAPKAPK2;ITGAV;PDGFRA;NRG2;PPP1CC;SHOC2;GFRA1;FGF17;PIK3CA;PSMD13;FLT3;RASAL2;RANBP9;RGL2;ABHD17C;MEF2C;MAPK8;SOS1;FGF5;PSME4;LYPLA1;LRRC7
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.8117994802655109,1.2288663713338073,0.22413793103448276,0.8496116530755067,1.0,4/5,17.94%,LDLR;LRP2;RNF128;CD81
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.7157611570410809,1.2288176929023658,0.2037037037037037,0.8488574825262946,1.0,3/11,6.53%,IDO1;IDO2;TDO2
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.6267903701364691,1.228769682072139,0.23529411764705882,0.848119163203124,1.0,6/23,14.62%,SYVN1;RNF185;RNF139;RNF5;MAN1A2;DERL2
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.7922036144844233,1.2286905946994215,0.22641509433962265,0.8474958379220796,1.0,2/5,9.38%,SIRT1;AUTS2
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),-0.7577415244963814,-1.2285275977308503,0.19230769230769232,1.0,1.0,4/7,12.70%,SCN5A;CACNA1G;KCNA5;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.7248379273501695,1.2275416646668782,0.21428571428571427,0.8517998753112073,1.0,4/16,11.11%,PNP;SYK;IL23R;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6185681312842519,1.227476009794544,0.17307692307692307,0.8511455931534451,1.0,2/19,2.84%,CGNL1;LZTR1
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.481001631612636,1.2273212398002704,0.046511627906976744,0.8509164699574122,1.0,30/194,12.15%,TNFSF14;NOX5;ADRA1A;ESPL1;PAWR;BOK;MYC;TNFRSF19;EGLN3;CDK11A;EFNA5;GDF6;RNF152;DCC;IL2RA;DAPK2;DUX4;SEPTIN4;TLR2;DLC1;PIK3CA;HIP1;FOXO1;PAK5;TNFRSF10B;CASP10;LIG4;PLAGL1;DPF1;RRAGC
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.7400193301354047,-1.2272636202846747,0.2972972972972973,1.0,1.0,2/7,5.12%,PLK3;GOLGA2
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.6623153761880547,1.2271677665838812,0.2413793103448276,0.8507866094773605,1.0,3/14,8.93%,IL4;CD40;PAXIP1
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.6619382318567488,1.2269947515312556,0.25925925925925924,0.8507415921323218,1.0,5/17,11.70%,ITGAX;MYRF;UNC13B;RIMS2;ATPSCKMT
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.6262002641153518,-1.2269883815482399,0.24489795918367346,1.0,1.0,4/23,11.77%,SIGIRR;TRIB1;DHX58;TYRO3
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.8197624332979188,1.2267565184538536,0.2549019607843137,0.8506544405327423,1.0,2/5,15.21%,LHFPL2;PLCB1
prerank,GO_Biological_Process_2021__glucocorticoid biosynthetic process (GO:0006704),-0.7139014301737441,-1.2267220257102234,0.3,1.0,1.0,4/7,8.26%,HSD11B1;CYP21A2;HSD3B2;HSD3B1
prerank,GO_Biological_Process_2021__cellular triglyceride homeostasis (GO:0035356),0.8227381281822183,1.2266755349350889,0.22413793103448276,0.8501596752373601,1.0,1/5,1.94%,SIRT1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.6309986427479015,1.2265670939506834,0.16363636363636364,0.8495817102834196,1.0,6/28,8.96%,IGF1;FGFR3;STAT5A;SIX4;AGR2;LATS1
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.7176172614819896,-1.226381917718753,0.22448979591836735,1.0,1.0,2/9,17.02%,TRPV1;CHP1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.5969674057568618,-1.2263114379306668,0.17073170731707318,1.0,1.0,7/37,10.10%,KCNMB2;KCNJ16;KCNN3;KCNN2;KCNE1;KCNQ1;KCNJ15
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5895561800638908,1.2262748353264048,0.21951219512195122,0.8497767407040944,1.0,6/31,5.09%,F2;CCL5;IL26;F2R;ERBB4;IL10RA
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.7706570835084063,-1.2261831283923041,0.2830188679245283,1.0,1.0,3/8,13.11%,KCNE2;KCNE1;CAV1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6843252436631291,-1.226020049727401,0.2962962962962963,1.0,1.0,1/15,0.17%,TERT
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.6329694827600952,1.2260044634625789,0.14814814814814814,0.8499853619741192,1.0,9/22,14.30%,FGFR3;TGFBR1;FGFR1;PDGFRA;SPEF2;DSCAML1;RAB33B;WWOX;LRP6
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.6462178505807704,1.225943423202244,0.25,0.849409475678267,1.0,1/21,0.15%,MT4
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.7454571936059252,1.2256469481364365,0.18181818181818182,0.8489460138831314,1.0,2/7,5.50%,GSTM2;SLC8A1
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.7454571936059252,1.2256469481364365,0.18181818181818182,0.8489460138831314,1.0,2/7,5.50%,GSTM2;SLC8A1
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.7842579457768878,1.2253584764957173,0.16071428571428573,0.8494197825646123,1.0,4/6,19.69%,SMAD6;BMPR1A;EFNA1;BMPR2
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.5354514403324027,-1.2252501040481343,0.23529411764705882,1.0,1.0,8/73,3.47%,ALB;EHF;CAPN8;CLDN4;CD24;FAM3D;MUC5B;KIF12
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.5883691901779025,1.22516765255346,0.22916666666666666,0.8492652142898565,1.0,11/37,10.29%,IGF1;TNFRSF18;FGFR3;CCL5;ERBB4;IL4;HCLS1;IL15;CD40;IL23R;FLT3
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.6218980706451449,-1.224990230471111,0.23684210526315788,1.0,1.0,3/16,8.97%,TEK;HCK;NTRK3
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.5432186768945106,1.2247721194791412,0.19230769230769232,0.849890786686265,1.0,5/57,6.24%,HGF;MYC;ACD;FGF2;PARM1
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.6739419112464656,1.224722839306348,0.2,0.8491518218803693,1.0,4/14,12.52%,LRRC4C;PTPRD;GPC4;LRFN5
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.5367938068873503,-1.224655986546243,0.16666666666666666,1.0,1.0,17/76,17.78%,DDX11;PRKCD;GOLGA2;PPP1CA;IFIT2;JUN;TMC8;LRPAP1;TTBK1;ZFPM1;GTF2F1;CAV1;DAB2;CYP2D6;CTSZ;E2F1;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),-0.7578234745211025,-1.2245985132311017,0.21739130434782608,1.0,1.0,2/7,16.51%,CARTPT;KCNB1
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.7328005266333787,-1.22455259115779,0.11904761904761904,1.0,1.0,4/14,8.69%,DUOX1;VGF;RFC3;KCNJ11
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.5632518608157738,-1.2244746998875669,0.14,1.0,1.0,14/61,14.41%,SELE;NLRP1;BST1;IL1RL2;ALOX5;PTGES;AHSG;HCK;DHX58;TMSB4X;PIK3AP1;AKNA;ALOX15;UFL1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.6208659789782566,1.2244717925982627,0.22916666666666666,0.8492481544921253,1.0,7/23,21.16%,DRD5;SNCA;PDE4B;RYR2;GABPA;ABL1;MAPK3
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.830723513415819,1.2243491651319154,0.28,0.848830719453829,1.0,1/5,0.07%,VEGFC
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.7584646669215598,1.2242800386388193,0.22,0.8484003200146495,1.0,1/8,3.41%,ENPP1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.4993726912195908,1.224001884258402,0.09090909090909091,0.8485387012396773,1.0,23/121,10.01%,MXRA5;CGNL1;DACH1;IGF1;C3;SLC12A1;ADGRL4;RIN2;CDH6;SLC12A3;DOCK1;BGN;CXCL12;RNF182;POSTN;PDGFRA;FAM114A1;CD40;PLSCR4;PRICKLE2;SMARCD3;GSN;MEDAG
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.7913226317412548,1.2239555103553943,0.20833333333333334,0.8478466745592519,1.0,3/5,20.64%,EIF3E;FMR1;NCBP1
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.689508975258946,1.223524254082287,0.22033898305084745,0.8486625477176921,1.0,2/17,4.30%,TGFBR1;ROBO2
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),0.7158138209712213,1.223292864445865,0.2631578947368421,0.8477791464771803,1.0,3/10,6.53%,IDO1;IDO2;TDO2
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),0.7158138209712213,1.223292864445865,0.2631578947368421,0.8477791464771803,1.0,3/10,6.53%,IDO1;IDO2;TDO2
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.7056467623200811,-1.2231850668178088,0.2391304347826087,1.0,1.0,1/11,3.07%,STX11
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.7247345875125973,1.2231780570815778,0.24561403508771928,0.8474215212267342,1.0,1/9,1.31%,UNC5C
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.46740587156042535,-1.2231061565711203,0.1346153846153846,1.0,1.0,5/180,1.18%,CD44;DUSP4;NTRK1;APIP;TEK
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.7636710109706648,1.2224842486951002,0.22448979591836735,0.8494728546991713,1.0,4/9,16.76%,SIRT1;MLXIPL;PRKAA1;DGAT2
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.776077530126672,1.2219855577612837,0.2641509433962264,0.849744959917422,1.0,4/5,22.21%,ZFP36L2;NPR2;ZFP36;PDE1B
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.776077530126672,1.2219855577612837,0.2641509433962264,0.849744959917422,1.0,4/5,22.21%,ZFP36L2;NPR2;ZFP36;PDE1B
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.45258115585411374,-1.2219109910755146,0.07142857142857142,1.0,1.0,8/216,3.13%,TRIP10;EPN1;RTP1;SUN3;SYNJ2;M6PR;STX11;TLCD2
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.7749092156518044,1.2218886707259835,0.23333333333333334,0.8492084417977367,1.0,3/6,19.15%,SLC25A13;SLC1A6;SLC25A12
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.5746867969140228,1.2218811310923514,0.18333333333333332,0.8483168047272651,1.0,10/38,15.86%,LDLR;ODC1;SPOP;CHMP6;SPOPL;ZDHHC2;CHEK2;MAPK8;PLAUR;PM20D2
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.7922436529753478,1.221729081900864,0.16923076923076924,0.8480840824805568,1.0,4/7,17.47%,ADIPOR2;HPSE;CD34;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.6824029068360025,1.2216125597632341,0.19230769230769232,0.8477287959968657,1.0,7/13,21.61%,SIRT1;PLCG2;TICAM1;CD74;GPRC5B;KIT;CAMK4
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.491143240714189,-1.2213010317555724,0.17307692307692307,1.0,1.0,3/122,1.18%,CD44;NTRK1;TEK
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.6522503138812794,1.2210498340764888,0.2653061224489796,0.8494913685734657,1.0,1/20,0.15%,MT4
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.47770019876508846,1.220495567341328,0.08620689655172414,0.8512365547224137,1.0,18/109,12.71%,SIPA1;SEMA5A;TNFRSF18;EPHA7;CCL5;EFNA5;ANGPT1;CXCL12;ITGAV;ABL2;EPHA8;DSCAM;PLXNB1;ZDHHC2;PLXNB2;FRMD5;PPP3CA;KNG1
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.5653547726199576,1.2204402681446658,0.1568627450980392,0.8505383113403423,1.0,7/40,12.93%,LGALS9;FZD5;CD244;SCRIB;IL23R;PDE4B;IL18R1
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.5944676236798152,1.2202654635063206,0.21568627450980393,0.8503997757382182,1.0,9/28,10.25%,LGALS9;IGF1;IDO1;ICOSLG;SCRIB;HMGB1;TMIGD2;BTN2A2;IL23R
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.5242400411941793,-1.2199316643035825,0.1956521739130435,1.0,1.0,3/35,4.75%,SIRPG;TNFSF18;FGL1
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),0.7543934914608842,1.2195676194331748,0.2777777777777778,0.8528321072721896,1.0,1/6,0.50%,ADRA1A
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.7406667263760125,-1.21930204479694,0.32075471698113206,1.0,1.0,1/13,0.42%,NTRK1
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.7693750037305994,1.2192221224146393,0.2903225806451613,0.8533435938906208,1.0,4/7,21.69%,PYHIN1;RO60;AXL;GAS6
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.7131279168616127,1.2189671050228115,0.14814814814814814,0.8535282675777706,1.0,2/11,12.22%,CCDC125;FRMD5
prerank,GO_Biological_Process_2021__adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),0.7685199920646317,1.2189403773774183,0.2916666666666667,0.8527363843393576,1.0,1/7,0.64%,DRD5
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.5409837143347458,1.218572569953635,0.24528301886792453,0.8538016422123552,1.0,15/40,22.25%,SYK;NEDD4;RAB31;SAG;SNCA;RAMP3;PICALM;DNM3;CALCRL;CD81;ARRB2;LMBRD1;ITGB2;GRB2;MX2
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.7154599056802996,1.2185300654346256,0.2222222222222222,0.8532276077181175,1.0,3/12,9.82%,IGF1;BMP2;IGFBP6
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.7063001377687039,1.2185262472450658,0.23636363636363636,0.8523979933550871,1.0,4/10,25.16%,GREM1;LYN;MAPK3;RNF13
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.6376521564894346,1.2184675775108627,0.26785714285714285,0.8517186319283743,1.0,3/17,14.62%,SYVN1;AUP1;DERL2
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.4914800409607168,1.218062156308975,0.05660377358490566,0.8524163444069823,1.0,30/109,18.64%,CGNL1;FGFR3;CLIC6;ARHGEF17;MMP15;EFS;CLDN2;UNC13B;ADGRL2;NEO1;PRICKLE2;BCAM;MAGI1;PLXNB1;HTR2C;BCAR1;ID4;TMEM98;PTPRU;FRZB;COBL;CPE;GPRC5B;PDZRN3;RNF128;PRLR;FLRT3;FARP1;TMEM178A;MPDZ
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.787337126517353,-1.2180138002907177,0.26666666666666666,1.0,1.0,2/5,9.53%,CIITA;TAF7
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.658534863526109,-1.2176024022351757,0.18867924528301888,1.0,1.0,3/18,9.04%,NPTX2;BEGAIN;CACNG5
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.5499228056504377,1.2175731295171404,0.24390243902439024,0.8537458068339348,1.0,7/32,12.20%,ARHGAP24;LZTR1;CCDC125;DLC1;ABL2;KANK1;SPRY3
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.6404791171896558,1.2175630051978001,0.2653061224489796,0.8528922076739891,1.0,2/14,9.38%,ARHGAP24;AUTS2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion import (GO:0090281),-0.7748611243151502,-1.217559225729814,0.28,1.0,1.0,1/5,2.24%,MRLN
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.7883107595560687,1.2175468550029727,0.15789473684210525,0.8520269498619771,1.0,2/6,5.19%,HCLS1;CXCL12
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.678181888282843,1.2170950244989711,0.1836734693877551,0.8530571833171094,1.0,6/12,29.42%,CEP135;KIAA0586;CEP120;CEP290;OOEP;SCFD1
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.5497565429404625,1.217085046895254,0.1568627450980392,0.8522338087504698,1.0,9/34,10.67%,CFH;F2;C3;C6;CD59;C9;CPN1;C5AR2;C3AR1
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.6386366678082711,-1.2170662597721822,0.275,1.0,1.0,1/16,3.07%,STX11
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.7216377380732162,1.216720734381009,0.22807017543859648,0.8529802282437676,1.0,1/10,1.76%,MYC
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.5683199738321539,1.2165249822169604,0.18181818181818182,0.8529083999345672,1.0,8/32,22.01%,RAB27A;SDC4;SNCA;RAB9A;RAB27B;STXBP5;CADPS;CADPS2
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.7088192396250474,-1.216506265945826,0.2777777777777778,1.0,1.0,1/9,0.84%,GUCY2C
prerank,GO_Biological_Process_2021__regulation of plasma membrane organization (GO:1903729),0.7961692848121319,1.2163002742233722,0.24489795918367346,0.8531175850699237,1.0,2/5,9.95%,NOX5;GSN
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.6289030731149599,1.2162970423292923,0.1956521739130435,0.8522307684534268,1.0,1/14,0.70%,TIMELESS
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),0.7895527942857068,1.2161470949872253,0.2,0.8519463950036176,1.0,2/8,4.68%,IL4;H2BC21
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.7006261612439433,1.2160056618682895,0.2,0.8516092801306949,1.0,5/10,20.22%,RAPGEF3;RAP1A;SGSM3;RAP2A;RAPGEF2
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.7489057080437143,-1.2159828214532264,0.20930232558139536,1.0,1.0,1/7,3.13%,TLCD2
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.7673155003961851,1.2159296347581607,0.2698412698412698,0.8510863974380957,1.0,4/7,21.28%,TMEM39A;UBQLN4;IRAK3;PHF23
prerank,GO_Biological_Process_2021__multinuclear osteoclast differentiation (GO:0072674),-0.7400790802461971,-1.2157584792310268,0.3157894736842105,1.0,1.0,1/5,4.47%,TNFRSF11A
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.4698717146603456,1.2156525707284611,0.09259259259259259,0.8514028279506589,1.0,22/182,9.37%,VEGFC;FGF10;IRGM;F2;C3;HGF;SIRT1;RAPGEF3;ERBB4;FGF2;EFNA5;ANGPT1;BMP2;PELI2;TNIK;ACVR2A;FAM20A;HDAC3;CD40;DLC1;FGF17;LEPR
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.6198993113486229,1.2156504216142874,0.14583333333333334,0.8505356614995159,1.0,1/14,0.09%,GATA4
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.7156376200932786,1.2155427886533536,0.23529411764705882,0.8500420639371844,1.0,5/10,16.58%,RBPJ;SMAD4;RYR2;CPE;HEY2
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.742056886782433,1.215354203918801,0.24,0.849947406814464,1.0,2/6,14.47%,PTPRD;PTPRU
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),-0.6946699442144099,-1.2152816906315873,0.2553191489361702,1.0,1.0,2/9,5.07%,NUPR1;ACTN3
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),-0.6946699442144099,-1.2152816906315873,0.2553191489361702,1.0,1.0,2/9,5.07%,NUPR1;ACTN3
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.5731005649663269,1.2152487711973683,0.1836734693877551,0.8495746868573566,1.0,8/33,16.05%,SLC26A3;SLC26A6;SLC4A7;SLC9A2;CA2;SLC9C2;SLC9A9;SLC4A1
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.5401515952169722,1.2148725297441771,0.2033898305084746,0.850526408104617,1.0,11/42,20.10%,SLC7A11;SLC38A3;SLC38A4;SFXN2;SLC7A9;SLC25A13;SLC3A2;SLC1A6;SLC36A1;SLC25A12;SLC7A6
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.538349724928967,1.214859774802455,0.18518518518518517,0.8496910502866964,1.0,12/47,17.36%,MME;FAIM;HES6;PCM1;PAX6;LIG4;LRP2;RGS14;SPEN;HEY2;CTNNB1;NUMB
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.7326931155348405,-1.21481958413106,0.2978723404255319,1.0,1.0,2/11,15.90%,ALOX5;LTC4S
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.7249343855059327,-1.2148126048266759,0.16216216216216217,1.0,1.0,4/13,16.36%,ZWILCH;SPDL1;TTK;CDK1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.6102189919377451,1.2144547075705734,0.1956521739130435,0.8504689718299873,1.0,9/28,17.65%,DUSP29;RORA;SGCZ;MEGF10;MEF2C;TBX18;DMD;HEY2;TMEM204
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.5570131182741765,-1.2142366468463228,0.1951219512195122,1.0,1.0,1/65,0.03%,SLC28A2
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),-0.7929250157436627,-1.2139045664832622,0.24,1.0,1.0,2/7,0.44%,UROC1;AMDHD1
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),-0.7929250157436627,-1.2139045664832622,0.24,1.0,1.0,2/7,0.44%,UROC1;AMDHD1
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.652256936698731,1.2138546984310514,0.2549019607843137,0.8523141691455887,1.0,3/18,14.88%,PLOD2;GAMT;PLSCR1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.6930150252141775,1.2137265737346408,0.21428571428571427,0.8520859398593555,1.0,2/14,2.85%,IGF1;NRG1
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.5467088137543499,1.2136584930663883,0.14814814814814814,0.8514499416161746,1.0,11/45,10.25%,PNP;IGF1;SYK;CCL5;IL4;ICOSLG;IL15;HMGB1;CCDC88B;TMIGD2;IL23R
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.7512748692898257,1.2135912107632363,0.22413793103448276,0.8508415562039835,1.0,5/9,23.10%,DNAJB2;SACS;SNCAIP;DNAJB1;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.5781650609180713,1.2135449902282727,0.21666666666666667,0.8501555629724187,1.0,6/34,12.71%,CSTA;F2;TM4SF20;NLRP7;DNAJC1;KNG1
prerank,MSigDB_Hallmark_2020__Coagulation,0.5023517966964525,1.2130512852607112,0.1875,0.8515058994540616,1.0,15/98,8.34%,PROZ;CFH;F2;C3;RAPGEF3;KLKB1;ITGA2;GNG12;MMP15;F12;F3;DPP4;C9;TF;CPN1
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.7889823589374265,1.212978575415021,0.24561403508771928,0.8500319398159344,1.0,2/5,6.35%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.7889823589374265,1.212978575415021,0.24561403508771928,0.8500319398159344,1.0,2/5,6.35%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.57260096796854,1.2129633075152102,0.22807017543859648,0.8483809259182128,1.0,8/19,17.68%,HIBCH;BCAT1;HSD17B10;AUH;HIBADH;ACAD8;ALDH6A1;BCKDHB
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.57260096796854,1.2129633075152102,0.22807017543859648,0.8483809259182128,1.0,8/19,17.68%,HIBCH;BCAT1;HSD17B10;AUH;HIBADH;ACAD8;ALDH6A1;BCKDHB
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.8001709632626423,1.2128563526245668,0.2558139534883721,0.8479497915422227,1.0,4/5,17.47%,HIF1A;RBPJ;NFE2L2;VEGFA
prerank,PanglaoDB_Augmented_2021__Macrophages,0.499684045777872,1.212850750598939,0.1702127659574468,0.8471411232043943,1.0,22/120,8.34%,LGALS9;STAB1;ITGAX;SYK;CCL5;TGFBR1;EGLN3;CSF3R;PPARG;SASH3;SAMSN1;PIK3R5;IL10RA;RBPJ;FGL2;TLR2;LAIR1;HPGDS;MARCHF1;SIGLEC1;TFEC;CYP27A1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.5994868180779883,-1.2126949943604084,0.18867924528301888,1.0,1.0,6/29,9.98%,DUSP4;COL4A2;LAMB3;LAMB1;NODAL;MMP9
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),0.7017958198797132,1.212658846738786,0.26,0.8462839875949505,1.0,3/12,4.62%,AASS;HYKK;ALDH7A1
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),0.7017958198797132,1.212658846738786,0.26,0.8462839875949505,1.0,3/12,4.62%,AASS;HYKK;ALDH7A1
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.7235730747456504,1.2126007358045119,0.1935483870967742,0.845544505651289,1.0,1/12,0.40%,PNP
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.7819194923385375,1.2124131360060175,0.23076923076923078,0.8454563103088922,1.0,1/5,14.58%,COL22A1
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.45541023281773424,1.21239355078374,0.17391304347826086,0.8446672275191626,1.0,25/187,9.78%,PNP;SLC7A11;CCNG1;STARD4;CDC25A;SHMT2;EGLN3;PLOD2;INSIG1;PHGDH;LDLR;ADD3;SCD;ADIPOR2;NFIL3;IDH1;FGL2;ELOVL5;UBE2D3;BCAT1;HMGCS1;CYB5B;MTHFD2L;PSMD13;GMPS
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.6620463748966119,-1.212174841853457,0.21052631578947367,1.0,1.0,9/18,28.53%,SPRED3;SPRED2;SPRED1;EIF5A;HIC1;RPS20;RPL37;MSX1;UBB
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.5400316133728017,1.2120655736054446,0.11764705882352941,0.845345301582253,1.0,11/39,21.70%,SLC7A11;SLC38A3;SLC38A4;SLC7A9;SLC19A1;SLC36A1;SLC7A6;SLC25A30;SLC16A7;SLC7A8;SLC25A14
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.4869901554730366,1.212031365432814,0.13333333333333333,0.8446486172422943,1.0,22/87,19.35%,IRS1;INSIG1;KAT2B;PPARG;LPIN3;ENPP1;RAB31;RELA;FER;CRHBP;FOXO1;GCK;NR4A2;CPEB1;SLC30A10;TBC1D4;DENND4C;IRS2;CAPN10;HDAC9;PRKACB;SLC25A33
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.617049396259275,-1.2118877048114363,0.18181818181818182,1.0,1.0,1/25,0.23%,RFX6
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.6348655374854677,1.2118454417540463,0.16,0.8445487358979673,1.0,3/22,4.73%,IGF1;HIF1A;ZBTB20
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.724837023550569,1.211727553258571,0.29411764705882354,0.8443326814504526,1.0,4/11,17.47%,RORB;DSCAM;TULP1;VEGFA
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.623296053035278,1.2116743517459867,0.20833333333333334,0.8437037026598689,1.0,12/31,18.30%,BOK;SIRT1;FHIT;ZNF385B;DYRK2;TP53BP2;PML;PHLDA3;HIPK1;BCL3;TP53;JMY
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.5837500882597607,1.21154303580399,0.17857142857142858,0.8435663574094471,1.0,4/38,5.23%,IGF1;CCL5;PPARG;CCN4
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.5799254545419972,1.2115329829550177,0.19642857142857142,0.8427718189153365,1.0,5/47,3.48%,FGF10;TGFBR1;ZBTB1;NRG1;WNT4
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.4695952325333262,-1.2113569029656766,0.09803921568627451,1.0,1.0,23/190,7.68%,CD44;SPON2;TEK;COL4A2;ENTPD2;TNXB;NR4A1;COL5A1;COL4A1;MGP;MFAP5;PRKCD;FBLN2;OAF;ERCC1;PCSK6;MEOX1;TAGLN;EGR1;HCK;NOX4;LAMB1;COL6A3
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.5423325273863427,1.2113303528947958,0.14893617021276595,0.8427387116727378,1.0,5/50,2.91%,LGALS9;IGF1;F2R;FZD5;PYHIN1
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.5435300892094856,1.2109594833396302,0.14893617021276595,0.8434390176304553,1.0,8/44,11.92%,IGF1;ITGA11;UTRN;CHODL;SOX6;MKX;SGCG;MEF2C
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.6689673405152267,1.2107704198361755,0.20754716981132076,0.8435209852308844,1.0,7/18,16.25%,ACSM2A;RORA;NR1H3;PLA2G12B;MLXIPL;ANGPTL4;PNPLA8
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.6781214245844136,1.2106235630703934,0.2909090909090909,0.8432304281995813,1.0,7/15,17.73%,GRIP1;MOV10;NTNG2;SPRY3;DVL2;FZD4;MACF1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.6028459764996351,1.2105696724446198,0.26,0.8426069435255494,1.0,14/31,24.41%,IRS1;SIRT1;RORA;ZNF692;RORC;SIRT7;SDHAF3;IRS2;FBP1;PDK1;AKT2;PDK4;OGT;ADIPOR1
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.7955688326942547,1.2104228903349628,0.19230769230769232,0.8422666194722991,1.0,4/5,20.24%,ENPP1;SMPDL3A;DCTPP1;ENPP3
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5491121744097168,-1.210209392984386,0.19230769230769232,1.0,1.0,17/44,25.41%,RFC3;POLQ;SMUG1;PARP1;LIG1;XRCC1;RPA3;RFC2;RFC1;LIG3;MBD4;PNKP;POLL;PARG;APEX1;RPA2;OGG1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.547226406147822,1.210142695604565,0.16326530612244897,0.8422982215836597,1.0,7/34,6.66%,GPR55;ADRA1A;FLT1;FGFR1;FGF2;ESR1;PDGFRA
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),-0.7908844539336842,-1.2100057040105305,0.3157894736842105,1.0,1.0,1/5,6.01%,ST6GALNAC2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.5130615213976346,1.2099816429268575,0.1875,0.841946093053149,1.0,11/85,8.67%,CCL5;SLFN11;FGF2;CALCR;DCC;CCN4;CCN6;AGR2;SNCA;RAMP3;SLC25A24
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.7112625924250869,-1.2097467036744605,0.20754716981132076,1.0,1.0,3/7,26.79%,POLQ;POLL;PMS2
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.6568655687629739,-1.2096222188795518,0.21739130434782608,1.0,1.0,2/18,4.93%,NPAS4;DRD2
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),-0.7725385078261697,-1.2093270194136496,0.24074074074074073,1.0,1.0,3/6,13.11%,FLOT1;APOA1;CAV1
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.8089715603782204,1.2092132310873427,0.25,0.8440988022138248,1.0,1/5,2.55%,STAT5A
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.5189242725124433,1.2090867398012841,0.14545454545454545,0.8439115108059252,1.0,11/66,6.24%,SELPLG;ITGAX;CCL5;CSF3R;PIK3R6;SASH3;PIK3R5;CD244;HCLS1;IL10RA;LAIR1
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.6139196120104293,1.2089176809407487,0.25,0.8437883453219263,1.0,10/24,20.58%,MME;FAIM;LMOD3;LIG4;LRP2;RGS14;SPEN;NUMB;CX3CR1;BAD
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.7653747094149028,1.2087824510470395,0.2222222222222222,0.8435253034893845,1.0,2/7,2.98%,RENBP;ALDH1A1
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),0.7718298948661422,1.2087396919794768,0.18181818181818182,0.8428810141249683,1.0,3/6,14.23%,CCL5;HMGB1;TRPM2
prerank,GO_Biological_Process_2021__caveola assembly (GO:0070836),-0.7916630652871541,-1.2087256646934597,0.2653061224489796,1.0,1.0,3/5,18.30%,CAV2;CAV1;CAV3
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.5931545800764446,1.2084382712421755,0.2,0.8431024851146641,1.0,6/23,17.47%,SEMA5A;SEMA6C;DSCAM;SEMA3E;SEMA6D;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.6704953498465762,1.2081487263058166,0.24,0.8435648272330464,1.0,2/16,3.79%,RUNX1;BMP2
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.6151728367790568,1.2081103323903464,0.2,0.8429224069153721,1.0,6/24,13.65%,PLEKHG2;HCLS1;CXCL12;LATS1;FCHSD2;DBN1
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.7007951048135017,1.2080404432016796,0.24489795918367346,0.8424080078379229,1.0,2/11,18.08%,CD59;CD55
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.6296285050812811,1.2080110298241427,0.20689655172413793,0.8417046784675927,1.0,4/22,17.81%,MYC;LIG4;PRKAA1;TP53
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.625045257627439,1.2077638254678225,0.1724137931034483,0.8419009164270899,1.0,6/30,10.12%,RUNX1;ESR1;KCTD6;LATS1;UBA5;NCOA2
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.7238347216926134,1.2077402622991196,0.28,0.8411741927703889,1.0,5/11,8.41%,LRP4;NLGN1;NRXN1;CEL;NLGN4X
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.7984416170375025,1.2076875530387094,0.2459016393442623,0.8398385434640503,1.0,1/5,3.25%,TOX
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.7984416170375025,1.2076875530387094,0.2459016393442623,0.8398385434640503,1.0,1/5,3.25%,TOX
prerank,GO_Biological_Process_2021__coronary artery morphogenesis (GO:0060982),0.7794940719055358,1.207045620421872,0.2222222222222222,0.841610947987346,1.0,3/5,17.47%,TGFBR1;LRP2;VEGFA
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.7587916299883283,1.2070408371533745,0.3,0.8407992358636515,1.0,2/9,4.34%,PRMT1;PRDM14
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.45777051684905873,1.2069208541425511,0.09523809523809523,0.8406179218896742,1.0,33/188,13.34%,IGF1;FAM83H;FLT1;SEMA5A;FERMT3;HGF;ITGAX;CCL5;TGFBR1;F2R;IL4;SNAI1;BMP2;TCAF2;CXCL12;SEMA6C;CASS4;PDGFRA;VSIR;F3;FER;CAVIN1;PDGFC;WASHC1;HAS2;CARMIL1;BCAR1;PPP3CA;FAM89B;IGF1R;CPNE3;SEMA3E;MGAT5
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.6629065188904012,-1.2067589889576136,0.34782608695652173,1.0,1.0,2/15,3.86%,F7;IL6R
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.5496449608356148,1.2067320370346588,0.2222222222222222,0.8405751652906682,1.0,4/33,14.99%,TIMELESS;CHEK2;CDC5L;H2AX
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.7616857039195878,1.206635033406408,0.32727272727272727,0.840118288392106,1.0,2/8,4.04%,INSL5;NLGN1
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),0.7626186384239619,1.20652225638197,0.3125,0.8397626180412113,1.0,2/7,13.81%,PDLIM4;GRIN2D
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.6849155749583687,-1.2064781184253848,0.28846153846153844,1.0,1.0,3/15,1.10%,SELP;SELE;SELL
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.6159741178496446,1.2064059294759115,0.2857142857142857,0.8393450051876122,1.0,5/15,18.12%,TGFBR1;MLC1;SMAD2;LRP6;ABCA2
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.7190441505968054,1.2063050236197903,0.2777777777777778,0.8389532355327453,1.0,5/8,19.69%,SNAI1;SMAD2;CRB2;MESP1;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.7165979100445354,1.2060181307923905,0.22580645161290322,0.8391248536946067,1.0,2/10,4.97%,MYCN;LIN28A
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.7639805597369831,1.2058760888090316,0.25,0.8387840220082371,1.0,1/6,1.94%,SIRT1
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.7257991128850322,-1.2053553341733712,0.3,1.0,1.0,4/9,22.50%,MAP1LC3B2;GABARAPL1;BECN1;MAP1LC3A
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.7257991128850322,-1.2053553341733712,0.3,1.0,1.0,4/9,22.50%,MAP1LC3B2;GABARAPL1;BECN1;MAP1LC3A
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.7427131273940717,1.2053067642817121,0.22033898305084745,0.8403281077853224,1.0,5/9,20.02%,HDAC3;HDAC2;SMARCAD1;HDAC9;HDAC1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.6548779375990736,1.2052825186626865,0.20408163265306123,0.8395504458079223,1.0,2/13,9.35%,RPP40;RRS1
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.5707696315780603,1.2051732920920835,0.14814814814814814,0.8391354665292796,1.0,11/42,19.82%,NRG1;TLR2;ITGAV;EPHA3;SNCA;NR1H3;PTEN;PLSCR1;PXK;NDFIP2;MCTP1
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),0.7264373773679957,1.205072416288591,0.2653061224489796,0.8387586175194104,1.0,1/9,3.80%,PCSK5
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.7174168779521922,1.2049568271800553,0.3333333333333333,0.8385067998393019,1.0,1/8,2.47%,IL4
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.5033751203394956,1.204919019720826,0.18181818181818182,0.8378953400473067,1.0,23/104,10.22%,MXRA5;LAMA4;CFH;MRGPRF;MME;PRRX1;ADGRL4;SSC5D;BGN;COL6A2;CXCL12;LTBP2;TLR2;POSTN;CCDC80;ITGAV;PDGFRA;ABI3BP;CYBRD1;PCDH18;MEDAG;TNC;COL5A3
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.5456026037529698,1.2040849830102656,0.1702127659574468,0.8404114343892807,1.0,11/47,14.38%,RAB27A;SEPTIN4;RALA;SYT1;RAB3C;SNCA;CHMP6;RIMS2;HAP1;RAB9A;RAB27B
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.6072547142710283,1.2040020831103047,0.23529411764705882,0.8399976257064065,1.0,13/34,22.19%,CSTA;HDAC2;DSP;SCEL;CERS3;USH2A;CTNNB1;AKR1C3;CASP3;JAG1;HDAC1;ANXA1;ERCC3
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.5643605787708602,1.2039283585570562,0.21428571428571427,0.8395350849797794,1.0,9/30,15.21%,WNT4;BMP2;ADGRV1;ACVR2A;SLC8A1;BMPR1A;MEF2C;GPM6B;ANO6
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.5944085439365285,1.2039002281009268,0.2,0.8389002486859911,1.0,6/22,12.44%,CHRM2;MYBPH;TNNT1;ATP1A2;KCNB2;PPP1R12B
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.6491368320340055,1.2037660992257881,0.27586206896551724,0.8387609743733553,1.0,6/20,15.49%,ADRA1A;SLC8A1;JPH1;GRIN2D;TRPM2;RYR2
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.7825526001516018,1.203461362663634,0.2982456140350877,0.8393133804176456,1.0,2/5,15.94%,CNTNAP2;CNTN2
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.6209577935549908,1.2033449942537358,0.2,0.8389396155989478,1.0,6/24,17.32%,MT4;SLC39A8;SLC39A12;SLC30A10;MT1M;SLC30A1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.6346741294678667,1.2029525028985992,0.33962264150943394,0.8396140209180594,1.0,7/18,25.45%,ACD;TERF1;TENT4B;GNL3L;POT1;HNRNPU;HNRNPC
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),-0.7686876575189396,-1.202887181970735,0.3076923076923077,1.0,1.0,3/7,15.60%,CYP24A1;SFRP1;CDKN2D
prerank,GO_Biological_Process_2021__regulation of T cell tolerance induction (GO:0002664),0.7807609981981231,1.2025657981920157,0.22,0.8403610013401724,1.0,3/5,21.36%,IL2RA;CLC;HLA-B
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.6114885579205819,1.202493524410024,0.1836734693877551,0.8398520136572504,1.0,7/38,14.00%,IGF1;PPARG;PYHIN1;HMGB1;CPNE1;MAPK8;PLAUR
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.5593825896839699,1.2023517002250557,0.14814814814814814,0.8395774643104428,1.0,12/45,12.52%,IL1RAPL2;CLSTN2;NLGN1;ROBO2;PDLIM5;TLR2;NRXN1;SNCA;PTPRD;GPC4;MEF2C;LRFN5
prerank,GO_Biological_Process_2021__cGMP biosynthetic process (GO:0006182),-0.7378812987450196,-1.2023097515173926,0.25,1.0,1.0,1/7,0.84%,GUCY2C
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.6044452270164165,1.2023077155606055,0.24561403508771928,0.83908247317202,1.0,4/19,14.30%,SEMA5A;SEMA6C;SEMA3E;SEMA6D
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6712003094869269,1.2022162874313536,0.2641509433962264,0.8386374834277363,1.0,6/14,20.31%,VCAN;BGN;DSEL;CSGALNACT1;BCAN;CSPG4
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.7483736141664574,1.2020765228356527,0.26785714285714285,0.8383771295508671,1.0,2/8,9.78%,SHMT2;GMPS
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6402114616447229,1.2019866315868748,0.30434782608695654,0.8380193449598947,1.0,6/16,26.55%,IL26;LYN;CARD9;RNF13;STK25;MID1
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.5347995641838136,-1.2018427506277074,0.17647058823529413,1.0,1.0,9/58,4.96%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;CYTH4;IL6R;LTB
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.6522083577225115,1.2017900641337664,0.17307692307692307,0.8379679707509998,1.0,7/18,16.70%,PAXIP1;AUTS2;CTCFL;SMAD4;MYB;BCOR;CTNNB1
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.588725074290921,1.2016170321891062,0.21739130434782608,0.8376967781903017,1.0,3/40,5.57%,STK26;SIRT1;RELA
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),-0.7417881415675254,-1.2015030604132446,0.22727272727272727,1.0,1.0,2/8,4.93%,DRD4;DRD2
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.7078123390573736,1.2012975174800447,0.2641509433962264,0.838707725898478,1.0,3/9,6.01%,GRIP1;GRIP2;SCRIB
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.6734439554518172,-1.201187194918642,0.3023255813953488,1.0,1.0,2/12,5.43%,RNF8;RECQL5
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.7243712947713181,-1.2009917160441632,0.2391304347826087,1.0,1.0,2/7,16.17%,CD200R1;ADTRP
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.7024053542178411,1.2008691297523792,0.39215686274509803,0.8396070059380834,1.0,3/10,5.28%,SIRT1;CDKN2A;ABI3
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.6499660550705317,-1.2008258861603391,0.21739130434782608,1.0,1.0,4/14,12.13%,ENTPD2;AK8;AK7;ENTPD5
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.8069135831604209,1.2007421770204905,0.16666666666666666,0.839310665323456,1.0,3/6,19.00%,NRG1;MESP1;HDAC9
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.7188724031817288,1.2006409361270525,0.3333333333333333,0.8388810019006667,1.0,6/10,25.90%,FOXO3;SLC25A33;TFB1M;TFB2M;MTERF2;MTERF1
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.6389533001400014,1.2002708029800975,0.1864406779661017,0.8396924473101984,1.0,5/19,8.41%,LRP4;NLGN1;NRXN1;CEL;NLGN4X
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.48042035442674763,1.200233789956504,0.16129032258064516,0.8390324181224269,1.0,19/118,10.38%,TSPAN12;BOK;GNG12;RORA;EPDR1;LRIG3;FKBP5;SLC7A2;ARHGEF17;MMP15;GAMT;UNC13B;ADGRL2;BCAT1;MAGI1;KCTD3;PLXNB1;CLDN12;AOX1
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),0.7655537261624653,1.1997578471981138,0.24074074074074073,0.8403276600199379,1.0,1/5,5.41%,EFL1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.6701497829904126,1.1996777019700344,0.26666666666666666,0.8398259064469819,1.0,3/13,9.74%,C3;SLC26A6;CA2
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.7575336329245133,1.1996444790411236,0.22413793103448276,0.8391918455606401,1.0,4/7,18.04%,GRIN3A;NLGN1;PTEN;EFNA1
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.6796929959188174,1.1996293918688046,0.24444444444444444,0.8384258511103859,1.0,4/11,27.66%,ZNF675;NPPA;HIPK3;PDCD4
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.7464269423537768,-1.1995149003038648,0.3125,1.0,1.0,2/7,10.96%,DNAAF1;CCDC40
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.5848477981278679,1.1994230007371804,0.18,0.8384955857268052,1.0,12/18,35.11%,INTS6L;EXOSC4;INTS6;INTS14;INTS8;EXOSC5;EXOSC2;EXOSC8;EXOSC9;EXOSC7;INTS1;INTS2
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.7590153317361074,1.1989938482916043,0.20588235294117646,0.8395074109137116,1.0,1/6,2.84%,KAT2B
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.7145432683864248,1.1988850226745542,0.2127659574468085,0.8391536042452761,1.0,2/7,10.21%,DCP1B;PATL2
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.7278963916553319,1.1988488925188068,0.32142857142857145,0.8384869767525062,1.0,2/6,7.89%,SLC22A3;SNCA
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.6128929338635477,1.1987564289749888,0.3114754098360656,0.8379661484081233,1.0,2/21,4.60%,PLD6;GDAP1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.6041291322445506,1.1983272235180635,0.22916666666666666,0.8388061964048024,1.0,5/31,10.26%,SMYD1;SMYD2;WDR5B;PAXIP1;EZH2
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.55818202700286,1.198260892080375,0.22916666666666666,0.8382379508090214,1.0,9/33,10.67%,CFH;F2;C3;C6;CD59;C9;CPN1;C5AR2;C3AR1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5970433941194171,1.1981834871446961,0.2641509433962264,0.8378269237153246,1.0,6/30,15.21%,FGF10;PLCG2;UBE2E2;EZH2;CCND3;PLCB1
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.6127688866281744,-1.1980702711184297,0.26666666666666666,1.0,1.0,2/20,10.80%,MTFR2;UQCRC1
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.7481191974048128,1.197360783137233,0.2830188679245283,0.8402008525725988,1.0,1/6,3.24%,LDLR
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.6668360276230133,-1.1973445657070445,0.2857142857142857,1.0,1.0,1/9,1.30%,PRDM1
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.6952302196786339,1.1967857227852645,0.2727272727272727,0.8418749546574475,1.0,2/9,10.60%,GRIN3A;GRIN3B
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.7040853143316068,1.1966708813158378,0.16666666666666666,0.8416533422818838,1.0,5/13,20.46%,NPY;LHX6;PTEN;RAPGEF2;MAP2
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.698412440578649,1.1964219310274387,0.2,0.8417432921380038,1.0,4/10,19.15%,SLC1A3;SLC25A13;SLC1A6;SLC25A12
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.5759805372645619,-1.1962145316579582,0.1568627450980392,1.0,1.0,16/33,25.41%,RFC3;SMUG1;PARP1;LIG1;XRCC1;RPA3;RFC2;RFC1;LIG3;MBD4;PNKP;POLL;PARG;APEX1;RPA2;OGG1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5330220830100594,1.196179391317473,0.18518518518518517,0.8420363293291074,1.0,8/48,15.59%,CNTNAP2;NYAP2;TNIK;PLXNB1;GPM6A;DBN1;SNX2;SGK1
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.49636415956258995,1.1960913478865198,0.15,0.8416837893474165,1.0,15/84,9.44%,BOK;SHMT2;ZBTB1;KCNC2;EHD1;PRMT1;VSTM5;UGDH;MAT2A;TIFA;C9;SNCA;WDCP;STING1;MCU
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.7488728312404024,-1.1960602272490157,0.35294117647058826,1.0,1.0,1/5,4.61%,PDHX
prerank,GO_Biological_Process_2021__regulation of potassium ion export across plasma membrane (GO:1903764),0.741896012262542,1.1960300775465933,0.37254901960784315,0.8410096872470544,1.0,3/6,23.16%,NPPA;ANO6;DLG1
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.7205633810581511,1.1959682936390037,0.2037037037037037,0.8404799104162135,1.0,3/11,5.09%,CARNS1;UGDH;NANP
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.45262945781607844,1.1956709734959594,0.10909090909090909,0.8408683268385679,1.0,31/106,21.29%,MCOLN3;KCNC2;PMP2;TRPM8;ZNF493;ST18;CACNB4;NRXN1;SLC24A2;SYNPR;CTNNA2;SCN2B;HCN1;PROX1;GRM4;MYT1L;MOBP;SEZ6L;CNTN2;PCSK2;RPS6KA5;XKR4;STMN4;NR3C1;UNC13C;SLC7A14;AMER2;ATP1B2;CADPS;ASPA;HTR5A
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.7194823225883804,1.1954961621975158,0.2857142857142857,0.8407085869286748,1.0,2/10,6.66%,TGFBR1;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),0.7666063488483894,1.1954946085026188,0.27450980392156865,0.8399308731572328,1.0,1/6,2.81%,FGF2
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),-0.7916952469426172,-1.1951981659087274,0.2830188679245283,1.0,1.0,3/6,9.36%,SCN5A;KCNQ1;KCNA5
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.42829258003569226,1.1950436568663625,0.07142857142857142,0.8413996915484055,1.0,91/604,12.41%,VEGFC;IGF1;ADRA1A;FGF10;SMAD6;TIMELESS;FLT1;IRS1;TCIRG1;CDKN2C;RUNX1;FGFR3;ITGAX;BOK;ACE2;MYC;SIRT1;TGFBR1;F2R;FGFR1;EGLN3;ERBB4;GNRH1;IL4;STAT5A;FGF2;KAT2B;NRG1;KSR1;CDKN2A;FBXO5;BMP2;TENM1;PRMT1;CDCA7L;SIX4;ST18;IL7R;KANK2;DUX4;HCLS1;SMYD2;RELA;PTGFR;CCN6;SSTR3;TRAPPC14;DNAJB2;WNT9A;ITGAV;WWTR1;PDGFRA;TP53INP1;P3H2;POU3F2;FER;IL15;DPP4;HDAC2;LIFR;TOB1;DLC1;RNF139;PDGFC;CBFA2T3;ARID2;PTPN14;MAGI2;FGF17;TMEM115;TMIGD3;FRK;IGFBP6;RPS6KA2;EZH2;FLT3;EFNB2;ITGA1;BMPR1A;PTPRK;CNOT6L;HP1BP3;SINHCAF;HAS2;GDF9;MVD;NCK2;PROX1;PTEN;H2AC6;CTBP2
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.5701688186178231,-1.1948448494040824,0.20408163265306123,1.0,1.0,2/34,1.76%,TERT;TERF2IP
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.7067384105803414,1.1946272285943258,0.21052631578947367,0.8420943879017435,1.0,3/10,10.56%,SHMT2;GCAT;RIDA
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.650845171498677,1.194577228996613,0.3333333333333333,0.841542828986899,1.0,3/17,4.62%,AASS;HYKK;ALDH7A1
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.5520792723787414,-1.1945250086462693,0.16666666666666666,1.0,1.0,3/35,9.57%,HK2;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.5232290433783624,-1.194498513381781,0.1276595744680851,1.0,1.0,6/53,13.11%,TERT;FLOT1;HFE;MMP9;WNT3A;CAV1
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.542914250147701,-1.1940778638065457,0.13793103448275862,1.0,1.0,14/51,12.12%,UROC1;ALB;HABP2;AHSG;F7;FGL1;PAH;DBH;HAO2;TTBK1;PRODH2;CDHR2;APOA1;C3P1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.5686052316155108,1.1935530053442298,0.23529411764705882,0.8450199141404613,1.0,7/37,13.04%,FERMT3;CD99;MEGF10;MYL12A;PDGFRA;CSRP1;HSPB1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.6792365540253941,1.193542371837318,0.16981132075471697,0.8442773162536705,1.0,5/24,15.58%,LDLR;NPC2;MTTP;PITPNM1;SLC44A4
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.693436941365684,1.1935295976485916,0.2545454545454545,0.8435242605251857,1.0,6/11,19.73%,PLA2G10;CD74;MFHAS1;GPR137B;PLSCR1;LYN
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.571425287597467,1.193381339272987,0.21568627450980393,0.8427422476777496,1.0,11/30,15.95%,SCRIB;DLC1;VANGL2;PHACTR4;PLXNB2;PRICKLE1;DVL2;LRP6;LRP2;COBL;DEAF1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.571425287597467,1.193381339272987,0.21568627450980393,0.8427422476777496,1.0,11/30,15.95%,SCRIB;DLC1;VANGL2;PHACTR4;PLXNB2;PRICKLE1;DVL2;LRP6;LRP2;COBL;DEAF1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.5250472062504796,1.1933379176486,0.19148936170212766,0.8421459640059619,1.0,22/66,15.60%,SMAD6;VWC2L;IL4;FGF2;PPARG;NEDD4;BMP2;CRIM1;ACVR2A;BMPER;UBE2D3;SMAD1;VWC2;BMPR1A;DAND5;SMAD4;SPRY3;GREM1;LRP2;SPART;BAMBI;SMAD5
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.5314199438602241,-1.1932709642103676,0.1956521739130435,1.0,1.0,6/57,12.43%,TRMO;BUD23;CMTR1;METTL6;FTSJ3;TARBP1
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.6308624936181841,1.1932011190599352,0.3090909090909091,0.8418335130014792,1.0,3/27,4.40%,GATA4;WNT4;SIX4
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.7050254550632099,1.1925325027701295,0.2037037037037037,0.8438638696630845,1.0,1/9,2.31%,ERBB4
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.6431560752929208,1.192508342795684,0.23404255319148937,0.8431858816373746,1.0,6/19,11.28%,SLC12A1;SLC12A3;SLC8A1;SCNN1B;CYP4F12;ATP1A2
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.4945482263536529,1.1921497991820644,0.19230769230769232,0.844012942329257,1.0,18/85,10.07%,MXRA5;SMIM3;MME;ACTG2;GNG12;LRIG3;FBLIM1;LTBP2;SDC4;POSTN;MYOF;WWTR1;F3;FAM114A1;DSP;MYH11;IGFBP6;TNC
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.7220704381728933,1.1919978925870978,0.2916666666666667,0.8438759944034263,1.0,4/8,10.84%,TGFBR1;NRG1;RBPJ;BMPR1A
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),0.7458544144595545,1.1917493905472403,0.2909090909090909,0.8440442002257056,1.0,3/8,6.92%,ALDH1A1;ALDH1B1;ACSS2
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.724137712883054,1.191593841663538,0.22413793103448276,0.843790309675447,1.0,2/8,3.01%,HIF1A;PADI2
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.5218799308264671,1.1913735372650491,0.20408163265306123,0.8438178186277265,1.0,20/63,16.76%,SIRT1;INSIG1;EHD1;LDLR;NPC2;RORA;CYP39A1;ABCA1;MTTP;PLA2G10;ABCG8;CYP7B1;NR1H3;PLA2G12B;SOAT2;ABCG5;LIPG;SOAT1;AKR1C1;DGAT2
prerank,GO_Biological_Process_2021__negative regulation of vitamin metabolic process (GO:0046137),0.7701302415206883,1.1913421520770018,0.3125,0.8432020492805115,1.0,1/5,3.09%,SNAI1
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.5081235072085346,1.1913369201341966,0.2,0.8424471863899795,1.0,17/64,17.47%,MME;FAIM;ROBO2;CHODL;PTPRD;SMARCD3;PLXNB1;LIG4;PLXNB2;LRP2;CAPRIN1;RGS14;SPEN;CTNNB1;CDKL5;NUMB;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.6306647378230383,1.190891645188446,0.22033898305084745,0.8435031359686098,1.0,2/27,1.62%,IGF1;HGF
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.5247053332813468,1.1908698631161119,0.21428571428571427,0.8428076859524603,1.0,9/52,14.41%,CCNG1;CDKN2C;CDC25A;CCNA2;CNPPD1;CCNB3;CCND3;SERTAD1;CCNH
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.6310476962785196,1.190622852916907,0.2692307692307692,0.8429291822451965,1.0,3/18,4.40%,ITGAX;FGF2;SIX4
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.6009731657992785,1.1905930224487686,0.2413793103448276,0.8423053645405751,1.0,6/21,17.85%,GRIN3A;LLPH;NLGN1;MEF2C;FOXO6;FMR1
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.6761981280830787,1.1904464522468394,0.21666666666666667,0.8423340430697497,1.0,2/13,1.49%,MSH4;TOP2A
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.7617971581103614,1.1904063967706437,0.2777777777777778,0.8416886494475823,1.0,2/6,14.46%,LDLR;LRP2
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.6593952544303833,-1.1899961975991773,0.2765957446808511,1.0,1.0,1/14,0.17%,TERT
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.7758052214283772,1.18988507819141,0.18867924528301888,0.8426466766069792,1.0,1/5,3.93%,DCC
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.6892696872654084,1.1898577942451405,0.32142857142857145,0.8419789656692132,1.0,3/8,7.29%,SYK;CCL5;IL15
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.693962767967517,1.1896555139017426,0.3137254901960784,0.8420310142832795,1.0,3/10,7.89%,IRS1;CD244;SNCA
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.7362419836437801,1.1894618890375064,0.22641509433962265,0.8419903358209585,1.0,1/6,4.75%,JADE3
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.6931791824863346,1.189430893232142,0.35714285714285715,0.8413597248676074,1.0,1/11,1.76%,MYC
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.6808861925335885,1.189269125478304,0.2222222222222222,0.8411347898686099,1.0,5/11,21.43%,AANAT;METAP1D;NAA16;NAA11;NAA50
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.6725817547396944,1.189058252061333,0.3,0.8412797935041557,1.0,6/10,26.96%,FZD5;RIPPLY2;MESP1;DDIT3;WLS;SHH
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.5181896930831598,1.1886247921740185,0.12195121951219512,0.8422898556853694,1.0,5/43,5.57%,RBM20;MYCN;LIN28A;RIOK2;RELA
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.44877553910595497,1.1886095607314349,0.11320754716981132,0.8416151294362049,1.0,39/210,16.12%,IRGM;ATP6V0D2;HGF;BOK;DEPP1;FZD5;NEDD4;GFAP;TFEB;RNF152;DAPK2;IL10RA;MID2;PIP4K2A;PRKAB2;TP53INP1;TICAM1;HTRA2;HMGB1;FOXO3;ABL2;ATG101;TAB2;LEPR;KEAP1;TRIM65;FOXO1;WASHC1;RRAGC;MAPK8;ATP6V0B;MTMR9;HSPB1;MTMR3;GPR137B;ATF6;FBXL2;PRKAA1;TAB3
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6970167480901479,1.1885637667259625,0.27586206896551724,0.8410222307321704,1.0,6/12,19.39%,RENBP;UAP1;GNPNAT1;GNPDA2;GFPT1;B4GALNT2
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.7307172237000378,1.1884287557053586,0.23076923076923078,0.8407755915520987,1.0,3/8,25.01%,BACE2;ITM2B;ABCA7
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.49405778013590446,1.1883464198496636,0.17073170731707318,0.8402994674744013,1.0,13/82,8.34%,MME;TMPRSS2;KLKB1;MYRF;MMP16;PCSK5;HGFAC;F12;PRSS3;VSIR;F3;HTRA2;CPN1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.7738236581385259,1.188106381074344,0.19148936170212766,0.840662674706722,1.0,3/7,18.31%,CCL5;NOC2L;IRS2
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.6985549984175131,-1.1878014316895242,0.2765957446808511,1.0,1.0,2/8,10.86%,TAF7;SPI1
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),0.8008179840784457,1.1877772748842024,0.2413793103448276,0.840527229697198,1.0,2/5,8.79%,ALDH9A1;ACADM
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),0.8008179840784457,1.1877772748842024,0.2413793103448276,0.840527229697198,1.0,2/5,8.79%,ALDH9A1;ACADM
prerank,GO_Biological_Process_2021__mesenchymal to epithelial transition (GO:0060231),-0.6453291491393349,-1.187644000871005,0.3111111111111111,1.0,1.0,3/6,17.38%,PAX2;FZD7;PAX8
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5608086239770137,1.187217947371643,0.24074074074074073,0.8419775182460346,1.0,4/33,7.83%,SIRT1;RORA;ESR1;PPM1A
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle contraction (GO:0060452),0.7666849415468201,1.1871154738098946,0.3,0.8414566632822408,1.0,1/5,0.50%,ADRA1A
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),0.7642140359023719,1.1867965518394639,0.20754716981132076,0.8420573589768666,1.0,5/6,23.43%,GREM1;IL33;LYN;ENPP3;BLK
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.7296120590360439,1.1865949492479044,0.34,0.8421885710724746,1.0,4/8,21.16%,MAP2K6;CHEK2;ABL1;MAPK3
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.5545275953626493,1.1861940067262666,0.17543859649122806,0.8428788668189502,1.0,12/38,20.53%,MAP3K11;TNFRSF19;TAB2;MAP4K2;MAPK8;IRAK1;ARHGEF6;TAB3;MAPK10;ADORA2B;GPS1;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.5451543718106443,1.185416716655502,0.25862068965517243,0.8451303538314056,1.0,8/44,9.71%,C3;IL4;NLGN1;RAB31;BICD1;TF;SNCA;HIP1
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.4522901425079122,1.1852497308100187,0.15,0.844996421747818,1.0,40/183,19.92%,LAMA4;C3;CDKN2C;STAT5A;PPARG;ANGPT1;ADIPOR2;STOM;IDH1;JAGN1;ACADS;PPP1R15B;ABCA1;SLC25A1;LIFR;TOB1;HIBCH;CAVIN1;ACADM;ACAA2;MTARC2;RAB34;PGM1;TANK;SLC19A1;ANGPTL4;DNAJC15;FZD4;COX6A1;DNAJB9;GPD2;REEP6;GPHN;GBE1;RIOK3;PHLDB1;DHCR7;CRAT;ITGA7;ACOX1
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5777113866390016,1.1851554430908715,0.17857142857142858,0.8445211980551153,1.0,8/28,18.05%,LIN28A;SMAD1;SMAD2;MRPL44;PRKRA;HNRNPA2B1;PUS10;AGO3
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.5225174087475017,1.1851164954458984,0.14814814814814814,0.843898950593693,1.0,19/57,18.93%,FGF10;TNIK;RALA;EFS;PDLIM4;CASS4;GAB1;FER;NPHS2;AUTS2;MCU;GSN;BCAR1;PTK7;RICTOR;FARP2;RAP2A;CAPN10;KIT
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.6421388256063092,-1.1850719707240553,0.30612244897959184,1.0,1.0,1/21,0.17%,TERT
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.6982051653337278,1.1848247318023521,0.2830188679245283,0.8442210291089552,1.0,3/9,19.70%,RNF139;GAS1;STX18
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.6241038588970248,1.1847885076009768,0.3,0.843577437941242,1.0,2/18,4.60%,PLD6;GDAP1
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.4219218189034215,1.184510045898989,0.1111111111111111,0.8438311670632566,1.0,110/459,21.49%,DACH1;TIMELESS;SIRT1;TSHZ3;IL4;FOXP2;SLFN11;NRG1;PPARG;SFMBT2;MDFIC;ENPP1;WNT4;CDKN2A;RORB;BMP2;NFIL3;SYNCRIP;SIX4;SAMD4A;LIN28A;RBPJ;RELA;ZEB1;ZNF706;HDAC3;HDAC2;TOB1;GMNN;RNF139;ATXN1;CBFA2T3;YAF2;SPINDOC;NPAS1;SMAD2;PATL2;EZH2;MAGEL2;LOXL2;RIDA;FOXO1;MBTD1;PTPRK;PASD1;NR1D2;SP3;SMAD4;DPF1;PROX1;CTBP2;TLE2;ZNF281;MYB;ATF7IP;DPF3;TERF1;HSPA8;HEXIM2;ID4;ZBTB33;MLXIPL;PRICKLE1;PML;ZNF639;BCOR;RUNX1T1;NR2F2;EPC1;KAT6A;POU2F1;CAPRIN1;PLCB1;SPEN;CNOT8;DEAF1;MESP1;BAP1;HEY2;BCL3;CTNNB1;MTERF3;SMARCA2;RPS6KA5;FOXN3;TP53;FMR1;CITED2;EED;ZNF12;PSPC1;HDAC9;ZBTB4;NR3C1;NAB1;PAIP2B;BMPR2;TRIM28;LIMD1;HDAC1;HINFP;SFMBT1;DDIT3;PASK;ATP8B1;SCMH1;DPF2;LSM14A;TNFSF4;NANOS1
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.6785336825014701,1.184408646859635,0.25,0.8435064095779494,1.0,1/10,2.58%,ZBTB1
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.7503774317446432,1.184256565253297,0.22641509433962265,0.8417555751878593,1.0,3/8,14.91%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.7503774317446432,1.184256565253297,0.22641509433962265,0.8417555751878593,1.0,3/8,14.91%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.7503774317446432,1.184256565253297,0.22641509433962265,0.8417555751878593,1.0,3/8,14.91%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.5883493421615406,-1.1840819902329263,0.24074074074074073,1.0,1.0,1/30,0.17%,TERT
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.6136761969265951,1.184054183265063,0.2413793103448276,0.8417613166858382,1.0,8/21,20.48%,SEMA5A;DSCAM;DBN1;L1CAM;CDKL5;VEGFA;MACF1;GOLGA4
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.7504761443583035,1.1838388163465245,0.32142857142857145,0.8410624792960153,1.0,1/6,3.41%,ENPP1
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.7504761443583035,1.1838388163465245,0.32142857142857145,0.8410624792960153,1.0,1/6,3.41%,ENPP1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.5219437742605691,1.1838106187592945,0.22916666666666666,0.8404267328875678,1.0,20/62,16.76%,SIRT1;INSIG1;EHD1;LDLR;NPC2;RORA;CYP39A1;ABCA1;MTTP;PLA2G10;ABCG8;CYP7B1;NR1H3;PLA2G12B;SOAT2;ABCG5;LIPG;SOAT1;AKR1C1;DGAT2
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.6995485365558866,1.1837636671739329,0.22448979591836735,0.8398708827844477,1.0,3/10,10.67%,GPR33;C5AR2;C3AR1
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.7177931478864312,1.1835708813308348,0.2830188679245283,0.8397320649463592,1.0,2/8,10.54%,EHD1;ZDHHC2
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.4696810314252148,1.183490588474529,0.16326530612244897,0.8393350841997785,1.0,30/150,11.83%,LRRC3B;NXPH1;RIT2;PRKG1;GRM3;HRH3;CADM2;PCBP3;PDE1A;SLC17A6;CNTNAP2;PENK;ZDHHC22;NRXN1;RAB3C;SLC24A2;OLFM3;SYNPR;GPSM1;HIVEP2;GRM5;LRRTM3;ADGRB3;CTNNA2;PAK5;TMEM196;HCN1;GRIK3;PPM1E;GNG4
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.6660070154328093,1.1834628049265403,0.20754716981132076,0.8386918421677807,1.0,5/13,24.21%,ELP4;CTU1;DPH3;TRMT9B;MTO1
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.7272345574876834,1.1834210033069075,0.32075471698113206,0.8381057998151372,1.0,2/7,4.82%,RUNX1;HCLS1
prerank,GO_Biological_Process_2021__regulation of norepinephrine secretion (GO:0014061),0.8110812722244869,1.1831898782841612,0.32727272727272727,0.8383275854509549,1.0,2/5,7.71%,HRH3;ADRA2C
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),0.5962396798845317,1.1831261462913423,0.2,0.8378660360495922,1.0,1/20,2.20%,SHMT2
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.5079776668586377,1.1830496916912583,0.13333333333333333,0.8374835929899783,1.0,8/67,9.98%,LGALS9;SYK;F2R;MAPKAPK2;TLR2;PLCG2;HMGB1;C5AR2
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.6478413674469063,1.1827796422892505,0.2545454545454545,0.8379288692725987,1.0,1/13,2.18%,ZBTB7B
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.4967744392300036,1.1825344683123704,0.17073170731707318,0.8382952049466768,1.0,30/153,15.60%,PLD6;SIRT1;SOX5;RAPGEF3;FGFR1;LLPH;FBXO5;BMP2;NLGN1;GRIP1;SOX6;RALA;NRXN1;APELA;ELAPOR2;AGR2;NEUROD2;PAXIP1;MCU;CORO1C;BMPR1A;ACVR1B;DVL2;RPS6KA1;FZD4;PHLDB2;NCOA3;PLCB1;FOXO6;COBL
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.7165734234729227,1.1819348685320032,0.3392857142857143,0.8399662741997466,1.0,1/5,5.57%,RELA
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.6774140908986912,-1.1818841422775872,0.24,1.0,1.0,2/9,7.72%,FOXM1;RPS27L
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.5439426710724705,1.1816662069844992,0.2549019607843137,0.8403859440214406,1.0,6/29,16.87%,SEMA5A;SEMA6C;SEMA3E;SEMA6D;KIAA0319;DIP2B
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.654909281443681,-1.1815710100172416,0.3333333333333333,1.0,1.0,2/13,5.43%,RNF8;RECQL5
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.6763611327089,-1.1813096595287693,0.2926829268292683,1.0,1.0,1/17,0.84%,GUCY2C
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.5953839786929676,1.1807950798250315,0.22641509433962265,0.8427205655311266,1.0,6/19,26.04%,JADE3;MSL2;HCFC1;KANSL3;OGT;MSL3
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.5449944248711169,-1.1807626693500073,0.2127659574468085,1.0,1.0,2/49,1.76%,TERT;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.638909100735921,1.1804990791221646,0.3111111111111111,0.8428589233412564,1.0,4/15,11.28%,ADRA1A;APELA;NPPA;ATP1A2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.6462833385024387,-1.1803790766465283,0.35555555555555557,1.0,1.0,1/14,1.92%,KDM4D
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.7388620892743468,1.1801272994051926,0.2549019607843137,0.843675264140825,1.0,5/8,23.85%,TLR2;IL33;EDN1;FCER2;JAK2
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.6023734398942978,1.180001209494602,0.2413793103448276,0.8433570972562825,1.0,7/23,15.66%,SLC26A6;ZBTB20;LIN28A;UNC13B;IGF1R;SLC2A5;PRKAA1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.7618960477539911,1.1799829928987233,0.25,0.8426843055906695,1.0,1/8,2.93%,NEDD4
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.7703708134205407,-1.1797802539371731,0.3148148148148148,1.0,1.0,2/5,6.88%,AGBL1;AGBL3
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.7845329567751415,1.1797218351472678,0.2698412698412698,0.8430107407204882,1.0,3/5,21.28%,TMEM39A;UBQLN4;PHF23
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.510476868273581,1.17969174958366,0.18,0.8424058879842189,1.0,29/120,14.31%,RUNX1;PBX3;TGFBR1;FZD5;WNT4;RORB;OLIG1;TENM3;TENM1;OLIG2;MANF;UGDH;FUT9;WNT9A;EPHA5;POU3F2;PAX6;NEUROD2;PTPRD;LHX6;NLGN4X;INSM2;EMX1;MEF2C;NR4A2;FZD1;MYT1L;LRP6;FZD4
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.48857278659877185,1.17951614682454,0.14634146341463414,0.8422448978605965,1.0,13/77,7.75%,SEMA5A;SIRT1;FGFR1;HIF1A;STAT5A;RIN2;FGF2;ANGPT1;RRAS;SP1;ANXA3;CD40;HMGB1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.7526525588720158,-1.1793366487727808,0.23529411764705882,1.0,1.0,2/9,14.60%,TICRR;CDC6
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.43830948584022617,1.1791713431554474,0.10416666666666667,0.8427589051824637,1.0,71/290,18.48%,MITF;LGALS9;IGF1;FGF10;ITGAX;ITGB8;MYC;TGFBR1;ZBTB7B;IL4;HIF1A;RAB27A;MYCN;FGF2;ANGPT1;CALCR;ACTG2;BMP2;SP1;RBPJ;ZNF804A;MOV10;TLR2;SCRIB;PLCG2;VSIR;TICAM1;F3;PAX6;AGR2;SNCA;RAMP3;SMAD1;RESF1;RIMS2;ANK2;MAGI2;FGF17;CTCFL;GSN;VAMP3;MEF2C;MAPK8;CD34;GREM1;ATF7IP;FGF5;RBMS3;MYOM1;CD74;PLSCR1;HCFC1;PRKAA1;NFE2L2;PIK3CD;TBC1D5;RAB29;UBR5;HEY2;IL33;CSF1;VEGFA;FAM98A;GABPA;TP53;FMR1;MAZ;AGO3;CITED2;AFDN;ARRB2
prerank,GO_Biological_Process_2021__isoleucine metabolic process (GO:0006549),0.7764146020006937,1.1791466588873893,0.2727272727272727,0.8421668807036682,1.0,1/5,13.89%,HSD17B10
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.6408920401519486,1.1790681789951845,0.25925925925925924,0.8417525451974516,1.0,2/18,2.71%,RUNX1;CD22
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.6408422540123782,-1.17889418602644,0.21052631578947367,1.0,1.0,1/17,0.60%,HK2
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.4961822136794813,-1.1787712844348117,0.17391304347826086,1.0,1.0,10/92,11.75%,ANKK1;FBXO43;PLK3;BUB1;SFRP1;ENTR1;PLK4;CAV2;IHO1;KIF20B
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.5447597008982824,1.178710596573641,0.21428571428571427,0.8424863016391497,1.0,9/35,18.37%,EFNA5;EPHA3;BICD1;KLHL42;CDK2AP2;PHLDB2;PRKAA1;MACF1;PHLDB1
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.7314900937552075,1.178433244688735,0.3103448275862069,0.8429322003407442,1.0,4/9,14.46%,SIRT1;LEPR;GCK;LRP2
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.6530319320619169,1.178316550230075,0.2692307692307692,0.8427495597363976,1.0,6/15,28.90%,TELO2;GPR137B;RRAGD;PIP4P1;SIK3;PIH1D1
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.7336432778813999,1.1783155662817273,0.19607843137254902,0.8420280275790891,1.0,1/6,3.69%,RORB
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.5019796635425411,1.1779609577767622,0.18,0.8425281477746374,1.0,14/76,17.52%,MT4;MYC;COX19;SLC39A8;TF;ANKRD9;CYBRD1;SMAD4;SLC39A12;HJV;SLC30A10;MT1M;SLC30A1;FRRS1
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.7834399360980437,1.1777000269354307,0.2777777777777778,0.8427088376611651,1.0,4/5,21.16%,RPS6KA4;RPS6KA5;FMR1;MAPK3
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.6640492030918902,1.1775166740154943,0.35,0.8427026273217386,1.0,3/11,16.44%,MLC1;CRHBP;DYRK3
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.6502897737124695,-1.1773655601942106,0.3333333333333333,1.0,1.0,3/16,9.08%,WTIP;NEK8;WWC1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.6224911929505413,1.1773454192334447,0.23076923076923078,0.8425867614564809,1.0,5/27,4.16%,TNFRSF18;RUNX1;IL4;ZBTB1;IL2RA
prerank,GO_Biological_Process_2021__endochondral ossification (GO:0001958),0.7761349071356588,1.1771809918225082,0.2608695652173913,0.8424710931459809,1.0,2/6,11.92%,FGFR3;MEF2C
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.6046513922050372,1.1769484553819252,0.2727272727272727,0.8424979449740324,1.0,6/19,16.66%,MYC;ZNF706;LOXL2;ZC3H13;NCOA3;CNOT2
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.49218871593689334,1.1767946247432475,0.17647058823529413,0.842426303584285,1.0,25/94,19.00%,RBM20;TGFBR1;ERBB4;KAT2B;BMP2;PCSK5;PDLIM5;PDLIM4;APELA;FGF12;TAB2;PIK3CA;MEF2C;PTEN;DVL2;BCOR;CRB2;FBN1;HEY2;NXN;FLRT3;KDM6A;CITED2;PDLIM7;HDAC9
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.6461952800344879,1.1763114178227647,0.33962264150943394,0.8438630289468562,1.0,4/13,10.55%,PPP1R14D;PPP1R15B;MAGI2;ITGA1
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),0.7848728976176482,1.176289436535309,0.26785714285714285,0.8432115881560532,1.0,1/5,2.39%,SLC22A3
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.73928605474543,1.1761845741978307,0.2692307692307692,0.8428558437687764,1.0,2/9,8.79%,ACADS;ACADM
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.6609867077809195,1.1761739125509652,0.30434782608695654,0.8421518548170601,1.0,6/11,22.92%,IRS1;AKR1C1;DGAT2;AKR1C3;PID1;PDK4
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.6598399130703185,1.1761602533699336,0.2972972972972973,0.8415144126416786,1.0,7/13,14.28%,PADI2;CDCA4;SERTAD2;ELOF1;ARID1A;ARID1B;SERTAD1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.7465018702588203,1.1760861292096352,0.2222222222222222,0.8410412955550183,1.0,1/6,4.04%,NLGN1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.5268197826534847,-1.1759206181835793,0.19148936170212766,1.0,1.0,8/38,10.10%,KCNMB2;STAC;KCNJ16;KCNN3;KCNN2;KCNE1;KCNQ1;KCNJ15
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.6349807059858179,1.1759198149156331,0.1956521739130435,0.8409713107973753,1.0,9/22,23.79%,ROBO2;TLR2;DLC1;CORO1C;PTEN;PHLDB2;IKBKB;ACE;SLIT1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.6487135666460051,1.1755689526159472,0.20833333333333334,0.8416076459887669,1.0,5/18,14.62%,SYVN1;RNF185;RNF139;RNF5;DERL2
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),0.7174722258663169,1.1755368926836522,0.2641509433962264,0.8411030825413187,1.0,2/7,9.05%,SLC22A3;SLC29A2
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.6625678615925426,-1.1751057738699449,0.2765957446808511,1.0,1.0,2/12,9.08%,WTIP;WWC1
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.6888737929863017,-1.1748566542973662,0.3829787234042553,1.0,1.0,3/9,17.78%,FLOT1;HTR2B;PDGFB
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.4578374225660038,1.1747805921930845,0.2,0.8432567150451247,1.0,34/128,12.41%,NXPH1;EPHA7;LSAMP;SOX5;SLC35F1;GRM3;LRRC4C;CADM2;SLC17A6;ROBO2;PCLO;ZDHHC22;FUT9;NRXN1;RAB3C;POU3F2;PAX6;EPHA3;NOVA1;OLFM3;LHX6;SYNPR;HIVEP2;ANK2;LRRTM3;ADGRB3;CTNNA2;PAK5;GRIK3;NOL4;NPAS3;ZNF536;PROX1;GPM6B
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.6158760051237967,1.1745373289744174,0.25,0.843282632772134,1.0,1/21,0.81%,IRGM
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.7066609530087442,1.1742127763501378,0.2830188679245283,0.8439690165614496,1.0,1/8,1.70%,ACE2
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.4908092903790531,-1.1740545361486476,0.22,1.0,1.0,14/70,18.74%,UVSSA;ERCC1;RFC3;PRPF19;GTF2H2;COPS7A;LIG1;XRCC1;RPA3;RFC2;RFC1;COPS7B;LIG3;COPS6
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.7036582240403939,1.1739455539003578,0.23636363636363636,0.8442431260948742,1.0,2/7,7.41%,RIT2;ABCA1
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.6423031669174253,-1.1739322267114818,0.3,1.0,1.0,1/15,1.28%,INHA
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4875481276226175,1.1736266556599981,0.18867924528301888,0.8447978297351193,1.0,16/76,12.19%,C3;CCL5;FRMPD1;TULP3;CALCR;MRAP2;KCTD8;SAG;CNGA1;KLK14;RAMP3;KLK5;PDE6A;CAMKMT;GNG4;PDE6H
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6536302133313593,1.173491189911351,0.15254237288135594,0.8447143579809939,1.0,6/16,19.44%,PDGFRA;FER;PDGFC;BCAR1;RGS14;ABL1
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.7005242770195721,1.1731005770341698,0.28,0.845408026077051,1.0,5/9,20.81%,SIRT1;KLF15;PRKAA1;DIP2B;DIP2A
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.6232909658374491,1.1730318441835104,0.2,0.844989921593574,1.0,3/21,10.17%,FGF2;PRR5L;CORO1C
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.6960343878995816,1.1729397689634113,0.2807017543859649,0.8446479330336791,1.0,2/6,20.02%,TENT4B;ELAVL4
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.531604843060726,-1.1728579978436193,0.2549019607843137,1.0,1.0,8/61,13.03%,EPN1;RHBDF1;MVP;PTPN3;CEACAM1;MMP9;WDR54;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.6855465151392537,1.1725592461220555,0.2545454545454545,0.8455121466370927,1.0,5/7,30.85%,CPEB1;FMR1;CPEB2;CPEB4;CPEB3
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.6258341869383737,1.1725523136287774,0.20689655172413793,0.8448368717102716,1.0,9/20,19.73%,SP1;RELA;LRRTM3;RANBP9;PICALM;EFNA1;ABCA2;CASP3;LYN
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.7120725990920604,-1.1723015357846227,0.2549019607843137,1.0,1.0,4/9,11.81%,IRF4;SLC11A1;GBP2;GBP6
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.7983092144224391,-1.1721322765477113,0.2857142857142857,1.0,1.0,1/5,7.65%,POLR3H
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.5280343350470267,1.1720643410107194,0.2,0.8461400905742392,1.0,17/51,28.25%,SAMD4A;DCP1B;PATL2;CNOT6L;CNOT4;EXOSC4;CNOT8;CNOT2;EXOSC1;ZFP36;PAN3;LSM2;PATL1;EXOSC5;DIS3;EXOSC2;RC3H1
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.5356335951884788,1.1717910897323016,0.22,0.8465284386263221,1.0,5/35,7.72%,TVP23B;LTBP2;RAB3C;ABCA1;MTTP
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.6178195214475849,1.1717333591351418,0.2727272727272727,0.8460471212848985,1.0,4/20,15.03%,TSHZ3;SLC24A2;GRIN2D;RGS14
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.6475955638910261,1.171650675041974,0.23076923076923078,0.8457595606483934,1.0,3/19,7.17%,RENBP;UGDH;UAP1
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.5432128231720339,-1.1713929025896006,0.1891891891891892,1.0,1.0,2/25,1.10%,MYH7;SCN5A
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.5689468308894902,1.1710689563656165,0.2765957446808511,0.8470041129183025,1.0,9/32,11.53%,RAPGEF3;KSR1;ADGRG6;EPHA5;PDE7A;RIMS2;NUDT4;NPPA;HTR2C
prerank,GO_Biological_Process_2021__bundle of His cell action potential (GO:0086043),-0.7118649581059188,-1.171057997165984,0.40384615384615385,1.0,1.0,2/5,9.36%,SCN5A;KCNA5
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.7343776586582702,-1.1708532218369987,0.38636363636363635,1.0,1.0,1/5,2.19%,CTNNA1
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.7343776586582702,-1.1708532218369987,0.38636363636363635,1.0,1.0,1/5,2.19%,CTNNA1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle cell differentiation (GO:2000726),0.7796758276860638,1.170784031006772,0.25,0.8474118517487687,1.0,3/5,11.63%,BMP2;SOX6;SMAD4
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.7582105180236716,1.1707010157730489,0.32727272727272727,0.8469848656924692,1.0,1/8,0.40%,PNP
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.640754991818132,1.1705241804468114,0.375,0.8469325300197503,1.0,7/17,17.47%,NRG1;BMP2;SLC8A1;MYH11;MEF2C;MESP1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),0.7728329896860833,1.1704151571057846,0.3148148148148148,0.8466881287463922,1.0,1/5,0.38%,LGALS9
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.5763198609389111,-1.1701927987251979,0.32142857142857145,1.0,1.0,6/26,6.18%,H1-3;H1-4;TERF2IP;H1-2;ERCC1;NIBAN2
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.48050623435626916,1.1701455632310673,0.16279069767441862,0.8470094460592549,1.0,22/92,19.47%,GSTM2;ANGPT1;VCAN;BGN;SLC35B2;CHSY3;UGDH;MAT2A;HPGDS;DSEL;ST3GAL6;SLC35D2;CSGALNACT1;CHST6;CBS;CTH;BCAN;B4GALT3;MPST;GSTA4;PRELP;CHST15
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.6972873207422248,1.1701262975992228,0.3137254901960784,0.8463710611273413,1.0,2/9,17.61%,ADRB1;CPS1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.7631785313349659,1.1698593766659615,0.3137254901960784,0.8468837836494072,1.0,2/5,11.19%,DSEL;CSGALNACT1
prerank,GO_Biological_Process_2021__calcitonin family receptor signaling pathway (GO:0097646),0.7731116715100793,1.169740992730547,0.2807017543859649,0.8465763932479797,1.0,4/5,20.11%,CALCR;RAMP3;CALCRL;IAPP
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.7550479166810317,1.169569424682204,0.3050847457627119,0.8464715002038831,1.0,3/6,12.35%,ZDHHC12;NRXN1;PTEN
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.787569262528766,1.1693970654171295,0.2222222222222222,0.8464411359812369,1.0,2/6,11.28%,TSHZ3;ATP1A2
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.4557465203069731,1.169114092875878,0.11627906976744186,0.8468035189982028,1.0,23/122,13.46%,PLEKHH2;NXPH1;SLC35F1;SLC1A3;GFAP;IFI44;SLC17A6;ZDHHC22;MEGF10;TMEM200C;POU3F2;STOX2;MAGEL2;NHLH1;PAK5;GRIK3;NPAS3;ZNF536;GPM6B;DLL3;IGF1R;MGAT5;ID4
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.6087427707569744,1.16867522847853,0.3275862068965517,0.8478121893793418,1.0,4/22,9.15%,INSIG1;MDFIC;RAB23;LMAN1
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.5756604519466179,1.1684826880595174,0.2807017543859649,0.8478443705991227,1.0,12/23,26.28%,TGFBR1;ROBO2;BMPR1A;SMAD4;PROX1;HEY2;CITED2;BMPR2;BMP4;SMAD7;SLIT2;ZFPM2
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.6109096167472602,1.168250288164807,0.2777777777777778,0.8480458941193029,1.0,3/32,4.40%,GATA4;WNT4;SIX4
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.5459616254719238,1.1680896453737237,0.16666666666666666,0.8480355160419969,1.0,13/54,12.02%,PNP;FGF10;CCL5;TNFSF13B;IL4;SASH3;IL15;CD40;CCDC88B;IL23R;HLA-E;MEF2C;NCK2
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.7301457154692004,1.1678907705040849,0.32786885245901637,0.8479934456514252,1.0,2/9,7.82%,RFWD3;WDR76
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.7395705868126345,1.1678308745386425,0.25,0.8475395611463634,1.0,2/5,16.44%,ZFAND1;DYRK3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.6153685900204688,1.167737157441108,0.2631578947368421,0.8471391841269227,1.0,7/19,17.81%,SIRT1;DYRK2;PML;PHLDA3;HIPK1;BCL3;TP53
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.6053332998043508,1.1675651531856055,0.2549019607843137,0.8470030585401487,1.0,8/23,17.05%,SIRT1;ABHD17B;HDAC3;ABHD17C;ABHD10;LYPLA1;SIRT6;SIRT7
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.7195467406750213,1.1675429528686023,0.3333333333333333,0.8463509342944444,1.0,2/9,9.37%,INSL5;LEPR
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.648154372488702,1.167472728689159,0.3,0.8458788289130409,1.0,3/10,12.35%,RELA;FUT9;IRAK1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.4379490153752794,1.1673688168143734,0.14,0.8455442288645353,1.0,23/201,9.39%,PCOLCE2;CARNS1;FSTL5;CCDC74B;FAIM;NRG1;EFNA5;ASIC1;CLSTN2;CYB561;PCLO;STOM;H2BC21;ABHD3;MEIG1;GADL1;CNPPD1;FGF12;CLGN;SPEF2;MANEA;LRRIQ1;AK1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.480683169887239,1.1673291089490556,0.17391304347826086,0.8449579528776899,1.0,20/108,16.06%,FGFR3;TNFRSF19;LRP4;GFAP;SLC38A3;DOCK1;ARHGEF17;LIFR;ALCAM;PLXNB1;FAM43B;BCAR1;ID4;SLC19A1;PTPRU;KAZN;GPR37;CPE;GPRC5B;TNFRSF21
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.6968216808206756,1.1670842406431208,0.29310344827586204,0.8450656817534765,1.0,5/10,17.42%,SMAD1;SMAD2;MRPL44;HNRNPA2B1;PUS10
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.7094884479151663,1.1670433079195952,0.24,0.8445017378796724,1.0,4/11,23.62%,ASF1A;ASF1B;H3-3A;RBBP4
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.7022259872902478,1.1670291636956385,0.3673469387755102,0.8438653289160483,1.0,7/8,29.80%,MAPKAPK2;CX3CR1;ZFP36;SIRPA;CD47;FOXP1;CD274
prerank,GO_Biological_Process_2021__regulation of natural killer cell cytokine production (GO:0002727),0.695231065376284,1.1668836140105563,0.2553191489361702,0.8430561467545762,1.0,4/5,30.06%,HLA-E;HLA-F;RAET1G;CD160
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell cytokine production (GO:0002729),0.695231065376284,1.1668836140105563,0.2553191489361702,0.8430561467545762,1.0,4/5,30.06%,HLA-E;HLA-F;RAET1G;CD160
prerank,GO_Biological_Process_2021__regulation of glomerular mesangial cell proliferation (GO:0072124),-0.7319402394680721,-1.1668472517608945,0.36363636363636365,1.0,1.0,1/5,3.86%,IL6R
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.7642595362396297,-1.1667570089094597,0.3181818181818182,1.0,1.0,4/7,14.04%,OVGP1;CHI3L1;AMDHD2;CHIT1
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.7060956255136547,-1.1666437356980703,0.3902439024390244,1.0,1.0,1/5,7.50%,SVIP
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.5510709037092832,1.1666094092249837,0.25,0.8432381907236184,1.0,6/20,21.16%,RPS6KA4;PAXIP1;SMAD4;RPS6KA5;RUVBL2;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.741813363628213,1.1660576579909012,0.32,0.8448097205313051,1.0,1/6,4.97%,LIN28A
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.62496342465191,-1.1660164784719105,0.30434782608695654,1.0,1.0,2/12,10.52%,PARP2;PARP1
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.8124699074991308,1.1659499932906892,0.3023255813953488,0.8444471122778706,1.0,2/6,17.85%,EIF3E;FMR1
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.6993135104485915,1.1658262462470967,0.32727272727272727,0.8442102829634377,1.0,2/7,10.93%,TOP2A;LIG4
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.7254762872230432,-1.1658118196609486,0.35294117647058826,1.0,1.0,2/6,7.64%,RFTN1;FLOT1
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.7936706546598029,-1.1657755096555131,0.35,1.0,1.0,2/5,17.91%,SSU72;CTDP1
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.47485944265972463,1.1656677413050875,0.18604651162790697,0.8441197746825513,1.0,14/125,9.65%,CTDNEP1;FAM83H;TULP3;EHD1;SIX4;CNTLN;TOR1B;BANP;BICD1;WASHC2A;AUP1;ANK2;BBS9;TULP1
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.70520612332731,-1.1656339911140294,0.3023255813953488,1.0,1.0,4/10,13.62%,PDXDC1;ENPP2;FUCA1;CYP1B1
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.6707804933645638,-1.165568535821929,0.3125,1.0,1.0,2/12,11.67%,AGBL1;FOLH1B
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.7447131215538131,1.1654432567482886,0.32142857142857145,0.8442273097896484,1.0,2/6,7.82%,RFWD3;WDR76
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.7176380981817491,1.1653198342953999,0.37254901960784315,0.8439912337468201,1.0,3/9,11.43%,NEDD4;ATP1A2;HECW2
prerank,GO_Biological_Process_2021__regulation of prostaglandin biosynthetic process (GO:0031392),0.7716460716966024,1.1652679527605165,0.3137254901960784,0.8435163681806055,1.0,4/5,21.89%,SIRT1;CD74;ANXA1;PIBF1
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5878286734403001,1.1649931002783271,0.22448979591836735,0.8437592049103534,1.0,7/15,19.45%,SNAI1;BMP2;RBPJ;BMPR1A;NOTCH2;HEY2;JAG1
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.726640164909469,-1.1649486543023815,0.4117647058823529,1.0,1.0,1/6,10.00%,DHX58
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.47812334932112616,1.1648138236512926,0.20930232558139536,0.8436175167191127,1.0,16/71,23.14%,RBM20;HNRNPH1;AFF2;KHDRBS2;FASTK;QKI;KHDRBS3;DYRK1A;PTBP2;RBM12B;FUS;RRP1B;MBNL2;SRSF3;HSPA1A;HNRNPF
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.48197616315878694,1.164605311298249,0.2222222222222222,0.8436420345742854,1.0,12/88,12.40%,NEDD4;GFAP;SEC22B;ODC1;ASB5;BANP;CHMP6;ZDHHC2;FOXO1;CHEK2;HECW2;TIPARP
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.5798618615257667,1.1645866443490451,0.32075471698113206,0.8430135041822711,1.0,4/23,14.62%,SYVN1;AUP1;LMAN1;DERL2
prerank,GO_Biological_Process_2021__leukocyte chemotaxis involved in inflammatory response (GO:0002232),-0.8251972768415445,-1.1645560186323616,0.2978723404255319,1.0,1.0,1/5,3.41%,ALOX5
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.47817424483746157,1.164238027019469,0.21739130434782608,0.8437841635321145,1.0,17/99,11.92%,SMAD6;SIRT1;SOX5;TGFBR1;WNT4;ZFP36L2;LTBP2;SOX6;SMAD1;SMAD2;CGN;BMPR1A;PTPRK;PXN;SMAD4;GDF9;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.5774975155942178,1.1641543084483965,0.18,0.8434359410415478,1.0,10/31,27.74%,ACD;NEK7;CTNNB1;POT1;MAPK3;MAPK15;NAF1;HMBOX1;CCT3;TNKS
prerank,GO_Biological_Process_2021__equilibrioception (GO:0050957),0.7441999675032006,1.163938219564276,0.24561403508771928,0.8434915466789756,1.0,1/5,0.49%,PCDH15
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.6729560020022477,1.1639032751591407,0.33962264150943394,0.8429581452553861,1.0,2/9,4.63%,DERL3;UBE2J1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.7635356852835874,1.16376524817538,0.33962264150943394,0.8427559555852876,1.0,2/7,15.01%,SPSB4;MARCHF7
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6493339341770847,-1.1635499449142237,0.29508196721311475,1.0,1.0,2/15,3.18%,PDXDC1;ENPP2
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.6864219588526588,-1.1634170048915713,0.2553191489361702,1.0,1.0,3/12,13.11%,KCNE2;KCNQ1;CAV1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.4070761558718218,1.1629231919016745,0.11363636363636363,0.844916295240676,1.0,104/486,18.54%,VEGFC;IGF1;FGF10;FLT1;TNFRSF18;IRS1;TCIRG1;FGFR3;ITGAX;MYC;CCL5;SIRT1;TGFBR1;F2R;FGFR1;ERBB4;IL4;RAB27A;SLFN11;FGF2;NRG1;CALCR;MYRF;CDKN2AIP;FBXO5;MLC1;PRMT1;CDCA7L;IL7R;HCLS1;LGI1;CXCL12;RELA;PTGFR;TLR2;ITGAV;WWTR1;PDGFRA;POU3F2;FER;IL15;DPP4;HDAC2;LIFR;PDGFC;RAMP3;FGF17;TULP1;EZH2;FLT3;EFNB2;CNOT6L;SINHCAF;HAS2;GDF9;MVD;EXOSC4;FRMD5;MAPK8;PROX1;PTEN;SMC5;PPP3CA;FASN;GREM1;FGF5;IGF1R;MLXIPL;DVL2;ZNF639;ACACA;SERTAD1;RPS6KA1;LRP6;DERL2;ACACB;BAMBI;MARCHF7;HCFC1;RYR2;SLC44A4;PRKAA1;PHIP;CNOT8;GAB2;PRLR;CSF1;VEGFA;WNT2;FAM98A;CDK4;AKR1C3;RHOG;FMR1;MAZ;CD81;NOXO1;CITED2;RHOD;IRS2;IER5;CAPN10;IL2RB;H3-3A
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.7197537557144534,-1.1628941523495513,0.35,1.0,1.0,1/6,8.95%,CEACAM1
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.5830552321444553,1.1628140599620742,0.24615384615384617,0.8445273329762227,1.0,6/22,15.49%,MYBPH;SCN10A;ANK2;ATP1A2;DMD;RYR2
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.5709022785505399,1.1626242473027208,0.28,0.8445097499053262,1.0,7/31,14.94%,UNC5C;EPHA7;SEMA6C;ITGAV;SEMA3E;SEMA6D;LGR6
prerank,GO_Biological_Process_2021__lipoxin biosynthetic process (GO:2001301),-0.7542248982989754,-1.1626181492507701,0.3508771929824561,1.0,1.0,3/7,15.90%,ALOX5;ALOX15;LTC4S
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.5886408235456242,-1.162291695407162,0.32142857142857145,1.0,1.0,4/24,10.93%,ERCC1;XPC;PARP1;GTF2H2
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.6809700731405206,1.1621270837902977,0.3137254901960784,0.8457373488994971,1.0,1/9,0.68%,SMAD6
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.7605829121998137,1.1621245423820639,0.33962264150943394,0.8450710413161339,1.0,4/6,21.61%,PLCG2;TICAM1;KIT;CAMK4
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.4699386722558868,1.162105634472307,0.1896551724137931,0.844457169355187,1.0,22/119,10.01%,GATA4;MXRA5;IGF1;MRGPRF;ESRRG;SLC22A3;ADGRL4;ALDH1A1;MAFB;INSL3;BGN;CXCL12;NR5A2;EFS;POSTN;PDGFRA;FAM114A1;LIFR;PLSCR4;PRICKLE2;TAC1;MEDAG
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5579505495644785,1.1620934780798398,0.25,0.8438340121500122,1.0,6/25,24.84%,FAIM;TNFRSF10B;FADD;TNFRSF10A;SERPINE1;ARHGEF2
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.7422707157866141,1.161549077009698,0.32142857142857145,0.8452120966886427,1.0,2/6,14.46%,NLGN1;LRP2
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.7572303079557932,-1.161402951910487,0.3617021276595745,1.0,1.0,3/5,20.56%,PRKCD;PRKCH;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.6595856945785171,1.1609284591198858,0.34782608695652173,0.8466494803094856,1.0,4/11,11.03%,EPS8L2;NLGN1;EPS8;DEF8
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.7303119571840455,1.1609150343922907,0.37735849056603776,0.8460363071922443,1.0,2/5,13.67%,ABCC2;SLC19A1
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.6516750925402179,1.1607907432635391,0.2982456140350877,0.8457925048196402,1.0,5/11,20.31%,VCAN;BGN;BCAN;HEXB;CSPG4
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.5785835578664016,1.1603660154657698,0.29508196721311475,0.8466431691631369,1.0,6/25,13.39%,SMYD1;SMYD2;METTL21C;METTL18;ATPSCKMT;SETD7
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.6059365643688412,-1.160315458276893,0.2711864406779661,1.0,1.0,4/18,14.15%,ERCC1;PARP1;GTF2H2;RPA3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.6059365643688412,-1.160315458276893,0.2711864406779661,1.0,1.0,4/18,14.15%,ERCC1;PARP1;GTF2H2;RPA3
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.6323478083721736,-1.1598597872462575,0.3404255319148936,1.0,1.0,4/15,11.23%,RFTN1;NAXE;FLOT1;MYADM
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.4391354329453301,-1.1598430603750405,0.16666666666666666,1.0,1.0,32/251,10.32%,CD44;COL23A1;COL24A1;COL4A2;ICAM3;COL27A1;COL5A1;PXDN;COL4A1;MFAP5;AGRN;LOXL4;MATN4;TGFBI;COL28A1;ITGA9;LAMB3;F11R;FLOT1;LAMB1;COL6A3;COL11A2;ADAM19;ADAMTS9;ADAMTS3;CREB3L1;SPARC;COL26A1;COL1A1;MMP9;VIT;ACAN
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.7483283744811907,-1.1597148861452233,0.35,1.0,1.0,2/7,8.13%,SLC6A6;OLFM4
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.5573057905134872,1.1595265740209975,0.3442622950819672,0.849035234138827,1.0,2/34,1.62%,IGF1;HGF
prerank,GO_Biological_Process_2021__cellular response to UV-A (GO:0071492),0.6865537821605782,1.1591432879843582,0.2826086956521739,0.8498615539252175,1.0,1/8,1.52%,MME
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.6007612810730214,-1.159087024314306,0.22,1.0,1.0,3/25,9.57%,HK2;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5835381371257319,1.1589828007464247,0.21428571428571427,0.8499113096350898,1.0,8/19,21.16%,RPS6KA4;PAXIP1;PRKAA1;RPS6KA5;DIP2B;RUVBL2;DIP2A;MAPK3
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.4882107970941648,1.1588164620708747,0.21818181818181817,0.8499609864302754,1.0,12/74,9.05%,VAPB;DRD5;CCL5;TMTC2;CXCL12;SLC8A1;FAM20A;SLC24A2;CD40;CASR;SNCA;ANK2
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),0.6957795591478031,1.158796561710362,0.2857142857142857,0.8493791439903602,1.0,1/12,0.40%,PNP
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.47229597201681456,1.1585957809834577,0.14545454545454545,0.8493070459444622,1.0,19/87,14.82%,CRX;SV2C;CDH7;AANAT;SAG;GABRG3;CNGA1;RCVRN;SLC24A2;RGR;SLC2A11;PDE6A;HCN1;PDE6H;MYT1L;MGAT4C;ADRB1;RP1L1;TMEM145
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.6067377825904201,-1.1584175344897174,0.2857142857142857,1.0,1.0,6/17,21.15%,KIF2B;STMN1;STMN3;KATNB1;KIF18B;KIF24
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.6715963952530972,-1.1583487805102595,0.3541666666666667,1.0,1.0,3/6,20.56%,PRKCD;PRKCH;PRKCA
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.7213073614356521,1.1581918063066807,0.3673469387755102,0.8502519029346547,1.0,1/7,3.23%,MYRF
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.6222307242306053,1.1581588875259723,0.23255813953488372,0.8496915311273135,1.0,4/21,14.98%,CBLB;CHMP6;NCK2;ERRFI1
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.64892484086418,-1.1577756592361823,0.32075471698113206,1.0,1.0,1/13,0.37%,ACTC1
prerank,GO_Biological_Process_2021__purine ribonucleoside catabolic process (GO:0046130),0.7482180067205015,1.157768044573868,0.29310344827586204,0.8503503260711943,1.0,2/5,8.14%,PNP;ADA
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.651500899135981,1.1573511902354294,0.2962962962962963,0.8510385140846868,1.0,2/14,8.93%,IL4;PAXIP1
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.5903612950160912,-1.1572903145499258,0.2727272727272727,1.0,1.0,6/23,15.19%,ABCA4;RFT1;ABCB1;ABCB4;ATP9B;ATP8B4
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.700947850932107,1.1571960951750042,0.3404255319148936,0.8509552553530157,1.0,6/13,15.29%,TGFBR1;GDF6;ACVR2A;SMAD2;ACVR1B;HJV
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.6537648112511425,1.156972199908853,0.26785714285714285,0.8509227695653474,1.0,1/12,2.87%,PPARG
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.7304602328752714,1.156632967841922,0.3508771929824561,0.851426714537856,1.0,1/5,14.88%,PLSCR1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.6925573444971126,1.1562349996894385,0.32,0.8524860489228705,1.0,3/11,7.56%,VCAN;BGN;DSEL
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.5676213278894114,1.1559460828711292,0.23809523809523808,0.8527555700177897,1.0,10/25,28.64%,KAT2B;KAT6A;RUVBL2;ATAT1;NAA50;CPA4;EP300;MSL3;KAT6B;PHF20L1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.6174863788177849,1.155618343266534,0.37037037037037035,0.8530549572296736,1.0,6/14,20.58%,ASPH;FADD;PERP;LGMN;RIPK2;BAD
prerank,PanglaoDB_Augmented_2021__Podocytes,0.4476291757280746,1.155600875002445,0.17307692307692307,0.8524257237301063,1.0,35/168,15.80%,DACH1;PLEKHH2;ARHGAP24;PLOD2;GNG12;MAFB;DOCK1;LRIG3;ARHGEF17;WWTR1;MYO1E;UNC13B;ADGRL2;DPP4;LIFR;TOB1;PLSCR4;PRICKLE2;NPHS2;KANK1;BCAM;MAGI2;MAGI1;LOXL2;RASAL2;QKI;BCAR1;HTRA1;SEMA3E;NR2F2;FZD4;EMC2;CRB2;CPE;DST
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.5997264020110591,1.1555748478370684,0.24074074074074073,0.8518882034025052,1.0,5/18,10.93%,TGFBR1;BMP2;CHD7;FUT8;LIG4
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.48418619730665496,1.1553968858306547,0.1896551724137931,0.8519156013692538,1.0,14/85,15.14%,SMAD6;IL17RD;SIRT1;TGFBR1;ZEB2;PPM1A;LATS1;SMAD2;DAND5;SMAD4;FAM89B;NREP;BAMBI;VASN
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.6780126973428293,1.1550389962667047,0.2903225806451613,0.8524663309164412,1.0,3/10,20.95%,PSMD13;PSMG2;PSMD4
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5669360419112327,1.1549352274697129,0.2727272727272727,0.8521412379889943,1.0,6/39,10.84%,F2;GSTM2;F2R;SNCA;ANK2;JPH1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.646080080669522,1.154915166358569,0.288135593220339,0.851515178755837,1.0,3/11,10.94%,ALDH9A1;ACADM;CPT1C
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.47740698333941023,1.1548991044176198,0.19148936170212766,0.8509202216535801,1.0,22/66,28.99%,VAPB;TOR1B;LMAN1;UBE2J2;LMAN2L;SEC61A1;REEP6;TOR1AIP2;STX5;STX18;TMCC1;MAPK15;EIF2AK3;BNIP1;TMEM33;LPCAT3;ALDH3A2;VAPA;APP;REEP4;ZBED3;SEC31A
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.6773071200940989,1.154851561062707,0.3137254901960784,0.850426528104139,1.0,1/17,2.73%,RAB27A
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6913716348000746,1.154804366385355,0.29310344827586204,0.8498333483535638,1.0,5/11,19.39%,RENBP;UAP1;GNPNAT1;GNPDA2;GFPT1
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.5574973422733448,1.1547149447858351,0.20454545454545456,0.8494314319574015,1.0,10/26,21.70%,SLC26A7;SLC26A6;SLC35B2;SLC26A4;RACGAP1;SLC44A4;SLC36A1;SLC19A2;SLC25A30;SLC25A14
prerank,GO_Biological_Process_2021__hydrogen sulfide metabolic process (GO:0070813),0.7718537543727302,1.1545649744758948,0.34782608695652173,0.8494405525474524,1.0,4/5,18.32%,ETHE1;CBS;CTH;MPST
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),0.569079982507047,1.154064847524968,0.2698412698412698,0.8503298554659112,1.0,5/20,25.21%,TIMM22;TIMM10;BAD;MAIP1;TIMM9
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),0.7082444070899785,1.1540599215479754,0.30434782608695654,0.8496686347384884,1.0,2/6,19.93%,TBCA;TBCE
prerank,GO_Biological_Process_2021__neurotransmitter loading into synaptic vesicle (GO:0098700),0.7802594593070701,1.1540238344850282,0.24561403508771928,0.8491482552054621,1.0,1/5,3.91%,SLC17A6
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.70964206002252,1.1537979142598154,0.3333333333333333,0.8493072513699084,1.0,1/5,3.86%,ADIPOR2
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.6237553267546052,1.1537602362921828,0.2777777777777778,0.8487480748342859,1.0,3/14,7.04%,BMP2;SOX6;HDAC3
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5180930895924408,1.1537203051920664,0.2833333333333333,0.8482694729580694,1.0,11/36,16.70%,TGFBR1;SNAI1;BMP2;WWTR1;SMAD2;EZH2;LOXL2;SMAD4;BAMBI;CRB2;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),0.5949333417628714,1.1534082202373672,0.23404255319148937,0.8487772315029095,1.0,8/24,22.81%,FZD5;PLCG2;HLA-E;CD55;KIT;HLA-F;TNFSF4;RAET1G
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),0.7794212469007631,1.1533985770867907,0.33962264150943394,0.8475041124122485,1.0,2/5,13.68%,ENPP1;SLC52A1
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),0.7794212469007631,1.1533985770867907,0.33962264150943394,0.8475041124122485,1.0,2/5,13.68%,ENPP1;SLC52A1
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.4932890845432103,1.1533861449678595,0.18181818181818182,0.8468789613277612,1.0,12/78,4.12%,ADRA1A;SMYD1;PREX2;COL9A1;FAM110D;HIF3A;SLC35F1;PPP1R3A;CADM2;ASB15;LRP1B;KBTBD12
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.4875235786967122,1.1533728899275715,0.16326530612244897,0.8462845507152854,1.0,25/103,20.46%,SIPA1;CDKN2C;SIRT1;ENPP1;CDKN2A;CDKN2AIP;DCC;NAIF1;DNAJB2;SERTAD2;DACT3;SMAD4;GNG4;ACVR1B;PML;KIAA0319;FRZB;SMARCA2;DIP2B;DCBLD2;TP53;FBP1;BMPR2;ST7L;MAP2
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.6336805619562793,-1.1533318120356693,0.34615384615384615,1.0,1.0,1/18,0.42%,NTRK1
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),0.6702169146816452,1.1532159189852667,0.3898305084745763,0.846077833574523,1.0,1/9,1.82%,CCL5
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.6204499903093015,1.1532113642695803,0.2807017543859649,0.8454651378499328,1.0,8/17,26.88%,ODC1;CHMP6;ZDHHC2;CHEK2;FAP;FURIN;HGS;ZDHHC7
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.6469585455809574,1.152967536116472,0.3333333333333333,0.8454574116498886,1.0,2/11,5.82%,F2R;NAPEPLD
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.5827661135181933,-1.152874703235146,0.3076923076923077,1.0,1.0,7/25,16.47%,RPF2;DDX18;LAS1L;FTSJ3;NSA2;NHP2;RRP15
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.5499754256142653,1.1528665386469055,0.25862068965517243,0.8451132865913077,1.0,3/23,14.58%,RAPGEF3;RAP1A;COL22A1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.5727591724712533,1.152487337307986,0.3148148148148148,0.8458572414685707,1.0,3/18,17.26%,ESR1;LRWD1;RUVBL2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.5528137008493733,-1.1524538183303443,0.2549019607843137,1.0,1.0,8/36,16.63%,ERCC1;RFC3;PARP1;GTF2H2;FAN1;RPA3;RFC2;RFC1
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),0.601691238715698,1.152438890941239,0.3,0.8454145458668275,1.0,1/18,0.38%,LGALS9
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.7109786455284055,1.1523377228656193,0.29545454545454547,0.8452785509960803,1.0,2/9,3.79%,NRG1;BMP2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.4721722477031223,1.1523165839753158,0.2765957446808511,0.8447087462428693,1.0,25/91,15.32%,C1GALT1C1;TMTC2;PLOD2;GALNT8;POGLUT2;GALNT7;TET2;MUC20;GALNT3;GXYLT1;C1GALT1;GALNT12;GALNT1;MUC13;MUC7;B3GLCT;POMT2;FKRP;SLC35C1;CRPPA;B3GALNT2;POGLUT3;SDF2L1;TMTC3;POMK
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.6394631748059929,-1.1518583614720228,0.3148148148148148,1.0,1.0,3/11,13.98%,CXCL13;P2RY12;CDH17
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.6162894894233258,1.1518230761539339,0.30952380952380953,0.8458154196013932,1.0,3/12,7.50%,PCM1;CCDC120;BICD1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.6166745931582532,-1.1514831888879096,0.37209302325581395,1.0,1.0,4/14,7.66%,PXDN;COL4A1;LAMB3;LAMB1
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.5922281276401602,-1.1511052601502627,0.2916666666666667,1.0,1.0,1/20,0.42%,NTRK1
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.6311294144138332,1.151101941413714,0.3181818181818182,0.84787574431143,1.0,4/15,16.11%,NRG1;BMP2;MEF2C;MESP1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.504800679498275,1.150984197805821,0.18518518518518517,0.8477185986303061,1.0,6/60,3.50%,MAP3K11;CDKN2C;MYC;CDC25A;CCNA2;CDKN2A
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.6608570919849075,1.1509360563579687,0.25,0.8473060127650084,1.0,2/13,5.05%,FGD4;VSTM5
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.6190290536642327,1.150713122710421,0.3076923076923077,0.8475229443555428,1.0,4/19,7.22%,GDF6;BMP2;PRMT1;RELL1
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.764506969647341,1.1505821371103118,0.25,0.8473369718049866,1.0,3/6,17.47%,APELA;ACVR1B;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.7216327388955343,1.1505258452917295,0.3673469387755102,0.8468863767073534,1.0,3/9,5.28%,SIRT1;CDKN2A;ABI3
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.6204177626625749,1.1504712161013155,0.40425531914893614,0.8463874496812067,1.0,2/11,10.84%,BMP2;BMPR1A
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.5328815557540111,1.1501952312179475,0.2916666666666667,0.8466925875705055,1.0,11/38,18.35%,NEDD4;DCC;TNIK;ADGRB3;HECW2;DBN1;CSMD3;KIAA0319;COBL;CDKL5;RAP2A
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.7840719705511674,1.1499452651628483,0.29508196721311475,0.8468895823962654,1.0,1/5,2.98%,ALDH1A1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5171843921987334,1.1498498320903148,0.25,0.846626547644149,1.0,15/69,21.28%,ANGPT1;BMI1;SEPTIN4;HDAC3;SPSB4;DCUN1D1;ARRDC3;PAXIP1;PRICKLE1;MARCHF7;BIRC3;NDFIP2;UBE2D1;RIPK2;PHF23
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.5104479224005448,1.149561390374242,0.25,0.8469503556686264,1.0,10/52,19.28%,VAPB;CCL5;NR5A2;ZC3HAV1;TMEM39A;PROX1;PLSCR1;PKN2;OASL;BANF1
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),0.7935461319607005,1.1490231968687874,0.34,0.8484847322540191,1.0,2/5,11.50%,HAP1;CEP135
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.718766717871397,-1.1482776931285055,0.36363636363636365,1.0,1.0,3/6,25.95%,TGFB1;FGFR2;TGFB2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.5753691803644079,1.1481555142018838,0.2727272727272727,0.8509243845633974,1.0,6/24,23.20%,FKBP5;P3H2;PPIF;PPIL6;CWC27;NKTR
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.4156794484638957,1.1479968522490007,0.14285714285714285,0.8510101515152806,1.0,83/381,17.56%,SEMA5A;CHRM2;LSAMP;TGFBR1;FZD5;ERBB4;NRTN;IL1RAPL2;FGF2;NRG1;EFNA5;ZEB2;POU6F2;CDH2;NLGN1;VCAN;TENM1;THOC6;ROBO2;CRIM1;ADGRG6;ADGRV1;LGI1;SOX6;SDK1;NRXN1;NAV3;WWTR1;POU3F2;ST8SIA4;PAX6;ZC4H2;CHD7;NEUROD2;CNTN6;FGF12;ACHE;ATXN1;PDGFC;SCD5;SNTG2;DSCAML1;ACTL6A;GFRA1;FGF17;DSCAM;NPAS1;ROGDI;GSN;HAP1;NHLH2;NHLH1;GPM6A;LIG4;EMX1;DPF1;MEF2C;GLRB;PROX1;PTEN;GPM6B;DPF3;FGF5;TRPC5;MYT1L;ACVR1B;MOBP;APBA1;DYRK1A;ADORA1;L1CAM;DNM3;GJB1;RAB29;MESP1;HAPLN1;NOTCH2;CNTN4;BCAN;ARTN;FLRT3;VEGFA;WNT2
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.4891994525093957,1.1477924341404109,0.23809523809523808,0.8511055328233359,1.0,15/65,18.20%,CCL5;GPSM3;CCN4;NAPEPLD;TLR2;NFKBIZ;IL15;SNCA;MEF2C;POLR3G;PLSCR1;GPRC5B;PLA2G7;IL33;RIOK3
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),-0.7345344019407776,-1.1477260723059342,0.3673469387755102,1.0,1.0,1/6,2.27%,DRD4
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.5403016307933454,1.147615057390878,0.27419354838709675,0.8510644512993083,1.0,4/22,9.75%,TGFBR1;GRIN3A;GLRA1;SMAD2
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.6766082856919846,1.1473458507584684,0.2826086956521739,0.8513347808224393,1.0,4/11,21.56%,HIF1A;HAP1;ACTR10;TRAK2
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),0.7504674638409157,1.1472421919954594,0.32,0.8510505307452096,1.0,2/6,11.50%,HAP1;CEP135
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.4511664584913911,1.1469535105643673,0.19148936170212766,0.8513981816735336,1.0,17/143,4.55%,IGF1;ADRA1A;FGF10;FLT1;EPHA7;FGFR3;SYK;RIT2;F2R;FGFR1;FGF2;RRAS;ROR1;KSR1;BMP2;PELI2;TNIK
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.5891493352210883,1.1468326701089655,0.2553191489361702,0.8512210967518562,1.0,9/27,18.30%,BOK;FHIT;ZNF385B;PAXIP1;TP53BP2;GREM1;BCL3;TP53;JMY
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.5616148618695369,1.1467903375760733,0.30612244897959184,0.8507241699206695,1.0,6/23,13.67%,SLC1A3;SLC26A7;SLC26A6;ABCC2;SLC25A13;SLC19A1
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.7246770196653431,1.1464459309849953,0.39215686274509803,0.850594586766107,1.0,2/7,9.14%,MDFIC;RAB23
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.7246770196653431,1.1464459309849953,0.39215686274509803,0.850594586766107,1.0,2/7,9.14%,MDFIC;RAB23
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5664679323407478,-1.1463795960018195,0.2631578947368421,1.0,1.0,4/34,4.85%,SELP;SELE;IGSF21;UMOD
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),0.7451714758932855,1.1463465595507294,0.4,0.850312178326317,1.0,1/6,2.04%,F2R
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.4785912891429225,-1.146275469274532,0.23404255319148937,1.0,1.0,7/80,2.82%,EHF;CLDN4;TMEM184A;GPR39;SERINC2;CLDN1;C6ORF132
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.6260122474835267,-1.1459764961163201,0.3333333333333333,1.0,1.0,2/15,5.60%,PNPLA1;PNPLA4
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.7490717268499512,1.1456755726484842,0.3541666666666667,0.8518967139558022,1.0,2/6,9.47%,TCAF2;GRM5
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.47943454669896035,1.1455318665993797,0.20689655172413793,0.8518456826305809,1.0,11/64,13.08%,FGF10;FGFR3;FGFR1;FGF2;HNRNPH1;GALNT3;SHOC2;FGF17;FLRT2;TIAL1;FGF5
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.636526100999355,1.1454508747367629,0.30612244897959184,0.8514857183469838,1.0,3/16,5.54%,KAT2B;DLGAP5;RBPJ
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),0.5678793638643859,1.14531919221595,0.23404255319148937,0.8512324368676023,1.0,1/23,0.05%,SGO1
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),0.6732247808256092,1.1452134513975867,0.36538461538461536,0.8509313250915085,1.0,3/9,7.44%,SIRT1;IL4;HDAC2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.6640170551775291,1.1451606991773933,0.32786885245901637,0.8505150467391093,1.0,4/8,23.10%,RAP1GDS1;MCU;MICU1;BCAP31
prerank,GO_Biological_Process_2021__DNA protection (GO:0042262),0.7578206181864502,1.1451070866481772,0.3508771929824561,0.85011864726019,1.0,2/5,12.75%,DCTPP1;CBS
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),0.7610652802930222,1.1450815744789231,0.32786885245901637,0.8495496737875904,1.0,1/5,7.89%,SNCA
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.7529045896476029,1.145020749270495,0.2641509433962264,0.8491161364576075,1.0,4/6,16.07%,SIRT1;CDKN2A;MEF2C;PIK3CD
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.4690853520416596,1.1449726595350413,0.20408163265306123,0.8486736411343249,1.0,32/111,19.62%,MT4;SYT15;ITPKB;NLGN1;GLRA1;ADGRV1;SYT6;SYT1;PLCG2;TF;NEUROD2;SNCA;CRHBP;SLC25A24;CPNE4;CPNE7;CPNE1;MEF2C;MAPK8;CPNE3;TRPM2;DLG2;PPIF;CPNE2;PRKAA1;MT1M;AKR1C3;RYR3;SLFN14;SYT3;LGMN;FBP1
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.48534429434119336,1.1448598248614275,0.22641509433962265,0.8484525804590165,1.0,21/120,12.43%,GATA4;RBM20;TGFBR1;ERBB4;KAT2B;BMP2;PCSK5;SGCZ;PDLIM5;PDLIM4;APELA;CHD7;FGF12;DLC1;TAB2;SGCG;DAND5;SCUBE1;MEF2C;PTEN;FLRT2
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.6455208479379654,1.1445352592790656,0.3333333333333333,0.848912859984988,1.0,5/14,15.77%,LPIN3;CEPT1;SELENOI;ETNK1;ETNPPL
prerank,GO_Biological_Process_2021__positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),0.756971125797468,1.1444976134289289,0.2982456140350877,0.8484523370875459,1.0,3/5,21.36%,ABCD2;CD74;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.7078911448473735,1.144470875643077,0.29310344827586204,0.8479063039207573,1.0,2/7,4.49%,NLGN1;RORA
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.5482620287566246,1.1443982799856358,0.22033898305084745,0.8475524892649435,1.0,7/34,10.25%,LGALS9;SYK;TLR2;PLCG2;CD40;HMGB1;IL23R
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.7355496788955485,1.144332135550243,0.3684210526315789,0.8471418222364661,1.0,2/7,11.90%,ITGAV;NR1H3
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.661563465741525,1.1439546854798488,0.3269230769230769,0.8477733738926291,1.0,5/12,21.17%,ELOVL5;TECRL;ELOVL4;TECR;ELOVL6
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.7147237557974075,1.1434738509292246,0.38181818181818183,0.8488432382550849,1.0,5/7,26.90%,ANGPT1;VEGFA;SH3GL2;TJP2;TJP1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.547781161229134,1.143432045193121,0.22448979591836735,0.8483848183710906,1.0,4/27,7.89%,SYK;IL4;PLCG2;SNCA
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),-0.7231509488322421,-1.143427448226837,0.3170731707317073,1.0,1.0,3/6,11.69%,IL18BP;ALOX5;IL18
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),-0.7231509488322421,-1.143427448226837,0.3170731707317073,1.0,1.0,3/6,11.69%,IL18BP;ALOX5;IL18
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.5761693296395951,1.1433765207800817,0.3,0.8479366134050957,1.0,5/33,10.25%,PNP;IL4;ZBTB1;VSIR;IL23R
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.7412017409008548,-1.1433090950994569,0.3333333333333333,1.0,1.0,1/5,3.83%,CRACR2A
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.7330524326845607,1.1432172878248499,0.3148148148148148,0.8479082918168059,1.0,3/6,25.01%,BACE2;ITM2B;ABCA7
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.7239871441908525,1.1430401851805185,0.33962264150943394,0.8478990534748619,1.0,2/7,7.07%,CDH2;PAX6
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),0.8067022515541229,1.1430320721645972,0.2830188679245283,0.8472809585941962,1.0,1/5,0.38%,LGALS9
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.5783650358718441,-1.1430114749447147,0.2765957446808511,1.0,1.0,6/29,9.36%,SCN5A;KCNE2;CACNA1G;KCNE1;KCNQ1;KCNA5
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.6060938320617107,1.1429696685111392,0.3333333333333333,0.8462375005129747,1.0,6/17,26.08%,PRSS3;TCN2;ABCD4;LMBRD1;MMAB;MTR
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.6060938320617107,1.1429696685111392,0.3333333333333333,0.8462375005129747,1.0,6/17,26.08%,PRSS3;TCN2;ABCD4;LMBRD1;MMAB;MTR
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.6804776633273544,1.1427579417159828,0.3157894736842105,0.8462959710576917,1.0,1/8,1.94%,SIRT1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion-dependent exocytosis (GO:0045955),-0.6966861914692464,-1.1425548267480683,0.43137254901960786,1.0,1.0,1/5,4.39%,CBARP
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),0.7389566882349763,1.1424774620120144,0.29545454545454547,0.8464586959386139,1.0,2/7,7.98%,F2R;SPX
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.517089714346018,1.1423711983536822,0.2711864406779661,0.8462894327007336,1.0,11/58,10.29%,FLT1;MAP3K11;FGFR1;FGF2;PIK3R6;TENM1;PIK3R5;CD40;PDGFC;EZH2;FLT3
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.5325475686703303,1.1423060993412402,0.24074074074074073,0.8459404598108752,1.0,9/34,15.21%,WNT4;BMP2;ADGRV1;ACVR2A;SLC8A1;BMPR1A;MEF2C;GPM6B;ANO6
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.4685495995127438,1.1423050333466922,0.20930232558139536,0.8453269932496708,1.0,16/112,10.31%,LGALS9;NOX5;ACE2;IL26;ICOSLG;IRF8;CCN4;MAPKAPK2;RPS6KA4;IL15;CCDC88B;STING1;TMIGD2;BTN2A2;C5AR2;CADM1
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.6592391818007554,1.1422863873785387,0.3333333333333333,0.8447711750705812,1.0,3/12,3.12%,TMEM100;RIN2;RRAS
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.617480696556992,1.1421985791179745,0.2857142857142857,0.844461890897694,1.0,3/12,18.40%,RPIA;H6PD;RPE
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.7278148425749877,-1.1421643564272783,0.3888888888888889,1.0,1.0,6/8,24.60%,DARS2;SARS2;GARS1;AARS2;TARS2;WARS2
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.6844789013941897,-1.1421618504011166,0.36538461538461536,1.0,1.0,1/7,5.62%,SENP3
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.5597206108865562,1.1421039859996085,0.25,0.8441719486114609,1.0,5/36,10.58%,MYC;HDAC3;MARVELD3;ZNF675;FOXO1
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.6947307494620252,1.1417734838512115,0.2833333333333333,0.8447034303693253,1.0,4/12,8.96%,ERBB4;WNT4;SCRIB;LATS1
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.6742666762808107,-1.1417573026161383,0.3469387755102041,1.0,1.0,2/11,12.20%,MEFV;PYDC1
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.5518990246066083,1.1417492876289599,0.3275862068965517,0.8442062798745853,1.0,2/20,2.47%,CCL5;IL4
prerank,GO_Biological_Process_2021__intermediate filament bundle assembly (GO:0045110),0.7652967594804212,1.141479473647663,0.3559322033898305,0.844491961114227,1.0,1/5,5.79%,NEFH
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.6388203964829037,1.1414056219344713,0.30357142857142855,0.8441275182722182,1.0,8/14,20.02%,SIRT1;HDAC3;HDAC2;SMARCAD1;SIRT6;SIRT7;HDAC9;HDAC1
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.6126121485662086,1.140760025209625,0.36363636363636365,0.8457301169031198,1.0,2/13,4.63%,DERL3;UBE2J1
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.729634187498137,1.1407527273481846,0.358974358974359,0.8451208431304731,1.0,3/6,17.81%,PHGDH;SRR;PSPH
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),0.7557622648753682,1.1406797826290913,0.2982456140350877,0.8441021245890051,1.0,1/5,2.39%,SLC22A3
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),0.7557622648753682,1.1406797826290913,0.2982456140350877,0.8441021245890051,1.0,1/5,2.39%,SLC22A3
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.5976453544411678,-1.1404502598927542,0.3191489361702128,1.0,1.0,4/19,6.93%,SCN5A;KCNE2;CACNA1G;KCNE1
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.6484133514189659,-1.140419018465368,0.3191489361702128,1.0,1.0,6/10,22.43%,P2RY11;P2RY12;TRPV1;CIB2;HSP90B1;P2RX4
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.6256972834082901,1.14018141341688,0.29508196721311475,0.8451840715161986,1.0,10/17,23.74%,SCRIB;ERBIN;LRRC7;DLG2;CRB2;DLG3;PARD3;CRB1;DLG1;CLIC4
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),-0.6621489129507643,-1.1401274919021909,0.28846153846153844,1.0,1.0,1/10,6.80%,B3GALT5
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.6149993428361336,1.1399088825737351,0.36065573770491804,0.8453644579878119,1.0,6/11,18.50%,GABRG3;GABRA5;GABRG1;GABRB2;GABRE;GABRA4
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.6063232129995346,1.1396164652301848,0.32727272727272727,0.8457881490068986,1.0,2/19,3.67%,CDC25A;FBXO5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),-0.7280211980694615,-1.1396055678538068,0.30434782608695654,1.0,1.0,5/5,27.22%,WNT7A;WNT5A;MAPT;NLGN2;DVL1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.5759826956292683,1.1394968652891384,0.27450980392156865,0.8455840252760793,1.0,3/28,7.38%,RBM20;PRDX6;TRA2A
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.5068541857785691,1.1394839720519947,0.2826086956521739,0.8449966705335827,1.0,12/43,20.67%,ACE2;SLC8A1;ANK2;NPPA;ATP1A2;NPR2;RYR2;ASPH;RYR3;CORIN;TRPC1;ATP1B2
prerank,GO_Biological_Process_2021__collecting duct development (GO:0072044),-0.6602398993113607,-1.1392549656812336,0.32608695652173914,1.0,1.0,2/5,10.65%,PAX2;PTCH1
prerank,GO_Biological_Process_2021__metanephric collecting duct development (GO:0072205),-0.6602398993113607,-1.1392549656812336,0.32608695652173914,1.0,1.0,2/5,10.65%,PAX2;PTCH1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.4362897233167821,1.1391745127503767,0.17391304347826086,0.845260796410544,1.0,23/118,15.32%,C1GALT1C1;PLOD2;GALNTL5;GALNT7;TET2;FUT9;ALG6;MGAT2;GAL3ST1;ST8SIA4;SLC39A8;MAGT1;ST3GAL6;NUS1;GALNT1;FUT8;ALG9;POMT2;MGAT5;MGAT4C;B3GALNT2;MGAT4A;POMK
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.5583400975932263,-1.1390537214169822,0.2857142857142857,1.0,1.0,13/25,23.78%,AFG3L2;APOO;SPG7;DNAJC11;LETM1;DMAC2L;ATP5F1A;ATP5F1E;ATP5ME;SAMM50;ATP5MC3;ATP5PB;ATP5F1B
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.41966240351942985,1.138985668569913,0.16666666666666666,0.8451509084506125,1.0,73/384,16.91%,DACH1;TIMELESS;SIRT1;TSHZ3;IL4;FOXP2;NRG1;PPARG;SFMBT2;MDFIC;WNT4;CDKN2A;RORB;BMP2;NFIL3;SIX4;RBPJ;RELA;ZEB1;ZNF706;HDAC3;HDAC2;GMNN;ATXN1;CBFA2T3;YAF2;SPINDOC;NPAS1;SMAD2;EZH2;MAGEL2;LOXL2;FOXO1;MBTD1;PTPRK;PASD1;NR1D2;SP3;SMAD4;DPF1;PROX1;CTBP2;TLE2;ZNF281;MYB;ATF7IP;DPF3;HSPA8;HEXIM2;ID4;ZBTB33;MLXIPL;PRICKLE1;PML;ZNF639;BCOR;RUNX1T1;NR2F2;EPC1;KAT6A;POU2F1;PLCB1;SPEN;DEAF1;MESP1;BAP1;HEY2;BCL3;CTNNB1;MTERF3;SMARCA2;RPS6KA5;FOXN3
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.4098939121515392,1.138747030114791,0.17647058823529413,0.8453025311133294,1.0,55/302,20.95%,DERL3;CDC20B;SIRT1;NEDD4;SPSB2;FBXO5;SYVN1;UBE2J1;PELI1;DNAJB2;RNF185;FBXL3;UBE2D3;SPSB4;ANKRD9;SPOP;UBE3D;AUP1;SPOPL;ANAPC16;PSMD13;KLHL15;FBXL14;TBL1X;HECW2;RNF5;UBE2U;KLHL42;UBE4A;PSME4;UBE2J2;PML;FBXL15;DERL2;RMND5A;FBXL2;NFE2L2;PSMA1;NHLRC3;DNAJB9;CTNNB1;ARRB2;SMURF1;FBXL20;TMUB2;FBXW5;FEM1B;FZR1;HSPA5;UBE2D1;UBE2A;UBE2E1;STT3B;DDIT3;PSMD4
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.731318905535216,-1.1386973074886086,0.3877551020408163,1.0,1.0,3/5,24.94%,CGAS;PDE10A;THBS1
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.693495496195512,-1.138695068478668,0.3404255319148936,1.0,1.0,1/15,0.17%,TERT
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.722625410333071,-1.138622043283022,0.4186046511627907,1.0,1.0,1/5,3.88%,CD200R1
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),-0.651912880774141,-1.138470934127627,0.32653061224489793,1.0,1.0,3/8,10.48%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.5413913206422092,1.1383559552723603,0.24074074074074073,0.8460042380044179,1.0,13/45,23.00%,PBX3;PCSK5;RBPJ;APELA;TEAD2;BMPR1A;RARB;COBL;HEY2;KIT;ERCC3;PBX1;TEAD3
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.7396339846604666,1.1383420623029878,0.35185185185185186,0.8454280286068666,1.0,1/5,7.27%,DCP1B
prerank,PanglaoDB_Augmented_2021__Interneurons,0.4099907255988381,1.1380835563791445,0.17391304347826086,0.8457281396224676,1.0,47/278,12.07%,TIMELESS;NXPH1;LYPD1;RIT2;PNOC;SLC35F1;NXPH4;GRM3;KCNC2;CADM2;PCBP3;PDE1A;RORB;NPY;SLC17A6;RORA;RGS10;VSX2;DHRS3;SYT1;ZDHHC22;KCNQ5;PARM1;NRXN1;RAB3C;ADGRL2;PAX6;OLFM3;FGF12;LHX6;RAMP3;SYNPR;HIVEP2;GRM5;LRRTM3;ADGRB3;CTNNA2;OXR1;PCF11;HAP1;SCN2B;PAK5;TMEM196;GABRA5;NOL4;GNG4;FCHSD2
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.43046450923669394,1.137846771403608,0.16666666666666666,0.8459533605731931,1.0,96/421,16.79%,GATA4;MITF;IGF1;RUNX1;MYC;ESRRG;TGFBR1;F2R;ERBB4;RFPL2;IL4;HIF1A;MYCN;FGF2;PPARG;PYHIN1;GDF6;SNAI1;TFEB;MED17;MYRF;MDFIC;WNT4;MAFB;RORB;BMP2;NFIL3;MLLT3;SIX4;FLI1;RORA;FANK1;SP1;RELA;NR5A2;ESR1;TEAD2;TP53INP1;PAX6;HDAC2;PPM1A;ELF4;ELK1;RYBP;FOXO3;YAF2;KLF6;KDM3A;CTCFL;SMARCD3;SMAD2;FOXO1;TCF4;TBL1X;NR1D2;HNRNPD;CHEK2;SP3;SMAD4;NPAS3;NR1H3;MEF2C;ARID1A;ZNF281;MYB;ATF7IP;FZD1;PICALM;CREB3L2;ZXDC;SPIN1;ARID1B;CD74;MLXIPL;PML;CREB1;NR2F2;RPS6KA1;LRP6;FZD4;DYRK1A;PAX3;EPC1;KAT6A;BAMBI;PLCB1;HCFC1;SMAD5;PHIP;DEAF1;MESP1;NAA16;HEY2;BCL3;CTNNB1;SMARCA2
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.4550988492360374,-1.1377878220640405,0.21153846153846154,1.0,1.0,15/80,13.11%,DUSP4;SPRY4;DUSP6;PRKCD;FOXM1;SPRED3;SPRED2;UCHL1;PEBP1;CAMK2N1;SPRED1;GBP1;DUSP9;DAB2IP;CAV1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.6994062256926623,1.1377312460965756,0.3103448275862069,0.8457411464171318,1.0,4/7,28.57%,PICALM;EFNA1;LYN;EPHA4
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6486751405657334,1.1375227839937616,0.3333333333333333,0.8458916844999917,1.0,3/12,14.98%,CBLB;CHMP6;ERRFI1
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.6798711873762255,1.1375087471580492,0.25,0.8453362116196966,1.0,5/12,17.24%,SIRT1;PLCG2;CD74;GPRC5B;IRAK3
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.6458509501113289,-1.1374531304311242,0.2826086956521739,1.0,1.0,2/10,7.72%,FOXM1;RPS27L
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.5848858223712478,1.1373748667495767,0.23076923076923078,0.8451991431307718,1.0,3/24,9.38%,SEMA5A;ALCAM;AUTS2
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.6831961874122676,-1.1373473172567705,0.30434782608695654,1.0,1.0,3/8,14.55%,CHTF18;RFC3;RFC2
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.6831961874122676,-1.1373473172567705,0.30434782608695654,1.0,1.0,3/8,14.55%,CHTF18;RFC3;RFC2
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),0.750792727081545,1.1372289869282421,0.2982456140350877,0.8451086392056668,1.0,1/6,10.31%,CADM1
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.6826808121461347,1.1372149955781081,0.36666666666666664,0.8445456656723361,1.0,3/8,24.21%,HSD17B10;TRMT5;MTO1
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.47761574536582,1.1370216307508754,0.34,0.8444928029317339,1.0,23/72,25.26%,ZEB2;PDE4DIP;LMAN1;PLXNB1;RAB33B;SIRT7;CENPV;MFF;STX5;STX18;CAMSAP2;SAR1A;MAPK3;USP6NL;MAPK15;TBC1D25;CLIC4;AKAP9;MIEF2;EP300;SPATA4;TMEM33;PAK2
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.6635498084637117,-1.1368171105340557,0.34146341463414637,1.0,1.0,1/9,0.37%,ACTC1
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.5310275919289701,1.1367464556452036,0.2857142857142857,0.845013722514089,1.0,6/26,9.44%,TRPC4;MCUB;SLC8A1;SMDT1;CASR;MCU
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5760748055302023,1.1365580746918176,0.32142857142857145,0.8448773790838333,1.0,10/23,29.16%,TIFA;MAP2K6;TAB2;IRAK1;TAB3;RIPK2;TAB1;TRAF6;CYLD;IFIH1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.5512022119296689,1.136480367916439,0.2619047619047619,0.8445933913485715,1.0,5/32,5.54%,SMAD6;LRP4;ENPP1;BMP2;RBPJ
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.49691278703340674,1.1360102737808218,0.23529411764705882,0.845602485317913,1.0,2/45,2.37%,ESPL1;SNX18
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.518107112133968,1.1357930495878135,0.2413793103448276,0.845724362001767,1.0,3/33,1.22%,REP15;TCIRG1;ATP6V0D2
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.4835182615689986,1.1357907283063853,0.2222222222222222,0.8451176730763713,1.0,21/94,14.47%,IL17RD;C1QL1;LRP4;GNG12;CDH2;TENM3;SIX4;CNN3;ADGRL2;LIFR;ADRA2C;MAGI1;SERTAD4;GPR161;GLRB;BCAR1;FIGN;ID4;FJX1;NR2F2;PTPRU
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.5481708113616152,-1.1356781418234498,0.26785714285714285,1.0,1.0,3/26,6.62%,KCNMB2;SCPEP1;PER2
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.7322698805708664,1.1356683209742542,0.4067796610169492,0.8450554520290195,1.0,3/6,25.10%,SMURF1;FNBP1L;HGS
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.7154325376288271,1.1353323363093026,0.38596491228070173,0.8450232805307637,1.0,2/7,12.14%,HGF;BCAR1
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.7154325376288271,1.1353323363093026,0.38596491228070173,0.8450232805307637,1.0,2/7,12.14%,HGF;BCAR1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),0.6451614337978593,1.1350954972495853,0.3050847457627119,0.8453657857511371,1.0,3/10,25.21%,TIMM22;TIMM10;TIMM9
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.47122585668713096,1.1350676863359312,0.24444444444444444,0.8448350188975353,1.0,31/107,21.40%,NXPH1;LSAMP;RIT2;GRM3;KCNC2;SLC17A6;FUT9;NRXN1;OLFM3;SYNPR;MAGI2;GRM5;LRRTM3;CTNNA2;PAK5;TMEM196;NOL4;GABRG1;DLG2;GRM1;CNTN2;SLC1A6;UNC79;CSRNP3;STMN4;RBFOX1;TRPM3;AMER2;CADPS;HTR5A;KCTD16
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.6071486073378762,1.1350391535373818,0.3157894736842105,0.8443417327671393,1.0,2/20,3.50%,SIRT1;CDKN2A
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),0.6208838380137934,1.1348063197777258,0.25862068965517243,0.8446472947707544,1.0,2/15,2.71%,FGF10;CD22
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.6632409584076979,1.1347593328980339,0.3584905660377358,0.8442098513754219,1.0,4/8,31.51%,PRIMPOL;POLG2;POLG;DNA2
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.6214849439684863,1.1346048596177827,0.2903225806451613,0.8441028272215868,1.0,7/14,21.27%,SCD;SLC25A1;SCD5;FASN;ACACA;DIP2A;ACSS1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.6269173590557715,1.134585885850658,0.36363636363636365,0.8435382322440652,1.0,5/18,20.02%,SMYD1;HDAC3;PIEZO1;HDAC9;HDAC1
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.6965401774119293,1.134068821667078,0.36,0.8444655568041121,1.0,5/7,25.72%,PLCG2;FAM3A;CX3CR1;CARD9;BCL10
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.4803683940295247,1.1338195577649373,0.15384615384615385,0.8449162072010907,1.0,9/57,10.85%,MYC;CDC25A;ZBTB1;NEDD4;SAG;CNGA1;RGR;PDE6A;PTPRK
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.5030663801189219,-1.1337501702211894,0.2553191489361702,1.0,1.0,23/102,14.54%,MS4A8;CFAP61;PVALB;AK8;VWA3A;RGS22;DNAAF1;DRC1;TMEM107;AK7;ANGPTL2;ZBBX;CCDC40;GAS2L2;RSPH1;S100B;CFAP221;APOBEC4;RIIAD1;DNAH2;CFAP52;HDC;ADH7
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.6444796094960353,1.1336704709691554,0.3584905660377358,0.8447815804400798,1.0,1/7,3.79%,BMP2
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),-0.6914937147276222,-1.1335705036865327,0.32558139534883723,1.0,1.0,2/7,2.27%,NPAS4;DRD4
prerank,GO_Biological_Process_2021__caveolin-mediated endocytosis (GO:0072584),0.6901311959446773,1.1334446674454548,0.38181818181818183,0.8449483840437465,1.0,1/5,3.69%,MLC1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),0.6670352393173397,1.1334210990106832,0.425,0.8438501463122291,1.0,4/8,24.27%,UQCC3;BCS1L;SLC25A33;UQCRFS1
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),0.6670352393173397,1.1334210990106832,0.425,0.8438501463122291,1.0,4/8,24.27%,UQCC3;BCS1L;SLC25A33;UQCRFS1
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.7133050511356203,1.1332319401546171,0.3793103448275862,0.8439534920388228,1.0,3/9,19.15%,NXF5;HNRNPA2B1;RBFOX1
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.6917739426371199,1.1330779897861323,0.3076923076923077,0.8438746394046808,1.0,3/9,14.47%,C3;PLA2G10;IKBKE
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.5993138149844855,1.133048851028926,0.3220338983050847,0.8434320521049037,1.0,3/18,11.43%,NEDD4;TCAF2;HECW2
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.5640300495374838,1.1330010197448241,0.2962962962962963,0.8429810010886515,1.0,8/27,14.24%,SIRT1;ENPP1;ZFP36L2;RORA;WWTR1;FOXO1;ANKRD26;RUNX1T1
prerank,GO_Biological_Process_2021__regulation of apoptotic cell clearance (GO:2000425),0.7162261770456261,1.1330001578553592,0.3617021276595745,0.8424034213984053,1.0,2/5,7.75%,C3;HMGB1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.7481595398789217,1.1328769826111762,0.3220338983050847,0.8422169635699371,1.0,1/5,7.84%,ZNF274
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.7058986076153141,1.1327845054465675,0.2982456140350877,0.8419219231580626,1.0,3/7,18.40%,RPIA;DCXR;RPE
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),0.6936165556948506,1.1327384318696876,0.34,0.8414822735541568,1.0,3/7,12.83%,LRAT;RPE65;BCO1
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.5305635124587238,-1.132430605366651,0.3023255813953488,1.0,1.0,7/40,18.05%,ABRAXAS1;TICRR;CDC6;BRCA1;CDK1;BLM;MRNIP
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.6384179426221592,-1.1322837123304494,0.23404255319148937,1.0,1.0,3/15,5.63%,ABCA4;PDE6B;CNGB1
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),-0.6339383932231923,-1.1322383996383785,0.3404255319148936,1.0,1.0,2/15,2.62%,MYH7;STAC
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.4582612468644987,1.132185739885618,0.23728813559322035,0.8428547826805272,1.0,20/161,15.48%,SWSAP1;IGF1;IRGM;PYHIN1;SYVN1;TELO2;ANK2;HIP1;TBL1X;CHEK2;ZNF207;BAG2;PTEN;ATF7IP;MTMR9;CREB1;PRKRA;CCNH;MARCHF7;HCFC1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.5897322154284852,1.1319212717399207,0.27906976744186046,0.8430848927929138,1.0,8/26,21.36%,CSTA;DSP;SCEL;CERS3;AKR1C3;CASP3;JAG1;ANXA1
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.4432030654379293,1.131920353944168,0.22448979591836735,0.8425006338041048,1.0,56/154,24.53%,SCN7A;FSTL5;LSAMP;LRRC4C;EFNA5;CADM2;TOX;CYB561;PCLO;LIX1;PCDH17;NRXN1;NOVA1;OLFM3;ANK2;SCN3A;GUCY1A2;PIK3CA;TAC1;ADGRB3;FBXO7;ZDHHC2;PAK5;TMEM196;CNTN1;ZNF536;TSHZ1;TAFA1;CPE;CNTN2;MAPK10;HMGCLL1;RET;STXBP5;CSRNP3;STMN4;RBFOX1;GAL;SLC7A14;ELAVL4;HIVEP3;MAP2;ADGRL3;GOLGA7B;KCTD16;AKAP6;PPFIA2;CLVS2;PARVA;SNAP91;DCLK1;SNX21;SCRT1;ASXL3;CYTH3;RGS7BP
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.6513992839280938,-1.1319158623173677,0.29411764705882354,1.0,1.0,5/10,19.02%,XDH;DAB2IP;ADAMTS12;PIK3CB;DCN
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.5388386171993951,-1.13172547635625,0.2682926829268293,1.0,1.0,4/45,7.09%,CLDN4;CTNNA1;CLDN1;F11R
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.5404432003959191,-1.131714475541629,0.2692307692307692,1.0,1.0,7/34,16.63%,ERCC1;RFC3;PARP1;GTF2H2;RPA3;RFC2;RFC1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6167016696443636,1.1316663014864567,0.4222222222222222,0.8427487464959865,1.0,4/10,14.66%,SIRT1;SNCA;NOC2L;KLF15
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.6687383443828856,1.131570971627614,0.3559322033898305,0.8425268342760358,1.0,4/6,29.45%,LHX6;PEX13;HTR6;FGF13
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5061515304360897,1.1315123638539304,0.3148148148148148,0.8420795864395529,1.0,19/51,17.13%,EMB;CDH2;TENM3;ROBO2;SDK1;CNTN6;DSCAML1;DSCAM;NECTIN2;PTPRT;CADM1;IGSF11;HMCN1;PLXNB2;PTPRM;L1CAM;CNTN2;CNTN4;MYPN
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.710275398470856,1.1314430419140633,0.32,0.8417051227807789,1.0,2/10,10.27%,HIF1A;FBXO7
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.4084782539677936,1.1313983945884725,0.16279069767441862,0.8412500652230287,1.0,41/366,7.51%,VEGFC;IGF1;FGF10;FLT1;IRS1;TCIRG1;FGFR3;ITGAX;MYC;CCL5;SIRT1;TGFBR1;F2R;FGFR1;ERBB4;IL4;FGF2;NRG1;TOX;FBXO5;BMP2;BMI1;PRMT1;CDCA7L;IL7R;HCLS1;CCN4;RBPJ;RELA;PTGFR;HPSE;ITGAV;MEGF10;WWTR1;PDGFRA;POU3F2;FER;IL15;DPP4;HDAC2;LIFR
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.4417635822390511,-1.13138051344087,0.2,1.0,1.0,12/126,7.93%,TRIP10;ARAP3;RAC2;RASGRF2;OBSCN;STARD8;VAV3;FOXM1;ARHGAP15;ARHGDIB;ARHGAP12;TAGAP
prerank,GO_Biological_Process_2021__cellular response to macrophage colony-stimulating factor stimulus (GO:0036006),0.7257313688145882,1.1313777851846851,0.37037037037037035,0.8401078462792857,1.0,2/5,22.21%,FER;PDE1B
prerank,GO_Biological_Process_2021__response to macrophage colony-stimulating factor (GO:0036005),0.7257313688145882,1.1313777851846851,0.37037037037037035,0.8401078462792857,1.0,2/5,22.21%,FER;PDE1B
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.6913962294554417,1.131209404666932,0.42857142857142855,0.8401045773387071,1.0,2/8,10.93%,SIRT1;LIG4
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.590653069896496,1.1311984829308286,0.34,0.8395170916202884,1.0,6/25,13.89%,IDO1;HPD;IDO2;TDO2;CBS;HSD17B10
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.6591610490593388,1.1310868532851241,0.3333333333333333,0.8393795139774815,1.0,2/14,8.94%,BOK;ACAA2
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.4382573408114631,1.131003581227696,0.14893617021276595,0.8390356927259415,1.0,36/142,20.39%,OSTC;ALDH1A1;PRDX6;ADIPOR2;IDH1;GLUL;UGDH;ODC1;ACADS;TDO2;CEL;ALDH9A1;ECI1;ELOVL5;HIBCH;CRYZ;HMGCS1;ACADM;ACAA2;RAP1GDS1;CA2;FASN;HSD17B10;SLC22A5;AUH;LGALS1;GPD2;SMS;REEP6;BCKDHB;ACSL4;GRHPR;CRAT;ACOX1;ECI2;RDH16
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.6388864278412756,1.130699077447762,0.34615384615384615,0.8393471032470867,1.0,5/18,7.75%,LGALS9;SYK;IL4;PLCG2;HMGB1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.7050420613358557,1.1306882809844183,0.3333333333333333,0.8382041516112622,1.0,2/7,10.58%,KCNC2;FOXO1
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.7050420613358557,1.1306882809844183,0.3333333333333333,0.8382041516112622,1.0,2/7,10.58%,KCNC2;FOXO1
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.7122107073765691,-1.1306485590006765,0.3695652173913043,1.0,1.0,2/6,8.91%,ZP3;C1S
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),0.633710966827848,1.1305904858661466,0.2857142857142857,0.8378442056438321,1.0,7/14,15.72%,GPR55;IL4;MAFB;ZNF675;LRRC17;GPR137B;FBN1
prerank,GO_Biological_Process_2021__lipid hydroxylation (GO:0002933),-0.7359789350934631,-1.1305439264970771,0.4,1.0,1.0,1/5,3.29%,CYP2E1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.6239286817301232,1.1301362637843289,0.3090909090909091,0.8388085078370388,1.0,6/17,20.73%,SYT1;RIMS2;SMURF1;SYT3;CPNE9;SYT17
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.43158388148136934,1.130119573305479,0.20967741935483872,0.8382788198748234,1.0,39/230,14.30%,VEGFC;FGF10;IRGM;F2;C3;EPHA7;HGF;SIRT1;ERBB4;FGF2;EFNA5;ANGPT1;PRR5L;BMP2;PELI2;TNIK;ACVR2A;WWTR1;FAM20A;PPP1R15B;HDAC3;FER;BMPER;CD40;FGF17;LEPR;GRM5;CORO1C;AKTIP;PLXNB2;PTEN;HSPB1;FGF5;CCND3;CD74;DVL2;PLAUR;PML;LRP6
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6658780698192759,1.1297547496522489,0.3448275862068966,0.8390092528319674,1.0,4/12,15.78%,HGF;PYCR1;GPR37;NFE2L2
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.5431372012162806,1.1296296899593965,0.23636363636363636,0.8387836316757027,1.0,9/45,10.39%,VEGFC;SEMA5A;RSPO3;FGF2;ANGPT1;NRARP;BMPER;EFNB2;LOXL2
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.6391300217587953,1.1295587824048317,0.28,0.838371016056365,1.0,5/8,31.25%,NECTIN2;PLSCR1;LYN;MILR1;CRLF2
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.6839678707356859,-1.1293771572270281,0.43636363636363634,1.0,1.0,2/7,13.04%,DGAT2L6;DGAT1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.42738230958103457,1.1288183345045726,0.23076923076923078,0.8402585846344047,1.0,33/164,16.07%,PLD6;FGF2;PIK3R6;LPIN3;PIK3R5;ABHD3;PIP4K2A;SLC44A5;PIK3C2B;PLCG2;CHPT1;PCYT1B;PLA2G10;ACHE;CEPT1;INPP4B;CPNE7;PIK3CA;ACP6;CPNE1;SELENOI;ABHD8;PTEN;MTMR9;CPNE3;MTMR3;PI4K2B;PLSCR1;PITPNM1;ETNK1;SLC44A4;ETNPPL;PIK3CD
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.5483379995565923,1.1287427966026262,0.2807017543859649,0.8399167751383119,1.0,9/28,19.15%,SLC1A3;SLC38A3;SLC7A2;SLC7A9;SLC25A13;SLC3A2;SLC1A6;SLC36A1;SLC25A12
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.759650428265581,-1.128717365358952,0.39215686274509803,1.0,1.0,1/5,7.82%,OAS3
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.6876045591894311,-1.1284560832318817,0.43137254901960786,1.0,1.0,4/8,23.40%,CYP4F2;ALOX12B;AQP1;ABCB11
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.6345976629930221,1.1281125469906406,0.32653061224489793,0.8411686964555469,1.0,2/10,10.21%,DCP1B;PATL2
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.6784640800098303,1.1280100609690384,0.37037037037037035,0.8409690457292085,1.0,3/11,7.89%,HIF1A;TF;SNCA
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4370183009252592,1.1279816519389771,0.2631578947368421,0.8404763483925719,1.0,21/121,10.13%,DRD5;CHRM2;LGR5;ADGRL4;HTR1F;CALCR;OPRK1;INSL3;ADGRG6;ADGRG4;PTGFR;RXFP2;ADGRL2;ABCA1;GRM8;GPR12;GPR26;RAMP3;GNAI3;GPR161;ADGRB3
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.5347259885728393,-1.1276391045021468,0.3191489361702128,1.0,1.0,10/36,13.11%,SCN5A;KCNE2;CACNA1G;DSG2;KCNE1;KCNQ1;KCNA5;CTNNA3;SCN3B;CAV1
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.6819002632812523,1.1275237932582975,0.41379310344827586,0.8414943443820371,1.0,5/7,31.55%,MOGAT2;DGAT2;PLA2G15;PNPLA2;MOGAT1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5054853894439872,1.1274472113558718,0.30434782608695654,0.8410996039947571,1.0,6/53,7.75%,LGALS9;SYK;FZD5;TLR2;PLCG2;HMGB1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),0.737829830959355,1.1274038254080543,0.38,0.8406521874602053,1.0,2/5,12.69%,RBPJ;GREM1
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.6901237330799409,1.1272843194282332,0.3050847457627119,0.840497901638076,1.0,3/13,14.44%,PPARG;RELA;NFATC3
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.701339275364036,1.1271418157568465,0.37037037037037035,0.8404146919904517,1.0,3/8,22.30%,LRRC55;NPPA;AKAP6
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.6097252234947079,1.1270206831585934,0.4523809523809524,0.8402519304089691,1.0,7/19,14.10%,SMAD6;LRP4;ENPP1;RBPJ;MEF2C;GREM1;BCOR
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),0.7267273822551672,1.1268972937032609,0.25,0.8401424673418254,1.0,1/5,15.61%,CTU1
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),0.7068358176541241,1.1268139953123149,0.2777777777777778,0.8397944839475582,1.0,2/11,4.31%,PADI2;PRMT1
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.6150951351246545,1.126650943699908,0.35294117647058826,0.8397296536784021,1.0,8/10,29.59%,SLC8A1;MYH11;VEGFA;JAG1;ALPK3;ALPK2;CXADR;NOTCH1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.618766049437153,1.1266201738256731,0.30357142857142855,0.8392500190032439,1.0,4/11,20.78%,INSIG1;CD81;GCC2;SAR1A
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),-0.6740923662449589,-1.126616114271681,0.3695652173913043,1.0,1.0,1/9,0.96%,MPO
prerank,PanglaoDB_Augmented_2021__Microglia,0.47836027809161513,1.126544630923358,0.24074074074074073,0.8389298290253163,1.0,16/94,9.04%,LGALS9;TCIRG1;ITGAX;TGFBR1;CSF3R;SASH3;MAFB;PIK3R5;PTGS1;IL10RA;FGL2;LAIR1;HPGDS;SIGLEC1;CD40;STING1
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.5806392377632678,1.126431618007788,0.32727272727272727,0.8387687556691108,1.0,3/21,8.14%,SOCS2;STAT5A;SOCS6
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),0.7042883202422962,1.1262965520237869,0.3488372093023256,0.8385902843741267,1.0,1/5,4.40%,SIX4
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.7182679883544882,1.1262837668477133,0.37254901960784315,0.8380775308148751,1.0,1/6,13.09%,TANK
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.5501647440063202,-1.1262684000174732,0.28205128205128205,1.0,1.0,6/30,18.05%,ABRAXAS1;TICRR;BRCA1;CDK1;BLM;MRNIP
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.5223002228023746,1.1260336289010688,0.28,0.8383396424440578,1.0,9/44,12.26%,TGFBR1;FGFR1;BMP2;PCSK5;SIX4;CHD7;FUT8;LIG4;PROX1
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.6380825079234432,-1.1259864735566028,0.3829787234042553,1.0,1.0,2/12,3.48%,TAFA3;IL31RA
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.6380937287788495,1.1258846996318206,0.35714285714285715,0.8381618308803388,1.0,2/8,18.05%,PEX11A;MFF
prerank,GO_Biological_Process_2021__metanephric nephron tubule development (GO:0072234),-0.7013624588878989,-1.1258569195386112,0.34146341463414637,1.0,1.0,3/5,17.38%,PAX2;OSR1;PAX8
prerank,GO_Biological_Process_2021__adult heart development (GO:0007512),-0.7300212581276356,-1.1258481543014212,0.4166666666666667,1.0,1.0,1/5,0.85%,MYH7
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.6855586437183068,1.125835754973699,0.35714285714285715,0.8377207038909669,1.0,4/8,26.67%,SPX;ACSL1;SLC27A1;CD36
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.6370066864614743,1.1254688596222537,0.3617021276595745,0.8383336934435424,1.0,4/16,15.69%,SLC8A1;SLC9A2;SLC9C2;SLC9A9
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.6493487779014219,1.1253470035607451,0.3888888888888889,0.8381123836103459,1.0,3/12,7.56%,VCAN;BGN;DSEL
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.6830937190822276,1.1250852685963857,0.3333333333333333,0.8384261813290445,1.0,2/6,13.65%,NEUROD2;DBN1
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.541206298071339,1.1249732882770724,0.23728813559322035,0.8380824515613198,1.0,6/38,8.18%,MYC;RFWD3;FBXO5;SMYD2;WDR76;SMG1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.5048250135211295,-1.1248443442070069,0.25925925925925924,1.0,1.0,8/56,9.14%,SELE;XCR1;NMUR2;P2RY11;BTK;CAMKK2;P2RY12;TPCN2
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.6324919230906912,1.1246679734290392,0.3673469387755102,0.8385359279256149,1.0,7/12,32.22%,SCRIB;SYNE4;RAP2A;ZDHHC7;MYO9A;OPHN1;RAB10
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.6507710267692974,1.12460359726093,0.35555555555555557,0.8382188396296566,1.0,5/10,12.69%,BMP2;SOX6;EFNB2;MEF2C;GREM1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.45966895128811175,1.1245582980474242,0.25,0.8378147482586229,1.0,31/127,18.76%,SLC26A3;DRD5;CCL5;RAPGEF3;URI1;INSIG1;AANAT;SLC26A6;NRIP1;RORA;ESR1;RAMP3;CRHBP;STING1;HCN1;ATP1A2;MEF2C;TIPARP;GABRB2;RAP1A;TRPM2;NCOA3;CTNNB1;RORC;RUVBL2;LCOR;RIOK3;SSTR1;RYR3;CASP3;GABRB1
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.48374619416573766,1.1243407884694232,0.17857142857142858,0.8379529316012866,1.0,11/93,9.15%,RUNX1;SYK;TGFBR1;RAPGEF3;LRP4;NRG1;NRXN1;NEUROD2;SNCA;FRMPD4;LMAN1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.7462863736478716,1.1243049728392602,0.3508771929824561,0.8375321067733099,1.0,2/5,24.89%,TANK;OTUD4
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.654759097683983,1.1240882046389986,0.23404255319148937,0.8376964712998743,1.0,1/11,2.61%,KCNC2
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.679195702940308,1.1240728402847076,0.37735849056603776,0.8371891942419145,1.0,5/15,7.07%,ROBO2;TLR2;PCM1;ELAPOR2;PAX6
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.41498513003231235,-1.1240095135518466,0.25,1.0,1.0,12/306,4.30%,CD44;NTRK1;TEK;INHA;TERF2IP;FGF1;IL11;ENPP2;TEC;ANGPT4;IL6R;ATG14
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.41711308690216264,1.123970972883403,0.2127659574468085,0.8369004502663256,1.0,42/258,10.39%,NOX5;ADRA1A;ITGAX;SYK;ESRRG;SIRT1;SOX5;TGFBR1;IL26;F2R;ZBTB7B;IL4;FGF2;TRPM8;SNAI1;SCD;TRPV2;FBXO5;BMP2;ADIPOR2;NLGN1;SIX4;SOX6;PRKAB2;APELA;PLAC8;WWTR1;HDAC3;IL15;ABCA1;CCDC88B;ACHE;PDGFC;PAXIP1;KDM3A;TMIGD2;LEPR;SMAD2;EZH2;HAP1;CADM1;LOXL2
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.5000610352762299,1.123706555529656,0.1836734693877551,0.8372738984213547,1.0,18/64,16.58%,FGFR3;RAPGEF3;GRIN3A;BMP2;DCC;ELAPOR2;ZNF706;NEUROD2;KANK1;HYAL3;LOXL2;SINHCAF;SPRY3;GREM1;KLF7;KIAA0319;ANP32B;HEY2
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.6092290915133676,-1.1236940101011728,0.3333333333333333,1.0,1.0,3/11,13.61%,NLRP1;IRF5;NOD1
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.5206004490459191,-1.1236682197634225,0.23636363636363636,1.0,1.0,11/51,7.93%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;CYTH4;LTB;KLRB1;CD5;TAGAP
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.48569461336795017,1.1236648812923185,0.19148936170212766,0.8368114478715389,1.0,12/89,10.93%,TOP2A;MYC;NDC80;SIRT1;PADI2;RFWD3;HDAC3;HDAC2;LATS1;LRWD1;EZH2;LIG4
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.7047063635774824,-1.1236448784684254,0.40816326530612246,1.0,1.0,1/8,0.37%,ACTC1
prerank,GO_Biological_Process_2021__lymphocyte apoptotic process (GO:0070227),0.7587358785619451,1.1235761363209464,0.3148148148148148,0.8365496339280091,1.0,2/5,16.47%,TNFRSF21;CLC
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.5808185851050174,-1.1234660403823573,0.34615384615384615,1.0,1.0,2/14,2.46%,DND1;ZC3H12D
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.6281998642002988,-1.1230648229348112,0.34146341463414637,1.0,1.0,4/10,21.69%,ALAS2;MED1;NCKAP1L;G6PD
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.577374896464333,1.122828208439155,0.29310344827586204,0.8384694250699423,1.0,6/22,13.37%,PPARG;ITGAV;ABCA1;PLA2G10;NR1H3;MSR1
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.5041617582391823,1.1228269649454214,0.23214285714285715,0.8379028916746247,1.0,11/42,24.86%,FZD5;HTRA2;INF2;SIRT7;MFF;IAPP;MARCHF5;PID1;SREBF2;MIEF2;EP300
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.3852132233263651,1.122752814221995,0.1568627450980392,0.8375193720067827,1.0,130/857,14.02%,CRX;GATA4;MITF;LGALS9;IGF1;FGF10;RBM20;RUNX1;ITGAX;ACE2;ITGB8;MYC;ESRRG;SIRT1;TGFBR1;ZBTB7B;TULP3;CDK11A;IL4;HIF1A;RAB27A;MYCN;FGF2;ICOSLG;ANGPT1;CALCR;TFEB;SFMBT2;PCBP3;PRDM8;ACTG2;HNRNPH1;WNT4;HES6;MAFB;HMG20B;POU6F2;RORB;BMP2;BMI1;NFIL3;PRDM14;RORA;SP1;AFF2;HCLS1;ZNF462;CCN4;SOX6;SLC8A1;RBPJ;RELA;NR5A2;ZNF804A;MOV10;TLR2;ESR1;NFKBIZ;TEAD2;NFIA;WWTR1;ABCC2;PLCG2;VSIR;TICAM1;ELAVL2;SLC39A8;F3;PAX6;RPS6KA4;CHD7;AGR2;NOVA1;CIAO3;SSBP2;TOB1;ZNF274;RYBP;ATXN1;RAMP3;SMAD1;YAF2;ZNF195;GPBP1L1;RIMS2;ANK2;FGF17;ZNF675;RO60;CTCFL;BTN2A2;GSN;FASTK;METTL18;NCOA2;EZH2;NFKBID;BMPR1A;ZNF114;NR1D2;HP1BP3;CPNE1;TRIM26;HNRNPD;CHEK2;SP3;DMTF1;MEF2C;ZNF536;MAPK8;PROX1;TIPARP;CD34;ZNF117;ZNF281;MYB;ZNF212;MAGED1;FGF5;PICALM;RBMS3;MSR1;MYOM1;SPIN1;MLF1;ACVR1B;CD74;MLXIPL;DVL2;PML
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.7150078652662066,-1.1227435201218257,0.36585365853658536,1.0,1.0,2/5,17.02%,GOLGA2;CHP1
prerank,GO_Biological_Process_2021__alpha-beta T cell differentiation (GO:0046632),0.7713610525013161,1.1223330597115224,0.43636363636363634,0.8383592137872329,1.0,2/5,12.84%,ZBTB7B;ITK
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.6915912975025725,1.1217627915856978,0.34615384615384615,0.8396919307457472,1.0,2/6,21.16%,IL33;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.7240677645277306,1.121255964748042,0.4375,0.8410401735165753,1.0,7/7,27.62%,PLA2G10;ABCG8;ABCG5;ABCA2;SREBF2;SHH;NFKB1
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),0.7109442634733051,1.1211686538368686,0.2608695652173913,0.8406988499061784,1.0,1/7,0.30%,GPR55
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.6159683821205133,-1.1211272686029197,0.35,1.0,1.0,4/14,10.55%,P2RY11;P2RY12;KCNJ11;TRPV1
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),-0.6910228135331656,-1.1209178837358278,0.40476190476190477,1.0,1.0,2/7,15.60%,CYP24A1;CDKN2D
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.6499954145026559,1.1206306560289605,0.3269230769230769,0.8418024198935814,1.0,2/8,17.08%,AUP1;SQLE
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.6611001360880912,1.1206206381197754,0.3157894736842105,0.841244955502056,1.0,8/12,23.73%,ZBTB1;TICAM1;IL23R;HLA-E;HLA-F;AXL;GAS6;IL12A
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.6185027735940545,-1.1204687569852112,0.25,1.0,1.0,2/16,5.43%,SCN5A;PTPN3
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.6768868240085852,1.1204294465562439,0.4406779661016949,0.841258327352917,1.0,3/7,26.60%,MEGF10;ANXA1;THBS4
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.7447535602412819,1.1204112064422522,0.38596491228070173,0.84019813024074,1.0,1/5,5.82%,NAPEPLD
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.7447535602412819,1.1204112064422522,0.38596491228070173,0.84019813024074,1.0,1/5,5.82%,NAPEPLD
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.547032525489249,1.120090419476195,0.2608695652173913,0.8405914705532377,1.0,7/22,17.47%,ITGB8;APELA;AGGF1;EGFL7;HAS2;HEY2;VEGFA
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.6561437466781752,-1.1198071224656296,0.41509433962264153,1.0,1.0,2/8,12.13%,ENTPD2;ENTPD5
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.5753780440090515,1.1197854976848847,0.36065573770491804,0.8411307305066167,1.0,4/23,12.35%,PRKG1;PPARG;MEF2C;PTEN
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.678317348635964,1.1196782787304764,0.3898305084745763,0.8408600452012801,1.0,3/9,10.13%,C3;EPHA8;ADGRB3
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.4578330758869097,1.1190574239457862,0.22807017543859648,0.842258702661334,1.0,13/81,7.08%,MXRA5;MRGPRF;SEMA5A;NYNRIN;ADGRL4;ACTG2;BGN;CXCL12;FBLIM1;EFS;POSTN;PDGFRA;FAM114A1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.4809028121013391,1.1189234658825982,0.24,0.842116583539198,1.0,12/77,11.85%,SMAD6;SIRT1;TGFBR1;LTBP2;SMAD1;SMAD2;CGN;BMPR1A;PTPRK;PXN;SMAD4;GDF9
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),0.6863884614250093,1.1184644783817062,0.34615384615384615,0.8430056332684505,1.0,2/10,4.84%,WHRN;ADGRV1
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.7451592381609992,1.1183730356687789,0.28,0.8426399755327943,1.0,4/5,25.46%,SETD2;SETMAR;ASH1L;SETD5
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.670165188616378,1.1181987336636985,0.3888888888888889,0.8426094267648196,1.0,2/7,17.90%,GAL3ST1;B4GALT3
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.6694014005612736,-1.1180843242708736,0.3953488372093023,1.0,1.0,3/9,8.31%,SLCO2A1;ABCC4;ABCC3
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.42459227721356274,1.1179186721219765,0.18181818181818182,0.8429819106674344,1.0,29/152,16.88%,SMAD6;IL17RD;SIRT1;TGFBR1;PPARG;ENPP1;RORB;ZFP36L2;RORA;CRIM1;ADGRV1;WNT9A;ITGAV;WWTR1;ABCA1;FOXO1;SINHCAF;NR1H3;PTEN;MYB;GREM1;ANKRD26;RUNX1T1;BAMBI;VASN;ANP32B;USH2A;CNTN4;NELFB
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.4572152461685494,1.1178782083875778,0.20408163265306123,0.8425570200037389,1.0,20/115,10.66%,MXRA5;FGF10;LAMA4;MRGPRF;HGF;PRRX1;ADGRL4;PPARG;GFAP;BGN;COL6A2;CXCL12;SLC8A1;POSTN;PDGFRA;PLSCR4;PCDH18;IGFBP6;MEDAG;TPM2
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),-0.8016815684127478,-1.1177811523286922,0.38181818181818183,1.0,1.0,1/5,3.41%,ALOX5
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.6203129650408497,1.1177357534165127,0.34782608695652173,0.842475210332141,1.0,5/12,23.32%,UBA5;UBA6;UBA3;SENP6;SAE1
prerank,PanglaoDB_Augmented_2021__Goblet Cells,-0.4828942477557334,-1.1176454665131033,0.2553191489361702,1.0,1.0,10/60,5.54%,MS4A8;EHF;CAPN8;CLDN4;CLCA1;FAM3D;MUC5B;SPDEF;SLC9A8;CAPN9
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.511025245589621,1.1175418630218323,0.33962264150943394,0.8425218671484074,1.0,7/43,18.93%,SIRT1;ZBTB1;PRIMPOL;REV1;PCLAF;FAAP20;POLK
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.6567497046342704,1.1175007914104194,0.38,0.8420895791765381,1.0,2/9,6.81%,EGLN3;P3H2
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.6128433183144766,1.1173870219657542,0.3333333333333333,0.8418886024132568,1.0,3/12,18.35%,SCRIB;SYNE4;RAP2A
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.6554927093486768,1.1173399924010214,0.37735849056603776,0.841491470135381,1.0,2/9,17.47%,PHKA1;GBE1
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.5402203983832513,1.117256582534358,0.29411764705882354,0.8411887441199246,1.0,10/40,12.55%,ITGA8;MME;TGFBR1;LRP4;WNT4;PCSK5;C1GALT1;HAS2;PROX1;TBX18
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.5225363288951056,-1.117102302549185,0.2777777777777778,1.0,1.0,2/16,4.75%,ASS1;FGL1
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.5042409219210383,-1.1167899897874944,0.30612244897959184,1.0,1.0,11/57,8.78%,P2RY10;CD24;PRDM1;IRF4;CD53;ANGPT4;KCNA3;MS4A4A;JCHAIN;TAGAP;LY86
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.48651280071072966,1.1167103726444076,0.2641509433962264,0.8424642439476374,1.0,6/49,3.95%,SMAD6;SIRT1;PPARG;GDF6;MAFB;STEAP4
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),-0.7045229391782916,-1.1165363294449298,0.4,1.0,1.0,2/6,11.71%,SLC19A3;ACP3
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.600846249252552,1.1164706387110819,0.3090909090909091,0.8425874305071028,1.0,6/21,19.62%,HRH3;NEDD4;SNCA;GPM6B;PXK;WNK1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),0.5743140965535887,1.116324334523593,0.27450980392156865,0.8419906425537236,1.0,2/17,6.90%,GSTM2;HPGDS
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),0.5743140965535887,1.116324334523593,0.27450980392156865,0.8419906425537236,1.0,2/17,6.90%,GSTM2;HPGDS
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.6012828609262242,1.1162798295738532,0.38461538461538464,0.8415695011060536,1.0,1/15,2.25%,NXF1
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.7094586719200876,1.1162687008572116,0.38181818181818183,0.8410469098214471,1.0,1/7,1.97%,STARD4
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.46261216866566,1.1161399268624383,0.25,0.8408478176981027,1.0,20/88,10.29%,IGF1;FLT1;HGF;CCL5;SIRT1;F2R;FGFR1;FGF2;NEDD4;ROR1;PIK3R5;HCLS1;DIPK2A;PIP4K2A;PDGFRA;GAB1;PDGFC;PIK3CA;PLXNB1;FLT3
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.4295513956307629,1.1161223344882127,0.19148936170212766,0.8403348827778769,1.0,51/186,18.31%,SEMA5A;UNC5C;EPHA7;EMB;NRTN;EFNA5;DCC;EFNA2;ROBO2;SPTBN5;LGI1;CXCL12;SEMA6C;UNC5D;NRXN1;EPHA5;GAB1;EPHA3;CNTN6;PLA2G10;ALCAM;DSCAML1;EPHA8;GFRA1;DSCAM;PIK3CA;PLXNB1;EFNB2;RANBP9;PLXNB2;SOS1;KLF7;SEMA3E;PTPRM;SEMA6D;LGR6;L1CAM;CNTN2;PIK3CD;GAB2;NOTCH2;CNTN4;RPS6KA5;ARTN;MYPN;RET;VEGFA;RHOG;EFNA1;LAMA5;IRS2
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.6156200549505276,1.1159104890574822,0.3508771929824561,0.8404843569045631,1.0,5/14,26.05%,INTS6L;INTS6;ERI1;INTS14;INTS8
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.4242853432839565,-1.1157684538449297,0.23404255319148937,1.0,1.0,13/175,6.67%,CD44;COL4A2;COL5A1;COL4A1;MGP;MFAP5;FBLN2;CRLF1;GPC1;TGFBI;SFRP1;TAGLN;RGS4
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.5760468738266257,1.115713567391685,0.3157894736842105,0.8400371289035229,1.0,4/15,23.96%,JADE3;HCFC1;KANSL3;OGT
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.5760468738266257,1.115713567391685,0.3157894736842105,0.8400371289035229,1.0,4/15,23.96%,JADE3;HCFC1;KANSL3;OGT
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),-0.7145939424065567,-1.1151847333400802,0.3877551020408163,1.0,1.0,1/5,4.05%,ABCC4
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.4791252669514503,1.1151644150847866,0.25,0.8413210785708287,1.0,14/64,13.52%,IRS4;IRS1;TCIRG1;ATP6V0D2;GAB1;FER;ATP6V0A4;PIK3CA;FOXO1;BCAR1;SOS1;ATP6V0B;IGF1R;SH2B2
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.4612614091040612,1.1150183305639247,0.2545454545454545,0.8412241291863479,1.0,27/121,13.04%,MITF;LAMA4;TYR;PRRX1;RAB38;PPARG;ENPP1;GNG12;BMI1;DOCK1;POSTN;PPFIBP1;CCDC80;ITGAV;WWTR1;EPS8;FAM114A1;PRICKLE2;PTPN14;TNC;LOXL2;RASAL2;HMCN1;KLC2;HTRA1;PXDC1;HSPB1
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),0.7113003019446636,1.1149306116213114,0.34615384615384615,0.8409920140016333,1.0,1/6,6.63%,TCN2
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.7236439583113148,1.1148469590861692,0.4,0.8407686543067707,1.0,2/7,21.62%,TRPM7;SLC7A8
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),0.7314758363423572,1.1147621436493593,0.3620689655172414,0.8405455881200484,1.0,2/6,20.81%,TSR3;RPUSD2
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.664075779544989,1.1147221130346006,0.3469387755102041,0.8401371529241848,1.0,5/15,17.23%,NRG1;CDH2;MEF2C;LRP6;KLHL12
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.7136228692739146,1.1146277507949405,0.3728813559322034,0.839956962053888,1.0,3/8,14.31%,GRIP1;DVL2;FZD4
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.7272492481400193,1.114587236959467,0.3888888888888889,0.8394904517161166,1.0,1/6,0.09%,GATA4
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.574362808056467,-1.1144049958415982,0.24489795918367346,1.0,1.0,2/24,5.60%,PNPLA1;PNPLA4
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.4228630536200386,1.1140669174632252,0.23404255319148937,0.8403132087990871,1.0,68/396,14.02%,CRX;GATA4;MITF;ESRRG;TGFBR1;CCNA2;TULP3;CDK11A;HIF1A;TFEB;PRDM8;HES6;MAFB;POU6F2;FBXO5;RORB;BMP2;NFIL3;RORA;SP1;HCLS1;SOX6;RELA;NR5A2;ESR1;TEAD2;NFIA;WWTR1;ELAVL2;SLC39A8;RPS6KA4;CHD7;SSBP2;ZNF274;GMNN;RYBP;FOXO3;ATXN1;YAF2;ZNF195;GPBP1L1;GRM5;ZNF675;METTL18;NCOA2;EZH2;ZNF114;NR1D2;HP1BP3;HNRNPD;CHEK2;SP3;DMTF1;MEF2C;ZNF536;RBBP6;ZNF117;ZNF281;MYB;ZNF212;MAGED1;SPIN1;MLF1;ACVR1B;ESCO1;MLXIPL;DVL2;PML
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.6511276884581725,1.1136258761361593,0.45454545454545453,0.8410170492547494,1.0,4/8,28.60%,FOXO1;BAD;GSK3A;CLOCK
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5732955006790188,1.113559451490049,0.3392857142857143,0.8406264651415003,1.0,4/25,15.21%,FGF10;UBE2E2;CCND3;PLCB1
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.4661972860678357,1.1135168200006298,0.29545454545454547,0.8401775494915342,1.0,37/115,18.64%,SCN7A;PRKG1;EDIL3;LRP4;PRDX6;VCAN;PENK;EFS;MEGF10;TMEM200C;ADGRL2;LIFR;PTPRD;STOX2;PCDH18;PRICKLE2;PABPC5;ANK2;GFRA1;GUCY1A2;MAGEL2;LRFN5;ID4;COL11A1;RUNX1T1;SEMA6D;FRZB;CPE;GPRC5B;PDZRN3;MAPK10;CCDC3;VAT1L;CSRNP3;COL25A1;TMEM178A;MPDZ
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.5283231126473598,1.1133536903619312,0.3137254901960784,0.8400484422596857,1.0,6/32,14.30%,SEMA5A;SEMA6C;PLXNB1;PLXNB2;SEMA3E;SEMA6D
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.5713292386282864,1.1132995541422186,0.32608695652173914,0.8397012315676066,1.0,3/28,4.07%,NDC80;LLGL1;NDE1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.6105669402682727,-1.1131394238516197,0.38095238095238093,1.0,1.0,1/13,3.43%,PRKCD
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.4264392146556974,1.1126319135832754,0.3076923076923077,0.8412589137229233,1.0,44/211,14.30%,DRD5;CHRM2;SLC12A7;GABRR1;RIT2;PNOC;GABRR2;GRM3;SLC1A3;HRH3;HTR1F;OPRK1;NPY;NLGN1;GLRA1;PENK;SYPL1;GABRG3;SYT1;CACNB4;NRXN1;UNC13B;CEL;NOVA1;SNCA;GPR176;GRIK2;NLGN4X;GRM5;RPS6KA2;HAP1;SCN2B;UTS2;KCND2;GABRA5;HTR2C;GLRB;GRM4;GABRG1;GABRB2;GRM7;APBA1;RPS6KA1;LRP6
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.6030310299168111,1.112597270737244,0.32727272727272727,0.8408526775005467,1.0,6/23,14.00%,RBPJ;AGR2;HIP1;HAP1;PDE6H;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.7489064406881272,1.1125913654161543,0.42857142857142855,0.8403212909698361,1.0,4/5,23.85%,TLR2;IL33;FCER2;JAK2
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.5080983413576178,1.1125402216215823,0.3137254901960784,0.839949687694677,1.0,16/57,17.89%,LGALS9;RUNX1;SIRT1;IL4;PPARG;EFNA2;IL15;CBFA2T3;OSCAR;PML;PIK3CD;GAB2;CSF1;VEGFA;CDK4;FARP2
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.590457578170156,1.1124353221231464,0.3275862068965517,0.839704084583567,1.0,3/23,5.88%,MYRF;PRDM8;TLR2
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-0.7026685108399857,-1.1123913195683994,0.4222222222222222,1.0,1.0,4/6,20.56%,LY86;BMP6;LY96;PRKCA
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.6711254034904804,1.1118683615382132,0.37254901960784315,0.8404924379725582,1.0,2/6,17.90%,GAL3ST1;B4GALT3
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.6711254034904804,1.1118683615382132,0.37254901960784315,0.8404924379725582,1.0,2/6,17.90%,GAL3ST1;B4GALT3
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.7207292390634473,1.111827683597357,0.38,0.8400632292251647,1.0,2/5,16.86%,RPS6KA4;RPS6KA5
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5782321371994013,1.1117980998445374,0.29411764705882354,0.839626231872446,1.0,5/18,13.52%,GPR33;C5AR2;C3AR1;BCAR1;SH2B2
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.45596522360407754,1.1111319287050276,0.24,0.8411331622508783,1.0,23/99,14.93%,MME;CCL5;TGFBR1;URI1;SOCS2;ROBO2;PTPN20;HCLS1;ACVR2A;HTRA2;RAMP3;STING1;PTPN14;NCOA2;FLT3;BMPR1A;MAPK8;TIPARP;IL18R1;CPNE3;ACVR1B;LRP2;NCOA3
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.6962540457130295,1.1107762545474797,0.33962264150943394,0.8416712555700315,1.0,4/9,22.07%,IRS1;ABCD2;IRS2;AKT2
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.5779258843381228,-1.110405631798531,0.3170731707317073,1.0,1.0,3/19,8.85%,NUPR1;ACTN3;PGP
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6430892382566462,1.1103159168506391,0.38596491228070173,0.8426168112536888,1.0,3/11,12.14%,HGF;MUC20;BCAR1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.6118925935797309,1.110175286664319,0.26666666666666666,0.8425372412353479,1.0,7/16,18.72%,SP1;RELA;LRRTM3;PICALM;EFNA1;ABCA2;CASP3
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.7622186427137825,1.1101095159728525,0.40350877192982454,0.8422331609634562,1.0,1/5,4.30%,ROBO2
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.6100322045923944,-1.1100549981874535,0.41304347826086957,1.0,1.0,5/19,17.81%,BUD23;FTSJ3;EMG1;MRM1;NSUN4
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),0.450271937948308,1.1099999302662897,0.24390243902439024,0.8420042967250712,1.0,16/138,11.68%,TNFSF14;TNFRSF18;CCL5;SIRT1;TNFSF13B;ZFP36L2;ST18;RELA;CD40;FOXO3;CRHBP;ERBIN;PSMD13;HYAL3;ZFAND6;HAS2
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.5659878876808832,1.10970314907307,0.3673469387755102,0.8424736217451735,1.0,8/16,24.54%,SHMT2;SRR;CBS;CTH;PSPH;DAO;GLYAT;BAAT
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.5660057820774808,1.1097006164823056,0.37037037037037035,0.8419293881393948,1.0,7/26,13.99%,MOB1A;TEAD2;WWTR1;LATS1;SAV1;AMOTL1;DVL2
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),0.7026748586004365,1.1094330008537483,0.35714285714285715,0.8421990148934277,1.0,4/8,19.45%,SCUBE1;CD34;MESP1;JAG1
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.44411249829568494,1.1093782533334693,0.23529411764705882,0.8417883354742219,1.0,19/171,7.51%,SEMA5A;RUNX1;TSPAN12;RSPO3;SIRT1;FRMPD1;RFNG;TULP3;VWA2;SOCS2;MDFIC;CDKN2AIP;LLGL1;RORA;DHRS3;KCTD8;ESR1;WWTR1;LIFR
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.6186132439044618,1.109319104657348,0.37254901960784315,0.8415024880371356,1.0,2/13,8.45%,YAE1;ISCA2
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.6689469968645523,-1.1091904996038215,0.3673469387755102,1.0,1.0,1/13,0.17%,TERT
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.631734818578481,1.108730392018,0.3333333333333333,0.8421981493432584,1.0,3/11,8.33%,GRM3;ADGRV1;GNAI3
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.631734818578481,1.108730392018,0.3333333333333333,0.8421981493432584,1.0,3/11,8.33%,GRM3;ADGRV1;GNAI3
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.6325915487731937,-1.1087125745282478,0.35714285714285715,1.0,1.0,2/8,8.48%,AK8;AK7
prerank,GO_Biological_Process_2021__negative regulation of adaptive immune response (GO:0002820),0.7167334907253674,1.1085978299776504,0.33962264150943394,0.8420201108086695,1.0,1/5,3.71%,SAMSN1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.4169435162977999,1.1085240389790953,0.19230769230769232,0.8416604600192721,1.0,28/157,13.96%,RIT2;LRRC4C;RETREG3;ROR1;TOX;CDH2;DCC;TENM3;ABI3;PDLIM5;ZNF804A;FUT9;EPHA3;HDAC2;ABL2;KANK1;MAGI2;CTNNA2;FBXO7;EFNB2;PLXNB2;NTNG2;PTEN;FZD1;RAP1A;LRRC7;DBN1;PTK7
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.634062208328194,-1.1081592346324611,0.37037037037037035,1.0,1.0,4/14,14.29%,KCNE2;KCNE1;KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.46000778145374877,1.1080519440804188,0.288135593220339,0.8425320411618633,1.0,36/128,20.47%,HNF4G;ESRRG;KAT2B;PPARG;MED17;RORB;RORA;RBPJ;NR5A2;ESR1;TEAD2;WWTR1;HDAC3;TAF3;TBL1X;NPPA;NR1D2;NR1H3;NR4A2;RARB;CCNH;TAF5;THRB;TAF2;NOTCH2;RORC;MNAT1;GTF2B;MAZ;HDAC9;NR3C1;CCN2;POLR2H;NR6A1;HDAC1;TAF4
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.5968081530854709,1.1077108527176482,0.30357142857142855,0.8429980129419926,1.0,2/15,4.49%,SIRT1;RORA
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.5886666177892038,1.1071747180815599,0.3404255319148936,0.8440326086408722,1.0,6/14,26.13%,PAXIP1;NECTIN2;KMT5B;TNFSF4;SHLD2;SHLD1
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.7218273782880229,1.1070071675922313,0.3541666666666667,0.8440188504958154,1.0,1/7,2.33%,PLOD2
prerank,GO_Biological_Process_2021__regulation of digestive system process (GO:0044058),0.7504568334475451,1.106934237067352,0.28,0.8437908954944849,1.0,3/6,9.55%,FGF10;OPRK1;EPB41
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),0.6727476561082876,1.1066819928111913,0.3673469387755102,0.8441148932026904,1.0,2/9,8.30%,SCD;SCD5
prerank,GO_Biological_Process_2021__regulation of T-helper 1 cell differentiation (GO:0045625),0.7148136540947393,1.1066814862445165,0.4339622641509434,0.843574486740973,1.0,3/5,28.09%,ANXA1;TNFSF4;CD80
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.6995427092807749,-1.1066243218709595,0.43478260869565216,1.0,1.0,1/5,6.56%,PEX7
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.6995427092807749,-1.1066243218709595,0.43478260869565216,1.0,1.0,1/5,6.56%,PEX7
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.6161185240772452,1.1065165904103804,0.3269230769230769,0.843561056909723,1.0,2/14,9.22%,TIMELESS;ARID2
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.7312992253820121,1.1064848765117898,0.40425531914893614,0.8431120930412693,1.0,2/5,25.72%,NAA16;NAA30
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.4696830301147794,1.1064649612620556,0.2826086956521739,0.8425980013582306,1.0,15/77,11.28%,SLC5A8;SCN7A;SLC12A1;ASIC1;SLC12A3;SLC5A12;SLC8A1;SCNN1B;SLC24A2;SCN10A;SCN3A;SCN2B;HCN1;SLC6A16;ATP1A2
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.6128853459310308,-1.1064113276854775,0.4,1.0,1.0,1/11,1.00%,NPAS4
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.5234501962035971,1.1063215300932463,0.26785714285714285,0.8425688059046856,1.0,5/29,8.59%,IRS1;STAT5A;CALCR;RAMP3;ERBIN
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.5713432132408444,1.1062402346761264,0.35185185185185186,0.8423674012152162,1.0,6/24,11.92%,NEDD4;ABHD17B;PDLIM5;CTNNA2;ABHD17C;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.5829930887343348,1.1061382961991197,0.39622641509433965,0.8421416624698113,1.0,4/20,13.44%,SIRT1;PPARG;NR1H3;ABCA8
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),-0.6443920439321472,-1.1056760877079201,0.37209302325581395,1.0,1.0,1/5,0.25%,KLRC1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.46505471312611385,1.1056686539849936,0.2916666666666667,0.8430630577172863,1.0,9/65,14.31%,SIPA1;SEMA5A;ANGPT1;DSCAM;PLXNB1;PLXNB2;KNG1;ADAMDEC1;FZD4
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.40873014531541485,1.1055272421728488,0.17391304347826086,0.8429190288559204,1.0,58/272,19.00%,LGALS9;IGF1;RUNX1;ITGB8;SIRT1;HIF1A;MYCN;FGF2;KAT2B;SFMBT2;WNT4;BMP2;BMI1;SYNCRIP;ZFP36L2;SAMD4A;LIN28A;MOV10;ESR1;ABCC2;RPS6KA4;TOB1;NUDT16L1;RNF139;BTN2A2;PATL2;EZH2;RIDA;BMPR1A;CPNE1;MEF2C;TIPARP;CD34;ZNF281;PICALM;RBMS3;MSR1;DXO;EPC1;CAPRIN1;PTBP2;PRKAA1;CNOT8;NOTCH2;HEY2;RPS6KA5;VEGFA;CCDC3;CENPV;FMR1;AGO3;CITED2;EED;NDFIP2;H3-3A;SLFN14;ADAM10;HDAC9
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.5735451100785408,-1.1053934900980358,0.27906976744186046,1.0,1.0,1/20,0.60%,HK2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5476044084070746,1.105256098075129,0.3793103448275862,0.8432333378434775,1.0,5/28,11.11%,KLRD1;NECTIN2;IL23R;CADM1;HLA-E
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.6536928954027263,-1.1050499837409207,0.36,1.0,1.0,1/11,0.17%,TERT
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.6255014917048888,1.1048998792853677,0.30612244897959184,0.8437352978393146,1.0,3/15,6.35%,TSHZ3;NLGN1;NRXN1
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.7153460653709766,1.1047814654713708,0.3508771929824561,0.8419526741560879,1.0,3/6,21.17%,ELOVL5;ELOVL4;ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.7153460653709766,1.1047814654713708,0.3508771929824561,0.8419526741560879,1.0,3/6,21.17%,ELOVL5;ELOVL4;ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",0.7153460653709766,1.1047814654713708,0.3508771929824561,0.8419526741560879,1.0,3/6,21.17%,ELOVL5;ELOVL4;ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.7153460653709766,1.1047814654713708,0.3508771929824561,0.8419526741560879,1.0,3/6,21.17%,ELOVL5;ELOVL4;ELOVL6
prerank,GO_Biological_Process_2021__regulation of urine volume (GO:0035809),-0.6559801591001753,-1.1047488945073862,0.36363636363636365,1.0,1.0,1/6,3.52%,TRPV5
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.5689129171869542,1.1045040693943577,0.36,0.8422419494668464,1.0,7/24,18.05%,PEX12;ABCD3;ABCD2;PEX11A;PEX2;ABCD4;MFF
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.7314781839531965,-1.1044764862644285,0.42857142857142855,1.0,1.0,2/5,14.45%,TRAIP;TEX264
prerank,GO_Biological_Process_2021__regulation of ribonuclease activity (GO:0060700),-0.6956420669652403,-1.1044680795460184,0.375,1.0,1.0,3/5,14.23%,OAS3;OAS1;OAS2
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.41133098907607285,1.104213551301657,0.19642857142857142,0.8425227131044003,1.0,37/229,17.81%,MYC;TGFBR1;CDC25A;SHMT2;CCNA2;HIF1A;KAT2B;ESR1;STAMBPL1;USP12;INO80E;SMAD1;SENP8;ACTL6A;INO80D;KEAP1;SMAD2;PSMD13;NFRKB;SMAD4;PTEN;PSME4;CCP110;HCFC1;RCE1;USP45;USP31;BAP1;PSMA1;RNF128;STAM2;MINDY2;BIRC3;IL33;USP38;SUPT3H;TP53
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.5875391765034476,1.1040624864276283,0.36363636363636365,0.8425182253381484,1.0,4/26,3.44%,TEX101;ASB17;CRISP1;GCNA
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5334739902191036,1.1038348043510675,0.3220338983050847,0.8426927072610283,1.0,9/33,16.83%,NEDD4;UTRN;FGF12;FGF14;SCN2B;HECW2;NETO1;DMD;GLRX
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.5866470418216805,1.1036152499148086,0.40425531914893614,0.8429320051192127,1.0,5/10,19.45%,SNAI1;RBPJ;NOTCH2;HEY2;JAG1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.4387567554730716,1.1033209926857603,0.27906976744186046,0.8434066093145948,1.0,32/131,21.22%,LRP4;DCC;CNTNAP2;NYAP2;NLGN1;LLGL1;TNIK;NEFH;ALCAM;DSCAML1;PLXNB1;CTNNA2;GPM6A;CPNE1;NTNG2;PTEN;KLF7;DBN1;LRP2;SGK1;CNTN4;CTNNB1;FLRT3;ZDHHC17;WASL;FARP1;SLITRK5;MYO16;MAP2;PARD3;DIP2A;SLITRK6
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.6931517305556387,1.1026542019108594,0.4,0.8448224539877156,1.0,4/6,27.64%,FOXO1;DNAJC3;EIF2AK3;NFKBIA
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.6856586696702068,1.1024813069107768,0.32653061224489793,0.8448489852724289,1.0,3/6,9.99%,MYOF;ANK2;BIN1
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.6851044911685908,1.1023370617060522,0.3902439024390244,0.8448187196168039,1.0,2/6,13.16%,SIRT1;KLF7
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.7803233034797747,1.102291831369391,0.3888888888888889,0.8444319181886185,1.0,2/5,16.84%,SLC15A2;BIRC3
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.41581604883475615,1.1022581090455144,0.2916666666666667,0.844013208836095,1.0,66/359,15.48%,CRX;GATA4;MITF;ESRRG;TGFBR1;TULP3;CDK11A;HIF1A;TFEB;PRDM8;HES6;MAFB;POU6F2;RORB;BMP2;NFIL3;RORA;SP1;HCLS1;SOX6;RELA;NR5A2;ESR1;TEAD2;NFIA;WWTR1;ELAVL2;SLC39A8;RPS6KA4;CHD7;SSBP2;ZNF274;RYBP;ATXN1;YAF2;ZNF195;GPBP1L1;ZNF675;NCOA2;EZH2;ZNF114;NR1D2;HP1BP3;HNRNPD;CHEK2;SP3;DMTF1;MEF2C;ZNF536;ZNF117;ZNF281;MYB;ZNF212;MAGED1;SPIN1;MLF1;ACVR1B;MLXIPL;DVL2;PML;ZNF263;TAF5;ZNF280B;ZNF502;ZNF257;HCFC1
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.5719132458808133,-1.102203228736554,0.3023255813953488,1.0,1.0,2/17,6.42%,FGF1;MBTPS2
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.7016182454812151,-1.1021585580949265,0.41304347826086957,1.0,1.0,5/5,29.86%,P2RY12;CD9;P2RX4;TGFB2;AZU1
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.5043443014379224,1.1020833702468675,0.2571428571428571,0.8439754329183213,1.0,5/33,7.75%,LGALS9;SYK;HIF1A;TLR2;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.7057792706494928,1.101962584897332,0.37735849056603776,0.8437435768741468,1.0,1/5,6.71%,PPP1R15B
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.7401264901389162,1.101123328515649,0.46808510638297873,0.8452761249686995,1.0,3/5,24.66%,SLC35B2;PAPSS2;SLC26A2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.7401264901389162,1.101123328515649,0.46808510638297873,0.8452761249686995,1.0,3/5,24.66%,SLC35B2;PAPSS2;SLC26A2
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.7113067562462447,1.101070834737343,0.45454545454545453,0.8449147142517598,1.0,1/5,9.71%,HIP1
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.7153325641446966,1.100962310591489,0.36,0.8448522859580209,1.0,2/6,24.32%,LIG4;ERCC8
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),0.5046012830733894,1.1008711182047133,0.24489795918367346,0.844652860218716,1.0,13/52,18.20%,LGALS9;CCL5;SIRT1;SASH3;IL15;IL23R;MYB;POLR3G;CD74;PLSCR1;FADD;CD81;RIOK3
prerank,GO_Biological_Process_2021__catecholamine uptake (GO:0090493),0.7284408503158203,1.100606771688478,0.4,0.8449935856524905,1.0,1/5,2.39%,SLC22A3
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.7505094396825106,1.1005828019652137,0.4262295081967213,0.8445688323444618,1.0,2/5,16.46%,IMMP2L;IMMP1L
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.4186689254614673,1.1001744559363655,0.32142857142857145,0.8451989165046211,1.0,65/290,21.13%,PKNOX1;PRRX1;HNF4G;ESRRG;SOX5;ZBTB7B;ZBTB1;KAT2B;PPARG;MED17;RORB;MLLT3;RORA;SP1;RBPJ;NR5A2;ESR1;TEAD2;WWTR1;ELP4;HDAC3;TSC22D1;PAPOLA;TAF3;PCF11;TBL1X;NPPA;NR1D2;ELOF1;NR1H3;CDK12;INTS6;NR4A2;RARB;TAF1A;CCNH;POU2F1;TAF5;THRB;ELL2;TAF2;DEAF1;EAF2;NOTCH2;NELFB;RORC;MNAT1;GTF2B;MAZ;ARRB2;INTS11;HDAC9;CSTF3;NR3C1;ETV7;CCN2;NFIC;POLR2H;NR6A1;HDAC1;TAF4;WDR33;NCBP1;NOTCH3;SETD2
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.4490436378688364,1.1001741511761036,0.29411764705882354,0.8446700060437295,1.0,22/129,17.39%,HEMGN;SMOC1;RUNX1;TGFBR1;FGFR1;MAFB;NLGN1;MEGF10;MOSMO;EPHA3;BIN1;NR1D2;SINHCAF;GREM1;RPS6KA1;NREP;PHLDB2;TRPS1;ANP32B;HEY2;RORC;CSF1
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.6271971578729254,1.1000750442054505,0.32142857142857145,0.8444070133569881,1.0,4/12,21.17%,ELOVL5;ELOVL4;TECR;ELOVL6
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.7159492837878425,1.099924174321183,0.36538461538461536,0.8443371424565339,1.0,2/7,8.18%,ERBB4;LHX6
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.541215016890619,1.099838578867366,0.35294117647058826,0.8439863779286385,1.0,3/27,11.28%,NOX5;ATP6V0A4;ATP1A2
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),0.6784183070094489,1.0998166275423265,0.39622641509433965,0.8435076830723608,1.0,4/5,25.72%,PLCG2;CX3CR1;CARD9;BCL10
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.6047045652427243,-1.0993733470327407,0.3877551020408163,1.0,1.0,2/13,2.68%,CLDN4;CLDN1
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.49985477302195325,-1.0992506501575454,0.3148148148148148,1.0,1.0,9/43,13.03%,DUSP4;DUSP6;SPRED3;SPRED2;CAMK2N1;SPRED1;GBP1;DUSP9;DAB2IP
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.7009298246681044,1.0992389325956362,0.3617021276595745,0.8446011153838842,1.0,3/5,26.67%,TLR2;TLR1;CD36
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.6057768673165091,1.0989705591697545,0.4230769230769231,0.844827779122021,1.0,2/17,2.04%,CHRM2;F2R
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.44253277624190784,1.0988723935330638,0.3191489361702128,0.844653759488046,1.0,23/111,17.24%,CCL5;HIF1A;PELI2;ST18;RELA;PELI1;NLRP7;RPS6KA4;PELI3;CD40;TAB2;PSMD13;HYAL3;HAS2;IRAK1;TANK;PSME4;PLCB1;TAB3;PSMA1;MAP3K8;RPS6KA5;IRAK3
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.5480485409121951,1.0986316580906172,0.3333333333333333,0.8443943485240483,1.0,3/23,5.89%,ZDHHC11;ZDHHC12;ZDHHC22
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.5480485409121951,1.0986316580906172,0.3333333333333333,0.8443943485240483,1.0,3/23,5.89%,ZDHHC11;ZDHHC12;ZDHHC22
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.6177958091651575,1.09791878562697,0.3684210526315789,0.8461072895477743,1.0,1/14,1.13%,IRS1
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.6365670775109276,1.0973691335990765,0.37037037037037035,0.8472189930890935,1.0,1/10,2.47%,IL4
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.4195667594458834,1.0973431495904291,0.16666666666666666,0.8467247027075357,1.0,52/223,18.31%,SEMA5A;UNC5C;EPHA7;EMB;NRTN;EFNA5;DCC;LLGL1;EFNA2;ROBO2;SPTBN5;LGI1;CXCL12;NEFH;SEMA6C;UNC5D;NRXN1;EPHA5;GAB1;EPHA3;CNTN6;PLA2G10;DSCAML1;EPHA8;GFRA1;AUTS2;DSCAM;PIK3CA;CTNNA2;EFNB2;RANBP9;NTNG2;PTEN;SOS1;KLF7;SEMA3E;SEMA6D;LGR6;L1CAM;CNTN2;PIK3CD;GAB2;NOTCH2;CNTN4;RPS6KA5;ARTN;MYPN;RET;ZDHHC17;EFNA1;LAMA5;IRS2
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.7543502788124997,1.0973237324706924,0.3548387096774194,0.8462469823571099,1.0,2/5,11.90%,ITGAV;NR1H3
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-0.6866171783517284,-1.0973118516740028,0.391304347826087,1.0,1.0,4/7,12.70%,SCN5A;KCNQ1;KCNA5;SCN3B
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.6815598880575351,1.09728152989289,0.37735849056603776,0.845849587154112,1.0,2/10,5.09%,RENBP;NANP
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.47817270432777603,1.0972208430481318,0.2830188679245283,0.8454845578960531,1.0,2/53,2.54%,SHMT2;HIF1A
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.4819677185695041,1.0967525198699033,0.3684210526315789,0.8464339360470625,1.0,12/47,20.74%,RUNX1;KAT2B;PRMT1;MOV10;CNOT4;MEF2C;AGO3;H3-3A;HDAC1;KMT2C;FAXDC2;GP1BA
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.5008607667207275,1.0967446153752416,0.3469387755102041,0.8459257452132195,1.0,14/43,22.89%,LLGL1;RAB31;RAB34;GGA1;GOLPH3L;EXOC6;ARL3;MACF1;BLZF1;VAMP4;GCC2;GOLGA4;COMMD1;EXOC6B
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),-0.7228281955262865,-1.0967185466760152,0.4,1.0,1.0,3/6,14.23%,OAS3;OAS1;OAS2
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.5431885039678782,1.0964825475207698,0.37254901960784315,0.8462135341759078,1.0,4/31,5.89%,ZDHHC11;ZDHHC12;GLUL;ZDHHC22
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.708790127051196,1.0964331327930312,0.2916666666666667,0.8458730285907596,1.0,2/5,20.46%,ABL1;MAP2
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.48723203383733793,1.0963877581862866,0.38,0.8455011691937382,1.0,7/44,13.80%,CCNA2;SLFN11;FBXO5;GMNN;RBBP6;TERF1;ESCO1
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),0.5408253239354816,1.0963418884059593,0.3404255319148936,0.8451694630192432,1.0,5/19,11.46%,IL4;CD22;SASH3;HLA-E;VAMP3
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.5911181374800041,1.096313054086445,0.3584905660377358,0.8447508937865391,1.0,4/14,15.49%,ADRA1A;NPPA;ADRB1;RYR2
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.46002654609425253,1.0962795893211155,0.27586206896551724,0.8443566279144464,1.0,30/114,22.13%,PPARG;LDLR;SCD;SP1;ODC1;PRKAB2;FDFT1;HDAC3;HMGCS1;SMARCD3;PSMD13;NCOA2;TBL1X;NR1D2;MVD;FASN;PSME4;ACACA;CHD9;ACACB;SC5D;PSMA1;SQLE;IRS2;PLPP1;DHCR7;PSMD4;ELOVL6;SREBF2;IDI1
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),0.7352941889845148,1.0961204762643095,0.4727272727272727,0.8443669766454381,1.0,1/5,5.79%,DMC1
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.5746582379766838,1.0959022540814312,0.34545454545454546,0.8445040199036402,1.0,5/18,13.44%,SLC22A3;ABCC2;SLC15A2;ABCC11;ABCA8
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.6304914526745932,1.0957972054627645,0.3728813559322034,0.8443164069155231,1.0,3/13,8.33%,GRM3;ADGRV1;GNAI3
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.5216574800490243,1.095721900430121,0.30612244897959184,0.8440578397112329,1.0,8/36,15.48%,IRGM;GFAP;LATS1;METTL18;SNCAIP;HSPA8;RAP1A;HCFC1
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.5421807753087947,1.0956889104202372,0.3333333333333333,0.8436256894817966,1.0,4/30,4.72%,CDKN2C;SLFN11;CDKN2A;KANK2
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.5718065367196801,-1.09530046497301,0.34782608695652173,1.0,1.0,4/26,7.86%,LDB1;RNF8;RECQL5;BTBD18
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.49294846204791753,1.0952898770368393,0.2619047619047619,0.844252635035781,1.0,18/62,10.29%,IGF1;FLT1;HGF;CCL5;SIRT1;F2R;FGFR1;FGF2;NEDD4;ROR1;PIK3R5;HCLS1;PDGFRA;GAB1;PDGFC;PIK3CA;PLXNB1;FLT3
prerank,GO_Biological_Process_2021__sensory perception of sour taste (GO:0050915),0.7524815425461799,1.0949245525565494,0.5,0.8448551257370662,1.0,1/5,3.12%,ASIC1
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.6820196032770279,-1.094855217313772,0.42857142857142855,1.0,1.0,1/5,6.90%,RAB7B
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),-0.6410764612851343,-1.0944349221005805,0.42,1.0,1.0,3/8,7.66%,PXDN;LAMB3;LAMB1
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.7094578326221921,1.0943115403174135,0.4339622641509434,0.8460959697004231,1.0,2/5,10.16%,FRMPD4;CTNNA2
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.6091247385520262,1.0942376326759498,0.4418604651162791,0.8452712214124841,1.0,4/15,14.90%,DLC1;CORO1C;PTEN;PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.6091247385520262,1.0942376326759498,0.4418604651162791,0.8452712214124841,1.0,4/15,14.90%,DLC1;CORO1C;PTEN;PHLDB2
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),-0.7217867785751106,-1.0941841150506426,0.425,1.0,1.0,2/6,6.37%,BFSP1;WNT7A
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4957026679642971,1.0940279634204382,0.32,0.8454542080432846,1.0,11/46,12.69%,SMAD6;TGFBR1;GDF6;BMP2;ACVR2A;BMPER;INHBC;BMPR1A;SMAD4;GDF9;GREM1
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.5206710504931948,1.093985217951693,0.35,0.8450624087212276,1.0,15/52,23.10%,GDAP1;TIMM22;SLC25A24;MTX2;FBXO7;SLC25A13;BCS1L;AIP;SLC25A31;PPIF;MFF;TIMM10;BAD;MAIP1;BCAP31
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.7399555064628355,1.0934440279459134,0.3333333333333333,0.8463071947695872,1.0,2/5,11.19%,ANGPT1;CSGALNACT1
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.4497893738296516,1.093333307788575,0.2391304347826087,0.8460882968207496,1.0,16/114,9.44%,VAPB;DRD5;F2;CCL5;SLC35G1;TRPC4;SCGN;CXCL12;MCUB;SLC8A1;SMDT1;SLC24A2;CD40;CASR;ANK2;MCU
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.4266854384763458,1.0932565351727814,0.1774193548387097,0.845846097641357,1.0,26/149,13.08%,STK26;FLT1;MAP3K11;FGFR3;FGFR1;ERBB4;DAPK2;TNIK;STK33;RIOK2;MAPKAPK2;PDGFRA;FER;MAP3K9;MEX3B;SMG1;EPHA8;MAPKAPK3;MAP3K21;FLT3;VRK2;CHEK2;IRAK1;CDK12;ITK;IGF1R
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.6473063106636369,1.0931825011769725,0.3617021276595745,0.8456041943681091,1.0,1/8,2.47%,IL4
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.58112998401807,1.093102447090089,0.45161290322580644,0.8447997555837445,1.0,2/13,13.31%,COQ10A;FDXR
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.58112998401807,1.093102447090089,0.45161290322580644,0.8447997555837445,1.0,2/13,13.31%,COQ10A;FDXR
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.5254401303030167,1.0930897859959428,0.35294117647058826,0.8443081451285629,1.0,11/33,15.95%,SCRIB;DLC1;VANGL2;PHACTR4;PLXNB2;PRICKLE1;DVL2;LRP6;LRP2;COBL;DEAF1
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.5803598816328388,1.092828563982942,0.26229508196721313,0.8444750503804581,1.0,2/17,1.82%,IGF1;CCL5
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.3811539258029174,-1.0927844130388993,0.23076923076923078,1.0,1.0,32/602,8.13%,CD44;ALB;NTRK1;APIP;MPO;TEK;NUPR1;TNFSF18;HMGN5;DUSP6;SPDEF;IL31RA;PLK3;ANGPT4;RASGRF2;OBSCN;BCL2L2;PRAME;OLFM1;ACTN3;VAV3;SFRP1;NIBAN2;BEX2;PAX2;IRF5;HCK;IFIT2;CLU;JUN;WNT10B;OLFM4
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.5168179324449697,1.0927665017253436,0.3269230769230769,0.8441407878668228,1.0,4/41,2.55%,IRS1;SIRT1;ZBTB7B;STAT5A
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),0.6579811298731781,1.092523940283494,0.45098039215686275,0.8444327566986827,1.0,3/6,27.68%,GALK1;GALT;GALM
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.5290708262967713,-1.0920667719581219,0.32142857142857145,1.0,1.0,2/33,1.90%,DNASE1L1;ENTPD2
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.6078471687000668,1.091920448509524,0.3269230769230769,0.8455609013941255,1.0,1/11,1.52%,MME
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.6617989770944438,1.091854601650577,0.46551724137931033,0.8452187750913304,1.0,1/9,5.82%,PIP4K2A
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.5361332571436837,1.0915413115151054,0.3584905660377358,0.8455954508933774,1.0,5/27,14.53%,SIRT1;PPARG;NR1H3;ABCA8;LIPG
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.515457081066891,1.091337938039694,0.3157894736842105,0.8456204979838937,1.0,16/56,16.70%,CDH20;CDH7;CDH6;CDH2;CDH12;CLDN12;CDHR3;CDH10;CDH8;GJB6;GJB1;CDH24;PKP4;GJC1;PKN2;CTNNB1
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),-0.6626802172902541,-1.091323779557156,0.4423076923076923,1.0,1.0,1/5,25.59%,ABHD12B
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6723913689253646,1.0912585001645028,0.44642857142857145,0.8454115425349443,1.0,4/8,19.09%,VAMP1;SNCA;VAMP3;VAMP4
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.70091184689038,1.0912115466983496,0.36,0.844961215921862,1.0,2/5,17.05%,PRIMPOL;SIRT7
prerank,GO_Biological_Process_2021__cellular response to magnesium ion (GO:0071286),0.7128305855390702,1.0911387139421644,0.4576271186440678,0.8446672275191625,1.0,3/5,19.62%,RYR3;SLFN14;FBP1
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.656706371551907,-1.0909132623527493,0.40384615384615385,1.0,1.0,1/9,1.07%,GINS3
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.5928541364251532,-1.090881511307699,0.4,1.0,1.0,3/16,11.69%,IL18BP;HLA-DRB1;IL18
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.583697366176222,1.0908195923906243,0.36363636363636365,0.8450898060387949,1.0,5/16,21.85%,LPIN3;MOGAT2;DGAT2;AGMO;GPAT3
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.549751545878283,1.0907971125855147,0.3333333333333333,0.8446171514034667,1.0,8/25,14.91%,LRP4;NLGN1;SCRIB;NRXN1;MAGI2;SAV1;LRRC7;DLG2
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.6701211028318063,1.0907694480788723,0.36,0.8441683950853532,1.0,1/9,1.94%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.6929153392312131,1.0904857750753645,0.375,0.8445283424921157,1.0,5/6,27.67%,SNCA;ANXA2;ANXA1;AKT2;C2CD5
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.6549569442601385,1.0903074591816084,0.42857142857142855,0.8445228489499408,1.0,6/10,28.99%,ZNF692;SIRT7;SDHAF3;FBP1;OGT;PDK2
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.4160068389880336,1.0902665401196052,0.2631578947368421,0.8441137695158154,1.0,56/266,14.91%,DRD5;CHRM2;SLC12A7;GABRR1;RIT2;PNOC;GABRR2;GRM3;SLC1A3;HRH3;HTR1F;OPRK1;NPY;SLC17A6;NLGN1;GLRA1;PENK;SYPL1;GABRG3;SYT1;CACNB4;PDLIM4;NRXN1;UNC13B;CEL;NOVA1;SNCA;GPR176;CRHBP;GRIK2;NLGN4X;LIN7A;GRM5;RPS6KA2;HAP1;SCN2B;GRIK3;UTS2;KCND2;GABRA5;HTR2C;GLRB;FCHSD2;PTEN;GRM4;HSPA8;GABRG1;GABRB2;GRM7;GRIN2D;APBA1;RPS6KA1;LRP6;PPFIA3;CDH8;DLG2
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.5917833568979065,-1.0902029280769046,0.375,1.0,1.0,3/10,16.04%,KDM4D;HR;KDM4B
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.4954300250789766,-1.0899724423658037,0.35185185185185186,1.0,1.0,6/41,8.08%,KCNMB2;SCN5A;KCNE2;CACNA1G;KCNE1;KCNQ1
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.6785576586777285,1.089707443041612,0.3584905660377358,0.8452487692779648,1.0,4/7,31.89%,SFXN2;SLC38A5;SLC38A2;SLC7A10
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.6143056236021137,1.0896664142913144,0.35714285714285715,0.8448319934438666,1.0,1/15,1.32%,C3
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.5585634980726324,1.089244751933667,0.35714285714285715,0.8457482659155278,1.0,4/24,8.16%,HIF1A;PRMT1;ACVR2A;FOXO3
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.6180954989530355,1.0891583247180805,0.4,0.8455097732489127,1.0,5/7,34.71%,CORO1C;TMCC1;SH3GLB1;SLC25A46;SPAST
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.6490163673872947,1.08887270599381,0.4406779661016949,0.8459602525198124,1.0,1/9,0.09%,GATA4
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.4831616480857042,1.0888390354698478,0.3191489361702128,0.8455827185440603,1.0,10/47,14.50%,HEMGN;FERMT3;PRSS57;GPSM3;BORCS6;HYAL3;MSRB1;CCND3;RNF166;FRAT1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.5092464396273612,1.088500510222225,0.3333333333333333,0.8459475962091362,1.0,11/58,15.78%,SIRT1;URI1;SNAI1;SYVN1;CXCL12;HTRA2;HSPB1;NOC2L;PLAUR;PPIF;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.6375661053820034,1.08834771122619,0.3673469387755102,0.8458176941772005,1.0,6/7,24.67%,PLSCR1;ITGB2;ITGAM;HNRNPU;DHX9;SETMAR
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.6078500645234668,1.0879975652937206,0.4032258064516129,0.846166553541764,1.0,6/13,22.70%,SLC8A1;ATP1A2;RYR2;GJC1;ATP1B2;GJA1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.5620600010247951,-1.0879351162992075,0.3695652173913043,1.0,1.0,8/23,24.08%,XPC;PARP1;COPS7A;COPS7B;COPS6;COPS3;COPS8;COPS5
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.6878348897825989,1.0878348662084394,0.36,0.846005816796713,1.0,3/5,25.65%,BCL11B;GAS6;JAM2
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.4179407778527253,1.0875902261618677,0.32608695652173914,0.8462153615266851,1.0,43/247,14.31%,SLC26A3;DRD5;IRGM;IRS1;RAPGEF3;INSIG1;KCNC2;AANAT;SLC26A6;BRINP3;RORB;NRIP1;GLRA1;RORA;RELA;TLR2;ESR1;WNT9A;PDGFRA;TICAM1;NLRP7;FER;EPHA3;HTRA2;HMGB1;RAMP3;CRHBP;ABL2;FOXO1;PTPRK;HCN1;PXN;NR1H3;MEF2C;PDE4B;RRAGC;MAPK8;IRAK1;RAP1A;CPEB1;PTK7;CREB1;FZD4
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.5563158222401765,1.0865146055059418,0.38,0.848975194493872,1.0,10/19,16.58%,GATA4;SMAD1;BMPR1A;NPPA;SMAD4;TBX18;GJB6;SMAD5;NOTCH2;HEY2
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.4593818713642555,1.0864822156969536,0.2708333333333333,0.8485512318648452,1.0,11/95,14.02%,CTDNEP1;SYK;SIX4;TOR1B;BANP;NXT1;TAF3;RRS1;RANBP17;PRICKLE1;PML
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.5512259079113879,1.0863601307577826,0.3333333333333333,0.8484356301418476,1.0,3/23,10.28%,NDE1;FYCO1;HAP1
prerank,PanglaoDB_Augmented_2021__Neurons,0.3927041481879313,1.0861624593058952,0.20754716981132076,0.8486278357146348,1.0,40/267,12.26%,IGF1;NXPH1;RIT2;RESP18;GRM3;CADM2;PDE1A;NPY;SLC17A6;CNTNAP2;PCLO;RORA;B3GAT2;CHODL;NEFH;CACNB4;ZDHHC22;NWD2;NRXN1;RAB3C;CNRIP1;SACS;OLFM3;SYNPR;GPR162;ZCCHC7;GRM5;TAC1;LRRTM3;ADGRB3;CTNNA2;HAP1;SCN2B;PAK5;TMEM196;GPATCH8;CTTNBP2;NOL4;PPP1R9A;PROX1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.6408896043491772,1.0859248267871835,0.36666666666666664,0.8486737560390039,1.0,9/11,35.60%,RANBP9;PICALM;ABCA2;ABCA7;APOE;TMED10;FLOT2;PRNP;ROCK1
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.7577911808027968,1.0856920657411218,0.42592592592592593,0.8489500973138864,1.0,2/5,6.35%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.6911577879049733,-1.085650061171947,0.3684210526315789,1.0,1.0,4/6,28.75%,SVIP;USP14;AQP11;UBXN1
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.5203476984464896,-1.0853473758782626,0.34615384615384615,1.0,1.0,3/26,12.01%,RTP1;RTP5;OTOF
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.5420227410392655,1.0850576619156105,0.3333333333333333,0.8504622565925855,1.0,8/37,7.89%,SLC12A7;TMTC2;SLC12A1;SLC12A3;SLC8A1;FAM20A;SCNN1B;SNCA
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.509335101129651,1.0849882772484079,0.41509433962264153,0.8502077386483176,1.0,7/43,10.60%,CCL5;F2R;CASR;ANK2;GRAMD2A;EPB41;GRIN3B
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.6306366490469797,-1.0849235495521465,0.38095238095238093,1.0,1.0,1/12,2.28%,BST1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.42574218600635483,1.0849181138002286,0.3,0.8499381868714113,1.0,10/85,7.31%,FGF10;HIF1A;RIN2;FGF2;ANGPT1;RRAS;INSL3;DOCK1;PLCG2;ANXA3
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.6278984437592989,1.0846922776200665,0.36538461538461536,0.8500521667512237,1.0,3/8,17.62%,GALNT3;GALNT1;GALNT16
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.6492599397447849,1.0846125486700195,0.4528301886792453,0.8498519656910686,1.0,2/10,18.53%,TERF1;NDFIP2
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6262182703455582,1.084453513538013,0.35714285714285715,0.849874000261219,1.0,1/10,1.44%,RUNX1
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.6689114576119916,1.0842890812009396,0.4666666666666667,0.8497736003169263,1.0,3/6,29.45%,PEX13;HTR6;FGF13
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.5829923864596859,1.0838030835054226,0.4,0.8506978793369729,1.0,7/19,29.93%,FKBP5;PPIF;PPIL6;CWC27;NKTR;PPIL1;PPIB
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),0.683860504099447,1.0835884547275492,0.3770491803278688,0.8508645586793313,1.0,3/7,20.65%,ELAPOR2;KLF7;MAFF
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.3536531695116371,1.0835156825377743,0.15384615384615385,0.850549916483076,1.0,161/908,17.25%,STK26;CSTA;CTDNEP1;ASB17;DUSP29;MAP3K11;HS3ST5;C3;SYK;PRKG1;RAB38;HIF3A;SIRT1;TGFBR1;FGFR1;EGLN3;PLOD2;CDK11A;SOCS2;HIF1A;ASB18;SPSB2;ENGASE;ASB15;CDK18;BMP2;CDH2;EVA1A;VCAN;DAPK2;GALNTL5;TNIK;PTAR1;ACVR2A;PENK;METAP1D;MAPKAPK2;KLHL21;MMP15;ERG;FUT9;FAM20A;ASB5;UBE2E2;CEL;FBXL3;DYRK2;PPP4R1;ST8SIA4;RPS6KA4;FER;PPP1CC;TF;UBE2D3;SPSB4;PPM1A;DCUN1D1;MAP3K9;PTPRD;ANKRD9;MEX3B;SOCS6;FBXO30;IP6K3;CDK14;GAN;SENP8;ZC3HAV1;ABL2;DSP;KCTD6;LATS1;PTPN14;KEAP1;ST3GAL6;PTPRT;FRK;PSMD13;MAP3K21;LTBP1;FASTK;PPM1L;TNC;MAP4K2;NUS1;FBXO7;NIM1K;LOXL2;FBXL14;QPCT;PAK5;BMPR1A;PTPRK;PTP4A2;PRKCSH;VRK2;CHEK2;PPM1E;KLHL42;MAN2A1;MAPK8;IRAK1;PTEN;TIPARP;CDK12;PPP3CA;KNG1;DNAJC3;DCAF5;STRADA;ASB6;PSME4;PPP3CC;UBA3;PTPRM;MTMR3;ACVR1B;DUSP2;CREB1;KLHL13;DYRK1A;FBXL15;PTPRU;IKBKE;CSNK1G3;MAP3K1;B3GALNT2;UBXN7;NEK7;HIPK1;MGAT4A;FBXL2;RCE1;SGK1;PRKAA1;FBN1;CPE;GPAA1;PADI4;PIK3CD;LGALS1;MAPK10;CTH;BAP1;SIRT6;PSMA1;DYRK3;LIMK2;PKN2;CD247;PXK;KTN1;TGM6;GLRX;RPS6KA5;SIRT7;CDKL5;FBXO11;IRAK3;RET;PPEF2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4608003203589088,1.0833249264809997,0.3170731707317073,0.8506783240057747,1.0,17/83,10.13%,ADRA1A;DRD5;LGR5;ADGRL4;CALCR;ADGRG6;ADGRG4;PTGFR;RXFP2;ADGRL2;ABCA1;GPR12;ADRA2C;GPR26;RAMP3;GPR161;ADGRB3
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.5121474903448561,1.0832678482908362,0.36538461538461536,0.8503565379812528,1.0,8/35,20.82%,PEX12;UBE2D3;UBE3D;FANCL;MARCHF7;KLHL12;RAG1;UBE2E1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4618306774557835,1.0831932653860308,0.3541666666666667,0.8499893939222573,1.0,8/96,9.76%,TNFSF14;TNFRSF18;TNFSF13B;ST18;RELA;CD40;FOXO3;PSMD13
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.3816784890376502,1.0831753078726243,0.1956521739130435,0.8495541161708259,1.0,86/461,17.45%,UHRF2;MKRN3;HIF3A;SIRT1;HIF1A;LZTR1;NEDD4;SPSB2;RNF152;RFWD3;SYVN1;PELI2;PEX12;UBE2J1;RNF182;TRIM50;PELI1;KLHL21;KLHL8;RNF185;ASB5;UBE2E2;FBXL3;MARCHF1;PELI3;NEUROD2;UBE2D3;MSL2;SPSB4;ANKRD9;RNF139;FBXO30;UBE2Z;RNF146;SPOP;RNF217;GAN;UBE3D;UBE2E3;KEAP1;ANAPC16;PSMD13;LNPEP;FBXO7;FBXL14;AKTIP;TRIM26;RNFT1;HECW2;FANCL;UBE2U;SHPRH;KLHL42;CNOT4;RBBP6;ARIH1;UBE2QL1;UBA6;UBE4A;PSME4;UBE2J2;TSPAN17;KLHL24;RNF166;KLHL13;FBXL15;RMND5A;MARCHF7;MIB1;TRIM52;RNF25;FBXL2;NFE2L2;PDZRN3;MARCHF3;PSMA1;PEX2;NHLRC3;UBR5;RNF208;RNF26;CTNNB1;FBXO11;KLHL7;KLHL12;RNF38
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5766732454332049,1.0831148258968266,0.4528301886792453,0.848692716698871,1.0,2/14,7.81%,ZFP36L2;TOB1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5766732454332049,1.0831148258968266,0.4528301886792453,0.848692716698871,1.0,2/14,7.81%,ZFP36L2;TOB1
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.6214202437069742,1.0830038269092763,0.3888888888888889,0.8485555835797434,1.0,5/15,19.28%,NXT1;ANP32A;XPO1;RGS14;BANF1
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.5669373596680294,1.0828051723235725,0.39622641509433965,0.8486162321745809,1.0,1/18,0.53%,FGF10
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.41782206289005364,1.0826742691397764,0.24444444444444444,0.8486008464939205,1.0,36/182,21.23%,KCTD21;NEDD4;SPSB2;SYVN1;KLHL8;RNF185;SPSB4;RNF146;RNF217;KCTD6;KEAP1;ANAPC16;PSMD13;KLHL15;FBXO7;FBXL14;RNF5;CNOT4;UBQLN4;RBBP6;ARIH1;UBA6;UBE4A;RNF166;MIB1;RNF128;FBXO11;NDFIP2;SMURF1;RNF19B;FZR1;UBE2D1;RNF144A;UBE2A;UBE2E1;RNF130
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.4104883668934734,1.082095944411924,0.28888888888888886,0.8498457131114151,1.0,42/264,15.37%,MAP3K11;TOP2A;EPHA7;PAWR;BOK;SIRT1;TGFBR1;PLEKHG2;FGD4;BMP2;DAPK2;FANK1;SEPTIN4;DKKL1;ARHGEF17;SCRIB;UNC13B;HTRA2;HMGB1;SNCA;DLC1;RYBP;FOXO3;UBE2Z;LATS1;BIN1;RPS6KA2;FOXO1;TNFRSF10B;ARHGEF16;BNIP3L;TP53BP2;MAPK8;KNG1;SOS1;PHLDA1;RBM5;ARHGEF6;PHLDA3;ATF6;ANO6;FRZB
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.5770838255713249,-1.0820905998221575,0.36065573770491804,1.0,1.0,3/26,5.33%,PM20D1;SPTLC3;ARG2
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.711790858132454,-1.0820675974391993,0.5116279069767442,1.0,1.0,4/5,24.56%,SF3A3;SF3A1;SLU7;SF3A2
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.7144714449504083,1.0820314156286628,0.38181818181818183,0.8494654298776565,1.0,2/6,9.43%,VAPB;GRAMD2A
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.48942510824851826,1.0818690270653393,0.38596491228070173,0.849381325100879,1.0,9/54,13.27%,RIT2;CD22;ZFYVE16;EPHA3;SNCA;ABL2;HIP1;PICALM;STON2
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.5664201501331754,-1.0816386341013142,0.3111111111111111,1.0,1.0,3/24,4.93%,NPAS4;DRD4;DRD2
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),0.660660105052948,1.0815400028268962,0.45098039215686275,0.8498505385418541,1.0,3/5,27.93%,SIRT7;FBLL1;TRMT112
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.5948593518801212,1.0813994303722487,0.3389830508474576,0.8498268969698213,1.0,3/16,11.01%,WNT4;DKKL1;GCK
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5677741187358529,1.0811680035579152,0.37037037037037035,0.8500455045811761,1.0,7/22,10.29%,FLT1;IRS1;FGFR3;FGF2;PDGFRA;EPHA8;FLT3
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.557290351950444,-1.0811671118124648,0.2926829268292683,1.0,1.0,4/15,5.48%,TNFSF18;RAC2;BST1;ZP3
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.488920335888975,1.081103787503572,0.36,0.8498023922003981,1.0,13/55,20.74%,RUNX1;KAT2B;MAFB;PRMT1;MOV10;CNOT4;MEF2C;AGO3;H3-3A;LYN;HDAC1;KMT2C;GP1BA
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.6468962241465237,1.08101476740124,0.45098039215686275,0.8495217632762584,1.0,6/8,35.31%,GAL3ST1;B4GALT3;UGT8;GALC;B3GALT2;FA2H
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.624445430054477,1.0806446201219533,0.4107142857142857,0.8501028559294902,1.0,3/14,12.20%,PADI2;ESR1;ARID1A
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.6692111371202942,1.0806309436899462,0.4186046511627907,0.8496486928050732,1.0,1/8,3.69%,RORB
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.6247590672785608,1.0803293882847471,0.34,0.8500554430520652,1.0,2/19,2.87%,IRGM;PPARG
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.7054058128557977,1.0803104894156779,0.46808510638297873,0.8496395546269453,1.0,2/6,5.37%,BMP2;SOX6
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6483523216070981,-1.080114203182446,0.5333333333333333,1.0,1.0,4/8,19.02%,XDH;DAB2IP;PIK3CB;DCN
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.6304803189351759,-1.0801034028803187,0.36363636363636365,1.0,1.0,2/8,8.48%,AK8;AK7
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.5765444547659165,-1.0800341430959197,0.35185185185185186,1.0,1.0,3/20,10.93%,XPC;PARP1;GTF2H2
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.455818892879445,1.0800166993209022,0.22448979591836735,0.8500006030671998,1.0,20/85,11.68%,HS3ST5;ANGPT1;VCAN;HS3ST3B1;BGN;HS3ST1;CHSY3;UGDH;HS3ST2;SDC4;GPC5;DSEL;HS2ST1;GPC4;ST3GAL6;EXT1;SLC35D2;CSGALNACT1;CHST6;HAS2
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.6923085983346108,1.0800032438694809,0.5192307692307693,0.8495324968982161,1.0,3/9,7.36%,WHRN;ADGRV1;SLC4A7
prerank,GO_Biological_Process_2021__embryonic forelimb morphogenesis (GO:0035115),-0.7111949927043657,-1.0799371018606208,0.4,1.0,1.0,2/5,15.15%,WNT7A;OSR1
prerank,GO_Biological_Process_2021__forelimb morphogenesis (GO:0035136),-0.7111949927043657,-1.0799371018606208,0.4,1.0,1.0,2/5,15.15%,WNT7A;OSR1
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.6550736942578804,1.079844039319908,0.3620689655172414,0.8494790621091843,1.0,7/8,33.79%,GLRX;BAD;AKT2;STOML2;ANK3;MTLN;VCP
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.3803740848699399,-1.0797594468069784,0.2708333333333333,1.0,1.0,34/436,8.18%,CD44;IL10RB;IRF4;TNFSF18;CXCL13;DUOX1;IL11;CD86;IL1RL2;IL18BP;ALOX5;PRKCD;IL31RA;TEC;IL6R;TNFRSF11A;CRLF1;FOS;LTB;IFI27;TRIM5;CAMK2A;F13A1;CIITA;INPP5D;PSMB4;IRF5;EGR1;HCK;HLA-DRB1;IFIT2;OAS3;TNFRSF4;OAS1
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.6776291017223339,1.0795658693968444,0.41509433962264153,0.8497041185662315,1.0,2/8,21.54%,HEXB;NAGA
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.5837831641641327,-1.0795337341097704,0.3877551020408163,1.0,1.0,5/15,10.34%,APOBEC3H;APOBEC3G;BTBD18;PIWIL2;DDX4
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.6268614348632382,1.0794943169119295,0.4074074074074074,0.8493799008274516,1.0,1/10,1.43%,CD99
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.6112452555712062,1.0794334744631675,0.4117647058823529,0.8485372927574635,1.0,3/9,21.16%,GABPA;ABL1;MAPK3
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.6112452555712062,1.0794334744631675,0.4117647058823529,0.8485372927574635,1.0,3/9,21.16%,GABPA;ABL1;MAPK3
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.536736524884227,1.079394668473057,0.40384615384615385,0.8481617720929583,1.0,8/28,11.09%,FLT1;IRS1;FGFR3;FGF2;PDGFRA;EPHA8;FLT3;WASHC1
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.5658476995332357,1.0791455728498929,0.3695652173913043,0.8483494249652154,1.0,3/19,4.83%,CHRM2;LYPD1;RGS10
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.6125146380867382,-1.0787747548319258,0.5,1.0,1.0,2/7,18.75%,SFRP1;STK17A
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.47862226028698485,1.078597415308841,0.2857142857142857,0.84952669481182,1.0,9/51,12.02%,PNP;CCL5;IDO1;IL4;SDC4;IL15;CCDC88B;IL23R;NCK2
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),0.6965157732079205,1.078330394554703,0.4339622641509434,0.8497732880508987,1.0,1/6,1.43%,CD99
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.6316254428347521,-1.0782939118317034,0.391304347826087,1.0,1.0,1/16,0.36%,SELP
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.5302766290238453,1.0782294769641454,0.34782608695652173,0.8495701928469735,1.0,6/31,17.85%,ZBTB7B;RPS6KA4;PAXIP1;RPS6KA5;RUVBL2;FMR1
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.6594257251797477,1.0779840856798868,0.46153846153846156,0.8494789262449587,1.0,2/6,14.91%,CRHBP;DLG2
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.6594257251797477,1.0779840856798868,0.46153846153846156,0.8494789262449587,1.0,2/6,14.91%,CRHBP;DLG2
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.48196086533571825,1.0779395634905833,0.37777777777777777,0.8491193408629168,1.0,13/59,16.86%,ERBB4;NRG1;GAB1;NRG2;ERBIN;PIK3CA;NCK2;BCAR1;SOS1;CPNE3;SLC30A10;FAM83A;RPS6KA5
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.5700050688187398,1.0779301865123765,0.2857142857142857,0.8486705024194916,1.0,1/16,1.69%,BOK
prerank,PanglaoDB_Augmented_2021__Pericytes,0.42876552074463886,1.077888797847903,0.28,0.8482968681444799,1.0,24/124,13.75%,MXRA5;LAMA4;MRGPRF;PRRX1;ADGRL4;ANGPT1;GNB4;STEAP4;BGN;LHFPL6;COL6A2;CXCL12;POSTN;PDGFRA;PLSCR4;PCDH18;INPP4B;MEDAG;SYNPO2;NR1H3;HTRA1;TBX18;ABCA8;ANPEP
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.6759430003810187,-1.077563505288049,0.4444444444444444,1.0,1.0,2/5,27.07%,VPS25;VPS36
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.6759430003810187,-1.077563505288049,0.4444444444444444,1.0,1.0,2/5,27.07%,VPS25;VPS36
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.5424503760103987,-1.0775216428579781,0.3103448275862069,1.0,1.0,7/20,20.15%,DUOX1;P2RY12;CCDC25;TGFB1;NTN1;PDGFB;TWIST1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.5344981631365062,1.077423945333547,0.423728813559322,0.8493044929648079,1.0,4/25,9.16%,IRS1;ENPP1;PIP4K2A;KANK1
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.61293644004691,-1.0773601144669513,0.37037037037037035,1.0,1.0,3/14,12.02%,SLC5A10;SLC2A8;SLC5A1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.5290699691175735,-1.0772674773785205,0.32558139534883723,1.0,1.0,7/43,10.10%,KCNMB2;KCNJ16;KCNN3;KCNN2;KCNE1;KCNQ1;KCNJ15
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.49637642460720327,1.0770319211440307,0.3469387755102041,0.8501020797113643,1.0,15/47,20.06%,PLCH1;FGF2;ITPKB;PLCG2;INPP1;IP6K3;INPP4B;NUDT4;PTEN;NUDT4B;PLCB1;PLCD1;IMPA1;IP6K1;MINPP1
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.6800005012131103,1.0769810963802382,0.41818181818181815,0.849698444187369,1.0,4/5,17.50%,HIBCH;BCAT1;HIBADH;ALDH6A1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.43937143899411446,1.0766637811178603,0.23529411764705882,0.8501744874431358,1.0,18/86,22.90%,EIF3E;SYNCRIP;SAMD4A;LIN28A;C8ORF88;TOB1;RNF139;PATL2;RIDA;CPEB1;CAPRIN1;CNOT8;FMR1;PAIP2B;LSM14A;NANOS1;EIF2AK3;CPEB2
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.4760581700434131,1.0766304900034795,0.2833333333333333,0.849771277680042,1.0,5/49,2.58%,LGALS9;PNP;CCL5;IL4;ZBTB1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.6690444232260613,1.0765416256062144,0.4444444444444444,0.8494652848975879,1.0,3/8,24.84%,PELI1;BIRC3;ARHGEF2
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.5252491046592639,1.076533095564168,0.3584905660377358,0.8489960102009375,1.0,11/28,18.34%,SOCS2;NRIP1;ESR1;LOC400499;RAMP3;CRHBP;NCOA3;CTNNB1;RUVBL2;LCOR;SSTR1
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.5965470500809601,1.0764253293108375,0.45098039215686275,0.8487948915820333,1.0,6/17,18.72%,GSTM2;SLC8A1;CRHBP;RYR2;RYR3;CASP3
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.45593509713646635,1.0762721098540444,0.2857142857142857,0.8487425935591656,1.0,12/46,26.04%,JADE3;MSL2;ACTL6A;EPC1;HCFC1;RUVBL2;KANSL3;OGT;ING3;EP300;ZZZ3;MSL3
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.6510181741839487,-1.0759822502267133,0.4444444444444444,1.0,1.0,1/9,1.23%,NUPR1
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.44712696512322564,1.0756567792649085,0.2727272727272727,0.850115977556828,1.0,12/62,22.18%,U2AF1;THOC6;LIN28A;PAPOLA;PCF11;TENT4B;SRSF11;CSTF3;PNPT1;WDR33;NCBP1;SRSF3
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.6240833993524706,-1.0756496705826477,0.4583333333333333,1.0,1.0,2/12,4.76%,APOBEC3H;APOBEC3G
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.45606486263712204,-1.0751011340266423,0.2916666666666667,1.0,1.0,7/75,3.47%,EHF;CLDN4;TMEM184A;GPR39;SERINC2;CLDN1;KIF12
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.6258016478799276,1.0750288653071352,0.4406779661016949,0.8517994503300136,1.0,3/13,9.39%,PNP;AK3;AK1
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.5039536335919539,-1.0747768124775665,0.36,1.0,1.0,2/44,1.28%,MPO;GPX3
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.6319573351383043,1.0747489381132662,0.3617021276595745,0.8521682520809203,1.0,2/8,1.49%,ESPL1;TOP2A
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.5928418089541018,1.0746334562403932,0.38596491228070173,0.8519584716866524,1.0,7/19,16.70%,FZD5;FRAT2;FZD1;DVL2;LRP6;FRAT1;CTNNB1
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.42601519964833257,1.0745369524584312,0.21153846153846154,0.8517711570963464,1.0,24/125,15.32%,EPHA7;PBX3;PHGDH;CDH2;CNTNAP2;ROBO2;AFF2;SOX6;ADGRL2;ATXN1;PCDH18;SPEF2;DSCAML1;ROGDI;CTNNA2;HAP1;EMX1;PLXNB2;PROX1;PTEN;SHROOM4;GRIN2D;PITPNM1;POMK
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.6059042255557373,1.0745020832003616,0.4406779661016949,0.8513767539563362,1.0,2/16,3.09%,RUNX1;SNAI1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),0.6098757845112582,1.0745012760965955,0.3125,0.8508866118987908,1.0,5/13,16.70%,PAXIP1;AUTS2;SMAD4;MYB;CTNNB1
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),-0.6920679400107428,-1.074338230461303,0.4186046511627907,1.0,1.0,1/6,5.33%,ARG2
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.6092138902006152,1.0743194678050456,0.40384615384615385,0.8508259558748708,1.0,5/14,23.02%,RAPGEF3;ANP32B;TP53;GAS6;GTSE1
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.42969705196007213,1.0743118194631225,0.3137254901960784,0.8503810399819993,1.0,23/105,11.66%,STAB1;HIF1A;ITGA2;RIN2;MAFB;PTGS1;TLR2;ESR1;ITGAV;TCN2;ABCA1;GRM8;SIGLEC1;CASR;CYP27A1;TMIGD3;CA2;GSN;EFNB2;C3AR1;OSCAR;SMAD4;EGFL7
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.5329778996410822,1.0739249122771395,0.26,0.8510668016150833,1.0,10/41,14.46%,HRH3;PCLO;SYT1;NRXN1;SNCA;LIN7A;RIMS2;GRM4;HSPA8;PPFIA3
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.44880679300070486,1.0738099471187457,0.3137254901960784,0.850939704437285,1.0,6/58,15.21%,MAP3K11;TNFRSF19;HMGB1;MAP4K2;MFHAS1;PLCB1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.5111047417838793,1.073746412168373,0.37777777777777777,0.8506282975304247,1.0,10/38,10.54%,FERMT3;EPHA7;EFNA5;TENM3;FUT9;MEGF10;DPP4;ADA;MAGI1;ZDHHC2
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.646985957881596,1.0735346143841522,0.4782608695652174,0.8507449395370119,1.0,3/12,16.44%,AFF2;PML;DYRK3
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),0.6579322303429862,1.0735017041791435,0.4230769230769231,0.8498435291174582,1.0,2/5,20.35%,TICAM1;TICAM2
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.6579322303429862,1.0735017041791435,0.4230769230769231,0.8498435291174582,1.0,2/5,20.35%,TICAM1;TICAM2
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.47644865256927155,1.0734859014389988,0.35185185185185186,0.8494009596381077,1.0,8/77,5.96%,SELPLG;FLT1;RUNX1;RRAS;TOX;BMI1;ZFP36L2;TET2
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5294096879196166,1.073373073547034,0.32075471698113206,0.8492605382964017,1.0,9/34,20.25%,NEDD4;PADI2;ESR1;KDM3A;ARID1A;UBR5;PLPP1;NR3C1;TRIP4
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.4991396068718672,1.0733271358122414,0.29411764705882354,0.8489805725144631,1.0,6/48,8.80%,TGFBR1;ERBB4;NRG1;NRG2;ZSWIM5;ABL2
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.4286094671947072,-1.0732426509966735,0.3111111111111111,1.0,1.0,7/147,3.15%,SLC28A2;SELE;KCNMB2;SELL;NLRP3;GPR132;MEFV
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.5769583521239284,1.0730375233487741,0.3559322033898305,0.8493402634478201,1.0,3/19,10.27%,FZD5;HTRA2;FBXO7
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.621048008687582,1.0730061870715484,0.36538461538461536,0.8489650936089522,1.0,3/13,14.33%,MME;BACE2;DYRK1A
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.4574476635857035,1.0729988533801238,0.2857142857142857,0.8485169492656441,1.0,15/80,9.37%,SYK;ESRRG;ZBTB7B;IL4;TRPM8;SCD;TRPV2;ADIPOR2;PRKAB2;PLAC8;HDAC3;ACHE;PDGFC;KDM3A;LEPR
prerank,GO_Biological_Process_2021__protein localization to microtubule plus-end (GO:1904825),-0.6981503292406953,-1.0729415195198977,0.5,1.0,1.0,1/5,11.25%,GAS2L2
prerank,GO_Biological_Process_2021__protein localization to microtubule end (GO:1905725),-0.6981503292406953,-1.0729415195198977,0.5,1.0,1.0,1/5,11.25%,GAS2L2
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.5993792398474991,1.072903774268441,0.41379310344827586,0.8482893998878295,1.0,2/11,12.07%,GSN;FCHSD2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.512759450535689,1.0724234366746503,0.3125,0.8492352185933001,1.0,3/32,2.91%,LGALS9;FZD5;PYHIN1
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.5597795814606156,-1.0722265815657304,0.4,1.0,1.0,3/18,11.90%,GINS3;RFC3;LIG1
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.4595479157481271,1.0721363433239315,0.28,0.84962304999304,1.0,8/74,13.17%,NXF1;U2AF1;THOC6;WASHC4;ATXN1;RANBP17;XPO1;STRADA
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.4569963080761278,1.0718024283877448,0.25,0.8501935287315733,1.0,13/96,6.66%,MXRA5;LAMA4;MRGPRF;PRRX1;ADGRL4;SSC5D;BGN;COL6A2;CXCL12;LTBP2;POSTN;CCDC80;PDGFRA
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.3860916107466596,1.0717948876819972,0.2653061224489796,0.8497240026556386,1.0,63/322,21.23%,KCTD21;SIRT1;NEDD4;SPSB2;SYVN1;PELI1;KLHL8;RNF185;UBE2D3;SPSB4;ANKRD9;RNF146;SPOP;RNF217;UBE3D;KCTD6;SPOPL;KEAP1;ANAPC16;PSMD13;KLHL15;FBXO7;FBXL14;TBL1X;HECW2;RNF5;UBE2U;KLHL42;CNOT4;UBQLN4;RBBP6;ARIH1;UBA6;UBE4A;PSME4;RNF166;PML;RMND5A;MIB1;NFE2L2;PSMA1;NHLRC3;RNF128;CTNNB1;UBAP1;FBXO11;UBAP1L;PTPN23;ARRB2;NDFIP2;SMURF1;MVB12A;FBXW5;RNF19B;FEM1B;FZR1;UBE2D1;RNF144A;UBE2A;UBE2E1;DDIT3;PSMD4;RNF130
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.672060834253748,1.0717815586179615,0.4,0.8492696415151295,1.0,9/11,26.96%,MANF;NR4A2;LRP6;CTNNB1;VEGFA;WNT2;RYK;CDNF;SHH
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.5293728452041531,1.0717543444533744,0.45,0.8488669748058765,1.0,4/26,9.16%,IRS1;ENPP1;PIP4K2A;KANK1
prerank,MSigDB_Hallmark_2020__DNA Repair,0.43711128651199177,1.0715836995924668,0.3090909090909091,0.8488958741258666,1.0,18/140,17.81%,PNP;SAC3D1;AK3;CANT1;HCLS1;RALA;ADA;BCAM;AK1;REV3L;PDE4B;NPR2;NT5C3A;SEC61A1;SMAD5;NELFB;GTF2B;TP53
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.43058862773301904,1.0711580219507664,0.2830188679245283,0.8496185034585905,1.0,28/90,28.65%,MAP3K11;TNFRSF19;HDAC3;HMGB1;MARVELD3;ZNF675;MAP4K2;IGF1R;MFHAS1;PLCB1;RAP2A;PHLPP1;CCN2;CARD9;ANKRD6;ZNF622;MAPK8IP2;ZMYND11;EGFR;FKTN;TRAF6;GADD45G;TRAF5;MAP4K4;SIRPA;CYLD;DUSP15;APP
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.4312906804664929,-1.0708877234746685,0.3125,1.0,1.0,10/85,8.18%,SELP;MPO;NLRP1;CXCL13;PRKCD;IL6R;JCHAIN;SLC11A1;OAS3;OAS1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.624824912013836,-1.0708743286271905,0.39655172413793105,1.0,1.0,7/12,15.15%,XDH;SPRED3;SPRED2;MMP9;SPRED1;CAV1;OSR1
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),0.677787229097498,1.07072142623906,0.38596491228070173,0.8506030624053768,1.0,1/6,2.39%,SLC22A3
prerank,GO_Biological_Process_2021__C-terminal protein deglutamylation (GO:0035609),-0.7250296171087646,-1.0705454280494275,0.46,1.0,1.0,2/5,11.67%,AGBL1;FOLH1B
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.6241937929240299,-1.0701651241956833,0.4230769230769231,1.0,1.0,2/15,5.72%,TERT;FOXM1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.6692628549192732,1.0701187520687083,0.3695652173913043,0.8519804056005462,1.0,4/6,28.90%,LRWD1;RUVBL2;NIPBL;PIH1D1
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.665667966568624,1.0696905321648573,0.48214285714285715,0.8528458624854155,1.0,3/8,12.35%,NLGN1;NRXN1;PTEN
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.4843938670965667,-1.0696426949772184,0.3137254901960784,1.0,1.0,2/38,4.30%,MAP1LC3B2;ATG14
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.6748402649833012,1.0695762272762683,0.49019607843137253,0.8527339863470783,1.0,2/8,14.41%,CDK12;CCNH
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.622582785856551,-1.069476811548008,0.32,1.0,1.0,3/12,14.90%,RAC2;RAC1;NTN1
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.6614239170389897,1.0694234936512532,0.41304347826086957,0.8526586473763067,1.0,1/5,1.94%,SIRT1
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.4270366308134984,1.0692335555829982,0.2857142857142857,0.85269984101769,1.0,27/175,11.26%,ZDHHC11;IRGM;KLRD1;C3;SYK;SHMT2;IL4;PPP1R14B;PPARG;H2BC21;MID2;RELA;TIFA;TLR2;F12;PLCG2;FER;CD40;HMGB1;SNCA;GCH1;STING1;FRK;IL23R;MSRB1;HLA-E;TRIM26
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.4888068089715878,1.0689015458006357,0.3269230769230769,0.853170144407086,1.0,15/64,17.69%,URI1;SOCS2;ROBO2;LMO2;LOC400499;RAMP3;CRHBP;NCOA2;GCK;ATP1A2;MEF2C;NCOA3;THRB;AKR1C1;AKR1C3
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.5742046562325457,1.068784060112314,0.3787878787878788,0.8530147196287376,1.0,3/16,9.37%,RUNX1;IL15;LEPR
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.668640813343419,1.068261175254767,0.375,0.854196343393909,1.0,3/8,16.93%,CHPT1;PLA2G10;PLA2G7
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.4881982832294167,1.0682154315723094,0.26,0.8538517152474775,1.0,7/37,18.96%,FGF2;ITPKB;IP6K3;GPHN;CPS1;MOCOS;IP6K1
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.5304982756678963,-1.0681602268958905,0.33962264150943394,1.0,1.0,10/40,17.78%,RAC2;BST1;FBLN2;VIT;MYADM;ALOX15;RAC1;FZD7;PIK3CB;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.5071078715557988,1.0681564915307706,0.4107142857142857,0.8535510207399305,1.0,11/40,13.40%,TENM1;LMOD3;FER;GSN;BIN1;CRACD;LMOD2;CARMIL1;NCK2;FCHSD2;SPIRE2
prerank,GO_Biological_Process_2021__positive regulation of defense response to bacterium (GO:1900426),-0.72615540140246,-1.0679951346057888,0.4489795918367347,1.0,1.0,1/5,0.69%,PGC
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),0.6671863852148332,1.0679405049284079,0.4262295081967213,0.8531246306192143,1.0,1/7,5.88%,TLR2
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),0.6671863852148332,1.0679405049284079,0.4262295081967213,0.8531246306192143,1.0,1/7,5.88%,TLR2
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),0.595699424978753,1.0679377006320632,0.4117647058823529,0.8526437260923714,1.0,4/14,20.35%,TICAM1;PPIF;TRPM7;TICAM2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.6003666412453151,1.0672603326798822,0.40816326530612246,0.854067760460689,1.0,5/19,14.25%,CDKN2A;LATS1;PTEN;HEXIM2;NR2F2
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.42475161689830926,1.0672118240942352,0.3148148148148148,0.8537605538797349,1.0,33/183,17.96%,ESPL1;CDKN2C;TOP2A;MYC;NDC80;CDC25A;CCNA2;HIF1A;EFNA5;FBXO5;SYNCRIP;ODC1;EZH2;RASAL2;E2F4;HNRNPD;XPO1;HSPA8;H2AZ2;RACGAP1;PML;DMD;LMNB1;H2AX;NOTCH2;BCL3;RPS6KA5;FOXN3;MNAT1;SQLE;G3BP1;CDK4;UCK2
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.6456013034469164,1.0671197167738908,0.4107142857142857,0.8534681588646519,1.0,2/10,6.74%,SYK;PLCG2
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.44656455987085025,1.066929927847028,0.28,0.8534941615192101,1.0,20/101,18.53%,MITF;LLGL1;TEAD2;CD40;LIN7A;SLC7A9;MATN1;MAGI1;RANBP9;VAMP3;PICALM;CD74;PML;GPAA1;CD247;MNAT1;CD2AP;WASL;TP53;IL2RB
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),0.6927890554951746,1.0669256262490945,0.4406779661016949,0.8530288504331343,1.0,3/7,5.01%,CFH;IL4;CD59
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.6949660843974024,1.0667856973002072,0.4666666666666667,0.8530261878204684,1.0,2/6,16.60%,AKTIP;RNF26
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.5453263706990448,1.0667816512215054,0.3125,0.8525616620212376,1.0,11/38,19.45%,MYC;RBPJ;HDAC2;FZD1;DVL2;FRAT1;HEY2;CTNNB1;NUMB;TP53;JAG1
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.4485873429413076,1.0667453851693285,0.32,0.8522130593234226,1.0,11/82,11.53%,VAPB;DRD5;CCL5;CXCL12;SLC8A1;SLC24A2;CD40;CASR;ANK2;ATP1A2;HTR2C
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.6478629125604853,1.0666190550266224,0.4230769230769231,0.8521387730887685,1.0,7/10,26.87%,MEF2C;TBX18;HEY2;TMEM204;BMP4;MRTFA;MRTFB
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.34801729299966855,1.0665160987887214,0.1875,0.85187725252698,1.0,348/1744,19.50%,CRX;GATA4;DACH1;MITF;AASS;IGF1;SMAD6;EBF1;PKNOX1;TPRX1;ZSCAN4;RUNX1;HGF;PRRX1;ZNF300;DMRT3;HNF4G;MYC;ESRRG;HIF3A;ZNF792;SIRT1;PBX3;SOX5;IL26;FZD5;ZBTB7B;TSHZ3;IL4;URI1;ZBTB40;HIF1A;STAT5A;ZBTB1;FOXP2;MYCN;FGF2;KAT2B;PPARG;DBX2;SNAI1;LPIN3;TFEB;MED17;TOX;ZEB2;TSHZ2;ZNF493;HES6;CDKN2A;MAFB;LMO1;POU6F2;RORB;BMP2;BMI1;OLIG1;NFIL3;ZNF518A;NRIP1;OLIG2;PRDM14;SIX4;ZNF582;FLI1;RORA;ST18;ZGLP1;KANK2;ZBTB20;IRF8;SP1;DUX4;HCLS1;ACVR2A;ZNF462;SOX6;VSX2;LCORL;SMYD2;RBPJ;RELA;NR5A2;MOV10;ZEB1;LMO2;VEZF1;TLR2;TET2;ZBTB2;ESR1;ZBTB26;ERG;ZNF283;TEAD2;NFIA;PLAC8;ZNF599;WWTR1;BBX;ELP4;ZNF543;ZSCAN20;ZNF595;POU3F2;MED13L;HDAC3;PAX6;RFXAP;RPS6KA4;ZNF467;MKX;HDAC2;ZSCAN23;NCOA5;MYPOP;CD40;SSBP2;NEUROD2;UBE2D3;HMGB1;PPM1A;ZNF274;SNCA;ELF4;DUXA;ELK1;FOXO3;LHX6;ATXN1;TFEC;PTOV1;SMAD1;ZNF230;ZNF41;HIVEP2;KLF6;ACTL6A;ZNF202;ZNF561;KDM3A;INSM2;STING1;RIPPLY2;TAF3;AUTS2;ZNF675;CTCFL;SMARCD3;NPAS1;FRK;SMAD2;ZNF771;ZNF426;ZNF165;NCOA2;EZH2;ZNF669;LOXL2;ZNF692;NHLH2;NHLH1;ZNF239;FOXO1;TCF4;ONECUT2;BCL11B;E2F4;ZBTB41;BMPR1A;TBL1X;PASD1;NR1D2;ZNF292;EMX1;PHF21A;SP3;SLTM;SMAD4;PLAGL1;ZNF704;DMTF1;DPF1;NPAS3;NR1H3;MEF2C;NCK2;ZNF536;ARID1A;ZNF347;PROX1;CDC5L;PTEN;ZNF175;CTBP2;ZNF778;CDK12;TBX18;PPP3CA;TIAL1;ZNF281;MYB;GREM1;HDGFL3;ZNF212;NR4A2;DPF3;ZBTB10;RNF2;KLF7;HEXIM2;NOC2L;MXD4;MYT1L;ZNF20;ID4;CREB3L2;ZXDC;ZBTB33;ZNF652;ARID1B;ZNF182;MLXIPL;TSHZ1;DVL2;WWOX;RARB;CREB1;ZNF639;BCOR;VGLL3;NR2F2;RPS6KA1;LRP6;SMARCD2;ZNF263;RFX5;CCNH;NFATC3;PAX3;ZNF780B;KLF15;EPC1;KAT6A;POU2F1;PCGF5;PLSCR1;ZNF442;GABPB1;NCOA3;ETV3;ATF6;THRB;VRTN;HJV;FOXO6;HCFC1;ZFP30;SPEN;SMAD5;PHIP;TRPS1;ZNF607;NFE2L2;HSF2;DEAF1;POGZ;MESP1;SIRT6;EAF2;PEX2;ZNF623;MYDGF;ZNF776;ZNF584;HEY2;CNOT2;CTNNB1;SMARCA2;ZNF672;FADD;RPS6KA5;RORC;MNAT1;IL33;CHD1;SIRT7;THAP3;ZNF276;ZNF786;RUVBL2;ZNF654;NUFIP1;VEGFA;TGIF1;WNT2;CDK4;MXI1;LCOR;SUPT3H;GABPA;WASL;TP53;CSRNP3;MAZ;ZNF784;MIER3;CD81;EFNA1;AGO3;MED30;ABCA2;CITED2;EED;TEF;ZNF12;ZNF30;JMY;ZNF234;TTC21B;IER5;NSD1;ZNF33A;FUS;PER3;ZNF518B;CSRNP2;KDM5B;KIT;HDAC9;DNAJB1;ZBTB4;BRWD1;PCGF1;ZNF251;ZNF322;ZXDA;ZNF782;NR3C1;ETV7;IRF3;ARNT;NFIC;ZNF311;ABL1;JAG1;TFCP2L1;ZSCAN2
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.49910044363703465,1.066300214185049,0.32,0.8519544478849682,1.0,19/57,20.60%,IL4;TOX;NFIL3;BLNK;LY6D;PLCG2;CHD7;KLF6;LEPR;FLT3;PIK3CD;DNAJB9;RAG2;ZAP70;KIT;HDAC9;GPR89A;RAG1;AXL
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.6478869230539314,-1.0660476534603505,0.44680851063829785,1.0,1.0,4/7,13.36%,GPX3;PRKCD;RNF112;XRCC1
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.5597802830794498,-1.0660121874595163,0.40425531914893614,1.0,1.0,4/15,17.00%,CRLF1;OAS1;OAS2;STAT1
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.5049185221501472,-1.0658865840000034,0.3191489361702128,1.0,1.0,7/46,6.82%,PM20D1;SPTLC3;ASS1;PNPLA1;ARG2;DEGS2;ALOXE3
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.6840179391814927,-1.0657200923844585,0.4489795918367347,1.0,1.0,2/5,8.19%,CARTPT;UBASH3B
prerank,GO_Biological_Process_2021__adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911),0.6485664188094986,1.0656335955618572,0.5306122448979592,0.8505271763079881,1.0,2/5,14.06%,NUDT4;NUDT4B
prerank,GO_Biological_Process_2021__diadenosine hexaphosphate metabolic process (GO:1901908),0.6485664188094986,1.0656335955618572,0.5306122448979592,0.8505271763079881,1.0,2/5,14.06%,NUDT4;NUDT4B
prerank,GO_Biological_Process_2021__diadenosine pentaphosphate catabolic process (GO:1901907),0.6485664188094986,1.0656335955618572,0.5306122448979592,0.8505271763079881,1.0,2/5,14.06%,NUDT4;NUDT4B
prerank,GO_Biological_Process_2021__diphosphoinositol polyphosphate metabolic process (GO:0071543),0.6485664188094986,1.0656335955618572,0.5306122448979592,0.8505271763079881,1.0,2/5,14.06%,NUDT4;NUDT4B
prerank,GO_Biological_Process_2021__adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910),0.6485664188094986,1.0656335955618572,0.5306122448979592,0.8505271763079881,1.0,2/5,14.06%,NUDT4;NUDT4B
prerank,GO_Biological_Process_2021__diadenosine pentaphosphate metabolic process (GO:1901906),0.6485664188094986,1.0656335955618572,0.5306122448979592,0.8505271763079881,1.0,2/5,14.06%,NUDT4;NUDT4B
prerank,GO_Biological_Process_2021__diadenosine hexaphosphate catabolic process (GO:1901909),0.6485664188094986,1.0656335955618572,0.5306122448979592,0.8505271763079881,1.0,2/5,14.06%,NUDT4;NUDT4B
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),0.689835818259749,1.065630866153138,0.47058823529411764,0.8500671531976048,1.0,2/5,24.40%,BBIP1;ARL13B
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.6682569460070582,1.0654073256396692,0.4583333333333333,0.8501449702618957,1.0,2/5,21.16%,MAPK8;MAPK3
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.6003688930872636,1.0651905616326536,0.42857142857142855,0.8504088703222584,1.0,6/13,23.87%,RORB;TULP1;CRB2;VEGFA;RP1;CEP290
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.5936251496125102,-1.065084746286554,0.3488372093023256,1.0,1.0,1/11,2.68%,CLDN1
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.5031262527003849,1.064995239274152,0.3170731707317073,0.8504506285336934,1.0,7/31,17.26%,RAPGEF3;RPS6KA4;SNCA;PAXIP1;NOC2L;RPS6KA5;RUVBL2
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.6101753359417007,1.0649313025595006,0.36538461538461536,0.8501132628662902,1.0,2/7,21.36%,PPP3CA;ANXA1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.5307553290390441,1.0644825673267289,0.4888888888888889,0.8508628331972273,1.0,4/21,12.41%,EFNA5;EPHA3;CORO1C;GPM6B
prerank,GO_Biological_Process_2021__neuron fate specification (GO:0048665),0.6751604725688551,1.064396905681654,0.4423076923076923,0.8506042024343928,1.0,2/5,13.36%,POU3F2;MYT1L
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.520749695986342,1.0642464948992434,0.40816326530612246,0.8505886354666501,1.0,2/24,3.23%,ITGAX;MYRF
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.6623098754381248,-1.0639625607919536,0.37777777777777777,1.0,1.0,2/6,16.27%,RAC1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.5720326006633798,1.0637651601035452,0.39655172413793105,0.851365239331839,1.0,1/13,5.68%,SDC4
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.5545262521767163,1.0635815289906685,0.4032258064516129,0.8514277254516025,1.0,2/17,8.97%,SDC4;CHMP6
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.6425453323945307,1.0635394685594124,0.45614035087719296,0.8511265835476839,1.0,5/7,19.69%,GSN;HIPK1;RYR2;CAPN10;BMPR2
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.4483662029771554,1.0634830620380786,0.3137254901960784,0.8508400248051835,1.0,16/69,20.67%,ACE2;SLC8A1;APELA;SCN10A;ANK2;TMIGD3;NPPA;ATP1A2;NPR2;KCNG2;RYR2;ASPH;RYR3;CORIN;TRPC1;ATP1B2
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),0.6856773712009832,1.0634434578335505,0.52,0.850468335138108,1.0,3/6,19.69%,NPPA;ADRB1;BMPR2
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.6282582099492535,1.063255970495808,0.39285714285714285,0.8506023470921278,1.0,4/9,20.16%,CPNE7;CPNE1;CPNE3;HDHD5
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.6242665733509097,1.0631957884217622,0.3870967741935484,0.8502809901007103,1.0,4/8,22.98%,MAGI2;DAND5;FSTL3;LEMD3
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.34496102465747713,1.0628319798708106,0.18,0.8509125795988665,1.0,284/1778,15.83%,CRX;GATA4;DACH1;MITF;IGF1;SMAD6;TIMELESS;EBF1;PKNOX1;TPRX1;ZSCAN4;RUNX1;PRRX1;ZNF300;DMRT3;HNF4G;MYC;ESRRG;HIF3A;ZNF792;SIRT1;PBX3;SOX5;TGFBR1;F2R;ZBTB7B;ERBB4;TSHZ3;TULP3;CDK11A;RFPL2;IL4;URI1;ZBTB40;HIF1A;STAT5A;ZBTB1;FOXP2;MYCN;FGF2;NRG1;PPARG;PYHIN1;GDF6;DBX2;SNAI1;TFEB;SFMBT2;MED17;MYRF;TOX;MDFIC;ZEB2;TSHZ2;ZNF493;PRDM8;WNT4;HES6;CDKN2A;CDK18;MAFB;POU6F2;FBXO5;RORB;BMP2;OLIG1;NFIL3;ZNF518A;TENM1;OLIG2;MLLT3;PRDM14;SIX4;ZNF582;FLI1;RORA;FANK1;ST18;ZGLP1;ZBTB20;IRF8;SP1;DUX4;HCLS1;SOX6;VSX2;LCORL;RBPJ;RELA;NR5A2;ZEB1;VEZF1;ZBTB2;ESR1;ZBTB26;ERG;ZNF283;TEAD2;NFIA;ZNF599;WWTR1;BBX;ELP4;ZNF543;ZSCAN20;ZNF706;TP53INP1;ZNF595;POU3F2;ELAVL2;MED13L;HDAC3;SLC39A8;PAX6;RFXAP;RPS6KA4;ZNF467;MKX;HDAC2;CHD7;ZSCAN23;MYPOP;SSBP2;NEUROD2;HMGB1;PPM1A;ZNF274;ELF4;DUXA;ELK1;GMNN;RYBP;FOXO3;LHX6;ATXN1;TFEC;CDK14;CBFA2T3;SMAD1;YAF2;ZNF230;ZNF41;ZNF195;HIVEP2;GPBP1L1;KLF6;ACTL6A;ZNF202;ZNF561;KDM3A;ZNF675;CTCFL;SPINDOC;SMARCD3;NPAS1;SMAD2;ZNF771;ZNF426;ZNF165;NCOA2;EZH2;MAGEL2;ZNF669;LOXL2;ZNF692;NHLH2;NHLH1;ZNF239;FOXO1;TCF4;ONECUT2;BCL11B;E2F4;ZBTB41;MBTD1;PTPRK;TBL1X;ZNF114;PASD1;NR1D2;HP1BP3;ZNF292;EMX1;HNRNPD;CHEK2;SP3;SLTM;SMAD4;PLAGL1;ZNF704;DMTF1;DPF1;NPAS3;NR1H3;MEF2C;ZNF536;ARID1A;ZNF347;PROX1;CDC5L;ZNF175;CTBP2;ZNF778;ZNF117;TBX18;TLE2;TIAL1;ZNF281;MYB;ATF7IP;HDGFL3;ZNF212;NR4A2;DPF3;MAGED1;ZBTB10;FZD1;HSPA8;KLF7;PICALM;HEXIM2;MXD4;MYT1L;ZNF20;POLR3G;ID4;CREB3L2;ZXDC;ZBTB33;SPIN1;ZNF652;ARID1B;MLF1;ACVR1B;CD74;ZNF182;MLXIPL;TSHZ1;PRICKLE1;DVL2;PML;CREB1;ZNF639;BCOR;VGLL3;RUNX1T1;NR2F2;RPS6KA1;LRP6;FZD4;SMARCD2;DYRK1A;ZNF263;RFX5;CCNH;NFATC3;PAX3;ZNF780B;KLF15;EPC1;KAT6A;POU2F1;BAMBI;PCGF5;TAF5;ZNF442;ETV3;ZNF280B;RGS14;ATF6;ZNF502;PLCB1;VRTN;FOXO6;ZNF257;HCFC1;ZFP30;SPEN;SMAD5;PHIP;TRPS1;ZNF607;NFE2L2;HSF2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.550396359573165,1.0626636159619405,0.41818181818181815,0.8509963890276294,1.0,2/22,3.67%,CDC25A;FBXO5
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.5284505970614514,-1.0625431776302885,0.37254901960784315,1.0,1.0,6/29,10.00%,TRIM56;IRF5;FLOT1;OAS3;OAS1;DHX58
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.605720418735182,1.0623752007198952,0.4745762711864407,0.8514138543993869,1.0,3/12,21.86%,ELOVL5;ACOX1;ACSL1
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.369178633014146,1.062254269964813,0.21951219512195122,0.8512417984484216,1.0,202/966,17.86%,CRX;GATA4;MITF;IGF1;RUNX1;HGF;ZNF300;HNF4G;MYC;ESRRG;SIRT1;TGFBR1;IL26;F2R;FZD5;ERBB4;RFPL2;IL4;HIF1A;MYCN;FGF2;KAT2B;PPARG;PYHIN1;GDF6;PADI2;SNAI1;LPIN3;TFEB;MED17;MYRF;MDFIC;ZEB2;WNT4;MAFB;LMO1;RORB;BMP2;NFIL3;NRIP1;MLLT3;SIX4;FLI1;RORA;FANK1;ST18;ZGLP1;IRF8;SP1;DUX4;HCLS1;ACVR2A;ZNF462;RBPJ;RELA;NR5A2;LMO2;VEZF1;TLR2;TET2;CDCA4;ESR1;ERG;TEAD2;NFIA;ASF1A;PLAC8;WWTR1;TP53INP1;POU3F2;HDAC3;PAX6;RFXAP;RPS6KA4;HDAC2;CD40;SSBP2;HMGB1;PPM1A;ELF4;ELK1;RYBP;FOXO3;TFEC;PTOV1;SMAD1;YAF2;KLF6;KDM3A;STING1;AUTS2;CTCFL;SERTAD2;SMARCD3;SMAD2;NCOA2;NHLH2;NHLH1;FOXO1;TCF4;ONECUT2;BCL11B;E2F4;BMPR1A;TBL1X;NR1D2;HNRNPD;CHEK2;SP3;SMAD4;PLAGL1;ELOF1;DPF1;NPAS3;NR1H3;MEF2C;NCK2;ARID1A;PROX1;CDC5L;ZNF175;CTBP2;PPP3CA;ZNF281;MYB;GREM1;ATF7IP;NR4A2;DPF3;FZD1;KLF7;PICALM;CREB3L2;ZXDC;SPIN1;ARID1B;CD74;MLXIPL;DVL2;PML;WWOX;RARB;CREB1;ZNF639;NR2F2;SERTAD1;RPS6KA1;LRP6;FZD4;SMARCD2;DYRK1A;ZNF263;RFX5;NFATC3;PAX3;KLF15;EPC1;KAT6A;POU2F1;BAMBI;PCGF5;PLSCR1;GABPB1;NCOA3;ATF6;H1-10;THRB;PLCB1;HJV;HCFC1;SMAD5;PHIP;NFE2L2;HSF2;DEAF1;POGZ;MESP1;EAF2;NAA16;MYDGF;HEY2;BCL3;CTNNB1;SMARCA2;FADD;RPS6KA5;RORC;IL33;SIRT7;THAP3;RET;RUVBL2;NUFIP1;VEGFA;WNT2;RHOG;SUPT3H;GABPA;WASL;TP53;CSRNP3;MAZ
prerank,GO_Biological_Process_2021__heart trabecula formation (GO:0060347),-0.6582136358566902,-1.062114884801402,0.46938775510204084,1.0,1.0,1/5,1.18%,TEK
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.5525255071486423,1.0620386684428893,0.3709677419354839,0.8513465670173336,1.0,1/20,1.94%,SIRT1
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.5752460865115344,1.0619321713045975,0.391304347826087,0.8512598093761462,1.0,4/12,20.56%,PCM1;BICD1;GCC2;SAXO2
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5499505230171204,1.0615007637033067,0.39285714285714285,0.8521084168480006,1.0,6/24,17.39%,RUNX1;HCLS1;IL23R;CD74;FADD;CSF1
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.46539355888088574,1.0613197806652146,0.32608695652173914,0.8521063127064249,1.0,2/42,2.50%,CSTA;URI1
prerank,GO_Biological_Process_2021__cytidine to uridine editing (GO:0016554),-0.7208745028209455,-1.0613033564823453,0.4186046511627907,1.0,1.0,2/6,4.76%,APOBEC3H;APOBEC3G
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.47458746630759113,1.0611600088911863,0.3469387755102041,0.852061745453677,1.0,17/72,14.58%,PCDH15;LHFPL3;CDC14A;ROR1;EPS8L2;WHRN;ALDH7A1;ADGRV1;CCDC50;ATP6V0A4;TBL1X;TPRN;SLC26A4;COL11A1;GRM7;LRP2;PAX3
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.5611092489822853,1.0609762216261622,0.34782608695652173,0.8522648059245613,1.0,2/10,6.77%,PCM1;CCDC120
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.41677706174713114,1.0608655810952563,0.36,0.8521141537410424,1.0,37/146,19.16%,LRRC3B;FGFR3;CDH20;PMP2;SLC1A3;AANAT;GFAP;CADM2;NRXN1;CD40;NTSR2;SYNPR;GRM5;PLXNB1;LRRTM3;ADGRB3;SRR;ATP1A2;ACSBG1;GPM6B;BAALC;HTRA1;GABRG1;SLC39A12;LUZP2;NFATC3;GJB6;GPRC5B;CNTN2;BYSL;PLA2G7;SLC1A6;TMEM178A;GSTA4;PLP1;RBFOX1;KCNJ10
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5609625628675369,1.0607716316538085,0.38596491228070173,0.8519354036056741,1.0,5/22,19.17%,NEDD4;UBAP1;UBAP1L;PTPN23;MVB12A
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.47172816223245706,1.0607140206531493,0.43103448275862066,0.851665043686917,1.0,10/49,14.30%,SEMA5A;ERBB4;NRTN;SEMA6C;CORO1C;PHACTR4;AMOTL1;SEMA3E;SGPL1;SEMA6D
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.45262668710927617,1.0604874713861199,0.3617021276595745,0.8520231550052364,1.0,25/63,20.73%,SYT15;ITPKB;NLGN1;ADGRV1;SYT6;SYT1;PLCG2;NEUROD2;CRHBP;SLC25A24;CPNE4;CPNE7;CPNE1;MEF2C;CPNE3;TRPM2;PPIF;CPNE2;PRKAA1;AKR1C3;RYR3;SYT3;LGMN;CPNE9;SYT17
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5291908772521166,1.0604774092612337,0.375,0.8515978498807393,1.0,5/25,12.35%,ZNF804A;CTNNA2;FBXO7;NTNG2;PTEN
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.48539606994847406,-1.0602440358888192,0.43636363636363634,1.0,1.0,4/36,1.74%,P2RY10;SIRPG;SELL;TRAF3IP3
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.4613066758062907,1.0601675300425717,0.375,0.8519203532027303,1.0,15/61,21.70%,SLC1A3;SLC7A2;SLC39A8;SLC25A1;SFXN2;SLC25A13;SLC19A1;SLC44A4;SLC3A2;SLC1A6;SLC25A12;SLC25A30;SLC16A7;SLC7A8;SLC25A14
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.42797393836966974,1.0600553966409485,0.3111111111111111,0.8517703854302985,1.0,26/140,13.82%,GAS2L3;CGNL1;RHOBTB3;KASH5;LMOD3;EFS;CASS4;MYO1E;EPS8;CORO7;GAS2;MCU;HIP1;GSN;CORO1C;TPM2;ARHGAP25;LMOD2;CARMIL1;PPP1R9A;BCAR1;PROX1;SHROOM4;SPIRE2;DBN1;RHOBTB1
prerank,GO_Biological_Process_2021__phosphate ion homeostasis (GO:0055062),0.6486754825267432,1.059634005918418,0.41818181818181815,0.8523811901853374,1.0,1/7,3.41%,ENPP1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.6624302809937225,1.05951829965871,0.391304347826087,0.8523507940905518,1.0,1/6,2.22%,EGLN3
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.659122048304324,1.0594165525204544,0.49056603773584906,0.8521586272180969,1.0,2/6,8.18%,ROBO2;LHX6
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.49603365437206326,-1.0592726299013278,0.34545454545454546,1.0,1.0,5/28,12.25%,ACOT1;ACSM6;MLYCD;ACOT2;ACSM4
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.49603365437206326,-1.0592726299013278,0.34545454545454546,1.0,1.0,5/28,12.25%,ACOT1;ACSM6;MLYCD;ACOT2;ACSM4
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.474384331520603,1.0592390299998689,0.3392857142857143,0.8522268216763149,1.0,3/45,1.22%,REP15;TCIRG1;ATP6V0D2
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.48735733466179665,-1.0591328413490695,0.23404255319148937,1.0,1.0,7/60,2.39%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;CYTH4
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.6402811028115604,1.0591223963823388,0.43636363636363634,0.8521262871779429,1.0,2/9,11.43%,NEDD4;HECW2
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.6430596286068313,-1.059102714718143,0.42857142857142855,1.0,1.0,1/6,6.07%,SFRP1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.446802241516749,1.059067104530073,0.3888888888888889,0.8518151597714501,1.0,28/98,26.18%,TGFBR1;ANGPT1;SEPTIN4;IVNS1ABP;DNAJB2;HDAC3;DCUN1D1;PAXIP1;SPOPL;WASHC1;BAG2;PRICKLE1;NXN;GNL3L;BIRC3;SIRT7;ARRB2;NDFIP2;UBE2D1;RIPK2;PHF23;COMMD1;HSPA1A;OGT;N4BP1;SMAD7;BCL10;TRAF6
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.622202886432322,1.0589401572265882,0.35294117647058826,0.8516798619647358,1.0,1/12,2.18%,ZBTB7B
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.6428446926607095,-1.0588983221476798,0.4090909090909091,1.0,1.0,5/7,34.09%,AQP1;SCTR;AQP11;AQP4;CLN3
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.651581673712632,-1.0587651441563957,0.475,1.0,1.0,1/8,3.29%,CYP2E1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.47448962354232954,1.058495733799156,0.35185185185185186,0.8524637762353654,1.0,13/48,15.21%,ENPP1;WNT4;BMP2;ADGRV1;ACVR2A;SLC8A1;BMPR1A;MEF2C;GPM6B;GREM1;BCOR;ANKH;ANO6
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.6253243387580243,1.0583511539238122,0.43636363636363634,0.8523352841290576,1.0,3/8,16.07%,PIK3C2B;PIK3CA;PIK3CD
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.5396413058950854,1.0583285320375202,0.375,0.8519406240488087,1.0,5/19,17.85%,NLGN1;RIMS2;RAP1A;RIMS4;FMR1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4968796256332692,1.058278995451539,0.3392857142857143,0.8515744112704353,1.0,12/44,19.44%,BOK;SIRT1;DYRK2;HTRA2;CHEK2;PML;IKBKE;PHLDA3;HIPK1;BCL3;TP53;ABL1
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.6240927472250475,1.0581786329926328,0.4444444444444444,0.8513766087852227,1.0,1/9,2.87%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.5994966055921129,-1.058025752096917,0.3404255319148936,1.0,1.0,1/17,0.69%,CLDN4
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.6329827916927951,1.0579039678866338,0.39215686274509803,0.8517247613578228,1.0,1/9,1.61%,FGFR3
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.6455813206109264,1.0578679871846828,0.41379310344827586,0.8513312923347515,1.0,3/8,18.93%,CLMP;COBL;KIT
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.48187016375535946,-1.0578484848509357,0.34146341463414637,1.0,1.0,5/40,5.23%,SCN5A;DRD4;CRACR2A;DRD2;CAMK2A
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.663221963788762,1.0577928404871753,0.36538461538461536,0.8510291089256466,1.0,3/6,23.21%,NLGN4X;PTEN;CBLN1
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.4260710252598044,1.0577337839070156,0.275,0.8507342392320385,1.0,26/101,16.94%,GRM3;LRRC4C;CLSTN2;CDH2;NLGN1;MCTP2;LGI1;NRG3;SYT1;CEL;GRM8;GRIK2;NLGN4X;RIMS2;GRM5;GRIK3;SNCAIP;ATP1A2;MEF2C;PTEN;GRM4;GRM7;GRM1;PXK;GRID2;DGKZ
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5534221100894005,1.0576839577876391,0.38,0.8503908196478926,1.0,6/18,11.19%,HS3ST5;HS3ST3B1;UGDH;HS2ST1;EXT1;CSGALNACT1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.4954101868754845,-1.057494040138763,0.30434782608695654,1.0,1.0,10/42,10.40%,IRF4;IFI27;IRF5;EGR1;IFIT2;OAS3;OAS1;IFIT3;HLA-C;GBP2
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.4954101868754845,-1.057494040138763,0.30434782608695654,1.0,1.0,10/42,10.40%,IRF4;IFI27;IRF5;EGR1;IFIT2;OAS3;OAS1;IFIT3;HLA-C;GBP2
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.5948779211063016,1.0574116132920246,0.46808510638297873,0.8506269196206826,1.0,2/8,7.72%,NRXN1;NEUROD2
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),0.6787926626701792,1.0573561147903843,0.45161290322580644,0.8502630092875916,1.0,4/6,30.35%,IL23R;CARD9;SMAD7;IL23A
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.42999750955743493,1.0572765804206756,0.36538461538461536,0.8499901049885051,1.0,16/104,12.82%,ATP6V0D2;SIRT1;IL4;NEDD4;PRKAB2;SMG1;GNAI3;GPSM1;ATG101;STING1;PIK3CA;EPM2A;BNIP3L;RRAGC;MAPK8;ATP6V0B
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.6713043208364157,1.0570018788682427,0.44642857142857145,0.8502887351737605,1.0,3/5,25.79%,HMGB1;TNFSF4;STOML2
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),0.6975063684255094,1.0569235225022238,0.3673469387755102,0.8500578879174062,1.0,1/5,19.54%,TIMP1
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.5609916224881649,1.0568592136871742,0.46,0.84978553794115,1.0,2/18,3.79%,WNT4;BMP2
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),0.7103930288705409,1.0568461146581152,0.45454545454545453,0.849381337410642,1.0,3/5,22.13%,MVD;IDI2;IDI1
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.6865708345307411,1.0568390182918632,0.4782608695652174,0.8489428178171726,1.0,2/6,2.87%,SIRT1;PPARG
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.6284456368721195,-1.0565131655327924,0.4375,1.0,1.0,4/10,17.93%,SLX4;ERCC1;EXO1;BLM
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.6284456368721195,-1.0565131655327924,0.4375,1.0,1.0,4/10,17.93%,SLX4;ERCC1;EXO1;BLM
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.6284456368721195,-1.0565131655327924,0.4375,1.0,1.0,4/10,17.93%,SLX4;ERCC1;EXO1;BLM
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.6272103730042302,-1.056506235867154,0.46511627906976744,1.0,1.0,5/12,11.48%,NUPR1;ALOX5;MBTPS2;CLU;WFS1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.4333026194633829,1.0561275437250055,0.3829787234042553,0.8502833315648795,1.0,27/151,13.37%,LGALS9;IGF1;RUNX1;ITGB8;SIRT1;HIF1A;MYCN;FGF2;SFMBT2;LDLR;WNT4;BMP2;APOBEC1;MOV10;ESR1;ABCC2;ANKRD13D;ANKRD13A;BMPR1A;CPNE1;MEF2C;TIPARP;CD34;ZNF281;PICALM;RBMS3;MSR1
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.4183480808444966,1.0560710028127853,0.38636363636363635,0.8499975608521928,1.0,9/94,7.89%,F2;CCL5;GPSM3;CCN4;NAPEPLD;TLR2;NFKBIZ;IL15;SNCA
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.5022005930348785,1.0560189651046445,0.38181818181818183,0.8497259787360589,1.0,4/35,3.42%,SLC26A3;RAPGEF3;AANAT;SLC26A6
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.6160409156278401,1.05562772613083,0.4186046511627907,0.8503910833836023,1.0,5/12,25.80%,PGRMC2;DGAT2;RORC;ARID5B;SOX8
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.6616971536978318,1.05552457560467,0.4523809523809524,0.8502512996309587,1.0,2/9,11.92%,FGFR3;MEF2C
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),-0.6280354557887051,-1.0553926605144455,0.3673469387755102,1.0,1.0,4/7,19.64%,DRD2;TRPV1;RYR1;HTR1B
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.6893553489694513,1.055096685361904,0.4642857142857143,0.8508876889097844,1.0,2/6,19.35%,ABCC11;SLC25A33
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.5418807372542664,-1.0549744923120514,0.42857142857142855,1.0,1.0,2/19,2.97%,COL5A1;MFAP5
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.4549341622382079,-1.0549511737658672,0.3076923076923077,1.0,1.0,14/63,16.63%,DNASE1L1;REXO4;RNASE1;ERCC1;RFC3;RAD50;PARP1;GTF2H2;IHO1;FAN1;RPA3;RFC2;MUS81;RFC1
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.6470772514973024,-1.0549076375481135,0.5476190476190477,1.0,1.0,2/9,13.71%,DRD2;SHANK1
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.5141343945441625,-1.0547132077278791,0.42,1.0,1.0,4/21,7.66%,TNXB;PXDN;LAMB3;LAMB1
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.5783371649567682,1.0546760124488794,0.37735849056603776,0.8516965183630842,1.0,4/9,32.07%,SYNE4;RAP2A;MYO9A;OPHN1
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),-0.7241257884820047,-1.0546585568731908,0.5,1.0,1.0,2/7,9.55%,PRDM7;RAD51AP1
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.4807444047827674,1.0544305546725843,0.3953488372093023,0.8518746376380449,1.0,10/28,24.26%,CDKN2A;DLC1;CORO1C;PTEN;SEMA3E;PHLDB2;JAG1;NEXMIF;ADAM15;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.5278373910513251,1.054361221439522,0.3333333333333333,0.8516236750186801,1.0,4/23,9.40%,CCL5;CD244;SNCA;DSCAM
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.5514035015191988,-1.0541078924891718,0.39215686274509803,1.0,1.0,1/14,1.30%,PRDM1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.6690636826332816,1.0541041705309053,0.45614035087719296,0.8518915220563265,1.0,2/8,7.24%,CDH2;FER
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4727436998742201,1.0540728521350686,0.43902439024390244,0.851502617311647,1.0,10/65,10.79%,BOK;F2R;EGLN3;PPARG;F3;SNCA;DLC1;HIP1;TNFRSF10B;CASP10
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070),0.7193647417040144,1.0538434667343326,0.4897959183673469,0.8516666450683708,1.0,1/5,3.32%,MRAP2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.44363219579741375,1.0536296214123393,0.3269230769230769,0.8517752748588883,1.0,12/65,12.26%,FERMT3;ITGA8;TMEFF2;ITGAV;FER;LAMB4;MEGF9;VAMP3;PXN;NTNG2;MEF2C;PROX1
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.45509222664395954,-1.0534480631589702,0.32075471698113206,1.0,1.0,4/64,5.37%,H1-3;H1-4;H1-2;RNF8
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.4649567365409338,1.053301266257761,0.34782608695652173,0.8520148693647194,1.0,9/47,5.74%,NXPH2;PNOC;NXPH4;UTS2R;OPRK1;NPY;GLRA1;PENK;SSTR3
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.4337160952812563,-1.0531877409259198,0.3137254901960784,1.0,1.0,14/130,6.32%,SLC28A2;EHF;TREH;SPON2;CLCA1;GFRA2;AQP7;SLC51A;RBP2;ABHD11;DEGS2;GULP1;BEST4;CYP4F2
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.40515843774153515,1.0530501550411044,0.2727272727272727,0.852171462998579,1.0,31/197,15.57%,CCNG1;CDKN2C;MYC;CDC25A;CCNA2;CDKN2A;NDE1;CEP70;PCM1;EPS8;FBXL3;CEP152;CDK14;BCAT1;LATS1;CCNB3;DCTN3;CHEK2;CEP135;DYNC1I2;CNTRL;PPP1R12B;PHLDA1;NEDD1;ACVR1B;CCND3;FBXL15;CCNH;CCP110;PLCB1;TAF2
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.5205907788968099,1.0526920221608251,0.29411764705882354,0.8527965188050985,1.0,4/31,3.91%,SLC26A3;SLC22A3;SLC26A7;SLC17A6
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),0.6033749278104867,1.052466899857451,0.49019607843137253,0.8530145170426824,1.0,1/7,2.98%,ALDH1A1
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),0.600415446680938,1.0523580451485528,0.45,0.8528261117941942,1.0,6/13,22.25%,PYHIN1;RO60;AXL;GAS6;KLHL20;MX2
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.4021452655410061,1.0523482148639758,0.2692307692307692,0.8524039695226109,1.0,22/121,15.57%,CDC25A;CCNA2;NDE1;CEP70;PCM1;FBXL3;CEP152;CDK14;LATS1;DCTN3;CHEK2;CEP135;DYNC1I2;CNTRL;PPP1R12B;PHLDA1;NEDD1;FBXL15;CCNH;CCP110;PLCB1;TAF2
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.6583049650369194,1.0523118521563266,0.47368421052631576,0.8520785551591478,1.0,2/7,13.08%,RRS1;XPO1
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.6624640560125519,1.0522632605244573,0.5178571428571429,0.8517741084094883,1.0,4/7,24.40%,BBIP1;RAB29;ARL3;ARL13B
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.5023707406992021,-1.0519803114749093,0.39622641509433965,1.0,1.0,8/52,12.82%,TERT;ALOX5;CLU;UBASH3B;KIF26A;APOA1;WFS1;IGFBP3
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.5267797347047429,-1.0519133620100276,0.4634146341463415,1.0,1.0,7/27,21.15%,KIF2B;STMN1;STMN3;DSTN;KATNB1;KIF18B;KIF24
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.44896815393603073,1.0518181643219502,0.4,0.852534762512991,1.0,10/50,15.10%,HIF1A;ENGASE;ST6GALNAC3;HPSE;ST8SIA4;FUT8;PRKCSH;MAN2A1;MAN1A2;MGAT4A
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.6478212247060828,-1.0518136450422517,0.48936170212765956,1.0,1.0,1/6,12.89%,TCF7
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.4236400609782436,1.0518079003311862,0.3333333333333333,0.8521068120409119,1.0,26/147,10.66%,MXRA5;LAMA4;MRGPRF;SMOC1;ITGA8;PRRX1;PRKG1;ADGRL4;KAT2B;ANGPT1;RRAD;MSRB3;ACTG2;BGN;CXCL12;ZBTB44;POSTN;CCDC80;PDGFRA;PLSCR4;PDE4DIP;PCDH18;MYH11;MEDAG;ITGA1;TPM2
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),0.62265089038933,1.0517686475304704,0.5178571428571429,0.8517685269222672,1.0,2/13,7.07%,IGF1;PAX6
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.5563157325201232,1.0515887089441887,0.38181818181818183,0.851800963006281,1.0,6/21,15.49%,GSTM2;SLC8A1;ANK2;ATP1A2;DMD;RYR2
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.6593100639070568,1.0515330257006552,0.45098039215686275,0.8515180407552814,1.0,4/6,27.62%,RELA;PNPT1;ZSWIM8;NFKB1
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.5473814348785125,1.051472243695392,0.3673469387755102,0.8512354201271505,1.0,6/17,19.07%,BMI1;RYBP;RNF2;BCOR;PCGF5;PCGF1
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.6512789651815283,-1.0513496520563324,0.41304347826086957,1.0,1.0,6/7,33.41%,PINK1;TOMM7;MFN2;PRKN;OPTN;HDAC6
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),0.6384258463350767,1.0513495990674369,0.47540983606557374,0.8511174420743753,1.0,1/7,6.65%,ELAPOR2
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.6490325915921902,-1.051291496960324,0.42857142857142855,1.0,1.0,1/5,11.32%,AR
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.6490325915921902,-1.051291496960324,0.42857142857142855,1.0,1.0,1/5,11.32%,AR
prerank,GO_Biological_Process_2021__regulation of sequestering of zinc ion (GO:0061088),0.7004685904912102,1.051227407304945,0.42857142857142855,0.8510064335774047,1.0,2/5,20.15%,SLC30A4;SLC30A2
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.5314333487011271,1.0510607877704452,0.37777777777777777,0.8510049875775699,1.0,4/26,9.81%,LGALS9;SDC4;SCRIB;BTN2A2
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.5820164162559501,1.0510442502171509,0.375,0.8505865085142181,1.0,5/12,31.08%,ABL2;ABL1;EDN1;PDP1;PDP2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.6454306414082059,1.0510299984561753,0.5909090909090909,0.8497167377020226,1.0,6/7,34.15%,EXOSC4;EXOSC5;EXOSC2;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.6454306414082059,1.0510299984561753,0.5909090909090909,0.8497167377020226,1.0,6/7,34.15%,EXOSC4;EXOSC5;EXOSC2;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.5525751660936045,-1.05072873564796,0.47368421052631576,1.0,1.0,1/15,4.15%,CMTR1
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.46080182033488226,-1.050266305363392,0.3559322033898305,1.0,1.0,10/69,9.14%,SELP;SELE;XCR1;NMUR2;P2RY11;BTK;GPR143;CAMKK2;P2RY12;TPCN2
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.6036692354571452,1.0501029294126905,0.4727272727272727,0.8516954444857795,1.0,1/10,1.59%,PLD6
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.6259157167827578,-1.0500953091596923,0.375,1.0,1.0,2/6,14.60%,DNAAF1;AHI1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.3976041436708872,1.0500451846164314,0.35714285714285715,0.8513457086051761,1.0,33/169,16.03%,GRM3;PMP2;GFAP;HEPACAM;MYRF;NDRG2;OLIG1;OLIG2;ST18;DPY19L1;NRXN1;GAMT;TF;NTSR2;SYNPR;DSCAML1;GRM5;PTPRT;LRRTM3;GPR62;ATP1A2;ANLN;FAM163B;GPM6B;FASN;GABRG1;SLC39A12;MOBP;DLG2;GPR37;GPRC5B;CNTN2;GJB1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.5209928294195084,1.0499474457847788,0.3584905660377358,0.8510986212748063,1.0,9/21,30.46%,NAV3;HDGFL3;MID1IP1;CAMSAP2;ARHGEF2;CIB1;FGF13;CLASP2;CLASP1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5682247360326517,-1.0498606618747661,0.45454545454545453,1.0,1.0,2/10,13.62%,PRKCD;CYP1B1
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.4241926538732166,1.0497464454433494,0.34615384615384615,0.8511516508273913,1.0,44/225,17.26%,FGF10;SEMA5A;LGR5;LRP4;ZEB2;BMP2;MLLT3;DKKL1;NRARP;WWTR1;GPC5;PPM1A;CDK14;RNF146;LATS1;KANK1;PSMD13;IGFBP6;SCEL;TBL1X;DACT3;TLE2;GREM1;RBMS3;PSME4;PRICKLE1;PTK7;DVL2;TMEM170B;LRP6;FZD4;PTPRU;CSNK1G3;FRAT1;FZD6;BAMBI;LGR6;FRZB;GPRC5B;PSMA1;UBR5;CTNNB1;KLHL12;RUVBL2
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.40833428553563533,1.049451599514007,0.35135135135135137,0.8514906975861745,1.0,30/127,12.58%,CXXC4;LSAMP;LRRC4C;EFNA5;CADM2;MAFB;NPY;SLC17A6;ROBO2;SCGN;PCDH17;UNC5D;NRXN1;PLPPR1;RAB3C;PAX6;NOVA1;CD40;CASR;FGF12;RIPPLY2;PTPRT;ADGRB3;PAK5;TMEM196;NOL4;KCNB2;CNTN1;PROX1;UBE2QL1
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),0.442135012110868,1.0492501013996762,0.36363636363636365,0.8515843092800491,1.0,10/73,20.95%,CDC20B;FBXO5;ANAPC16;PSMD13;PSME4;PSMA1;FZR1;UBE2D1;UBE2E1;PSMD4
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.48023174377561867,-1.04910119190556,0.39285714285714285,1.0,1.0,3/46,2.36%,H1-3;H1-4;H1-2
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.48893149228097854,1.0487331592490443,0.34615384615384615,0.8524466806627421,1.0,13/44,16.70%,CDH20;CDH7;CDH6;CADM2;CDH2;CDH12;NECTIN2;CADM1;CDHR3;CDH10;CDH8;CDH24;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.4764765922833063,1.0487011510428934,0.34146341463414637,0.8520772561948483,1.0,6/50,7.75%,SYK;MYC;SIRT1;F2R;HTRA2;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.6466881834249687,1.0484963577088129,0.4727272727272727,0.8521228311454352,1.0,3/9,20.10%,TERF1;TP53;POT1
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),0.6207788400086217,1.0480519421862775,0.46153846153846156,0.8528748581564909,1.0,1/11,0.30%,ZDHHC11
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5812948966367364,1.0478117303122327,0.5344827586206896,0.8530218088564525,1.0,4/11,19.87%,PRKG1;MEF2C;DOCK4;DOCK5
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.4500074659130681,-1.047730528768521,0.38181818181818183,1.0,1.0,7/54,9.36%,RFX6;CELA2A;ALOX5;PER2;HFE;KCNJ11;KCNA5
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.42062920497703027,1.0471903516142127,0.3469387755102041,0.8542815244606508,1.0,47/154,21.92%,IRGM;IRS1;URI1;INSIG1;BRINP3;RORB;NRIP1;RORA;RELA;ESR1;WNT9A;TICAM1;NLRP7;EPHA3;HTRA2;HMGB1;RAMP3;CRHBP;ABL2;ATP1A2;NR1H3;MEF2C;PDE4B;MAPK8;IRAK1;PTK7;CREB1;FZD4;NCOA3;RORC;RET;RUVBL2;WNT2;LCOR;SSTR1;NR3C1;LYN;CX3CR1;TICAM2;AXL;ADNP2;ZFP36;CARD16;TNFSF4;TNIP3;GNAI1;PID1
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.41172735711538333,-1.0468391811865463,0.3076923076923077,1.0,1.0,6/205,2.29%,CD44;NTRK1;CD24;TEK;FGF1;IL11
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),-0.6094104184875997,-1.0467309319822549,0.425,1.0,1.0,1/6,5.40%,PAH
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.4544169222701401,1.046672086648244,0.3684210526315789,0.8552075672172097,1.0,19/73,16.56%,F2R;CDH20;CDH7;CDH6;CADM2;CDH2;CDH12;SDK1;MARVELD3;NLGN4X;DSP;NECTIN2;CADM1;CDHR3;CDH10;CDH8;CDH24;PKP4;GJC1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.640676781509538,-1.0466379017514913,0.4318181818181818,1.0,1.0,5/7,29.73%,PINK1;MAPT;HAX1;PRKN;ATP5IF1
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.539137437978463,1.046376173281874,0.38181818181818183,0.855664886295242,1.0,1/22,0.38%,LGALS9
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 7 signaling pathway (GO:0034155),-0.6980713059641621,-1.0463625828679575,0.45,1.0,1.0,1/5,11.08%,TASL
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),-0.6980713059641621,-1.0463625828679575,0.45,1.0,1.0,1/5,11.08%,TASL
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.63678536602274,-1.046309557446456,0.5,1.0,1.0,2/7,3.43%,DDX11;PRKCD
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.5170938919475473,1.0462020187051662,0.43137254901960786,0.8557897302793235,1.0,7/28,20.83%,MAP3K11;ZNF675;NPPA;DVL2;PPEF2;EDN1;HIPK3
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.6230855795044756,1.046116594547692,0.4444444444444444,0.8555826246833016,1.0,7/12,22.38%,ZFP36L2;LIG4;FADD;RAG2;RAG1;MR1;PTPRC
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.5147400695807638,1.046088780318302,0.4230769230769231,0.8552268361372511,1.0,9/40,14.46%,HRH3;PCLO;SYT1;NRXN1;SNCA;LIN7A;GRM4;HSPA8;PPFIA3
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.49374552177961945,-1.0460430329549804,0.375,1.0,1.0,6/39,10.00%,TRIM56;IRF5;FLOT1;OAS3;OAS1;DHX58
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.6279533871390397,-1.0460394503778692,0.40476190476190477,1.0,1.0,2/7,11.97%,ADCK1;VAT1
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.6205609429687624,-1.0458485063264717,0.45,1.0,1.0,5/14,17.00%,DUOX1;VGF;KCNJ11;RYR1;STAT1
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.6850070365563159,1.0456832666490397,0.5098039215686274,0.8560078863732523,1.0,2/7,20.86%,BCL3;CARD16
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.5585397364606866,1.0455079382476529,0.5272727272727272,0.8560105872586862,1.0,2/14,13.31%,COQ10A;FDXR
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.5773736739169816,1.0454364196358696,0.43137254901960786,0.8556956802169652,1.0,8/15,30.19%,CORO7;AP1AR;KLHL20;MON2;VPS13A;EPS15;GBF1;KIF16B
prerank,GO_Biological_Process_2021__cellular water homeostasis (GO:0009992),-0.6593167407968202,-1.0454017046451933,0.4523809523809524,1.0,1.0,5/5,34.09%,AQP1;SCTR;AQP11;AQP4;CLN3
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.4773310419968445,-1.0453681392067944,0.39215686274509803,1.0,1.0,2/36,2.46%,DND1;ZC3H12D
prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.42147212649359006,1.0453606053680211,0.3469387755102041,0.8554418901701685,1.0,23/137,11.11%,KLRD1;F2;STAB1;CCL5;F2R;IL4;HIF1A;ICOSLG;CDKN2A;IL2RA;IRF8;HCLS1;ACVR2A;TLR2;ST8SIA4;IL15;CD40;ELF4;ACHE;BCAT1;TAP1;GALNT1;HLA-E
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.5452545290071729,1.0453441435991522,0.40384615384615385,0.8550128548334645,1.0,8/29,12.47%,LGALS9;SYK;IL4;PLCG2;VSIR;HMGB1;IL23R;CD34
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.37208798537110516,1.0453203140983987,0.3148148148148148,0.8545842699275602,1.0,107/446,21.16%,STK26;FLT1;MAP3K11;FGFR3;SYK;PRKG1;TGFBR1;FGFR1;CCNA2;ERBB4;CDK11A;GDF6;CDK18;BMP2;DAPK2;TNIK;ACVR2A;STK33;ABI3;RIOK2;MAPKAPK2;TLR2;ERG;MAP2K6;FAM20A;PDGFRA;DYRK2;PPP4R1;RPS6KA4;FER;EPHA3;MAP3K9;MEX3B;SMG1;IP6K3;CDK14;ABL2;EPHA8;LATS1;MAPKAPK3;FRK;SMAD2;MAP3K21;FASTK;MAP4K2;RPS6KA2;FLT3;NIM1K;PAK5;STK32B;BMPR1A;VRK2;CHEK2;MAPK8;IRAK1;CDK12;IGF1R;STRADA;ACVR1B;CREB1;RPS6KA1;DYRK1A;CCNH;IKBKE;CSNK1G3;MAP3K1;NEK7;RICTOR;HIPK1;SGK1;PRKAA1;PIK3CD;MAPK10;DYRK3;LIMK2;PKN2;PXK;RPS6KA5;CDKL5;IRAK3;RET;CDK4;MAST1;STK38L;ZAP70;ADAM10;KIT;PRKACB;AKT3;ABL1;FAM20B;WNK1;BMPR2;LYN;PIM2;ERC1;EPHB4;CDK16;PDK1;IKBKB;HIPK3;PASK;STK36;STK32C;CDK8;CILK1;MAPK3
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.6847112333787287,1.0448768962619088,0.4375,0.8552957648476331,1.0,2/5,20.82%,UBE2E2;UBE2E1
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.6714132439630798,-1.0448371957962677,0.52,1.0,1.0,1/7,5.75%,KMT2B
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.641288569604634,-1.0446523001700194,0.5,1.0,1.0,3/10,5.62%,XYLT2;CHST9;XYLT1
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),-0.594262952642299,-1.0446332768472502,0.4528301886792453,1.0,1.0,1/14,1.22%,ABCA4
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.4483062599997799,1.044473212069544,0.37037037037037035,0.8559930339002542,1.0,12/81,11.21%,SIPA1;ARHGAP24;TBC1D3L;TBC1D8B;TBC1D12;CCDC125;SYDE2;SCRIB;CORO1C;ARHGAP45;ARHGAP25;ARHGEF16
prerank,GO_Biological_Process_2021__tongue development (GO:0043586),0.6746352157780912,1.0443293228570776,0.46,0.8559620511367356,1.0,1/5,4.40%,SIX4
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.5133647033327331,-1.0441827502900192,0.41818181818181815,1.0,1.0,6/29,9.98%,RTF1;COL4A2;LAMB3;LAMB1;NODAL;MMP9
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.664509854677807,1.043945996036567,0.4358974358974359,0.856570714568386,1.0,2/8,19.23%,SMG1;MLST8
prerank,GO_Biological_Process_2021__response to interleukin-4 (GO:0070670),-0.6480947566826538,-1.043922367205074,0.48,1.0,1.0,1/5,12.89%,TCF7
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.5883541984947739,-1.0436068694628136,0.4146341463414634,1.0,1.0,6/10,24.08%,COPS7A;COPS7B;COPS6;COPS3;COPS8;COPS5
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.6819521856120028,1.0435388462143091,0.4489795918367347,0.8572325746653238,1.0,4/6,29.10%,NOC2L;IRS2;BCL10;FOXP1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.4979235996904533,-1.0435251600800168,0.40816326530612246,1.0,1.0,3/23,14.25%,RAC2;CLRN1;RAC1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.5037640623423753,-1.0435091640052265,0.391304347826087,1.0,1.0,8/38,17.41%,CLDN4;CLDN1;F11R;CLDN15;CLDN16;CLDN5;MARVELD2;CLDN20
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.6734360263869388,1.043471466327507,0.4107142857142857,0.8565308320250686,1.0,1/5,18.57%,KMT5B
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.6734360263869388,1.043471466327507,0.4107142857142857,0.8565308320250686,1.0,1/5,18.57%,KMT5B
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.6050038145687103,1.0434541994727422,0.46296296296296297,0.8561301207108197,1.0,4/10,13.52%,ABHD17B;ABHD17C;ABHD10;LYPLA1
prerank,GO_Biological_Process_2021__positive regulation of dopamine receptor signaling pathway (GO:0060161),-0.6696471272443048,-1.0433879146164904,0.4791666666666667,1.0,1.0,2/5,15.76%,CAV2;VPS35
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.46246037182403193,1.0431996424857273,0.40384615384615385,0.8563610557779625,1.0,4/42,13.43%,CTDNEP1;CHMP6;BIN1;IRAG2
prerank,GO_Biological_Process_2021__extracellular exosome biogenesis (GO:0097734),0.743363029459058,1.0430651514820242,0.4915254237288136,0.8563501291327482,1.0,2/5,12.47%,RAB27A;CD34
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),-0.6668131822988489,-1.042722150488578,0.5128205128205128,1.0,1.0,2/8,1.23%,TEK;NUPR1
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.5359619078627245,-1.0425012849347282,0.4375,1.0,1.0,3/20,4.62%,KCNMB2;SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.6380379878425086,-1.0423745891541043,0.58,1.0,1.0,3/7,8.19%,SFRP1;CARTPT;UBASH3B
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.4382483832684004,1.041636499135553,0.3269230769230769,0.8600488365140344,1.0,19/74,21.22%,SEMA5A;DCC;LLGL1;NEFH;DSCAML1;CTNNA2;VASH2;NTNG2;KLF7;GRM7;NREP;L1CAM;CNTN4;ZDHHC17;PLP1;SLITRK5;CAMSAP2;PARD3;SLITRK6
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.6162003545514627,1.041461042971705,0.5094339622641509,0.8596345033258339,1.0,1/9,1.70%,ACE2
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.6162003545514627,1.041461042971705,0.5094339622641509,0.8596345033258339,1.0,1/9,1.70%,ACE2
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.3960456119667851,1.0414080868601616,0.3877551020408163,0.8593071021539678,1.0,22/112,20.95%,PRR5L;ZFP36L2;SAMD4A;MAPKAPK2;MOV10;ZC3HAV1;PSMD13;HNRNPD;EXOSC4;ANP32A;HSPB1;XPO1;HSPA8;PSME4;CNOT8;PSMA1;FMR1;EXOSC1;CSDC2;PNPT1;ZFP36;PSMD4
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.5801569753163632,1.0413737564539975,0.44642857142857145,0.858953265213124,1.0,3/14,6.66%,F2;PRKG1;PDGFRA
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.48547462810205483,1.0412980018389637,0.44680851063829785,0.8587135388702506,1.0,7/35,18.54%,H2BC21;ASF1A;ASF1B;H2AX;ANP32B;PADI4;H3-3A
prerank,GO_Biological_Process_2021__type B pancreatic cell development (GO:0003323),0.6707391595123274,1.0410606759848744,0.44642857142857145,0.858908732393599,1.0,1/6,3.87%,CDH2
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.4637574593458377,-1.0409548339618084,0.38461538461538464,1.0,1.0,11/82,12.99%,NTRK1;PM20D1;CD200R1;CRLF1;FOXQ1;KDM2B;WFS1;TYRO3;FGF20;NRBP2;PTK2B
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.5622634825486836,-1.0407749570223763,0.37209302325581395,1.0,1.0,3/17,3.71%,SELP;CELA2A;TEC
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.4615388798430377,1.0406424847404978,0.37735849056603776,0.8595983211173651,1.0,13/62,9.16%,GPR55;RIT2;F2R;GPR174;EPS8L2;CCDC125;KANK2;GPR17;EPS8;ABCA1;DLC1;ABL2;KANK1
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.6403099859225013,-1.0406353077434158,0.4318181818181818,1.0,1.0,1/12,0.37%,ACTC1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.6974576490384803,1.040548155762973,0.49019607843137253,0.859338592442911,1.0,1/5,6.73%,UNC13B
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.5692013444466001,1.040475505060614,0.4339622641509434,0.8590457495392997,1.0,7/21,23.57%,RUNX1;KLF7;ERRFI1;CTSV;MAFF;ZFP36;BMP4
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.648060616851086,1.0404069252731243,0.45652173913043476,0.8587732307763389,1.0,5/10,13.84%,NRG1;SPX;VAMP3;NR1H3;CD74
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.4720110843146733,1.0403251618851106,0.39622641509433965,0.8585210045129175,1.0,12/56,17.56%,HSD17B2;BRINP3;RORB;WNT9A;EPHA3;HTRA2;ABL2;PTK7;CREB1;FZD4;RET;WNT2
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5701439757022777,1.0403127524263505,0.47540983606557374,0.8581090456664254,1.0,5/18,11.09%,TGFBR1;HIF1A;DNAJB2;DCUN1D1;WASHC1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.5294480607186461,1.0399130833537693,0.35185185185185186,0.8586703076043826,1.0,4/23,19.23%,PRR5L;SMG1;RICTOR;MLST8
prerank,GO_Biological_Process_2021__glycerol-3-phosphate metabolic process (GO:0006072),-0.6661651675612374,-1.03989351008926,0.5283018867924528,1.0,1.0,1/5,21.52%,GK5
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.4572046662464505,1.0398390266375563,0.42,0.8583852291406946,1.0,19/62,18.37%,IL17RD;TGFBR1;SNAI1;BMP2;WWTR1;EPHA3;SMAD2;EZH2;LOXL2;SMAD4;PTEN;GREM1;BAMBI;PHLDB2;CRB2;VASN;CTNNB1;EFNA1;PHLDB1
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.4681870972324969,1.0397047373567272,0.32142857142857145,0.8582934719499689,1.0,8/60,12.35%,TNFSF14;LGALS9;RELA;TLR2;PPM1A;TSPAN6;CPNE1;IRAK1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.5348685538530594,1.0396003004201335,0.43137254901960786,0.8581020203849948,1.0,7/22,19.69%,TGFBR1;BMPR1A;LRP2;HEY2;VEGFA;JAG1;BMPR2
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),0.5725679024443708,1.0395666420342269,0.40816326530612246,0.8577245897986356,1.0,10/22,18.40%,GPR55;IL4;MAFB;ZNF675;IL23R;LRRC17;GPR137B;FBN1;CSF1;TMEM178A
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.5102057195577049,1.0394939166551853,0.4576271186440678,0.8574937559002128,1.0,5/33,5.99%,FGF10;MYC;FGF2;BMP2;NRARP
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.6115561632000872,1.0394344184364552,0.4528301886792453,0.857176810560838,1.0,1/10,1.94%,SIRT1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.5687308198220543,-1.0393456522825637,0.4074074074074074,1.0,1.0,1/14,1.90%,ENTPD2
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.6215909037919841,1.039308094537915,0.46,0.8570394423766549,1.0,1/10,2.87%,PPARG
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),0.6451903110314381,1.0391851871598414,0.4634146341463415,0.8570083832536453,1.0,2/10,3.71%,TYR;HPD
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),0.6900335857739793,1.0391030987048873,0.4807692307692308,0.8568248195461435,1.0,1/5,3.02%,ICOSLG
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.45276617249905404,1.0386100775197435,0.38095238095238093,0.8575694502093242,1.0,7/58,10.80%,CWH43;ZDHHC12;GLUL;ZDHHC22;PIGQ;ZDHHC2;PIGF
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.38931606515731887,1.0385987428062502,0.391304347826087,0.8571671552443564,1.0,37/131,23.32%,RAPGEF3;FZD5;PRR5L;TCAF2;TENM1;HCLS1;PCM1;HDAC3;HTRA2;UBE2D3;RHOU;ZDHHC2;TP53BP2;MAPK8;UBE2J2;PPP3CC;ZFAND1;ANP32B;RAB29;BAP1;UBR5;TP53;CD81;MFF;TRIM28;ITGB2;BAD;SAR1A;ZIC1;PPP1R13B;MYO1C;GAS6;SREBF2;AKT2;ITGAM;GTSE1;SAE1
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5729364745324885,1.0384823156707241,0.5102040816326531,0.8570367676711639,1.0,12/18,38.65%,RIDA;DXO;YTHDF2;MEX3D;PUM1;YTHDF3;YTHDF1;CELF1;METTL16;ROCK1;GIGYF2;FTO
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.6701355853864177,-1.0383667092128357,0.5,1.0,1.0,2/5,10.43%,HMGCL;MCCC2
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.5923899628939607,-1.038275040764587,0.42592592592592593,1.0,1.0,1/9,0.91%,TRIM56
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.4757593212413351,1.037927676890599,0.35555555555555557,0.8581573858382145,1.0,14/47,10.71%,HPSE2;HS3ST5;HS3ST3B1;B3GAT2;HS3ST1;UGDH;HS3ST2;SDC4;HPSE;GPC5;HS2ST1;GPC4;EXT1;SLC35D2
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.5687291455559316,1.0379026407397254,0.4074074074074074,0.8578017141553531,1.0,2/13,11.51%,RENBP;CHST6
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.682297647502092,1.0378548247716681,0.49206349206349204,0.8574926892992576,1.0,1/6,16.47%,CLC
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.5303430338999513,1.0377589502168703,0.43137254901960786,0.8572632801172263,1.0,7/26,20.65%,HIF1A;HDAC2;ADRA2C;GREM1;NCOA3;HDAC1;EDN1
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.5791672592302085,1.03727572531065,0.40816326530612246,0.8580314259929288,1.0,2/14,9.65%,HS3ST5;NECTIN2
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.43330472300300876,1.0371960535136309,0.4222222222222222,0.857808577135174,1.0,22/95,20.02%,MYC;SIRT1;ZBTB1;KAT2B;ESR1;HDAC2;ACTL6A;SMARCD3;ARID1A;MYB;ARID1B;SMARCAD1;SMARCD2;HCFC1;PADI4;SMARCA2;RUVBL2;KDM6A;KDM5B;NPM3;SATB2;HDAC1
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),-0.6587680093984919,-1.0371597840028186,0.5192307692307693,1.0,1.0,1/5,1.10%,SCN5A
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.4925075502447042,1.0368366405207312,0.39622641509433965,0.858331529085058,1.0,8/27,17.47%,LHFPL2;GLRA1;APELA;PLA2G10;HYAL3;ACVR1B;PLCB1;VEGFA
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.4406216433760608,1.036821807967576,0.35555555555555557,0.8579504845997693,1.0,18/67,28.64%,KAT2B;JADE3;ACTL6A;EPC1;KAT6A;TAF5;RUVBL2;SUPT3H;NAA50;CPA4;ING3;EP300;ZZZ3;MSL3;KAT6B;BRPF1;ATF2;PHF20L1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.4474287240826562,1.0366077171554784,0.45454545454545453,0.8581234930085183,1.0,10/64,6.15%,GPR55;ADRA1A;DRD5;CHRM2;F2R;GPR174;OPRK1;GPR17;GPR33;ESR1
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.6378372742725685,1.0365369928932948,0.43636363636363634,0.85793399303692,1.0,1/7,1.82%,CCL5
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),-0.6523375774357466,-1.0363291396119227,0.47058823529411764,1.0,1.0,2/5,22.70%,ACOT4;SUCLG2
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.6113984458064471,1.0362680288618862,0.45901639344262296,0.8581924306366442,1.0,3/11,22.25%,ITGAV;CTNNB1;GRB2
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.5021766065137879,-1.0361922649848667,0.32,1.0,1.0,3/27,4.85%,UMODL1;CXCL13;UMOD
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.5795769312531814,-1.0361900280458163,0.4423076923076923,1.0,1.0,3/19,9.26%,NUPR1;FLOT1;CDC37
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.41248771972153614,-1.0361431108503714,0.35294117647058826,1.0,1.0,13/91,12.10%,SIGIRR;TEK;NLRP3;MEFV;ALOX5;PRKCD;DRD2;TRIB1;DHX58;CCN3;APOA1;TYRO3;FFAR4
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.3727514019873476,1.0360791499521549,0.30434782608695654,0.8582531708651151,1.0,47/303,12.98%,ADRA1A;SMAD6;CDKN2C;MYC;IL26;F2R;ERBB4;GNRH1;KAT2B;PPARG;CDKN2A;BMP2;TENM1;ST18;KANK2;DUX4;SMYD2;CCN6;SSTR3;DNAJB2;WNT9A;TP53INP1;P3H2;TOB1;MARVELD3;DLC1;RNF139;CBFA2T3;MTSS1;ARID2;PTPN14;MAGI2;TMEM115;TMIGD3;FRK;IGFBP6;PLXNB1;RPS6KA2;ITGA1;PTPRK;NCK2;PROX1;PTEN;H2AC6;CTBP2;GREM1;MAGED1
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.42270713868060494,1.0355564085699562,0.32727272727272727,0.8592939295706273,1.0,15/91,9.37%,SYK;ESRRG;ZBTB7B;IL4;TRPM8;SCD;TRPV2;ADIPOR2;PRKAB2;PLAC8;HDAC3;ACHE;PDGFC;KDM3A;LEPR
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),0.6522175697472071,1.0354531936646163,0.5098039215686274,0.8591436647813798,1.0,3/8,20.89%,GLUL;CPS1;GLUD1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.5306877084512497,1.0349047995187706,0.38461538461538464,0.8599857741503962,1.0,3/21,11.67%,TUBA1C;CCDC88B;DYNC1I2
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.6023102892632686,-1.0348635528650378,0.5,1.0,1.0,4/8,16.97%,IL11;ZFPM1;MED1;ZNF385A
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.6027662463697303,1.034601018804167,0.5333333333333333,0.8603344499752723,1.0,3/12,3.04%,RAPGEF3;IL4;EHD1
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.4432757893427409,-1.0345588659937341,0.41509433962264153,1.0,1.0,17/86,9.27%,P2RY10;TBC1D10C;SELL;SP140;TRAF3IP3;CD53;CYTH4;CD86;ALOX5;LTB;ZBTB32;BTK;TAGAP;CD72;TMC8;LY86;PAX5
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.6245574905761777,-1.0341454133196715,0.45098039215686275,1.0,1.0,3/8,26.73%,DCN;RACK1;SRC
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.5703788423356946,1.034085833674887,0.4482758620689655,0.86120791243139,1.0,5/17,18.14%,WNT4;PRKCSH;PROX1;COBL;CITED2
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6343883312292646,1.0338667608209984,0.41509433962264153,0.8614178288108695,1.0,5/9,18.12%,IGF1;SOAT1;PLCB1;IL33;ABCA2
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.6368666821839073,1.0338220490566603,0.5333333333333333,0.8611160392367828,1.0,2/5,25.11%,VPS13A;VPS13D
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.6139267114470607,-1.0337875828377323,0.4489795918367347,1.0,1.0,2/11,10.78%,SLCO2A1;SLCO2B1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.4217317275406865,1.0335159410836259,0.3409090909090909,0.8614109935287938,1.0,27/137,12.81%,MXRA5;LAMA4;MRGPRF;ITGA8;PAWR;PRRX1;ADGRL4;BGN;CRIM1;CXCL12;LTBP2;POSTN;CCDC80;PDGFRA;FAM114A1;ABI3BP;PLSCR4;DLC1;PCDH18;MEDAG;NCOA2;TPM2;HMCN1;MEF2C;HTRA1;TBX18;NR4A2
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.38279724138649185,1.0334935577760733,0.27450980392156865,0.8610440060533193,1.0,37/256,14.80%,FGF10;SIPA1;CDC14A;UHRF2;CDKN2C;MYC;SIRT1;TGFBR1;CDC25A;CDK11A;KAT2B;CDKN2A;FBXO5;BMP2;DLGAP5;MAP2K6;TP53INP1;FBXL3;HTRA2;GMNN;INSM2;MAGI2;BIN1;RPS6KA2;PTPRK;PHACTR4;PLAGL1;TP53BP2;PROX1;PCLAF;MLF1;MLXIPL;PML;LRP6;SPATA22;BOP1;NEK7
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.5995924876448793,1.0334536662765035,0.38461538461538464,0.8607101303065393,1.0,4/8,22.43%,NFE2L2;HSPA5;DDIT3;EIF2AK3
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.5880855492181386,-1.0334316385419176,0.4117647058823529,1.0,1.0,3/14,11.15%,RPF2;DDX18;FTSJ3
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.5632327285547406,1.0333847295769116,0.4727272727272727,0.8604485810964915,1.0,1/17,0.86%,MAP3K11
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.4797178303779535,1.0332621444523047,0.38636363636363635,0.8603900660131475,1.0,7/43,15.37%,ZBTB7B;PPARG;BMP2;NAPEPLD;MEDAG;CREB1;FRZB
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.5054613946900638,1.033179784429528,0.4074074074074074,0.8601877838376726,1.0,6/29,15.66%,ZBTB20;LIN28A;UNC13B;IGF1R;MLXIPL;PRKAA1
prerank,GO_Biological_Process_2021__auditory receptor cell morphogenesis (GO:0002093),0.6960163752705897,1.0331033817419222,0.5217391304347826,0.8595030062225749,1.0,1/5,4.53%,WHRN
prerank,GO_Biological_Process_2021__auditory receptor cell stereocilium organization (GO:0060088),0.6960163752705897,1.0331033817419222,0.5217391304347826,0.8595030062225749,1.0,1/5,4.53%,WHRN
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.43781348304714895,1.0329635973432045,0.36,0.8594255074044018,1.0,14/114,11.30%,ZDHHC11;AP1M2;ZDHHC12;NLGN1;PEX12;GDAP1;LTBP2;ZDHHC22;TIMM22;RAB3IP;FBXO7;HAP1;ZDHHC2;ZFAND6
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.6717561631827749,1.0328767174783162,0.5094339622641509,0.8587360245716564,1.0,2/7,8.31%,ASF1A;ASF1B
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.6717561631827749,1.0328767174783162,0.5094339622641509,0.8587360245716564,1.0,2/7,8.31%,ASF1A;ASF1B
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.5289442459667932,-1.0328153788311385,0.4489795918367347,1.0,1.0,1/19,0.17%,TERT
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.4541079314655955,1.031652702592538,0.4074074074074074,0.8613769061495448,1.0,6/45,9.12%,SLC7A11;SLC38A3;SLC38A4;SLC7A2;SLC7A9;SLC25A48
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.6039040759692136,1.0314019912481398,0.35185185185185186,0.8616438767633001,1.0,7/12,23.87%,RORB;TULP1;RP1L1;VEGFA;ARL3;RP1;CEP290
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.6378663124578966,1.0310726923347124,0.4909090909090909,0.8620603317041904,1.0,3/9,12.51%,MYRF;PTEN;ABCD2
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.42442415797535354,1.0310414478474426,0.42592592592592593,0.8617019388457797,1.0,31/82,31.46%,AP1M2;LLGL1;CORO7;ACBD3;HSPA8;SORCS1;EXOC6;ARL3;RP2;KLHL20;MON2;SH3GL2;COMMD1;EXOC6B;VPS13A;CLVS2;HGS;PUM1;EXOC4;EPS15;MYO5A;FTL;GBF1;APP;SCFD1;VAMP8;KIF16B;ARRB1;AP4B1;DNAJC6;AP1G2
prerank,GO_Biological_Process_2021__epithelial tube formation (GO:0072175),-0.7074331253920416,-1.0309835215766459,0.5306122448979592,1.0,1.0,3/5,16.85%,PAX2;PODXL;FGFR2
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.4412183835325063,-1.0309426281012177,0.375,1.0,1.0,12/75,9.52%,CLEC4F;MPO;CD53;CYTH4;CD86;LILRB3;MS4A4A;HCK;SLC11A1;HFE;LY86;VDR
prerank,GO_Biological_Process_2021__mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337),-0.5747460242451052,-1.0305662547791505,0.475,1.0,1.0,3/5,22.46%,PAX2;PAX8;SMO
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.6223541644653632,1.030292091851807,0.41935483870967744,0.8633668047226655,1.0,1/7,10.17%,ADARB2
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.39870280021482046,1.0302840511485447,0.28846153846153844,0.8629431016041366,1.0,22/122,15.57%,CDC25A;CCNA2;NDE1;CEP70;PCM1;FBXL3;CEP152;CDK14;LATS1;DCTN3;CHEK2;CEP135;DYNC1I2;CNTRL;PPP1R12B;PHLDA1;NEDD1;FBXL15;CCNH;CCP110;PLCB1;TAF2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.49034266779829494,-1.0302106004878764,0.34,1.0,1.0,4/24,13.11%,SCN5A;DSG2;CTNNA3;CAV1
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.47275526339338303,1.0298321189115396,0.38596491228070173,0.863650463568122,1.0,7/31,18.04%,NLGN1;ABI3;PDLIM5;PTEN;DBN1;CAPRIN1;EFNA1
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.5379160128972441,1.0295872461371902,0.3541666666666667,0.8639154759296789,1.0,3/12,13.29%,SIRT1;SNCA;NOC2L
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.6328798270056033,1.0295395444779651,0.4716981132075472,0.863576525207204,1.0,3/6,23.08%,PCLO;ERC1;ERC2
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.6493859726608091,1.0295061667751897,0.4375,0.8632573809009483,1.0,3/6,21.62%,SLC3A2;SLC6A15;SLC7A8
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.6344153579971903,1.0293312845051559,0.4909090909090909,0.8633017073270578,1.0,1/6,9.15%,LMAN1
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.6133806854642692,1.0293273305184079,0.5087719298245614,0.8628858005705063,1.0,3/8,25.62%,ACHE;LIMD1;TNN
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.4177257128975015,1.0292786907905014,0.36538461538461536,0.8625480522060198,1.0,13/87,8.86%,SLC26A3;LAMA4;SEMA5A;LSAMP;BGN;SCGN;FREM1;ADGRG4;PDGFRA;MTTP;PTPRD;FGF14;MOGAT2
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5620836437042264,-1.0291736773351892,0.38636363636363635,1.0,1.0,7/14,23.78%,DMAC2L;ATP5F1A;ATP5F1E;ATP5ME;ATP5MC3;ATP5PB;ATP5F1B
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5077433778954135,1.0288910585699302,0.43137254901960786,0.8630005938161185,1.0,2/19,2.93%,HIF1A;NEDD4
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.42156925501710624,-1.0287719301736509,0.36538461538461536,1.0,1.0,10/98,8.72%,MS4A8;TERT;FAM3D;CAPN9;MYO5B;ITGA9;KCNQ1;OLFM4;HEPH;ZBTB7C
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.42044257661001005,1.0287537241014733,0.32142857142857145,0.8629155255229304,1.0,26/117,13.00%,MXRA5;MRGPRF;ADGRL4;GNG12;FRAS1;DOCK1;BGN;LRIG3;CXCL12;SDC4;POSTN;CCDC80;WWTR1;F3;FAM114A1;DPP4;PLSCR4;PRICKLE2;DSP;COBLL1;MEDAG;AOX1;HAS2;HTRA1;PXDC1;FZD1
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.4882178282823091,-1.0286875423871638,0.4146341463414634,1.0,1.0,7/34,17.93%,DDX11;TRAIP;RTEL1;NUCKS1;ZRANB3;ZGRF1;BLM
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5908889112145684,1.0286636407576168,0.43548387096774194,0.8626429569355418,1.0,1/14,3.72%,SYVN1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.4236756651071274,1.0286064306913774,0.37254901960784315,0.8623448016572044,1.0,24/109,14.77%,RIT2;RETREG3;ROR1;TOX;TENM3;ROBO2;GRIP1;CHODL;ZNF804A;FUT9;EPHA3;PTPRD;ABL2;MAGI2;PLXNB1;PLXNB2;CARMIL1;FZD1;RAP1A;LRRC7;PTK7;DVL2;FZD4;CAPRIN1
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),0.6621923239307109,1.028455813212853,0.48,0.8622537294059184,1.0,2/5,7.61%,HIF1A;CIAO3
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),0.5706206107242693,1.0283929691094642,0.4807692307692308,0.8619625281013406,1.0,1/12,2.62%,KCNK2
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.5779929150964942,1.0282131531398864,0.5,0.8620524929015492,1.0,7/14,21.27%,TDO2;HMGCS1;MVD;ACACA;ACACB;DIP2A;ACSS1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.6241088575045421,-1.028134322674604,0.4772727272727273,1.0,1.0,1/6,3.27%,ASS1
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.6460465386971954,1.0277425321275862,0.43636363636363634,0.8628843754152898,1.0,3/7,23.75%,RP1L1;ARL3;RP1
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.4457103922298043,-1.0275449806231494,0.38461538461538464,1.0,1.0,16/100,8.62%,SELE;NLRP1;GUCA1B;BST1;IL1RL2;ALOX5;SPAAR;PTGES;AHSG;PDE6B;TRIM5;CNGB1;PPEF1;HCK;NMT1;P2RY12
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.42132960778743017,-1.0272521025123604,0.3469387755102041,1.0,1.0,14/67,15.98%,TEK;NLRP3;MEFV;ALOX5;PRKCD;DHX58;CCN3;APOA1;TYRO3;FFAR4;MAPK7;TNFAIP6;VPS35;TRAF3IP1
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.5826586951599226,-1.0272378977953174,0.5098039215686274,1.0,1.0,2/10,10.52%,PARP2;PARP1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.500417572347093,1.027028374406164,0.4222222222222222,0.8643732217744344,1.0,14/30,34.15%,DCP1B;EXOSC4;CNOT8;EXOSC1;LSM2;PATL1;EXOSC5;DIS3;EXOSC2;LSM3;DCP2;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.4766444313857049,1.027019517914386,0.48214285714285715,0.8639590720188234,1.0,9/40,20.22%,SNAI1;WNT4;DKKL1;GCK;PROX1;CD34;AKR1C3;ABCA2;RAPGEF2
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),0.4702046019375084,1.0269803612745096,0.35294117647058826,0.8636033203217429,1.0,7/39,18.20%,RIOK2;TSR3;PWP2;RPS5;RIOK1;ERAL1;RIOK3
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.41993997290540125,1.0269732657467692,0.3695652173913043,0.8631770926410682,1.0,21/97,14.03%,CDH20;PMP2;SLC1A3;GFAP;NDRG2;GLUL;SLC8A1;NRXN1;NTSR2;RAMP3;CYP27A1;PLXDC2;SYNPR;GRM5;PTPRT;TMIGD3;RTN1;ATP1A2;BAALC;SLC39A12;SEZ6L
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.4703525034066384,1.0269366004440468,0.48,0.8628220888071686,1.0,5/51,9.14%,IRGM;TP53INP1;ATG101;STING1;RAB23
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.41213445340320026,1.0269203859880256,0.3559322033898305,0.8624224102584543,1.0,43/174,18.92%,SLC7A11;CCNG1;F2R;RRAD;CDKN2A;CDKN2AIP;EPS8L2;BMP2;CTSF;STOM;SP1;TCN2;HDAC3;DCXR;TSC22D1;TOB1;ADA;FOXO3;PTPN14;AK1;MAPKAPK3;TAP1;NHLH2;PLXNB2;IRAK1;TPRKB;FDXR;MXD4;IRAG2;ACVR1B;CCND3;CCP110;PHLDA3;SEC61A1;KRT17;SLC3A2;PERP;TP53;CD81;IER5;SLC19A2;CSRNP2;SAT1
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.4211811905825349,1.0263396340227453,0.3541666666666667,0.8635791068089662,1.0,27/103,15.75%,CXXC4;TSPAN12;FGFR3;HNF4G;C1QL1;CKMT1A;LRP4;EFNA2;PCLO;LRIG3;SLC7A2;MMP15;NRARP;MAGI1;PLXNB1;EFNB2;ONECUT2;CGN;JPH1;ARHGEF16;BCAR1;FAM222A;ID4;NR2F2;TMEM54;COBL;CPE
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.641176331986403,1.0261324575252206,0.4807692307692308,0.863744975696392,1.0,2/7,10.58%,MYC;FOXO1
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.683571584369286,1.0260600423435877,0.49122807017543857,0.8634096673854137,1.0,3/6,19.20%,RENBP;NPL;GNPDA2
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.4859711441284571,1.0257341479361646,0.38,0.8639478160650341,1.0,5/27,8.98%,IGF1;FGF10;ITGAV;ERBIN;SHOC2
prerank,GO_Biological_Process_2021__androgen biosynthetic process (GO:0006702),-0.6704224614198606,-1.0257319464724615,0.48936170212765956,1.0,1.0,3/6,16.18%,HSD3B2;HSD3B1;MED1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.49620164964061203,1.0254948867446547,0.4444444444444444,0.8641902541588625,1.0,5/37,8.96%,F2;PYHIN1;GLUL;WWTR1;LATS1
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.3537498263856139,1.0252275772224673,0.2857142857142857,0.8644837591595647,1.0,153/787,18.28%,DACH1;MITF;AASS;TIMELESS;RUNX1;MYC;SIRT1;ZBTB7B;TSHZ3;IL4;URI1;ZBTB1;FOXP2;NRG1;PPARG;SNAI1;SFMBT2;MDFIC;ZEB2;WNT4;CDKN2A;RORB;BMP2;BMI1;NFIL3;NRIP1;SIX4;ZNF582;ZGLP1;KANK2;IRF8;VSX2;SMYD2;RBPJ;RELA;ZEB1;ZBTB2;ESR1;ZNF599;ZNF706;HDAC3;PAX6;HDAC2;NCOA5;MYPOP;UBE2D3;HMGB1;PPM1A;ZNF274;SNCA;GMNN;FOXO3;ATXN1;TFEC;CBFA2T3;YAF2;ZNF202;INSM2;RIPPLY2;TAF3;ZNF675;SPINDOC;NPAS1;FRK;SMAD2;EZH2;MAGEL2;ZNF669;LOXL2;ZNF692;ZNF239;FOXO1;MBTD1;PTPRK;TBL1X;PASD1;NR1D2;PHF21A;SP3;SMAD4;DPF1;NR1H3;MEF2C;ZNF536;PROX1;ZNF175;CTBP2;ZNF778;TLE2;ZNF281;MYB;ATF7IP;NR4A2;DPF3;HSPA8;RNF2;KLF7;HEXIM2;NOC2L;MXD4;MYT1L;ZNF20;ID4;ZBTB33;MLXIPL;PRICKLE1;PML;WWOX;RARB;CREB1;ZNF639;BCOR;RUNX1T1;NR2F2;ZNF263;EPC1;KAT6A;POU2F1;THRB;PLCB1;HJV;HCFC1;SPEN;TRPS1;DEAF1;MESP1;BAP1;SIRT6;PEX2;HEY2;BCL3;CNOT2;CTNNB1;MTERF3;SMARCA2;RPS6KA5;FOXN3;RORC;IL33;SIRT7;VEGFA;TGIF1;MXI1;LCOR;TP53;MAZ;MIER3;MAF1;EFNA1;CITED2;EED;ZNF12;PSPC1
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.6652081823489322,1.0251801833702732,0.5,0.8641551617311181,1.0,4/8,23.37%,PROX1;GRID2;CBLN1;CEND1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.61896539547652,-1.0251383467191713,0.42105263157894735,1.0,1.0,2/9,18.29%,CLTA;AP2A2
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.61896539547652,-1.0251383467191713,0.42105263157894735,1.0,1.0,2/9,18.29%,CLTA;AP2A2
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.5307545274629316,1.0250062666709285,0.40384615384615385,0.8641472525776568,1.0,9/20,22.38%,F2R;FGF2;PLCG2;HTR2C;TRPM2;RYR2;RYR3;HTR2A;PTPRC
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.42584698987479996,-1.0249473255190473,0.3617021276595745,1.0,1.0,28/102,13.28%,ALB;ASS1;CYP2E1;HABP2;F7;UPB1;HSD11B1;SLC22A8;SLC9A8;CRYL1;PAH;TGFBI;CYP4F2;SLC13A3;NOX4;GNG13;HAO2;SLC22A6;CACNG5;PRODH2;APOB;SMLR1;SLC5A1;C3P1;SLC22A1;SLC36A2;BHMT;SLC4A4
prerank,GO_Biological_Process_2021__hyaluronan biosynthetic process (GO:0030213),0.6475197277769331,1.0249383603904745,0.4444444444444444,0.8639152105786413,1.0,1/6,11.68%,HAS2
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.48899484098427504,1.024731448519953,0.3018867924528302,0.8640034412732319,1.0,12/37,26.61%,SIX4;ROGDI;HAP1;MESP1;WNT2;ANXA1;TRAK2;RYK;CDK6;SPOCK1;BTBD2;CHAC1
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.6312092182988359,1.0245422062662173,0.5094339622641509,0.864110777068717,1.0,1/12,4.15%,MLLT3
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.5492410705453302,-1.024523504273436,0.48,1.0,1.0,5/15,9.36%,KCNE2;KCNN2;KCNE1;KCNQ1;KCNA5
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.4590490975519332,-1.0239786300644669,0.32653061224489793,1.0,1.0,13/64,8.11%,P2RY10;SIRPG;SELL;SP140;TRAF3IP3;CD53;CYTH4;LTB;CNGB1;KLRB1;CD5;TAGAP;TNFRSF4
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.5505901189251861,-1.0239228958588693,0.46938775510204084,1.0,1.0,1/18,1.79%,NLRP1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.5871555071320483,1.0239119298056696,0.45901639344262296,0.8652666979181491,1.0,3/12,14.07%,PCSK5;PDGFRA;RARB
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.5974150726603036,1.0237225838882202,0.46296296296296297,0.8652710382669109,1.0,2/13,9.14%,MDFIC;RAB23
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.4752544154896001,1.0235309191469073,0.4067796610169492,0.8653392553633146,1.0,3/36,5.54%,KAT2B;ROBO2;RBPJ
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.436014551797666,-1.0233178093569975,0.3898305084745763,1.0,1.0,13/72,8.25%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;CYTH4;LTB;KLRB1;ARHGAP15;CD5;TAGAP;TMC8
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.43045527530974015,1.0231632999473923,0.41304347826086957,0.8658224253141641,1.0,9/79,8.96%,CDKN2C;MYC;CDC25A;CDKN2A;CDK18;FBXO5;CDK14;BCAT1;LATS1
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.685180556026515,1.0227930061945592,0.4666666666666667,0.8662923519287218,1.0,3/6,13.71%,ROBO2;ALCAM;PTPRM
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.4298563275239051,1.0221557869564808,0.4090909090909091,0.8674953505838386,1.0,13/65,13.81%,SULT2A1;ACSM2A;SULT6B1;AMPD1;AK3;ENPP1;EFL1;GNAI3;RAB23;OXSM;ENTPD7;THEM5;TPST2
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.466781090495509,1.0220436535934676,0.37037037037037035,0.8673774414888408,1.0,8/33,12.82%,TCIRG1;ATP6V0D2;RAB38;RAB31;RAB39A;ATP6V0A4;RAB34;ATP6V0B
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.6652713884878168,1.0218076333248962,0.48,0.8670846518554917,1.0,1/7,19.37%,ATG2B
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.6652713884878168,1.0218076333248962,0.48,0.8670846518554917,1.0,1/7,19.37%,ATG2B
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.40897703364376997,-1.021728931652506,0.39285714285714285,1.0,1.0,15/123,8.82%,SELP;SELE;TRIM56;SIGIRR;IL1RL2;MEFV;IL18BP;IL6R;TNFRSF11A;TIMP4;CIITA;SLC11A1;CHI3L1;PTPN7;LAMP3
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),0.6711792251177249,1.0216467064071861,0.4838709677419355,0.8666524602544383,1.0,2/6,21.69%,NECTIN2;GAS6
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),0.6711792251177249,1.0216467064071861,0.4838709677419355,0.8666524602544383,1.0,2/6,21.69%,NECTIN2;GAS6
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.694547633957697,1.021248254237579,0.5208333333333334,0.8673111382641546,1.0,3/5,23.01%,HMGB1;CD74;MBP
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),0.6445474826458517,1.0210148791453255,0.5087719298245614,0.8673907220610673,1.0,1/6,2.47%,IL4
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),0.6136279319956399,1.0209330235280925,0.49019607843137253,0.8672033855936224,1.0,1/9,1.44%,GREM2
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.4516099780127538,-1.0202713290080025,0.525,1.0,1.0,7/53,13.17%,CELA2A;TPP1;CEACAM1;ADAMTS9;PRPF19;DAB2IP;DENND3
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.6040709248462472,1.0202591119219209,0.43103448275862066,0.8684577369195381,1.0,2/7,16.70%,CDH2;CTNNB1
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),0.6524085962214615,1.0202036858152852,0.49122807017543857,0.8681748521126598,1.0,1/8,3.67%,FBXO5
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.5877362679152209,-1.0201289836511134,0.43478260869565216,1.0,1.0,3/14,12.27%,KCNE2;KCNE1;KCNS1
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),-0.7166642000358027,-1.0196792114098039,0.543859649122807,1.0,1.0,2/6,15.90%,ALOX5;LTC4S
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),0.6672613040062925,1.0194573680109713,0.5306122448979592,0.8696875881810902,1.0,2/7,15.33%,ATPSCKMT;PPIF
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.5807751790109165,1.0193898318435548,0.48,0.869410716589825,1.0,3/9,17.47%,TENM3;LRP6;VEGFA
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.41404726470617936,1.0190859484961081,0.41379310344827586,0.8697869018633504,1.0,42/156,21.16%,HNF4G;ESRRG;KAT2B;PPARG;MED17;RORB;RORA;RBPJ;NR5A2;ESR1;TEAD2;WWTR1;HDAC3;CAVIN1;TAF3;TBL1X;NPPA;NR1D2;NR1H3;NR4A2;RARB;TAF1A;CCNH;TAF5;THRB;TAF2;NOTCH2;POLR1H;RORC;MNAT1;GTF2B;MAZ;HDAC9;NR3C1;CCN2;POLR2H;NR6A1;HDAC1;TAF4;TFB1M;NOTCH3;MAPK3
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.5426303615058827,1.0189204054868866,0.4339622641509434,0.869782641325016,1.0,1/17,0.48%,IGF1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),-0.6412170831654469,-1.018913556406364,0.5111111111111111,1.0,1.0,3/6,25.81%,HFE;TNFRSF14;TARM1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.5461594506818948,-1.0187263464154361,0.4318181818181818,1.0,1.0,3/11,12.00%,CD24;NPHS1;PODXL
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.4556380845021564,-1.018647034226262,0.4117647058823529,1.0,1.0,8/53,10.10%,KCNMB2;KCNE2;KCNJ16;KCNN3;KCNN2;KCNE1;KCNQ1;KCNJ15
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.49176892514569454,1.0185820026050483,0.41509433962264153,0.8702785705536784,1.0,5/22,18.09%,MED17;ESR1;PAXIP1;TP53;MED30
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.580551344833891,1.0185412112263812,0.47368421052631576,0.8699576548541539,1.0,2/9,7.41%,SMAD6;ABCA1
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.684500253083298,-1.018439532466841,0.5116279069767442,1.0,1.0,2/5,26.76%,ATP6V0A2;ATP6AP1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.6412244851448934,1.0182667329564843,0.5370370370370371,0.8702822285937617,1.0,6/7,35.40%,DDR2;CLASP2;MELTF;CLASP1;CARMIL2;PDPN
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.49316000140967065,1.0182149790600823,0.4603174603174603,0.8699995595206664,1.0,2/18,9.65%,HS3ST5;NECTIN2
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.4061333871610757,1.018156645456362,0.3953488372093023,0.8697424444381944,1.0,20/102,12.15%,LGR5;SLC35F1;LRRC4C;LRP4;CADM2;PCLO;VSX2;SAG;NEFH;ZDHHC22;UNC5D;MEGF10;TMEM200C;PAX6;STOX2;ANK2;PAK5;GRIK3;NOL4;ZNF536
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.5454063638928193,1.01806704402994,0.4772727272727273,0.8695676888329721,1.0,8/12,28.62%,FER;CD55;ENPP3;RPS19;LGALS3;APPL1;RC3H1;CD47
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.5982747309299365,-1.0178993210678688,0.5434782608695652,1.0,1.0,1/12,0.65%,KCNMB2
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.6285388129452194,1.017723894851553,0.5178571428571429,0.8700559493521179,1.0,2/9,1.81%,PNP;AMPD1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),0.5842977134687226,1.0177166223130258,0.5208333333333334,0.8696477523269506,1.0,2/9,2.47%,LGALS9;IL4
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.623033676763613,1.0176140389441657,0.5,0.869530059914164,1.0,4/8,16.97%,IL4;HMGB1;TMEM98;RORC
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.618386087461319,-1.0172558268795706,0.5111111111111111,1.0,1.0,2/8,10.89%,MFAP5;KDM2B
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),-0.7010581519191493,-1.0171474342674156,0.5510204081632653,1.0,1.0,1/6,3.27%,ASS1
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.365432803450498,1.017081138031201,0.4528301886792453,0.870446259612633,1.0,84/362,21.16%,STK26;MAP3K11;EPHA7;SYK;PRKG1;TGFBR1;FGFR1;CDK11A;CDK18;BMP2;DAPK2;TNIK;ACVR2A;MAPKAPK2;ERG;FAM20A;DYRK2;PPP4R1;RPS6KA4;FER;MAP3K9;MEX3B;IP6K3;CDK14;LATS1;PIK3CA;FRK;MAP3K21;FASTK;MAP4K2;NIM1K;PAK5;BMPR1A;VRK2;CHEK2;MAPK8;IRAK1;CDK12;STRADA;ACVR1B;CREB1;DYRK1A;IKBKE;MAP3K1;NEK7;HIPK1;POMK;SGK1;PRKAA1;PIK3CD;MAPK10;DYRK3;LIMK2;PKN2;PXK;RPS6KA5;DGKZ;CDKL5;IRAK3;RET;CDK4;MAST1;STK38L;ZAP70;ADAM10;PRKACB;AKT3;ABL1;FAM20B;WNK1;BMPR2;LYN;PIM2;LIMD1;DGKD;CDK16;PDK1;IKBKB;HIPK3;PASK;STK36;CDK8;CILK1;MAPK3
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.5986174142208148,1.0168897631124443,0.4528301886792453,0.8704984026700978,1.0,2/11,2.02%,SIRT1;RAPGEF3
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.5806257713539298,1.0168524940755728,0.5,0.8701852489473368,1.0,3/13,15.78%,RNF185;RNFT1;NFE2L2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.6508267949401981,-1.0167521812196836,0.46808510638297873,1.0,1.0,3/6,21.11%,FOXO4;FGFR2;MYOCD
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.43146512033674994,1.0167362431086462,0.3541666666666667,0.8701430549230782,1.0,16/71,15.08%,TGFBR1;GDF6;ZEB2;BMP2;ACVR2A;RBPJ;ELAPOR2;SMAD2;INHBC;BMPR1A;SMAD4;GDF9;ACVR1B;FBXL15;CRB2;KIAA0319
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.41740783241358637,1.0165564099158344,0.3409090909090909,0.8701952698236741,1.0,22/105,15.37%,MXRA5;LAMA4;MRGPRF;PRRX1;ADGRL4;BGN;CXCL12;POSTN;PDGFRA;FAM114A1;PLSCR4;MYH11;MEDAG;TPM2;SYNPO2;HTRA1;INTS6;ABCA8;TMEM98;FZD4;OLFML3;FRZB
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.4170536901814892,1.016342159525192,0.3584905660377358,0.8703291788907267,1.0,13/75,19.45%,RUNX1;LMO1;ZFP36L2;LMO2;PDGFRA;PSMD13;BMPR1A;MYB;PSME4;PSMA1;NELFB;ABL1;JAG1
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.5878662882884576,-1.0161709029459682,0.46808510638297873,1.0,1.0,1/11,1.47%,DOCK8
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.5451988969232823,1.016123090619974,0.4,0.870538377257637,1.0,3/21,3.50%,CDKN2C;SIRT1;CDKN2A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.6421521561586755,1.016013953078744,0.5178571428571429,0.8704018638796921,1.0,3/5,27.95%,FOXO1;LMNA;TRPC3
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.478554892560767,1.0159147163828957,0.49056603773584906,0.8701901373070295,1.0,6/24,24.45%,RALA;MCU;INF2;MFF;MARCHF5;MIEF2
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.4472255141079644,1.0157132119732197,0.3469387755102041,0.8702986840779234,1.0,3/39,3.40%,PADI2;NDRG2;GNB4
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5328906888455768,1.0155358393493752,0.40384615384615385,0.8704133976502588,1.0,7/27,22.17%,AGR2;HIP1;HAP1;PDE6H;PLAUR;DGKD;ARAP1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.5995339755510334,-1.0154171789896522,0.42592592592592593,1.0,1.0,4/7,26.06%,CAV1;CALM1;TRDN;CALM3
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.570313115115946,-1.015414287695206,0.4782608695652174,1.0,1.0,1/9,5.37%,RNF8
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.5880606284924498,-1.0154030475169744,0.46153846153846156,1.0,1.0,3/6,17.53%,NODAL;ARHGDIB;ACVR1C
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.5001799549466681,-1.0153829008461541,0.4634146341463415,1.0,1.0,6/28,10.96%,TTC12;DNAH17;DNAAF1;DRC1;CFAP73;CCDC40
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.4669411865421318,1.0153216065395405,0.4090909090909091,0.8705405386919826,1.0,17/75,14.58%,PCDH15;LHFPL3;CDC14A;ROR1;EPS8L2;WHRN;ALDH7A1;ADGRV1;CCDC50;ATP6V0A4;TBL1X;TPRN;SLC26A4;COL11A1;GRM7;LRP2;PAX3
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.5135850936905205,1.0151370949489218,0.42857142857142855,0.870642489211588,1.0,4/27,7.89%,SLC17A6;NLGN1;PCLO;SNCA
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.4375575605277369,1.0149609516117193,0.37777777777777777,0.8706817045469867,1.0,9/64,13.68%,SHMT2;ENPP1;PRSS3;TCN2;MTHFD2L;AOX1;MTHFD2;SLC19A1;SLC52A1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.46748400049987243,1.0149444299768986,0.41818181818181815,0.8702826445246945,1.0,7/45,14.42%,TGFBR1;RAPGEF3;SYNPO2;PPM1E;PXN;CARMIL1;SORBS3
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.43467234569206387,1.0148512027437004,0.43137254901960786,0.8700967274866691,1.0,20/81,21.16%,PELI2;ST18;RELA;PELI1;RPS6KA4;PELI3;TAB2;PSMD13;IRAK1;PSME4;PLCB1;TAB3;PSMA1;MAP3K8;RPS6KA5;IRAK3;RIPK2;IKBKB;PSMD4;MAPK3
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.6394852066759801,1.014605394408831,0.4838709677419355,0.8702549854692352,1.0,3/10,12.47%,TBC1D8B;MYO1E;CD34
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.4293608202699963,1.0145827458499714,0.4,0.8698692180726896,1.0,15/63,19.44%,BOK;DEPP1;DAPK2;PIP4K2A;ABL2;KEAP1;RRAGC;HSPB1;MTMR3;GPR137B;FBXL2;VPS29;RMC1;RRAGD;ABL1
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.45690447334116574,1.013979786745898,0.40816326530612246,0.8711083984911968,1.0,17/55,19.97%,ADIPOR2;ACADS;ECI1;PECR;ACADM;ACAA2;ABCD3;ABCD2;BDH2;ECHDC1;HSD17B10;AUH;CYP4V2;PEX2;ABCD4;ACOX1;ECI2
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.4760008479775726,1.0139531117918734,0.5087719298245614,0.8707538179120698,1.0,8/42,18.93%,ZBTB1;PRIMPOL;POLE2;REV3L;REV1;PCLAF;FAAP20;POLK
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.6455707549729471,1.0139387640076518,0.49019607843137253,0.8703808548910159,1.0,4/6,23.85%,IL4;PRLR;PIBF1;JAK2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.6510301314014458,1.0139191760743362,0.45614035087719296,0.8700207324842499,1.0,5/6,33.79%,BAD;AKT2;STOML2;MTLN;VCP
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.49680059103672397,1.0138863686364383,0.4230769230769231,0.8696671957710833,1.0,4/30,7.21%,F2;HIF1A;TICAM1;NLRP7
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.41591726133784795,1.0138288155012385,0.375,0.8694012668412145,1.0,22/82,20.47%,MCOLN3;TRPM8;SLC35G1;TRPV2;TRPC4;MCUB;SLC8A1;ITGAV;SMDT1;SLC24A2;MCU;TRPC5;GRIN2D;TRPM2;ANO6;TRPM7;TRPV3;RYR3;MICU1;TRPM3;ATP2C1;TRPC1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.5924610713034707,-1.013554083174612,0.5306122448979592,1.0,1.0,3/11,17.00%,CDC37;IFNGR2;STAT1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.40020486825579377,1.0135190856804481,0.3695652173913043,0.8697212330200299,1.0,24/115,16.07%,CWH43;SOCS2;FGF2;PIK3R6;ITPKB;PIK3R5;PIP4K2A;PIK3C2B;PLCG2;PIGQ;SOCS6;SMG1;IP6K3;INPP4B;PIK3CA;EFR3A;PIGF;PTEN;MTMR9;MTMR3;PI4K2B;PITPNM1;PIGP;PIK3CD
prerank,PanglaoDB_Augmented_2021__B Cells,-0.4163463962708305,-1.0131270482035246,0.4166666666666667,1.0,1.0,21/111,9.27%,P2RY10;TBC1D10C;CD24;SELL;SP140;IRF4;TRAF3IP3;CD53;BST1;CYTH4;CD86;LTB;JCHAIN;CD5;TAGAP;CD72;POU2AF1;TMC8;LY86;IFIT3;PAX5
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.6472389070361552,1.0131223777291825,0.5370370370370371,0.8701592052995489,1.0,5/8,31.84%,SLC39A8;SLC39A14;ABCB7;SLC25A28;SLC11A2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5772017484657379,1.0130844373065455,0.5102040816326531,0.8699058727457826,1.0,2/16,5.19%,SNAI1;CXCL12
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5059067514969382,1.0129190029299462,0.38095238095238093,0.8700509382198987,1.0,14/28,34.15%,DCP1B;EXOSC4;CNOT8;EXOSC1;LSM2;PATL1;EXOSC5;DIS3;EXOSC2;LSM3;DCP2;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.4643278667668071,1.0125453876705834,0.38461538461538464,0.8707119679193459,1.0,10/45,11.83%,FERMT3;ITGA8;TMEFF2;ITGAV;FER;LAMB4;MEGF9;VAMP3;PXN;NTNG2
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.5951071769476437,1.0125161894837367,0.45,0.8703530785233271,1.0,2/10,6.35%,PCDH15;NRXN1
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.4867410771654199,-1.0121178310000376,0.43478260869565216,1.0,1.0,6/24,19.06%,KIF2B;STMN1;STMN3;TRPV4;KATNB1;KIF18B
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.6757251238064494,-1.012057362444639,0.52,1.0,1.0,1/6,2.14%,TNXB
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.4122196161059064,1.01174303732079,0.41509433962264153,0.872050746714513,1.0,34/100,20.92%,LSAMP;SLC35F1;ROBO2;PCDH17;ZDHHC22;UNC5D;NRXN1;RAB3C;TMEM200C;NOVA1;PTPRD;ANK2;MAGI2;GUCY1A2;ADGRB3;CTNNA2;MAGEL2;CPT1C;ATP1A2;CNTN1;GPM6B;RUNX1T1;FAT3;CNTN2;GJC1;GRID2;FMN2;CSRNP3;PLP1;RBFOX1;TRPM3;ATP1B2;ADGRL3;CADPS
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.5270947163615057,1.0116446471520002,0.4166666666666667,0.8718654125607478,1.0,9/18,32.07%,SYNE4;RAP2A;FERMT1;CYTH1;PARD3;CYTH3;CLASP1;MYO9A;OPHN1
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.549680555575239,1.011495440558568,0.4375,0.8718726470351141,1.0,3/14,17.93%,EXOSC4;TENT4B;ERI1
prerank,GO_Biological_Process_2021__L-alanine transport (GO:0015808),0.6265085306385715,1.0107716341793602,0.5964912280701754,0.8733127958099915,1.0,1/7,3.70%,SLC38A3
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.5287074391522137,-1.0106445943804236,0.47058823529411764,1.0,1.0,4/27,6.93%,SCN5A;KCNE2;KCNN2;KCNE1
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.5736191501961543,1.0106381448987714,0.5333333333333333,0.8732635239266855,1.0,2/9,7.72%,NRXN1;NEUROD2
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.4829513196046643,1.010471546636364,0.4339622641509434,0.8732081024166055,1.0,9/31,20.22%,NEDD4;TNIK;PTPRD;ADGRB3;HECW2;CAPRIN1;CDKL5;RAP2A;RAPGEF2
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.5064999129536394,-1.0104595022488132,0.5,1.0,1.0,12/21,25.95%,HSD3B2;HSD3B1;CAV1;ABCB4;TGFB1;TGFBR3;SLIT3;UBE3A;CATSPER4;YAP1;THBS1;TGFB2
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.4200988053068177,-1.0098603284730576,0.42857142857142855,1.0,1.0,13/80,16.41%,KIF2B;ARF3;KDELR1;COPG2;KIF15;KIF26A;RAB6C;COPG1;KIF22;ERGIC1;ATP9B;ARFGAP3;KIF4A
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.4021442047121134,-1.0098277986037738,0.4146341463414634,1.0,1.0,30/135,15.24%,EHF;CLDN4;F5;CD24;TMEM184A;FAM3D;CLDN1;C6ORF132;INCENP;MYO5B;LAMB3;PLEKHS1;SLC46A2;CDH3;CEACAM1;KIF15;SERPINB5;VSIG2;APOA1;MISP;KIF20B;MAL2;ALOX15;GPX2;EMILIN2;STAP2;BRCA1;SDR16C5;EXO1;TMC4
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5198660512731041,1.0097179019439981,0.41818181818181815,0.8746331371475808,1.0,8/21,28.53%,MAP2K6;TAB2;IRAK1;TAB3;RIPK2;TAB1;TRAF6;CYLD
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.6083058650689664,1.0094266560400236,0.5777777777777777,0.8749609618566271,1.0,4/11,20.80%,F2R;PLPP1;DGKD;PARD3
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.43670562392515355,1.0094248328825859,0.3877551020408163,0.8745396999587665,1.0,21/119,16.51%,FGF10;SEMA5A;LGR5;ZEB2;NRARP;GPC5;PPM1A;RNF146;KANK1;PSMD13;SCEL;TBL1X;PSME4;PTK7;CSNK1G3;FRAT1;BAMBI;LGR6;GPRC5B;PSMA1;UBR5
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),-0.625200173035781,-1.009352316910949,0.5,1.0,1.0,1/6,4.32%,CRYM
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.6276170523679597,1.0092172222339142,0.44642857142857145,0.8745827343799341,1.0,1/6,2.87%,PPARG
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.5415891415281063,1.0092126554171306,0.4772727272727273,0.8741682419005282,1.0,5/23,11.92%,SIX4;SGCZ;PGM5;SGCG;MEF2C
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.680842871030413,1.0087928719599142,0.5636363636363636,0.8747922643700476,1.0,1/7,2.93%,NEDD4
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.5247556964546518,1.0087620903330394,0.44,0.8744336562165553,1.0,6/23,13.40%,SNX18;DOCK1;GSN;ARHGAP25;MSR1;SPIRE2
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.5824553393710027,1.008748080099074,0.4666666666666667,0.8740321792486732,1.0,3/12,20.35%,TICAM1;TRPM7;TICAM2
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.5479951268191001,-1.008684891079824,0.375,1.0,1.0,4/16,9.92%,DRD4;DRD2;DBH;LRTOMT
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.5485365969491828,-1.0080001162225571,0.4318181818181818,1.0,1.0,7/15,23.78%,DMAC2L;ATP5F1A;ATP5F1E;ATP5ME;ATP5MC3;ATP5PB;ATP5F1B
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.44628020776732313,1.0079417086090972,0.37254901960784315,0.8758277375978587,1.0,11/51,15.46%,CHRM2;HRH3;HTR1F;OPRK1;INSL3;GRM8;GNAI3;GRM4;GRM7;NPY1R;GPR37
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.4864044821429767,1.0079206849707472,0.42,0.8754506465951086,1.0,4/30,4.73%,IGF1;IL4;HIF1A;ZBTB20
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.4182985865161375,-1.007917166077844,0.391304347826087,1.0,1.0,3/80,1.92%,TERT;DDX11;KDM4D
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.5882283467463449,-1.0077189783516585,0.4523809523809524,1.0,1.0,3/10,8.95%,KLRC1;HFE;CEACAM1
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.6540755800534453,-1.0073656037329404,0.48,1.0,1.0,1/11,2.86%,SPTLC3
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.6540755800534453,-1.0073656037329404,0.48,1.0,1.0,1/11,2.86%,SPTLC3
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),-0.6751962195517134,-1.0069102733433648,0.543859649122807,1.0,1.0,1/5,8.99%,KIF17
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),-0.6751962195517134,-1.0069102733433648,0.543859649122807,1.0,1.0,1/5,8.99%,KIF17
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),0.6124106812136131,1.00647418144464,0.5531914893617021,0.878754091510863,1.0,1/7,11.68%,HAS2
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.6442628522798317,1.0061264446052087,0.515625,0.8791399840509252,1.0,3/9,12.47%,TBC1D8B;MYO1E;CD34
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.5289957545144359,-1.0060816981200293,0.45454545454545453,1.0,1.0,3/18,13.00%,ASS1;CLU;SMAD3
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.38830019679706373,1.0060658236082136,0.4444444444444444,0.8788603846349886,1.0,36/225,12.97%,C3;EPHA7;PBX3;PHGDH;IL1RAPL2;MYRF;POU6F2;CDH2;CNTNAP2;VCAN;THOC6;ROBO2;AFF2;SOX6;ADGRL2;PAX6;CHD7;CNTN6;ATXN1;PDGFC;PCDH18;SNTG2;DSCAML1;NPAS1;ROGDI;GSN;HAP1;NHLH2;NHLH1;LIG4;EMX1;PLXNB2;PROX1;PTEN;NR4A2;SHROOM4
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5484778759092631,1.005997471677705,0.48214285714285715,0.878599519801388,1.0,4/15,11.00%,F2;H2BC21;FAM3A;MUC7
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.6574437926736665,-1.005943257826877,0.5609756097560976,1.0,1.0,1/8,0.43%,DUOXA1
prerank,GO_Biological_Process_2021__cerebellar granule cell differentiation (GO:0021707),0.6840782405011903,1.0058062636813394,0.5,0.8786711474011104,1.0,3/5,23.21%,PROX1;GRID2;CBLN1
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.5464893688875057,1.0057618153857322,0.45098039215686275,0.8783860239493856,1.0,1/16,1.82%,CCL5
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.6604533344437667,1.0056558986967374,0.391304347826087,0.8778043071612892,1.0,4/5,30.46%,PHLDB2;PHLDB1;CLASP2;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.6604533344437667,1.0056558986967374,0.391304347826087,0.8778043071612892,1.0,4/5,30.46%,PHLDB2;PHLDB1;CLASP2;CLASP1
prerank,MSigDB_Hallmark_2020__E2F Targets,0.3857313041583155,1.0056553624444016,0.3877551020408163,0.8773849071100895,1.0,24/189,14.99%,ESPL1;TIMELESS;CDKN2C;TOP2A;MYC;CDC25A;CDKN2A;SYNCRIP;DLGAP5;ASF1A;MCM7;ASF1B;TK1;GINS1;EZH2;HNRNPD;CHEK2;MTHFD2;DCTPP1;XPO1;RACGAP1;CCP110;LMNB1;H2AX
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.6500394899548961,-1.0052555072284135,0.52,1.0,1.0,3/8,11.67%,AGBL1;AGBL3;FOLH1B
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.45881568093705377,1.0051620007468285,0.48214285714285715,0.8781075665447647,1.0,12/40,25.05%,LDLR;ITGAV;BANP;PTX3;IRAK3;FMN2;IAPP;EDN1;MDM4;CRYAB;EGFR;APOE
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.43149692574778237,1.0049865090362142,0.46938775510204084,0.878117873614991,1.0,16/57,20.71%,TGFBR1;CDKN2AIP;LGI1;AGR2;EXOSC4;ZNF639;RPS6KA1;DERL2;PLCB1;SLC44A4;H3-3A;ADAM10;BRAT1;SLC25A33;NCBP1;ADNP2
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.524477356572068,1.004838361496817,0.5166666666666667,0.8780975103786254,1.0,1/14,2.84%,KAT2B
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.45606450106960816,1.0048287857315938,0.4489795918367347,0.8777032871875917,1.0,8/36,13.21%,LRP4;NLGN1;NRXN1;CEL;PTPRD;NLGN4X;PTEN;PICALM
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.3901948118167497,1.0046061699408988,0.4576271186440678,0.8777627822062015,1.0,30/215,12.81%,GATA4;CXXC4;IRS1;KCTD21;CCL5;TULP3;FGF2;NEDD4;ENPP1;BMP2;DCC;KANK2;PIP4K2A;NRARP;KLK14;MOSMO;SNCA;CRHBP;NLGN4X;KCTD6;KANK1;PTPRT;EZH2;PHACTR4;GPR108;DACT3;EGFL7;SPRY3;PTEN;NR4A2
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),0.5408229572111116,1.004586746178073,0.4,0.8773690941150033,1.0,1/14,0.10%,TNFSF14
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.5549072648342674,1.0045639380082196,0.43333333333333335,0.8770125034496881,1.0,3/12,3.79%,MYC;FGF2;BMP2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.4828771912137925,1.0045348634947913,0.4444444444444444,0.8766378997297533,1.0,3/36,2.91%,LGALS9;FZD5;PYHIN1
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.5002525981806727,1.0043958190288405,0.425531914893617,0.8765754965625772,1.0,4/27,11.41%,ABHD17B;ABI3;PDLIM5;ABHD17C
prerank,GO_Biological_Process_2021__metanephric mesenchyme development (GO:0072075),0.6103481166319962,1.0041849593624281,0.5636363636363636,0.8766781681876535,1.0,2/8,4.40%,WNT4;SIX4
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.44660217698680654,1.0041280352111908,0.42857142857142855,0.8764447594056527,1.0,11/49,18.96%,EPS8L2;ARHGAP5;EPS8;RHOU;PHACTR4;CNKSR1;ROPN1B;RHOG;RHOD;RHOB;GNA13
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.6102869344168209,1.0041276778962829,0.5,0.8760283960995218,1.0,3/7,23.48%,MVD;IDI2;PDSS2
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.41145728332664544,1.0039359630826052,0.3541666666666667,0.8760091217092525,1.0,20/126,11.39%,GATA4;MITF;RBM20;SMYD1;PRKG1;PPP1R3A;FGF2;RRAD;PDE1A;ADIPOR2;PDLIM5;ASB5;MTTP;IP6K3;SGCG;SYPL2;NPPA;LMOD2;ATP1A2;SYNPO2
prerank,MSigDB_Hallmark_2020__Complement,0.38641627452632155,1.003924234583719,0.38461538461538464,0.8756055605406153,1.0,25/158,10.79%,CFH;F2;C3;CCL5;KLKB1;EHD1;GNB4;CBLB;PIK3R5;PCLO;CD59;ANXA5;ZEB1;MMP15;PRSS3;DYRK2;F3;DPP4;C9;FDX1;GNAI3;PIK3CA;CA2;MSRB1;CASP10
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.4215211673080898,1.0038169551131118,0.35,0.8754462697278358,1.0,20/115,15.40%,TEX101;ASB17;LRRC46;GCNA;C2ORF78;GALNTL5;DKKL1;MEIG1;TEX15;DMC1;PRNT;UBE3D;POTEA;SPINK2;SPATA3;MARCHF11;MLF1;SPAG6;SLC25A31;MORN5
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.4857804649681085,1.0037498481579084,0.49056603773584906,0.8751469611714024,1.0,8/29,16.58%,GATA4;RBPJ;BMPR1A;MEF2C;PROX1;CPE;MESP1;HEY2
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.6224908606606704,1.003696968069864,0.4888888888888889,0.8749149418015859,1.0,1/7,16.51%,UBR5
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.6449451957910493,1.0035273171707517,0.5344827586206896,0.874908417560838,1.0,1/5,18.26%,HEXB
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.5859885362509887,1.0035012187170393,0.47540983606557374,0.8745611037109741,1.0,4/12,10.25%,ZBTB7B;LY9;IL15;IL23R
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.5815613391988351,-1.0034910792890375,0.47058823529411764,1.0,1.0,2/7,16.81%,SFRP1;TGFBR3
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.5144561817859129,1.0031592348049532,0.4375,0.8748223944977531,1.0,13/23,23.57%,IL4;PPARG;IRF8;LY6D;FLT3;TRPM2;VEGFA;LYN;AXL;GAS6;PDE1B;BLK;BMP4
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.5772509375235918,1.0029594851088206,0.46511627906976744,0.8749618404522336,1.0,3/10,7.89%,THRSP;CCN6;SNCA
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.583268042767098,1.0028291681614014,0.4782608695652174,0.8748945363066912,1.0,2/12,1.82%,FLT1;CCL5
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),-0.5045365893251985,-1.0027395423748902,0.45652173913043476,1.0,1.0,2/15,5.22%,DNAH17;DNAAF1
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.46132671386451435,1.002494213931165,0.4117647058823529,0.8752646334968534,1.0,12/51,11.92%,LLGL1;MCTP2;SEPTIN4;RALA;SYT1;RAB3C;RIMS2;HAP1;SNCAIP;DNAJC1;VAMP3;MEF2C
prerank,GO_Biological_Process_2021__pharyngeal arch artery morphogenesis (GO:0061626),0.6592558630668413,1.0020125052543605,0.5245901639344263,0.8759925857260523,1.0,3/5,23.57%,BMPR1A;BMPR2;BMP4
prerank,GO_Biological_Process_2021__regulation of myoblast proliferation (GO:2000291),0.6362204754870522,1.0019777308821889,0.5263157894736842,0.8756882226801547,1.0,1/5,6.50%,MEGF10
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.34960145334449716,1.0019639013792654,0.4230769230769231,0.8753174260143626,1.0,152/735,18.14%,CRX;GATA4;MITF;IGF1;RUNX1;HGF;ZNF300;HNF4G;MYC;SIRT1;IL26;FZD5;IL4;HIF1A;MYCN;FGF2;KAT2B;PPARG;LPIN3;TFEB;MED17;ZEB2;LMO1;RORB;BMP2;NRIP1;RORA;ST18;ZGLP1;IRF8;SP1;DUX4;HCLS1;ACVR2A;DLGAP5;ZNF462;RBPJ;RELA;NR5A2;LMO2;VEZF1;TLR2;TET2;ESR1;ERG;NFIA;PLAC8;WWTR1;POU3F2;HDAC3;PAX6;RFXAP;RPS6KA4;HDAC2;CD40;SSBP2;HMGB1;ELF4;ELK1;FOXO3;TFEC;PTOV1;SMAD1;KLF6;PAXIP1;STING1;AUTS2;CTCFL;SMARCD3;SMAD2;NCOA2;NHLH2;NHLH1;FOXO1;TCF4;ONECUT2;BCL11B;E2F4;BMPR1A;TBL1X;NR1D2;SP3;SMAD4;PLAGL1;DPF1;NR1H3;MEF2C;NCK2;PROX1;CDC5L;ZNF175;CTBP2;CDK12;PPP3CA;MYB;GREM1;NR4A2;DPF3;KLF7;MLXIPL;DVL2;WWOX;RARB;CREB1;ZNF639;NR2F2;RPS6KA1;LRP6;SMARCD2;ZNF263;RFX5;NFATC3;PAX3;KLF15;EPC1;KAT6A;POU2F1;PCGF5;PLSCR1;GABPB1;NCOA3;ATF6;THRB;HJV;HCFC1;SMAD5;PHIP;NFE2L2;HSF2;POGZ;MESP1;EAF2;MYDGF;HEY2;CTNNB1;SMARCA2;FADD;RPS6KA5;IL33;SIRT7;THAP3;RUVBL2;NUFIP1;VEGFA;WNT2;GABPA;WASL;TP53;CSRNP3;CD81;MED30;CITED2
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.5321803291257334,1.0018733886133182,0.4117647058823529,0.8751288593882828,1.0,6/12,31.30%,PATL2;LIMD1;LSM14A;PATL1;RC3H1;LSM3
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.43088439105410803,-1.0013406302882717,0.34375,1.0,1.0,13/64,12.91%,EHF;CLDN4;FAM3D;CYP24A1;ST6GALNAC2;LAMB3;F11R;ABCC3;VDR;SERPINB5;IL18;CXCL16;CRH
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.41423190324176185,1.0013380124339166,0.3448275862068966,0.8760009383680135,1.0,20/128,9.95%,GATA4;C3;BOK;PADI2;MAFB;SELENBP1;BGN;MEIG1;CXCL12;ARHGEF17;SDC4;EPS8;GAMT;FAM114A1;TF;PLSCR4;ABCG8;BCAM;NECTIN2;GSN
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5812559895796366,1.0012390685202295,0.42592592592592593,0.8758425121610547,1.0,4/9,8.14%,FERMT3;CCL5;DPP4;ADA
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.4252401855437965,1.0010941054030171,0.40384615384615385,0.8758113714538673,1.0,22/68,25.01%,RAPGEF3;TMEFF2;DNAJB2;SACS;EPHA3;CRACD;CARMIL1;HSPA8;IRAK3;VEGFA;WASL;RIOK3;DNAJB1;MCTP1;IAPP;HSPA5;FAP;WASHC2C;HSPA1A;CRYAB;EP300;ABCA7
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.540180028817732,-1.000616346344523,0.5,1.0,1.0,3/17,13.00%,ASS1;CLU;SMAD3
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.523782091335742,1.0005887224771008,0.4444444444444444,0.8766576923225877,1.0,6/23,13.27%,NLGN1;SYT1;CEL;SNCA;NLGN4X;STON2
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.6460165617962819,1.0005061013113958,0.4925373134328358,0.8764386966227882,1.0,2/7,8.96%,ERBB4;LATS1
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.4545981081970354,1.000078918513037,0.4528301886792453,0.8770904681983971,1.0,13/45,20.06%,PLCH1;ITPKB;PLCG2;INPP1;IP6K3;INPP4B;NUDT4;PTEN;PLCB1;PLCD1;IMPA1;IP6K1;MINPP1
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),0.5257811239066429,0.999864733729451,0.4807692307692308,0.8772521664366917,1.0,3/15,10.05%,IGF1;WEE2;HYAL3
prerank,GO_Biological_Process_2021__nephron tubule development (GO:0072080),0.6326207488943578,0.99980665753822,0.5357142857142857,0.8769909209366659,1.0,2/5,11.92%,MTSS1;MEF2C
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.6481027080355752,-0.9996954521949442,0.5490196078431373,1.0,1.0,3/6,16.14%,SPI1;AKNA;TRPV4
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.5085101729857644,0.9996561912687046,0.4583333333333333,0.8770015878966152,1.0,2/30,6.55%,PAWR;EPS8
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.49165347691967054,0.9996222041261075,0.46,0.8767226027066619,1.0,4/30,12.35%,LRP4;PCM1;PAX6;PTEN
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.47196725889143193,-0.9995379639375389,0.5,1.0,1.0,11/50,16.26%,SLX4;RNF8;ERCC1;FANCG;FANCC;RAD51AP1;RAD51AP2;FAN1;NUCKS1;RPA3;MUS81
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.532094720053465,0.999467997636857,0.47058823529411764,0.8766911659108362,1.0,7/21,9.93%,HS3ST5;HS3ST3B1;UGDH;HPSE;HS2ST1;HS3ST4;EXT1
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.5573234714799344,-0.9988440332810599,0.45652173913043476,1.0,1.0,1/9,4.36%,PIAS3
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.5595426544875841,0.9988414429160749,0.5208333333333334,0.8779800111679446,1.0,5/14,24.14%,LIN28A;CPEB1;FMR1;CPEB2;DHX9
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.5580446321606571,-0.9986657396486913,0.48936170212765956,1.0,1.0,4/13,16.94%,PRPF19;USP4;SRSF10;PRPF6
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.6297350059291654,-0.9986268991254448,0.5434782608695652,1.0,1.0,3/8,14.33%,CDHR2;PODXL;USH1C
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.4725158004751644,0.9984704212268287,0.45161290322580644,0.8784541751782761,1.0,5/31,7.89%,ACE2;NEDD4;KCNJ3;SCN10A;SNCA
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.618195581040025,-0.998198936597606,0.5,1.0,1.0,1/10,0.91%,FBXO43
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.521128494506236,-0.9981864506982892,0.42857142857142855,1.0,1.0,1/19,0.25%,KLRC1
prerank,GO_Biological_Process_2021__estrogen biosynthetic process (GO:0006703),0.6142391361679337,0.9979655555727426,0.5660377358490566,0.8793254062325938,1.0,1/7,1.12%,HSD17B2
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.4983751368945202,0.9977100024860307,0.532258064516129,0.8796058533561176,1.0,2/27,4.49%,SIRT1;RORA
prerank,GO_Biological_Process_2021__definitive hemopoiesis (GO:0060216),-0.6966799064077365,-0.9973368611754172,0.5652173913043478,1.0,1.0,2/5,2.97%,TEK;MFAP5
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.41139860309730825,0.997030825338975,0.40476190476190477,0.8808969377523748,1.0,21/124,11.45%,EPHA7;SIRT1;SLC35F1;ERBB4;POU6F2;EFNA2;SCGN;ZDHHC22;UNC5D;TMEM200C;POU3F2;ELAVL2;IGDCC3;SPSB4;B4GALNT4;GRM5;EZH2;MAGEL2;PAK5;NOL4;PPM1E
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4231230308534479,0.9969781105100308,0.5,0.8805809569275607,1.0,10/79,13.39%,CDKN2C;SLFN11;CDKN2A;FBXO5;ZFP36L2;KANK2;PSMD13;PTEN;CDK2AP2;PSME4
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.37586198793345366,0.9965889799002438,0.39285714285714285,0.8811189234640082,1.0,57/238,25.32%,MYC;TGFBR1;CDC25A;CCNA2;HIF1A;KAT2B;ESR1;STAMBPL1;USP12;INO80E;SMAD1;SENP8;ACTL6A;INO80D;KEAP1;SMAD2;PSMD13;NFRKB;SMAD4;PTEN;PSME4;CCP110;HCFC1;RCE1;USP45;USP31;BAP1;PSMA1;RNF128;STAM2;BIRC3;IL33;USP38;TP53;ARRB2;SENP6;JOSD2;GPS1;UBE2D1;PSMD4;ACTR5;TNIP3;OTULINL;BRCC3;USP9X;TAB1;BARD1;MDM4;OGT;POLB;EP300;OTUD4;OTUD7B;HGS;USP18;SMAD7;ASXL1
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.6156468739766908,0.9963926604064367,0.5272727272727272,0.881259804758305,1.0,2/8,10.58%,KCNC2;FOXO1
prerank,GO_Biological_Process_2021__tyrosine catabolic process (GO:0006572),0.711959994358384,0.9962616794691358,0.5128205128205128,0.8811302837634077,1.0,1/5,3.71%,HPD
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.3782001289273357,0.9961873583033299,0.3958333333333333,0.8808748163782201,1.0,20/154,11.26%,IGF1;MYC;HIF1A;TFEB;LDLR;PCBP3;HMG20B;BMI1;PRDM14;AFF2;ZNF462;SLC8A1;NFKBIZ;NOVA1;CIAO3;TOB1;RO60;NFKBID;TRIM26;HNRNPD
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.44333234035479707,-0.9958959590762293,0.46296296296296297,1.0,1.0,4/50,2.36%,H1-3;H1-4;TERF2IP;H1-2
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.5029763371895638,0.9953244867354749,0.43137254901960786,0.8825817202932771,1.0,7/30,14.09%,CTDNEP1;LDLR;ZBTB20;ELOVL5;NR1H3;MLXIPL;CREB1
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),0.609283323796067,0.9951731171313445,0.5208333333333334,0.8826136991253615,1.0,4/6,28.25%,TNFRSF21;LYN;BLK;RC3H1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.6606790010325161,0.9951095915557912,0.6078431372549019,0.8823758817382521,1.0,3/5,25.78%,DOCK4;DOCK5;CHRM3
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.4557034055376601,0.9949513237651467,0.4489795918367347,0.8824498708121815,1.0,3/49,1.94%,FGF10;MYC;SIRT1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.5631133446763725,0.9948096831606866,0.5106382978723404,0.882409995719122,1.0,1/13,3.27%,CYB561
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.592489301215172,0.9947921963739927,0.5555555555555556,0.8820289311419248,1.0,2/13,3.87%,NRG1;CDH2
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.6549464981480492,0.9946684221290542,0.5192307692307693,0.881959370919154,1.0,4/5,28.92%,PXN;NCK2;MAPK8IP2;NCK1
prerank,GO_Biological_Process_2021__choline transport (GO:0015871),0.6712224628992989,0.9944398142936812,0.5964912280701754,0.8822487270771007,1.0,2/5,28.01%,SLC44A4;SLC44A2
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.46614827338209136,-0.9943723708396712,0.4375,1.0,1.0,9/50,17.17%,NUPR1;KCNE2;RHBDF1;LAMP3;DDRGK1;DAB2IP;UFL1;PSME3;GLMN
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.4960843694325539,0.9943676633308808,0.4117647058823529,0.8820595677522859,1.0,3/20,2.04%,ADRA1A;ACE2;F2R
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),0.6519867462585829,0.9939659368974216,0.6101694915254238,0.8822073585306915,1.0,2/5,14.96%,RORB;CRB2
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),0.6519867462585829,0.9939659368974216,0.6101694915254238,0.8822073585306915,1.0,2/5,14.96%,RORB;CRB2
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.4774490493193386,0.9938278850938044,0.46153846153846156,0.8822692114556315,1.0,12/37,18.59%,F2R;FGF2;TRPV2;SLC8A1;PLCG2;SLC24A2;HTR2C;GRIN2D;TRPM2;RYR2;TRPV3;RYR3
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.507107226917856,-0.9937564381707819,0.46808510638297873,1.0,1.0,9/26,12.36%,TTC12;DNAJB13;DNAAF1;DRC1;RSPH9;CCDC40;CFAP74;RSPH1;CFAP46
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.4125371504491074,0.9937205490531686,0.42857142857142855,0.8821758655328802,1.0,12/84,14.62%,DERL3;SYVN1;UBE2J1;DNAJB2;RNF185;RNF139;AUP1;RNF5;POMT2;UBE4A;UBE2J2;DERL2
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.5079675322122444,0.9936763014348621,0.4888888888888889,0.8818440378950637,1.0,8/32,18.93%,TFEB;BORCS6;DEF8;RAB34;KLC2;PIK3CD;FAM98A;KIT
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.445439965171446,0.9934019219538069,0.46808510638297873,0.8820788550978439,1.0,8/66,6.66%,IGF1;PLCH1;IRS1;FGFR1;NYAP2;PIK3R5;PIK3C2B;PDGFRA
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.4758082827784811,-0.9933075629610564,0.4117647058823529,1.0,1.0,2/42,1.06%,GUCY2C;ADSS1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.64743549595452,0.9932917285719998,0.5925925925925926,0.8815412865925066,1.0,3/6,14.65%,PPARG;SOAT2;SOAT1
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.64743549595452,0.9932917285719998,0.5925925925925926,0.8815412865925066,1.0,3/6,14.65%,PPARG;SOAT2;SOAT1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.3839826880862994,0.9931929209495304,0.3877551020408163,0.8814365876892487,1.0,20/170,14.60%,CDC14A;FBXO5;NDE1;ZFP36L2;RIOK2;CEP70;KCNH5;PCM1;CEP152;ANAPC16;PSMD13;DCTN3;HECW2;CEP135;DYNC1I2;ANLN;CNTRL;PSME4;NEDD1;CCP110
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.570276559903823,0.9931188367226186,0.484375,0.881230828884596,1.0,1/12,1.65%,RENBP
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.5180583588500872,-0.9929325496732972,0.4444444444444444,1.0,1.0,4/31,1.75%,P2RY10;SIRPG;SPON2;ICAM3
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4908825908897906,0.9928586172548954,0.5,0.8814237529985884,1.0,11/34,27.74%,ACD;NEK7;HNRNPA2B1;CTNNB1;POT1;MAPK3;MAPK15;NAF1;HMBOX1;CCT3;TNKS
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.3957593895847664,0.9927925630623999,0.5185185185185185,0.8811825210829866,1.0,21/97,16.53%,NPC1L1;SLC10A3;LDLR;NPC2;ABCC2;ABCA6;ABCA1;MTTP;ABCG8;SLC10A5;NCOA2;ABCD3;ABCD2;SLC10A1;ABCC11;ABCA8;ABCG5;PITPNM1;SLCO1A2;ABCA9;AKR1C1
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.3765168755472381,0.9926208474679749,0.5106382978723404,0.8812742726009339,1.0,51/246,19.44%,MAP3K11;TOP2A;PAWR;SYK;BOK;SIRT1;PLEKHG2;FGD4;BMP2;DAPK2;FANK1;SEPTIN4;DKKL1;ARHGEF17;SCRIB;UNC13B;HTRA2;HMGB1;SNCA;RYBP;FOXO3;UBE2Z;LATS1;BIN1;RPS6KA2;FOXO1;TNFRSF10B;ARHGEF16;BNIP3L;MAPK8;KNG1;SOS1;PHLDA1;RBM5;ARHGEF6;PHLDA3;ATF6;ANO6;FRZB;CTNNB1;FADD;TP53;CSRNP3;VAV2;JMY;RHOB;CASP3;GNA13;TNFRSF10A;MCF2;ABL1
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.618374751544249,0.9925521369178006,0.5740740740740741,0.8809739386739069,1.0,1/7,3.24%,LDLR
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),0.6397931978595001,0.9924488095381659,0.5,0.8808579186630036,1.0,1/6,3.97%,NPC2
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.47386597964992444,0.9924322389462359,0.4418604651162791,0.8804868472408007,1.0,9/36,18.37%,EFNA5;SKA3;EPHA3;BICD1;CDK2AP2;PHLDB2;PRKAA1;STMN4;PHLDB1
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.5583158015404096,-0.9923717550248661,0.5681818181818182,1.0,1.0,3/16,9.92%,BFSP1;WNT7A;LRTOMT
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.5837543616382801,0.992346611161999,0.5576923076923077,0.8802762601862106,1.0,1/12,1.13%,IRS1
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.6182097973172023,-0.9921860244746066,0.576271186440678,1.0,1.0,1/8,2.09%,PLAAT4
prerank,MSigDB_Hallmark_2020__Apical Junction,0.3871285358985599,0.9921114591803216,0.4074074074074074,0.8804215741260049,1.0,15/180,4.06%,ITGA10;CERCAM;IRS1;COL9A1;CD99;SYK;NEGR1;INSIG1;NRTN;ITGA2;CDH6;CADM2;RRAS;ACTG2;VCAN
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.39059781096660656,0.9920181955957319,0.4107142857142857,0.8802586170413482,1.0,5/120,5.04%,SGO1;ESPL1;NDC80;NDE1;DLGAP5
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.6046583024290143,0.9918975838431213,0.53125,0.8801491169803909,1.0,7/9,31.01%,ZSWIM5;VEGFA;ZSWIM8;ZSWIM4;TUBB2B;YTHDF1;ZSWIM6
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.4385646189668638,0.9913679407123159,0.38333333333333336,0.8810224798257147,1.0,13/63,13.65%,PLEKHG2;TENM1;HCLS1;FER;LATS1;KANK1;BIN1;CRACD;LMOD2;CARMIL1;NCK2;FCHSD2;DBN1
prerank,"GO_Biological_Process_2021__pentose-phosphate shunt, non-oxidative branch (GO:0009052)",0.6693573648695135,0.9910684873150365,0.5892857142857143,0.8813979661608665,1.0,2/5,18.40%,RPIA;RPE
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.6051037643693999,-0.9910248939707909,0.5476190476190477,1.0,1.0,2/8,12.10%,CRYM;FFAR4
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.38345654447710087,-0.9908185357413698,0.47368421052631576,1.0,1.0,14/123,12.10%,RFX6;GFRA3;TMEM179;ENPP2;ADCYAP1;SCG3;TRPA1;TTBK1;VWA5B2;GLP2R;CELF3;LRRTM1;INA;FFAR4
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.45464807368169247,0.9907769637666632,0.5,0.8817139588606651,1.0,8/75,12.02%,EPHA7;EFNA5;EFNA2;EPHA5;EPHA3;EPHA8;EFNB2;NCK2
prerank,PanglaoDB_Augmented_2021__Platelets,0.39691531442233713,0.9906036751174196,0.4117647058823529,0.8816749358442189,1.0,17/136,6.48%,TNFSF14;SELPLG;NOX5;FERMT3;ITGAX;CCL5;F2R;CSF3R;ITGA2;PIK3R6;SASH3;ANGPT1;CD244;PTGS1;HCLS1;FGL2;CYP2U1
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.6186454326232538,-0.990568497516419,0.5306122448979592,1.0,1.0,1/6,2.67%,CD86
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.513100910137841,0.9903616471036082,0.54,0.8817955015761888,1.0,10/32,28.53%,HDAC3;MARVELD3;ZNF675;NPPA;HIPK3;ZMYND11;FKTN;PDCD4;SIRPA;CYLD
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.5652218279978528,0.9901546799234765,0.5098039215686274,0.8818568899973057,1.0,2/11,6.00%,INSIG1;PDIA2
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.4606320027771362,0.9901093583417536,0.4318181818181818,0.8815757937058971,1.0,2/42,1.94%,FGF10;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.5933349017378989,0.9900664781630396,0.5,0.8812536469575167,1.0,5/10,19.49%,ELOVL5;NR1H3;ABCD2;MLXIPL;MID1IP1
prerank,GO_Biological_Process_2021__positive regulation of respiratory burst (GO:0060267),-0.6207091427183815,-0.9898731342666799,0.5294117647058824,1.0,1.0,1/5,6.12%,JCHAIN
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.4146088205477549,0.9896811708015594,0.45098039215686275,0.8818696601793269,1.0,27/88,17.85%,F2;ACE2;CCL5;STARD4;IL4;PPARG;ANGPT1;SCRIB;DCXR;SNCA;PLA2G10;RAMP3;MAGI2;VAMP3;NR1H3;FASN;GREM1;ACACA;ACACB;TBC1D5;RAB29;AKR1C1;CSF1;VEGFA;AKR1C3;TP53;FMR1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.4179224925916802,0.9894612648523985,0.47368421052631576,0.8820606098027411,1.0,10/76,9.16%,IGF1;FGF10;LZTR1;EPS8L2;KANK2;EPS8;DLC1;ERBIN;SHOC2;KANK1
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.5108336510368556,-0.9893428734891068,0.48936170212765956,1.0,1.0,2/13,1.88%,DOCK8;CXCL13
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.42388970403141807,0.9891731575827303,0.48214285714285715,0.8823574602768055,1.0,10/52,18.05%,PLD6;BOK;RALA;HTRA2;MCU;FBXO7;PLAUR;PPIF;TP53;MFF
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.6630091240314776,0.988968567006788,0.48,0.8824714360205759,1.0,1/7,1.06%,GSTM2
prerank,GO_Biological_Process_2021__regulation of growth rate (GO:0040009),-0.6391502679720669,-0.9887726999826124,0.6,1.0,1.0,1/5,4.27%,RFTN1
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.4787495311201909,0.988626891001672,0.4423076923076923,0.8828561419771245,1.0,11/26,23.57%,FLT1;MLLT3;FLT3;MLF1;TP53;PRRC2C;KIT;ACE;PTPRC;FSTL3;BMP4
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.48562430891283426,0.9885552427170038,0.46774193548387094,0.8826225692111839,1.0,5/29,13.44%,SIRT1;PPARG;PLA2G10;NR1H3;ABCA8
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),-0.6690888430281571,-0.9885032394877165,0.5961538461538461,1.0,1.0,4/5,32.38%,BAIAP3;STX1B;PRKN;GPER1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.5005120019985836,0.9884430346941354,0.4727272727272727,0.8824715627249986,1.0,5/23,11.19%,IGF1;CANT1;HPSE;HS3ST4;CSGALNACT1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),0.6091017827736024,0.9882729709932457,0.5,0.8825323610521724,1.0,1/6,3.05%,HTR1F
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.5747609791477721,-0.9874945609946368,0.5370370370370371,1.0,1.0,2/9,12.21%,RAB7B;MTURN
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.47463840469378293,0.9874639117353994,0.42857142857142855,0.8840623389985334,1.0,8/52,11.48%,RNF152;SYVN1;PELI1;UBE2E2;UBE2D3;RNF146;UBE2E3;RNF5
prerank,GO_Biological_Process_2021__myeloid dendritic cell differentiation (GO:0043011),0.6087140467332608,0.9872178316981148,0.5535714285714286,0.8842692110777424,1.0,1/6,2.47%,IL4
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5818647626833309,0.9869844206138214,0.5892857142857143,0.8844817657177267,1.0,5/12,21.36%,FGF2;VEGFA;HDAC9;AKT3;ANXA1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.44537984389211593,-0.9869359728981018,0.4074074074074074,1.0,1.0,5/40,10.00%,DDX11;TERF2IP;FOXM1;RAD51AP1;RTEL1
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.40196574004564406,0.9867762861507591,0.4666666666666667,0.8846589129022538,1.0,21/112,12.58%,LRRC3B;NXPH1;KCNC2;GFAP;CADM2;SLC17A6;NKAIN2;PARM1;OLFM3;NTSR2;SYNPR;ANK2;GRM5;PTPRT;LRRTM3;ADGRB3;PAK5;TMEM196;ZNF536;LRFN5;UBE2QL1
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.4840548811168045,0.9867440939471622,0.5102040816326531,0.8843196717583678,1.0,7/28,16.05%,SLC26A6;SLC4A7;SLC9A2;CA2;SLC9C2;SLC9A9;SLC4A1
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.545391880863134,0.9865662234366716,0.5081967213114754,0.884350142874103,1.0,3/16,10.13%,C3;EPHA8;ADGRB3
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.4248550724236018,-0.9865240045812926,0.4375,1.0,1.0,12/81,8.00%,EHF;CLDN4;TMEM184A;FAM3D;CLDN1;C6ORF132;SPDEF;PTH1R;MYO5B;LAMB3;SYTL2;ANKRD30A
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.4323862253725312,0.9862909291001063,0.39215686274509803,0.8845915772213923,1.0,11/55,19.33%,LRP4;DCC;NLGN1;HDAC2;KANK1;EFNB2;PTEN;KIAA0319;RAB29;EFNA1;MCF2
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.5708093988832466,0.9862469966546233,0.5357142857142857,0.8843231289195554,1.0,7/10,39.03%,BDH2;GGCT;CHAC1;CHAC2;CNDP2;MGST2;GCLC
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.3700683950097054,0.9862231898146832,0.39622641509433965,0.883967092395019,1.0,35/160,29.84%,EIF3E;SAMD4A;DCP1B;SMG1;PATL2;RPS5;CNOT6L;CNOT4;EXOSC4;RPL21;DXO;TENT4B;CNOT8;RPL18A;CNOT2;RPL7;ERI1;RPS3A;NCBP1;ZFP36;RPL23A;PAN3;PATL1;RPL9;CSDE1;EXOSC5;RPS29;RPS19;PABPC1;RC3H1;PPP2R2A;RPS15A;SMG9;RPS23;TUT4
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.42269746977393796,0.9861908563559116,0.40816326530612246,0.8836347915498224,1.0,17/58,19.20%,RENBP;ALLC;TRHDE;NAALADL1;GADL1;PLA2G10;LNPEP;RIDA;CYP3A4;NPL;ANPEP;SGPL1;CTH;PNPLA8;PLA2G7;MPST;GNPDA2
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),0.5669248402887743,0.9861410978376509,0.5,0.8833729955011819,1.0,1/10,1.82%,CCL5
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.6253749952641336,-0.9861124819124417,0.5192307692307693,1.0,1.0,2/7,15.40%,ATG14;CALM1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.5086554707307025,0.9860370759453205,0.5370370370370371,0.8832400833130476,1.0,4/25,9.05%,CCL5;F2R;CXCL12;ANK2
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.5197103568444595,0.9860221047514398,0.3584905660377358,0.8828793420690976,1.0,5/23,13.56%,RUNX1;SNAI1;PDLIM5;MEF2C;RAP1A
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.5475489372796033,-0.9859479040050412,0.4772727272727273,1.0,1.0,1/12,1.23%,NUPR1
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.5266581425809342,0.9858574952799282,0.5333333333333333,0.8828694615816042,1.0,1/11,1.94%,SIRT1
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),0.619163576754745,0.9858008546156138,0.5208333333333334,0.8822426891781957,1.0,1/5,2.98%,ALDH1A1
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),0.619163576754745,0.9858008546156138,0.5208333333333334,0.8822426891781957,1.0,1/5,2.98%,ALDH1A1
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.5808338060115641,-0.9857565064812417,0.5384615384615384,1.0,1.0,3/10,12.99%,CD200R1;P2RY12;PTK2B
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.48949633910598606,-0.9856917966863311,0.4444444444444444,1.0,1.0,5/24,16.04%,KDM4D;KDM2B;HR;KDM1B;KDM4B
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),0.6218960485067112,0.9856005542246752,0.6122448979591837,0.8822797852008771,1.0,2/6,34.42%,NDUFV1;COA6
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.47120866164125885,0.9854455627139764,0.49056603773584906,0.8822818578976888,1.0,6/29,22.61%,STK33;CHEK2;CDC5L;H2AX;HINFP;DOT1L
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.6421930190217316,-0.9854304911211491,0.5,1.0,1.0,1/5,20.56%,PRKCA
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.5168630143427801,-0.985245277582094,0.4897959183673469,1.0,1.0,1/15,1.36%,INSRR
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),0.564918493386076,0.9847089062536212,0.4883720930232558,0.8835779591328025,1.0,2/11,2.47%,LGALS9;IL4
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.5963855950832097,0.984683420894494,0.46296296296296297,0.8832415147119119,1.0,2/10,14.07%,PPARG;RARB
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.432222554184885,0.9843960752216863,0.4666666666666667,0.8835052145898226,1.0,15/67,16.99%,PRDX6;ABHD3;PIGQ;PLA2G10;IP6K3;CPNE7;ACP6;PIGF;CPNE1;CPNE3;PNPLA6;PLCB1;PIGP;PLA2G7;PLCD1
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.5261133336227619,-0.9843507630540956,0.5319148936170213,1.0,1.0,1/18,0.37%,ACTC1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.6230295023654502,0.9843331380358362,0.5,0.8828100318036455,1.0,2/8,8.34%,CEL;CYP27A1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.6230295023654502,0.9843331380358362,0.5,0.8828100318036455,1.0,2/8,8.34%,CEL;CYP27A1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.48818380560204677,-0.9842072486921455,0.5,1.0,1.0,4/37,5.96%,ACTC1;F5;SCPEP1;DLL4
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),0.6057316914696664,0.9840697224878822,0.5,0.8830619374027708,1.0,2/9,16.02%,DLGAP5;POGZ
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.5177724217999117,0.9839825509773608,0.44642857142857145,0.8828194975766149,1.0,9/22,21.86%,ELOVL5;ACSBG1;THEM5;FAR2;DGAT2;TECR;ACSL4;ELOVL6;ACSL1
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.49959807816306684,0.9837883576769942,0.5490196078431373,0.8829956343769111,1.0,7/28,25.70%,RAB27A;CHMP6;STAM2;MVB12A;VTA1;HGS;VPS37D
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.6308631860572094,0.9836573810523933,0.5714285714285714,0.882852177816683,1.0,1/5,6.83%,TICAM1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.5490840254354085,0.9836360747761721,0.5185185185185185,0.8824824452831055,1.0,2/16,1.05%,LGALS9;TNFRSF18
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.3773548596015197,-0.9836240128898743,0.46,1.0,1.0,15/162,13.00%,TERT;HK2;MTFR2;PTCD2;BIK;FANCG;AFG3L2;IFIT2;ADCK1;PARP1;CAV2;DNM1;NIPSNAP2;TIMM44;SPG7
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.44826954103628625,0.9835984612963442,0.49206349206349204,0.882171073093555,1.0,6/42,8.93%,SYK;TNFSF13B;IL4;SASH3;CD40;PAXIP1
prerank,PanglaoDB_Augmented_2021__T Cells,-0.417722508027079,-0.9835408892339248,0.5833333333333334,1.0,1.0,16/91,9.02%,P2RY10;TBC1D10C;SIRPG;SELL;TRAF3IP3;CD53;CYTH4;LTB;FMNL1;BATF3;KLRB1;CD5;TAGAP;TNFRSF4;TXK;IFIT3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.426268206597822,0.9832879666587645,0.4339622641509434,0.882532785574145,1.0,13/64,20.95%,HIF3A;EGLN3;HIF1A;RBPJ;PSMD13;PSME4;NFE2L2;PSMA1;VEGFA;CITED2;ARNT;LIMD1;PSMD4
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.4670738516846384,-0.983268597708676,0.4375,1.0,1.0,10/41,19.84%,CLDN4;CLDN1;F11R;CLDN15;CLDN16;CLDN5;MARVELD2;CLDN20;PATJ;LSR
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.549837552636391,0.9826185270272655,0.509090909090909,0.8836478357342222,1.0,8/15,35.11%,INTS6L;INTS6;INTS11;INTS14;INTS8;INTS3;INTS1;INTS2
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.6105472395096057,0.9824711222562503,0.5087719298245614,0.883602920141651,1.0,2/9,8.34%,CEL;CYP27A1
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),0.5895092823610164,0.9821215303747746,0.5517241379310345,0.884044588995041,1.0,1/7,8.92%,RHOU
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.5708636747138682,0.9820296410328956,0.5357142857142857,0.8838837435304064,1.0,3/11,13.65%,LATS1;KEAP1;DBN1
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.6031040007934398,0.9820086077097463,0.5102040816326531,0.8835320727577958,1.0,3/7,14.93%,MLLT3;CDK2AP2;NCOA3
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.5776992415209998,0.9819736882667123,0.5,0.8832501309581322,1.0,4/13,10.42%,SPR;GCH1;CYB5B;MTARC2
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.4347238398798604,0.981778848607424,0.5,0.8832690947400041,1.0,14/47,26.20%,STK33;PAXIP1;CHEK2;CDC5L;H2AX;BCL3;TP53;ABL1;HINFP;GRB2;DOT1L;MDM4;SESN2;BID
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.3918036047224824,0.9817626123495471,0.40816326530612246,0.8829181747142948,1.0,27/106,22.04%,PADI6;SIRT1;CCNA2;PADI2;PRMT1;RPS6KA4;HDAC2;CTCFL;EZH2;TBL1X;UBE2U;EYA2;KAT6A;PADI4;RPS6KA5;SIRT7;RUVBL2;SUPT3H;MIER3;NSD1;HDAC9;TBL1Y;HDAC1;UBE2A;NAA50;BRMS1L;MIER1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.41821051524718406,0.9816221032589478,0.47058823529411764,0.8828101860895976,1.0,23/76,20.60%,LGALS9;MAPKAPK2;TLR2;PLCG2;TICAM1;UBE2D3;HMGB1;TAB2;MAPKAPK3;IRAK1;MAP3K1;TAB3;BIRC3;FADD;IRAK3;LGMN;UBE2D1;TICAM2;ITGB2;RIPK2;SCARA3;IKBKB;TLR1
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.6010859084375343,-0.9813077134764124,0.5869565217391305,1.0,1.0,3/6,23.71%,XRCC1;FANCB;RAD21L1
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.5109391072510637,0.9813074188400156,0.5111111111111111,0.8831180207332336,1.0,6/16,23.85%,IL4;SNCA;CX3CR1;ITGB2;ITGAM;JAK2
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.5539470857037511,-0.9810612817466036,0.44680851063829785,1.0,1.0,6/9,37.31%,ATP5F1A;ATP5MC3;ATP5PB;ATP5F1C;VPS9D1;ATP5PD
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),0.6459952812851292,0.9805735243097345,0.5254237288135594,0.8844471136915419,1.0,1/6,1.67%,SYK
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.5783002642814654,0.9805509286834285,0.5208333333333334,0.8841020637425141,1.0,3/7,26.08%,CBS;CTH;MTR
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.4209633241737505,0.9805346007240836,0.42857142857142855,0.8837688558030367,1.0,16/95,22.27%,NXF1;U2AF1;THOC6;SMG1;NXT1;NXF5;SRSF11;HNRNPA2B1;RANBP2;FMR1;WDR33;NCBP1;ZFP36;NUP153;SRSF3;DDX19B
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.4645786092227199,-0.9802835230278919,0.5102040816326531,1.0,1.0,2/44,0.61%,NTRK1;DDX11
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.5479936679510654,0.9802457135286583,0.5370370370370371,0.8840411266679914,1.0,3/12,11.92%,PRKG1;BMPR1A;MEF2C
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.5806754197173707,0.9801912483499792,0.5416666666666666,0.8838004213139367,1.0,5/9,21.29%,HTR1F;HTR2C;HTR1E;HTR2A;HTR5A
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.4978400173235932,-0.9798775783452001,0.5,1.0,1.0,3/17,10.52%,SLX4;RTEL1;PARP1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.39682918537738604,-0.9797404514114004,0.45614035087719296,1.0,1.0,5/179,3.13%,ANXA8;GOLGA8B;SUN3;ALS2CL;TLCD2
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.490957552440821,0.9797189102304129,0.5576923076923077,0.8845331103994917,1.0,11/24,27.57%,TLR2;TAB2;IRAK1;MAP3K1;TAB3;IRAK3;TLR1;TAB1;TRAF6;CD36;TLR5
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.5556551233632191,0.9796167014612812,0.5666666666666667,0.8845053676991327,1.0,2/13,12.22%,CCDC125;FRMD5
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),0.6441151089416826,0.9795139174308403,0.5409836065573771,0.8844834031344474,1.0,2/5,16.52%,FBN1;NOTCH2
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.5395024332321092,0.9794888615948211,0.5614035087719298,0.8841681712653643,1.0,6/15,12.47%,NOX5;SEMA5A;NRARP;BMPER;LOXL2;CD34
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.4128413008446445,0.9793790755628539,0.4666666666666667,0.8840888956222404,1.0,11/71,22.18%,U2AF1;CPSF4L;THOC6;PAPOLA;PCF11;TENT4B;SRSF11;CSTF3;WDR33;NCBP1;SRSF3
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.6154055177990541,0.9791169649941445,0.5686274509803921,0.8843142067672859,1.0,3/6,11.63%,SMAD1;SMAD2;SMAD4
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.5667739554711506,-0.9789837451461362,0.4827586206896552,1.0,1.0,1/12,3.41%,ALOX5
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.5587597669706357,0.9789542493982283,0.5102040816326531,0.884275137828206,1.0,12/16,39.29%,TMEM98;TNFRSF21;TENM4;HES5;PTPRZ1;TNFRSF1B;NOTCH1;NF1;DRD3;PTN;SLC45A3;HES1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.35188811333736647,0.9789043726595642,0.425531914893617,0.8840179666512781,1.0,109/567,18.16%,DACH1;MITF;AASS;RUNX1;MYC;SIRT1;ZBTB7B;IL4;URI1;ZBTB1;FOXP2;PPARG;NEDD4;SNAI1;ZEB2;BMP2;BMI1;NFIL3;NRIP1;ZNF582;ZGLP1;KANK2;IRF8;VSX2;SMYD2;RBPJ;RELA;ZEB1;ZBTB2;ESR1;ZNF599;HDAC3;PAX6;HDAC2;NCOA5;MYPOP;UBE2D3;HMGB1;PPM1A;ZNF274;SNCA;FOXO3;ATXN1;TFEC;ZNF202;INSM2;RIPPLY2;TAF3;ZNF675;FRK;SMAD2;EZH2;ZNF669;LOXL2;ZNF692;ZNF239;TBL1X;NR1D2;PHF21A;SMAD4;NR1H3;MEF2C;ZNF536;PROX1;ZNF175;CTBP2;ZNF778;ZNF281;MYB;NR4A2;RNF2;KLF7;HEXIM2;NOC2L;MXD4;MYT1L;ZNF20;ID4;WWOX;RARB;BCOR;NR2F2;ZNF263;NFATC3;EPC1;THRB;HJV;HCFC1;SPEN;TRPS1;DEAF1;SIRT6;PEX2;HEY2;CNOT2;SMARCA2;RORC;IL33;SIRT7;VEGFA;TGIF1;MXI1;LCOR;TP53;MAZ;MIER3;EFNA1;CITED2;EED
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.6394400662835805,0.9788478185888297,0.5192307692307693,0.8837151219854179,1.0,3/5,22.12%,CRACD;CARMIL1;WASHC2C
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.460959842500843,0.9786785867275597,0.4,0.8837968145613759,1.0,8/30,21.98%,GLUL;SLC39A8;PYCR1;CPS1;RIMKLA;GLUD1;RIMKLB;OAT
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.4297339460251639,-0.9786722395475529,0.42,1.0,1.0,16/67,18.77%,TRIM56;DDX41;IRF5;FLOT1;POLR3H;POLR3E;OAS3;OAS1;DHX58;NFKB2;OAS2;CGAS;POLR1C;STAT1;POLR3A;IRF1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.5305238015623539,-0.97807813162394,0.4489795918367347,1.0,1.0,4/16,15.40%,SPRED3;SPRED2;SPRED1;CALM1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.6431847974684635,0.9776276257065322,0.5689655172413793,0.8859422313590758,1.0,6/9,34.75%,ABCD2;SLC30A10;SLC18A2;ABCB7;PPARA;TRAP1
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),0.5613612779989207,0.9775967275512084,0.5306122448979592,0.8856160129930413,1.0,2/13,13.08%,RRS1;XPO1
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.4683444944091014,0.9775794221328438,0.4727272727272727,0.8852671747330452,1.0,8/31,20.75%,PLEKHG2;HCLS1;LATS1;FCHSD2;DBN1;ABL1;MAP2;CAMSAP2
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.5684940542447767,0.9775669452866692,0.45652173913043476,0.8849186472421005,1.0,4/10,28.99%,ATP6V0A4;SLC26A4;PDK4;PDK2
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.35710784881067575,0.9772035944331158,0.3829787234042553,0.8854688720205856,1.0,57/353,17.45%,UHRF2;MKRN3;HIF3A;SIRT1;HIF1A;LZTR1;NEDD4;SPSB2;RNF152;RFWD3;SYVN1;PEX12;RNF182;TRIM50;KLHL21;KLHL8;ASB5;FBXL3;NEUROD2;UBE2D3;MSL2;SPSB4;DCUN1D1;ANKRD9;RNF139;UBE2Z;GAN;UBE2E3;KEAP1;ANAPC16;UBA5;FBXO7;TRIM26;HECW2;SHPRH;CNOT4;ARIH1;UBA6;UBE2J2;UBA3;TSPAN17;KLHL24;KLHL13;FBXL15;MIB1;TRIM52;RNF25;FBXL2;NFE2L2;PDZRN3;MARCHF3;PEX2;RNF26;RANBP2;FBXO11;KLHL7;RNF38
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.4566321599505665,0.9769565415573815,0.45652173913043476,0.8856868462908897,1.0,12/34,23.83%,MLC1;NEFH;RNF139;HAP1;ATPSCKMT;GAS1;REEP6;TTC21B;CAPN10;MAP2;MX2;CRYAB
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),-0.6281093077770007,-0.9767002083097898,0.631578947368421,1.0,1.0,2/8,8.13%,BST1;OLFM4
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.5828982490600979,0.9763630754916515,0.5689655172413793,0.886779399348932,1.0,2/9,7.24%,SYK;FER
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),0.598502471149759,0.9763364408467459,0.5932203389830508,0.8864479641187404,1.0,1/7,10.16%,CTNNA2
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.5274717334925845,0.9762585181823208,0.4782608695652174,0.8862196464552046,1.0,3/18,4.83%,CHRM2;HRH3;RGS10
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.5040909120346047,-0.9761882802563148,0.4897959183673469,1.0,1.0,2/17,6.30%,ENC1;PSMB4
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.6199968359500769,0.9760069601640542,0.5333333333333333,0.8865339672885045,1.0,2/7,28.30%,ATG2B;ATG9A
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.57553139473413,0.9755974073067476,0.5517241379310345,0.8872189843422866,1.0,1/10,5.88%,TLR2
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.5198995571686241,0.9755427202167789,0.5,0.8869221711156899,1.0,6/22,25.05%,PIK3CA;HSPA8;ABL1;MAP2;CAMSAP2;APOE
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.586491335636213,0.9755262928985309,0.5208333333333334,0.8865457897660759,1.0,2/11,8.04%,COX19;ANKRD9
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.5598262168730458,-0.9752561968443804,0.5384615384615384,1.0,1.0,4/14,12.82%,IL11;UBASH3B;KIF26A;IGFBP3
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.49586780008430204,0.975056390738349,0.5254237288135594,0.8872355899666681,1.0,9/26,21.42%,FZD5;ZBTB1;IL23R;HLA-E;FADD;CD55;HLA-F;HLA-B;TNFSF4
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),0.6606279713237251,0.9745787095028391,0.5932203389830508,0.8879532646123289,1.0,1/5,12.50%,TPRKB
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.5765469889027995,-0.9744868104203783,0.5098039215686274,1.0,1.0,2/12,8.08%,CLDN4;KCNQ1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.4222819001404077,0.9743349394615747,0.46511627906976744,0.8880837523160741,1.0,18/75,15.69%,SCN7A;SLC12A1;ASIC1;SLC12A3;SLC8A1;SCNN1B;SLC24A2;SCN10A;SLC9A2;SCN3A;SCN2B;HCN1;SLC6A16;ATP1A2;SCN9A;SLC9C2;ANO6;SLC9A9
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.6075911739654828,0.9742467336479615,0.5555555555555556,0.8879010563135977,1.0,3/6,17.31%,SPIRE2;ESPN;FMN2
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),0.6006647243575065,0.9739875656242468,0.6140350877192983,0.8880769686257771,1.0,1/8,3.70%,SLC38A3
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.41677008278993144,0.973917568092675,0.39655172413793105,0.8878091306455429,1.0,10/71,14.62%,DERL3;SYVN1;UBE2J1;DNAJB2;RNF185;AUP1;RNF5;UBE4A;UBE2J2;DERL2
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5565407224834659,0.9737059456920235,0.5102040816326531,0.8878996590813909,1.0,4/10,17.81%,ESR1;HMGB1;ATF7IP;TP53
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),-0.6067978625090322,-0.9731573065016571,0.5217391304347826,1.0,1.0,2/6,9.98%,HFE;MMP9
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.5211496961799403,0.9731115338016657,0.5098039215686274,0.8889219689377307,1.0,5/21,14.25%,CDKN2A;LATS1;PTEN;HEXIM2;NR2F2
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.47735155311938354,0.9730441120537356,0.4909090909090909,0.8887279470510304,1.0,9/49,14.50%,MYC;FZD5;FRAT2;LIX1;FZD1;HSPA8;DVL2;LRP6;FRAT1
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.5995620494916981,0.972852403980621,0.559322033898305,0.88875550200262,1.0,5/9,28.90%,RUVBL2;NUFIP1;NAF1;SHQ1;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.42859586272014005,0.9726774890232731,0.48333333333333334,0.888766008954656,1.0,7/48,11.21%,DPP10;STAC2;EPHA3;AGR2;RAMP3;EPB41;ARHGEF16
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.4102660620996391,0.9726727933491464,0.4745762711864407,0.8883794629973483,1.0,13/44,22.04%,SIRT1;HDAC3;HDAC2;TBL1X;SMARCAD1;SIRT6;SIRT7;MIER3;HDAC9;TBL1Y;HDAC1;BRMS1L;MIER1
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.45104403735280096,-0.9725891472422319,0.5384615384615384,1.0,1.0,5/51,7.78%,NTRK1;SLC6A6;FOS;EGR1;CLU
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.5840559418878567,0.972537771797336,0.5,0.8882937442062354,1.0,4/9,18.93%,WHRN;ADGRV1;COL11A1;KIT
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.37230971315224715,0.9725069784795741,0.5283018867924528,0.8879587507991572,1.0,43/177,20.59%,RAB38;FRMPD1;EHD1;MRAP2;NLGN1;DPP10;TNIK;ZDHHC22;SCRIB;NRXN1;RAB3C;ARL5A;RAMP3;LIN7A;ANK2;MAGI2;SAV1;RAPGEF6;EFR3A;ZDHHC2;KCNB2;RAB34;ANK1;KCNIP4;RAP1A;LRRC7;PACS1;TSPAN17;LRP6;DLG2;SYNE3;CPE;RAB29;DENND4C;ARL3;CD81;RAP2A;SMURF1;DLG3;RAPGEF2;BSG;ITGB2;IKBKB
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.40169094170616804,0.9724939586943753,0.48214285714285715,0.8875957299078733,1.0,9/87,6.51%,FGF10;STAB1;PRRX1;PPARG;GNG12;KANK2;LRIG3;TEAD2;WWTR1
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.4753290999699225,0.9722471073007845,0.46,0.8878162207436362,1.0,5/29,5.08%,IGF1;CANT1;HS3ST3B1;B3GAT2;UGDH
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.5935173143463008,0.9722425530344369,0.5079365079365079,0.8874309440588944,1.0,1/10,2.84%,KAT2B
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.4914285809985593,-0.9721490425906765,0.5384615384615384,1.0,1.0,3/23,8.08%,KCNMB2;PER2;KCNQ1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.4245213111029808,-0.9719071285084999,0.5217391304347826,1.0,1.0,12/84,9.02%,TRIM56;APOBEC3H;NLRP1;RNASE1;APOBEC3G;IFI27;TRIM5;IFIT1B;IFIT2;OAS3;OAS1;IFIT3
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.4019900879566786,0.9718114205079306,0.42592592592592593,0.8880699367263591,1.0,21/65,17.87%,FZD5;CDH2;NLGN1;SDK1;NRXN1;ACHE;NLGN4X;DSCAM;PLXNB1;LRRTM3;GPM6A;PLXNB2;LGI2;PTEN;FZD1;GABRB2;DNM3;RAB29;GRID2;FLRT3;FARP1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),0.6165240816299908,0.9717691267533178,0.5192307692307693,0.8877697061845196,1.0,2/6,13.37%,EHD1;MSR1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5681635966871653,0.9716523573059466,0.5625,0.8876845194023558,1.0,5/10,23.88%,ANK2;LRRC55;GAL;ATP1B2;AKAP9
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.49962204445851466,0.9716461809731366,0.4528301886792453,0.887311277243975,1.0,5/15,30.85%,TOB1;TENT4B;ZFP36;PABPC1;CPEB3
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.522242982835897,0.9716197245211711,0.5094339622641509,0.8869496573279962,1.0,3/20,7.07%,IGF1;PCM1;PAX6
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.44640047539187433,-0.9712714023754745,0.46938775510204084,1.0,1.0,5/30,9.71%,CD86;FGL1;HLA-DRB1;CEACAM1;PDCD1LG2
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),0.5667182858237085,0.9711835727299905,0.509090909090909,0.8874858545052892,1.0,1/11,1.82%,CCL5
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.4103425997344208,0.9711457187720228,0.5652173913043478,0.8872147502072627,1.0,15/73,15.08%,PCDH15;TYR;POU6F2;WHRN;ADGRV1;DHRS3;PAX6;GRM8;CRYZ;TULP1;CRYGS;RPE65;COL11A1;RPGR;ATF6
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.631407642292189,0.9710577637302522,0.5306122448979592,0.8870228395837992,1.0,3/6,11.63%,HIF1A;BMPR1A;SMAD4
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.5056735232780956,0.9709291684815442,0.4791666666666667,0.8868649206442916,1.0,2/23,4.07%,NDC80;NDE1
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.5588181672970864,0.9708267721343863,0.576271186440678,0.8868085657084637,1.0,3/10,9.44%,MCUB;SMDT1;MCU
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.5357428115726335,0.9708058141405314,0.5192307692307693,0.886459381449988,1.0,5/13,22.98%,ZFP36L2;NR3C1;ZFP36;ANXA1;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.49897313685920286,-0.9705626097103306,0.46938775510204084,1.0,1.0,5/20,10.34%,APOBEC3H;APOBEC3G;BTBD18;PIWIL2;DDX4
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.5421039102564895,-0.9701041429048273,0.5409836065573771,1.0,1.0,1/9,3.41%,ALOX5
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.4908305013947207,0.9699548529312386,0.45652173913043476,0.8881541262619899,1.0,4/21,10.41%,TOP2A;DNASE2B;HMGB1;ENDOG
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.4356292438225662,0.9699201331366183,0.5272727272727272,0.8878609321545281,1.0,5/53,9.14%,IRGM;TP53INP1;ATG101;STING1;RAB23
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.36365994308698757,0.9698897719787074,0.4423076923076923,0.8875398702307595,1.0,27/191,16.70%,SIRT1;NEDD4;SPSB2;SYVN1;PELI1;RNF185;UBE2D3;SPSB4;ANKRD9;SOCS6;RNF139;SPOP;UBE3D;SPOPL;PSMD13;TBL1X;HECW2;RNF5;UBE2U;KLHL42;PSME4;PML;RMND5A;NFE2L2;PSMA1;NHLRC3;CTNNB1
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),-0.5571406795982661,-0.969871685725631,0.5714285714285714,1.0,1.0,2/6,6.36%,FGF1;PAX2
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.45722177088704113,0.9697118051937528,0.5423728813559322,0.8876126591392379,1.0,11/33,19.73%,TNFSF13B;IL4;CD22;SASH3;CD40;MEF2C;CD74;TNFRSF21;CD81;IRS2;LYN
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.6149150617517627,-0.9696830924455321,0.5652173913043478,1.0,1.0,6/6,38.53%,GRN;ATP6AP2;CLN3;PPT1;CLN6;TMEM9
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.5836634802094851,0.9695639618641944,0.5294117647058824,0.8876123247928601,1.0,3/8,17.47%,TGFBR1;LRP2;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.47774859208148573,0.9686969876597566,0.43137254901960786,0.8892129819376734,1.0,5/18,24.45%,RALA;MCU;MFF;MARCHF5;MIEF2
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.5668478845639713,0.9686705050969402,0.5098039215686274,0.8888694301576928,1.0,3/7,9.30%,MYO1E;NPHS2;MAGI2
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),0.6350376029837794,0.9686329556868857,0.5185185185185185,0.8886159801325965,1.0,2/5,24.30%,DTYMK;DUT
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.5189791388969595,-0.9685771842064816,0.5,1.0,1.0,1/18,1.71%,RAC2
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.5230169075293336,0.9683996078428478,0.5454545454545454,0.88874424204086,1.0,4/16,8.78%,PCSK5;WNT9A;PDGFRA;DSCAML1
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.6224390955770752,0.9682431694789665,0.5,0.8887209838768774,1.0,1/6,16.17%,BAP1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.4454447048428601,0.9682221573603034,0.43103448275862066,0.8884286933408734,1.0,7/48,11.21%,DPP10;STAC2;EPHA3;AGR2;RAMP3;ZDHHC2;ARHGEF16
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.41349703257795495,0.9678390928906065,0.4897959183673469,0.889027506057973,1.0,4/67,4.98%,NOX5;ESPL1;SNX18;SEPTIN4
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.5664529753538258,-0.967746435137194,0.5208333333333334,1.0,1.0,4/11,16.15%,UPB1;NT5C;UPP1;TYMP
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.46546704942983674,-0.9677242852823718,0.3953488372093023,1.0,1.0,4/22,7.09%,SELP;SELE;UMOD;F11R
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),-0.6199668762888868,-0.967703802841805,0.5849056603773585,1.0,1.0,3/5,22.20%,PER2;E2F1;E2F3
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.42029660996813534,-0.9676025354863123,0.5306122448979592,1.0,1.0,8/47,12.20%,PALM3;SIGIRR;OAS3;OAS1;RNF113A;TRAIP;APOA1;PYDC1
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.46236992290642875,0.9674217425481709,0.45454545454545453,0.889569793144403,1.0,13/39,20.71%,BRINP3;RORB;WNT9A;EPHA3;HTRA2;ABL2;PTK7;CREB1;FZD4;RET;WNT2;LYN;ADNP2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.5135166810741068,-0.9674146917959103,0.5384615384615384,1.0,1.0,1/16,4.48%,EML3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),0.6235395254411076,0.9673165069133856,0.6037735849056604,0.8894286592042671,1.0,4/7,23.73%,VSIR;DDIT3;TNFSF4;IL12A
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.6096335978926145,0.9670560622284886,0.5172413793103449,0.8896233783114084,1.0,2/8,12.75%,SHMT2;CBS
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.4309381930330841,-0.9670149221177334,0.4222222222222222,1.0,1.0,3/61,1.15%,CD24;PALM3;SIGIRR
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.5755917458127096,-0.9669900954670843,0.5416666666666666,1.0,1.0,1/8,2.29%,IL11
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.5170357806325839,-0.9669214492921383,0.5,1.0,1.0,2/17,4.62%,SCN5A;CACNA1G
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.5464207290384957,-0.9668783641217953,0.5641025641025641,1.0,1.0,3/15,13.30%,SARS1;DARS2;DTD1
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.5309664033466195,-0.9668415926221409,0.5294117647058824,1.0,1.0,4/16,12.82%,IL11;UBASH3B;KIF26A;IGFBP3
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),-0.589201587052654,-0.9667072333323421,0.5581395348837209,1.0,1.0,2/5,29.70%,BNIPL;ATCAY
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),0.5823549604286481,0.9666151327619915,0.5357142857142857,0.8901702912186314,1.0,2/8,13.84%,CD244;CD74
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5637250206390322,0.9665015439286069,0.5416666666666666,0.8900123083418534,1.0,2/10,11.06%,BIN1;NPPA
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.4268798449049388,0.9663276679874954,0.4888888888888889,0.8900556381932422,1.0,13/66,15.37%,SIRT1;PPARG;ENPP1;BMP2;ZFP36L2;RORA;WWTR1;MEDAG;FOXO1;ANKRD26;CREB1;RUNX1T1;FRZB
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.5890163138702487,0.9662683808923163,0.5961538461538461,0.889825227377629,1.0,1/8,9.70%,PTPRT
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.477270046958843,0.9660943521415499,0.5111111111111111,0.8898295174085983,1.0,2/24,0.50%,GPR55;ADRA1A
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.46443907323852246,-0.9660283180829796,0.47058823529411764,1.0,1.0,9/35,13.89%,TERT;FOS;EGR1;JUN;SPI1;ATOH8;FOSL1;SMAD3;TGFB1
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.42151122027312427,0.9659806374038009,0.46,0.8896775378210138,1.0,14/90,22.27%,NXF1;U2AF1;THOC6;SMG1;NXT1;NXF5;SRSF11;HNRNPA2B1;RANBP2;WDR33;NCBP1;NUP153;SRSF3;DDX19B
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.6301713437301584,-0.9654755212451688,0.58,1.0,1.0,1/5,4.34%,TST
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.6162281117235013,0.9651509338186842,0.5576923076923077,0.8913387034635238,1.0,2/5,26.67%,STMP1;CD36
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.41106103363885993,-0.9646612094003694,0.5957446808510638,1.0,1.0,7/62,10.77%,PLA2G2C;PLAAT4;ENPP2;AGPAT4;PLCB2;PGP;PLB1
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.6008470721405311,0.9645842331215781,0.543859649122807,0.8923292978718831,1.0,4/7,34.47%,IGF1R;INSR;PICK1;PRNP
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.5761367198985264,0.9645567554344543,0.5660377358490566,0.8919980747145029,1.0,2/7,23.75%,GALK1;GALT
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.3902968495026578,-0.9643311990745409,0.5,1.0,1.0,23/141,12.54%,SELE;TEK;NLRP1;BST1;NLRP3;IL1RL2;MEFV;ALOX5;PRKCD;PTGES;AHSG;CD200R1;ZP3;HCK;MMP9;CCN3;TMSB4X;APOA1;IL18;TYRO3;FFAR4;PIK3AP1;AKNA
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.34520628644261153,-0.9642561181222138,0.5357142857142857,1.0,1.0,33/393,9.53%,TRIP10;NTRK1;ARAP3;CD24;TEK;PRDM1;RAC2;FGF1;BST1;PAK6;PLK3;RASGRF2;OBSCN;STARD8;RPF2;NEK8;VAV3;IER3;PRKD2;GPR143;ARHGAP15;ARHGDIB;ARHGAP12;TAGAP;RFC3;LBH;CHD4;CEACAM1;NTRK3;WWC1;RAD50;TAF11;TAF7
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.41368223211756733,0.964118822354992,0.5294117647058824,0.8926866771316994,1.0,12/43,22.04%,SIRT1;HDAC3;HDAC2;TBL1X;SIRT6;SIRT7;MIER3;HDAC9;TBL1Y;HDAC1;BRMS1L;MIER1
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.45130789009169253,0.9637191331770749,0.4444444444444444,0.8932298931464213,1.0,7/36,23.18%,ATXN1;NXT1;ANP32A;XPO1;RGS14;NCBP1;GEMIN6
prerank,GO_Biological_Process_2021__long-chain fatty acid catabolic process (GO:0042758),0.5930626943943678,0.963652503585606,0.5,0.8930044723270261,1.0,2/5,14.38%,GLYATL2;AIG1
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.36241588503358135,0.9636220291526963,0.5,0.89269022247149,1.0,34/143,19.93%,NRG1;ANGPT1;DNAI4;DLGAP5;IMMP2L;CHCHD4;VAMP1;SNCA;PDE4DIP;SMAD1;HIP1;SMAD2;PSMD13;BIN1;TCF4;VAMP3;DNAAF3;PXN;SMAD4;ANLN;NCK2;PICALM;PSMG2;DMD;HIGD1C;POGZ;HIGD1B;PRLR;GTF2B;DNAAF2;TBCA;VAMP4;MID1IP1;TBCE
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.42492270834717805,-0.9635999300843775,0.5192307692307693,1.0,1.0,11/54,11.61%,CLDN4;COL5A1;CLDN1;ALOXE3;FLG;COL1A1;HRNR;FLG2;STMN1;WNT10A;ALOX12B
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),0.5900124773309687,0.9635966153171666,0.6136363636363636,0.8923706829707855,1.0,1/10,3.95%,STEAP4
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.6035090154283294,0.9635653937961024,0.55,0.8920569790880293,1.0,3/6,25.79%,HLA-E;ANXA1;STOML2
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.5282917281736766,0.9632841405271217,0.5,0.8922603285080943,1.0,1/24,0.40%,PNP
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),-0.6098555042688193,-0.9629319864753999,0.6086956521739131,1.0,1.0,4/8,20.90%,DRD2;HTR2B;HTR1D;EDN3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4656389431176088,0.962629652136787,0.48,0.8934632932463566,1.0,7/29,21.51%,BOK;TP53BP2;MAPK8;PPP3CC;TP53;BAD;PPP1R13B
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.5074892394074721,-0.9623601670120876,0.5283018867924528,1.0,1.0,1/27,0.17%,TERT
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.5568395783138337,-0.9619728810824714,0.5892857142857143,1.0,1.0,6/9,26.12%,MEOX1;PTCH1;SMO;PPP2R3A;SFRP2;MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),0.6200073473823458,0.9618327957299312,0.5862068965517241,0.8951204823412219,1.0,1/6,10.16%,CTNNA2
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.5195886010950747,0.9616381908777426,0.5344827586206896,0.8952390016244383,1.0,1/13,1.76%,MYC
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.39354658993866704,0.9615919273116302,0.5,0.8950190392115049,1.0,15/70,17.16%,PLOD2;MMP15;ST8SIA4;UBE2D3;ABL2;ST3GAL6;LOXL2;QPCT;UBA3;CSNK1G3;FBXL2;CPE;PADI4;BAP1;FBXO11
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.3964769883320941,0.961050051202552,0.5348837209302325,0.8958416908742992,1.0,20/106,14.83%,SHMT2;ZBTB1;KCNC2;EHD1;ASIC1;STEAP4;PRMT1;VSTM5;TIFA;TDO2;ALDH9A1;C9;TK1;CRYZ;HCN1;HSD17B10;TRPM2;ACACA;TMEM120A;ACACB
prerank,GO_Biological_Process_2021__positive regulation of lipoprotein particle clearance (GO:0010986),0.6298381754518787,0.9609203891539101,0.5531914893617021,0.8957879308444768,1.0,5/5,37.03%,LIPG;ANXA2;GPIHBP1;LDLRAP1;GPLD1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),0.6619906333917563,0.9608888433916492,0.5869565217391305,0.8950603337293856,1.0,1/5,5.20%,DIPK2A
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),0.6619906333917563,0.9608888433916492,0.5869565217391305,0.8950603337293856,1.0,1/5,5.20%,DIPK2A
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.526387799279223,0.9604741357756617,0.5686274509803921,0.8956712106507546,1.0,4/15,17.69%,CD40;GSN;ANO6;AKR1C3
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.5159155238753661,0.9604554291130264,0.5,0.8953354399303961,1.0,4/15,12.69%,BMP2;HPSE;PLXNB1;GREM1
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),0.5843528507767441,0.960198859633397,0.509090909090909,0.8955364161557695,1.0,1/6,9.65%,NECTIN2
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.4623615018221884,0.9599770430021358,0.4888888888888889,0.8956045447144174,1.0,4/24,14.30%,TIMELESS;KLK14;TBX18;LRP6
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.44540313675010784,0.9595231491662077,0.4888888888888889,0.8962804460199969,1.0,11/42,10.71%,HS3ST5;HS3ST3B1;HS3ST1;UGDH;HS3ST2;SDC4;GPC5;HS2ST1;GPC4;EXT1;SLC35D2
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.5556953891588925,0.9594806533159214,0.5471698113207547,0.8960223177677283,1.0,5/19,10.25%,ZBTB7B;LY9;VSIR;IL15;IL23R
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.4383007689618178,-0.9593737403043859,0.5961538461538461,1.0,1.0,7/35,15.40%,PRKCD;PPP6R1;ARPP19;PTPA;TGFB1;ANKLE2;CALM1
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.5997454016418096,0.9593676814683613,0.54,0.8959134780628296,1.0,1/6,7.89%,SNCA
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.5021848627886346,-0.9590538851339809,0.4791666666666667,1.0,1.0,2/18,1.88%,DOCK8;CXCL13
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.641396375046853,0.9589504208670384,0.5961538461538461,0.8964448919277296,1.0,4/6,31.45%,ANGPTL4;HDAC9;RGS2;PLIN5
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.5005452813709224,0.9589078386415958,0.509090909090909,0.8961153141616459,1.0,2/13,2.81%,SEMA5A;FGF2
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.35194905540416843,0.9588579422313533,0.5652173913043478,0.8958742413593788,1.0,71/464,12.71%,ADRA1A;SMAD6;SIPA1;SEMA5A;CDKN2C;MYC;SIRT1;F2R;ERBB4;GNRH1;FGF2;KAT2B;ANGPT1;ENPP1;CDKN2A;CDKN2AIP;FBXO5;BMP2;TENM1;ST18;KANK2;DUX4;CCN4;SMYD2;NAIF1;TEX15;CCN6;SSTR3;TLR2;DNAJB2;WNT9A;TP53INP1;P3H2;TDRD9;AGR2;HTRA2;TOB1;DLC1;GMNN;RNF139;CBFA2T3;ARID2;PTPN14;MAGI2;DSCAM;SERTAD2;TMEM115;TMIGD3;FRK;BTN2A2;IGFBP6;PLXNB1;RPS6KA2;ITGA1;PTPRK;SINHCAF;VAMP3;DACT3;SMAD4;PLXNB2;GNG4;NR1H3;BNIP3L;TP53BP2;NCK2;PROX1;PTEN;H2AC6;CTBP2;CD34;KNG1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.4913093999031658,0.9587229974620552,0.559322033898305,0.8958042324962874,1.0,5/21,14.37%,IL4;LATS1;SMAD2;SMAD4;NREP
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.44810849537030684,-0.9585796543210785,0.5094339622641509,1.0,1.0,2/58,3.43%,TERT;PRKCD
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.4299452592427395,0.9581642071259128,0.5471698113207547,0.8966212583690146,1.0,9/40,16.86%,GAB1;ERBIN;PIK3CA;NCK2;BCAR1;SOS1;SLC30A10;FAM83A;RPS6KA5
prerank,GO_Biological_Process_2021__cellular ion homeostasis (GO:0006873),0.659386739791857,0.9581509566014287,0.6557377049180327,0.8962536222724924,1.0,1/5,16.05%,SLC4A1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.4708279220408671,0.9577918011345654,0.6101694915254238,0.8966073828364725,1.0,9/32,19.57%,TULP3;EHD1;BBS9;TULP1;ROPN1B;RAB29;ARL3;TTC21B;IFT140
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.4833559338875608,-0.9575082436875841,0.52,1.0,1.0,3/25,6.07%,PRKCD;MVP;SFRP1
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3940164765910685,0.9573095936428354,0.4318181818181818,0.8973349822780856,1.0,32/122,20.02%,MYC;SIRT1;ZBTB1;KAT2B;PADI2;SNAI1;ESR1;HDAC3;HDAC2;ACTL6A;SMARCD3;LRWD1;EZH2;LOXL2;HP1BP3;ARID1A;MYB;SETD7;SMARCAD1;SMARCD2;HCFC1;PADI4;HMGN4;SMARCA2;CHD1;RUVBL2;KDM6A;KDM5B;BRWD1;NPM3;SATB2;HDAC1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3673934151508718,0.9572674845607327,0.5106382978723404,0.8970280097464021,1.0,36/160,20.78%,PROZ;VAPB;F2;GOLT1A;SEC22B;SPTBN5;CD59;ANK2;LMAN1;TRAPPC3L;BET1;TMEM115;COL7A1;DCTN3;DYNC1I2;ANK1;LMAN2L;MIA2;RAB29;COG5;VTI1A;KLHL12;CD55;TMED1;TMED3;TRAPPC8;STX17;VAMP4;TFG;STX5;TRAPPC1;ACTR10;SEC24B;TICAM2;TRAPPC2;SAR1A
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),0.511452602261547,0.9570814886727083,0.5102040816326531,0.8970456451091087,1.0,4/21,3.59%,GPR55;MYC;IL4;MAFB
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),0.6199700483489697,0.9570771003887544,0.5370370370370371,0.896667623400937,1.0,3/5,34.81%,ANXA2;NR1H4;LDLRAP1
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.4279624805786052,0.9568971139570959,0.46296296296296297,0.896668919663872,1.0,19/46,26.23%,FGFR1;CEP85L;AUTS2;GPM6A;MEF2C;NR4A2;LRP12;KIAA0319;CDKL5;VEGFA;RAPGEF2;ADGRL3;ASTN2;PEX13;USP9X;SPOCK1;NRCAM;DNER;SDCCAG8
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.5103583706955613,0.9568178347076529,0.48936170212765956,0.8964670724961147,1.0,2/16,12.00%,CEP135;CEP120
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.5952112542526357,0.9566892807324991,0.5370370370370371,0.8963806454641113,1.0,4/6,39.96%,DLG1;CYLD;DUSP10;DUSP1
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.46753678275542837,0.9564561924583749,0.5272727272727272,0.8965137180658577,1.0,8/28,25.46%,TET2;METTL21C;ATPSCKMT;VCPKMT;KMT5B;SETD2;OGT;SETD5
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.5359022545482443,0.9563699008649911,0.5172413793103449,0.8959793014735632,1.0,6/9,45.07%,VTA1;CHMP1A;CHMP2B;IST1;CHMP5;CHMP7
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.5359022545482443,0.9563699008649911,0.5172413793103449,0.8959793014735632,1.0,6/9,45.07%,VTA1;CHMP1A;CHMP2B;IST1;CHMP5;CHMP7
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.5191320398656519,-0.9562625106196575,0.4090909090909091,1.0,1.0,5/18,20.54%,TIMP4;PTPN3;PACSIN3;ADAM8;ADAM9
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.5872394163177135,-0.9561993613076365,0.5111111111111111,1.0,1.0,1/12,3.41%,ALOX5
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.4617364161966992,0.9561033752666317,0.5208333333333334,0.896221947613285,1.0,5/29,16.87%,FGFR3;DCC;PTEN;KIAA0319;DIP2B
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.4846802223806031,0.95584322722643,0.5645161290322581,0.8963220032526418,1.0,8/27,18.47%,FGF10;SCRIB;MTSS1;MEF2C;RYR2;MESP1;CTNNB1;RHOB
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.38847131614767993,-0.9555218514750476,0.5192307692307693,1.0,1.0,12/128,8.13%,GFRA3;NTRK1;FGF1;MAPK4;TST;NRN1;CAMK2A;LGI4;MPZ;TAGLN;ARNT2;TCEAL6
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.5046255311776379,0.9554915437300179,0.5208333333333334,0.8966683020883394,1.0,3/14,14.88%,TLR2;HMGB1;PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.5707133984958498,0.9552575423491539,0.5185185185185185,0.8969048733839876,1.0,3/8,19.73%,PICALM;EFNA1;LYN
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5195492830750428,-0.955245209576494,0.5116279069767442,1.0,1.0,1/13,2.27%,DRD4
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.6163400321883785,0.9552219413310569,0.6226415094339622,0.8966107206357918,1.0,2/7,11.43%,RIOK2;HECW2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.5419965723353477,-0.9550846709327993,0.5098039215686274,1.0,1.0,5/12,12.70%,SCN5A;KCNN2;KCNQ1;KCNA5;SCN3B
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.5206369815349883,-0.9550429477467118,0.5869565217391305,1.0,1.0,4/21,4.93%,DRD4;STAC;CBARP;DRD2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.48523967798869516,0.9550111990030424,0.5172413793103449,0.8966995067153994,1.0,8/20,23.10%,MCUB;SMDT1;RAP1GDS1;MCU;MICU1;PDZD8;MAIP1;BCAP31
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.3927007742273309,-0.9549368081537702,0.5454545454545454,1.0,1.0,20/98,18.74%,UVSSA;SLX4;ERCC1;FANCC;RFC3;XPC;PRPF19;PARP1;GTF2H2;FAN1;COPS7A;LIG1;XRCC1;RPA3;RFC2;RFC1;COPS7B;LIG3;PNKP;COPS6
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5547950331157735,0.9544170944264774,0.5833333333333334,0.8975860569971118,1.0,4/13,19.74%,APOBEC1;RESF1;ATF7IP;TRIM28
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.5145415896229557,-0.9543940573388525,0.6041666666666666,1.0,1.0,2/16,8.18%,OAS3;OAS1
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.5829129206038767,0.9541294981229507,0.6363636363636364,0.8978819217592097,1.0,2/8,7.24%,SYK;FER
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.35575846940674044,0.9539965306536365,0.5,0.8978280943420293,1.0,44/234,15.78%,NOX5;SCN7A;SLC12A1;MCOLN3;KCNC2;KCNK2;TRPM8;SLC1A3;ASIC1;TRPV2;TRPC4;SLC12A3;KCNH7;SLC8A1;KCNH4;KCNQ5;KCNH8;KCNH5;ITGAV;SLC39A8;SCNN1B;SLC24A2;SCN10A;ATP6V0A4;SLC9A2;SCN3A;LRRC55;SCN2B;HCN1;SLC6A16;KCND2;ATP1A2;KCNB2;SCN9A;TRPC5;KCNG2;SLC9C2;TRPM2;ANO6;KCNF1;SLC30A10;SLC30A6;SLC9A9;KCNAB3
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.4631974478902235,0.9539528802140926,0.5476190476190477,0.8975396317902149,1.0,1/24,0.92%,MSH4
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),0.6502375219192502,0.9538821050287096,0.6458333333333334,0.8973277894000465,1.0,3/5,22.38%,LRRC17;TP53;PTPRC
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.4985489242983424,-0.9538632493652379,0.5098039215686274,1.0,1.0,1/17,4.71%,LDB1
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.4492461029217563,0.9535189415889948,0.52,0.8978631964087039,1.0,8/33,20.47%,TRPC4;SLC39A8;TF;TRPC5;SLC30A10;SLC30A1;ATP2C1;TRPC1
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.5976676484746702,-0.9533413582058055,0.5714285714285714,1.0,1.0,4/9,18.26%,TAF11;TAF7;TBP;TAF7L
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.41913976524645113,-0.9522660125193032,0.5263157894736842,1.0,1.0,11/67,6.58%,ALB;CLDN4;CLDN1;KIF12;HABP2;AHSG;FGL1;DSG2;PAH;FOXM1;MYO5B
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.558487213933198,0.9520842574993464,0.5441176470588235,0.9007583242672487,1.0,2/8,11.93%,ENGASE;MAN2A1
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.5779482334054725,-0.9520559755085873,0.4909090909090909,1.0,1.0,1/7,6.91%,PRKD2
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),-0.5781036404844416,-0.9519486508869718,0.5882352941176471,1.0,1.0,1/6,2.64%,TIE1
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.4748758071407823,0.9518425854515977,0.5,0.9008831901245582,1.0,2/19,6.44%,CTDNEP1;TOR1B
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5354715359597128,0.9517218202872658,0.5862068965517241,0.9007084129458698,1.0,6/16,21.86%,ELOVL5;ACSBG1;TECR;ACSL4;ELOVL6;ACSL1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),0.6215762888361374,0.9516311345035479,0.5686274509803921,0.9005120085226141,1.0,1/5,6.14%,DNAJB2
prerank,"GO_Biological_Process_2021__positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)",0.6359660926353742,0.951505260147185,0.6538461538461539,0.900408276238929,1.0,2/5,4.15%,RSPO3;MLLT3
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.5303615210133964,-0.9514391931750689,0.5121951219512195,1.0,1.0,3/14,16.11%,F11R;S1PR3;CLDN5
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.4682338406059545,0.9514075125235477,0.48148148148148145,0.900282874884481,1.0,10/26,20.31%,VCAN;BGN;CHSY3;UGDH;DSEL;CSGALNACT1;BCAN;HEXB;CHST15;CSPG4
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.40901498078881265,0.9513200325212658,0.49206349206349204,0.9000705889647131,1.0,26/85,24.90%,MYC;CDC25A;ZBTB1;NEDD4;RELA;PRIMPOL;PTPRK;REV1;MAPK8;NOC2L;PCLAF;BCL3;RUVBL2;TP53;FMR1;POLK;UBE2A;SCARA3;TMEM161A;ERCC3;MAP4K3;IL12A;ERCC8;N4BP1;EP300;EGFR
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.5746495067304401,-0.9509718720798263,0.5,1.0,1.0,2/6,21.54%,BRCA1;DNMT1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.41116795725686756,-0.950740584770114,0.5106382978723404,1.0,1.0,5/54,9.45%,HK2;DDX18;LAS1L;PLK4;RABEPK
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.582968557806006,0.9507369083224291,0.6181818181818182,0.9006786963126754,1.0,3/9,14.44%,PPP3CA;PPP3CC;NFATC3
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.582968557806006,0.9507369083224291,0.6181818181818182,0.9006786963126754,1.0,3/9,14.44%,PPP3CA;PPP3CC;NFATC3
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.3974011465181688,0.9504876875959904,0.6041666666666666,0.9007868837128704,1.0,21/90,10.58%,LGALS9;SMAD6;HSD17B2;F2R;SOCS2;PPARG;SCD;PELI1;MAPKAPK2;ESR1;LOC400499;FER;SNCA;FOXO3;ERBIN;GCH1;TAB2;MAPKAPK3;IL23R;SRR;FOXO1
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.4093634408778221,-0.9504741951187008,0.5208333333333334,1.0,1.0,15/82,9.97%,COL23A1;COL24A1;COL4A2;COL27A1;COL5A1;PXDN;COL4A1;LOXL4;COL28A1;LAMB3;COL6A3;COL11A2;ADAMTS3;COL26A1;COL1A1
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.5850510662766392,-0.9504383001826401,0.5609756097560976,1.0,1.0,1/8,4.91%,OLFM1
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.5144706588281166,0.9502936526831685,0.6078431372549019,0.9008189914886844,1.0,3/17,15.58%,SLC22A3;SLC22A5;SLC44A4
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.4732114000270716,-0.9502227498020449,0.41304347826086957,1.0,1.0,1/17,0.61%,DDX11
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.3853064117219078,0.9500394257165105,0.62,0.901002984505493,1.0,26/102,15.94%,PMP2;ALDH1A1;GFAP;NDRG2;FREM1;PCDH17;DHRS3;EFS;NRXN1;MEGF10;PTPRD;RAMP3;ANK2;PTPRT;GRIK3;ATP1A2;CNTN1;ZNF536;GPM6B;INTS6;ID4;CRTAC1;L1CAM;FRZB;GPRC5B;CNTN2
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.5062412750872562,0.9498208491301613,0.5283018867924528,0.9011434370397716,1.0,6/17,25.74%,ANO6;AFDN;ADAM10;BAD;NUP153;AHCTF1
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.3907467595317909,-0.9493368466364163,0.4666666666666667,1.0,1.0,19/90,12.15%,P2RY10;SELL;DOCK8;TRAF3IP3;CD53;CYTH4;CD86;CUX2;JCHAIN;BTK;IRF5;HCK;TAGAP;LY86;CARD6;SPI1;ZFAT;LAMP5;PARVG
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.41034848550679676,0.9492844098848785,0.4489795918367347,0.9018366992762219,1.0,14/93,22.27%,NXF1;U2AF1;THOC6;SMG1;NXT1;NXF5;SRSF11;HNRNPA2B1;RANBP2;WDR33;NCBP1;NUP153;SRSF3;DDX19B
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.5373243915562687,0.9490925379361514,0.5416666666666666,0.9018683103207261,1.0,3/12,23.84%,HAP1;TRAK2;MEF2A
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.608395259867349,0.9490575639473617,0.6271186440677966,0.9015965821637878,1.0,2/7,10.25%,ZBTB1;IL23R
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.45828380402164465,0.9490417949697525,0.48,0.901260114756626,1.0,6/39,14.42%,TGFBR1;RAPGEF3;PPM1E;PXN;CARMIL1;SORBS3
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.5207447910119787,0.9485853057533714,0.6,0.9019251015930179,1.0,4/12,13.00%,NLGN1;NLGN4X;LRRTM3;FZD1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.4149811607201733,0.948473415175231,0.5769230769230769,0.9017997479625822,1.0,12/64,8.80%,FLT1;FGFR3;SYK;FGFR1;ERBB4;IL4;ABI3;PDGFRA;FER;EPHA3;IL15;ABL2
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.480275165400256,0.9484017418584962,0.5106382978723404,0.9015933920863878,1.0,5/28,7.89%,SYT15;HRH3;SYT6;SYT1;SNCA
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immune response to tumor cell (GO:0002842),-0.5915402496239053,-0.948334750048042,0.5306122448979592,1.0,1.0,1/5,7.55%,HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.4752271502798956,0.9482205177712509,0.5531914893617021,0.9016250256880506,1.0,3/27,9.22%,TIMELESS;PAXIP1;ARID2
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.506900188782795,0.9481526906894215,0.47058823529411764,0.9014729430909567,1.0,9/21,22.38%,F2R;FGF2;PLCG2;HTR2C;TRPM2;RYR2;RYR3;HTR2A;PTPRC
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.43970787541236794,0.9478610992841563,0.5686274509803921,0.9017368164315642,1.0,7/39,18.31%,ZBTB20;LIN28A;UNC13B;GCK;IGF1R;PRKAA1;IRS2
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.5090836131284237,0.9476907331871655,0.5185185185185185,0.9018007385225263,1.0,1/14,0.92%,SMYD1
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.575645227161783,0.9473946246161276,0.6122448979591837,0.9021236068356507,1.0,4/8,19.62%,SNCA;RYR3;SLFN14;FBP1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.4507406904299464,0.947379980165549,0.5961538461538461,0.9017774018886663,1.0,7/27,17.76%,IL4;MARVELD3;CORO1C;PTEN;PTPRM;NR2F2;PTPN23
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.4795301819829879,0.9471093398565342,0.5471698113207547,0.9020460960839447,1.0,5/23,13.86%,ADIPOR2;PRKAB2;ELOVL5;NR1H3;MLXIPL
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.41490297235348383,0.9469839090314144,0.47368421052631576,0.901937331886326,1.0,13/57,20.47%,HIF1A;NEDD4;SNCA;LOXL2;SLC25A13;PPP3CA;PLSCR1;SLC30A4;GPHN;SLC25A12;SLC30A2;ZACN;TRPC1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.6093081509999282,0.946971443938987,0.5614035087719298,0.901618574231155,1.0,2/5,24.00%,FBXO7;LANCL1
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.5832305884652331,-0.9467655614940185,0.5625,1.0,1.0,1/7,5.37%,RNF8
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.6116757699190866,0.9465327684631102,0.6071428571428571,0.9022692987965363,1.0,3/7,26.67%,SLC15A2;BIRC3;CD36
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.40796705181189885,0.9464965612096472,0.5769230769230769,0.9019775804616652,1.0,9/60,12.93%,LGALS9;FZD5;CD244;SCRIB;VSIR;HMGB1;IL23R;PDE4B;IL18R1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),0.648958529027742,0.9463258574812791,0.5740740740740741,0.9019604874056256,1.0,2/5,23.10%,RAP1GDS1;BCAP31
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.4036473566900748,0.9463182484715702,0.5769230769230769,0.9015992313895922,1.0,10/69,14.33%,PLEKHH2;LDLR;NAV3;SNCA;KANK1;PIK3CA;SMAD4;HDGFL3;HSPA8;DYRK1A
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.44155778193212103,0.9462603538447653,0.5957446808510638,0.9013565390060674,1.0,4/41,7.04%,RAPGEF3;NEDD4;HCLS1;HDAC3
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.5372380575808251,0.9462594602739403,0.6153846153846154,0.9009797177104962,1.0,4/13,18.27%,PCM1;CEP120;SYNE3;SUN2
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),0.6053060312405423,0.9460121252402125,0.5625,0.9011725403055604,1.0,2/5,29.59%,FLRT3;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.4699014746435191,0.9458941898630453,0.5535714285714286,0.9011450816547194,1.0,10/23,25.02%,HIF1A;RBPJ;ATF6;NFE2L2;VEGFA;TP53;HSPA5;DDIT3;ATF3;SESN2
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.4668218495163751,0.9458339974397066,0.5660377358490566,0.9009137173123886,1.0,7/32,13.21%,C3;IL4;BICD1;TF;HIP1;SMAP1;PICALM
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5188183425425205,0.9456348235417914,0.5208333333333334,0.9009400326336878,1.0,6/21,15.30%,RAB27A;CCN6;PLCG2;SNCA;ABCD2;SLC30A10
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.441146070025925,-0.9455733272395294,0.5,1.0,1.0,5/37,10.52%,DDX11;KDM4D;FOXM1;RAD51AP1;PARP1
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.4096278379007681,-0.9454102266803098,0.4772727272727273,1.0,1.0,14/81,7.93%,P2RY10;KLRC1;SIRPG;SELL;SPON2;TRAF3IP3;CD53;CYTH4;HSD11B1;LTB;DOCK2;KLRB1;CD5;TAGAP
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.48725510834915337,0.9453171561466036,0.6181818181818182,0.9012987740252683,1.0,5/30,13.04%,FERMT3;MYL12A;PDGFRA;CSRP1;HSPB1
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.5287517238149193,0.9451757834878382,0.5434782608695652,0.9012873880224547,1.0,8/11,29.59%,ZFP36L2;NELFB;JAG1;HNRNPU;YTHDF2;HES5;N4BP2L2;NOTCH1
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.4332411793597051,0.9450194991171583,0.576271186440678,0.9011474292390322,1.0,4/37,6.74%,PNP;RUNX1;NAV3;PLCG2
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),0.5731218412187064,0.94491599890834,0.6037735849056604,0.9010182978126753,1.0,3/8,7.75%,CCL5;EPS8;HMGB1
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.4352405649554332,0.9446998871101149,0.576271186440678,0.9011622836779932,1.0,11/50,22.12%,EHD1;VPS26C;SNX31;DENND1B;WASHC1;ANKRD50;VPS29;PTPN23;MICALL1;VPS50;WASHC2C
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.6061084653331661,-0.944644526703446,0.6153846153846154,1.0,1.0,2/6,29.20%,TRDN;EHD3
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.48492561152921476,-0.9444503243314896,0.5714285714285714,1.0,1.0,5/31,14.25%,RAC2;ENPP2;CLRN1;RREB1;RAC1
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.37179202066686096,0.9444018978027501,0.5254237288135594,0.9014827294634666,1.0,39/149,17.55%,IL17RD;PAWR;MYC;FZD5;LRP4;ROR1;GNG12;FRAS1;TENM3;DOCK1;ALDH7A1;LRIG3;CD59;FBLIM1;TEAD2;ADGRL2;LIFR;SMAD1;DSP;PTPN14;MAGI1;TSPAN6;SMAD2;SMAD4;CLDN6;FZD1;PTK7;PML;LRP6;L1TD1;ANO6;SMAD5;GJB1;GJC1;BCL3;NXN;CTNNB1;PIWIL1;DCBLD2
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.628242177100971,0.9443666524184111,0.5818181818181818,0.9011610673608822,1.0,4/6,12.03%,MAPKAPK2;MAPKAPK3;CARMIL1;RAB34
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.633794598564328,-0.9443462203136309,0.5121951219512195,1.0,1.0,4/5,29.73%,PINK1;HAX1;PRKN;ATP5IF1
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.5689423215861115,-0.9442033810927756,0.6078431372549019,1.0,1.0,1/8,3.18%,ENPP2
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.5304958067020269,0.9441473891080662,0.5471698113207547,0.9011925386709817,1.0,5/11,37.49%,TERF1;CCT3;CCT7;DKC1;CCT4
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.4619757765871626,0.9437753321872613,0.5964912280701754,0.9017584066658658,1.0,5/25,8.69%,TCIRG1;ATP6V0D2;RAB38;RAB39A;ATP6V0A4
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.5874477930895926,-0.943772838578178,0.543859649122807,1.0,1.0,2/7,12.81%,ENPP2;RREB1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.46574091691106856,0.9437300508153333,0.5087719298245614,0.9014904511327154,1.0,3/21,6.74%,PNP;RUNX1;PLCG2
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.5354280148467763,0.9436795982161752,0.6,0.9008431187498019,1.0,5/18,12.52%,IL1RAPL2;SNCA;PTPRD;GPC4;LRFN5
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.5354280148467763,0.9436795982161752,0.6,0.9008431187498019,1.0,5/18,12.52%,IL1RAPL2;SNCA;PTPRD;GPC4;LRFN5
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5704454601307734,0.9435862301975048,0.5384615384615384,0.9007466082082514,1.0,1/8,2.54%,HIF1A
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.4866578855872971,0.943561325114231,0.5283018867924528,0.9004368521203405,1.0,2/16,4.04%,RAB27A;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.5175991743867547,-0.9435436230624715,0.625,1.0,1.0,7/18,22.46%,SFRP1;PDCL;TXNDC15;DCDC2;EVC;TTC23;SMO
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.44199899484589955,-0.943499989588792,0.54,1.0,1.0,20/59,17.76%,NUPR1;ALOX5;XDH;SFRP1;CEACAM1;VDR;SPARC;CAV2;ATOH8;WDR77;DAB2IP;CAV1;TGFB1;CDKN1C;SCG2;MED1;TGFBR3;FGFR2;STAT1;RGCC
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.5811676865253395,-0.9434403282868253,0.5714285714285714,1.0,1.0,4/5,41.43%,MAPT;DNM1L;CLUH;ARMC1
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.4694194952817191,-0.9432024140203962,0.5869565217391305,1.0,1.0,4/35,14.01%,CENPH;RNF8;ITGB3BP;SMARCA5
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.39015257570569695,-0.9428009536073506,0.5892857142857143,1.0,1.0,3/97,2.09%,ACOT1;PM20D1;PLAAT4
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5821046167800124,0.9427081807826997,0.6271186440677966,0.9019558616142023,1.0,2/9,6.36%,FGF2;APELA
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.33550694583962054,0.9426655181695127,0.5454545454545454,0.9017311205237599,1.0,26/317,9.14%,REP15;TCIRG1;ATP6V0D2;TVP23B;RAB38;TBC1D3L;ACD;TBC1D8B;PPARG;EHD1;TBC1D12;LRP1B;IL10RA;RAB31;LTBP2;RAB3C;VPS26C;ABCA1;TF;MTTP;ARL5A;SNX31;RAMP3;ATP6V0A4;ARRDC3;RAB23
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.5384377571387022,-0.9423429765320587,0.5869565217391305,1.0,1.0,3/16,11.75%,FBXO43;CAV2;KIF20B
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.5630826486735806,0.9423167324758105,0.6153846153846154,0.9021350939406625,1.0,6/12,39.36%,TIPARP;PARP8;PARP14;PARP9;PARP6;PARP3
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.5564271753461256,-0.942304142690262,0.6,1.0,1.0,3/15,10.52%,NUPR1;ACTN3;PARP1
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.5375783164245771,-0.9421970789164203,0.56,1.0,1.0,1/11,2.45%,DGAT2L6
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.5414039943211303,0.9421877216034792,0.5625,0.9020169508799467,1.0,4/14,10.42%,SPR;GCH1;CYB5B;MTARC2
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.40816353836900415,0.942171152181933,0.49019607843137253,0.9016913437894198,1.0,14/96,22.27%,NXF1;U2AF1;THOC6;SMG1;NXT1;NXF5;SRSF11;HNRNPA2B1;RANBP2;WDR33;NCBP1;NUP153;SRSF3;DDX19B
prerank,GO_Biological_Process_2021__CRD-mediated mRNA stabilization (GO:0070934),0.6197658657290677,0.9416784404990305,0.6545454545454545,0.9025789426197135,1.0,1/5,4.39%,SYNCRIP
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),-0.5532122672544835,-0.9416552678364806,0.5576923076923077,1.0,1.0,3/8,17.32%,WNT7A;ARF1;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.4860214827214909,-0.9416005837471212,0.5660377358490566,1.0,1.0,9/25,13.89%,TERT;FOS;EGR1;JUN;SPI1;ATOH8;FOSL1;SMAD3;TGFB1
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.41754932352060714,0.9414456692074261,0.5283018867924528,0.9027000588543186,1.0,15/60,21.60%,UHRF2;RNF185;UBE2D3;RNF146;UBE3D;RNFT1;CNOT4;KLHL24;MARCHF7;TRIM52;RNF208;RAG1;RNF19B;UBE2A;MARCHF5
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.5326278535892475,0.9414299948927394,0.5925925925925926,0.9020334168236119,1.0,4/14,14.32%,ARID2;SMARCD3;ARID1A;SMARCD2
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.5326278535892475,0.9414299948927394,0.5925925925925926,0.9020334168236119,1.0,4/14,14.32%,ARID2;SMARCD3;ARID1A;SMARCD2
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.3993575602646386,0.9413764645840134,0.5531914893617021,0.9018465643535751,1.0,14/74,18.72%,PRR16;EIF3E;SAMD4A;SP1;RELA;LRRTM3;HNRNPD;PLXNB2;PICALM;BCL3;FMR1;EFNA1;ABCA2;CASP3
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.6231848794066839,-0.9410169965543573,0.627906976744186,1.0,1.0,2/5,21.11%,LRPAP1;MYOCD
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.4497130113663646,-0.9409230731314694,0.56,1.0,1.0,1/22,4.15%,CMTR1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3821046982942427,0.9408672352089733,0.4716981132075472,0.9026048521192663,1.0,32/143,20.95%,LRP4;BMP2;MLLT3;DKKL1;WWTR1;LATS1;PSMD13;IGFBP6;DACT3;TBX18;TLE2;GREM1;RBMS3;PSME4;PRICKLE1;DVL2;TMEM170B;LRP6;FZD4;PTPRU;FZD6;FRZB;MESP1;PSMA1;KLHL12;RUVBL2;TLE4;LIMD1;AMER2;HDAC1;DDIT3;PSMD4
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.45525374188520934,-0.9407214967659272,0.4418604651162791,1.0,1.0,5/30,7.78%,HK2;BIK;CAMK2A;IFIT2;CLU
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.41058698166683144,0.9405782327250172,0.5319148936170213,0.9028159218196629,1.0,3/56,3.15%,STK26;SIRT1;TFEB
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.6141307650540894,0.9404945844815715,0.6458333333333334,0.9026130641673431,1.0,1/7,5.50%,SLC8A1
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.5877851734399108,0.9404130507709019,0.6363636363636364,0.9024474902622062,1.0,3/6,33.56%,VPS18;NDP;ULK3
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.44731610671520294,-0.9403755659287143,0.475,1.0,1.0,3/43,2.62%,MYH7;SCN5A;STAC
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),0.5371201648165994,0.9401519445080044,0.5357142857142857,0.9026477634320318,1.0,4/10,23.85%,TSR3;NOP10;RPUSD2;NAF1
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.5804683653382314,0.9400912511453855,0.5555555555555556,0.902424034078378,1.0,1/5,21.16%,MAPK3
prerank,GO_Biological_Process_2021__determination of left/right asymmetry in lateral mesoderm (GO:0003140),0.6276334848397881,0.939990954601097,0.6,0.902348771065958,1.0,4/5,26.96%,DAND5;CITED2;FOXH1;SHH
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.34364047921667046,0.939820533996252,0.6274509803921569,0.9023688549153747,1.0,45/299,15.10%,ASB17;C3;RAB38;HIF3A;SOCS2;HIF1A;ASB18;SPSB2;ASB15;CDH2;EVA1A;VCAN;PENK;KLHL21;ASB5;FBXL3;TF;SPSB4;DCUN1D1;ANKRD9;SOCS6;FBXO30;GAN;SENP8;KCTD6;KEAP1;PSMD13;LTBP1;TNC;FBXO7;FBXL14;PTP4A2;PRKCSH;KLHL42;KNG1;DNAJC3;DCAF5;ASB6;PSME4;UBA3;ESCO1;KLHL13;FBXL15;UBXN7;MGAT4A
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.3542898514727815,0.9396447188745157,0.6590909090909091,0.902378339379411,1.0,44/238,18.53%,MITF;PAWR;ACD;NLGN1;LLGL1;PCLO;FBLIM1;SPAG16;NEFH;TEAD2;EPS8;HORMAD1;CD40;NLGN4X;LIN7A;SLC7A9;RHOU;MATN1;MAGI1;GSN;LRRTM3;RANBP9;VAMP3;HAS2;SYCP2;GPM6B;FZD1;PICALM;NOC2L;CD74;PML;ESPN;RP1L1;GPAA1;CD247;MNAT1;CD2AP;GORASP2;RHOG;WASL;TP53;TOGARAM1;RHOD;IL2RB
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.4908329333229239,0.9396034457671532,0.4827586206896552,0.9020916182171661,1.0,5/20,16.35%,PEX12;GDAP1;ABCD3;ABCD2;PEX2
prerank,GO_Biological_Process_2021__dehydroascorbic acid transport (GO:0070837),-0.6182834655839294,-0.9394071150759439,0.6304347826086957,1.0,1.0,1/5,10.14%,SLC2A8
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.6467320123535135,-0.9393749271009771,0.62,1.0,1.0,2/5,25.04%,SLF1;XRCC4
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.4433896538118434,-0.9389375375997985,0.5576923076923077,1.0,1.0,8/29,20.41%,MAP1LC3B2;ATG14;RUBCNL;CALM1;TECPR1;LIX1L;GABARAPL1;CHMP3
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.5546150017010176,-0.938817903127705,0.5217391304347826,1.0,1.0,4/12,16.15%,UPB1;NT5C;UPP1;TYMP
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.5792567300557151,0.9387996434360032,0.5660377358490566,0.9033278094015119,1.0,1/6,2.54%,HIF1A
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.49724521902677365,-0.93867991746755,0.574468085106383,1.0,1.0,5/21,7.80%,GUCA1B;PDE6B;CNGB1;PPEF1;NMT1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.5348631570799299,0.9385944335174825,0.6333333333333333,0.9034584404918282,1.0,3/13,4.04%,ADRA1A;ZDHHC12;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.3809919336788034,0.9385055085570516,0.48936170212765956,0.9032825661548918,1.0,18/81,15.60%,RIT2;RETREG3;ROR1;TOX;TENM3;ZNF804A;FUT9;EPHA3;ABL2;MAGI2;PLXNB2;FZD1;RAP1A;LRRC7;DBN1;PTK7;CAPRIN1;COBL
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.409261530869192,0.9384119362629652,0.48936170212765956,0.9031121168871288,1.0,11/51,13.09%,LGALS9;CCL5;HIF1A;RELA;NLRP7;CD40;SNCA;HYAL3;HAS2;IRAK1;TANK
prerank,GO_Biological_Process_2021__negative regulation of meiotic nuclear division (GO:0045835),-0.5914061744898913,-0.9382479449320565,0.5208333333333334,1.0,1.0,1/6,0.91%,FBXO43
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.4778512940948664,-0.9379771737794191,0.5625,1.0,1.0,5/30,8.08%,SCN5A;KCNE2;CACNA1G;KCNE1;KCNQ1
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.45032881293020244,0.9373030584855515,0.48,0.9054807112423477,1.0,10/25,30.46%,NAV3;HDGFL3;MID1IP1;CAMSAP2;ARHGEF2;CIB1;MAP1B;FGF13;CLASP2;CLASP1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.502818512184527,-0.9371171136682268,0.5576923076923077,1.0,1.0,4/15,16.15%,UPB1;NT5C;UPP1;TYMP
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.40659204168139285,0.937109259574998,0.6170212765957447,0.905604967826959,1.0,9/54,9.38%,GPR55;IGF1;FGF10;F2R;GPR174;GPR17;ERBIN;SHOC2;AUTS2
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),0.5704973673610775,0.9368402267900068,0.6607142857142857,0.9058187813552102,1.0,2/6,7.29%,CCL5;IL15
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.49363604424617996,-0.9368350384541322,0.49019607843137253,1.0,1.0,2/21,4.09%,DNASE1L1;REXO4
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.4405186289837883,0.9365109204138637,0.4339622641509434,0.9062854702396206,1.0,13/38,28.70%,CCN6;PYCR1;SPART;SLC25A33;ABL1;PPA2;HEBP2;BAD;PID1;AKT2;STOML2;PRELID1;OPRD1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),0.5874112453465121,0.9365043884187897,0.5961538461538461,0.9059244289395595,1.0,1/5,18.03%,MAF1
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.37895883134566344,-0.9359642765733888,0.48148148148148145,1.0,1.0,7/95,3.52%,EHF;CLDN4;SLCO2A1;FAM3D;KCNJ1;PTGES;TRPV5
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.45233389553355796,0.9358896708957664,0.5,0.9069595895050093,1.0,5/33,8.16%,HIF1A;MAFB;PRMT1;ACVR2A;FOXO3
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.3694612601512726,0.9356764798440816,0.5714285714285714,0.9070040045465585,1.0,19/120,11.81%,SLC12A7;SLC12A1;KCNC2;KCNK2;SLC1A3;KCNJ3;SLC12A3;KCNH7;KCNH4;KCNQ5;KCNH8;KCNH5;SLC24A2;SLC9A2;LRRC55;HCN1;KCND2;ATP1A2;KCNB2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.40388361910689496,-0.9356222631252069,0.5192307692307693,1.0,1.0,15/51,25.87%,GPR132;PSMB4;RFPL1;PSMC4;PSMD8;SKP1;ATF5;PSME3;PSMD12;PSMC3;PSMC2;PSMD2;PSMA5;PSMC1;PSMD3
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.42909832271969467,-0.9352400908222434,0.5531914893617021,1.0,1.0,5/58,8.56%,F5;F8;GOLGA2;PPP6R1;TRAPPC2L
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.42909832271969467,-0.9352400908222434,0.5531914893617021,1.0,1.0,5/58,8.56%,F5;F8;GOLGA2;PPP6R1;TRAPPC2L
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.42909832271969467,-0.9352400908222434,0.5531914893617021,1.0,1.0,5/58,8.56%,F5;F8;GOLGA2;PPP6R1;TRAPPC2L
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.5090900431427638,0.935232808742758,0.559322033898305,0.9075852352633059,1.0,5/15,26.71%,IGF1R;IRAK3;MTRF1;TBC1D25;INSR
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.4200609232808824,-0.9349963836858985,0.6481481481481481,1.0,1.0,8/49,7.19%,SELP;SELE;CD24;PALM3;TNFRSF11A;TRIB1;IRF5;SLC11A1
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.4157472898701812,0.9347478289853753,0.6166666666666667,0.9083711730847125,1.0,17/67,16.93%,ACSM2A;SCD;FDFT1;ACSS2;SCD5;ABCD3;OXSM;MVD;FDXR;IDI2;ACACA;LIPG;OLAH;STAR;PRKAA1;ELOVL4;PRLR
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.5946075677263388,0.9346345427434751,0.6122448979591837,0.9082256338964194,1.0,6/7,39.29%,TMEM98;HES5;NOTCH1;NF1;DRD3;HES1
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),-0.4808524089783554,-0.9345987746309122,0.5,1.0,1.0,2/14,7.09%,PIAS3;EGR1
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.3897669494958726,0.9343359616304474,0.5777777777777777,0.9085533255265111,1.0,27/85,21.86%,SLC7A11;SLC26A7;SLC10A3;SLC26A6;SLC38A3;SLC38A4;SLC7A2;ABCC2;SLC7A9;SLC10A5;SLC25A48;NCOA2;SLC10A1;ABCC11;SLC19A1;SLCO1A2;AKR1C1;SLC3A2;SLC36A1;SLC7A14;SLC7A6;SLC25A30;ATP8B1;SLC6A15;SLC7A8;SLC25A14;ACSL1
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.3696743006676421,0.9342569023833163,0.5681818181818182,0.9083605390359606,1.0,28/137,18.97%,VAPB;GSTM2;LPIN3;PCSK5;ABHD3;NANP;SLC44A5;HPGDS;CHPT1;ELOVL5;PCYT1B;ACHE;CEPT1;GCH1;PPM1L;CERS3;SGPL1;DMD;CERS5;SLC44A4;ELOVL4;GPHN;ALDH3B1;CPS1;PLPP1;MOCOS;SAMD8;GSTA4
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.6105197819844717,0.9340809503243098,0.6727272727272727,0.9083832626518613,1.0,3/5,13.74%,ACVR2A;SMAD2;ACVR1B
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.5440095447946541,0.9339665409556174,0.6181818181818182,0.9082537073999537,1.0,5/10,32.79%,CPEB1;NCBP1;CPEB3;CDC73;NUDT21
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.5775005360544021,-0.9337288545753123,0.58,1.0,1.0,3/6,15.24%,MYADM;APOA1;MAPK7
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.5775005360544021,-0.9337288545753123,0.58,1.0,1.0,3/6,15.24%,MYADM;APOA1;MAPK7
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.5250842644074891,0.9336567113051986,0.5208333333333334,0.9084916327479535,1.0,9/15,39.04%,INTS6;ZCCHC8;INTS11;INTS8;INTS3;INTS1;INTS2;INTS7;INTS5
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.5013766498002109,0.9335329117596254,0.5272727272727272,0.9084093536461135,1.0,7/20,25.09%,TTLL2;TPGS1;TTLL9;NAA11;TTLL7;TTLL8;AGBL4
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),0.6006151195740728,0.9330106567075095,0.7037037037037037,0.9091609263760775,1.0,1/9,3.12%,ASIC1
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.4872188392986452,0.9328345635170731,0.5932203389830508,0.9092356951353442,1.0,1/13,3.24%,LDLR
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.3369370526478302,0.9326683978841889,0.6410256410256411,0.9092999236268127,1.0,42/250,19.57%,STK26;FHDC1;CDC14A;EHD1;FGD4;TNIK;VSTM5;SPAG16;SSTR3;TRAPPC14;PCM1;RAB3IP;CEP20;MTSS1;RAB23;BBS9;RAPGEF6;GSN;LZTFL1;BBIP1;SSX2IP;CARMIL1;KIAA0586;RABL2B;RAP1A;ARHGEF6;RPGR;ANO6;DNM3;DZIP1L;CD2AP;EXOC6;CEP19;ARL3;PTPN23;RHOD;RAP2A;RP2;KIT;DZIP1;ATAT1;IFT140
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.5944309271115686,-0.9325750416815157,0.6153846153846154,1.0,1.0,2/6,18.88%,RNF213;SERPINB9
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.5044365696585,0.9324561190629032,0.4727272727272727,0.9094426625455208,1.0,2/14,11.43%,RIOK2;HECW2
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.6343391256911998,0.9323964512648479,0.65,0.9092083374740467,1.0,3/5,33.89%,ABCA2;APOE;LAPTM5
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.49635356656441054,0.9319004936718654,0.5538461538461539,0.9099580548100866,1.0,1/13,8.97%,CHMP6
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.6072603675166895,0.9316616221015143,0.6,0.9101369694471209,1.0,1/6,3.01%,PADI2
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.4577881559390329,0.9315960133346276,0.5192307692307693,0.9098974189072244,1.0,5/31,16.19%,SIRT1;RNF152;EPM2A;PRKAA1;KPTN
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5187530013549371,0.9315887759862247,0.6136363636363636,0.9095639795696725,1.0,3/14,12.35%,CCL5;TICAM1;IRAK1
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.5209362736178312,0.9315675886709907,0.5230769230769231,0.9092569350399057,1.0,2/12,3.48%,TGFBR1;WNT4
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.49877063526537435,0.931564589709257,0.5471698113207547,0.9088874685892595,1.0,1/22,1.94%,SIRT1
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.6157654349321805,0.9313358859713501,0.64,0.9089933677256044,1.0,4/7,28.65%,ABL1;APOE;EPHA4;APP
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.5718949322191467,0.9312251287679026,0.5789473684210527,0.9088434802548271,1.0,5/9,38.09%,AGO3;DHX9;DICER1;TARBP2;CLP1
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.4353378444892301,0.9309940151367393,0.5454545454545454,0.908886716141869,1.0,12/39,21.62%,TRPM8;SLC7A2;SFXN2;ATP1A2;TRPM2;SLC22A5;SLC44A4;TRPM7;SLC3A2;TRPM3;KCNJ8;SLC7A8
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.41555429953989004,0.9308821253157662,0.5964912280701754,0.9087474218418486,1.0,15/57,18.31%,SIRT1;PPARG;ZBTB20;TLCD3B;ABCA1;NR1D2;ABHD8;NR1H3;MLXIPL;LIPG;PRKAA1;PNPLA8;DGAT2;ABCA2;IRS2
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.49655421983962356,0.9305058347510818,0.5625,0.9089276448749593,1.0,3/18,9.95%,ADD3;EPS8;GSN
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.49655421983962356,0.9305058347510818,0.5625,0.9089276448749593,1.0,3/18,9.95%,ADD3;EPS8;GSN
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.40942497126242994,0.9304980107578581,0.5714285714285714,0.908569775383272,1.0,13/35,26.24%,LRP4;CTNNA2;PTEN;KLF7;WASL;FARP1;MAP2;DIP2A;MAPK8IP2;MEF2A;DOCK10;PHACTR1;MAP6
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.3530798728033357,0.9304915867936764,0.6037735849056604,0.9082226071788969,1.0,26/155,11.95%,PNP;CFH;CCL5;IDO1;HIF1A;IFI44;ISOC1;IRF8;XAF1;IL10RA;FGL2;PELI1;TOR1B;ST8SIA4;IL15;MARCHF1;CD40;GCH1;AUTS2;RAPGEF6;TAP1;BANK1;TRIM26;APOL6;MTHFD2;PDE4B
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.5185610512093178,0.930424934220187,0.5714285714285714,0.9079901990837139,1.0,4/18,7.72%,RIT2;CD22;PLCG2;NEUROD2
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.5142417508011221,-0.9302371332135861,0.5777777777777777,1.0,1.0,4/16,9.83%,SPRY4;GPC1;PRKD2;CREB3L1
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.626856288331199,0.9302291373086302,0.6326530612244898,0.9080544637480699,1.0,4/5,35.24%,GPAA1;PIGT;PIGU;PIGK
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.5408502544922453,-0.9301181708995508,0.6590909090909091,1.0,1.0,4/16,14.60%,KIF2B;BUB1;IHO1;CDC6
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.5000983536434221,0.9300814291302965,0.5531914893617021,0.9080094894185226,1.0,4/11,22.43%,NFE2L2;HSPA5;DDIT3;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.5103437492991207,0.9298892802165889,0.5217391304347826,0.9080529051955171,1.0,3/22,14.36%,GSTM2;JPH1;DMD
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.42990506788285854,0.9297177006413134,0.5370370370370371,0.908075505163969,1.0,12/47,23.10%,SYK;PELI3;ZNF675;CPNE1;HIPK1;BIRC3;FADD;CCDC3;IKBKB;CARD16;GAS6;HSPA1A
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.42973039917082384,0.9295152610459364,0.6111111111111112,0.908139631499138,1.0,5/32,8.69%,TCIRG1;ATP6V0D2;RAB38;RAB39A;ATP6V0A4
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.4886108764253845,0.9294563312990903,0.5961538461538461,0.9079182020645534,1.0,2/10,10.84%,BMP2;BMPR1A
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.6000434045191002,-0.9290602458616898,0.62,1.0,1.0,1/6,16.37%,SHANK3
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),0.6174933524801226,0.9289700552232649,0.6,0.9086984063441618,1.0,1/5,11.46%,VAMP3
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.3604805377210579,0.9289362894372287,0.5681818181818182,0.9083991282568713,1.0,20/165,14.22%,U2AF1;HNRNPH1;SF3B1;SYNCRIP;LIN28A;APOBEC1;IVNS1ABP;SNRPN;RBMS1;BICD1;NOVA1;ATXN1;SNRNP48;ADARB2;HNRNPD;MRPL44;RRAGC;CDK12;RBM5;TENT4B
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.4599049031959212,0.9288305370887404,0.5319148936170213,0.9082245244047005,1.0,8/34,15.29%,NLGN1;SYT1;CEL;SNCA;NLGN4X;PICALM;STON2;DNM3
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5293178436049758,0.9287897167901974,0.6,0.907956774404622,1.0,3/15,12.51%,F2;NLRP7;ABCD2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.4795348451871144,0.9285134501326154,0.5106382978723404,0.9081865701484959,1.0,10/19,30.84%,NCK2;PTEN;MLXIPL;DMD;INPP5J;SMAD7;NLRP2B;NCK1;PDE4D;DDIT4
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.58413745727452,0.9283523695181446,0.5689655172413793,0.908167615958099,1.0,2/8,7.57%,PDGFRA;AGR2
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.5479532061693094,0.9281075710273358,0.5576923076923077,0.9084126707338073,1.0,5/9,27.86%,CSGALNACT1;GFPT1;B4GALNT2;EXTL2;FN3K
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.5481176829193706,-0.9279686066841883,0.5769230769230769,1.0,1.0,3/12,5.63%,ABCA4;PDE6B;CNGB1
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.5494808111478713,-0.9278368374682915,0.54,1.0,1.0,2/9,10.00%,SLX4;RTEL1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.4887821208036325,0.9277041610499673,0.6274509803921569,0.9089007185715633,1.0,5/23,14.72%,SIRT1;CDKN2A;SMC5;PML;KAT6A
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.41373503949825235,0.9270850517507988,0.5423728813559322,0.9098952473487399,1.0,13/72,17.74%,MRAP2;DPP10;STAC2;ABI3;EPHA3;AGR2;RAMP3;ZDHHC2;ARHGEF16;PICALM;STX8;NUMB;RHOG
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.5595096850616409,0.927062975913735,0.6,0.9095861107112901,1.0,2/12,6.74%,SYK;PLCG2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),0.6016464022054541,0.927062579178907,0.5740740740740741,0.9092203744383864,1.0,2/5,16.58%,MESP1;HEY2
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.4494353047576328,-0.9268394188374952,0.5319148936170213,1.0,1.0,4/32,4.93%,DRD4;IL11;RHBDF1;DRD2
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.40624351866355646,0.9266185003320956,0.58,0.9098261297150232,1.0,4/68,3.52%,TCIRG1;ATP6V0D2;TFEB;RNF152
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.5386713341213188,0.9265148454449662,0.6041666666666666,0.9096826372550721,1.0,9/14,27.95%,TRPC4;SLC39A8;TRPC5;SLC30A10;ATP2C1;TRPC1;SLC39A14;TMEM165;TRPC3
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.495156178859303,0.9264664478065684,0.5925925925925926,0.9094566713291754,1.0,6/24,19.62%,SIRT1;ZNF692;GCK;SIRT7;SDHAF3;FBP1
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.494959794998277,0.9264533005522019,0.609375,0.9091122132029015,1.0,3/26,7.71%,IGF1;NRG1;ADRA2C
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.5220073193631757,0.926363527441746,0.5660377358490566,0.9089382340558398,1.0,4/11,23.41%,MOV10;NTNG2;MACF1;FAM110C
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.4540368936042067,0.9261248565810317,0.5,0.9091149741617153,1.0,4/32,8.16%,HIF1A;PRMT1;ACVR2A;FOXO3
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.5512905298633872,0.9259894395781275,0.6744186046511628,0.9089926685889469,1.0,6/9,34.15%,EXOSC4;DXO;EXOSC5;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.5930429183627962,0.9256869906999557,0.5806451612903226,0.909256819865193,1.0,2/6,6.55%,CXCL12;EPS8
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.506042412102127,0.9252650726287603,0.6458333333333334,0.9098503202431799,1.0,3/17,12.08%,HELB;KLHL15;UBQLN4
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),-0.6042010187064598,-0.925218309701544,0.673469387755102,1.0,1.0,2/6,12.71%,TMEM107;NPHP4
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.4575375203746472,0.9251867382885524,0.5185185185185185,0.9095683000569088,1.0,10/19,24.81%,SLC39A8;SLC39A12;TRPM2;SLC30A10;SLC30A6;SLC30A4;SLC30A1;SLC30A2;SLC39A14;SLC39A6
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.5873469852801579,-0.9251454444664965,0.5434782608695652,1.0,1.0,3/9,17.99%,PCCB;MCCC2;BTD
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.57523641664786,0.9251367929228451,0.603448275862069,0.9092967961956028,1.0,3/7,35.70%,AGO3;DICER1;TARBP2
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.498460187105937,-0.924673008242597,0.6037735849056604,1.0,1.0,1/17,1.18%,TEK
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.5702962048443847,0.924219749078428,0.6166666666666667,0.9109593547645269,1.0,2/11,2.31%,ZBTB7B;ERBB4
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.5040093818167719,-0.9241482682392167,0.6326530612244898,1.0,1.0,4/18,13.89%,SLC5A10;SLC2A8;SLC5A1;SLC2A1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.4558535462254196,-0.9240433351898366,0.5357142857142857,1.0,1.0,7/30,13.48%,KCNE2;DRD2;KCNN2;KCNE1;KCNA5;PTK2B;KCNIP3
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.4699036346657983,-0.923967840410901,0.45098039215686275,1.0,1.0,1/26,0.42%,NTRK1
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.3675346478583893,0.9237854220352774,0.6153846153846154,0.9115306599364368,1.0,27/150,10.38%,MXRA5;CFH;MRGPRF;C3;RSPO3;C6;ADGRL4;PPARG;STEAP4;BGN;COL6A2;CXCL12;LTBP2;TLR2;POSTN;PDGFRA;FAM114A1;CAVIN1;PLSCR4;CYP27A1;TMEM26;H6PD;GSN;MEDAG;COL5A3;MPZL1;AOX1
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.6133519132029176,0.9235565775534905,0.6363636363636364,0.9116338508530033,1.0,2/5,32.80%,NAGA;GALC
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.5832595183287945,-0.9235490544949506,0.5918367346938775,1.0,1.0,1/6,5.37%,RNF8
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.43551774029213486,-0.9234448500973578,0.5106382978723404,1.0,1.0,3/32,12.43%,TRMO;METTL6;TARBP1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.4704060623167071,0.9231203618467227,0.5535714285714286,0.9122660742223198,1.0,5/27,20.15%,SLC4A7;SLC4A1;SLC30A4;WNK1;SLC30A2
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.3861257772866295,-0.9229822473662678,0.6,1.0,1.0,16/90,8.78%,P2RY10;TBC1D10C;SELL;SP140;DOCK8;TRAF3IP3;CD53;CYTH4;CD86;LTB;PSG2;STAG3;TAGAP;CD72;TMC8;LY86
prerank,GO_Biological_Process_2021__negative regulation of neuron migration (GO:2001223),0.6361916437840077,0.9229140602402188,0.6851851851851852,0.912368888871959,1.0,3/5,28.41%,NEXMIF;TNN;SRGAP2
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",-0.5684491891635178,-0.92291389268938,0.625,1.0,1.0,1/7,7.55%,HLA-DRB1
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.40193408720893425,-0.9228198946212373,0.5272727272727272,1.0,1.0,10/53,11.54%,CLDN4;TMEM184A;GPR39;DSG2;ALOXE3;LAMB3;WWC1;KRT86;SERPINB5;MISP
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.5547599375553343,0.9227489312758307,0.6111111111111112,0.9123894944383621,1.0,3/7,31.10%,TAP1;B2M;IDE
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),0.5747341569440813,0.92269566803693,0.5454545454545454,0.9121278848173907,1.0,2/6,18.91%,GPHN;MOCOS
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.5277297368103773,-0.9222873001614037,0.5365853658536586,1.0,1.0,4/10,15.08%,DUSP6;WWC1;DUSP9;LATS2
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.5755897872094597,0.9218487412299167,0.5471698113207547,0.9136000314519037,1.0,2/6,19.54%,UNC13B;UNC13C
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.500238936336703,-0.9218323449355476,0.6086956521739131,1.0,1.0,7/13,20.15%,TMIE;PAX2;USH1C;OSR1;FGFR2;PAX8;TWIST1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.46869864569244385,-0.9216973485912403,0.5555555555555556,1.0,1.0,7/31,12.79%,SELE;RIN3;FLOT1;LRPAP1;ARF1;WDR54;WNT3A
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.4587356885668691,0.9216970785983025,0.5294117647058824,0.9135585997643689,1.0,5/26,7.93%,CLSTN2;NLGN1;VSTM5;NRXN1;PTPRD
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.48878564205334385,-0.9216949298367993,0.5925925925925926,1.0,1.0,5/18,21.43%,SLX4;RAD50;BRCA1;BLM;UBE2V2
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.4160095674337783,0.921663177508001,0.5686274509803921,0.9132609636823409,1.0,7/54,12.40%,NEDD4;SEC22B;ASB5;VSIR;FOXO1;HECW2;TIPARP
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.44986987950797425,0.9215550279979945,0.5777777777777777,0.9131223687452784,1.0,4/31,12.08%,HELB;NUDT16L1;KLHL15;UBQLN4
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.41669736147783293,-0.9215324982148642,0.5853658536585366,1.0,1.0,12/76,7.93%,SELP;MPL;SPON2;CYTH4;LILRB3;PLK3;PRAM1;PDE6B;F13A1;HCK;SLC11A1;TAGAP
prerank,GO_Biological_Process_2021__regulation of natural killer cell proliferation (GO:0032817),0.5818032153734591,0.9208852073395363,0.5740740740740741,0.9142691712119553,1.0,2/6,11.11%,IL23R;HLA-E
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.5449860612091192,0.9206430065917524,0.625,0.9143555046894429,1.0,5/11,27.62%,EXOSC4;TENT4B;EXOSC5;FBLL1;EXOSC2
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.6010802091759949,-0.9204607491987198,0.6153846153846154,1.0,1.0,1/6,1.79%,NLRP1
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),-0.48562397473086966,-0.9203918994849056,0.5319148936170213,1.0,1.0,1/17,1.00%,NPAS4
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.4967847386395439,-0.9202613462030494,0.5833333333333334,1.0,1.0,3/11,13.89%,HFE;APOA1;TGFB1
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.5792067839120677,0.9201457555902434,0.6111111111111112,0.9151120424914236,1.0,1/8,5.82%,PIP4K2A
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.5865001881518456,0.9198465851106596,0.6226415094339622,0.9152849192425225,1.0,4/6,40.65%,TOR1AIP2;PLK1;NUTF2;NUP54
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.41338537158977845,-0.9196449355770604,0.62,1.0,1.0,12/62,8.11%,P2RY10;SIRPG;SELL;IRF4;TRAF3IP3;CD53;CYTH4;LTB;KLRB1;CD5;TAGAP;TNFRSF4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.45232903255256857,0.9195208236029153,0.5967741935483871,0.9156417091024233,1.0,6/28,11.95%,ADRA1A;SLC8A1;SCN10A;ANK2;NPPA;PDE4B
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.33019923514238175,0.919255266787874,0.6808510638297872,0.915839790198796,1.0,56/287,20.95%,MKRN3;NEDD4;RNF152;SYVN1;PELI2;UBE2J1;PELI1;UBE2E2;FBXL3;MARCHF1;PELI3;UBE2D3;FBXO30;RNF146;SPOP;RNF217;UBE3D;UBE2E3;PSMD13;LNPEP;FBXO7;MAGEL2;FBXL14;AKTIP;HECW2;RNF5;UBE2U;SHPRH;KLHL42;RBBP6;ARIH1;UBE2QL1;UBE4A;PSME4;UBE2J2;RNF166;FBXL15;RMND5A;PSMA1;NHLRC3;UBR5;RNF26;CTNNB1;FBXO11;ZNF738;SMURF1;FBXL20;MARCHF8;FBXW5;RNF19B;FZR1;UBE2D1;RNF144A;UBE2A;UBE2E1;PSMD4
prerank,GO_Biological_Process_2021__chylomicron remodeling (GO:0034371),-0.5894494945115285,-0.9191750834731112,0.5777777777777777,1.0,1.0,2/5,11.52%,APOA1;APOB
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.5090371445698635,-0.9191094625881294,0.6274509803921569,1.0,1.0,3/18,5.97%,PLK3;ZWILCH;BUB1
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.5309761817464828,0.9190694870335543,0.639344262295082,0.9158027249644154,1.0,5/12,20.21%,UGDH;APELA;SMAD2;MESP1;LMBRD1
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.3629646019022573,-0.9188669129480849,0.6935483870967742,1.0,1.0,17/162,9.97%,ACTC1;MYH7;GPX3;COL4A2;PVALB;SPDEF;AGRN;ACTN3;SVIL;TAGLN;CHRNG;COL6A3;CLU;FOXO4;SPARC;IFRD1;COL1A1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.39812797967119495,0.9188535044428033,0.5555555555555556,0.9159137754835636,1.0,12/65,12.35%,IRGM;FZD5;RELA;TLR2;TICAM1;NLRP7;HMGB1;NR1H3;MEF2C;PDE4B;MAPK8;IRAK1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.5623803363338167,0.9185847802789795,0.6666666666666666,0.9161472433067815,1.0,4/6,34.72%,CD34;DDAH1;HYOU1;ENO1
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.41003492050489254,0.9183438857834033,0.6326530612244898,0.9162937854767778,1.0,11/50,11.00%,C1GALT1C1;GALNT8;GALNT7;MUC20;GALNT3;GXYLT1;C1GALT1;GALNT12;GALNT1;MUC13;MUC7
prerank,PanglaoDB_Augmented_2021__Myocytes,0.38471136492630725,0.9180767977277188,0.5510204081632653,0.9164453116885815,1.0,20/115,11.62%,GATA4;SMYD1;PRRX1;PRKG1;IL4;PPP1R3A;DOCK1;SIX4;CHODL;TNNT1;ASB5;IP6K3;SGCG;SYPL2;TPM2;NPPA;WASHC1;LMOD2;SYNPO2;PXN
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.43500740382432374,0.9180283039276295,0.6363636363636364,0.9161786552873602,1.0,4/38,6.69%,TIMELESS;SLFN11;RFWD3;PRIMPOL
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4579925521079468,-0.918021063599419,0.5434782608695652,1.0,1.0,1/24,4.71%,LDB1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.34582345919565266,0.9179614025019147,0.6190476190476191,0.9159937511573236,1.0,23/215,9.16%,IGF1;IRS1;C3;RSPO3;SIRT1;TGFBR1;ZBTB7B;HIF1A;KAT2B;CDKN2AIP;RSPO2;BMP2;NLGN1;IL7R;RBPJ;TLR2;KLK14;NRXN1;ITGAV;F3;RIMS2;KLK5;KANK1
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),0.5710234329729711,0.9178472373029712,0.6153846153846154,0.9159159734925506,1.0,2/6,7.89%,CD244;SNCA
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.3547585222216131,0.9177120825105077,0.6170212765957447,0.9157364122150295,1.0,15/109,13.08%,FGF10;ERBB4;FGF2;NRG1;CCDC125;ABI3;NRG2;CAVIN1;ABL2;FGF17;PLXNB1;AMOTL1;PLXNB2;FRMD5;FGF5
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.44033206798567315,-0.9172186544358638,0.5918367346938775,1.0,1.0,8/24,27.20%,NCAPD3;TTN;CDK1;AKAP8L;NCAPD2;NCAPG2;NCAPH;SMC2
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.5581781001745141,0.9172081169691253,0.6166666666666667,0.9165801324944608,1.0,4/6,34.54%,COLGALT1;RB1;EFEMP2;AEBP1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.40114257485210614,0.9170029005103844,0.6086956521739131,0.9166395972815603,1.0,12/59,14.68%,ESPL1;FBXO5;BMI1;DUX4;ZFYVE19;RYBP;YAF2;EZH2;TERF1;RNF2;CCP110;EPC1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),0.6045434725956758,0.9169825431751403,0.6851851851851852,0.9159499971602404,1.0,2/5,23.73%,NECTIN2;IL12A
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),0.6045434725956758,0.9169825431751403,0.6851851851851852,0.9159499971602404,1.0,2/5,23.73%,NECTIN2;IL12A
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.3680268230845753,0.9168101117246655,0.5094339622641509,0.9159537364330358,1.0,16/86,15.79%,NOX5;PRR5L;PRDX6;HTRA2;SNCA;FOXO3;SLC25A24;KEAP1;PIK3CA;PYCR1;FOXO1;VRK2;ERMP1;PRKAA1;NFE2L2;ZFAND1
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),-0.6140986761542546,-0.916756345129208,0.6222222222222222,1.0,1.0,2/5,6.18%,DRD2;ADCYAP1
prerank,GO_Biological_Process_2021__positive regulation of osteoclast differentiation (GO:0045672),0.6334164418721046,0.9167031958691134,0.6507936507936508,0.915805067180375,1.0,4/5,30.35%,IL23R;CSF1;TRAF6;IL23A
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.5403280978199684,0.9165823245155476,0.5686274509803921,0.9157276099048929,1.0,4/11,20.67%,DMD;GLRX;WNK1;ATP1B2
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.3786862183015239,0.9163165177496644,0.5714285714285714,0.9159395556654224,1.0,11/101,8.15%,MXRA5;MRGPRF;PRRX1;PRKG1;GNG12;BGN;POSTN;WWTR1;ASB5;FAM114A1;ACHE
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.3545867872404099,0.9162928117509711,0.5283018867924528,0.9156337688557037,1.0,29/127,20.59%,EHD1;MRAP2;DPP10;TNIK;ZDHHC22;RAB3C;RAMP3;LIN7A;ANK2;RAPGEF6;EFR3A;ZDHHC2;KCNB2;RAB34;ANK1;KCNIP4;RAP1A;PACS1;TSPAN17;LRP6;RAB29;DENND4C;ARL3;CD81;RAP2A;SMURF1;RAPGEF2;BSG;IKBKB
prerank,GO_Biological_Process_2021__meiotic DNA double-strand break formation (GO:0042138),0.5559086004491052,0.9161021833205378,0.5714285714285714,0.9156782028757376,1.0,1/5,7.01%,HORMAD1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.46377642440990496,0.9160509887924092,0.5961538461538461,0.9154893742235732,1.0,14/35,22.38%,ZFP36L2;CHD7;LEPR;LIG4;PIK3CD;FADD;RAG2;ZAP70;KIT;GPR89A;RAG1;ANXA1;MR1;PTPRC
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.4437702528042944,-0.9157891567146617,0.5405405405405406,1.0,1.0,4/30,7.13%,RIN3;VAV3;NEB;PPP1CA
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.4598506849017761,-0.9153160164057629,0.5227272727272727,1.0,1.0,1/19,0.56%,SELE
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.43955675883884876,0.9153003615219705,0.5869565217391305,0.9167299173818863,1.0,6/48,6.66%,IGF1;PLCH1;IRS1;FGFR1;PIK3C2B;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.5638140723588125,0.9151061942615896,0.6415094339622641,0.9167434697823861,1.0,3/7,29.07%,PIBF1;INPP5F;PARP14
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.6170553892140542,0.9150802452752282,0.6136363636363636,0.9164278402936056,1.0,1/5,9.40%,DSCAM
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.5480818928672597,-0.9149877258561245,0.6410256410256411,1.0,1.0,2/9,8.87%,PER2;PIWIL2
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.47209235624702683,-0.914809028469536,0.5319148936170213,1.0,1.0,6/23,18.46%,CYP4F2;MYO5B;WFS1;RAB11A;ADCY1;AQP1
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.49321625058654955,0.9147592961925474,0.48148148148148145,0.9167148586003016,1.0,1/12,5.30%,MID2
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.4097244457485602,0.9145637888974324,0.5892857142857143,0.9167840629567967,1.0,6/46,12.03%,KCTD21;TULP3;RORA;MOSMO;KCTD6;RAB34
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.41837170495790277,0.9139403976517682,0.5925925925925926,0.9178952007050716,1.0,12/32,30.46%,NAV3;SNCA;HDGFL3;DYRK1A;MID1IP1;MAP2;CAMSAP2;ARHGEF2;CIB1;FGF13;CLASP2;CLASP1
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.5178883359922861,0.9138009832599902,0.5471698113207547,0.9178728746110033,1.0,5/13,21.70%,SLC25A13;SLC1A6;SLC25A12;SLC25A30;SLC25A14
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.4057850179585254,0.9137888074062521,0.5625,0.9175220420765083,1.0,4/69,3.52%,TCIRG1;ATP6V0D2;TFEB;RNF152
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.5362096863528163,-0.9136999900234639,0.5918367346938775,1.0,1.0,4/12,18.26%,TAF11;TAF7;TBP;TAF7L
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.5348336420306613,0.9136855165037892,0.6,0.9173281044420224,1.0,2/6,15.49%,ANK2;RYR2
prerank,GO_Biological_Process_2021__regulation of glucagon secretion (GO:0070092),-0.6191259126221162,-0.9135149862438124,0.6041666666666666,1.0,1.0,2/5,12.91%,FFAR4;CRH
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.496252761630042,0.9133183460441409,0.5849056603773585,0.9177554991642306,1.0,8/16,18.34%,NRIP1;ESR1;RAMP3;CRHBP;NCOA3;RUVBL2;LCOR;SSTR1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),0.5910408429737924,0.9131152177812423,0.6140350877192983,0.9178342282154186,1.0,1/6,0.40%,PNP
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.5669325569543984,0.912693627531874,0.5625,0.9185386338995513,1.0,4/9,21.16%,RPS6KA4;RPS6KA5;FMR1;MAPK3
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.5575023900020875,0.912665314798635,0.6730769230769231,0.9182336272012579,1.0,7/11,41.30%,PKD1;CPSF6;PKD2;CBR4;NUDT21;GRIN1;CPSF7
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.3875591626878597,0.9125831703787161,0.5636363636363636,0.9180498754602354,1.0,22/85,24.76%,U2AF1;PCBP3;ZFP36L2;NUDT16L1;PCF11;RIDA;DXO;SRSF11;HNRNPA2B1;TP53;AGO3;SLFN14;CSTF3;PNPT1;NCBP1;ZFP36;HIPK3;LSM2;HSPA1A;DHX15;AURKAIP1;YTHDF2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4822384820669225,0.9125521446182467,0.5689655172413793,0.917730178629687,1.0,4/25,12.35%,BMI1;DCUN1D1;ARRDC3;PTEN
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.5305898043040285,0.9123583480974367,0.6274509803921569,0.9178238783921114,1.0,4/14,13.86%,PPARG;ELOVL5;NR1H3;MLXIPL
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.514146082606407,-0.9123449465963354,0.5526315789473685,1.0,1.0,1/8,6.07%,SFRP1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.449621355720027,0.9123230734540703,0.59375,0.917569993746817,1.0,7/26,21.62%,SLC1A3;SLC7A2;SLC25A13;SLC3A2;SLC1A6;SLC25A12;SLC7A8
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.46762007940290934,0.9123094567590684,0.6111111111111112,0.9172609293924128,1.0,9/20,30.52%,BICD1;G3BP1;PRRC2C;LSM14A;YTHDF2;CSDE1;RPS23;YTHDF3;YTHDF1
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.45715330806692867,0.9119480785893279,0.6,0.9177271039032318,1.0,4/23,13.75%,TRHDE;NAALADL1;LNPEP;ANPEP
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.38309292309068343,0.9118528867668084,0.5576923076923077,0.9176295000364023,1.0,28/90,26.94%,TCAF2;DPP10;STAC2;EPHA3;AGR2;RAMP3;ARHGEF16;TP53BP2;MAPK8;PPP3CC;RHOG;TP53;CD81;MFF;ITGB2;BAD;PPP1R13B;MYO1C;STX3;AKT2;ITGAM;DLG1;MIEF2;EGFR;BID;SPTBN1;CIB1;LGALS3
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),0.43534580593757,0.9117836965061683,0.5689655172413793,0.9174263738472462,1.0,2/38,5.30%,MDFIC;MID2
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.583027108657796,0.9115959860211909,0.6470588235294118,0.9175048929280601,1.0,5/6,25.65%,GLRA1;TMEM98;TNFRSF21;EIF2AK3;JAM2
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),0.5361822102684757,0.9114959689927693,0.6557377049180327,0.917266802224291,1.0,1/6,9.90%,VANGL2
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.4071273308840216,0.9114402621582036,0.6071428571428571,0.9169937393022884,1.0,7/48,8.30%,GSTM2;SCD;PTGS1;CYP4Z1;ELOVL5;PLA2G10;SCD5
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.38633427388265973,0.9113811502632188,0.46938775510204084,0.916766075580716,1.0,7/64,7.40%,IGF1;TGFBR1;FAIM;IL4;RELA;ITGAV;PELI3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.5429675604393873,0.9113243906574807,0.5689655172413793,0.9165185148847828,1.0,4/9,22.86%,GPM6B;PICALM;LEPROTL1;COMMD1
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.3359681011109129,0.9112844079040442,0.6470588235294118,0.9162410470472496,1.0,58/317,19.74%,TIMELESS;HELB;TOP2A;BOK;MYC;SIRT1;ZBTB40;ZBTB1;SLFN11;CDKN2AIP;RFWD3;STK33;MAPKAPK2;MAP2K6;ASF1A;UBE2E2;DYRK2;HTRA2;WDR76;MCM7;AKTIP;FOXO1;POLE2;CHEK2;PAXX;FANCL;UBE2U;SHPRH;UBQLN4;RBBP6;SMC5;UBA6;TANK;PSME4;SETD7;PCLAF;PML;IKBKE;H2AX;USP45;UBR5;BCL3;MNAT1;SIRT7;FMN2;TP53;FMR1;RAD51B;FAAP20;KMT5B;POLK;ZBTB4;BRAT1;IRF3;ABL1;MACROD2;LYN;TRIM28
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.5518907656875467,0.9112799656363662,0.6181818181818182,0.9158835593191781,1.0,1/6,15.01%,MARCHF7
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.4921438870804667,0.9111833847246898,0.5535714285714286,0.9157769914273856,1.0,4/17,19.31%,URI1;ATP1A2;AKR1C3;NR3C1
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.3720527291677744,0.9111631012304914,0.6296296296296297,0.9154650611489568,1.0,27/102,17.03%,CGNL1;F2;OIT3;C6;CALCR;OPRK1;GHRLOS;CLDN2;MTTP;SLC7A9;ABCG8;MOGAT2;GRAMD2A;SLC6A16;PLA2G12B;PROX1;CYP3A4;ABCA8;NPY1R;FZD4;COL22A1;AGXT2;OLFML3;FRZB;GJB1;RNF128;ADAMTS6
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.36060437725611616,-0.9109502016133936,0.6808510638297872,1.0,1.0,11/103,7.78%,ALB;SELP;F5;F8;AHSG;ABCC4;STXBP2;F13A1;PCYOX1L;SCG3;CLU
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.36810979516461567,0.9107027627297892,0.5957446808510638,0.915979844572896,1.0,16/106,12.60%,CAPN13;FGFR3;TMPRSS2;NDRG2;BMI1;PLPPR1;PIK3C2B;NEO1;ZSWIM5;DSCAML1;PTPRT;PLXNB1;CGN;ZNF704;PPP1R9A;MYRIP
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.46847961248451886,-0.9106882258736572,0.5882352941176471,1.0,1.0,2/19,10.70%,EPOP;ATXN7L3
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.6153789548665244,0.9105308394435754,0.6862745098039216,0.916053614323274,1.0,3/5,34.08%,VPS41;PLEKHM1;ARL8B
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.5150214299529152,0.9104218066148406,0.5961538461538461,0.9159121111233415,1.0,5/13,21.70%,SLC37A4;SLC34A2;SLC20A1;SLC25A30;SLC25A14
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.3840587346360771,-0.9103880969017358,0.5892857142857143,1.0,1.0,9/86,9.36%,RFX6;CELA2A;FAM3D;ALOX5;SFRP1;PER2;KCNJ11;NNAT;KCNA5
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.5117029261153416,0.9100282429568008,0.5964912280701754,0.9163360642418075,1.0,2/13,5.22%,EIF3E;C8ORF88
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.4385762774885789,-0.9097160980639911,0.5652173913043478,1.0,1.0,4/31,14.35%,EML3;ANKRD53;GPSM2;DCTN1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.35183310512240257,0.9096342329635145,0.64,0.9169797365666371,1.0,18/107,12.61%,NOX5;HIF1A;PRR5L;PRDX6;PDGFRA;FER;HTRA2;SNCA;FOXO3;SLC25A24;KEAP1;PYCR1;FOXO1;PTPRK;VRK2;PXN;MAPK8;ERMP1
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.383076863628901,0.9093279300356296,0.5961538461538461,0.917442938003221,1.0,14/83,12.52%,FLT1;FGFR1;FGF2;PIK3R6;KSR1;TENM1;PIK3R5;CD40;PDGFC;EZH2;FLT3;SPRY3;IRAK1;CDK12
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.43518391637782944,-0.909262172791852,0.5714285714285714,1.0,1.0,4/33,9.57%,ACOT1;ACSM6;MLYCD;ACOT2
prerank,GO_Biological_Process_2021__regulation of excitatory synapse assembly (GO:1904889),0.5847949357231288,0.9089574090903482,0.625,0.9178757958857444,1.0,2/6,5.28%,VSTM5;ABI3
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.5385802086971687,0.908912563531855,0.6521739130434783,0.917598986759914,1.0,2/11,17.05%,EPS8;SIRT7
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.4481732315052037,0.9087917093051291,0.5714285714285714,0.917492166440568,1.0,6/31,11.70%,GSTM2;STAC2;ANK2;HAP1;LRRC55;ATPSCKMT
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.4056699234044434,0.9087915226771145,0.6086956521739131,0.9171358588031154,1.0,5/63,6.41%,FGFR3;BOK;IL4;DCC;ITGAV
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.47702902488149057,0.9084410889936467,0.52,0.9175981005621299,1.0,4/20,5.08%,VCAN;BGN;CHSY3;UGDH
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.3976905855979697,0.908386505319416,0.58,0.9173966418349242,1.0,10/58,17.38%,GLUL;RIOK2;DDX31;RRS1;XPO1;NOC2L;BOP1;BYSL;RPL7;RIOK1
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),0.6121610564367829,0.9083324631854893,0.6,0.9171554546204775,1.0,1/5,6.41%,ITGAV
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.5920065665412759,0.9082130183489283,0.6491228070175439,0.9170490133758645,1.0,3/6,29.45%,BMPR2;EIF2AK3;SULF1
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.5451536243036148,0.907882701915643,0.7,0.9174059557607667,1.0,7/10,35.18%,EXOSC4;DXO;EXOSC5;EXOSC8;EXOSC9;EXOSC7;PCID2
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.42713432926835837,0.9078106043823339,0.5714285714285714,0.9172795807317939,1.0,5/34,8.97%,PCLO;SYT1;UNC13B;SNCA;RIMS2
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.44832587343651614,0.9072279994434834,0.6071428571428571,0.9181588340639767,1.0,5/32,15.49%,SOCS2;SLC8A1;ANK2;TBX18;RYR2
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),0.5059271522678982,0.907145356390624,0.5,0.9179377224293302,1.0,1/10,3.24%,LDLR
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.4758686998580982,0.9071333970748215,0.62,0.9175974054350021,1.0,6/18,18.08%,FZD5;IL4;DENND1B;IL18R1;CD81;CD55
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.5489767085402282,-0.9070311966735213,0.6415094339622641,1.0,1.0,2/7,16.21%,CTPS1;PRPS1
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.5584889061199038,-0.9068217926433447,0.5869565217391305,1.0,1.0,1/7,0.91%,FBXO43
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.517793010383513,-0.9063825467247835,0.6538461538461539,1.0,1.0,2/12,2.67%,NLRP3;CD86
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.45586858421809995,-0.9063655935958221,0.6666666666666666,1.0,1.0,3/31,9.57%,ACOT1;CYP4F2;ACOT2
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.580521377830893,0.9057121827375928,0.6530612244897959,0.9203151911472814,1.0,4/6,40.65%,TTPA;GLTP;PLEKHA8;CERT1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.4998994736818132,-0.9055537346986328,0.6444444444444445,1.0,1.0,1/17,2.09%,PLAAT4
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.5230037127126459,-0.9053868838093111,0.5609756097560976,1.0,1.0,2/7,17.02%,GOLGA2;CHP1
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.43900579929779504,0.9047595378514051,0.6296296296296297,0.9221362436358279,1.0,3/34,8.29%,EPHA7;ENPP1;PDGFC
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.4491437237744721,0.9046577893252458,0.6,0.9219735554543357,1.0,1/19,1.82%,CCL5
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.4578186237705645,0.9044524996374581,0.5918367346938775,0.9220195789821032,1.0,3/19,2.90%,LGALS9;KLRD1;PIK3R6
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.40442951435555596,0.9042397326505732,0.6037735849056604,0.9220655669567401,1.0,11/53,10.29%,FLT1;FGFR3;SYK;FGFR1;ERBB4;ABI3;PDGFRA;FER;EPHA3;ABL2;FLT3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.4407296372304328,-0.9039908958120343,0.5882352941176471,1.0,1.0,7/24,17.51%,RFC3;LIG1;XRCC1;RPA3;RFC2;RFC1;LIG3
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.6249327657366317,0.9036303980497251,0.6666666666666666,0.9229452190753369,1.0,2/7,4.15%,RSPO3;MLLT3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.5895282918147476,0.9033884036512482,0.7222222222222222,0.923094986535716,1.0,3/7,20.60%,MFHAS1;LYN;TLR1
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",0.5794109127545162,0.9033247025884213,0.72,0.9228628209322615,1.0,2/7,12.66%,ZBTB7B;MYB
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.4395041918541209,0.903197292515733,0.5769230769230769,0.9227894506089672,1.0,4/24,14.36%,CACNB4;ANK2;JPH1;DMD
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.5154296633996953,0.9031864593244722,0.5660377358490566,0.9224783042622627,1.0,3/12,3.79%,SIRT1;WNT4;BMP2
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.5496079070613337,0.9030949590845135,0.6610169491525424,0.9222961740638321,1.0,2/7,23.83%,ANO6;PMP22
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.5293590983373945,0.9030581393372584,0.6326530612244898,0.9220696249259326,1.0,2/9,14.30%,MLC1;LRP6
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.39768632517726055,-0.9029552466599962,0.5777777777777777,1.0,1.0,19/75,17.48%,EHF;UPK1A;TST;ACTL8;PAX2;TAGLN;TPP1;ZNF703;CDHR2;E2F7;GSTK1;UPK3A;AKR1C2;FZD7;DAB2;VDAC1;CDK1;FGFR2;UPK2
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.4937102418927313,0.9028275452242951,0.6792452830188679,0.92216494318444,1.0,1/17,0.40%,CSTA
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.3943093333663103,-0.9026450668317462,0.7073170731707317,1.0,1.0,4/50,6.74%,DDX11;ERN2;TSPYL2;TPP1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.36339053584714315,-0.9024688014208894,0.7272727272727273,1.0,1.0,12/120,7.78%,NTRK1;TNFSF18;TERF2IP;NLRP3;TNFRSF11A;TRIM5;CAMK2A;RAB7B;PRKD2;BTK;FLOT1;CLU
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.5316526662340675,0.9024182379349688,0.6153846153846154,0.9226905959413967,1.0,2/11,4.30%,BMP2;ROBO2
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.5385914046386644,0.902325364675232,0.5925925925925926,0.9225136096824851,1.0,4/10,29.72%,RRAGD;SESN2;SESN1;GCN1
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.5285437228258743,0.9022822699270866,0.5434782608695652,0.9222675518069516,1.0,3/13,12.71%,HS3ST5;CD34;KNG1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.5459064974400891,-0.9022782827577807,0.6,1.0,1.0,1/8,3.15%,MEFV
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.4214902388825901,0.9021631086100371,0.5882352941176471,0.9221452209049412,1.0,11/33,16.53%,SLC10A3;NPC2;ABCC2;ABCG8;SLC10A5;NCOA2;SLC10A1;ABCC11;ABCG5;SLCO1A2;AKR1C1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.4676792333759852,0.9020236856990401,0.5510204081632653,0.9221217762656938,1.0,6/21,17.85%,LLPH;NLGN1;DBN1;CAPRIN1;FOXO6;FMR1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.5920415677792605,0.9019865021356879,0.7037037037037037,0.9214678354108998,1.0,4/5,24.67%,PLSCR1;HNRNPU;DHX9;SETMAR
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.5920415677792605,0.9019865021356879,0.7037037037037037,0.9214678354108998,1.0,4/5,24.67%,PLSCR1;HNRNPU;DHX9;SETMAR
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.5285364100584193,0.9017609509911543,0.6666666666666666,0.9215877615741763,1.0,11/16,31.41%,FZD5;CLC;CD55;HLA-F;TNFSF4;SMAD7;TRAF6;B2M;TNFRSF1B;MAP3K7;TRPM4
prerank,GO_Biological_Process_2021__bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),-0.5430150049932462,-0.9016805600553823,0.6,1.0,1.0,2/6,9.42%,DSG2;CTNNA3
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),-0.5430150049932462,-0.9016805600553823,0.6,1.0,1.0,2/6,9.42%,DSG2;CTNNA3
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.4936855788814468,0.9016451537053098,0.6078431372549019,0.9214511301486267,1.0,2/14,11.70%,IL4;ATPSCKMT
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.4840324933811439,-0.9012474908492274,0.6,1.0,1.0,2/14,6.07%,INHA;SFRP1
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.6100695780715955,0.9012257872376251,0.6296296296296297,0.9220097529961434,1.0,4/5,38.38%,PDE4B;PDE4D;CHGA;CAMK2D
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.482842207420216,0.9012230445539662,0.574468085106383,0.9216611498967182,1.0,4/16,5.54%,TGFBR1;NRG1;ADGRG6;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.3543246090979095,0.9007620141526937,0.6825396825396826,0.922248822170348,1.0,16/133,8.92%,FLT1;EPHA7;FGFR3;MYC;FGFR1;ERBB4;ACD;ROR1;BMI1;PARM1;PDGFRA;EPHA5;EPHA3;DCUN1D1;ARRDC3;EPHA8
prerank,GO_Biological_Process_2021__metanephric nephron tubule morphogenesis (GO:0072282),-0.6142464818964501,-0.9005752844584238,0.6666666666666666,1.0,1.0,2/5,17.38%,PAX2;PAX8
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.4904034104599162,0.9004580544421714,0.65625,0.9224962556112111,1.0,7/14,34.43%,PUF60;RBM17;DHX9;SRSF9;CELF4;CDK13;SFPQ
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.42061571240868284,0.9004351359619296,0.6,0.9221970925744576,1.0,8/40,17.73%,ROBO2;CHODL;PLXNB1;PLXNB2;DBN1;L1CAM;CDKL5;MACF1
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.4112115935013335,-0.9003393121318319,0.5660377358490566,1.0,1.0,9/62,9.08%,CLDN4;C6ORF132;PTGES;CRABP2;LYPD6;RHBDF1;ALOXE3;CDH3;WWC1
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.458818641738038,0.9002922896005188,0.5961538461538461,0.9221540350316657,1.0,11/36,19.66%,IL4;SYVN1;BLNK;PLCG2;KLF6;FLT3;DNAJB9;RAG2;KIT;HDAC9;RAG1
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),0.4892490689773066,0.9002456539050199,0.5319148936170213,0.9219044201172261,1.0,4/10,16.24%,LMOD3;PGM5;LMOD2;TMOD4
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.5846366652089414,0.9001710317775701,0.6274509803921569,0.9217287502200998,1.0,4/5,37.07%,CITED2;ASXL2;LMO3;PTGIS
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.52520243020112,-0.8999163931397651,0.5348837209302325,1.0,1.0,1/21,0.59%,NOSTRIN
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.49499413910426715,0.8998142534810142,0.5660377358490566,0.9220004847138205,1.0,1/10,2.93%,NEDD4
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.46938474973439576,-0.899780283737981,0.6382978723404256,1.0,1.0,5/15,19.66%,ADAMTS9;EDEM2;ADAMTS12;FBXO2;FBXO44
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.5115179593970595,0.8997609828884923,0.631578947368421,0.9217364752221542,1.0,3/11,5.90%,IL4;KLKB1;F12
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.5788598700935743,-0.89975583814504,0.7291666666666666,1.0,1.0,1/7,5.40%,PAH
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.4739949501793837,0.8996025145972498,0.5849056603773585,0.9216543855614807,1.0,8/22,23.29%,RAPGEF3;PTPN14;ANP32B;SIRT7;TP53;GAS6;GTSE1;BARD1
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.5152027931908987,-0.8994071057994176,0.5333333333333333,1.0,1.0,4/14,15.15%,CD24;CEACAM1;CAV1;OSR1
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.5025276418565878,0.8993596625501558,0.6296296296296297,0.9218129203448064,1.0,3/15,19.45%,CADM1;CD55;JAG1
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),0.5389842945108377,0.8992717931685287,0.6545454545454545,0.9216523434061927,1.0,1/7,4.29%,LMOD3
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.45188735552049203,-0.89905412282524,0.575,1.0,1.0,6/29,14.93%,CD24;SFRP1;AR;CAV1;RARA;BRCA1
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),0.541770766459041,0.8989535183128686,0.5882352941176471,0.921943211187366,1.0,1/7,13.89%,HSD17B10
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.5298120190640787,-0.8986746161635754,0.6111111111111112,1.0,1.0,1/17,2.86%,SPTLC3
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.44921041308617715,0.8986580967768136,0.6,0.9221259733337213,1.0,2/18,4.48%,CALCR;ZFP36L2
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.36719903961852707,0.8986542302281847,0.5909090909090909,0.9217938930535716,1.0,34/95,20.73%,SYT15;NEDD4;ITPKB;NLGN1;ADGRV1;SYT6;SYT1;PLCG2;NEUROD2;CASR;CRHBP;SLC25A24;CPNE4;CPNE7;CPNE1;SLC25A13;MEF2C;PPP3CA;CPNE3;TRPM2;PPIF;CPNE2;RYR2;PRKAA1;AKR1C3;RYR3;SLC25A12;SYT3;LGMN;KCNMB4;CPNE9;TRPC1;KCNMB1;SYT17
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),-0.5931011503955269,-0.8984187249237195,0.6086956521739131,1.0,1.0,1/5,3.49%,CCBE1
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.4694217045565908,0.8983568932011051,0.5789473684210527,0.9220451736786058,1.0,5/16,10.25%,IGF1;ICOSLG;HMGB1;TMIGD2;IL23R
prerank,GO_Biological_Process_2021__glomerulus vasculature development (GO:0072012),-0.5641902002986957,-0.8981982800657158,0.56,1.0,1.0,1/6,1.18%,TEK
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.40672520069727713,-0.8981868562367109,0.6041666666666666,1.0,1.0,6/68,6.81%,GOLGA8B;ABRAXAS1;HAUS7;GOLGA2;GOLGA8A;TUBGCP2
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.56437012811949,0.8980024488634651,0.6557377049180327,0.9223501429489896,1.0,3/7,30.87%,AXL;APPL1;APPL2
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.5784870394991857,0.8977931221944816,0.6326530612244898,0.9220832751336742,1.0,3/6,32.25%,CDC27;ANAPC7;TACC3
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.5784870394991857,0.8977931221944816,0.6326530612244898,0.9220832751336742,1.0,3/6,32.25%,CDC27;ANAPC7;TACC3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.38741092234567154,0.897776733931814,0.5636363636363636,0.9217763061774973,1.0,14/74,20.95%,HIF3A;EGLN3;HIF1A;PSMD13;PSME4;NFE2L2;PSMA1;VEGFA;TP53;DNAJB1;ARNT;LIMD1;DDIT3;PSMD4
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.5275455888721795,-0.8974860227117523,0.6481481481481481,1.0,1.0,1/12,5.96%,DLL4
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.38179862351455635,-0.8973188540120973,0.5365853658536586,1.0,1.0,8/44,12.44%,KDM4D;WARS1;ATG14;SPRED3;CCDC88C;SPRED2;SPRED1;ASPSCR1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.505345645327101,0.8971848557202667,0.6078431372549019,0.922614004438446,1.0,5/17,26.94%,CXCL12;CTNNB1;SLC30A1;GRM6;LGALS3
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.437559275639515,0.8969712731001034,0.5769230769230769,0.9228008441729616,1.0,7/27,17.80%,CORO7;GSN;MSRB1;SPIRE2;COBL;WASHC5;WASL
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.3322187133927149,0.8966323201228332,0.6976744186046512,0.9231048303687766,1.0,23/170,17.85%,SHMT2;PRR16;EIF3E;SYNCRIP;SAMD4A;LIN28A;TOB1;FOXO3;RNF139;GRM5;METTL18;PATL2;RIDA;HNRNPD;PLXNB2;HSPB1;RPS6KA1;EIF3H;CAPRIN1;CNOT8;BCL3;MTRF1;FMR1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.47502804341565086,-0.896444990928933,0.6730769230769231,1.0,1.0,2/15,7.24%,ADSS1;LHPP
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.5341624783618113,0.896417829024309,0.7096774193548387,0.9231154755710118,1.0,2/10,20.58%,BNIP3L;BAD
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),0.5803116369255665,0.8962993961358022,0.6727272727272727,0.9229405469363078,1.0,1/5,10.38%,AOX1
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.48752177641033245,-0.8959060538407972,0.7142857142857143,1.0,1.0,4/15,10.34%,HSF2BP;BTBD18;MOV10L1;DDX4
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.5286757636355562,0.8955853267569532,0.5849056603773585,0.9241960173437546,1.0,4/9,24.11%,SNCA;RAB33B;ANXA1;IL1RAPL1
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.5546449852021156,0.8954425717715226,0.6551724137931034,0.9241720789429343,1.0,2/8,7.27%,MYC;ZFYVE19
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.4558986417312091,-0.8953363020295964,0.5714285714285714,1.0,1.0,3/27,14.01%,CENPH;ITGB3BP;SMARCA5
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.4558986417312091,-0.8953363020295964,0.5714285714285714,1.0,1.0,3/27,14.01%,CENPH;ITGB3BP;SMARCA5
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.4773989396042364,0.8952587748315928,0.7049180327868853,0.9241920584563679,1.0,8/20,32.98%,AKTIP;STX8;PTPN23;SNX16;WDR81;HOOK1;KIF16B;RAB7A
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.5283487317094943,0.8951605103371799,0.6363636363636364,0.924036490447777,1.0,4/10,24.16%,KANK2;CNOT2;VPS18;FOXH1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.4022719524355621,-0.8950897888813776,0.5294117647058824,1.0,1.0,12/58,13.03%,TEK;COL4A2;ALOX5;ANGPT4;NIBAN2;NAXE;SARS1;FOXO4;SPARC;SPRED1;ADAMTS1;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.47891128425944335,0.89505930181457,0.6779661016949152,0.9238761663778747,1.0,4/17,9.44%,CD99;DAPK2;MOSPD2;MCU
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.39710874967035653,0.8950489945652663,0.62,0.9235356923721934,1.0,12/60,11.59%,MITF;LGALS9;ITGAX;CSF2RA;DDX60L;FGL2;TLR2;LAIR1;TFEC;C3AR1;HLA-E;APOL6
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),0.5207252732495599,0.8949270130937146,0.7241379310344828,0.9234682163395878,1.0,5/13,21.12%,H2BC21;TF;HLA-E;WFDC11;WFDC9
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.3674858741344198,-0.894659502121537,0.5510204081632653,1.0,1.0,21/107,15.41%,LDHC;YBX2;PARP2;CCT6B;BUB1;ADCYAP1;SCG3;MEP1B;OAZ3;PEBP1;PHF7;GAPDHS;DDX4;GSG1;SCG5;ALOX15;TTK;CDKN3;CHRM4;TNP1;SPATA6
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.5127944132856033,-0.8944245364267472,0.6956521739130435,1.0,1.0,3/11,11.63%,RIN3;LRPAP1;WDR54
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.5734035587179186,0.8944069743871329,0.6981132075471698,0.9242138328036393,1.0,1/5,7.75%,HMGB1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.5452780548414619,0.8943385409416239,0.6842105263157895,0.9239904177257421,1.0,3/10,7.89%,CBLB;F3;SNCA
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.5725805756994339,0.8942105624594512,0.6545454545454545,0.9239131165467904,1.0,3/6,22.07%,IRS2;ACSL1;AKT2
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.35321244056183,0.8940395740413617,0.6851851851851852,0.9239428595356984,1.0,34/162,20.95%,CXXC4;LRP4;BMP2;MLLT3;DKKL1;WWTR1;LATS1;PSMD13;IGFBP6;DACT3;TLE2;GREM1;RBMS3;PSME4;PRICKLE1;DVL2;WWOX;TMEM170B;LRP6;FZD4;PTPRU;FZD6;FRZB;PSMA1;NXN;KLHL12;RUVBL2;TLE4;APCDD1;LIMD1;AMER2;HDAC1;DDIT3;PSMD4
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.4218095373069801,-0.8940051350581885,0.6046511627906976,1.0,1.0,2/36,5.07%,NUPR1;ACTN3
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.4129549996037725,0.8938327444702229,0.5882352941176471,0.9240941086730194,1.0,6/41,24.86%,HIF1A;GCK;RANBP2;NUP153;OGT;EP300
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.5569994137100127,-0.8936184690427694,0.7,1.0,1.0,2/7,18.88%,RNF213;SERPINB9
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.39116202888700463,0.8935261950122162,0.6595744680851063,0.9244056006087035,1.0,7/76,4.40%,IGF1;FGF10;MYC;IL26;FGF2;ANGPT1;SIX4
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),-0.5048848932424009,-0.8932921437804476,0.6444444444444445,1.0,1.0,1/10,3.49%,CCBE1
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.5289944425506614,0.8929777804200508,0.6037735849056604,0.9252026042547636,1.0,3/9,19.80%,PTAR1;RCE1;PGGT1B
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.6072679095296678,0.8926748102400233,0.7142857142857143,0.9254406075146324,1.0,5/5,39.29%,DICER1;NOTCH1;SKI;RNF10;HES1
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),0.574448653986958,0.8925947545068184,0.673469387755102,0.9252464425685348,1.0,1/5,8.96%,KDM3A
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.5763026947341551,0.8922153816146999,0.6862745098039216,0.9258529993399203,1.0,1/5,3.94%,TENM3
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.5147538559994432,0.8920414683996285,0.56,0.9259061824287382,1.0,1/12,2.18%,ZBTB7B
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.40187304235856935,0.8916927510047999,0.6444444444444445,0.9262744655417035,1.0,15/40,16.58%,GATA4;NRG1;BMP2;SGCZ;SMAD1;SGCG;BMPR1A;NPPA;SMAD4;TBX18;GJB6;SMAD5;MESP1;NOTCH2;HEY2
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),0.5623898907843276,0.8912904428794094,0.6181818181818182,0.926831483704401,1.0,1/8,5.30%,MID2
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.5135935413198747,0.8910176641619011,0.5294117647058824,0.9270974026518548,1.0,2/14,8.04%,COX19;ANKRD9
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.46919382624012534,0.8907414850206195,0.6491228070175439,0.9272807931054449,1.0,6/21,17.97%,RUNX1;NLRP7;RNF139;BAG2;GAS1;ASTL
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.36471164326579175,-0.8906909292809699,0.6730769230769231,1.0,1.0,7/98,6.62%,RFX6;CELA2A;DRD4;ALOX5;RHBDF1;DRD2;PER2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.37167179860470845,-0.8906854114514354,0.6470588235294118,1.0,1.0,15/141,7.63%,SLC29A3;ACTC1;MYH7;PLAG1;YBX2;KCNE2;MEFV;C5;PDE6B;SNN;TG;CAPN9;CHRNG;MYO15A;STAG3
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.4365512914760772,0.8905862841486327,0.6333333333333333,0.927265564184868,1.0,8/28,20.21%,NEDD4;ZFYVE16;KPTN;RNF128;CD81;SNX16;GCC2;LMBRD1
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.5222281345115201,0.890485654514854,0.6470588235294118,0.9271390455259062,1.0,4/9,27.68%,GALK1;GALK2;GALT;GALM
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.536274536481246,0.8904640499757167,0.6226415094339622,0.9268191276383059,1.0,6/9,39.03%,GGCT;CHAC1;CHAC2;CNDP2;MGST2;GCLC
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.4460646602807154,0.8902194366181595,0.64,0.9270216889692398,1.0,7/20,20.98%,PRDX6;SMPDL3A;PNPLA6;LIPG;PLBD2;PLBD1;GPCPD1
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.5015783144116934,0.8901983917100228,0.5806451612903226,0.9267358919090929,1.0,1/11,4.55%,IDH1
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),-0.5360986570126892,-0.890188527885037,0.5961538461538461,1.0,1.0,2/7,11.52%,APOA1;APOB
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.45282702362604865,-0.889713063381819,0.6190476190476191,1.0,1.0,5/25,14.99%,AK8;RRM2;AK7;CTPS1;RRM1
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.5297001089801419,-0.8892997077465461,0.6363636363636364,1.0,1.0,1/6,16.14%,TRPV4
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.4190712524356532,0.8892769684049092,0.5952380952380952,0.9284313911531492,1.0,3/29,8.42%,CDK18;FBXO5;CDK14
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.34931168270258095,0.8887865680190297,0.6842105263157895,0.9292610299410081,1.0,28/123,20.59%,EHD1;MRAP2;DPP10;TNIK;ZDHHC22;RAB3C;RAMP3;ANK2;RAPGEF6;EFR3A;ZDHHC2;KCNB2;RAB34;ANK1;KCNIP4;RAP1A;PACS1;TSPAN17;LRP6;DENND4C;GORASP2;CD81;RAP2A;AFDN;SMURF1;RAPGEF2;BSG;IKBKB
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.5117074252488623,0.888638078640291,0.6923076923076923,0.9292161275220981,1.0,3/14,19.44%,FBXO5;BAG2;ABL1
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.4238585337194682,0.8886312865616212,0.6808510638297872,0.9288816710750698,1.0,8/44,20.55%,ZBTB1;PRIMPOL;REV1;PCLAF;FAAP20;POLK;UBE2A;WDR33
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.5524877086282121,-0.8883167981742827,0.62,1.0,1.0,1/7,3.80%,SLX4
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.4639241622423196,-0.8881850894290829,0.5454545454545454,1.0,1.0,2/12,4.76%,APOBEC3H;APOBEC3G
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.37687087493325777,-0.8879331964686635,0.6595744680851063,1.0,1.0,7/64,14.78%,TBC1D10C;PODXL;CAV1;RAB17;DCDC2;RAC1;USP17L2
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.5319567708733384,0.8878580977832485,0.7111111111111111,0.9301154772270869,1.0,4/9,22.81%,TICAM1;ITGB2;CAMK4;ITGAM
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.4431327031012445,0.8877262509688486,0.6607142857142857,0.9300461905348162,1.0,6/22,20.65%,PRR16;PTEN;VAV2;RAP1GAP2;DEPTOR;EDN1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.35994279982455224,-0.8876350545092782,0.6296296296296297,1.0,1.0,23/118,12.44%,P2RY10;CD53;XCR1;CYTH4;CD86;GPR132;ASS1;BATF3;RAB7B;HCK;SLC11A1;HLA-DRB1;HFE;TAGAP;LY86;LAMP3;ADAM19;PDCD1LG2;HLA-C;SPI1;CXCL16;PARVG;S100B
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.3892896373683257,-0.8872940206960817,0.6037735849056604,1.0,1.0,15/79,10.40%,SELL;WARS1;CMTR1;SP110;IFI27;TRIM5;PROCR;IFIT2;OAS1;LAMP3;C1S;IFIT3;DHX58;HLA-C;GBP2
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.5065780889404418,0.8872457141355472,0.5510204081632653,0.930806173220254,1.0,3/10,21.30%,ADA;PRPS2;HPRT1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.4225920673144162,-0.8871848797061705,0.5434782608695652,1.0,1.0,4/23,5.48%,TNFSF18;F7;IL6R;ZP3
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.4332924515153533,-0.8868982077036531,0.6170212765957447,1.0,1.0,6/38,7.41%,SPTLC3;PNPLA1;ST8SIA2;DEGS2;ALOXE3;B3GALT4
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.5170861379879245,0.8866736991365285,0.625,0.9315848628848483,1.0,2/10,8.67%,SPR;GCH1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.4570209194905758,0.886670636147664,0.7021276595744681,0.9312405105635628,1.0,1/17,1.76%,MYC
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.4916937393219602,0.8865834618976389,0.6428571428571429,0.9310890407797272,1.0,2/15,11.51%,RENBP;CHST6
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.4730628470683168,0.8865621608631444,0.6415094339622641,0.930749945910293,1.0,9/13,40.58%,TOB1;ZFP36;PABPC1;CPEB3;TNRC6B;BTG2;TNRC6C;TNRC6A;CNOT7
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.4507478872308911,0.8862302688656224,0.6458333333333334,0.9312291460756529,1.0,5/34,8.97%,SYT15;RAB27A;SYT6;SYT1;RIMS2
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.3619020557536873,-0.8860619466396737,0.625,1.0,1.0,11/87,9.13%,NTRK1;TEK;INSRR;DRD4;TIE1;TSPYL2;LDB1;CAMKK2;HLA-DRB1;NTRK3;RAD50
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.351315949759148,0.885918064951737,0.6727272727272727,0.9315492507693531,1.0,7/134,5.00%,STK26;TCIRG1;ATP6V0D2;SIRT1;TFEB;RNF152;TBL2
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.5088761177037051,0.8858493408415397,0.6296296296296297,0.931354616493064,1.0,2/8,7.75%,IL4;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.3987982200068542,0.8850576186036067,0.6557377049180327,0.9327222753803932,1.0,8/41,19.70%,SDC4;PIP4K2A;CNOT6L;CEP120;CCP110;CNOT2;G3BP1;STX18
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.44460728763978397,0.8847044538905999,0.6153846153846154,0.9330943158211072,1.0,7/32,18.36%,RNF152;TELO2;RRAGC;GPR137B;KPTN;DYRK3;RRAGD
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),-0.5199141358196506,-0.884524698353302,0.6744186046511628,1.0,1.0,3/10,17.38%,PAX2;OSR1;PAX8
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.4289172945329368,0.8845128506037481,0.5849056603773585,0.9331154580672638,1.0,5/27,20.22%,RAPGEF3;RAPGEF6;RAP1A;AFDN;RAPGEF2
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.3427557889282582,0.884422326780998,0.6792452830188679,0.9329637405474426,1.0,32/172,20.18%,CGNL1;SIRT1;URI1;CD22;RORA;RELA;ESR1;PPM1A;MAGI2;TSPAN6;EPM2A;ARHGAP25;BANK1;CPNE1;SPRY3;PTEN;TANK;NOC2L;PLAUR;PHLDA3;PPIF;PRKAA1;CD2AP;PPEF2;RIOK3;ARRB2;PHLPP1;DEPTOR;THEM4;LYN;LIMD1;DGKD
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.4675476753479557,0.8840995170579191,0.6379310344827587,0.9331672940479686,1.0,9/27,25.19%,FBXO5;TERF1;TP53;IRS2;ABL1;POT1;ZFP36;HNRNPU;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.3601034253415896,-0.884022645648926,0.6585365853658537,1.0,1.0,7/82,5.41%,NUPR1;INHA;TERF2IP;WARS1;ATG14;ACTN3;XDH
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.3841239834951719,0.8838490961162909,0.6,0.933293933393166,1.0,20/75,20.47%,CCL5;GRIN3A;TRPC4;SLC8A1;SLC39A8;RAMP3;MAGT1;TRPC5;TRPM2;LRP2;RYR2;CALCRL;TRPM7;SLC3A2;SLC30A1;NDFIP2;RYR3;MRS2;ATP2C1;TRPC1
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.5076028874285216,0.8837968435649928,0.6785714285714286,0.9330320146323905,1.0,3/12,13.00%,SLFN11;GMNN;TERF1
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.5563794937207293,-0.8837867836301774,0.6590909090909091,1.0,1.0,3/10,17.73%,SLC5A1;SLC2A1;HNF1A
prerank,GO_Biological_Process_2021__monoacylglycerol biosynthetic process (GO:0006640),-0.5526821686461623,-0.8837485648516654,0.6222222222222222,1.0,1.0,1/6,2.45%,DGAT2L6
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),-0.561800732691847,-0.8835855123032483,0.6388888888888888,1.0,1.0,1/6,1.88%,CXCL13
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.4709007398628507,-0.8832551045356276,0.6444444444444445,1.0,1.0,2/11,11.45%,TLCD2;APOA1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.39082750370778196,0.8831408657776894,0.6551724137931034,0.933896894907762,1.0,6/57,13.39%,RUNX1;LMO1;LMO2;PSMD13;MYB;PSME4
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.40440805341031405,0.8830768482274113,0.6122448979591837,0.9336876616215037,1.0,10/49,19.49%,CORO7;GSN;MSRB1;ZNF207;HDGFL3;SPIRE2;COBL;WASHC5;WASL;MID1IP1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.46804658619854145,0.8827274951666193,0.6346153846153846,0.9341061377637405,1.0,9/23,27.67%,TCAF2;MFF;ITGB2;MYO1C;AKT2;ITGAM;MIEF2;CIB1;C2CD5
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.3412527165470973,-0.8826580485983925,0.6470588235294118,1.0,1.0,17/169,10.80%,CYP1A2;CYP2E1;PTGES;SLC6A6;UPB1;HSD11B1;ARG2;XDH;CYP4F2;PTS;NMT1;ABCC3;ETS2;SMOX;ARPP19;MCCC2;SLC6A12
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.44101021231800097,-0.8825015100998881,0.6,1.0,1.0,2/23,5.43%,SCN5A;PTPN3
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.4764209129884967,0.88230721080931,0.5833333333333334,0.9346679630634191,1.0,10/24,25.42%,NLGN1;TENM1;RALA;GPM6A;WASL;FMR1;ARAP1;FNBP1L;PLPPR5;DOCK11
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.5833009856484129,0.8817064362990512,0.6341463414634146,0.9354208465147597,1.0,2/6,12.35%,ZFP36L2;PTEN
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.4209317560336521,-0.8815441503852659,0.5454545454545454,1.0,1.0,7/33,10.61%,DRD4;FAM3D;RHBDF1;DRD2;SFRP1;KCNJ11;CCN3
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.4590676739836203,0.8812101710007368,0.6078431372549019,0.9360583261538924,1.0,7/26,25.12%,H2BC21;TLR2;HLA-E;STAB2;MR1;IL12A;LBP
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.41567979220710405,0.8809880706488286,0.56,0.9361213289330659,1.0,4/38,3.91%,SLC12A7;SLC12A1;KCNJ3;SLC12A3
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.4397457561689815,0.8807709855080069,0.6428571428571429,0.9362129742764558,1.0,9/38,18.58%,PRMT1;METTL21C;CTCFL;EZH2;CAMKMT;ATPSCKMT;VCPKMT;FAM98A;NSD1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.4740601519923988,0.8806500737649158,0.6206896551724138,0.9360655616892206,1.0,3/12,13.83%,GFAP;DSP;KLHL24
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.42807080033630984,-0.880167840692171,0.6041666666666666,1.0,1.0,3/34,4.93%,NPAS4;DRD4;DRD2
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.5259101331643612,0.8799156862367332,0.5909090909090909,0.9372226577458456,1.0,2/9,12.44%,ATP1A2;PPP1R12B
prerank,GO_Biological_Process_2021__peptidyl-lysine oxidation (GO:0018057),-0.5604004439476713,-0.8799070978506159,0.6274509803921569,1.0,1.0,1/5,4.35%,LOXL4
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.3171738237781349,-0.87960926696314,0.75,1.0,1.0,9/290,3.12%,DUOXA1;SEPTIN12;TBC1D10C;RTP1;STX16;IFT27;ARL5C;STX11;ARF3
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.451606338058443,0.8795297326791209,0.6129032258064516,0.9376863386044297,1.0,3/23,8.01%,FGF10;TICAM1;CCDC88B
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.4445855987237426,0.8790043906031062,0.6382978723404256,0.9383454281910187,1.0,3/20,7.75%,LGALS9;VSIR;HMGB1
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.5176760115655665,0.8789606079839007,0.6041666666666666,0.9381067614902391,1.0,2/12,7.89%,PCSK5;SNCA
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.44323116406103835,-0.8788372491267827,0.64,1.0,1.0,3/34,4.07%,ACTC1;TMOD1;OBSCN
prerank,GO_Biological_Process_2021__apoptotic chromosome condensation (GO:0030263),0.5606515935231839,0.8787633761129631,0.6078431372549019,0.9381306728023179,1.0,1/5,1.49%,TOP2A
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.45544251823853055,0.8784347050867091,0.6379310344827587,0.9383548708322366,1.0,3/19,7.30%,PLD6;TEX15;TDRD9
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),-0.5141137343468158,-0.8782761580482223,0.5319148936170213,1.0,1.0,2/5,2.15%,CXCL13;FGF1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.4506374188760898,0.8779599867344179,0.625,0.9389269216409734,1.0,4/26,11.92%,FGF2;PPARG;HMGB1;MEF2C
prerank,GO_Biological_Process_2021__fatty acid omega-oxidation (GO:0010430),-0.5725464976242659,-0.8778619737597928,0.6304347826086957,1.0,1.0,2/5,14.54%,CYP24A1;ADH7
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.5508570933347883,-0.8777864947176786,0.6875,1.0,1.0,1/5,9.44%,NRDE2
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.5508570933347883,-0.8777864947176786,0.6875,1.0,1.0,1/5,9.44%,NRDE2
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),-0.5673645022551466,-0.8774778213030499,0.6829268292682927,1.0,1.0,2/8,11.22%,CACNG5;CACNG8
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),-0.5673645022551466,-0.8774778213030499,0.6829268292682927,1.0,1.0,2/8,11.22%,CACNG5;CACNG8
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.5023691387473864,0.8774490621475385,0.6862745098039216,0.9396891729266081,1.0,4/13,19.74%,RESF1;ATF7IP;SIRT6;TRIM28
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),0.5990128938221178,0.8772560618706708,0.7213114754098361,0.9396934068719468,1.0,1/5,4.47%,FLI1
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.5295929883245387,-0.8767073601734535,0.6129032258064516,1.0,1.0,1/8,1.04%,CD24
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.5200572515586139,0.8766172564035992,0.7291666666666666,0.9406500548488389,1.0,4/13,20.81%,PUS7L;PUS10;NOP10;RPUSD2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.5630248259912408,-0.8764731885649861,0.5588235294117647,1.0,1.0,2/7,18.88%,RNF213;SERPINB9
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.40345718316670043,0.87621464707273,0.5614035087719298,0.9410918794097893,1.0,4/41,11.60%,PLD6;PLA2G10;ACP6;ABHD8
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.4420715122241719,-0.8755303297236966,0.6440677966101694,1.0,1.0,2/31,1.10%,SELP;SELL
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),0.38192167086846796,0.8749490154101879,0.7368421052631579,0.9433035610153596,1.0,9/49,17.52%,MYC;NEO1;TF;CYBRD1;SMAD4;BDH2;PICALM;HJV;FRRS1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.3760847029281055,0.8747206030128752,0.7297297297297297,0.943311207819997,1.0,3/77,1.92%,IGF1;CDC14A;NDC80
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.36588202508891,0.8745514075862659,0.6346153846153846,0.9432950737729562,1.0,11/76,19.35%,COX19;IMMP2L;SDHAF1;CHCHD4;UQCC3;BCS1L;NDUFAF6;SCO2;NDUFB11;SDHAF3;SLC25A33
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.5062493149872166,0.8742867840342998,0.6545454545454545,0.9435879148732107,1.0,4/12,25.33%,MAGT1;MRS2;TUSC3;NIPAL1
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.3726807745687158,-0.8737463564662394,0.7115384615384616,1.0,1.0,4/58,6.07%,TERT;EPAS1;ANGPT4;SFRP1
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.5153083623773029,0.8735760728762443,0.6515151515151515,0.9447738257777207,1.0,5/8,36.30%,CTNNB1;GRB2;CBLL1;CBL;CDH1
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.41397227332889686,-0.8733591988766157,0.5641025641025641,1.0,1.0,12/31,26.33%,FGF1;TRPV1;TRPV4;DAXX;SLU7;RBBP7;MAPT;STUB1;BAG3;THBS1;DHX36;CLPB
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.34783969328899833,0.8732954667004709,0.6875,0.9450706537351408,1.0,22/161,11.21%,SIPA1;ARHGAP24;CCL5;RAPGEF3;F2R;TBC1D3L;SNX18;TBC1D8B;TBC1D12;CCDC125;RGS10;SYDE2;SCRIB;CD40;RAP1GDS1;RAPGEF6;PLXNB1;CORO1C;EZH2;ARHGAP45;ARHGAP25;ARHGEF16
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.4981282378962074,0.873169294344037,0.6415094339622641,0.9449256972309523,1.0,5/13,12.59%,AK3;ENPP1;AK1;SMPDL3A;DCTPP1
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.4888025883463368,0.8728269107300992,0.6415094339622641,0.9452507274375613,1.0,3/11,23.29%,PAPOLA;NCBP1;BARD1
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.49714307820483783,0.8726029722645386,0.6833333333333333,0.9453667593691593,1.0,2/12,2.47%,IGF1;IL4
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.5229886682346843,-0.8723898271134881,0.5909090909090909,1.0,1.0,1/8,0.61%,DDX11
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.5169551446985877,0.8722771963595221,0.7142857142857143,0.9457008724602107,1.0,4/13,20.97%,GLUL;PM20D2;GLUD1;ASPA
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.40373181168358124,0.8722380027270431,0.625,0.9454278901815919,1.0,7/41,14.02%,PYHIN1;RNF139;LATS1;UBQLN4;PTEN;XPO1;PML
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.359417724358386,0.8722266679975683,0.6842105263157895,0.9450982381124915,1.0,17/117,9.97%,MXRA5;GNG12;DOCK1;LRIG3;FBLIM1;SDC4;WWTR1;F3;FAM114A1;SCNN1B;MEX3B;DSP;BCAM;GRAMD2A;SERTAD4;IGFBP6;PLXNB1
prerank,GO_Biological_Process_2021__fat-soluble vitamin catabolic process (GO:0042363),-0.5466679303866667,-0.8720957396021005,0.6904761904761905,1.0,1.0,3/7,14.10%,CYP24A1;CYP4F2;CYP26B1
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.4289016405966523,0.8718938015498191,0.6491228070175439,0.9454273432095468,1.0,7/28,21.01%,FZD5;ST3GAL6;FZD1;NOTCH2;WNT2;JAG1;NOTCH3
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.49699870439465016,-0.871872275026012,0.6818181818181818,1.0,1.0,2/12,3.88%,TAFA3;CD200R1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.5083808495343703,0.8716842287400483,0.6491228070175439,0.9454673240392456,1.0,5/12,27.45%,SSC5D;BCL3;ANXA1;OTUD7B;MAPKBP1
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.41514603497739344,0.8713526297006648,0.673469387755102,0.9458007847803432,1.0,6/38,19.93%,KAT2B;JADE3;KAT6A;TAF5;SUPT3H;PHF14
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.5166543670438684,0.8712804111452058,0.6481481481481481,0.945608717002421,1.0,2/10,11.03%,SYK;DEF8
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.34680211591480625,0.8712386216380604,0.74,0.9453600241597998,1.0,18/154,10.75%,NXPH1;SLC35F1;HRH3;POU6F2;SLC17A6;DPP10;GRIP1;KCTD8;ZDHHC22;OLFM3;FGF12;CDK14;CPNE4;ADGRB3;MAGEL2;NHLH2;PAK5;TMEM196
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.5098429134681779,0.8707183066236246,0.6595744680851063,0.9459437825504579,1.0,3/11,17.69%,CD40;ANO6;AKR1C3
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),0.5858458594680391,0.8706437235506242,0.6785714285714286,0.9450472767117596,1.0,2/5,29.81%,APOE;ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),0.5858458594680391,0.8706437235506242,0.6785714285714286,0.9450472767117596,1.0,2/5,29.81%,APOE;ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),0.5858458594680391,0.8706437235506242,0.6785714285714286,0.9450472767117596,1.0,2/5,29.81%,APOE;ERLIN1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.47128352563015086,0.8702257046278292,0.6530612244897959,0.9454886367273357,1.0,1/13,3.73%,CPSF4L
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.5448445733016982,-0.8700482068526086,0.7083333333333334,1.0,1.0,1/6,7.88%,HFE
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.4468501677321201,0.8700190066865774,0.6666666666666666,0.9454718215389191,1.0,8/26,16.25%,LPIN3;NAPEPLD;PLA2G10;CEPT1;SELENOI;ETNK1;ETNPPL;PNPLA8
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.4438881048285335,-0.8697809651607962,0.6086956521739131,1.0,1.0,8/24,24.36%,LIMK1;SHANK1;RAC1;SHANK3;SYNPO2L;SYNPO;PFN2;FHOD1
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.364300602945646,0.8697400648951028,0.6140350877192983,0.9456107252676539,1.0,26/98,20.47%,CCL5;GRIN3A;MCOLN3;TRPM8;TRPV2;TRPC4;SLC8A1;ITGAV;SLC24A2;CASR;RAMP3;ANK2;TRPC5;TRPM2;ANO6;RYR2;CALCRL;TRPM7;SLC3A2;TRPV3;CACNA1I;RYR3;MICU1;TRPM3;ATP2C1;TRPC1
prerank,GO_Biological_Process_2021__regulation of activation of Janus kinase activity (GO:0010533),0.5766270659033562,0.8692770016939987,0.7407407407407407,0.9457467794187298,1.0,2/5,10.25%,CCL5;IL23R
prerank,GO_Biological_Process_2021__positive regulation of activation of Janus kinase activity (GO:0010536),0.5766270659033562,0.8692770016939987,0.7407407407407407,0.9457467794187298,1.0,2/5,10.25%,CCL5;IL23R
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.36999582890093813,0.8692572915918997,0.6071428571428571,0.9454376764404177,1.0,14/94,14.23%,SLC26A3;RAPGEF3;AANAT;SLC26A6;GLRA1;RELA;CRHBP;HCN1;MEF2C;RRAGC;GABRB2;RAP1A;CPEB1;TRPM2
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.5400404613543803,-0.8691221436474404,0.64,1.0,1.0,1/5,15.45%,PRDX1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.538824145602063,-0.868833475823751,0.5681818181818182,1.0,1.0,1/5,12.10%,CPSF3
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.34645904660950777,0.8687362724850544,0.6976744186046512,0.9461511874393164,1.0,23/100,12.35%,LGALS9;SMAD6;IRGM;F2R;RELA;PELI1;MAPKAPK2;TICAM1;NLRP7;FER;HMGB1;SNCA;ERBIN;GCH1;TAB2;MAPKAPK3;IL23R;SRR;NR1H3;MEF2C;PDE4B;MAPK8;IRAK1
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.37316725629618325,-0.8687342330015753,0.6842105263157895,1.0,1.0,6/67,7.82%,ACTC1;FRMD6;TMOD1;OBSCN;F11R;MYLK3
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.5785012735426878,-0.8685658057065972,0.7045454545454546,1.0,1.0,1/7,8.18%,OAS1
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.5785012735426878,-0.8685658057065972,0.7045454545454546,1.0,1.0,1/7,8.18%,OAS1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.4401415951672688,0.868305799047351,0.5961538461538461,0.9467181737102739,1.0,4/28,13.44%,IVNS1ABP;RO60;GTF3C4;POLR3G
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.47316181345161573,0.8681086711582681,0.6666666666666666,0.9468186515298124,1.0,4/24,8.97%,SYT15;SYT6;SYT1;RIMS2
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.5078010534101541,0.867902259633348,0.65,0.9469519997749197,1.0,1/11,4.30%,ROBO2
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.4108558900726901,0.8678058271022654,0.6730769230769231,0.9468123856705336,1.0,2/30,7.32%,SHMT2;STAMBPL1
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.4842745580790467,0.8672385707318427,0.7068965517241379,0.9475240883034517,1.0,3/10,18.92%,ODC1;SMS;SAT1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle tissue development (GO:0045843),-0.5622994481681447,-0.8671582664863037,0.65,1.0,1.0,3/5,20.38%,TGFB1;SOX15;USP19
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.3139319546625298,-0.8669088916685197,0.7924528301886793,1.0,1.0,37/302,11.65%,ACTC1;KIF2B;COL23A1;COL24A1;COL4A2;RAC2;COL27A1;TNXB;COL5A1;PXDN;COL4A1;PLK3;TMOD1;LOXL4;BFSP1;TGFBI;COL28A1;MYO5B;TUBGCP2;LAMB3;TSPAN15;MYO15A;COL6A3;ARHGAP12;CCDC88C;COL11A2;TRIOBP;ADAMTS3;COL26A1;COL1A1;MFGE8;MYO7B;STMN1;RND1;CLRN1;APOA1;P4HA3
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.37636446621360664,-0.8668497120802868,0.7254901960784313,1.0,1.0,4/53,5.27%,H1-3;H1-4;H1-2;POLR1G
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.43154088531432305,0.8668209428308814,0.6727272727272727,0.9480284209027714,1.0,1/27,1.94%,SIRT1
prerank,GO_Biological_Process_2021__mesonephros development (GO:0001823),0.5319049831264849,0.8663194380330482,0.6774193548387096,0.9486216733774154,1.0,1/8,0.53%,FGF10
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.3346839330255808,0.8662580051416412,0.6578947368421053,0.9483923970868469,1.0,36/113,18.61%,DEPP1;RESP18;EDIL3;ALDH1A1;MAFB;SCGN;PCDH17;PLPPR1;RAB3C;PAX6;DPP4;PTPRD;FGF14;MAGI1;PTPRT;MAGEL2;TMEM196;NOL4;KCNB2;PROX1;CNTN3;ID4;TMEM98;RUNX1T1;SEMA6D;FRZB;CPE;PDZRN3;MAPK10;PCSK2;CNTN4;HMGCLL1;CSRNP3;RAI2;SSTR1;PRRG2
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.4540692111851778,0.8659703833334166,0.6170212765957447,0.9485765336884101,1.0,3/11,28.30%,TRAPPC8;STX17;ATG9A
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.5851948423669002,-0.8656857223809369,0.6666666666666666,1.0,1.0,2/6,17.78%,TGFB1;PDGFB
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.5354752187300045,0.8656589954833264,0.6666666666666666,0.9487699242951552,1.0,3/9,15.11%,FDX1;FDXR;STAR
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.38343481656914497,-0.8655679047763047,0.7391304347826086,1.0,1.0,12/63,8.78%,EHF;CD53;CYTH4;CD86;CLDN1;ALOX5;MS4A4A;CIITA;HCK;HLA-DRB1;TAGAP;LY86
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.5405623971025679,0.8655156761024768,0.6981132075471698,0.9487285466412294,1.0,6/9,22.18%,NR4A2;FZD1;LRP6;CTNNB1;WNT2;RYK
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.37873292635594946,0.8652673959103167,0.6727272727272727,0.9488232332122929,1.0,25/99,16.25%,NEDD4;ALDH1A1;ISOC1;IDH1;PEX12;SLC35B2;CYP39A1;ABCA6;ALDH9A1;PECR;ABCA1;ATXN1;CYP27A1;ABCG8;CYP7B1;ABCD3;ABCD2;SOAT2;FDXR;ABCA8;CH25H;SLCO1A2;PEX11A;ABCA9;PNPLA8
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.44099185339637126,0.8651452055723647,0.7017543859649122,0.9487584207163073,1.0,6/24,13.84%,TNFSF13B;IL4;SASH3;CD40;MEF2C;CD74
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.37382058469017687,0.8650623339166051,0.6538461538461539,0.9485624081012574,1.0,13/62,21.36%,SEC22B;ITGAV;PSMD13;LNPEP;TAP1;HLA-E;VAMP3;PSME4;PSMA1;HLA-F;IKBKB;PSMD4;HLA-B
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.45044993496888663,0.8649693148037251,0.6607142857142857,0.9484274524790137,1.0,2/16,15.62%,CHMP6;CNTROB
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.3411484380046006,0.8648221537277575,0.7555555555555555,0.948381591038787,1.0,9/97,13.45%,TIMELESS;HELB;RBMS1;MCM7;TOP1MT;POLE2;REV3L;REV1;PCLAF
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.4746040387370797,-0.8647845244057171,0.6428571428571429,1.0,1.0,4/17,21.00%,DAB2IP;VPS35;AMER1;RGP1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.4124675627197607,0.8647340716359083,0.6875,0.9481952944918293,1.0,6/41,24.86%,HIF1A;GCK;RANBP2;NUP153;OGT;EP300
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.39387792453854614,0.8646957567795134,0.6923076923076923,0.9479623278414994,1.0,12/79,12.26%,SEMA5A;TENM1;NAV3;FER;BIN1;CRACD;LMOD2;SYNPO2;CARMIL1;NCK2;FCHSD2;PROX1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.4788266029197318,0.8644538498893133,0.7358490566037735,0.9480757675583887,1.0,4/19,17.36%,MRAP2;ABI3;PICALM;NUMB
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.4629065805251407,0.8644498831905867,0.6458333333333334,0.9477354389929364,1.0,4/19,14.60%,HAP1;CEP135;CEP120;CCP110
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.3958042205957674,0.8644402524188262,0.6585365853658537,0.9474000335001745,1.0,3/45,1.94%,FGF10;TIMELESS;SIRT1
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.5355853024937945,-0.8639982460793221,0.7608695652173914,1.0,1.0,1/5,14.25%,RAC1
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.39836415908593226,0.8639766708728718,0.6140350877192983,0.9479341933071602,1.0,4/42,11.60%,PLD6;PLA2G10;ACP6;ABHD8
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.5206231522769706,-0.8639620009515883,0.6086956521739131,1.0,1.0,1/9,0.61%,DDX11
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.5063761655798649,0.8638829488488639,0.6923076923076923,0.9477671539960416,1.0,3/11,26.08%,PIP4K2A;ANXA2;ELAPOR1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.46178711270721795,-0.8637418435633447,0.6326530612244898,1.0,1.0,3/23,2.29%,TEK;NUPR1;IL11
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.33996023062027286,0.8636132288985154,0.7547169811320755,0.9479878771352611,1.0,22/118,20.64%,PCBP3;HNRNPH1;SYNCRIP;APOBEC1;RBMS1;BICD1;NOVA1;PAPOLA;ATXN1;ADARB2;RNASET2;HNRNPD;MRPL44;LSM8;RBM5;HNRNPA2B1;NUFIP1;AGO3;POLR2H;ELAVL4;PNPT1;NCBP1
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.545808348168251,0.8633239690499356,0.717391304347826,0.9481524157911452,1.0,2/12,17.54%,PLA2G10;PLBD1
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.3812158646319983,0.8630541038683165,0.6481481481481481,0.9484148415880204,1.0,9/66,11.77%,PRKG1;EFNA5;FGD4;EPHA5;EPHA3;RAPGEF6;PLXNB1;ADAP1;PLXNB2
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.37815514635066066,0.8630397763950626,0.6956521739130435,0.9480845852422847,1.0,13/59,17.54%,LPIN3;ABHD3;SLC44A5;CHPT1;PCYT1B;PLA2G10;ACHE;CEPT1;NR1H3;SLC44A4;PNPLA8;PLA2G7;PLBD1
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.4764533636489834,-0.8629655319716726,0.58,1.0,1.0,3/10,20.00%,SCARF1;PTPRS;GRN
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.48435765970679034,-0.8629037347556786,0.5833333333333334,1.0,1.0,3/8,26.95%,RNF20;NELFE;SUPT5H
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.5249194816394763,0.8628532448468251,0.6842105263157895,0.9481556377885969,1.0,1/7,8.17%,NUDT16L1
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.5797030101643501,-0.8628421454764377,0.7272727272727273,1.0,1.0,3/5,24.94%,SERPINE2;CTSZ;THBS1
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.4772301231424183,-0.8625190833827096,0.6938775510204082,1.0,1.0,4/21,10.52%,TERF2IP;PARP2;SMUG1;PARP1
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.5095495171133709,0.8625128512840579,0.7,0.9484131149568599,1.0,1/11,1.44%,RUNX1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.40620175354286775,0.8624197228913778,0.7169811320754716,0.9482183646723392,1.0,9/33,18.05%,FZD5;MOV10;PDE6A;PPP3CA;FZD4;FZD6;PLCB1;CTNNB1;AGO3
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.44362548331636176,0.8623217278064643,0.6065573770491803,0.9480423896612328,1.0,4/21,21.11%,CHMP6;LEPROTL1;MVB12A;VTA1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.49324954937603016,-0.8622627333120483,0.5869565217391305,1.0,1.0,1/10,3.60%,WTIP
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.4434285082610164,-0.8622465553842552,0.603448275862069,1.0,1.0,1/25,0.73%,AMACR
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),0.49635057229433,0.8620469157281021,0.7307692307692307,0.9483182553423232,1.0,2/12,5.04%,NDC80;DLGAP5
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.48075818214666866,0.8616936150924204,0.6140350877192983,0.9487661617504556,1.0,3/13,15.27%,PPP1R15B;PPP3CA;PPP2R2B
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.4864587357776398,0.861652552324306,0.6530612244897959,0.9485296845025342,1.0,5/13,18.93%,WHRN;ADGRV1;COL11A1;TMEM120A;KIT
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.4306556458660303,0.8615779746234463,0.6382978723404256,0.9483585033567586,1.0,4/18,17.47%,EPHA5;RPS6KA4;RPS6KA5;VEGFA
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.39600111881970007,0.8609050385423898,0.6481481481481481,0.9494011215426608,1.0,9/45,20.50%,EFNA5;EPHA5;FER;GSN;REEP6;LYN;CDK16;MAP2;ADGRE2
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.4190379807619835,0.8608889122464023,0.5555555555555556,0.9490856481598866,1.0,8/32,14.00%,F2;KLKB1;F12;PDGFRA;F3;CD34;KNG1;PLAUR
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.44210679092851557,-0.8608642598077932,0.6666666666666666,1.0,1.0,1/17,1.87%,MTFR2
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.46293044467572164,0.8607216191571094,0.7142857142857143,0.9490445602647429,1.0,6/17,24.57%,PCM1;NEDD1;C2CD3;CCDC14;PIBF1;KIAA0753
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.4082808294427165,-0.8606178746140418,0.6,1.0,1.0,6/33,10.10%,KCNE2;KCNJ1;KCNJ16;KCNQ1;KCNJ11;KCNJ15
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.5436272778175681,-0.8605967378180681,0.6744186046511628,1.0,1.0,1/6,4.42%,RPF2
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.4535380191977595,0.8602672142175245,0.6415094339622641,0.9496816802305676,1.0,5/20,12.31%,SIX4;CSRP2;TNNT1;LMOD2;CSRP1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.46852082596187483,0.8601946950973127,0.6949152542372882,0.9494918186047416,1.0,5/15,13.84%,IL4;DAPK2;MOSPD2;MCU;CD74
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.4741636409047434,0.8600729122731182,0.68,0.9493485111212789,1.0,5/12,26.88%,SCRIB;VANGL2;LAMA5;LAMA3;ZDHHC7
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.3832598048485096,-0.8600085083540974,0.6808510638297872,1.0,1.0,7/80,3.47%,CLDN4;CD24;SLCO2A1;ENTPD2;FAM3D;ALS2CL;KIF12
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.39094997565378337,0.8598878135859466,0.7307692307692307,0.9493305877882636,1.0,9/33,20.31%,VCAN;BGN;GADL1;CTH;BCAN;HEXB;MPST;PRELP;CSPG4
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),-0.5590198879762,-0.8598486170837566,0.6,1.0,1.0,1/5,18.73%,AMER1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.3263596018322057,-0.8597374486181178,0.8064516129032258,1.0,1.0,22/252,10.52%,TERT;HMGB3;DNASE1L1;TERF2IP;PARP2;TICRR;SLX4;REXO4;RECQL5;ORC6;ERCC1;FANCG;FANCC;RPAIN;RFC3;POLQ;RAD50;XPC;RAD51AP1;RTEL1;SMUG1;PARP1
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),-0.49435922397690824,-0.8596965097977103,0.68,1.0,1.0,4/12,23.93%,TRPV1;CTSS;CHP1;GPR65
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.40818998570618986,0.8594583922710676,0.7346938775510204,0.9498739178221894,1.0,4/32,9.14%,MDFIC;HCLS1;HDAC3;RAB23
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.5256245466915225,0.8594431644733977,0.6349206349206349,0.9495637072053225,1.0,3/7,27.36%,PECR;PEX13;ALDH3A2
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.3732464303083841,0.8593926461731943,0.6779661016949152,0.94930470538322,1.0,6/61,13.39%,RUNX1;LMO1;LMO2;PSMD13;MYB;PSME4
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.5259883840635113,0.8593600302218621,0.6964285714285714,0.9490319902931138,1.0,4/6,38.84%,PIH1D1;NOP58;FBL;ZNHIT6
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.3540729149437964,0.8590207307892029,0.7692307692307693,0.9494079048201314,1.0,31/125,14.47%,FLT1;EPHA7;FGFR3;SYK;FGFR1;ERBB4;ROR1;BLNK;ACVR2A;EFS;CLNK;CASS4;PDGFRA;EPHA5;FER;EPHA3;LIFR;PTPRD;MTSS1;EPHA8;PTPRT;FRK;FLT3;MPZL1;NPPA;BCAR1;NPR2;IGF1R;ACVR1B;CNKSR1;PTPRU
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),-0.5341461415094217,-0.8589814928129539,0.6274509803921569,1.0,1.0,1/6,6.32%,CYP4F2
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.389685683073759,0.8587680487044218,0.6206896551724138,0.9495705686861128,1.0,15/76,24.86%,SIRT1;MAPKAPK2;BAG2;CD34;HSPA8;RANBP2;IER5;DNAJB1;CHORDC1;MLST8;MAPK3;NUP153;HSPA1A;CRYAB;EP300
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.5371265858543638,0.8587509098688981,0.6842105263157895,0.9492749108280885,1.0,2/9,7.86%,HIF1A;DCUN1D1
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.5069740076707859,-0.8586939404443836,0.6274509803921569,1.0,1.0,2/9,3.69%,F8;F7
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.5324914157634953,0.8586569262306425,0.65,0.9490905057376677,1.0,3/8,30.35%,IL23R;JAK2;IL23A
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.3550318030601849,0.858166073988841,0.723404255319149,0.9496693580455559,1.0,23/173,8.32%,VEGFC;LAMA4;CFH;FLT1;TMEM100;TDRD10;STAB1;OIT3;ADGRL4;BMP2;APOLD1;BGN;FLI1;CXCL12;POSTN;ERG;PLAC8;PDGFRA;DPP4;LIFR;PLSCR4;RAMP3;CRHBP
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.4047493878011365,-0.8580457568635205,0.6,1.0,1.0,3/28,7.19%,DND1;TENT5B;SLC11A1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.3711652323993402,0.8575809255033024,0.7272727272727273,0.9504512206275361,1.0,20/72,23.99%,LRP4;DCC;LLGL1;NEFH;DSCAML1;CTNNA2;NTNG2;MEF2C;KLF7;CNTN4;ZDHHC17;FARP1;SLITRK5;MAP2;PARD3;SLITRK6;RYK;MAPK8IP2;MEF2A;NRCAM
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.47253859517402474,0.857398003779549,0.75,0.9505161617683329,1.0,4/16,12.96%,MME;OPRK1;RETREG1;SCN9A
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.4647958607875751,0.8573211543483201,0.7636363636363637,0.9503315756460724,1.0,5/19,17.36%,MRAP2;ABI3;LZTFL1;PICALM;NUMB
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.5792524867616344,0.8571873510448145,0.7272727272727273,0.95025334424003,1.0,2/5,17.91%,SEC61A1;SEC61A2
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.35550597371673825,-0.8571791626564923,0.6666666666666666,1.0,1.0,12/104,9.14%,ACTC1;MYH7;LTB4R;CHRNE;TMOD1;ACTN3;NEB;TRIM72;CHRNG;MYOM3;CALD1;TPCN2
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.3365100722770828,0.8571011072686152,0.74,0.9500920685840946,1.0,8/71,11.19%,IGF1;CANT1;GALNTL5;FUT9;ST8SIA4;ST3GAL6;NUS1;CSGALNACT1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.4341730704093133,0.8569598168513173,0.6896551724137931,0.9500001342555346,1.0,3/19,9.44%,MCUB;SMDT1;MCU
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.48214778826873206,-0.8567996256476839,0.5686274509803921,1.0,1.0,2/11,12.61%,IFI27;NUCKS1
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.39569099934799157,0.8564489776754555,0.68,0.9507986477804723,1.0,8/63,14.43%,CCL5;EIF3E;C8ORF88;PPP1R15B;NCK2;DNAJC3;HSPB1;EIF3H
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.3031059648256542,0.8563943512236565,0.8571428571428571,0.9505543390670959,1.0,56/355,18.49%,IGF1;F2;C3;PLOD2;MSRB3;CSF2RA;PCSK5;CDH2;EVA1A;VCAN;MRPL28;PENK;MMP15;ST8SIA4;MRPS12;HTRA2;TF;UBE2D3;FDX1;ABL2;ST3GAL6;LTBP1;IGFBP6;TNC;LOXL2;MSRB1;QPCT;ZDHHC2;RPS5;PRKCSH;CHEK2;RNF5;KNG1;DNAJC3;RPL21;FDXR;UBA3;CSNK1G3;MGAT4A;ZAR1L;FBXL2;FBN1;CPE;PADI4;LGALS1;BAP1;RPL18A;KTN1;RPL7;FBXO11;SLC34A2;CSF1;RCN1;RPS3A;MRPL18;ADORA2B
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.527692824789228,0.8563013078536654,0.7045454545454546,0.950379356631645,1.0,6/11,25.47%,MYRF;PTEN;ABCA2;PLP1;TENM4;HES5
prerank,GO_Biological_Process_2021__pronephros development (GO:0048793),-0.5280667558448473,-0.8561758735526799,0.7073170731707317,1.0,1.0,3/6,17.38%,PAX2;OSR1;PAX8
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.4344125912238211,0.8561654635633348,0.5892857142857143,0.9503197100539396,1.0,6/25,12.84%,TCIRG1;RELA;VEZF1;RAB23;KLRG1;ITK
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.377856378620172,0.8559640299517812,0.7818181818181819,0.9503844888435918,1.0,16/76,17.85%,EPS8L2;NLGN1;TENM1;RALA;EPS8;AUTS2;PIK3CA;GPM6A;DEF8;WASHC1;ANLN;CEP120;CCP110;FAM98A;WASL;FMR1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.36844572354558336,-0.8557203819690973,0.717391304347826,1.0,1.0,14/105,10.67%,KLRC1;SELL;IRF4;ICAM3;CXCL13;CD200R1;FGL1;KLRB1;HLA-DRB1;COL1A1;DHX58;SPPL2B;HLA-C;MADCAM1
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.4726216777374995,-0.8554450027886498,0.7045454545454546,1.0,1.0,2/15,5.07%,NUPR1;ACTN3
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.37637338188413694,0.8553877518200765,0.7450980392156863,0.9511445932392657,1.0,12/72,12.17%,SYT15;NEDD4;KCNJ3;NKAIN2;SYT6;SYT1;TF;SCN10A;SNCA;CA2;VAMP3;NKAIN3
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.5554090542202037,0.8552873324536424,0.7540983606557377,0.9510110812561168,1.0,3/7,28.90%,RUVBL2;NUFIP1;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.5637914335649261,0.855262720406508,0.64,0.9506935922719492,1.0,2/6,23.10%,CPNE1;HSPA1A
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.4508312601282988,0.8549804514833718,0.7017543859649122,0.9509099500532147,1.0,6/21,16.43%,LRAT;CYP4F12;RPE65;CYP3A4;LRP2;CYP2R1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.4094653327556643,-0.8544745687459786,0.65,1.0,1.0,6/27,14.74%,NUPR1;KCNE2;CLU;DDRGK1;DAB2IP;CCDC22
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.43187189169867163,-0.8544623961693799,0.6458333333333334,1.0,1.0,7/30,24.52%,NDUFC1;NDUFS5;NDUFA10;NDUFA5;NDUFS1;NDUFA1;NDUFB4
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4100742336880483,0.8543810009044088,0.6785714285714286,0.9517423549985603,1.0,1/35,0.81%,IRGM
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.4467917092704725,0.8542479229064214,0.7272727272727273,0.951668579636374,1.0,6/19,15.10%,ST8SIA4;FUT8;PRKCSH;MAN2A1;MAN1A2;MGAT4A
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.4963429844936976,0.8542420316146369,0.7166666666666667,0.9513421191535171,1.0,3/10,7.75%,RUNX1;ZBTB7B;HMGB1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.5075487075975598,0.8540096488208648,0.6666666666666666,0.9514706576058989,1.0,2/8,7.89%,GFAP;SNCA
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.4321205221659461,-0.8538946138672855,0.6585365853658537,1.0,1.0,2/20,2.28%,RAC2;BST1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.47706132852604566,-0.853841172727231,0.6666666666666666,1.0,1.0,3/10,10.61%,RIN3;C5;CCN3
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.42446603107659736,-0.8537132418359562,0.6730769230769231,1.0,1.0,2/25,2.61%,P2RY10;PRAG1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.5432313944264417,0.8537046477715323,0.7804878048780488,0.9518149258899251,1.0,3/12,11.53%,KCNC2;NPPA;HTR2C
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.3663402303349309,0.8535446178694017,0.6666666666666666,0.9517871331089924,1.0,8/80,13.94%,SYK;PEX12;GDAP1;NXT1;RANBP17;ABCD3;ABCD2;PRICKLE1
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.46270467239574986,0.853257717680492,0.5964912280701754,0.952016325793428,1.0,6/11,30.46%,PHLDB2;CRB2;PHLDB1;TENM4;CLASP2;CLASP1
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.33083333336866644,0.8532326359450115,0.78,0.9517316070605765,1.0,20/153,13.52%,THEMIS;SYK;ICOSLG;BLNK;RELA;NFKBIZ;PLCG2;DENND1B;PAG1;TAB2;PIK3CA;PSMD13;BTN2A2;NFKBID;MEF2C;PDE4B;BCAR1;ITK;PSME4;SH2B2
prerank,GO_Biological_Process_2021__glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860),0.5632166296098122,0.8531990586238195,0.6825396825396826,0.9514562622759433,1.0,2/5,29.45%,RET;SULF1
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.45614899059507064,0.8529777348651923,0.6666666666666666,0.9516165713110747,1.0,5/20,14.93%,LPIN3;CEL;LDHD;CYP4F12;AGXT2
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.4130793556249158,0.8529703516788978,0.6792452830188679,0.951295642579335,1.0,2/21,3.79%,URI1;BMP2
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.5391014634117337,0.8529663483293717,0.6724137931034483,0.9509612011064611,1.0,1/6,17.42%,PUS10
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.4293383654782674,-0.8528172517878811,0.7083333333333334,1.0,1.0,3/27,9.26%,OAS3;OAS1;CDC37
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.46949498669396983,0.8523677560724233,0.6888888888888889,0.9517717137863351,1.0,4/16,29.57%,ATG2B;ATG3;ATG9A;ATG12
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.4605191951284966,-0.8521630672729138,0.6444444444444445,1.0,1.0,2/16,5.07%,IL10RB;ACTN3
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.33301472765513457,0.8519843444232086,0.8,0.9521147714326346,1.0,36/148,17.86%,RUNX1;FZD5;FGFR1;WNT4;HES6;OLIG1;OLIG2;SIX4;FUT9;WNT9A;POU3F2;CEP85L;NEUROD2;PTPRD;LHX6;NLGN4X;INSM2;AUTS2;GPM6A;EMX1;PLXNB2;MEF2C;NR4A2;FZD1;MYT1L;RACGAP1;FZD4;LRP12;KIAA0319;TAFA1;HEY2;CTNNB1;ARTN;CDKL5;WNT2;ACSL4
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.36453866993475015,-0.8518116033746149,0.75,1.0,1.0,9/91,6.82%,TERT;HK2;ERCC6L;CENPH;ZNF296;TICRR;DPPA2;BUB1;SLC7A3
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.5393466377120238,-0.8515890069299746,0.7045454545454546,1.0,1.0,1/7,1.76%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.4165120670013486,0.8514026576822626,0.6363636363636364,0.9528053306743588,1.0,1/28,0.92%,SMYD1
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.4241340777477397,-0.8513938189737351,0.6296296296296297,1.0,1.0,4/20,17.81%,BUD23;FTSJ3;NHP2;NSUN4
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),0.5343930981947154,0.8509696028023943,0.7241379310344828,0.9531889420911481,1.0,2/10,7.44%,TMEFF2;HDAC2
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.4314509937858557,-0.8509602350880542,0.7111111111111111,1.0,1.0,3/26,7.19%,SELP;IL6R;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.5727243456678157,0.8509239625110917,0.7755102040816326,0.952941296574184,1.0,2/5,39.76%,NCK1;DDX3X
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.3145941410356742,0.8507144616701966,0.9111111111111111,0.9530092069960565,1.0,65/327,26.62%,NXF1;U2AF1;HNRNPH1;THOC6;MRPL28;SYNCRIP;APOBEC1;RBMS1;BICD1;MRPS12;NOVA1;SMG1;ATXN1;NXT1;ADARB2;RPS5;HNRNPD;MRPL44;RRAGC;NR4A2;RPL21;MLF1;TSPAN17;RBM5;EPC1;NXF5;THRB;ZAR1L;SRSF11;HNRNPA2B1;RPL18A;BCL3;RANBP2;RPL7;NUFIP1;RPS3A;MRPL18;POLR2H;ELAVL4;WDR33;NCBP1;RPL23A;DNAJB11;XAB2;NUP153;SRSF3;DDX19B;MRPL11;MRPS15;HNRNPU;HNRNPF;NFKBIB;MEF2A;TAF1B;MRPL10;THAP1;MRPL41;RBM39;MRPL52;SRSF9;RPL9;MRPS33;TESC;RPS29;RPS19
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.5543542503101893,-0.8506768620793879,0.6923076923076923,1.0,1.0,4/5,26.06%,MAPK7;CALM1;RACK1;CALM3
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.3985727422766169,0.8504219198781744,0.7017543859649122,0.9531821583643019,1.0,6/35,22.91%,MRPS12;FOXO3;SLC25A33;MRPS34;TFB2M;MRPS15
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.5149030327980135,-0.8499863478028642,0.7,1.0,1.0,2/11,5.97%,ZWILCH;BUB1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.57586647161763,0.8498809213737611,0.7391304347826086,0.953221031384371,1.0,2/5,18.81%,SMC5;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.57586647161763,0.8498809213737611,0.7391304347826086,0.953221031384371,1.0,2/5,18.81%,SMC5;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.57586647161763,0.8498809213737611,0.7391304347826086,0.953221031384371,1.0,2/5,18.81%,SMC5;NSMCE2
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4574909453650882,-0.8497343161205175,0.6,1.0,1.0,1/11,4.93%,DRD2
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.44457212760335363,-0.8494064334823314,0.7021276595744681,1.0,1.0,8/36,19.64%,PRPF19;WDR77;PRMT7;USP4;SRSF10;PRPF6;COIL;SNRPD2
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.3718300314519722,0.8493771410434037,0.7017543859649122,0.953749545481182,1.0,3/45,7.07%,SMOC1;PBX3;PAX6
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.46760318997215083,0.8493146114289127,0.6545454545454545,0.9535251211365762,1.0,2/22,1.82%,SYK;CCL5
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.4843496430558049,0.8492747960747308,0.6862745098039216,0.9532643810385566,1.0,6/11,29.59%,FOXO1;SMAD4;LMNA;RGS2;GSK3A;NOTCH1
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.41684075728726394,-0.8490134702684319,0.62,1.0,1.0,4/30,13.78%,IFT27;GPC2;PTCH1;B9D1
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),0.5453234533029611,0.8489715574311493,0.6511627906976745,0.9535188522014454,1.0,1/5,13.08%,XPO1
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.4996487901388673,-0.8489670566216989,0.6744186046511628,1.0,1.0,1/11,3.93%,SLC17A9
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4727523480407336,0.8488102955685707,0.6730769230769231,0.953467881601871,1.0,1/12,3.73%,CPSF4L
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4010659632177521,0.8487193130276828,0.7083333333333334,0.9532712023243911,1.0,8/37,11.85%,TGFBR1;GDF6;BMP2;ACVR2A;INHBC;BMPR1A;SMAD4;GDF9
prerank,PanglaoDB_Augmented_2021__Follicular Cells,0.37288338893232886,0.848559946078656,0.7209302325581395,0.9532158026498542,1.0,19/78,15.47%,SULT2A1;HSD17B2;ACSM2A;OIT3;C6;SLC26A7;SLC15A1;SLC7A9;ABCG8;FRK;CYP4F12;PLA2G12B;KNG1;SLC10A1;CYP3A4;ABCG5;AGXT2;TMEM45B;MIA2
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.4447851865778062,0.8481626130316648,0.675,0.9536383286542665,1.0,1/24,2.50%,URI1
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.4373840487910766,0.848041689255987,0.6842105263157895,0.9535373413606382,1.0,6/27,16.35%,PEX12;GDAP1;ZFAND6;ABCD3;ABCD2;PEX2
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.4388068803070102,0.84795910638091,0.7678571428571429,0.9533318197328258,1.0,9/18,24.81%,SLC39A8;TRPM2;SLC30A10;SLC30A6;SLC30A4;SLC30A1;SLC30A2;SLC39A14;SLC39A6
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.38854307995694437,-0.8478783647172818,0.6326530612244898,1.0,1.0,3/33,7.19%,DND1;TENT5B;SLC11A1
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.33346481347085594,0.8478645091474789,0.7884615384615384,0.953185547609539,1.0,12/95,6.72%,SLC12A7;MYCN;HRH3;GOLT1A;EFNA2;SCGN;HGFAC;SYT1;SEMA6C;MMP15;PLPPR1;GAL3ST1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.394403883817299,0.8478438642475761,0.711864406779661,0.9528757639004026,1.0,5/35,9.15%,FZD5;HTRA2;UBE2D3;RHOU;LMAN1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.4025509440119788,-0.847272108209628,0.6666666666666666,1.0,1.0,5/45,10.52%,GPC2;GPC1;GPC3;HFE;PARP1
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.46075808501428184,0.8470185458091232,0.6444444444444445,0.9540563869878256,1.0,4/17,12.25%,KLKB1;F12;GSN;BAG2
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),0.4881870026676691,0.8469595477445929,0.6727272727272727,0.9538418891414596,1.0,2/14,8.44%,SHMT2;CBFA2T3
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.34287229001517683,0.8468702845340167,0.746268656716418,0.9536865634256948,1.0,14/108,19.17%,TCIRG1;LIX1;PIP4K2A;PRKAB2;CHMP6;ATG101;MTMR3;TMEM74;PRKAA1;TBC1D5;STAM2;MTERF3;STX17;MVB12A
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.5365734220041091,0.8461716268942295,0.7068965517241379,0.9545933429924597,1.0,3/8,15.78%,PYCR1;GPR37;NFE2L2
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.32486377624533097,0.8460215828684944,0.8541666666666666,0.9544923037694316,1.0,24/145,26.62%,CARNS1;PCSK5;MRPL28;MRPS12;RPS5;RPL21;DMD;ZAR1L;RPL18A;RPL7;RPS3A;MRPL18;RPL23A;MRPL11;FURIN;MRPS15;GGTLC2;MRPL10;MRPL41;MRPL52;RPL9;MRPS33;RPS29;RPS19
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.4266072258441912,-0.8458721874887191,0.6428571428571429,1.0,1.0,7/26,21.41%,ERN2;DAB2IP;DNAJC10;QRICH1;BRSK2;MAP3K5;BAK1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.38339776917606266,0.8456962847877787,0.6875,0.9548312541155238,1.0,3/46,4.98%,BOK;TGFBR1;SEPTIN4
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.45979065561325183,0.8456447752151014,0.7272727272727273,0.9545987266900834,1.0,7/13,29.42%,PPIF;ZFAND1;CPEB2;MKNK2;ATF3;GSTO2;GSTO1
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.4290236707504988,-0.8453834598163881,0.6170212765957447,1.0,1.0,2/16,9.13%,TERF2IP;RAD50
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.5147115527181588,0.8452668538960828,0.6842105263157895,0.9549645927253714,1.0,1/8,5.30%,MID2
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.34569343305309574,0.8448545280753061,0.8076923076923077,0.9553800357203271,1.0,16/153,8.97%,VEGFC;IGF1;FERMT3;HGF;SYT15;LHFPL2;PCLO;SYT6;MANF;RAB31;ANXA5;SYT1;TF;SNCA;CRHBP;RIMS2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.37590003228495306,0.8448193647936691,0.6923076923076923,0.9550886857066669,1.0,14/75,19.07%,FZD5;PRICKLE2;MAGI2;PSMD13;VANGL2;FZD1;PSME4;PRICKLE1;DVL2;FZD4;FZD6;PSMA1;ARRB2;SMURF1
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.5182449669042624,-0.8446885921418477,0.6666666666666666,1.0,1.0,3/8,16.62%,HMGCL;BDH1;SLC27A5
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.5017832080918676,0.8446567695151128,0.6938775510204082,0.9550963396028043,1.0,1/9,5.50%,SLC8A1
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.48124201659435856,-0.8445856565574738,0.7111111111111111,1.0,1.0,5/11,31.36%,ALOX12B;ATG10;WIPI1;WDR45B;PORCN
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.3792019357066165,0.8445777884355433,0.7647058823529411,0.954927487433481,1.0,6/34,12.49%,CDK11A;PAPOLA;KHDRBS2;SLTM;QKI;KHDRBS3
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.5293319411737646,-0.844334685502391,0.6046511627906976,1.0,1.0,3/8,8.08%,KCNE2;KCNE1;KCNQ1
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.5364721634548765,-0.8440687483814497,0.6964285714285714,1.0,1.0,1/6,1.52%,SOX30
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),-0.5456628584725544,-0.8438218837307696,0.6875,1.0,1.0,1/5,10.45%,RABGGTA
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.32411147491310527,0.8437525367779053,0.8333333333333334,0.9561114496757118,1.0,39/161,22.43%,TGFBR1;POGLUT2;MAPKAPK2;DYRK2;RPS6KA4;GALNT3;SMG1;LATS1;MAPKAPK3;RPS6KA2;GALNT1;STK32B;VRK2;MAPK8;RPS6KA1;DYRK1A;IKBKE;CSNK1G3;RICTOR;HIPK1;POGLUT3;SGK1;DYRK3;PKN2;RPS6KA5;GALNT16;MAST1;STK38L;AKT3;WNK1;NAA11;IKBKB;HIPK3;STK32C;CAMK4;GAS6;RPS6KA6;AKT2;EIF2AK3
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.482438583194558,-0.8436349875610836,0.5833333333333334,1.0,1.0,2/9,19.39%,ZFPM1;TPO
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.4926496117761493,0.8433233607513257,0.6808510638297872,0.9565393256534827,1.0,2/8,11.77%,PLXNB1;PLXNB2
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.3937875668498384,0.8428824331274957,0.6346153846153846,0.9570844435799419,1.0,15/39,29.79%,RALA;LMNB1;AIP;PLCB1;HNRNPA2B1;ANXA2;HNRNPF;IL12A;JAK2;PAK2;PDCD4;SIRPA;CD47;GSTO1;IL12RB2
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.5215885953218797,-0.8428508486951221,0.7333333333333333,1.0,1.0,2/8,12.81%,ZNF703;RREB1
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.5267638733751574,0.8428074155589984,0.7291666666666666,0.9568970526714906,1.0,1/8,9.43%,GRAMD2A
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.5420843359936596,0.8426110368694997,0.7,0.9569582672516356,1.0,2/6,32.26%,WASL;SH3GLB1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.35246347396018735,0.8424517040606693,0.6964285714285714,0.9569200842342905,1.0,20/103,17.54%,FGF2;PIK3R6;PIK3R5;PIP4K2A;PIK3C2B;PLCG2;PLA2G10;IP6K3;INPP4B;PIK3CA;PTEN;MTMR9;MTMR3;PI4K2B;MTMR11;PLCB1;PITPNM1;PIK3CD;PLCD1;PLBD1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.4133578581615057,0.8421107149715723,0.75,0.9571934306777844,1.0,6/28,14.25%,FGF2;PPARG;HMGB1;MEF2C;PTPRM;NR2F2
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.3775243654308807,0.8418039404418584,0.74,0.9573447356273672,1.0,7/65,10.60%,ZDHHC11;FRMPD1;ZDHHC12;ZDHHC22;RAB3IP;ZDHHC2;GRIN3B
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.4154871699314104,0.841778479062255,0.7321428571428571,0.9570673549922007,1.0,5/30,8.41%,NLGN1;SYT1;CEL;SNCA;NLGN4X
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.33519661531822403,0.8417479317786988,0.7169811320754716,0.9568217374619948,1.0,23/111,16.55%,RAB38;SLC22A3;LRP1B;TCN2;ABCA6;ABCA1;RAMP3;ABCG8;ARRDC3;TAP1;TOM1;ABCD3;ABCD2;ABCC11;ABCA8;SLC19A1;SLC22A5;ABCG5;LRP2;LMAN2L;SLCO1A2;ABCA9;CALCRL
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.4653915975583594,0.8416887977962643,0.68,0.9565808004315279,1.0,4/12,21.70%,SLC37A4;SLC20A1;SLC25A30;SLC25A14
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.5304217804070454,-0.8413551861576242,0.6862745098039216,1.0,1.0,1/5,7.13%,PPP1CA
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.34343589500906596,0.8413114292754321,0.8253968253968254,0.9570205314228164,1.0,13/101,10.29%,FLT1;F2;EPHA7;FGFR3;FGFR1;ERBB4;ROR1;PDGFRA;EPHA5;EPHA3;EPHA8;TAB2;FLT3
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.43519831331993064,0.8411760235251109,0.6885245901639344,0.9569193497518494,1.0,7/20,19.96%,TOX;SMARCD3;PROX1;LRP2;CTNNB1;VEGFA;CX3CR1
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.38975816544091313,0.8411094653636548,0.7857142857142857,0.9566921421565217,1.0,9/53,12.92%,HGF;IL10RA;SNCA;SMG1;TAB2;LEPR;PIK3CA;WASHC1;MTMR9
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.39074620820601186,0.8410674911793847,0.6875,0.9564200749178449,1.0,13/40,23.10%,ZFP36L2;NUDT16L1;RNASET2;RIDA;HNRNPD;DXO;AGO3;SLFN14;PNPT1;NCBP1;ZFP36;LSM2;HSPA1A
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.5186217460720818,0.8409489628587098,0.66,0.9563102091649895,1.0,3/10,7.07%,TGFBR1;POU3F2;PAX6
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),-0.5193150419264894,-0.8408698417462751,0.6888888888888889,1.0,1.0,2/6,17.77%,TAC4;TACR1
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),-0.5193150419264894,-0.8408698417462751,0.6888888888888889,1.0,1.0,2/6,17.77%,TAC4;TACR1
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),-0.5193150419264894,-0.8408698417462751,0.6888888888888889,1.0,1.0,2/6,17.77%,TAC4;TACR1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.3909853337761633,-0.8407946839673978,0.7333333333333333,1.0,1.0,6/38,7.19%,SIRPG;AHSG;SPACA3;C2;DOCK2;SLC11A1
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.39460712701758904,0.8407818954031729,0.782608695652174,0.9562499063446349,1.0,2/44,3.67%,IGF1;FBXO5
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.39446864053490827,-0.840642880438051,0.6739130434782609,1.0,1.0,12/32,21.14%,MBTPS2;AFG3L2;ADAM19;SPPL2B;MYH9;TGFB1;APH1B;MBTPS1;ADAM9;APH1A;RBMX;PRTN3
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.5156000682575897,0.8406146826380324,0.6190476190476191,0.9561581656368672,1.0,1/7,5.22%,ACADS
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.3782297509338651,0.8405443641974912,0.7317073170731707,0.9560035509541718,1.0,11/68,15.17%,LRP4;FBLIM1;SDK1;PPFIBP1;SNCA;MARVELD3;NLGN4X;GRM5;SEMA3E;PPFIA3;L1CAM
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.3166567230344915,0.8405138144170288,0.8723404255319149,0.9557277061132922,1.0,22/142,14.47%,CTDNEP1;DUSP29;DUSP23;PLPPR1;PPP4R1;PPP1CC;PPM1A;PTPRD;PTPN14;DUSP18;PTPRT;ACP6;PPM1L;PTPRK;PPM1E;PTEN;PPP3CA;PPP3CC;PTPRM;MTMR3;DUSP2;PTPRU
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.41654027548800865,0.8402331149962216,0.6666666666666666,0.9558743434258685,1.0,4/29,11.63%,PLEKHH2;KANK1;PIK3CA;SMAD4
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.3521108663815967,-0.8401992393818468,0.7241379310344828,1.0,1.0,15/96,17.61%,DDX11;INCENP;NEMP1;CHD4;PDCD11;DARS2;FTSJ3;SNRNP200;UCP3;TTF2;CHAF1A;MCM2;HNRNPL;ILF3;DHX38
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.3469904280186551,-0.8401743710333137,0.7407407407407407,1.0,1.0,10/109,7.75%,GFRA3;COL4A2;GFRA2;COL4A1;BOC;OLFML2A;GULP1;SFRP1;MPZ;ARNT2
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.3156171189765307,0.8398075191342942,0.8363636363636363,0.9563352391605424,1.0,25/188,23.09%,MYC;CCNA2;U2AF1;SYNCRIP;ODC1;HDAC2;MCM7;RPS5;HNRNPD;XPO1;PSMA1;HNRNPA2B1;G3BP1;RUVBL2;CDK4;PRPS2;TRIM28;NCBP1;UBE2E1;HPRT1;CANX;SNRPA;SRSF3;HNRNPU;LSM2
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.34764283100972093,-0.8397322503223543,0.6909090909090909,1.0,1.0,6/89,5.49%,TMEM179;RGS8;ST8SIA2;ZCCHC12;DRD2;VGF
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.4464326778478708,-0.8395398897922237,0.7068965517241379,1.0,1.0,2/11,2.67%,NLRP3;CD86
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.3890561866490885,0.8393501017370893,0.7647058823529411,0.9568407059414907,1.0,8/46,24.86%,HIF1A;GCK;RANBP2;PNPT1;NUP153;PRDM16;OGT;EP300
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.4758173600556165,0.8393354587981448,0.6964285714285714,0.9565335399192247,1.0,4/9,23.73%,CSF1;LYN;MAPK3;IL12A
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.5603305601008256,0.8393290461750058,0.7368421052631579,0.9562041574863368,1.0,2/6,8.55%,ALDH1A1;BCAT1
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),0.5011035668622459,0.8391033314902173,0.6666666666666666,0.9562786191000086,1.0,1/10,1.67%,SYK
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),0.4973519337064246,0.8390028808715485,0.6938775510204082,0.9562006054807306,1.0,2/6,27.85%,GTF3C4;GTF3C5
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.4409436662746974,0.8384831561838942,0.7049180327868853,0.9568710525540431,1.0,8/18,23.73%,NECTIN2;IL23R;HLA-E;FADD;HLA-F;HLA-B;MR1;IL12A
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),-0.5697877014627549,-0.8382885049368334,0.7857142857142857,1.0,1.0,1/8,3.27%,ASS1
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.38955164364746636,0.838236230505699,0.6842105263157895,0.9569900029850881,1.0,16/60,17.56%,FZD5;WNT4;FRAT2;WNT9A;PTEN;NR4A2;FZD1;DVL2;LRP6;FZD4;FRAT1;FZD6;FRZB;DIXDC1;CTNNB1;WNT2
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.4884070577005099,-0.8381717730099979,0.6808510638297872,1.0,1.0,2/10,5.97%,DDX11;BUB1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.4708842821121174,0.8379108455027531,0.7555555555555555,0.9572790478926342,1.0,1/13,4.99%,PHKA1
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.5539862502502584,0.8377507599616553,0.7368421052631579,0.9572187016730309,1.0,2/6,10.70%,CEP152;E2F4
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.47865972655209504,-0.8377502886632769,0.673469387755102,1.0,1.0,1/11,6.14%,RBM4
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.47865972655209504,-0.8377502886632769,0.673469387755102,1.0,1.0,1/11,6.14%,RBM4
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.5136093783128285,0.8376761992591142,0.7272727272727273,0.9569883386163869,1.0,2/9,4.15%,RSPO3;MLLT3
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.3754890222017778,0.8374814657047975,0.717391304347826,0.9569997144005564,1.0,7/37,14.68%,BMI1;DUX4;RYBP;YAF2;EZH2;RNF2;EPC1
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.4227242142701677,-0.8374409438801342,0.6666666666666666,1.0,1.0,3/29,14.01%,CENPH;ITGB3BP;SMARCA5
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.3758789125970572,0.8374106636806237,0.6666666666666666,0.9568277253938163,1.0,17/42,21.98%,NAALAD2;GLUL;GADL1;PYCR1;SRR;SLC25A13;CBS;THAP4;CPS1;RIMKLA;SLC25A12;GPT;GLUD1;ASPA;FOLH1;RIMKLB;OAT
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.42375185736102866,-0.8370915587557249,0.6363636363636364,1.0,1.0,1/25,1.91%,ARL5C
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.44675433933822495,0.8365846163247161,0.7457627118644068,0.9581043185642177,1.0,5/22,16.45%,ARHGAP24;ABI3;KANK1;CCP110;LIMK2
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.3440070986988548,0.8363166737792381,0.7818181818181819,0.9582314886824542,1.0,17/70,13.86%,IRS1;ACSM2A;SIRT1;HIF1A;PPARG;ADIPOR2;PAX6;CYB5R4;LEPR;MCU;FOXO1;GCK;BACE2;IGF1R;KLF7;HKDC1;MLXIPL
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.388277403981967,0.8363068493622721,0.7368421052631579,0.9579296946606204,1.0,9/39,13.57%,SIRT1;HIF1A;ZBTB20;LIN28A;UNC13B;FOXO1;GCK;IGF1R;HKDC1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.42498216500349617,-0.8362943701413345,0.7142857142857143,1.0,1.0,7/19,21.14%,ADAM19;SPPL2B;MYH9;ADAM9;APH1A;RBMX;PRTN3
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.4758670130707987,0.8361643121566978,0.6792452830188679,0.95781567830218,1.0,1/12,3.09%,ANGPT1
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),0.44472275370668635,0.8360769500367814,0.6721311475409836,0.9576213828114717,1.0,2/18,7.52%,GSTM2;ELOVL5
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.5122903600751734,0.8357875283896777,0.7540983606557377,0.9578601140400075,1.0,4/8,35.03%,EZH2;DOT1L;DPY30;SIRT2
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.4790253789624595,0.8355860925625856,0.6909090909090909,0.9577997755941108,1.0,3/12,12.31%,CSRP2;PGM5;CSRP1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.4128006465802418,-0.835161019517256,0.7358490566037735,1.0,1.0,3/24,9.71%,CD86;HLA-DRB1;PDCD1LG2
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.46308293761801167,0.8347564994723213,0.7230769230769231,0.9591398263783343,1.0,2/12,13.67%,SLC7A9;SLC19A1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.45479260378744385,0.8346745903423364,0.7254901960784313,0.9589542574825887,1.0,8/20,16.99%,IL4;PLA2G10;NR1H3;LRFN5;CD74;MFHAS1;GPR137B;IL33
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.3450814924620098,-0.8346283628995274,0.6875,1.0,1.0,19/112,10.15%,UROC1;EHF;PVALB;SPTLC3;KCNJ1;KCNJ16;AQP7;SLC22A8;UMOD;PDZD2;PTPN3;COL28A1;MYO5B;ADGRF5;ZBTB7C;SLC22A6;SLC3A1;VDR;MUC15
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.34958960762614283,0.83447378437369,0.8444444444444444,0.9589782780505981,1.0,13/79,17.81%,NDE1;CEP70;KCNH5;PCM1;CEP152;DCTN3;CEP135;DYNC1I2;CNTRL;NEDD1;CCP110;DYRK3;TP53
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.5054143671915212,-0.8342868853287265,0.6727272727272727,1.0,1.0,1/10,1.95%,BUD23
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.42675121500244506,0.8342525404814517,0.6666666666666666,0.9590423775739355,1.0,10/25,24.90%,MYCN;LIN28A;TP53;FMR1;LIMD1;ZFP36;BMP4;DHX9;PUM2;EGFR
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.4851451433523075,-0.8342502584400318,0.7115384615384616,1.0,1.0,4/14,17.38%,BTK;APOA1;WNT5A;TRIL
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.41066252174454215,0.8336915399244741,0.7049180327868853,0.9597165654372609,1.0,6/20,15.08%,TGFBR1;WWTR1;BMPR1A;SMAD4;FAM89B;KIAA0319
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),-0.562321139394199,-0.8334932331857107,0.7111111111111111,1.0,1.0,4/5,39.15%,TBL3;NOP9;NOP14;UTP20
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.562321139394199,-0.8334932331857107,0.7111111111111111,1.0,1.0,4/5,39.15%,TBL3;NOP9;NOP14;UTP20
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.562321139394199,-0.8334932331857107,0.7111111111111111,1.0,1.0,4/5,39.15%,TBL3;NOP9;NOP14;UTP20
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.4367967109832537,0.8334100328382802,0.660377358490566,0.9598872123753033,1.0,2/25,1.82%,SYK;CCL5
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.4951527943296921,0.8333460920506083,0.7037037037037037,0.9596616520083749,1.0,1/11,1.67%,SYK
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.4739400614301296,0.8332780447243316,0.6666666666666666,0.9594540433892885,1.0,6/15,24.57%,PCM1;NEDD1;C2CD3;CCDC14;PIBF1;KIAA0753
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.41366203784428135,-0.833237227059194,0.7307692307692307,1.0,1.0,2/18,5.75%,EEF1AKMT2;KMT2B
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.46505753481651185,0.8330185146551974,0.7555555555555555,0.9595845777854543,1.0,2/12,11.28%,SLC8A1;ATP1A2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),0.5199941816884985,0.832732000296582,0.7450980392156863,0.9597728175559701,1.0,4/6,33.34%,HEY2;VEGFA;NOTCH1;EFEMP2
prerank,GO_Biological_Process_2021__negative regulation of retinoic acid receptor signaling pathway (GO:0048387),-0.5465968967616018,-0.8325991590009348,0.7,1.0,1.0,2/5,14.10%,PRAME;CYP26B1
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.4030895883268668,0.8323585686638002,0.6666666666666666,0.96007647853414,1.0,4/26,7.69%,SEMA5A;IL4;ANGPT1;CD40
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.40548476077285833,0.8321088571711903,0.7213114754098361,0.9602377616511952,1.0,4/29,16.35%,PEX12;CHCHD4;DNAJC15;PEX2
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.47329038768900716,-0.8319255640287542,0.68,1.0,1.0,1/14,1.04%,CD24
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.3862218679172494,0.8317473144872171,0.7111111111111111,0.9607542303278176,1.0,3/43,7.83%,SMAD6;HMGB1;PPM1A
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.44365138467118753,-0.831730261469439,0.6470588235294118,1.0,1.0,6/19,10.93%,NLRP3;ADGRG3;CCN3;HDAC7;SPI1;TMSB4X
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.503690369731028,0.8315780196277437,0.7272727272727273,0.960679864943361,1.0,7/10,30.57%,ROBO2;BMP4;NPNT;SLIT2;SALL1;PKD1;PKD2
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.5499795599035271,-0.8314814138850192,0.68,1.0,1.0,2/8,10.96%,DNAAF1;CCDC40
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.39703678584825136,0.8313686307816472,0.7592592592592593,0.9607830767407343,1.0,7/34,17.47%,UNC5C;ACHE;RTN1;PML;L1CAM;HEY2;VEGFA
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.33942765586418067,0.8313185670695692,0.7333333333333333,0.9605534712613593,1.0,11/78,8.55%,AASS;CARNS1;SHMT2;IDO1;HYKK;ALDH7A1;GLUL;IDO2;TDO2;HIBCH;BCAT1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),-0.3705281543064581,-0.8311733548347505,0.7209302325581395,1.0,1.0,3/59,9.83%,TBC1D10C;ENTR1;TCHP
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),0.48263767423541704,0.8309670642158918,0.6595744680851063,0.9607897079244834,1.0,2/7,27.85%,GTF3C4;GTF3C5
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.36595580711517733,-0.8308778931758719,0.7551020408163265,1.0,1.0,9/58,12.20%,WARS1;TRIB1;TRIB2;UBASH3B;CEACAM1;CAMK2N1;TAF7;SPRED1;PYDC1
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.3945157485799667,0.8306426951614928,0.7872340425531915,0.9607387136493446,1.0,6/24,20.55%,PAPOLA;PCF11;TENT4B;CSTF3;PNPT1;WDR33
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.3945157485799667,0.8306426951614928,0.7872340425531915,0.9607387136493446,1.0,6/24,20.55%,PAPOLA;PCF11;TENT4B;CSTF3;PNPT1;WDR33
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.34688888143670976,0.8306280056823019,0.6538461538461539,0.9604252606211241,1.0,23/142,15.66%,CCNG1;SMYD2;PIP4K2A;PRKAB2;MAP2K6;TP53INP1;DYRK2;BANP;HDAC2;TAF3;RRS1;CHEK2;TP53BP2;NOC2L;PML;BOP1;KAT6A;TAF5;RICTOR;HIPK1;TAF2;SGK1;PRKAA1
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.43534666975779873,-0.8305077728409688,0.6122448979591837,1.0,1.0,5/18,11.02%,CELA2A;PRKCD;F11R;CEACAM1;SERPINE2
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),-0.4985200350093951,-0.8304840352024052,0.625,1.0,1.0,3/6,10.34%,BTBD18;PIWIL2;DDX4
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.37870517367666545,-0.8304114539062967,0.6923076923076923,1.0,1.0,5/45,7.35%,APIP;TRPV5;UPB1;GOLGA2;TRPA1
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.36022392498802414,0.830347917494513,0.6888888888888889,0.9606080682103832,1.0,13/71,14.23%,SLC12A7;SLC12A1;TRPV2;KCNJ3;SLC12A3;SLC8A1;SLC39A8;SLC24A2;SLC9A2;ATP1A2;SLC39A12;SLC9C2;TRPM2
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.38397781852415525,0.8301474473356064,0.7090909090909091,0.9607287656408714,1.0,7/29,17.05%,PRR5L;TENM1;PCM1;PTPN14;ZFAND1;RAB29;SIRT7
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.4279927944525411,-0.8298567715697663,0.7045454545454546,1.0,1.0,2/21,12.64%,EML3;GPSM2
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.5559393646936084,0.8298075427898335,0.7692307692307693,0.9610396944770191,1.0,4/6,35.74%,CDK6;HES5;EIF2B5;MT3
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.5113431967249221,-0.8296492941898421,0.6923076923076923,1.0,1.0,3/6,29.25%,CDC7;DBF4B;DBF4
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.45517745027771933,-0.8295636769693152,0.7777777777777778,1.0,1.0,1/10,3.27%,ASS1
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.4294509734259352,0.8293566020446743,0.7068965517241379,0.9615981754113643,1.0,10/30,22.91%,CCL5;SP1;NAPEPLD;ZNF639;CHD1;CX3CR1;HDAC1;RRP1B;CARD9;LRRC19
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.3418523320804674,0.8292074135459655,0.7948717948717948,0.9615503383449795,1.0,9/92,12.52%,U2AF1;SF3B1;SYNCRIP;IVNS1ABP;SNRPN;NOVA1;SNRNP48;RRAGC;CDK12
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.3589396911821269,0.8291469344913442,0.72,0.9613256801180586,1.0,22/83,19.44%,RHOBTB3;RAPGEF3;EFNA5;ABI3;EPS8;PDGFRA;EPHA5;EPHA3;DLC1;ABL2;PIK3CA;GPM6B;SEMA3E;RHOBTB1;TRPM2;RICTOR;NOTCH2;RHOG;RHOD;RHOB;MLST8;ABL1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.5152858704883622,-0.8290682556599224,0.7659574468085106,1.0,1.0,2/8,7.77%,DLL4;ARHGAP12
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.5360839902022547,0.8289244126320121,0.8333333333333334,0.9613310076341257,1.0,3/5,21.01%,GRM5;GABRE;ATP8B1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.46104979105347643,0.8287797595278061,0.7441860465116279,0.9612921483671107,1.0,5/13,27.66%,MAPKAPK2;ELAVL4;ZFP36;HNRNPC;ANGEL2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5096351275331487,0.8285850019135559,0.7222222222222222,0.9613063173320124,1.0,4/8,25.12%,NR1H3;TICAM2;NINJ1;LBP
prerank,GO_Biological_Process_2021__regulation of inositol phosphate biosynthetic process (GO:0010919),0.5482840791062871,0.8284038247375526,0.7111111111111111,0.9613160612857067,1.0,2/5,7.89%,CD244;SNCA
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3437440823936902,0.8281407296578414,0.8,0.9614493838326564,1.0,14/70,19.73%,SIRT1;CDKN2A;SLC8A1;LATS1;SPRY3;PTEN;HEXIM2;NR2F2;LRP6;RGS14;IRAK3;PKIA;ABL1;LYN
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.3892430956642232,0.827784207029136,0.7959183673469388,0.9618032270935332,1.0,9/35,20.84%,SIRT1;MAGI2;BANK1;PTEN;PHLDA3;ARRB2;PHLPP1;THEM4;DDIT3
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.45755438885712285,0.8274191525831565,0.782608695652174,0.9621700596895384,1.0,2/25,2.81%,FGF10;FGF2
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.5464495178685385,-0.8265778217621638,0.7333333333333333,1.0,1.0,1/5,12.61%,NUCKS1
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.35364302847735984,0.8265666751656989,0.74,0.9634273025816852,1.0,7/62,8.27%,LGALS9;ITGAX;CSF3R;FGL2;TLR2;SIGLEC1;TFEC
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),0.4952205801718878,0.8260079648273125,0.6842105263157895,0.9640401581414266,1.0,3/8,14.24%,SLC22A3;SLC25A48;SLC22A5
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.4818960944920202,0.8256851063124426,0.7083333333333334,0.9642516297953095,1.0,5/10,24.02%,SMPDL3A;ABCA8;ABCA2;SAMD8;SGMS1
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),0.42899820089023843,0.8256746505482461,0.7666666666666667,0.9639387990375942,1.0,1/25,3.29%,MDFIC
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.5115316639287041,0.8256653814433077,0.78,0.9632873703188664,1.0,3/8,15.49%,SNCA;PDE4B;RYR2
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.5115316639287041,0.8256653814433077,0.78,0.9632873703188664,1.0,3/8,15.49%,SNCA;PDE4B;RYR2
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.38162065831488695,0.8255271954875797,0.7115384615384616,0.9632348004525477,1.0,13/37,29.79%,RALA;LMNB1;AIP;PLCB1;HNRNPA2B1;ANXA2;HNRNPF;IL12A;JAK2;PAK2;PDCD4;GSTO1;IL12RB2
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.35535940802845395,-0.825442271183182,0.8070175438596491,1.0,1.0,17/78,14.85%,MS4A8;CHST9;PTPN3;CAPN9;MYO5B;PLEKHS1;AK7;ZBTB7C;ZBBX;CCDC40;MROH9;RSPH1;APOBEC4;CFAP52;ATP1B1;ADH7;TACC2
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.5608566211893924,0.8253156284579735,0.7192982456140351,0.9632878342865778,1.0,4/5,30.87%,PTPRC;APPL1;CD47;APPL2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.3378731113913506,0.8251143708102683,0.8695652173913043,0.9632880660323386,1.0,33/165,16.99%,CFH;TMEM100;PRRX1;ADGRL4;ITGA2;MYCN;MAFB;CSF2RA;BMP2;IL7R;IRF8;IL10RA;GALNT3;USP12;SPON1;GYPC;CA2;C3AR1;HKDC1;PLAUR;ZNF639;ANGPTL4;ADAMDEC1;MAP3K1;ANKH;PTBP2;CAB39L;CPE;GPRC5B;GUCY1A1;GLRX;BIRC3;IL33
prerank,GO_Biological_Process_2021__purine ribonucleoside metabolic process (GO:0046128),-0.5218450332339558,-0.8250165807680555,0.6666666666666666,1.0,1.0,1/5,11.71%,ACP3
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.40611688647352934,0.8247986965948589,0.6981132075471698,0.9634817060554933,1.0,11/29,26.77%,CCL5;HLA-E;POLR3G;PLSCR1;FADD;RIOK3;DHX9;LBP;SH2D1B;RPS19;NLRC5
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.45582225729007053,0.8247130168505086,0.7391304347826086,0.9633236821963688,1.0,1/13,4.99%,PHKA1
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.4079002731830673,-0.8246189136302986,0.7647058823529411,1.0,1.0,3/19,14.22%,BUB1;TTK;CENPF
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.4079002731830673,-0.8246189136302986,0.7647058823529411,1.0,1.0,3/19,14.22%,BUB1;TTK;CENPF
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.4079002731830673,-0.8246189136302986,0.7647058823529411,1.0,1.0,3/19,14.22%,BUB1;TTK;CENPF
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.5327588770636591,-0.8245198157449959,0.7209302325581395,1.0,1.0,2/7,8.97%,F7;NTRK3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),0.4673843119642642,0.8243070278608449,0.6530612244897959,0.963692883358143,1.0,3/10,12.52%,IL4;NR1H3;LRFN5
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.4306771233732917,-0.8242325149818069,0.5818181818181818,1.0,1.0,4/33,3.41%,CLDN4;DUOX1;CLDN1;ALOX5
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.35800862639576175,0.8240607674774566,0.6274509803921569,0.9638598397613569,1.0,11/66,19.62%,IGF1;HIF1A;ZBTB20;CBFA2T3;GCK;MLXIPL;PRKAA1;RANBP2;PFKFB4;ARNT;FBP1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),0.4862082213031601,0.8239977864433928,0.7169811320754716,0.9636403936898477,1.0,2/14,1.82%,SYK;CCL5
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.33573831345327465,0.8238560740990665,0.7857142857142857,0.9635702943106502,1.0,19/111,15.68%,TSPAN12;LRRC4C;FGF2;EFNA5;NEDD4;CDH2;TNIK;ABI3;PDLIM5;BMPER;ADGRB3;HECW2;VASH2;MEF2C;INF2;PHLDB2;CRB2;ZMYM4;PHIP
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.3937005000621327,0.8237181400394245,0.7115384615384616,0.9634958561359113,1.0,6/27,19.06%,ST3GAL6;SLC35D2;CHST6;B4GALT3;HEXB;PRELP
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.39463187918112,0.823643584056587,0.7777777777777778,0.9633249954920675,1.0,4/25,11.46%,SASH3;CD244;HLA-E;VAMP3
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.3442056741093063,0.8236335117049944,0.7547169811320755,0.9630052072055392,1.0,18/96,19.44%,IGF1;IL4;NRG1;ANGPT1;TNIK;ADRA2C;PAK5;TNFRSF10B;IRAK1;STRADA;RICTOR;PRLR;VEGFA;BORA;PRKACB;MLST8;TNFRSF10A;ABL1
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.4708211698911783,0.8235948447385667,0.7636363636363637,0.9627382228784093,1.0,4/15,17.67%,JAGN1;CBFA2T3;PML;CDK4
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",0.5118581422137907,0.8235790149350664,0.6808510638297872,0.9617851422991285,1.0,1/7,18.08%,CD55
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),0.5118581422137907,0.8235790149350664,0.6808510638297872,0.9617851422991285,1.0,1/7,18.08%,CD55
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",0.5118581422137907,0.8235790149350664,0.6808510638297872,0.9617851422991285,1.0,1/7,18.08%,CD55
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.35750175774964793,0.8235103143761299,0.8253968253968254,0.9616020846068045,1.0,12/67,12.26%,SEMA5A;TENM1;HCLS1;FER;BIN1;CRACD;LMOD2;SYNPO2;CARMIL1;NCK2;FCHSD2;PROX1
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.49588539383990227,-0.8234214716382575,0.6862745098039216,1.0,1.0,3/9,16.62%,HMGCL;BDH1;SLC27A5
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.43478675537922534,0.8233864070569967,0.703125,0.9614847720338864,1.0,1/18,2.71%,CD22
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.4400591446751447,-0.8228999165440458,0.6346153846153846,1.0,1.0,4/20,19.37%,ARPP19;PTPA;PPP1R1B;ENSA
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.48058227270428877,0.8227279606059764,0.6521739130434783,0.96239524408279,1.0,2/6,9.30%,MYO1E;MAGI2
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.5104257568106145,-0.822488364666526,0.6176470588235294,1.0,1.0,1/5,20.63%,RNF20
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.39283935252128266,0.8224012539568899,0.7647058823529411,0.9627236574195952,1.0,3/25,11.92%,LMOD3;SIX4;MEF2C
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.48193704734447873,0.8223958020772744,0.7627118644067796,0.9624006819732422,1.0,2/12,8.67%,SPR;GCH1
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.49905363530431374,0.8223667569611105,0.6481481481481481,0.9621347198705096,1.0,5/7,21.65%,GAB1;HSPB1;PIK3CD;VEGFA;MYO1C
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.5133076446362571,-0.8223268021349938,0.6428571428571429,1.0,1.0,3/9,26.72%,TASL;GRN;ATP6AP2
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.3966557437681477,0.8220708795604601,0.717391304347826,0.9623406034528923,1.0,6/42,19.95%,ST6GALNAC3;ESYT3;ESYT2;ABCA2;HEXB;ST8SIA1
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.4207096832226288,0.8220526133389503,0.6885245901639344,0.9620486477307826,1.0,6/25,16.85%,PEX12;GDAP1;ABCD3;ABCD2;PEX2;ABCD4
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.4580074955844784,-0.8212663450010594,0.7058823529411765,1.0,1.0,1/11,11.38%,AP3S2
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.4580074955844784,-0.8212663450010594,0.7058823529411765,1.0,1.0,1/11,11.38%,AP3S2
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3728550141132459,0.8211512194572204,0.8113207547169812,0.963249481600261,1.0,21/66,29.13%,ANGPT1;SEPTIN4;HDAC3;DCUN1D1;PAXIP1;TANK;PRICKLE1;BIRC3;NDFIP2;UBE2D1;RIPK2;PHF23;COMMD1;SAE1;SMAD7;BCL10;TRAF6;GSK3A;CENPX;MUL1;HDAC4
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.5156999564433458,-0.8211171284795006,0.7073170731707317,1.0,1.0,4/8,29.25%,CDC7;NUGGC;DBF4B;DBF4
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.36189720972400347,0.8206651459584774,0.7868852459016393,0.963808165601123,1.0,12/43,19.96%,SEMA5A;HGF;CXCL12;PDGFRA;ARHGEF16;BCAR1;DOCK4;VEGFA;RHOG;ARRB2;KIT;CX3CR1
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.5303761670071683,-0.8206131999735613,0.75,1.0,1.0,1/6,16.14%,TRPV4
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),0.4988824646654315,0.8204254448749039,0.8113207547169812,0.9639041683818628,1.0,4/8,20.46%,NEFH;HAP1;TTC21B;MAP2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),0.46927660779035435,0.8203381485315479,0.723404255319149,0.9637559538259349,1.0,3/14,16.44%,PLCG2;EZH2;DYRK3
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),0.509975122216787,0.8201811953505108,0.7358490566037735,0.963677573906913,1.0,2/6,14.30%,BMP2;LRP6
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.4886161879023807,-0.8198947576303882,0.717391304347826,1.0,1.0,1/9,5.40%,PAH
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.3934352546467734,-0.819612761676991,0.6444444444444445,1.0,1.0,12/35,19.37%,ASS1;ZNF703;MYADM;APOA1;PODXL;AKNA;TGFB1;MAPK7;ADTRP;BMP6;RGCC;GTPBP4
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.46368046979819133,0.819586996234617,0.6904761904761905,0.9645316247928489,1.0,3/15,3.09%,SEMA5A;IL4;ANGPT1
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),-0.5338957810172754,-0.819529267814192,0.6938775510204082,1.0,1.0,2/6,17.13%,CFAP73;PAFAH1B1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),0.49762293401153784,0.8194497378582718,0.7735849056603774,0.9640958457397248,1.0,3/6,39.96%,ANAPC15;CCNB1;DUSP1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),0.49762293401153784,0.8194497378582718,0.7735849056603774,0.9640958457397248,1.0,3/6,39.96%,ANAPC15;CCNB1;DUSP1
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.4500719038813451,0.8194250828151725,0.75,0.9638215953471084,1.0,1/14,4.99%,PHKA1
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),0.5262828408723856,0.8193993987274951,0.7307692307692307,0.9635562326458176,1.0,2/6,7.95%,GLRA1;FGF12
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.3322398042447644,0.8193875044588925,0.8571428571428571,0.9632606028167892,1.0,17/77,16.90%,SLC22A3;SLC26A7;SLC26A6;SLC35B2;CA13;SLC39A8;SLC4A7;CYB5R4;SLC25A24;CA2;ABCC11;SLC19A1;SLC52A1;SLCO1A2;SLC44A4;SLC4A1;SLCO4C1
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.39095468537598377,0.8193552147342642,0.6296296296296297,0.9629564768850095,1.0,9/26,26.63%,SIGLEC1;FCHSD2;PICALM;LMBRD1;CANX;SNAP91;SGIP1;FNBP1L;INPP5F
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.4593897548055206,-0.8193546266713153,0.7659574468085106,1.0,1.0,2/12,3.88%,DOCK8;CD200R1
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.5064169270116359,0.8193365179737429,0.7017543859649122,0.9626699430163496,1.0,1/5,17.82%,KDM6A
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.3610038914181184,0.8191824458218815,0.7708333333333334,0.9625791333545944,1.0,3/39,5.70%,TENT5A;SYNCRIP;MAPKAPK2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),0.43060052492304923,0.8190858156579311,0.6181818181818182,0.962423230274081,1.0,2/14,1.67%,LGALS9;SYK
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.5191928670795025,-0.8190506617315645,0.675,1.0,1.0,2/7,9.42%,DSG2;CTNNA3
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.49649398723000715,-0.8189324604366883,0.7450980392156863,1.0,1.0,3/7,12.87%,HMGCL;MCCC2;BCAT2
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.4726477989593733,0.8186624295134957,0.7636363636363637,0.9629317869467897,1.0,3/11,13.39%,SMYD2;METTL18;SETD7
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.3808572960626908,-0.818407882443268,0.7115384615384616,1.0,1.0,9/59,12.99%,NTRK1;CRLF1;FOXQ1;KDM2B;WFS1;TYRO3;FGF20;NRBP2;PTK2B
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.3109501661165768,0.8182749738111453,0.8571428571428571,0.9632707120654759,1.0,15/136,14.60%,CDC25A;FBXO5;NDE1;CEP70;KCNH5;PCM1;CEP152;PSMD13;DCTN3;CEP135;DYNC1I2;CNTRL;PSME4;NEDD1;CCP110
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),-0.544345353031412,-0.8182325871673368,0.6829268292682927,1.0,1.0,1/5,1.56%,DND1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),-0.544345353031412,-0.8182325871673368,0.6829268292682927,1.0,1.0,1/5,1.56%,DND1
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),-0.46821181308007437,-0.8180498864479903,0.6888888888888889,1.0,1.0,4/11,12.99%,RFLNB;AHSG;RFLNA;PTK2B
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.5308559459595935,0.8180246512085626,0.8333333333333334,0.9633620708698919,1.0,2/8,11.09%,PIP4K2A;WASHC1
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.3629102377071178,0.8176808774823267,0.7358490566037735,0.9636312173691771,1.0,9/78,12.51%,ZDHHC11;ZDHHC12;PEX12;GDAP1;ZDHHC22;RAB3IP;ZDHHC2;ABCD3;ABCD2
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.45535070727398463,-0.8176127392863509,0.78,1.0,1.0,2/12,5.96%,COL4A1;DLL4
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.4334263456979496,0.8168829799800352,0.8157894736842105,0.9645766490842058,1.0,9/22,21.69%,MYC;CRHBP;PPM1E;MEF2C;PDE4B;TP53;RAP2A;FBP1;GAS6
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.43616275479039623,0.8168286005161398,0.7894736842105263,0.9643423602526768,1.0,2/16,4.31%,MAFB;PRMT1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.48832176478290734,0.816793079163562,0.6862745098039216,0.9640562285827525,1.0,6/12,25.19%,ACVR2A;MAGI2;ACVR1B;FSTL3;LEMD3;SMAD7
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.4954598534349543,0.8161010704243892,0.7358490566037735,0.9649702375157706,1.0,2/7,20.82%,DCP1B;ZFP36
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.5356351972996268,-0.8157371724608795,0.6363636363636364,1.0,1.0,1/5,6.54%,SLC13A3
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.4067016707339399,0.8153399221834573,0.7241379310344828,0.9660741717347476,1.0,8/26,16.07%,SYK;BLNK;PLCG2;MEF2C;BCAR1;ITK;SH2B2;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.5319980489023026,0.8153396207377216,0.7090909090909091,0.9657487846779154,1.0,1/6,7.29%,IL15
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.3518734919362155,0.8151825121215657,0.7547169811320755,0.9657395290223856,1.0,12/60,21.36%,SEC22B;ITGAV;PSMD13;TAP1;HLA-E;VAMP3;PSME4;PSMA1;HLA-F;IKBKB;PSMD4;HLA-B
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.49644027295279025,0.8151115041065785,0.6862745098039216,0.9655183002588934,1.0,1/7,8.58%,LIN7A
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.3871430981222195,0.8149278916660204,0.82,0.9655739981838344,1.0,8/43,12.35%,MAPKAPK2;TIFA;TLR2;PLCG2;HMGB1;TAB2;MAPKAPK3;IRAK1
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.3944789690614005,0.8148958073771218,0.7272727272727273,0.9653010955394211,1.0,6/28,16.94%,CWH43;PIGQ;PIGF;GPAA1;PIGP;PGAP4
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.41887189210730363,0.8147863389153237,0.66,0.9651580287713182,1.0,4/24,7.89%,SYT15;SYT6;SYT1;SNCA
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.3959871476202516,0.8147367421595001,0.7142857142857143,0.9648940899971878,1.0,5/27,12.35%,NLGN1;NRXN1;NLGN4X;RIMS2;PTEN
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.554889487370867,0.8147128636118095,0.7758620689655172,0.964587140195032,1.0,4/5,35.74%,CDK6;EIF2B5;NF1;MT3
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.47545599541713085,-0.8144092977613174,0.7169811320754716,1.0,1.0,2/10,13.93%,GPC1;CD9
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.42820977671287186,-0.8143098426205672,0.7021276595744681,1.0,1.0,5/29,14.25%,ASS1;CLU;SMAD3;CAV1;RAC1
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.341383623606739,0.8141758205168887,0.8301886792452831,0.9652345397722039,1.0,19/112,16.79%,CDKN2C;CCL5;SIRT1;IL4;HIF1A;CDKN2A;FER;MCM7;DSCAM;GRM5;CORO1C;GCK;PLXNB2;HSPB1;PML;ROPN1B;PHIP;BTBD10;RANBP2
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),0.4725280471086163,0.8140608216758792,0.7017543859649122,0.9651477947397886,1.0,2/7,0.87%,LGALS9;KLRD1
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.3496674612576568,-0.8136683442074693,0.8297872340425532,1.0,1.0,12/91,9.02%,TRIM56;APOBEC3H;NLRP1;RNASE1;APOBEC3G;IFI27;TRIM5;IFIT1B;IFIT2;OAS3;OAS1;IFIT3
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.5091048972117154,-0.8136112907146595,0.7254901960784313,1.0,1.0,1/7,7.82%,OAS3
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.3104509351671861,0.813610690891126,0.8636363636363636,0.9655400164835534,1.0,31/171,16.05%,SLC7A11;C3;TYR;KAT2B;SLC10A3;SELENBP1;LMO2;VEZF1;PIGQ;HTRA2;DCUN1D1;SNCA;GYPC;FOXO3;BCAM;NUDT4;EPB41;CA2;GMPS;FBXO7;BNIP3L;ANK1;CDR2;PICALM;CCND3;RBM5;MFHAS1;NEK7;SLC30A10;ELL2;SLC4A1
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),-0.5620536159444611,-0.8134696816245536,0.7307692307692307,1.0,1.0,3/7,11.69%,IL18BP;HLA-DRB1;IL18
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.34788217606374744,0.8134569797494259,0.8085106382978723,0.9655049836825801,1.0,14/94,17.85%,PRR16;EIF3E;SAMD4A;HDAC2;PLA2G10;HNRNPD;PLXNB2;NR1H3;ASPH;BCL3;FADD;CSF1;PERP;FMR1
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.4467391795749791,0.8132823582778913,0.7068965517241379,0.9654699743856664,1.0,6/17,29.24%,PLA2G10;PNPLA8;PLA2G15;SLC27A1;LPGAT1;CDS2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.46796246319000534,0.8132287740722047,0.7674418604651163,0.9652410317830207,1.0,4/20,10.28%,GSTM2;STAC2;ANK2;HAP1
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.34966262189336006,0.8132286319824437,0.8148148148148148,0.9649174511488325,1.0,13/65,22.18%,NXF1;U2AF1;THOC6;NXF5;SRSF11;HNRNPA2B1;FMR1;RBFOX1;PNPT1;NCBP1;ZFP36;NUP153;SRSF3
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),-0.5340677724129586,-0.8130582061601315,0.7090909090909091,1.0,1.0,3/5,41.79%,LYPLA2;ABHD2;ABHD12
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.3954343968698871,-0.8127350042132346,0.7446808510638298,1.0,1.0,6/28,19.84%,CLDN1;F11R;MFSD2A;CLDN5;SLC1A1;LSR
prerank,GO_Biological_Process_2021__endoderm development (GO:0007492),0.49906930337358263,0.8124837263717272,0.7049180327868853,0.9657570481215452,1.0,1/9,0.09%,GATA4
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),0.466676457303292,0.8123749931797634,0.66,0.96566602564765,1.0,3/6,36.66%,ACE;N4BP2L2;EIF2AK2
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.5111406405270102,0.812341355703438,0.7058823529411765,0.9654330196992083,1.0,2/6,18.76%,GABRB2;GABRB1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.3072788534104677,0.8122271090499043,0.86,0.9653077431629788,1.0,9/123,8.32%,STAB1;SCGB3A2;SYK;NEDD4;LDLR;LRP1B;RAB31;SNCA;RAMP3
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.4395117326214655,-0.8122137465089234,0.723404255319149,1.0,1.0,5/19,17.26%,NEMP1;TMEM43;DCTN1;EMD;AKAP8L
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.32877677941016864,-0.8121342005309495,0.8163265306122449,1.0,1.0,23/146,12.91%,TEK;GPR39;CGA;HRH2;NLRP3;PTGDR;MEFV;ALOX5;PRKCD;CD200R1;P2RY11;PTH1R;ADCYAP1;HCK;HLA-DRB1;GPR83;GLP2R;CCN3;APOA1;TYRO3;FFAR4;MYH9;CRH
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.4552299714057147,0.8120157511271352,0.6923076923076923,0.965354610315131,1.0,1/14,1.44%,RUNX1
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.5203646611011605,0.8118936205169496,0.6909090909090909,0.9652466440636919,1.0,2/5,17.76%,VEGFA;PTPN23
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.3747169466512698,0.8117507211633685,0.7659574468085106,0.9651172569373452,1.0,8/39,11.48%,NEDD4;RNF152;PELI1;UBE2E2;PELI3;UBE2E3;MAGEL2;RNF5
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.46075101278761593,0.8116530570303683,0.7115384615384616,0.9649707676028647,1.0,5/18,13.40%,LMOD3;MAGEL2;WASHC1;LMOD2;SPIRE2
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),0.4824775456082275,0.8115817522115606,0.6666666666666666,0.9647470527751202,1.0,1/9,0.47%,NOX5
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.36696419323284357,-0.8115787423852524,0.8837209302325582,1.0,1.0,2/62,3.60%,DND1;WTIP
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.47034935604038536,0.8115726306397736,0.8,0.9644418955502642,1.0,3/11,9.73%,NRXN1;GCH1;UBA5
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.5271001882867715,0.8114643541086816,0.7592592592592593,0.9642914856946398,1.0,3/6,28.68%,TENM4;PTPRZ1;TNFRSF1B
prerank,GO_Biological_Process_2021__ammonium transport (GO:0015696),-0.5142948008210836,-0.811390783507628,0.7254901960784313,1.0,1.0,3/6,26.50%,AQP1;RHBG;RHCE
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.4467408345440097,0.8113039591440955,0.74,0.964231296568001,1.0,4/11,19.66%,HMGB1;LIG4;RAG2;RAG1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.44345518139866774,0.8112940317403351,0.7454545454545455,0.963926617056056,1.0,6/18,20.73%,SYT1;RIMS2;SMURF1;SYT3;CPNE9;SYT17
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.4659757003458424,0.8112593266647818,0.8166666666666667,0.9636821809657854,1.0,3/10,22.12%,WASHC2A;MICALL1;WASHC2C
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.3527500538602783,-0.8112062635966703,0.8222222222222222,1.0,1.0,15/78,20.35%,TRIM56;DDX41;IRF5;POLR3H;POLR3E;DHX58;NFKB2;CGAS;POLR1C;TRAF3IP1;POLR3A;IRF1;NLRP4;NLRX1;POLR3F
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.3633646001214255,0.8111580211970292,0.7391304347826086,0.9635365123455519,1.0,7/38,14.68%,BMI1;DUX4;RYBP;YAF2;EZH2;RNF2;EPC1
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.5596430682166763,0.8107156916424727,0.75,0.9640809415439845,1.0,4/6,25.05%,NLGN1;GPHN;LHFPL4;APOE
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.4244235149579193,-0.8106267732606987,0.7307692307692307,1.0,1.0,1/29,0.73%,AMACR
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),-0.5360311389222266,-0.8105858124786635,0.6666666666666666,1.0,1.0,3/5,26.08%,RFPL1;RNF34;RFFL
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.40839581119882934,0.8105413757379248,0.7948717948717948,0.964008070044245,1.0,3/26,5.88%,LGALS9;HIF1A;TLR2
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.3985599929147712,0.8101695644028442,0.7073170731707317,0.9642992904029187,1.0,3/25,10.80%,CWH43;PIGQ;PIGF
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.331037442616397,-0.8100081207452876,0.8928571428571429,1.0,1.0,5/115,6.72%,GOLGA8B;STX16;PLK3;GOLGA2;GOLGA8A
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.3359522133380763,-0.8097247214717178,0.725,1.0,1.0,10/112,7.30%,INSRR;CTNNA1;ASS1;EPAS1;AGRN;RHBDF1;GPC1;NFE2L1;MYO5B;TSPAN15
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.3404260558304764,0.8096997317337362,0.7674418604651163,0.9647701370395683,1.0,18/111,11.28%,ADRA1A;F2;F2R;SLC35G1;CALCR;TRPC4;SCGN;SLC8A1;PTGFR;GPR33;ESR1;PDGFRA;HMGB1;ABL2;TAC1;C5AR2;C3AR1;ATP1A2
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.41917375149409375,-0.8094411357422554,0.6938775510204082,1.0,1.0,3/19,9.75%,WTIP;NRDE2;MOV10L1
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.50853776651171,0.8090629374504021,0.7551020408163265,0.9655103107150218,1.0,3/7,21.09%,SGSM3;DENND4C;DENND4A
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.3482767911584553,0.8088518723485797,0.8333333333333334,0.9655525822241374,1.0,12/62,20.83%,TGFBR1;DYRK2;GALNT3;GALNT1;MAPK8;ACVR1B;DYRK1A;HIPK1;DYRK3;GALNT16;WNK1;HIPK3
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.5152357115782857,-0.8085083020012094,0.6590909090909091,1.0,1.0,1/5,2.82%,COL4A1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.41256081814322254,0.8083182445020134,0.7358490566037735,0.9661551337289475,1.0,4/21,5.63%,GPR55;F2R;GPR174;GPR17
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.5158963670491157,0.808313855203824,0.7833333333333333,0.9658551035275993,1.0,1/6,11.97%,BNIP3L
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.551827486034249,-0.808245480174075,0.7435897435897436,1.0,1.0,2/5,18.56%,HLA-DRB1;HLA-DMA
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.4956708740148449,-0.8080329688695216,0.6888888888888889,1.0,1.0,1/10,3.22%,TICRR
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.4014034749898382,-0.8075567041510737,0.7,1.0,1.0,8/22,28.53%,RFC3;RPA3;RFC2;RFC1;POLDIP2;RPA2;RPA1;UBB
prerank,GO_Biological_Process_2021__gastro-intestinal system smooth muscle contraction (GO:0014831),-0.5255549002672903,-0.8075050454287535,0.717391304347826,1.0,1.0,2/5,16.33%,HTR2B;HTR1D
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.3637755216154406,0.807489365423145,0.7254901960784313,0.9669871689060044,1.0,15/38,20.18%,C3;IL4;ANGPT1;BICD1;TF;MAGI2;HIP1;GREM1;TBC1D5;VEGFA;WASL;FMR1;ARRB2;ANXA2;DGKD
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.39891060024204517,-0.8074675857421036,0.7115384615384616,1.0,1.0,3/33,2.68%,CLDN4;DUOX1;CLDN1
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.4006945324877049,-0.8073855758396468,0.7454545454545455,1.0,1.0,6/32,21.52%,DGAT2L6;DGAT1;CAV1;CAV3;DGKA;GK5
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),0.4889730245857041,0.8071294951264398,0.7,0.967272448270307,1.0,1/7,5.56%,METAP1D
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),0.37088842347949785,0.8067572119733748,0.6909090909090909,0.9675917098209951,1.0,4/28,16.17%,SIRT1;ZC3HAV1;TIPARP;SIRT6
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.347300925029227,0.8067209696345099,0.7317073170731707,0.9673129513449591,1.0,11/69,12.35%,IRGM;CCL5;RELA;TICAM1;NLRP7;HMGB1;NR1H3;MEF2C;PDE4B;MAPK8;IRAK1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.5101794388961829,0.806617651030624,0.8181818181818182,0.9671795117286346,1.0,5/8,39.72%,ALDH6A1;DPYSL5;DPYSL3;DPYS;DPYD
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.45469210815805083,-0.8065962871802408,0.6808510638297872,1.0,1.0,1/13,1.71%,RAC2
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.36520357864538516,0.8063815877263398,0.8235294117647058,0.9673405989676243,1.0,1/26,1.11%,CDC14A
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.48907666698809843,0.8058243972028982,0.8125,0.9678940333149733,1.0,2/8,9.99%,BMP2;BIN1
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.5248491785822245,0.8057302203226204,0.7884615384615384,0.9677264186088403,1.0,2/7,24.14%,AGO3;DHX9
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.3216889520786218,-0.8055045072392542,0.8125,1.0,1.0,6/111,6.30%,TERT;EPAS1;PLK3;ANGPT4;SFRP1;PSMB4
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.30466578175272724,0.8054088594526362,0.9375,0.9679383198669828,1.0,22/131,15.27%,CTDNEP1;DUSP29;PPP1R15B;PPP4R1;PPP1CC;PPM1A;PTPRD;PTPN14;DUSP18;PTPRT;PPM1L;PTPRK;PPM1E;EYA2;PTEN;PPP3CA;PPP3CC;PTPRM;MTMR3;DUSP2;PTPRU;PPP2R2B
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4917521295658616,0.805160198666341,0.6785714285714286,0.9680563262525086,1.0,4/8,25.10%,PTPRT;BCL3;ADIPOR1;HGS
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.5209427437945502,0.8049976586860347,0.7692307692307693,0.968025149193518,1.0,2/5,19.34%,PTEN;DEPTOR
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.3277956969170164,0.8049259002256677,0.8269230769230769,0.9678406782462204,1.0,24/98,21.16%,SYK;RELA;PLCG2;FER;TAB2;PIK3CA;PSMD13;MAPK8;PPP3CA;SOS1;ITK;PSME4;NFATC3;MAP3K1;GAB2;TAB3;MAPK10;PSMA1;VAV2;KIT;LYN;IKBKB;PSMD4;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.44785570491784943,0.8047270591686517,0.7592592592592593,0.9678010786177478,1.0,3/14,8.62%,FGF2;BMPER;SMAD1
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.3414496479703882,0.8046189975737418,0.7678571428571429,0.9676465954520186,1.0,8/78,7.89%,GATA4;FGF2;KANK2;CCN4;CCN6;AGR2;HTRA2;SNCA
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.4195033999432115,-0.8046071263675353,0.6956521739130435,1.0,1.0,1/20,1.76%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.4195033999432115,-0.8046071263675353,0.6956521739130435,1.0,1.0,1/20,1.76%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.33275341621676635,-0.8044554400625415,0.8490566037735849,1.0,1.0,14/95,12.99%,WARS1;TSPYL2;ADCYAP1;TRIB1;TRIB2;CAMKK2;UBASH3B;CEACAM1;CAMK2N1;TAF7;CAMKK1;SPRED1;PYDC1;PTK2B
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.39102207401258166,0.8044532305442504,0.8421052631578947,0.9675645412009373,1.0,2/43,1.35%,TIMELESS;HELB
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.4917906516803371,0.8041853698200508,0.7833333333333333,0.967652665274248,1.0,4/7,21.36%,LNPEP;HLA-E;HLA-F;HLA-B
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.41424189086000207,-0.8041422922241902,0.7291666666666666,1.0,1.0,6/36,10.00%,HMGB3;RECQL5;ERCC1;RPAIN;RAD50;RTEL1
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",-0.43366385184179596,-0.8040136968489248,0.7674418604651163,1.0,1.0,3/16,15.89%,CHRNE;CHRNA2;COLQ
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.3990030726216445,0.8038689706864592,0.7368421052631579,0.9679575674177909,1.0,9/23,15.49%,TGFBR1;NRG1;RBPJ;DSP;BMPR1A;SMAD4;PROX1;LRP2;RYR2
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.4147934332122081,0.8037570367433555,0.7777777777777778,0.9678287385715176,1.0,4/27,6.41%,FGFR1;VCAN;POSTN;ITGAV
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.4443828793163644,-0.8037552557831559,0.717391304347826,1.0,1.0,1/11,2.66%,SYNJ2
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.4443828793163644,-0.8037552557831559,0.717391304347826,1.0,1.0,1/11,2.66%,SYNJ2
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.3852410569503703,-0.803705865324647,0.725,1.0,1.0,2/31,4.93%,SCN5A;DRD2
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),0.4818036599494812,0.803504251207154,0.7666666666666667,0.9676392959775175,1.0,3/7,27.26%,PIK3CD;KIT;MILR1
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),0.4818036599494812,0.803504251207154,0.7666666666666667,0.9676392959775175,1.0,3/7,27.26%,PIK3CD;KIT;MILR1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.29417575796575807,-0.8030753218158605,0.9545454545454546,1.0,1.0,13/370,6.72%,TERT;GOLGA8B;CFAP61;ARAP3;MTFR2;PTCD2;PAK6;WTIP;ZMYM6;GOLGA2;PEX7;FANCG;GOLGA8A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.39554850775994566,-0.802915588521977,0.7407407407407407,1.0,1.0,4/26,14.15%,XPC;PARP1;GTF2H2;RPA3
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.31648483270785205,-0.8025328709639159,0.92,1.0,1.0,26/150,16.48%,KDM4D;PARP2;ABRAXAS1;SLX4;RNF8;RECQL5;ERCC1;EYA1;MEIOB;POLQ;RAD50;RAD51AP1;PRPF19;RAD51AP2;PARP1;FAN1;AP5S1;CYREN;NUCKS1;XRCC1;SMARCA5;RPA3;BRCA1;TNKS1BP1;KDM4B;APTX
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.3139078593033679,0.8024778708847894,0.88,0.969047779185313,1.0,5/90,4.97%,CCL5;PRR16;EIF3E;SAMD4A;LIN28A
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),0.5298717074669632,0.8023378740778025,0.7543859649122807,0.9689866752461541,1.0,2/6,20.60%,MFHAS1;TLR1
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.485855094795843,-0.8022574639938592,0.675,1.0,1.0,2/9,13.11%,SVIP;CAV1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.3793763667642851,-0.8022055210851574,0.7708333333333334,1.0,1.0,5/50,12.69%,NDUFC1;TMEM126B;ECSIT;NDUFAF3;NDUFS5
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.3793763667642851,-0.8022055210851574,0.7708333333333334,1.0,1.0,5/50,12.69%,NDUFC1;TMEM126B;ECSIT;NDUFAF3;NDUFS5
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.3761752038306614,-0.8019049225391908,0.6739130434782609,1.0,1.0,1/44,0.60%,HK2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.45135777730098164,0.801894449414446,0.75,0.9694008580728413,1.0,8/16,26.94%,SAMSN1;PAG1;BANK1;TIGIT;PIBF1;IL4I1;GPNMB;LGALS3
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.3650169795562226,0.80152237184813,0.7058823529411765,0.9695899483386364,1.0,16/57,19.66%,IL4;CD22;BLNK;PLCG2;CD40;KLF6;FLT3;BANK1;MEF2C;PIK3CD;DNAJB9;RAG2;ZAP70;KIT;HDAC9;RAG1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.34423483763350476,0.8014705824025956,0.803921568627451,0.9693336643060038,1.0,14/55,14.22%,IRS1;ACSM2A;PPARG;ADIPOR2;PAX6;CYB5R4;LEPR;MCU;GCK;BACE2;IGF1R;KLF7;MLXIPL;TENT4B
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.4342948818349795,0.8011389527663564,0.7857142857142857,0.9695862381003822,1.0,2/16,2.61%,TIMELESS;KCNC2
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.34707573657571156,-0.8010247709444088,0.8333333333333334,1.0,1.0,12/78,15.27%,NUPR1;KCNE2;TRIB1;TRIB2;ARIH2;CLU;DDA1;DDRGK1;RFPL1;DAB2IP;CSNK1D;DAB2
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.5068973656820991,-0.8009078021495032,0.7755102040816326,1.0,1.0,4/7,16.77%,CBLN2;DCTN1;CHCHD10;RAB3A
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.4881053469347483,0.8001842181667206,0.8113207547169812,0.970753983245433,1.0,5/9,22.18%,FZD1;LRP6;CTNNB1;WNT2;RYK
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),-0.4103575247220989,-0.7999750231101993,0.7777777777777778,1.0,1.0,1/15,4.12%,FCHSD1
prerank,GO_Biological_Process_2021__negative regulation of anion transport (GO:1903792),0.5440362789119293,0.7997515301484164,0.74,0.9710737028699357,1.0,3/5,18.07%,HRH3;GRM7;GABRE
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.5230216534245871,0.7995208341823701,0.8035714285714286,0.9712026420741625,1.0,2/5,38.65%,TDG;FTO
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.3937671307745254,0.7994612253494803,0.782608695652174,0.9710266851991839,1.0,3/31,10.57%,TFEB;ABCA1;AKTIP
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.37638428704017657,-0.7993569046227343,0.8974358974358975,1.0,1.0,4/30,10.00%,SLX4;ERCC1;RAD50;RTEL1
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.2802124863056024,0.7991670809036566,1.0,0.9711936438194528,1.0,35/372,11.87%,FHDC1;IRGM;CDC14A;SAC3D1;RAB38;KASH5;EHD1;LMOD3;DLGAP5;SPAG16;SSTR3;TRAPPC14;PCM1;TP53INP1;HDAC3;RAB3IP;BICD1;CEP20;STARD9;PGM5;AUP1;CHMP6;ATG101;STING1;RAB23;BBS9;GSN;PATL2;LZTFL1;E2F4;LMOD2;BBIP1;SSX2IP;ANLN;KIAA0586
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),0.4547995262243254,0.7990404017882835,0.7169811320754716,0.9710220364447048,1.0,3/13,12.69%,TGFBR1;WNT9A;GREM1
prerank,GO_Biological_Process_2021__hepoxilin metabolic process (GO:0051121),0.4945545792037114,0.7989217262488553,0.7,0.9705480949464238,1.0,1/8,1.06%,GSTM2
prerank,GO_Biological_Process_2021__hepoxilin biosynthetic process (GO:0051122),0.4945545792037114,0.7989217262488553,0.7,0.9705480949464238,1.0,1/8,1.06%,GSTM2
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.508678108939755,-0.7985369075231848,0.75,1.0,1.0,2/7,14.74%,TMSB4X;CCDC22
prerank,"GO_Biological_Process_2021__negative regulation of blood coagulation, intrinsic pathway (GO:2000267)",-0.5172603430032803,-0.7985218815914411,0.6078431372549019,1.0,1.0,1/5,1.14%,F8
prerank,"GO_Biological_Process_2021__regulation of blood coagulation, intrinsic pathway (GO:2000266)",-0.5172603430032803,-0.7985218815914411,0.6078431372549019,1.0,1.0,1/5,1.14%,F8
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.4081345630532875,0.7983983855800192,0.6888888888888889,0.9710023951961075,1.0,6/41,13.79%,HELB;MYC;IL7R;SMG1;HNRNPD;SMARCAD1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.4549426697609285,-0.7982181369961069,0.6923076923076923,1.0,1.0,3/10,24.67%,AR;ZNF143;MTOR
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.48405453830584755,0.7980209530051275,0.74,0.9713127420696772,1.0,3/6,19.24%,TNFRSF10B;FADD;TNFRSF10A
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.4781287194097173,0.7978797006374729,0.6739130434782609,0.9712554187634127,1.0,3/7,17.85%,RAP1A;SLC30A1;FMR1
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.32897836769787997,0.7977914678293994,0.92,0.971058795176816,1.0,8/89,6.53%,FGF10;TIMELESS;PPARG;WNT4;BMP2;KANK2;APELA;CNN3
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.450168003992203,-0.7975489479468147,0.7755102040816326,1.0,1.0,2/15,4.05%,SLC17A9;ABCC4
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.3302751758498724,0.797258457949271,0.8604651162790697,0.9716305182344597,1.0,13/72,15.08%,TYR;POU6F2;ADGRV1;DHRS3;PAX6;GRM8;CRYZ;TULP1;CRYGS;RPE65;COL11A1;RPGR;ATF6
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.4245191465651968,0.7970871868964474,0.6862745098039216,0.9716195625448735,1.0,7/17,20.89%,EFNA2;OSCAR;GAB2;CSF1;FARP2;ANXA2;OSTM1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.38755003416098377,-0.7970338428210623,0.8070175438596491,1.0,1.0,7/52,6.36%,RAC2;BST1;NOXA1;ALOX5;XDH;FOXM1;PAX2
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.377383395444196,-0.7969770583398158,0.78,1.0,1.0,2/37,4.91%,ACTC1;OLFM1
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.49820655791898794,-0.7968453753823959,0.7777777777777778,1.0,1.0,1/5,8.62%,P2RY12
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),0.4917743999504418,0.7968231545132615,0.7115384615384616,0.971671887116793,1.0,4/7,34.65%,THEM5;HADHB;PLA2G6;LCLAT1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.46829070459004796,-0.7965951016610032,0.6595744680851063,1.0,1.0,3/11,9.83%,SPRY4;GPC1;CREB3L1
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.37767062973408105,-0.7961622477418296,0.7413793103448276,1.0,1.0,6/31,12.91%,DRD2;ADCYAP1;HFE;NNAT;FFAR4;CRH
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.4344518652307049,0.7961127079085749,0.7884615384615384,0.9725717583290031,1.0,4/20,7.89%,TMTC2;SLC8A1;FAM20A;SNCA
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.31159116553306343,-0.796106036913183,0.9245283018867925,1.0,1.0,35/195,25.45%,NARS1;WARS1;TMA7;ZC3H15;SARS1;DARS2;SARS2;CARS1;RPL38;MRPL23;PPA1;RPL12;MRPS21;GARS1;ABCF1;RPL37A;RPS8;RPS27;RPL4;MRPS18C;MRPL16;RPL5;MRPL9;RPL26L1;RARS1;COPS5;GATC;DRG1;RPS20;WARS2;RPL22;RPL34;RPL31;GTPBP2;RPL37
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.3896536766286249,0.7961058258556213,0.6981132075471698,0.9722654240721177,1.0,5/23,19.06%,ST3GAL6;SLC35D2;CHST6;B4GALT3;PRELP
prerank,GO_Biological_Process_2021__L-arginine import across plasma membrane (GO:0097638),0.509699082048238,0.7958394309403228,0.6949152542372882,0.9723722681426588,1.0,1/5,5.43%,SLC7A2
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.5030878249252088,-0.7956883903545456,0.7272727272727273,1.0,1.0,2/8,15.64%,RNF8;GPR183
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.42690526016358044,-0.7955805875551935,0.72,1.0,1.0,5/12,16.97%,CACNA1G;ZP3;SYT10;KCNB1;CACNA1H
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.48604106853247775,0.7953215637246374,0.7457627118644068,0.9727570786870599,1.0,1/8,7.89%,SNCA
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.31132216904964854,0.7951267246744473,0.9787234042553191,0.9726699721190889,1.0,23/150,14.81%,CCL5;PRKG1;RAPGEF3;F2R;SNX18;EFNA5;FGD4;RGS10;EPHA5;EPHA3;CD40;GPSM1;RAP1GDS1;RAPGEF6;PLXNB1;EZH2;ADAP1;PLXNB2;PICALM;RAP1A;SGSM3;ADRB1;GPR137B
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.3400271452752321,-0.7950178333246029,0.8043478260869565,1.0,1.0,11/57,20.56%,NUPR1;MEIS2;RARA;CCND1;EIF4EBP1;FGFR2;RGCC;PDGFB;NUDT16;USP19;PRKCA
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),-0.5728368254737013,-0.7949817222293879,0.8260869565217391,1.0,1.0,1/5,3.49%,CCBE1
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.4405409126742841,-0.7949045267149312,0.6904761904761905,1.0,1.0,3/14,8.41%,SYCE2;STAG3;SYCE1
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.4405409126742841,-0.7949045267149312,0.6904761904761905,1.0,1.0,3/14,8.41%,SYCE2;STAG3;SYCE1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.4470362853382389,0.7948891099244676,0.7735849056603774,0.972713429970931,1.0,2/10,0.87%,LGALS9;KLRD1
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.40973720449248796,-0.7948651677989946,0.7708333333333334,1.0,1.0,2/20,6.91%,TESPA1;PRKD2
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.37399903568443765,-0.7948091789339935,0.8604651162790697,1.0,1.0,5/27,12.59%,GPC2;GPC1;GPC3;AR;GBP1
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.31589677006362654,-0.7947586497724329,0.8947368421052632,1.0,1.0,20/142,14.97%,GPX3;NPTX2;NR4A1;PARP2;PRKCD;TST;FOS;OLFM1;EIF2S3;ENO2;RPN1;NTRK3;SLC6A12;TYRO3;DGAT1;MRPL23;ATP6V1F;ABCB1;CLTB;CDKN1C
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),0.40166088571615266,0.7944832715134316,0.7413793103448276,0.9729799117841832,1.0,4/21,12.19%,PRIMPOL;POLE2;REV3L;REV1
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),0.492666829446384,0.7943233506473021,0.7555555555555555,0.9725534339246265,1.0,3/6,16.58%,RBPJ;BMPR1A;HEY2
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),0.492666829446384,0.7943233506473021,0.7555555555555555,0.9725534339246265,1.0,3/6,16.58%,RBPJ;BMPR1A;HEY2
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.3813401612091031,-0.7942659091158198,0.7346938775510204,1.0,1.0,9/43,11.70%,SIRPG;AHSG;SPACA3;DOCK2;HCK;SLC11A1;OLFM4;APOA1;FER1L5
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.44076161457580965,0.7941922980402409,0.7543859649122807,0.9725085805050216,1.0,4/12,23.79%,LMAN1;SNX2;STX5;SNX1
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.3079222863693674,0.7936425170624283,0.9230769230769231,0.9730647898955093,1.0,37/151,24.60%,TGFBR1;MAPKAPK2;DYRK2;RPS6KA4;SMG1;LATS1;MAPKAPK3;RPS6KA2;STK32B;VRK2;MAPK8;RPS6KA1;DYRK1A;IKBKE;CSNK1G3;RICTOR;HIPK1;SGK1;DYRK3;PKN2;RPS6KA5;MAST1;STK38L;AKT3;WNK1;IKBKB;HIPK3;STK32C;CAMK4;GAS6;RPS6KA6;AKT2;EIF2AK3;MKNK2;STK32A;PIKFYVE;SGK2
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.35923066328094755,0.7935447825077361,0.8333333333333334,0.9728895472605775,1.0,10/52,18.94%,VAPB;ELOVL5;PPM1L;CERS3;SGPL1;CERS5;ELOVL4;ALDH3B1;PLPP1;SAMD8
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.3309426258417332,0.7934982462823555,0.8870967741935484,0.9726556151843175,1.0,22/85,17.56%,FZD5;WNT4;WNT9A;PLCG2;GPC4;PTEN;NR4A2;FZD1;DVL2;LRP6;FZD4;CSNK1G3;FRAT1;FZD6;FRZB;CPE;DIXDC1;NXN;CTNNB1;VPS29;KLHL12;WNT2
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.48497330201598754,-0.793438979176252,0.6904761904761905,1.0,1.0,3/8,29.79%,PDE3A;UBE2B;RNF157
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.40520762549162814,-0.7933146965874215,0.7,1.0,1.0,1/27,1.92%,KDM4D
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.41235440083095765,-0.7932588922956669,0.7105263157894737,1.0,1.0,4/24,11.48%,ALOX5;CLU;CREB3L1;WFS1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.3364218954686601,-0.793209217648374,0.7755102040816326,1.0,1.0,12/82,13.11%,WARS1;MVP;TRIB1;TRIB2;UBASH3B;CEACAM1;CAMK2N1;TAF7;SPRED1;PYDC1;DAB2IP;CAV1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.4163350068498992,0.7931864540778292,0.7678571428571429,0.9729047108372668,1.0,2/18,7.21%,IGF1;NLRP7
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.3107535674588259,0.7928084252756876,0.9591836734693877,0.9731578413296637,1.0,11/90,14.60%,NDE1;CEP70;PCM1;RAB3IP;CEP152;DCTN3;CEP135;DYNC1I2;CNTRL;NEDD1;CCP110
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.4846562306626412,-0.7928043704779436,0.7567567567567568,1.0,1.0,4/9,29.25%,E2F7;CDC7;DBF4B;DBF4
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.4594233086108408,0.7927882059588993,0.78,0.972894677589771,1.0,4/8,16.69%,NLGN1;PLXNB2;PTEN;GRID2
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.4682677495723556,-0.792724825605288,0.8392857142857143,1.0,1.0,2/13,6.91%,TESPA1;PRKD2
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.456652481977172,-0.7921534394946758,0.8292682926829268,1.0,1.0,1/12,1.10%,SCN5A
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.5035616845483277,0.7920442099652654,0.7115384615384616,0.9737852558517319,1.0,2/7,18.48%,SAG;ARRB2
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.4790221210902643,-0.7918926501681302,0.7111111111111111,1.0,1.0,3/8,15.64%,POU2AF1;PTK2B;GPR183
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.3364803122601033,-0.791507512945971,0.7959183673469388,1.0,1.0,16/109,10.10%,KCNMB2;KCNE2;KCNJ1;KCNJ16;SLC24A4;KCNN3;SLC9A8;KCNA3;KCNN2;KCNE1;KCNV1;KCNQ4;KCNQ1;KCNJ11;KCNA5;KCNJ15
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.43189784085787164,0.7914567996556411,0.7333333333333333,0.9744739682403168,1.0,4/20,18.12%,RORA;STAR;RORC;ABCA2
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.44807068330533256,-0.7913068990819551,0.7142857142857143,1.0,1.0,1/9,3.18%,ENPP2
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.5154616787881426,0.7912311049830478,0.7903225806451613,0.9745376137634837,1.0,4/7,35.49%,RPUSD2;TRUB2;PUS3;DKC1
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.4574548126951198,-0.7911473804386452,0.7659574468085106,1.0,1.0,4/12,8.18%,SIGIRR;MEFV;OAS3;OAS1
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.48435282949266056,-0.790933514758797,0.75,1.0,1.0,2/10,10.00%,TERF2IP;RTEL1
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.4603805210697136,0.7906377967686958,0.734375,0.9752088689425903,1.0,3/13,21.11%,CHMP6;LEPROTL1;VTA1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),0.4535628186384224,0.7905852542491228,0.8,0.9749789802185546,1.0,1/12,2.47%,IL4
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.45286196050525795,-0.7903309781312668,0.82,1.0,1.0,1/10,2.64%,TIE1
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.502697175565903,-0.7902261728234595,0.7551020408163265,1.0,1.0,3/6,6.47%,COL5A1;WNT7A;PLET1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.4311968203353125,-0.7902190983071342,0.6976744186046512,1.0,1.0,2/10,9.56%,TESPA1;CLPTM1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.38536486575273365,0.7901664804404185,0.7692307692307693,0.9754025641077185,1.0,2/29,2.87%,FLT1;PPARG
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.37260628891647923,0.7901644095056518,0.7777777777777778,0.975089030005304,1.0,9/46,24.31%,ST6GALNAC3;ESYT3;ST3GAL6;ESYT2;ABCA2;HEXB;NAGA;ST6GALNAC4;CTSA
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.48026672335132664,-0.7901169943373189,0.6595744680851063,1.0,1.0,5/10,18.10%,DNAAF1;RSPH9;CCDC40;SPATA6;BBOF1
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.43924808945292393,0.7901032270592605,0.7288135593220338,0.9745797227236789,1.0,1/14,2.73%,RAB27A
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.43924808945292393,0.7901032270592605,0.7288135593220338,0.9745797227236789,1.0,1/14,2.73%,RAB27A
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.33200985157768537,-0.789268104826823,0.8148148148148148,1.0,1.0,10/84,6.85%,TMEM52;HMGB3;H19;AGRN;PHLDA2;MBNL3;KDELR1;DSG2;BATF3;LAS1L
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.3366138370153734,0.7892036874304236,0.8297872340425532,0.9758268407006745,1.0,25/95,24.90%,IL4;MAP2K6;UBE2D3;FGF17;SMAD2;MAPK8;PTEN;ACACA;RPS6KA1;PLCB1;CAB39L;MAPK10;CDK4;THEM4;PIK3R3;PDK1;DDIT3;CAMK4;GRB2;MKNK2;NFKBIB;PPP2R1B;PIKFYVE;PRKAR2A;EGFR
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.3603306467587867,0.7886991897759981,0.8333333333333334,0.97634562635401,1.0,6/46,7.93%,ACE2;CLSTN2;CNTNAP2;NLGN1;NRXN1;PTPRD
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.4714463212246063,0.7886974645517623,0.7407407407407407,0.9760322953762348,1.0,2/6,27.98%,FADD;TRADD
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.37182264356146333,0.7886791018378663,0.8387096774193549,0.9757484171779857,1.0,9/41,22.07%,PEX12;CHCHD4;DNAJC15;SEC61A1;PEX2;SEC61A2;RTN2;HSPA5;AKT2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.400256899537318,-0.7886789485164184,0.7804878048780488,1.0,1.0,1/16,3.88%,CD200R1
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),0.5245680555339005,0.7882480079293691,0.7884615384615384,0.9761831809504818,1.0,3/6,27.62%,EXOSC4;EXOSC5;EXOSC2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.3425667984617078,-0.7881255983244096,0.8846153846153846,1.0,1.0,10/103,6.94%,P2RY10;CD24;CXCL13;XCR1;PTGDR;PLCZ1;NMUR2;DRD2;ADCYAP1;JPH2
prerank,GO_Biological_Process_2021__T cell chemotaxis (GO:0010818),-0.5035482273471132,-0.7881137916147722,0.7209302325581395,1.0,1.0,2/5,15.64%,CXCL16;GPR183
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.4178568032036335,0.7880614067611118,0.7636363636363637,0.9762209687162868,1.0,2/26,4.72%,SIRT1;KANK2
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.5137440266235339,0.7879138733786599,0.8070175438596491,0.9761668959076104,1.0,1/7,13.08%,XPO1
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.4101001895999958,0.7876026100715278,0.8333333333333334,0.9763674117992682,1.0,1/20,0.47%,NOX5
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.47519909266455385,0.7874396142301379,0.803921568627451,0.9763258415260092,1.0,2/6,14.01%,HSPA8;APBA1
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.46043691227087646,0.7874320018141135,0.7407407407407407,0.9760215692247631,1.0,1/9,3.59%,SSC5D
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.4146761495016582,0.7873902516953099,0.7647058823529411,0.9757633527494173,1.0,3/21,18.03%,TENM1;POLR3G;MAF1
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.32039195153808875,-0.7873778822826412,0.8245614035087719,1.0,1.0,11/141,6.38%,SELP;SELE;CLDN4;SELL;CLDN1;IGSF21;CDH4;UMOD;DSG2;MPZ;CDH23
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.4533529120958833,0.7872760284380647,0.8,0.9756219964506015,1.0,1/15,1.13%,IRS1
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.46416810668212655,0.7871912636233507,0.7659574468085106,0.9754307368377676,1.0,2/9,16.40%,METAP1D;NAA16
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.45120519401135784,-0.7871330884236201,0.7454545454545455,1.0,1.0,4/13,16.77%,TRIM72;FER1L5;MYH9;RAB3A
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.36338384391441697,-0.786296836742145,0.7608695652173914,1.0,1.0,6/61,7.55%,APIP;TRPV5;UPB1;GOLGA2;TRPA1;HLA-DRB1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.3900816499976346,0.7862811762909612,0.8301886792452831,0.9765931924453447,1.0,5/38,12.97%,HRH3;CHD7;MAGT1;GRM5;SHROOM4
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),0.5294706899215008,0.7861070447733518,0.7555555555555555,0.976252037812501,1.0,3/5,43.06%,DKC1;CCT4;TCP1
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),0.5294706899215008,0.7861070447733518,0.7555555555555555,0.976252037812501,1.0,3/5,43.06%,DKC1;CCT4;TCP1
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.4563712339325622,0.7858451765592309,0.703125,0.9763395989399302,1.0,3/11,15.60%,CARMIL1;SPIRE2;COBL
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.4579998231269174,-0.7856005623788397,0.74,1.0,1.0,2/13,14.93%,CEACAM1;BRCA1
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),-0.4934388510181313,-0.7854760143305968,0.75,1.0,1.0,2/7,8.31%,ABCC4;ABCC3
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.36128973304070305,-0.7852421865308329,0.875,1.0,1.0,9/51,12.15%,CD53;CYTH4;CD86;LILRB3;HCK;TAGAP;LY86;SPI1;PARVG
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.4045725265151168,0.7851823614134484,0.7894736842105263,0.9769719985164937,1.0,3/19,12.35%,FBXO5;BAG2;PTEN
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.3564257538599602,0.7849470898354991,0.8653846153846154,0.9771133261347283,1.0,6/51,11.97%,TCIRG1;CTSF;HTRA2;CHEK2;RNF5;BNIP3L
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.4004682248833886,0.7848161036951904,0.7547169811320755,0.9770300943678462,1.0,1/17,1.82%,CCL5
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.36836367831453526,0.7846963582988085,0.8727272727272727,0.9769012062469018,1.0,10/29,28.54%,GPM6B;PICALM;LEPROTL1;CTNNB1;ABCA2;STX3;COMMD1;ABCA7;TMEM35A;GBF1
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.435028990171885,-0.7845299567849398,0.6923076923076923,1.0,1.0,2/12,5.41%,ADSS1;XDH
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.4140723090475107,0.7842993004905007,0.8076923076923077,0.9772168930560274,1.0,7/25,12.96%,SCN7A;SLC8A1;SCN10A;SCN3A;SCN2B;ATP1A2;SCN9A
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.4796781949208231,-0.7842049784652002,0.7727272727272727,1.0,1.0,6/11,31.07%,AKAP8L;MYOCD;PARG;MTHFR;AKAP8;NNMT
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.3367805613322561,-0.7837754215908159,0.85,1.0,1.0,5/65,10.85%,DNASE1L1;DDX24;RECQL5;RAD50;GTF2F1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.3181543214462999,0.7837610973563486,0.875,0.9777566262593131,1.0,22/103,19.05%,SIPA1;RHOBTB3;FGD4;PCLO;TNIK;RHOU;NECTIN2;BIN1;PAK5;RANBP9;FMNL3;ANK1;RHOBTB1;ZMYM4;SYNE3;PHIP;DST;MAST1;RHOG;RHOD;RHOB;BRWD1
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.4313875179740094,0.7834824295259947,0.6949152542372882,0.9778393519907365,1.0,1/13,0.59%,FHDC1
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.45126593810056315,-0.7832566926757588,0.78,1.0,1.0,2/14,4.05%,SLC17A9;ABCC4
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.44647782419452514,0.7832026761856288,0.7647058823529411,0.9779220242990204,1.0,2/11,0.87%,LGALS9;KLRD1
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.47963603782072006,-0.7830178764321195,0.72,1.0,1.0,1/6,15.45%,PRDX1
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),-0.49709474946855403,-0.7830065966386673,0.7674418604651163,1.0,1.0,1/5,12.00%,PODXL
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.4263577215320955,0.782960244213347,0.7755102040816326,0.9779714531269367,1.0,2/15,9.95%,KANK1;GSN
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.3482624409310938,0.7828789448979944,0.85,0.9777844468369807,1.0,7/57,7.89%,GPSM3;CCN4;NAPEPLD;TLR2;NFKBIZ;IL15;SNCA
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.4852199414341801,-0.7826374069028496,0.8,1.0,1.0,1/15,2.63%,ERN2
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.5254544893915797,0.7824622584712353,0.75,0.9780494846790777,1.0,2/5,24.93%,TRIP11;C17ORF75
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.4472775922403061,0.782402028870366,0.7636363636363637,0.9778045473363305,1.0,8/18,27.17%,TAF3;PML;BCL3;SUN2;HNRNPU;BARD1;RANGAP1;ARL2BP
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),-0.48436701361228773,-0.7817426390155998,0.6976744186046512,1.0,1.0,2/7,5.23%,PRKCD;CAMK2A
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.33083297625916197,0.7816999850286765,0.875,0.97863291209731,1.0,7/81,8.34%,MME;AANAT;MMP16;PCSK5;F12;F3;CPN1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.446955371646922,0.7816527171168921,0.7333333333333333,0.9780686015595941,1.0,3/18,18.14%,ZEB2;SMAD4;CITED2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.446955371646922,0.7816527171168921,0.7333333333333333,0.9780686015595941,1.0,3/18,18.14%,ZEB2;SMAD4;CITED2
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.46738409925607244,0.7810924081259626,0.7419354838709677,0.978643576884207,1.0,4/9,25.05%,ABCA1;PRKACB;ABCA7;APOE
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.4142880515778975,0.7810522285560004,0.7884615384615384,0.9784112567995389,1.0,5/14,19.45%,RBPJ;BMPR1A;PROX1;HEY2;JAG1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.43995439059965696,0.7809700993908972,0.7115384615384616,0.9781914964989893,1.0,6/13,40.52%,TMEM33;REEP4;RAB10;REEP3;ATL2;REEP1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.3907726762298,-0.7809385617166207,0.8333333333333334,1.0,1.0,2/19,13.50%,CLU;HOPX
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.4987480360404596,0.7806967681689592,0.75,0.978290304566244,1.0,2/6,8.67%,SYK;GCH1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.31912139231315234,0.7805048908934425,0.9019607843137255,0.9782815628656598,1.0,23/98,21.16%,SYK;RELA;PLCG2;FER;TAB2;PIK3CA;PSMD13;MAPK8;PPP3CA;SOS1;ITK;PSME4;NFATC3;MAP3K1;GAB2;TAB3;MAPK10;PSMA1;VAV2;LYN;IKBKB;PSMD4;MAPK3
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.36187293499457623,0.7804823107145339,0.8,0.9780041976773614,1.0,7/32,19.96%,HES6;FOXO1;NOTCH2;HEY2;CTNNB1;HDAC9;CX3CR1
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.45706870061470406,0.780398620773709,0.6808510638297872,0.9777848507809659,1.0,2/9,11.92%,CD40;MEF2C
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.4586098760474301,-0.7801706276487964,0.7368421052631579,1.0,1.0,2/10,11.70%,SPACA3;FER1L5
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.46926004756672113,-0.779775124484061,0.717391304347826,1.0,1.0,4/7,16.72%,CTCF;PRMT7;KDM1B;DIRAS3
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.34976401700756166,0.7797210020909621,0.8333333333333334,0.9785609988364834,1.0,7/47,18.17%,SHMT2;IDH1;MTHFD2L;MTHFD2;SLC19A1;ME3;SDHAF3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.387273246018512,0.7796488941295083,0.8653846153846154,0.9783870305007308,1.0,4/42,4.98%,BOK;URI1;DAPK2;SEPTIN4
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.46560701670671234,0.7796393838397306,0.7692307692307693,0.9777753571196008,1.0,4/10,33.09%,RRAGD;SESN2;SESN1;UBR2
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.46560701670671234,0.7796393838397306,0.7692307692307693,0.9777753571196008,1.0,4/10,33.09%,RRAGD;SESN2;SESN1;UBR2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.3363124818269725,-0.7791759972243153,0.84,1.0,1.0,8/56,13.71%,NPTX2;CAMK2A;BEGAIN;CACNG5;CACNG8;CRH;PTK2B;SHANK1
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.3650395975598744,-0.7790229435532716,0.847457627118644,1.0,1.0,4/34,11.77%,OAS3;OAS1;DHX58;TYRO3
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.4311023796636943,0.778922745387266,0.7555555555555555,0.9785670110737769,1.0,2/13,7.26%,NYNRIN;RPP40
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.2883218129964592,-0.7789030434309782,1.0,1.0,1.0,32/283,18.48%,TERT;INHA;WARS1;TICRR;RECQL5;ORC6;SARS1;ALAS2;RFC3;RAD50;RPL38;MRPL23;PTMA;RPA3;RFC2;CDC6;KIN;BRCA1;EXO1;MCM2;RPL12;MRPS21;CDK1;E2F1;PAX8;ABCF1;CDC7;RPL37A;RPS8;BLM;POLR3A;RPS27
prerank,GO_Biological_Process_2021__positive regulation of sterol transport (GO:0032373),0.5204275971278589,0.7786496112738232,0.7818181818181819,0.9787025246399338,1.0,2/5,14.53%,NR1H3;LIPG
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),-0.49031925750404914,-0.7785526575650036,0.8536585365853658,1.0,1.0,1/9,4.40%,CUX2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),0.4798372115326708,0.7784729390599001,0.7647058823529411,0.9786977981173247,1.0,3/7,12.69%,EFNB2;MEF2C;GREM1
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.4642531406649567,-0.7784352005362997,0.75,1.0,1.0,4/10,11.18%,PHLDA2;NODAL;ADAM19;E2F7
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),0.48215831822816735,0.7782768447194814,0.75,0.9786683496437295,1.0,3/5,19.69%,BMPR1A;HEY2;BMPR2
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.46142618482944087,0.7780727555962268,0.8541666666666666,0.9786265615188077,1.0,4/11,24.08%,NOC2L;TP53;RBBP4;HIRIP3
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),0.484076034349176,0.7779530271240042,0.7872340425531915,0.9784859636225189,1.0,1/8,5.90%,F12
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.43681745341173334,0.7779044316238589,0.7636363636363637,0.9779087181883525,1.0,1/15,2.73%,RAB27A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.43681745341173334,0.7779044316238589,0.7636363636363637,0.9779087181883525,1.0,1/15,2.73%,RAB27A
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3487578916780161,0.7777887083083661,0.8431372549019608,0.9778589982595142,1.0,13/48,21.95%,FZD5;HTRA2;UBE2D3;RHOU;TP53BP2;MAPK8;UBE2J2;PPP3CC;BAP1;TP53;BAD;PPP1R13B;SREBF2
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.35886903594760783,-0.7777209975563365,0.8518518518518519,1.0,1.0,3/41,8.33%,SPRY4;PRKCD;UCHL1
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),-0.5492610888873354,-0.7776029206714594,0.8936170212765957,1.0,1.0,1/5,8.97%,NTRK3
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.3988096630050739,-0.777534611221559,0.7317073170731707,1.0,1.0,3/23,11.23%,PRKCD;TMSB4X;MYADM
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),-0.4943746157705128,-0.7772227322067753,0.7857142857142857,1.0,1.0,4/6,26.78%,CDHR2;SMO;YAP1;PTPRJ
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.44140460299292883,0.7771997833127566,0.7857142857142857,0.9784879416713405,1.0,2/15,5.19%,CCL5;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.448712230092075,-0.7771383902538695,0.7560975609756098,1.0,1.0,3/11,18.30%,CBARP;PACSIN3;CAV3
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.3721993703611317,0.7764897374761099,0.8888888888888888,0.9792480539710187,1.0,4/33,9.40%,SEMA5A;FGF2;F3;DSCAM
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.36593496615693594,-0.7763943205991669,0.7894736842105263,1.0,1.0,7/38,16.81%,INHA;ALAS2;ZFPM1;UFL1;ID2;MED1;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.34680366608599067,0.7763073198139728,0.7931034482758621,0.9792637180329473,1.0,9/59,12.07%,TENM1;NAV3;FER;BIN1;CRACD;LMOD2;CARMIL1;NCK2;FCHSD2
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.3586672212365065,0.776292415973019,0.896551724137931,0.9789917439213487,1.0,14/46,25.19%,FBXO5;IVNS1ABP;SPOPL;BAG2;MARCHF7;NXN;GNL3L;SIRT7;ARRB2;ABL1;HSPA1A;OGT;N4BP1;SMAD7
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.39261322509449087,-0.7762378541631214,0.8,1.0,1.0,4/29,12.59%,TESPA1;PRKD2;CEACAM1;GBP1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.32338393238928176,0.776107827733006,0.8431372549019608,0.9789499726384999,1.0,26/139,16.51%,FGF10;SEMA5A;RSPO3;LGR5;ZEB2;RSPO2;BMP2;TLR2;NRARP;GPC5;PPM1A;RNF146;KANK1;PSMD13;SCEL;TBL1X;PSME4;SPIN1;PTK7;CSNK1G3;FRAT1;BAMBI;LGR6;GPRC5B;PSMA1;UBR5
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.3323719164873699,-0.7759853386784717,0.875,1.0,1.0,7/94,7.13%,TERT;SOX30;ATP6V1C2;RSPO4;GPC3;SFRP1;PPP1CA
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.38393521571337014,0.7758080883592648,0.7735849056603774,0.9790601629279486,1.0,5/33,13.72%,TBC1D12;SEC22B;PIP4K2A;TMEM39A;MTMR3
prerank,GO_Biological_Process_2021__regulation of lymphocyte apoptotic process (GO:0070228),-0.47696257511749607,-0.7753919366918314,0.74,1.0,1.0,1/6,6.96%,BTK
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.34630947616399077,-0.7753520571165418,0.8837209302325582,1.0,1.0,4/62,12.43%,TRMO;DUS2;METTL6;TARBP1
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.43573334905562844,0.7746441250658461,0.7254901960784313,0.9801503223170824,1.0,3/14,7.66%,TRPV2;SLC8A1;SLC24A2
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.43573334905562844,0.7746441250658461,0.7254901960784313,0.9801503223170824,1.0,3/14,7.66%,TRPV2;SLC8A1;SLC24A2
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.3677875382548641,0.774554439046386,0.7321428571428571,0.9799769572507951,1.0,6/36,18.15%,PLD6;TDRD9;PRKRA;TENT4B;PIWIL1;ZCCHC8
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.3856311932804465,-0.7745356238926736,0.76,1.0,1.0,1/32,0.42%,NTRK1
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.3728359291664472,0.7738982854519082,0.8214285714285714,0.9806567330992332,1.0,5/22,12.35%,SLC24A2;ACHE;NLGN4X;GRIK3;PTEN
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.4607406010228807,0.7738619829150156,0.75,0.9803972213202664,1.0,1/10,5.50%,SLC8A1
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.44916368292219,0.7736062021246246,0.7321428571428571,0.9804534589003857,1.0,2/9,2.71%,ITGA11;ITGA2
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.43783321421787186,0.7733243417578233,0.7586206896551724,0.980575215587921,1.0,2/12,1.82%,SYK;CCL5
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.3965363632990498,0.7732917002381523,0.7407407407407407,0.9803159778857065,1.0,10/21,32.81%,MOGAT2;DGAT2;DGKZ;DGKD;PLA2G15;DGKE;PNPLA2;DGKI;MOGAT1;DGKH
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.45176029028081277,0.7731811951088846,0.7678571428571429,0.9798553036283941,1.0,1/9,11.09%,WASHC1
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.45176029028081277,0.7731811951088846,0.7678571428571429,0.9798553036283941,1.0,1/9,11.09%,WASHC1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.40992252925406375,0.773094132196868,0.8113207547169812,0.9796579222364296,1.0,1/18,1.49%,EPHA7
prerank,GO_Biological_Process_2021__hexose import across plasma membrane (GO:0140271),-0.5100382932694836,-0.7729288327679107,0.7727272727272727,1.0,1.0,2/5,13.89%,SLC5A1;SLC2A1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.3713481917804338,0.7728840986167432,0.7931034482758621,0.9796611090742078,1.0,5/27,18.54%,BMI1;EZH2;EPC1;EED;H3-3A
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.33252834853229485,-0.7728039953014417,0.7872340425531915,1.0,1.0,5/65,8.56%,F5;F8;GOLGA2;PPP6R1;TRAPPC2L
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.3256959567700868,0.7727172252664424,0.8823529411764706,0.9795743278855872,1.0,4/67,13.94%,SYK;NXT1;RANBP17;PRICKLE1
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.4773404193008846,0.7721835508723919,0.7413793103448276,0.9801539561507537,1.0,1/6,5.88%,TLR2
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.38677559316486293,0.7720825838179355,0.8297872340425532,0.9799975984694403,1.0,7/34,22.26%,CASS4;GRM5;GPRC5B;EFNA1;DLG3;GAS6;ACE
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.406665340872874,0.7720502785458625,0.8333333333333334,0.979739203589456,1.0,9/23,26.63%,PRDX6;PLA2G10;PNPLA6;PNPLA8;PLA2G7;GPCPD1;GDPD3;PLA2G15;INPP5F
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.39350733945935634,-0.7717862749198721,0.7833333333333333,1.0,1.0,6/28,15.19%,ABCA4;ABCB1;ABCB4;MFSD2A;ATP9B;ATP8B4
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.37971678657882874,-0.7716415265354153,0.7857142857142857,1.0,1.0,2/25,6.78%,NUPR1;LZTS1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.43413741902867226,0.7715279301509299,0.7547169811320755,0.980191617771034,1.0,1/11,4.61%,ADGRG6
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.42173667910116097,0.7710544764209291,0.7916666666666666,0.9804885955241549,1.0,5/16,27.11%,SLC8A1;ATP1A2;ATP1B2;ATP12A;KCNJ2
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.3803374925830748,0.7693486106181612,0.7966101694915254,0.9828057627163522,1.0,2/23,3.67%,ENPP1;FBXO5
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.41865827251201154,0.7690658351009397,0.782608695652174,0.9829507518094169,1.0,4/16,19.76%,HAP1;DLG2;DST;ACTR10
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.4525395565034501,-0.769026812744194,0.7551020408163265,1.0,1.0,4/10,12.94%,DMGDH;SMOX;LRTOMT;BHMT
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.3571418819503494,0.7689311141709376,0.8461538461538461,0.9828182781549526,1.0,5/29,14.91%,NLGN1;CRHBP;MEF2C;LRRC7;DLG2
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.41082954428704604,-0.7688200174274553,0.75,1.0,1.0,7/23,16.45%,DRD4;CBARP;DRD2;MMP9;GNB5;CALM1;CLIC2
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.49521875929069903,-0.7686452474099434,0.725,1.0,1.0,1/6,6.54%,SLC13A3
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),0.44995738589772355,0.7683927301955492,0.7346938775510204,0.9833260854298873,1.0,1/7,1.48%,TYR
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),-0.4711504334591354,-0.7683475862092788,0.7407407407407407,1.0,1.0,1/6,5.96%,DLL4
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.4527985688639181,-0.768209970833918,0.7317073170731707,1.0,1.0,1/9,5.40%,PAH
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.40237278654595476,0.7679965731408461,0.7586206896551724,0.9836501328726505,1.0,5/22,17.62%,PRMT1;METTL21C;CAMKMT;VCPKMT;FAM98A
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.3823720437849889,0.7677359225716511,0.7441860465116279,0.9837376189529498,1.0,3/32,15.80%,HIF1A;HAP1;DST
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.46373694458011533,-0.7675080438984154,0.7083333333333334,1.0,1.0,1/8,4.39%,CBARP
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.43212614445148273,0.767426284940928,0.7457627118644068,0.9835051728987164,1.0,3/12,10.17%,EFNA5;KANK1;CORO1C
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.43212614445148273,0.767426284940928,0.7457627118644068,0.9835051728987164,1.0,3/12,10.17%,EFNA5;KANK1;CORO1C
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.3524229461238243,0.7669733185867493,0.8,0.9839061063874001,1.0,13/46,16.53%,LRAT;ALDH1A1;DHRS3;SDC4;NAPEPLD;GPC5;PECR;GPC4;RPE65;BCO1;LRP2;CYP4V2;AKR1C1
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.4837458201930882,0.7668541855485423,0.7755102040816326,0.9837899036131712,1.0,2/7,13.29%,ABI3;RBMS3
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),-0.34376335421871484,-0.7662652413885718,0.8936170212765957,1.0,1.0,1/45,1.32%,HSPB3
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.42870294113102236,-0.7661950641272073,0.7307692307692307,1.0,1.0,2/10,9.13%,ERCC1;RAD50
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.3937657902633719,0.766178179126658,0.8085106382978723,0.9844346122155059,1.0,9/24,20.65%,PTGS1;HPGDS;CYP2S1;CD74;PNPLA8;AKR1C1;AKR1C3;ACOX1;EDN1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.4390117689738058,-0.7655159202265268,0.7551020408163265,1.0,1.0,2/9,13.87%,APOA1;ABCB4
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.49113905387286944,0.7652956610139263,0.7560975609756098,0.985335156695561,1.0,4/7,31.73%,SMS;MTR;ADI1;MSRA
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),-0.4883979676644377,-0.7652567942027847,0.8181818181818182,1.0,1.0,2/7,12.32%,STAC;NIPSNAP2
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.3864221035422472,-0.7650582904236353,0.7777777777777778,1.0,1.0,8/30,18.94%,RAC2;P2RY12;KIF17;PARVG;RAC1;PARVB;RHOQ;NCKAP1L
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.3925235419201536,0.7650443692484973,0.7543859649122807,0.985381255201252,1.0,7/25,23.45%,DMC1;HORMAD1;GDF9;FMN2;NANOS1;USP9X;TOB2
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.4735710802169474,-0.764994430203259,0.7441860465116279,1.0,1.0,2/7,14.90%,P2RY12;NTN1
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.40471644988224803,-0.7646439201529317,0.8269230769230769,1.0,1.0,6/16,12.91%,FAM3D;SFRP1;KCNJ11;CCN3;FFAR4;CRH
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.40485954088983833,-0.7642743474969643,0.7045454545454546,1.0,1.0,5/17,12.16%,NLRP3;MEFV;IL18;ENTPD5;TXN
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.4014213454549401,-0.7637365299206186,0.8048780487804879,1.0,1.0,5/26,9.16%,PDE6B;RBM4;PER2;PPP1CA;RBM4B
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.42129960504250874,0.7634679943682092,0.7547169811320755,0.9873946834778152,1.0,2/9,21.01%,VANGL2;ATP8B1
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.4369620643454899,-0.7632996677516403,0.8333333333333334,1.0,1.0,3/12,14.54%,SCPEP1;CYP26B1;ADH7
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.343574600453184,-0.7632446347042137,0.9183673469387755,1.0,1.0,10/77,12.99%,NTRK1;NUPR1;CRLF1;FOXQ1;KDM2B;WFS1;TYRO3;FGF20;NRBP2;PTK2B
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.3389821249216493,0.7631810151930619,0.8490566037735849,0.9875294988376009,1.0,13/77,19.07%,FZD5;PRICKLE2;PSMD13;VANGL2;FZD1;PSME4;PRICKLE1;DVL2;FZD4;FZD6;PSMA1;ARRB2;SMURF1
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.49604476665567887,-0.763110795954102,0.7391304347826086,1.0,1.0,2/5,15.64%,P2RY12;GPR183
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.29351060109711213,-0.7629557628373471,0.9591836734693877,1.0,1.0,15/243,8.56%,TERT;F5;F8;HGSNAT;CLDN1;MEFV;GOLGA2;JCHAIN;TUBGCP2;RSPH9;FANCC;AFG3L2;PPP6R1;HFE;TRAPPC2L
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.3567467866987129,-0.7625934871690448,0.8163265306122449,1.0,1.0,1/34,3.26%,MAP1LC3B2
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.5095620606419446,-0.7624616368624068,0.76,1.0,1.0,1/5,12.61%,NUCKS1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.413443482903801,0.7623327346696527,0.8245614035087719,0.9885051088864514,1.0,2/16,14.30%,PCSK5;LRP6
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),0.4355128952044697,0.762301926810228,0.723404255319149,0.9882252725037264,1.0,1/8,12.90%,GTF3C4
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.3868371666932242,-0.7622310653931285,0.8181818181818182,1.0,1.0,6/24,16.18%,PLAAT4;ETV4;VDR;PRKCH;ZFP36L1;MED1
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),0.45824748416148486,0.7621653400339181,0.8,0.9880674025656079,1.0,3/13,11.32%,STING1;UBA5;RETREG1
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.4143507648526439,-0.7620739703141218,0.7391304347826086,1.0,1.0,3/15,6.96%,INHA;SFRP1;BTK
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.4307052291130207,0.7619370144789606,0.7903225806451613,0.988100375891005,1.0,1/11,9.95%,GSN
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.5042716385224896,0.7618240450134998,0.7560975609756098,0.9879385879499804,1.0,2/9,3.04%,IL4;EHD1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.3421512108239265,-0.7617910292809644,0.8867924528301887,1.0,1.0,2/41,3.41%,CYP2E1;ALOX5
prerank,GO_Biological_Process_2021__negative regulation of catecholamine secretion (GO:0033604),0.4855194709943053,0.761712604635678,0.8269230769230769,0.9877850137405026,1.0,1/6,7.71%,ADRA2C
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.3757290085867463,-0.761202228642807,0.7291666666666666,1.0,1.0,8/24,21.69%,RRM2;B3GNT5;RRM1;ALG8;ALG11;ST8SIA6;GK5;G6PD
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.44243270401326407,-0.7603340352960274,0.6944444444444444,1.0,1.0,3/7,20.62%,LETM1;CLDN16;TESMIN
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.33248916669245504,0.7598314601577109,0.9038461538461539,0.990198055829298,1.0,6/46,11.86%,EFNA5;DOCK1;CASS4;KANK1;CORO1C;CARMIL1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.39526687688447054,-0.7597173534551234,0.8536585365853658,1.0,1.0,5/27,9.16%,PDE6B;RBM4;PER2;PPP1CA;RBM4B
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.4496644036398806,-0.7592482171882248,0.7446808510638298,1.0,1.0,4/5,33.41%,MAPT;BAG3;PRKN;HDAC6
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),-0.4902238389903051,-0.7592017425737119,0.7608695652173914,1.0,1.0,2/6,13.11%,CAMK2A;CAV1
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.4750509961182138,-0.7590472576030676,0.85,1.0,1.0,2/7,14.78%,DHX58;USP17L2
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.39559840822337006,0.7590005171892874,0.711864406779661,0.9911828304261624,1.0,6/19,18.12%,OSBPL6;NUS1;NR1H3;ABCA8;LIPG;ABCA2
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.4556823545402674,0.758974147638803,0.7924528301886793,0.9909108713676904,1.0,1/6,2.81%,FGF2
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.47426167822700305,-0.7584157902087418,0.7555555555555555,1.0,1.0,2/10,4.93%,SCPEP1;DRD2
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.3290006109326449,-0.7578309490653143,0.8461538461538461,1.0,1.0,11/85,9.53%,GPR39;CGA;HRH2;PTGDR;P2RY11;PTH1R;ADCYAP1;HCK;HLA-DRB1;GPR83;GLP2R
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.4113159480978179,0.757590626968552,0.746031746031746,0.9925064562259016,1.0,2/20,7.38%,PRDX6;TRA2A
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.3458757349533182,-0.7575620172700485,0.7727272727272727,1.0,1.0,8/49,10.86%,CYTH4;CD86;LILRB3;MS4A4A;HCK;SLC11A1;LY86;SPI1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.40309716123448186,0.7572689215622737,0.8363636363636363,0.9926918363507574,1.0,5/24,17.36%,MRAP2;ABI3;LZTFL1;PICALM;NUMB
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.33804069768723544,-0.7571614010304731,0.8125,1.0,1.0,4/64,3.43%,RAC2;BST1;PEAK3;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.42989463112985193,0.7568030821054476,0.7959183673469388,0.9930228330264101,1.0,2/16,9.99%,BMP2;BIN1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.27851322480861557,0.756711549590796,1.0,0.9928558558463103,1.0,54/298,22.30%,AP1M2;SYK;RAB38;TBC1D3L;ACD;TBC1D8B;EHD1;TBC1D12;NLGN1;RAB31;LTBP2;VPS26C;ARL5A;SNX31;NXT1;RAB23;LMAN1;HAP1;RANBP17;BCS1L;XPO1;RABL2B;STRADA;CD74;PRICKLE1;SGSM3;RPGR;TBC1D4;GGA1;TBC1D5;RAB29;VPS29;RAB28;STX8;STXBP3;TMED1;TMED3;RTN2;STX17;SMURF1;STX5;GRTP1;PPP1R10;TICAM2;RAB5B;EVI5L;SAR1A;TRAK2;MYO1C;STX3;NUP153;AKT2;USP6NL;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.3494351183651223,0.7566334244779446,0.7931034482758621,0.9926444821876814,1.0,3/37,3.12%,RIN2;UTRN;RRAS
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.3565083454924315,-0.7565744021677863,0.851063829787234,1.0,1.0,10/35,16.85%,EPOP;SFRP1;MEOX1;PAX2;WNT7A;FOXO4;UFL1;OSR1;HTR2B;FGFR2
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.3382705337068167,-0.7565668752754396,0.8888888888888888,1.0,1.0,11/49,20.69%,AHSG;TIMP4;SERPINI2;SERPINB5;SERPINE2;APH1B;PSME3;VTN;SERPINB9;SERPINA10;APH1A
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.4276834275746799,0.7565527130289122,0.7924528301886793,0.9924736848173688,1.0,3/13,18.74%,GRIK2;PPFIA3;SHISA8
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.45330549954237187,-0.7561543893799241,0.7804878048780488,1.0,1.0,2/8,10.93%,DDRGK1;TMSB4X
prerank,GO_Biological_Process_2021__negative regulation of intracellular transport (GO:0032387),-0.47816643625856353,-0.7561394777516548,0.7413793103448276,1.0,1.0,1/5,2.24%,MRLN
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),0.4621397723011785,0.7557736312667652,0.6896551724137931,0.9932450265580152,1.0,4/6,31.68%,DMD;KCNJ2;C12ORF57;SLC8A3
prerank,GO_Biological_Process_2021__pentose catabolic process (GO:0019323),0.5050396228879792,0.7554810199464341,0.8571428571428571,0.99332473829823,1.0,1/5,18.40%,RPE
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.37730483722972796,0.7552153456921143,0.875,0.9934650076058604,1.0,3/24,8.93%,ITGAX;ITGAV;DSP
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.4635925921382916,0.7551644898785538,0.7547169811320755,0.9932133822249123,1.0,2/6,8.94%,NAIF1;ACAA2
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.27492079349732823,0.7551455642602939,1.0,0.9929174972411096,1.0,13/138,13.39%,TENT5A;ZFP36L2;SAMD4A;MAPKAPK2;PSMD13;RIDA;HNRNPD;EXOSC4;ANP32A;HSPB1;XPO1;HSPA8;PSME4
prerank,GO_Biological_Process_2021__Schwann cell differentiation (GO:0014037),0.4794447986625992,0.7550957022253506,0.8076923076923077,0.9926540917571594,1.0,1/5,4.61%,ADGRG6
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.2972809895082455,0.7550369191211674,0.8775510204081632,0.992415064304336,1.0,17/110,18.54%,H2BC21;DMC1;ASF1A;GMNN;MCM7;PSMD13;TCF4;PSME4;CCNH;H2AX;ORC4;ANP32B;PADI4;PSMA1;MNAT1;CENPV;H3-3A
prerank,GO_Biological_Process_2021__negative regulation of cellular respiration (GO:1901856),-0.5090272593318602,-0.7547723502520659,0.825,1.0,1.0,1/5,5.07%,ACTN3
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.3270298072885205,-0.754622199723236,0.8269230769230769,1.0,1.0,1/68,0.76%,TBC1D10C
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.33547877832205913,0.7540647981893269,0.9074074074074074,0.9932481536772209,1.0,14/60,22.25%,SYK;DOCK1;PLCG2;PIK3CA;CD247;WASL;VAV2;ABL1;LYN;MAPK3;MYO1C;CRK;WIPF1;GRB2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.33547877832205913,0.7540647981893269,0.9074074074074074,0.9932481536772209,1.0,14/60,22.25%,SYK;DOCK1;PLCG2;PIK3CA;CD247;WASL;VAV2;ABL1;LYN;MAPK3;MYO1C;CRK;WIPF1;GRB2
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.38937157290078156,0.7540357363034558,0.7446808510638298,0.9929930382512662,1.0,5/26,5.08%,VCAN;BGN;B3GAT2;CHSY3;UGDH
prerank,GO_Biological_Process_2021__glyoxylate metabolic process (GO:0046487),-0.4862656663700319,-0.7540207365610007,0.72,1.0,1.0,2/6,10.39%,PRODH2;GOT2
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.46556102328123106,0.7539168803775738,0.819672131147541,0.992810629594006,1.0,4/8,23.64%,PICALM;DNM3;MX2;SNAP91
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.4664677453126146,0.7536139977473831,0.7735849056603774,0.9929345478690828,1.0,2/7,5.19%,CCL5;CXCL12
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.47297526858432093,0.7534701487339802,0.7454545454545455,0.9928449124210637,1.0,1/5,6.69%,PRIMPOL
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.4070256855608804,0.753452666641422,0.7719298245614035,0.992574136664338,1.0,4/13,15.08%,TGFBR1;BMPR1A;SMAD4;KIAA0319
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.29872310563920845,-0.7534215150152985,0.8936170212765957,1.0,1.0,22/140,13.11%,TERF2IP;WARS1;PRKCD;ATG14;MVP;XDH;SFRP1;TRIB1;TRIB2;SPRED3;SPRED2;UBASH3B;CEACAM1;NTRK3;CAMK2N1;TAF7;SPRED1;MYADM;PYDC1;IGFBP3;DAB2IP;CAV1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.42999401735196524,0.7528826993100811,0.8,0.9930643173510572,1.0,2/10,7.75%,F2R;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.32124419937425097,-0.7526516308991802,0.8125,1.0,1.0,8/75,8.71%,SIRPG;AHSG;GPC3;SPACA3;DOCK2;SLC11A1;FLOT1;CDH3
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.42426813930900764,-0.7525310363765132,0.75,1.0,1.0,2/10,8.71%,TYRP1;CDH3
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.45665460160439797,0.7523436337701759,0.7924528301886793,0.9934857819619489,1.0,2/8,26.69%,FCHSD2;WASF2
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),-0.4699703498869638,-0.7522712196357496,0.8,1.0,1.0,2/11,7.56%,TST;NOX4
prerank,GO_Biological_Process_2021__regulation of intestinal cholesterol absorption (GO:0030300),0.5058210857834902,0.7515666220035834,0.8269230769230769,0.9941081231160461,1.0,2/5,14.36%,ABCG8;ABCG5
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.33971353921354364,0.7515046674759068,0.8333333333333334,0.9938815280411039,1.0,15/51,25.06%,PRMT1;E2F4;CNOT6L;CHEK2;PLAGL1;CNOT4;PML;CNOT8;CNOT2;TP53;CDC25C;GTSE1;MDM4;EP300;RBL2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.4756711359533232,-0.7514712105544177,0.75,1.0,1.0,1/6,8.19%,UBASH3B
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.3798757525165519,0.751207276596577,0.7169811320754716,0.9940410226380091,1.0,5/25,9.21%,HPSE2;SDC4;HPSE;GPC5;GPC4
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.3045557217183801,-0.7510920966604464,0.9166666666666666,1.0,1.0,15/81,15.78%,STAC;KCNE2;CAMK2A;KCNE1;JPH2;CACNG5;MMP9;CACNG8;KCNS1;CRH;PTK2B;SHANK1;CTSS;CALM1;SHISA7
prerank,GO_Biological_Process_2021__lymphoid progenitor cell differentiation (GO:0002320),0.48645857501708994,0.7508482221683833,0.7777777777777778,0.9942325697578559,1.0,2/6,10.93%,FLT3;LIG4
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.4344690550482655,0.7508404363581104,0.8169014084507042,0.9939458816204424,1.0,3/11,22.23%,PEX12;PEX2;PEX13
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.4263766046787086,0.7501591542311181,0.803921568627451,0.99461932136848,1.0,3/8,18.78%,PTEN;PHLDB2;FERMT1
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.4069110312221245,-0.7500587844476608,0.8333333333333334,1.0,1.0,4/15,16.37%,WNT7A;SHANK1;EPHB1;SHANK3
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.4520153929287568,0.7497561024624275,0.8070175438596491,0.9948908136472823,1.0,3/12,20.89%,GLUL;DAO;GLUD1
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.44420562895864457,0.7494994345804888,0.7254901960784313,0.9949734777373788,1.0,2/8,15.22%,SPX;NENF
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.457922827238399,0.749369188762186,0.7818181818181819,0.994460706366061,1.0,1/7,4.61%,ADGRG6
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.457922827238399,0.749369188762186,0.7818181818181819,0.994460706366061,1.0,1/7,4.61%,ADGRG6
prerank,GO_Biological_Process_2021__neuroblast proliferation (GO:0007405),0.5037589340298595,0.7492877532619527,0.8392857142857143,0.994290781165739,1.0,3/6,17.00%,PLXNB2;RACGAP1;ARTN
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.42542322771192914,0.7488475462110085,0.8048780487804879,0.9945739795231109,1.0,6/14,19.92%,PTGS1;HPGDS;CYP2S1;AKR1C1;AKR1C3;ACOX1
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.3499599146137534,0.7487936576537063,0.82,0.9943480164062034,1.0,3/30,10.55%,PPP1R15B;MAGI2;ITGA1
prerank,GO_Biological_Process_2021__glutathione catabolic process (GO:0006751),0.5012322953666526,0.7486819804600489,0.8,0.9941983177688607,1.0,4/5,34.12%,CHAC1;DPEP1;GGT5;CHAC2
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3632552893866856,0.7485648840902249,0.803921568627451,0.9937590599809322,1.0,6/21,21.51%,TP53BP2;MAPK8;PPP3CC;TP53;BAD;PPP1R13B
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3632552893866856,0.7485648840902249,0.803921568627451,0.9937590599809322,1.0,6/21,21.51%,TP53BP2;MAPK8;PPP3CC;TP53;BAD;PPP1R13B
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),-0.5022203741434115,-0.7481695729707363,0.7924528301886793,1.0,1.0,3/6,7.64%,ACTN3;NIBAN2;FLOT1
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.32682037017503673,0.748093003704126,0.88,0.9941420520074973,1.0,12/42,24.76%,ZFP36L2;NUDT16L1;RIDA;EXOSC4;DXO;AGO3;SLFN14;PNPT1;ZFP36;LSM2;HSPA1A;YTHDF2
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.29648881342473127,0.7480021618895675,0.9803921568627451,0.9939765978533946,1.0,20/134,16.65%,THEMIS;ICOSLG;RELA;NFKBIZ;PLCG2;DENND1B;PAG1;TAB2;PIK3CA;PSMD13;BTN2A2;NFKBID;PDE4B;BCAR1;ITK;PSME4;TNFRSF21;PIK3CD;PSMA1;CD247
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),0.3161400276289024,0.7479059335548359,0.9230769230769231,0.993795245607019,1.0,12/68,13.09%,CCL5;SIRT1;ZFP36L2;RELA;CD40;CRHBP;ERBIN;GCH1;HYAL3;ZFAND6;HAS2;TANK
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.4608895024610636,0.7476295750477127,0.8367346938775511,0.9939019360870133,1.0,5/11,33.65%,NR1H3;SGK1;SGK2;STK39;PON1
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.3431693108755693,0.7476243404084715,0.8297872340425532,0.9936087819789865,1.0,7/40,17.61%,SIRT1;LPIN3;MOGAT2;LIPG;DGAT2;AGMO;CPS1
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.37384978066328467,0.747390718541884,0.9,0.9935356198303676,1.0,5/41,14.96%,CSTA;NLRP7;KNG1;SERPINB7;CRB2
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.3679634548988069,0.7472919408230834,0.7727272727272727,0.993386592527906,1.0,3/31,10.28%,NDE1;BICD1;HAP1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.32585462090461625,-0.7470765083884604,0.88,1.0,1.0,11/86,9.53%,GPR39;CGA;HRH2;PTGDR;P2RY11;PTH1R;ADCYAP1;HCK;HLA-DRB1;GPR83;GLP2R
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.36318897814873263,-0.7469606373316324,0.7924528301886793,1.0,1.0,2/32,6.74%,TERF2IP;TPP1
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.49114805960602204,0.7469146670110831,0.8444444444444444,0.9937249325832527,1.0,1/6,6.56%,ABCC2
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),-0.45414843901015545,-0.7463524620758131,0.7804878048780488,1.0,1.0,2/9,6.32%,CYP24A1;CYP4F2
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),0.3211802989074324,0.7460311619610676,0.82,0.99453820734305,1.0,13/56,14.53%,ACSM2A;CYP39A1;GAMT;CYP27A1;CYP7B1;OSBPL6;SRR;ABCD3;OXSM;CH25H;HSD17B10;ACACA;LIPG
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.4418980121118916,-0.7460247967734926,0.7843137254901961,1.0,1.0,1/12,7.83%,CCDC88C
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.39342450270323504,0.7459950203312408,0.8301886792452831,0.99430119288565,1.0,2/19,3.06%,AMPD1;AK3
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.4426284744987016,-0.7459587401697085,0.7804878048780488,1.0,1.0,2/9,11.03%,IFI27;CAV2
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),0.38240954489615564,0.7455166598120314,0.813953488372093,0.9946828275532674,1.0,4/20,11.56%,TSPAN12;FGF2;BMPER;VASH2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.49129123331565194,-0.7449229622814569,0.8076923076923077,1.0,1.0,1/5,12.82%,CTPS1
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.37035557205281217,-0.7447797312780076,0.8048780487804879,1.0,1.0,7/17,20.69%,MBTPS2;SPPL2B;TGFB1;APH1B;MBTPS1;ADAM9;APH1A
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.4728628650533055,-0.7442506046816129,0.8181818181818182,1.0,1.0,1/8,1.76%,TERF2IP
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3334927564272984,0.7439549101708303,0.8620689655172413,0.996416529122611,1.0,11/59,17.81%,RFWD3;PRMT1;E2F4;CNOT6L;CHEK2;PLAGL1;CNOT4;PML;CNOT8;CNOT2;TP53
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.3335661424006929,-0.7435989885424957,0.9090909090909091,1.0,1.0,20/90,12.55%,CFAP61;INSRR;ATP6V1C2;KCNJ16;DCDC1;SLC22A8;UMOD;RGS22;DNAAF1;PDZD2;COL28A1;WDR93;ADGRF5;ZBTB7C;SLC22A6;MUC15;CCDC40;P2RY14;ATP13A5;CFAP221
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.4126445297495104,0.743331352104467,0.7619047619047619,0.996932857852924,1.0,4/11,13.61%,MID2;GSN;TRIM26;PTX3
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.42600382039791623,-0.7433277923247923,0.7291666666666666,1.0,1.0,1/12,2.66%,SYNJ2
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.3530834290610866,0.7431624953389591,0.7843137254901961,0.996787087009144,1.0,3/39,4.06%,RHOBTB3;NLGN1;LLGL1
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.37929264043820893,-0.743073467056902,0.813953488372093,1.0,1.0,7/28,16.18%,SOX30;PAQR7;AR;CAV1;TGFB1;ADTRP;MED1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.304611609769768,0.7430193596920827,0.9285714285714286,0.9967131435130235,1.0,21/111,19.07%,FZD5;WNT4;MOV10;PRICKLE2;PSMD13;VANGL2;PDE6A;PPP3CA;FZD1;PSME4;PRICKLE1;DVL2;FZD4;FZD6;PLCB1;FRZB;PSMA1;CTNNB1;AGO3;ARRB2;SMURF1
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.3489285015940761,0.7423131839399503,0.8461538461538461,0.9973045990020558,1.0,4/30,9.20%,SCN7A;CACNB4;SCN10A;SCN3A
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.4701163823682111,0.7422935523230855,0.84375,0.9969995318408204,1.0,3/8,30.16%,BNIP3L;ATF2;RHOT1
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.5064143631847468,0.7422293768794597,0.8,0.9967503972415602,1.0,2/8,3.04%,IL4;EHD1
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.3921121261708974,-0.7421952134923843,0.8653846153846154,1.0,1.0,3/31,4.59%,AWAT1;ALOX5;HMGCL
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.3994785572070805,0.742005445584006,0.8148148148148148,0.996700439401037,1.0,4/21,19.55%,NEDD4;SMURF1;MVB12A;LGMN
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.28546024162526557,0.7419273988846717,1.0,0.9965191983455721,1.0,13/111,12.81%,NXPH1;HRH3;SLC17A6;TENM1;ZDHHC22;NRXN1;OLFM3;PAK5;TMEM196;GRIK3;NOL4;KCNB2;NR4A2
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),-0.43994137691196733,-0.7417428780637764,0.782608695652174,1.0,1.0,2/6,12.94%,BHMT2;BHMT
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.38534964967747887,0.7416818839539724,0.851063829787234,0.9965131008211198,1.0,4/18,12.35%,NLGN1;NRXN1;RIMS2;PTEN
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.34831691451348434,-0.7413395530788393,0.8444444444444444,1.0,1.0,7/58,12.24%,ABRAXAS1;RNF8;ERCC1;POLQ;RAD50;PRPF19;CYREN
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.3635524132560084,0.7407754915978226,0.8571428571428571,0.9973381487055043,1.0,5/37,5.74%,CHRM2;HRH3;HTR1F;NPY;SSTR3
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.4169749780674202,-0.740770030468694,0.7142857142857143,1.0,1.0,1/12,1.76%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.32056242088963216,-0.7407696151009081,0.8333333333333334,1.0,1.0,15/56,26.31%,GPR132;PSMB4;RFPL1;PSMC4;PSMD8;SKP1;PSME3;PSMD12;PSMC3;PSMC2;PSMD2;PSMA5;PSMC1;PSMD3;NABP2
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.30947305403464037,0.7407062135703719,0.8913043478260869,0.9970932701921787,1.0,14/70,15.34%,C1QL1;TENM3;EFNA2;VSX2;POU3F2;SPSB4;EPHA8;ONECUT2;BCAR1;DLL3;FJX1;NR2F2;RIMS4;FOXO6
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.4495133331464742,0.740557069032796,0.7547169811320755,0.9969558490810795,1.0,1/7,6.69%,PRIMPOL
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.3020187367342618,0.740497269220325,0.8928571428571429,0.9967072670706769,1.0,22/96,23.63%,SIRT1;PLOD2;KAT2B;METTL21C;LOXL2;ATPSCKMT;ESCO1;CTH;RANBP2;SIRT7;VCPKMT;NSMCE2;HDAC9;SENP6;TRIM28;KIAA1586;P3H3;NUP153;LIPT2;PLOD3;SAE1;BCL11A
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.368008716392793,0.7404092051810485,0.86,0.9965144444359711,1.0,3/22,14.98%,CBLB;CHMP6;ERRFI1
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.44269433788433554,-0.7402121087372525,0.8085106382978723,1.0,1.0,2/11,8.18%,RFTN1;OAS1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.28570234768351904,-0.7402008393883734,1.0,1.0,1.0,40/269,16.48%,PARP2;ABRAXAS1;TICRR;SLX4;REXO4;RNF8;RECQL5;ERCC1;FANCG;EYA1;FANCC;RPAIN;RFC3;POLQ;TRAIP;RAD50;XPC;RAD51AP1;SMUG1;RAD51AP2;PARP1;GTF2H2;FAN1;LIG1;NUCKS1;XRCC1;SMARCA5;RPA3;TEX264;RFC2;ZRANB3;BRCA1;EXO1;TNP1;CDKN2D;TNKS1BP1;KDM4B;MUS81;CDK1;APTX
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.3319428646707211,0.740117761928866,0.8333333333333334,0.9965639482444787,1.0,15/67,14.25%,SIPA1;CDKN2A;BRINP3;BMP2;SCRIB;HTRA2;GMNN;LATS1;RPS6KA2;PTPRK;TP53BP2;PTEN;HEXIM2;HECA;NR2F2
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.2828901323821263,0.7399797093885501,1.0,0.9964387685217293,1.0,35/152,20.49%,SLC5A8;SCN7A;SLC22A3;TRPM8;ASIC1;KCNJ3;SLC12A3;SLC5A12;SLC8A1;KCNH4;SCNN1B;SCN3A;ATP1A2;KCNB2;SCN9A;KCNG2;TRPM2;LRP2;PIEZO1;ANO6;KCNF1;SGK1;KCNAB3;TRPM7;SLC3A2;SLC5A4;SLC36A1;NDFIP2;KCNJ10;TRPM3;SLC7A6;KCNMB4;KCNJ8;SCNN1D;KCNMB1
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.4521035584053743,0.739798381423016,0.8,0.9963850929712431,1.0,1/5,3.59%,MAFB
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.3360591324595573,0.7397411313032242,0.8793103448275862,0.9961331037992563,1.0,5/32,15.40%,GMNN;MCM7;LRWD1;POLE2;ORC4
prerank,GO_Biological_Process_2021__response to acetylcholine (GO:1905144),0.5037488437861984,0.7397240845761642,0.8571428571428571,0.9958416130170847,1.0,4/5,49.50%,ATP2B4;CHRNB2;CHRNA7;CHRNA3
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.3377944929023641,0.7392492331309254,0.8813559322033898,0.9960815434319306,1.0,7/46,17.64%,EFL1;PWP2;RRS1;RPS5;BOP1;MTERF3;ERAL1
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.46057717858897457,0.7392490916959267,0.7843137254901961,0.995774395253259,1.0,1/10,8.00%,PLA2G10
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.41288389190605657,-0.7391723528228386,0.8,1.0,1.0,2/14,8.95%,CIITA;CEACAM1
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),0.4378589142506626,0.7390966614731976,0.76,0.9956496904476885,1.0,1/7,8.67%,GCH1
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),0.5142885693369071,0.7389371785484682,0.8392857142857143,0.9956003181332801,1.0,1/6,5.96%,TET2
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),-0.4602573734683539,-0.7388680302456453,0.7551020408163265,1.0,1.0,2/5,18.46%,RCSD1;AQP1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.3638718235017302,0.7386727498923711,0.8793103448275862,0.9956737239165865,1.0,6/28,16.17%,FZD5;HTRA2;UBE2D3;RHOU;UBE2J2;BAP1
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.4322552573795333,0.738428861108866,0.7868852459016393,0.9956560416756991,1.0,2/15,7.38%,PRDX6;TRA2A
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.3026137352035302,0.7383318556111786,1.0,0.9954325977785083,1.0,30/151,19.44%,STK26;SIRT1;DAPK2;FANK1;KANK2;SEPTIN4;TP53INP1;HIP1;FLT3;TNFRSF10B;CASP10;BNIP3L;TP53BP2;BCAR1;ANP32A;MAGED1;IFT57;SGK1;GAS1;ANP32B;LGALS1;BCL3;BIRC3;FBXO11;PERP;TP53;PHLPP1;TNFRSF10A;IRF3;ABL1
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.36316388807922423,0.7383228439171171,0.8666666666666667,0.995130172500551,1.0,7/31,21.16%,ABL2;PHACTR4;MAPK8;ABL1;MID1IP1;POT1;MAPK3
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.29687812375902206,0.7382526330604541,1.0,0.9949268015588824,1.0,24/122,16.16%,EDIL3;LRP4;ASIC1;TENM3;BGN;ARHGEF17;ADGRL2;LIFR;PRICKLE2;ANK2;GFRA1;MAGI1;GUCY1A2;BCAR1;HTRA1;CBS;FIGN;ID4;SEMA6D;FRZB;CPE;GPRC5B;PDZRN3;CTH
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.4704935545481112,0.738125049952817,0.8,0.9948263470595269,1.0,4/7,23.64%,PICALM;DNM3;MX2;SNAP91
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.290351507344731,-0.7381026911968163,0.9803921568627451,1.0,1.0,9/182,7.24%,DUSP4;HK2;PLA2G2C;PLAAT4;PLCZ1;INPP5D;PPP1CA;PLCB2;LHPP
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),0.4273344332511093,0.7379280704675072,0.8367346938775511,0.9947615250128945,1.0,3/11,28.49%,STX3;ABCA7;TMEM35A
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.4380549446098104,0.7377192323809361,0.7755102040816326,0.9946769874100424,1.0,4/9,18.32%,GADL1;CBS;CTH;MPST
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.4822528780563299,0.737705938268236,0.8214285714285714,0.9943831587750319,1.0,2/6,29.33%,SCARA3;SDF4
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.31462122618327965,-0.7372683777972575,0.9444444444444444,1.0,1.0,13/77,13.89%,TERF2IP;WARS1;ATG14;XDH;NTRK3;ARPP19;BEX4;PTPA;MYADM;IGFBP3;DAB2IP;XRCC1;TGFB1
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.3208767054045542,-0.7372488898908318,0.8653846153846154,1.0,1.0,16/53,27.67%,RPF2;LAS1L;NSA2;EBNA1BP2;NHP2;RRP15;MRTO4;BRIX1;RPL5;RPL26L1;EIF6;SURF6;RPL35A;WDR12;SNU13;NPM1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.46195466126379586,0.7368667435599809,0.8723404255319149,0.9952306717680408,1.0,3/11,19.74%,RESF1;ATF7IP;TRIM28
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.30692547747994764,0.7365458877310009,0.9230769230769231,0.9953197553975737,1.0,11/115,7.51%,RUNX1;CALCR;GNG12;BMI1;DOCK1;LRIG3;ARHGEF17;SCRIB;WWTR1;ASB5;LIFR
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.4740557771565801,0.7365347761595068,0.8275862068965517,0.995022053826801,1.0,1/7,7.57%,AGR2
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.3984686632105695,-0.7365236149096577,0.75,1.0,1.0,1/18,1.23%,NUPR1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.3926120934789932,0.7362993944706752,0.7719298245614035,0.995083531674509,1.0,3/12,20.46%,SNCA;DYRK1A;MAP2
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),0.45546966439767494,0.735904897027832,0.7884615384615384,0.9952751174523333,1.0,2/5,20.82%,GSN;ZFP36
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.40246115928705073,-0.7358433193238323,0.7619047619047619,1.0,1.0,3/23,4.93%,DRD4;CBARP;DRD2
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.3749107076012486,0.7355478233590562,0.8043478260869565,0.9955336098599933,1.0,8/23,34.80%,BAP1;MINDY2;OTUD4;OTUD7B;YOD1;USP8;MINDY1;USP33
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.3779612997035072,-0.735110033313675,0.8947368421052632,1.0,1.0,3/21,12.95%,BIK;MMP9;PDCD5
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.32670248868873636,0.735059351544801,0.8653846153846154,0.9958431817896475,1.0,3/71,3.60%,SWSAP1;SEM1;RFWD3
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.35662378009550555,-0.7347497278193855,0.8444444444444444,1.0,1.0,7/32,20.23%,STX11;DNM1;FER1L5;OTOF;CHP1;NAPG;GCA
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.474052817680994,0.7346894584122206,0.78,0.9960343584910007,1.0,1/5,20.58%,BAD
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.4198903497827233,-0.734592996404306,0.7209302325581395,1.0,1.0,3/8,20.15%,DAB2IP;PIK3IP1;TWIST1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.45391695147551636,0.7345771230882517,0.873015873015873,0.9958669714486604,1.0,4/8,33.19%,SNAPC1;ICE2;ZC3H8;SNAPC3
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.4393676528978428,0.7341636074962423,0.8305084745762712,0.9960737747847317,1.0,1/12,1.94%,SIRT1
prerank,GO_Biological_Process_2021__response to cocaine (GO:0042220),-0.5002510211471856,-0.7339829158908928,0.85,1.0,1.0,1/5,4.93%,DRD2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.34774008432570225,0.7336718707653886,0.9130434782608695,0.9963631192102143,1.0,9/31,20.30%,MCTP2;RIMS2;SNCAIP;MEF2C;RIMS4;SLC30A1;FMR1;MCTP1;KCNMB4
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.38906137686935854,0.7336373221293906,0.8909090909090909,0.9961013367385173,1.0,6/18,21.36%,CYB5R4;RIMS2;GAL;CDK16;EDN1;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.47510668457810473,0.7336052524987416,0.7924528301886793,0.9958279120739395,1.0,3/7,15.21%,GLRA1;PLA2G10;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.31452531480874574,0.7335491612074821,0.9245283018867925,0.9955939842105492,1.0,12/94,12.40%,NEDD4;SEC22B;PRMT1;ASB5;PLA2G10;IL23R;FOXO1;RANBP9;HECW2;NR1H3;MAPK8;TIPARP
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.3976104270965679,0.7334607252814282,0.8163265306122449,0.9953916534145463,1.0,2/16,5.01%,CFH;CD59
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.30457688323771814,-0.7334250631453998,0.9565217391304348,1.0,1.0,14/74,18.32%,WARS1;SLX4;BIK;ERCC1;FLOT1;CLU;LIMK1;SMAD3;DAB2IP;TGFB1;SYNPO2L;SMPD3;RGCC;SLF1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.3528089354448801,0.73334326624452,0.9302325581395349,0.9952090990742218,1.0,9/32,27.98%,FAIM;TNFRSF10B;FADD;TNFRSF10A;FEM1B;SERPINE1;ARHGEF2;LGALS3;TRADD
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),0.5086416949010403,0.7330974809822417,0.9148936170212766,0.9952231233317097,1.0,2/5,18.48%,SAG;ARRB2
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.30898104882951843,0.732998739249893,0.9130434782608695,0.9950525164998965,1.0,16/79,22.98%,PRDX6;TRA2A;NOVA1;KHDRBS2;NSRP1;PUF60;QKI;KHDRBS3;RBM5;FMR1;RBFOX1;SFSWAP;NCBP1;MBNL2;SRSF3;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.38282664856491333,0.7327894260343519,0.8070175438596491,0.9950469453359307,1.0,2/21,7.21%,IGF1;NLRP7
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.37051619545145353,0.7326581307014006,0.8214285714285714,0.9948725707954935,1.0,2/19,8.20%,SLC1A3;SFXN2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),0.4983931050875232,0.7324644695980094,0.8307692307692308,0.9947846426313545,1.0,2/5,19.96%,PLCG2;CX3CR1
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.4553274232635811,0.7323104105922289,0.8360655737704918,0.9946418413538435,1.0,1/8,6.50%,MEGF10
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.4730516088561365,-0.7319202834400041,0.782608695652174,1.0,1.0,2/5,18.66%,EDEM2;MAN1B1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.4730516088561365,-0.7319202834400041,0.782608695652174,1.0,1.0,2/5,18.66%,EDEM2;MAN1B1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.4730516088561365,-0.7319202834400041,0.782608695652174,1.0,1.0,2/5,18.66%,EDEM2;MAN1B1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.35879376141912983,0.7318774992052852,0.9,0.9949423296332814,1.0,9/33,22.43%,TBL2;FOXO3;NIM1K;MTMR3;PRKAA1;KPTN;TP53;HSPA5;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.4053368536585569,-0.7317601653337761,0.7916666666666666,1.0,1.0,1/8,1.88%,CXCL13
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.4053368536585569,-0.7317601653337761,0.7916666666666666,1.0,1.0,1/8,1.88%,CXCL13
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.45138829397512414,0.731566985854183,0.8333333333333334,0.9950230614516168,1.0,1/9,13.80%,RACGAP1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.35140025008325365,-0.7314909215817357,0.9272727272727272,1.0,1.0,7/46,14.94%,SPTLC3;PNPLA1;DEGS2;ALOXE3;ALOX12B;SGMS2;ASAH2B
prerank,GO_Biological_Process_2021__desmosome organization (GO:0002934),-0.45946998359917557,-0.7313626194139117,0.74,1.0,1.0,1/6,5.09%,DSG2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.4064922282481579,0.7313354225876965,0.7924528301886793,0.9950645464994154,1.0,4/10,37.49%,CCT3;CCT7;DKC1;CCT4
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.43084268934669756,-0.7311194906351096,0.813953488372093,1.0,1.0,2/10,25.46%,ASCC2;ASCC1
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.43084268934669756,-0.7311194906351096,0.813953488372093,1.0,1.0,2/10,25.46%,ASCC2;ASCC1
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.41100450431266633,-0.7308637452711867,0.7954545454545454,1.0,1.0,6/13,17.27%,PAH;DBH;SMOX;HDC;TPH1;SAT2
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.4638708213308322,-0.7307665118506572,0.8245614035087719,1.0,1.0,2/7,8.71%,TYRP1;CDH3
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.4638708213308322,-0.7307665118506572,0.8245614035087719,1.0,1.0,2/7,8.71%,TYRP1;CDH3
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.4215551923084832,0.7306330106113622,0.8793103448275862,0.9957094641578778,1.0,5/11,15.78%,HDAC3;MTSS1;HAS2;MEF2C;NFE2L2
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.37158552304281717,0.7305897157301594,0.8113207547169812,0.995445160358059,1.0,1/22,1.86%,RAB38
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.2846617685158896,0.7305350915783424,0.9767441860465116,0.9951849337908103,1.0,10/116,8.32%,DRD5;SYK;CALCR;SAMSN1;INSL3;RXFP2;PLCG2;FER;GPR176;RAMP3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.28460165074364563,0.7304812662852517,0.9811320754716981,0.9949483556156744,1.0,11/130,10.61%,IRGM;CCL5;TNIK;CASS4;SNCA;TELO2;TAB2;GRM5;IL23R;EZH2;PAK5
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.3325681385958627,0.7304465293331343,0.8372093023255814,0.9947119215198169,1.0,8/64,9.32%,TNFRSF18;SYK;CCL5;CXCL12;ITGAV;MEGF10;AGR2;MAGI1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.39758256731065933,0.7301625765277676,0.7592592592592593,0.9947651632917347,1.0,1/13,1.94%,SIRT1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.3319582706313042,-0.7299611377709733,0.8695652173913043,1.0,1.0,6/40,17.49%,ABRAXAS1;GOLGA2;MISP;KIF4A;RAB11A;BCCIP
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.36084753820188764,-0.7296693475743229,0.7872340425531915,1.0,1.0,1/24,2.66%,SYNJ2
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.3428694040459935,0.7292003207881146,0.9298245614035088,0.9956280330439862,1.0,5/67,5.99%,RFNG;KAT2B;LLGL1;RBPJ;NRARP
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.3504255694378565,0.728878377218792,0.88,0.9957396169060656,1.0,3/35,10.57%,TFEB;ABCA1;AKTIP
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.3376332409474481,0.7285720777039721,0.8695652173913043,0.9957573163276306,1.0,5/51,8.00%,LDLR;NPC2;ABCA1;MTTP;PLA2G10
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.41517943293712745,-0.7282493761785713,0.7755102040816326,1.0,1.0,1/12,1.76%,TERF2IP
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.43988957108981175,0.7282017896289577,0.7857142857142857,0.9958922400398662,1.0,1/7,2.18%,ZBTB7B
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.37996585594935856,0.7281394657764163,0.7954545454545454,0.9956637635304955,1.0,4/17,17.05%,CAVIN1;GTF3C4;SPIN1;SIRT7
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.4706586552551892,-0.7280464645551215,0.7659574468085106,1.0,1.0,2/6,20.14%,SLC6A20;SLC6A7
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.4464816259634984,0.7277308953268994,0.8909090909090909,0.9958337828163043,1.0,3/10,19.56%,MYOM1;PRKACB;GAL
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.4708373705440066,-0.7276931855249518,0.85,1.0,1.0,2/7,9.27%,FLOT1;ADAM19
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.37864985722432126,0.7275880491739034,0.88,0.9957421124580809,1.0,1/16,2.81%,FGF2
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.4861557636336251,0.727413380844403,0.8461538461538461,0.9956504977757505,1.0,1/7,7.47%,CHD7
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.2805794802586746,0.7272643363655619,0.9811320754716981,0.9955316253950287,1.0,35/198,20.83%,PKNOX1;SOX5;ZBTB7B;MLLT3;IVNS1ABP;TSC22D1;FOXO3;TAF3;RO60;RRAGC;NR4A2;GTF3C4;POLR3G;MLF1;TAF1A;CCNH;EPC1;TAF5;THRB;TAF2;DEAF1;EAF2;BCL3;NELFB;MNAT1;GTF2B;TP53;ARRB2;ETV7;SLC25A33;NFIC;POLR2H;TAF4;NCBP1;HIPK3
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.42054897989253054,-0.727145883809203,0.8181818181818182,1.0,1.0,3/10,11.45%,LOXL4;SUMF1;APOA1
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.3425814553338161,-0.7270297967686005,0.86,1.0,1.0,3/28,11.27%,SCN5A;LAMB1;WNT10A
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.4006080671431322,0.7268209465549358,0.8245614035087719,0.9958067978045901,1.0,5/16,16.31%,ALG6;NUS1;MVD;ALG9;DOLK
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.28421009878738185,-0.7265433521678955,0.9821428571428571,1.0,1.0,15/174,9.57%,HK2;LDHC;INHA;COL5A1;SLC6A6;FOS;GPC1;TGFBI;IER3;GPC3;CCNG2;JUN;ENO2;SAP30;GAPDHS
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.3791705830890285,0.726380336163073,0.8596491228070176,0.9960779037048936,1.0,7/15,28.54%,ANK2;RYR2;HSPA5;BCAP31;UBAC2;VAPA;GBF1
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.43460932703698674,0.7261059299374676,0.8235294117647058,0.9961422324424279,1.0,2/6,21.60%,FBP1;PFKP
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.31058089105265063,0.7261010040680211,0.8545454545454545,0.9958479824445347,1.0,10/72,13.94%,PYHIN1;DNAJB2;RNF139;CBFA2T3;RNF217;KEAP1;ARIH1;BAG2;PTEN;PRICKLE1
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),-0.47306905380127395,-0.7260007204769988,0.8431372549019608,1.0,1.0,1/5,21.52%,GK5
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.41360710809321644,0.725978834135027,0.7796610169491526,0.9956980624492847,1.0,5/11,30.72%,TBCCD1;ARHGAP21;STK25;RIPOR1;YWHAZ
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.2880730220534191,0.7258663718138634,1.0,0.9955365488876426,1.0,20/111,16.64%,ACSM2A;PPARG;LPIN3;ADIPOR2;MSMO1;CEL;ACADM;CPT1C;CYP4F12;ABCD3;ACSBG1;OXSM;ABCD2;FASN;SGPL1;ACACA;LIPG;PNPLA8;PEX2;ELOVL4
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.285126618912207,0.7258559493892961,0.925,0.9952427497935811,1.0,23/117,16.15%,LSAMP;LRP4;NPY;PCLO;PCDH17;UNC5D;NRXN1;RAB3C;LIFR;PTPRD;FAM171B;SYNPR;ANK2;GUCY1A2;ADGRB3;TMEM196;CNTN1;SLC26A4;SEMA6D;CPE;DST;CNTN2;MAPK10
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.3845844334466222,0.725682229508251,0.7959183673469388,0.9948230099740504,1.0,4/11,37.49%,CCT3;CCT7;DKC1;CCT4
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.3845844334466222,0.725682229508251,0.7959183673469388,0.9948230099740504,1.0,4/11,37.49%,CCT3;CCT7;DKC1;CCT4
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),-0.457474731346182,-0.7256353336305629,0.813953488372093,1.0,1.0,3/5,20.65%,SLC25A29;SLC6A20;PDZK1
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.398354938730444,0.7253856474088219,0.8301886792452831,0.994907032701005,1.0,4/14,14.72%,TOP2A;HMGB1;TOP1MT;KAT6A
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.32235706706260114,0.7252876512514667,0.9454545454545454,0.9946993358295936,1.0,15/62,23.43%,SYK;DOCK1;PLCG2;PIK3CA;CD247;WASL;VAV2;ABL1;LYN;MAPK3;MYO1C;CRK;WIPF1;GRB2;BLK
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.35944123223410473,-0.725228500148933,0.813953488372093,1.0,1.0,4/38,8.18%,APOBEC3H;APOBEC3G;OAS3;OAS1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.40999036693151697,-0.7251910287301253,0.8222222222222222,1.0,1.0,1/8,8.57%,OAZ3
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.3847005398504314,0.7247025700478389,0.7959183673469388,0.9952109965768657,1.0,2/20,5.14%,NEDD4;ZFYVE16
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.3277294639554274,0.7246697081947019,0.9245283018867925,0.9949605811881334,1.0,12/40,26.48%,HDAC2;ACTL6A;ARID1A;ARID1B;SMARCAD1;SMARCD2;SMARCA2;HDAC1;ACTR5;RBBP4;HNRNPC;SRCAP
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.3455388979997622,-0.724492968261499,0.7916666666666666,1.0,1.0,11/43,14.16%,GUCY2C;CLCA1;FAM3D;ANGPT4;DLL4;OLFM4;CEACAM1;SPINK4;SLC5A1;CDH17;GPX2
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.31448762587081813,0.7243075724096488,0.9333333333333333,0.9951415954750212,1.0,18/101,18.94%,VAPB;ST6GALNAC3;GAL3ST1;ELOVL5;ESYT3;TEX2;PPM1L;CERS3;ESYT2;SGPL1;CERS5;ELOVL4;TECR;ALDH3B1;ABCA2;HEXB;PLPP1;SAMD8
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.3400714146963498,-0.7242111224206549,0.8888888888888888,1.0,1.0,4/58,5.43%,NUPR1;TIMP4;GOLGA2;PTPN3
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.43677725927242145,0.7238813815548837,0.82,0.9953186161389811,1.0,1/11,3.09%,ANGPT1
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.4284199831841949,0.722988677246253,0.7708333333333334,0.996035272708172,1.0,3/9,14.65%,MTTP;SOAT2;SOAT1
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.4595006074944327,-0.7229354515177133,0.717391304347826,1.0,1.0,2/7,17.32%,KDM2B;WNT5A
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.2932119475499246,0.7228550760992251,0.9259259259259259,0.9958897213687286,1.0,15/96,14.47%,BOK;LRP4;GNG12;TENM3;ARHGEF17;TEAD2;GPR176;MAGI1;AMOTL1;BCAR1;HTRA1;FIGN;FJX1;NR2F2;PTPRU
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.3690845691801762,-0.7227755245706686,0.7380952380952381,1.0,1.0,3/13,15.11%,FLOT1;CAV1;CGAS
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.3838479310830873,-0.722767031757479,0.8604651162790697,1.0,1.0,3/24,7.30%,DLL4;NIBAN2;TSPAN15
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.45422526120996765,0.7225959968978197,0.8214285714285714,0.9959538155806811,1.0,1/6,4.11%,FHIT
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.2993917052267684,0.7224400968487646,1.0,0.9958626900593903,1.0,24/93,27.43%,MRPL28;MRPS12;MRPL54;MRPL44;EEF1D;MRPL58;ERAL1;MRPL18;MRPS9;MRPL49;MRPS34;MRPL50;MRPL11;MRPS15;MRPL48;LTN1;AURKAIP1;MRPL10;CHCHD1;MRPL41;MRPL52;MRPS33;EEF1A1;MRPL2
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.4577315524859263,-0.7217659125571937,0.8113207547169812,1.0,1.0,1/5,4.79%,CRYL1
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.4577315524859263,-0.7217659125571937,0.8113207547169812,1.0,1.0,1/5,4.79%,CRYL1
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.4577315524859263,-0.7217659125571937,0.8113207547169812,1.0,1.0,1/5,4.79%,CRYL1
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),-0.4193934811589808,-0.721730308628057,0.7857142857142857,1.0,1.0,2/9,6.96%,PAH;DBH
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.3239621437699163,0.7213718288971153,0.9166666666666666,0.9967955053499867,1.0,18/45,24.54%,INSIG1;CYP39A1;MSMO1;CYP27A1;CYP7B1;OSBPL6;CH25H;HSD17B10;SC5D;SQLE;AKR1C3;DHCR7;FAXDC2;HSD3B7;OSBPL3;OSBPL9;OSBPL7;BAAT
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.34313405266927444,0.7210833197847923,0.875,0.9968476367638388,1.0,2/33,4.98%,BOK;SEPTIN4
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.45877473798219687,-0.720988524391012,0.7708333333333334,1.0,1.0,2/6,13.03%,RAB7B;DAB2IP
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.3886308423284861,0.7209475342231635,0.8666666666666667,0.9967020599095103,1.0,5/16,22.70%,SLC1A3;SLC25A13;SLC1A6;SLC25A12;GJA1
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.34287892625622557,0.7208108960519881,0.85,0.9965488211360738,1.0,3/36,10.80%,CWH43;PIGQ;PIGF
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.4196369828209757,0.720357268958756,0.7586206896551724,0.9967830427143772,1.0,3/9,7.89%,WNT4;CD244;SNCA
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3190578460325493,0.7202016391970943,0.8867924528301887,0.9966685970086402,1.0,10/72,16.17%,CDC20B;DNAJB2;CBFA2T3;RNF217;KEAP1;ARIH1;BAG2;PRICKLE1;NFE2L2;SIRT6
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.34777094345543513,0.720034474665121,0.9387755102040817,0.9965735769775682,1.0,8/26,32.10%,EXOSC4;TENT4B;ERI1;NCBP1;LSM11;TUT4;LSM10;DCP2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.4338173320613016,-0.7199735749520898,0.7727272727272727,1.0,1.0,3/8,12.64%,SAPCD2;MISP;GPSM2
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",0.46564074034058467,0.7198787812248252,0.8363636363636363,0.9964631334479357,1.0,3/7,20.31%,SEC61A1;SEC61A2;HSPA5
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.4146735866955351,0.7196482618309628,0.8545454545454545,0.9964340057372858,1.0,3/11,20.31%,SEC61A1;SEC61A2;HSPA5
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.45400064972619036,-0.7195249395662806,0.8292682926829268,1.0,1.0,3/9,23.69%,KDM2B;KDM4B;RIOX1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.31332165723899474,0.7193313374106978,0.9473684210526315,0.9964745168800623,1.0,21/79,26.13%,MRPL28;MRPS12;MRPL54;MRPL44;MTRF1;MRPL58;ERAL1;MRPL18;MRPS9;MRPL49;MRPS34;MRPL50;MRPL11;MRPS15;MRPL48;AURKAIP1;MRPL10;CHCHD1;MRPL41;MRPL52;MRPS33
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.3555611508392581,-0.719160422700416,0.9583333333333334,1.0,1.0,4/25,10.00%,TERF2IP;ERCC1;RAD50;RTEL1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.3850044070849658,0.7188314987653003,0.8775510204081632,0.9968475387844237,1.0,1/18,2.50%,URI1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),-0.37278001270740074,-0.7187837588925475,0.8775510204081632,1.0,1.0,3/27,6.14%,CTNNA1;BOC;RBM4
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.41413959088388574,0.7184418257707779,0.7796610169491526,0.9970038669303658,1.0,2/10,12.03%,RAB39A;RAB34
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.40422251359458417,0.7182841783317495,0.8545454545454545,0.996866409522149,1.0,2/10,15.81%,NLRP7;GAS1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.2992219751907357,0.7180468600477526,0.9534883720930233,0.9968410675741004,1.0,7/60,13.30%,EFNA5;UTRN;CDKN2A;EPHA3;CORO1C;GPM6B;SEMA3E
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),0.44972740864133326,0.7177927707451429,0.7708333333333334,0.9969277400206006,1.0,2/7,17.81%,ESR1;TP53
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.361168710534196,0.7175170645237061,0.8245614035087719,0.9969332819148348,1.0,12/35,24.02%,CPNE7;NUS1;CPNE1;MVD;CPNE3;ABCA8;IDI2;DOLK;SAMD8;HDHD5;IDI1;SGMS1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.3297100744044277,-0.7172947660683916,0.8727272727272727,1.0,1.0,3/50,6.07%,TEK;LDB1;SFRP1
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.3681075534076501,-0.7171907379007805,0.8717948717948718,1.0,1.0,2/15,12.59%,CEACAM1;GBP1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.29715924879966243,-0.7165394937785364,0.9433962264150944,1.0,1.0,4/86,4.11%,CD24;ERN2;PRKCD;BCL2L2
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),-0.48007269445860545,-0.7163772559057254,0.8035714285714286,1.0,1.0,1/6,4.34%,TST
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.289275239002386,-0.7160379665697761,0.9807692307692307,1.0,1.0,9/67,11.75%,PLK3;DCDC1;DRD2;SVIL;ENTR1;PLK4;ANKRD53;E2F7;KIF20B
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.3327988067371909,0.716016261253695,0.9137931034482759,0.99842481292285,1.0,3/45,9.35%,NDC80;CHMP6;RRS1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.2768137563898307,-0.7159419262649163,0.9818181818181818,1.0,1.0,20/202,13.95%,TEKT3;CFAP61;ABCC4;TEKT5;DNAAF1;CNGB1;TTC8;TMEM107;TXNDC15;CYS1;PLK4;ATP6V1D;UBXN10;CFAP221;EXOC3;RAB17;CFAP52;B9D1;DCDC2;RAB8A
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.45158164721261923,-0.7158427735191337,0.8,1.0,1.0,1/6,10.61%,CCN3
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.3521675695193322,-0.7154018504182872,0.8571428571428571,1.0,1.0,5/29,11.13%,SYT12;CBARP;CACNA1G;SYT10;DOC2A
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),0.4480123650974994,0.7151768983034396,0.7454545454545455,0.9990897161383692,1.0,1/5,11.63%,SMAD4
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle remodeling (GO:0034372),-0.44793253191040727,-0.7147358475727786,0.8333333333333334,1.0,1.0,1/5,11.45%,APOA1
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.4776148624993051,0.7147107378466429,0.7916666666666666,0.9992836169801628,1.0,4/5,37.58%,VEGFA;EGFR;NOS1AP;ATP2B4
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),-0.41818894248541844,-0.7146217549298473,0.7954545454545454,1.0,1.0,2/9,16.97%,KCNJ11;CACNA1H
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.33051963996848854,0.7143707555134039,0.9,0.9994465514975502,1.0,7/50,13.45%,TYR;AANAT;PRIMPOL;RGR;REV1;MAPK8;PCLAF
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.4138966848408058,0.7142150500451095,0.7894736842105263,0.9993009810825272,1.0,4/10,13.61%,MID2;GSN;TRIM26;PTX3
prerank,GO_Biological_Process_2021__kidney mesenchyme development (GO:0072074),0.48360020945702586,0.7141183589675696,0.8125,0.9991131046927461,1.0,1/5,4.40%,SIX4
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.310186534372024,0.7138076624570903,0.9821428571428571,0.9991719187745709,1.0,11/75,19.47%,KAT2B;BMI1;SF3B1;CTCFL;EZH2;TAF1A;EPC1;POLR1H;EED;H3-3A;POLR2H
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.3615216291030414,0.7137284273859227,0.86,0.9989880452870323,1.0,2/31,6.55%,PAWR;EPS8
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.26383762624516366,0.7135443031343045,1.0,0.9988928427851037,1.0,27/192,21.31%,LIN28A;PWP2;SMAD1;SMAD2;MRPL44;EXOSC4;FARS2;INTS6;RPL21;PRKRA;BOP1;BYSL;HNRNPA2B1;RPL18A;MPHOSPH6;RPL7;PUS10;WDR36;AGO3;ZCCHC8;INTS11;EXOSC1;WDR18;TEX10;C1D;RPL23A;RRP1B
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.42975268033696923,0.7134663727253553,0.8245614035087719,0.9986860671127171,1.0,3/8,23.16%,WNK1;ATP1B2;DLG1
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.38490720586034205,0.7134318617430745,0.8367346938775511,0.9984370854477248,1.0,5/21,17.29%,GAL3ST1;TEX2;ST3GAL6;TECR;AGMO
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.42278977651105726,0.7132608996351228,0.8979591836734694,0.9982728871100676,1.0,1/8,8.16%,MCM7
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.47208117760062296,0.71317848236186,0.9074074074074074,0.9980395615258991,1.0,1/6,4.62%,ALDH7A1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.34326908731364564,0.7129571751628042,0.8823529411764706,0.9979909216720754,1.0,8/26,22.38%,SASH3;PAXIP1;HLA-E;VAMP3;DNAJB9;KMT5B;TNFSF4;PTPRC
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.39119813367074174,-0.7129070717138912,0.76,1.0,1.0,2/10,16.15%,OARD1;TYMP
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.4009245685283831,-0.7127161005295979,0.7380952380952381,1.0,1.0,2/11,9.83%,MBTPS2;CREB3L1
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.39203818492048687,0.7126962764146402,0.88,0.9979999643317492,1.0,3/16,11.63%,ST18;FER;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.4352490966751575,-0.7120211236716584,0.7906976744186046,1.0,1.0,1/9,1.76%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.4352490966751575,-0.7120211236716584,0.7906976744186046,1.0,1.0,1/9,1.76%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.34723168308601654,0.711965121461922,0.8688524590163934,0.9984969879677997,1.0,7/39,17.85%,NLGN1;TENM1;RALA;GPM6A;TRPM2;WASL;FMR1
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.39140535672917287,0.7118573560007021,0.8679245283018868,0.9983330170925356,1.0,4/14,14.34%,DSCAML1;BMPR1A;GREM1;FBXL15
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.36518576058641683,0.7116775008702524,0.88,0.9982613069924247,1.0,4/21,17.93%,RPP40;RRS1;URB1;ERI1
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.35082453537747676,-0.7110235526464692,0.875,1.0,1.0,9/48,11.12%,CD24;RAC2;ALOX5;JCHAIN;PLCB2;HCK;GNG13;SPI1;CDHR2
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.2988184936833591,0.7108359235260534,0.96,0.9983763878308961,1.0,9/92,11.00%,KLRD1;SYK;RELA;MUC20;PLCG2;TAB2;PSMD13;MUC13;MUC7
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.2988184936833591,0.7108359235260534,0.96,0.9983763878308961,1.0,9/92,11.00%,KLRD1;SYK;RELA;MUC20;PLCG2;TAB2;PSMD13;MUC13;MUC7
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.2988184936833591,0.7108359235260534,0.96,0.9983763878308961,1.0,9/92,11.00%,KLRD1;SYK;RELA;MUC20;PLCG2;TAB2;PSMD13;MUC13;MUC7
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.38678344421396577,0.7106046663020442,0.8301886792452831,0.9983354346472948,1.0,4/22,17.54%,PLA2G10;NR1H3;PNPLA8;PLBD1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.28925152837898405,-0.7105433464702681,1.0,1.0,1.0,22/114,17.76%,SIGIRR;NUPR1;NLRP3;TRIB1;ADGRG3;TNFRSF4;PTCH1;SPI1;TMSB4X;WFS1;PYDC1;MTURN;DAB2IP;CYP1B1;UFL1;CMKLR1;ID2;NFKBIE;SFRP5;CHP1;HAVCR2;BHLHE40
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.4687357739976617,0.7090579760278732,0.8571428571428571,0.9999356241056812,1.0,1/5,25.08%,TMEM33
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.36879744671461767,0.7088319031818577,0.8363636363636363,0.9998865638331155,1.0,5/21,26.08%,TBC1D12;MTMR3;ANXA2;PIKFYVE;ELAPOR1
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.35497951432238983,-0.7085001973533126,0.8653846153846154,1.0,1.0,6/26,11.26%,SYCE2;TERB1;STAG3;MEIOB;SYCE1;IHO1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.42545692389521267,0.7082063388390556,0.8448275862068966,1.0,1.0,7/12,41.27%,TRAPPC8;ACBD5;PIK3R4;PIK3C3;ATM;USP30;RB1CC1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.4433786262797364,-0.7080151049205715,0.8913043478260869,1.0,1.0,2/10,5.62%,XYLT2;XYLT1
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.48509427960181634,0.7075484550495977,0.9038461538461539,1.0,1.0,1/5,6.66%,PDGFRA
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.29540595647682805,0.707414579194813,1.0,1.0,1.0,21/94,26.13%,MRPL28;MRPS12;MRPL54;MRPL44;MTRF1;MRPL58;ERAL1;MRPL18;MRPS9;MRPL49;MRPS34;MRPL50;MRPL11;MRPS15;MRPL48;AURKAIP1;MRPL10;CHCHD1;MRPL41;MRPL52;MRPS33
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.27206799011874794,0.7070840418119125,1.0,1.0,1.0,25/182,22.92%,TCIRG1;IDH1;ECI1;MRPS12;HTRA2;FDX1;ACADM;ACAA2;MPC1;MTX2;BDH2;ATP6V0B;HSD17B10;COX6A1;COX10;MTRF1;ALDH6A1;TIMM10;SLC25A12;GLUD1;OAT;MRPL11;PDHA1;MRPS15;PDK4
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.36841754745925615,0.7070777700948139,0.8163265306122449,1.0,1.0,4/20,11.26%,MYC;SMG1;LIG4;HNRNPD
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.44240278573757863,0.7064195470785221,0.8301886792452831,1.0,1.0,3/9,15.21%,GLRA1;PLA2G10;PLCB1
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.39179880787782373,-0.7064146568491632,0.8333333333333334,1.0,1.0,3/17,14.35%,ANKRD53;GPSM2;DCTN1
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.30835110841376784,0.7063930587370367,0.9464285714285714,1.0,1.0,28/85,31.06%,MRPL28;MRPS12;MRPL54;MRPL44;MTRF1;MRPL58;ERAL1;MRPL18;MRPS9;MRPL49;MRPS34;MRPL50;MRPL11;MRPS15;MRPL48;AURKAIP1;MRPL10;CHCHD1;MRPL41;MRPL52;MRPS33;MRPL2;TRMT112;MRPL33;GFM2;GADD45GIP1;MRPL14;MRPL55
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.33929272164960445,0.7063704525442612,0.9148936170212766,1.0,1.0,4/28,10.55%,PPP1R15B;DLC1;MAGI2;ITGA1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.2896499981113991,0.7063378817926055,1.0,1.0,1.0,4/148,5.04%,SGO1;NDC80;NDE1;DLGAP5
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),0.40513680418987513,0.7059084559985134,0.8571428571428571,1.0,1.0,1/9,1.85%,PRKG1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.38483056148518757,0.7058627601283807,0.8727272727272727,0.9999907052536741,1.0,7/14,30.46%,DPP4;FAP;DDR1;DDR2;CLASP2;MELTF;CLASP1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.30875513240517366,0.705769633144266,0.9574468085106383,0.9998424946185661,1.0,13/68,19.95%,VAPB;TLCD3B;ELOVL5;PPM1L;CERS3;ABCA8;SGPL1;CERS5;ELOVL4;ALDH3B1;PLPP1;SAMD8;ST8SIA1
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.30169094462878454,-0.7056682131470944,0.9795918367346939,1.0,1.0,9/53,18.05%,ABRAXAS1;TICRR;RPS27L;CCND1;BRCA1;MUS81;CDK1;BLM;MRNIP
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.40295854418216215,0.705607994350307,0.8653846153846154,0.9997134642477917,1.0,3/12,11.63%,CHD7;SMAD2;SMAD4
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.39804545496933946,0.7056065404801455,0.8297872340425532,0.999416549051995,1.0,2/10,13.72%,MTMR9;MTMR3
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.3949590843436408,-0.7055957724497752,0.803921568627451,1.0,1.0,1/15,1.76%,TERF2IP
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.3580341773742577,-0.7055416340748406,0.8222222222222222,1.0,1.0,4/33,11.50%,DNAAF1;DNAH11;CCDC40;MMP21
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.34518260962469954,-0.7048437930588721,0.8222222222222222,1.0,1.0,6/33,16.36%,PLK3;GOLGA2;DDRGK1;UFL1;TEX264;CDK1
prerank,GO_Biological_Process_2021__oxaloacetate transport (GO:0015729),0.4295499639177024,0.7046556256572318,0.8333333333333334,1.0,1.0,2/5,21.70%,SLC25A30;SLC25A14
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.4282732990141377,-0.704531698974926,0.8695652173913043,1.0,1.0,2/8,18.30%,CAV1;CAV3
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.34759467460898374,0.7043447062935341,0.8958333333333334,1.0,1.0,5/22,14.90%,FGF2;PTEN;CD34;KNG1;PHLDB2
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.3038703285944226,-0.7043296912168405,0.9183673469387755,1.0,1.0,2/83,1.32%,TBC1D10C;STX16
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),0.3811763177956947,0.704281671319391,0.8545454545454545,0.9998693563177454,1.0,3/17,17.64%,PWP2;RPS5;ERAL1
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),0.45929144018376805,0.7042811141011228,0.8181818181818182,0.999572747193949,1.0,2/6,23.76%,GFUS;GMDS
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.4504575484778777,0.7040615838942771,0.8813559322033898,0.9994630846399378,1.0,5/7,42.97%,DPYSL5;DPYSL3;DPYS;DPYD;DPYSL2
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),0.2992691262688364,0.7040295841050125,0.9310344827586207,0.9992048769946111,1.0,20/79,26.13%,MRPL28;MRPS12;MRPL54;MRPL44;MRPL58;ERAL1;MRPL18;MRPS9;MRPL49;MRPS34;MRPL50;MRPL11;MRPS15;MRPL48;AURKAIP1;MRPL10;CHCHD1;MRPL41;MRPL52;MRPS33
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),-0.42382496501636946,-0.7040093299202992,0.8163265306122449,1.0,1.0,2/5,15.92%,ZP3;CD27
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.3113499829620579,-0.7038693914739181,0.9629629629629629,1.0,1.0,5/72,7.78%,PM20D1;CD200R1;FOS;EGR1;CLU
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),-0.43940187688421883,-0.7038124023059078,0.8260869565217391,1.0,1.0,1/6,1.86%,CGA
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.35856243286139144,0.7035001088862857,0.9285714285714286,0.9994877552746011,1.0,3/25,10.31%,PDGFRA;ZSWIM5;EFNB2
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.356915483447243,-0.703404268178488,0.8846153846153846,1.0,1.0,4/35,7.78%,NUPR1;FOS;EGR1;CLU
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4092930512613682,0.7033190015762157,0.8269230769230769,0.9994010649273315,1.0,6/12,29.07%,BCL3;PIBF1;ADIPOR1;HGS;INPP5F;PARP14
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.36440953096549916,-0.70329572483922,0.8717948717948718,1.0,1.0,5/18,15.11%,RFTN1;FLOT1;CAV1;IFNK;CGAS
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.4178760149856428,0.7031753955500831,0.8947368421052632,0.9992420904735704,1.0,2/12,12.10%,ALG6;ALG9
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.3231711425373115,-0.702978290091409,0.8867924528301887,1.0,1.0,4/36,15.98%,IFT27;KIF17;DYNLRB1;TRAF3IP1
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.46442273324396555,0.7022913887635466,0.8627450980392157,0.9999585906952074,1.0,1/6,9.38%,AUTS2
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.39765921510163094,-0.702222551652704,0.84,1.0,1.0,6/19,9.99%,IRF4;NLRP3;CD86;ZP3;HLA-DRB1;ZFPM1
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.45238098628122664,-0.7021078952132546,0.7857142857142857,1.0,1.0,3/8,25.41%,SMUG1;MBD4;OGG1
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.385560512972801,0.7019727450157447,0.851063829787234,1.0,1.0,3/13,17.05%,CAVIN1;SPIN1;SIRT7
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),-0.41490296366119683,-0.7019716968650543,0.8461538461538461,1.0,1.0,2/8,8.48%,AK8;AK7
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.31926188061551053,0.701500209376162,0.9302325581395349,1.0,1.0,15/56,21.36%,SIRT1;RELA;PDGFRA;FER;PTPRK;PXN;MAPK8;TRPM2;PPIF;NFE2L2;AKR1C3;RHOB;ABL1;MAPK3;ANXA1
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),0.4198259916503994,0.7013708463571683,0.92,1.0,1.0,1/10,8.16%,MCM7
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.4036750852849291,0.7007791773590297,0.8363636363636363,1.0,1.0,2/10,16.60%,TSPAN6;RNF26
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3698030841131658,0.700560191146456,0.8085106382978723,1.0,1.0,2/20,13.34%,PPP1R14D;MGAT5
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.32481342086980725,-0.7004770401887044,0.9152542372881356,1.0,1.0,8/38,22.62%,MTFR2;UQCRC1;ETFRF1;ETFDH;NR4A3;NDUFA5;NDUFS1;UQCRH
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.3970790117714327,-0.7004616642239073,0.9166666666666666,1.0,1.0,1/8,4.64%,DHDDS
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.2953736472631762,-0.7003326710636625,1.0,1.0,1.0,8/113,8.34%,NTRK1;DOCK8;RGS8;AGRN;SFRP1;ADCYAP1;F11R;ZC3H15
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.2880082979176053,0.6999100525535539,0.9803921568627451,1.0,1.0,6/97,9.92%,NXPH1;NGB;HRH3;B4GALNT4;GRM5;CAMK2N2
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.34621816371086384,-0.6994255000505042,0.8409090909090909,1.0,1.0,6/28,12.17%,SOX30;RNF8;FAM9B;TTC21A;TOPAZ1;RSPH1
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),-0.44029911267499133,-0.6991521292450958,0.8103448275862069,1.0,1.0,1/7,6.36%,PAX2
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.3727693651031265,-0.6988113446771467,0.85,1.0,1.0,1/14,5.24%,PPP1R17
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),-0.4916006670390577,-0.6982586453816337,0.8571428571428571,1.0,1.0,1/5,6.07%,SFRP1
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.34927604273841295,0.6981063788523736,0.9,1.0,1.0,2/21,8.45%,CIAO3;ISCA2
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.42902085354105773,0.6979928239134555,0.8888888888888888,1.0,1.0,3/6,25.05%,ABCA1;ABCA7;APOE
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.3745499621145275,-0.6977714105425898,0.8571428571428571,1.0,1.0,1/14,1.71%,RAC2
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.4128268286431554,0.6976888910937392,0.8545454545454545,1.0,1.0,2/8,26.80%,OTUD7B;YOD1
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.33828659973989994,0.697665827619296,0.9130434782608695,1.0,1.0,9/31,19.62%,DCXR;GALK1;PGM1;SLC37A4;GALK2;IRS2;BRAT1;CHST15;FBP1
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),0.46228048081388307,0.6971724018590403,0.8837209302325582,1.0,1.0,2/5,20.09%,HSD17B10;PNPT1
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.3596624115091188,0.6969987505741038,0.8823529411764706,1.0,1.0,2/15,8.67%,SPR;GCH1
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.46002818865465256,0.6965972564474583,0.9024390243902439,1.0,1.0,1/7,13.08%,XPO1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.3540078099621786,0.6964794444176527,0.9285714285714286,1.0,1.0,6/36,14.31%,EFNA5;CDKN2A;KANK1;CORO1C;SEMA3E;FZD4
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.36310205889246344,0.696382303581237,0.8823529411764706,1.0,1.0,5/15,27.49%,RUVBL2;NOP10;NAF1;SHQ1;CCT3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.2894018073573448,-0.6959695144940368,1.0,1.0,1.0,7/98,8.25%,SELP;WARS1;BIK;HCK;SVIP;CLU;TMC8
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.409150271365963,-0.6959556652828133,0.8260869565217391,1.0,1.0,3/12,24.36%,RAC1;AKAP13;FHOD1
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.389055741108721,0.6959340722024957,0.8983050847457628,1.0,1.0,4/9,18.32%,GADL1;GLYATL2;CTH;MPST
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.33055341914104014,0.6958625128560674,0.92,1.0,1.0,6/47,12.35%,DCC;HDAC2;KANK1;EFNB2;SPRY3;PTEN
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.43307267388712056,-0.6953876714992453,0.7727272727272727,1.0,1.0,2/10,16.47%,FOXM1;NEK6
prerank,GO_Biological_Process_2021__cell differentiation involved in metanephros development (GO:0072202),0.42769694928370855,0.6953178266926939,0.819672131147541,1.0,1.0,1/7,3.48%,WNT4
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.3016741225384521,0.6951663528306374,0.9444444444444444,1.0,1.0,11/50,16.53%,SLC16A5;SLC10A3;SLC26A6;ABCC2;SLC10A5;NCOA2;SLC10A1;ABCC11;SLCO1A2;SLC16A13;AKR1C1
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.2601146398960253,-0.6950535817982043,1.0,1.0,1.0,44/283,16.67%,TEKT3;IFT27;ABCC4;HAUS7;TEKT5;DNAAF1;CNGB1;TTC8;TMEM107;TBC1D32;RSPH9;TXNDC15;CYS1;KIF17;PLK4;ATP6V1D;CCDC40;UBXN10;CFAP74;RSPH1;CFAP46;CFAP221;NPHP4;EXOC3;HAUS1;TUBB;RAB17;TUBG1;CFAP52;B9D1;DCDC2;RAB8A;DCTN2;DYNLRB1;DCTN1;AHI1;CSNK1D;TUBB4A;SPATA6;TRAF3IP1;RSPH4A;CDK1;RAB11A;HAUS8
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.31890917658234014,-0.6949600120500262,0.8653846153846154,1.0,1.0,7/31,16.85%,FGF1;DRD2;SVIL;KIF20B;CDC6;HTR2B;FGFR2
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.41331480286056516,0.6946088574055536,0.9272727272727272,1.0,1.0,3/12,12.35%,SPEF2;CTNNA2;PTEN
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),0.37579029992292184,0.6944611434474747,0.9069767441860465,1.0,1.0,5/16,17.38%,KAT2B;RIOK2;METTL18;SIRT7;RIOK1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.33657078697085546,0.6944538887879875,0.9107142857142857,1.0,1.0,3/30,12.35%,PLCG2;EZH2;PTEN
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3459318068383586,0.6940188958784057,0.9245283018867925,1.0,1.0,6/23,22.98%,ACD;TERF1;TENT4B;GNL3L;POT1;HNRNPU
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.39928198716891183,-0.6937518039329951,0.8235294117647058,1.0,1.0,2/13,13.87%,ABCB1;ABCB4
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),-0.38559341223659804,-0.6934864707956264,0.75,1.0,1.0,2/7,11.69%,SLC11A1;IL18
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.3330907451121309,0.6934626220599235,0.9183673469387755,1.0,1.0,7/23,18.32%,AHCY;GADL1;CBS;CTH;SMS;CPS1;MPST
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.39683601902196164,-0.6931392278707602,0.9183673469387755,1.0,1.0,4/15,10.61%,FAM3D;SFRP1;KCNJ11;CCN3
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.4101944382076064,0.692585609317059,0.8909090909090909,1.0,1.0,1/13,1.72%,RSPO3
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.32033649850981444,-0.692196068333528,0.875,1.0,1.0,5/52,8.18%,APOBEC3H;APOBEC3G;TRIM5;OAS3;OAS1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.3606615097614639,-0.6916276202217977,0.8888888888888888,1.0,1.0,4/25,16.21%,MEFV;TTBK1;APH1B;PSME3
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.431951542684081,-0.6915280786764108,0.8181818181818182,1.0,1.0,7/7,56.82%,MSN;SORL1;ROCK2;EZR;EGF;RDX;MGAT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.431951542684081,-0.6915280786764108,0.8181818181818182,1.0,1.0,7/7,56.82%,MSN;SORL1;ROCK2;EZR;EGF;RDX;MGAT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.431951542684081,-0.6915280786764108,0.8181818181818182,1.0,1.0,7/7,56.82%,MSN;SORL1;ROCK2;EZR;EGF;RDX;MGAT3
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.3937766954810846,0.6912371180445606,0.84,1.0,1.0,5/14,18.81%,DMC1;TPRKB;SMC5;RAD54B;NSMCE2
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.40297012412696476,-0.6911780883641507,0.8444444444444444,1.0,1.0,1/12,3.27%,ASS1
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.3071968729821316,-0.6909161794529542,0.9166666666666666,1.0,1.0,9/56,16.77%,COL5A1;TLCD2;TRIM72;FER1L5;OTOF;MYH9;PACSIN3;DMKN;RAB3A
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),-0.4375401640710541,-0.6908952966697297,0.8478260869565217,1.0,1.0,2/5,16.97%,MED1;ZNF385A
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.2868600771010025,-0.6908304156698759,0.9318181818181818,1.0,1.0,6/91,11.03%,STX16;M6PR;ARF1;CLTA;ICA1;CAV2
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.4022885987865207,0.6905190685460582,0.7959183673469388,1.0,1.0,1/9,4.40%,SIX4
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.4371478798042646,-0.690158932990433,0.8333333333333334,1.0,1.0,2/5,14.41%,DDRGK1;UFL1
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),0.3911328386721977,0.689866762422509,0.819672131147541,1.0,1.0,1/6,16.70%,COX10
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.3682014345208553,0.6897079483429347,0.8823529411764706,1.0,1.0,2/17,17.08%,AUP1;SQLE
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.34301796868883705,0.6897063368859373,0.8771929824561403,1.0,1.0,6/27,22.70%,FGFR3;LRRC17;LRP6;TP53;PTPRC;GJA1
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.40122796350640844,-0.6895956097616028,0.85,1.0,1.0,5/11,13.93%,PRKCD;CEACAM1;ZNF703;SERPINE2;CD9
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.29398586769429164,0.6895280341748441,0.9824561403508771,1.0,1.0,14/100,12.51%,TOP2A;ALDH1A1;ISOC1;IDH1;SLC35B2;DHRS3;CEL;ALDH9A1;ELOVL5;ATXN1;CADM1;ABCD3;HSD11B2;ABCD2
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.3921827017459891,0.6894112936973176,0.8947368421052632,1.0,1.0,2/12,12.03%,RAB39A;RAB34
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.43576928568653805,-0.689288685192907,0.8857142857142857,1.0,1.0,1/8,13.28%,ATP6V0A2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta1 production (GO:0032908),-0.43902856414523656,-0.6889645157073148,0.7735849056603774,1.0,1.0,4/5,26.72%,LAPTM4B;TSKU;THBS1;ATP6AP2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3505231570461663,0.6888749483677925,0.8947368421052632,1.0,1.0,4/35,14.43%,FHIT;RYBP;PML;EIF3H
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.37607006462264303,0.6888422773529436,0.8666666666666667,1.0,1.0,4/15,21.36%,CYB5R4;RIMS2;GAL;ANXA1
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.34267041602301507,0.6880085194934482,0.9344262295081968,1.0,1.0,2/22,8.45%,CIAO3;ISCA2
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.39096009349115457,-0.6879008786431954,0.86,1.0,1.0,3/11,13.26%,AQP7;AQP8;UPK3A
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.28239272123444586,0.6878356547459713,0.9555555555555556,1.0,1.0,7/74,7.36%,RIN2;FGF2;ANGPT1;RRAS;GLUL;ANXA3;BMPER
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.3036725132639156,-0.6875852380937676,0.9259259259259259,1.0,1.0,15/53,26.53%,NDUFC1;UQCRC1;NDUFS5;COX6C;NDUFA10;COX7C;COX7A2L;NDUFA5;NDUFS1;UQCRH;NDUFA1;SDHC;NDUFB4;AFG1L;UQCR10
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.3073477613058299,0.6873760099234334,0.9629629629629629,1.0,1.0,6/46,17.52%,MYC;TF;CYBRD1;SMAD4;HJV;FRRS1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.3682441730710497,0.6869544956880832,0.9122807017543859,1.0,1.0,1/24,2.93%,NEDD4
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.4487656773951589,-0.686937090707264,0.8043478260869565,1.0,1.0,1/7,10.93%,GTF2H2
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.42452839840946005,0.6869345353484201,0.8813559322033898,1.0,1.0,3/6,28.52%,CD74;CARD9;SLA2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.39420650087790143,-0.6865195911965779,0.875,1.0,1.0,2/10,15.54%,GOLGA2;SKP1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.3401882763831618,0.6864793873431554,0.9038461538461539,1.0,1.0,5/25,18.53%,LLGL1;DNAJC1;HSPA8;STXBP5;NDFIP2
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.3168975124650088,0.6861458701677452,0.8974358974358975,1.0,1.0,6/27,18.65%,LIN28A;NUDT16L1;EXOSC4;TENT4B;ZCCHC8;SLFN14
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.3795406934858296,-0.6855618682241628,0.8260869565217391,1.0,1.0,5/12,16.73%,CLDN1;CBLN2;MYADM;DCTN1;CHCHD10
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.33386831812304657,0.6855283013404371,0.8666666666666667,1.0,1.0,8/33,27.50%,HAP1;HSPB1;RAB27B;DLG2;AP3M2;TRAK2;RAB21;KIF3B
prerank,GO_Biological_Process_2021__nodal signaling pathway (GO:0038092),0.4636992873095531,0.6854870141779631,0.9245283018867925,1.0,1.0,2/5,13.74%,SMAD2;ACVR1B
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.3870544805753837,-0.6852831516523082,0.8235294117647058,1.0,1.0,3/15,8.41%,PIGG;PIGH;PIGL
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.39002740240184286,0.6852012073538792,0.8571428571428571,1.0,1.0,3/11,18.49%,SPEF2;DYNC1I2;DNAAF2
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.4183448438413888,0.6849656686544103,0.8913043478260869,1.0,1.0,5/10,32.81%,DGKZ;DGKD;DGKE;DGKI;DGKH
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3014623856263844,0.6847014930653132,0.9814814814814815,1.0,1.0,19/68,25.06%,PRMT1;PAXIP1;E2F4;CNOT6L;CHEK2;PLAGL1;CNOT4;PML;CNOT8;BCL3;CNOT2;TP53;CDC25C;RPS6KA6;GTSE1;MDM4;EP300;SESN2;RBL2
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),0.4437216950200633,0.6843586819629995,0.8461538461538461,1.0,1.0,1/5,8.70%,GPSM1
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.3652376859448446,0.6842992954817635,0.9215686274509803,1.0,1.0,1/15,3.48%,WNT4
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.33263043698688516,0.6838780965231944,0.9076923076923077,1.0,1.0,7/34,14.23%,RAPGEF3;HCLS1;ABI3;PDGFRA;ABL2;SEMA3E;TRPM2
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.338490873622784,0.6838300213802956,0.8333333333333334,1.0,1.0,8/30,21.36%,SIRT1;RELA;TRPM2;PPIF;NFE2L2;RHOB;ABL1;ANXA1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.4185194453950771,0.6837986156360599,0.9166666666666666,1.0,1.0,5/8,27.68%,RBPJ;CTNNB1;RHOB;BMP4;STARD13
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),-0.46210251656198054,-0.6837489179781229,0.7608695652173914,1.0,1.0,1/5,13.87%,ABCB4
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),-0.40739556428655843,-0.6835906410037506,0.8545454545454545,1.0,1.0,4/12,14.13%,ALOX5;HAO2;ALOX12B;ALOX15
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),-0.4488439962424451,-0.6834553064894711,0.7884615384615384,1.0,1.0,1/6,3.43%,PRKCD
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.4344433359162415,0.6830949658722999,0.8771929824561403,1.0,1.0,1/7,20.59%,IKBKB
prerank,GO_Biological_Process_2021__negative regulation of response to food (GO:0032096),0.45441315229599377,0.6829638639552349,0.8367346938775511,1.0,1.0,2/5,15.22%,SPX;NENF
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.423706786844873,0.6828800237596367,0.8870967741935484,1.0,1.0,1/6,5.43%,SLC7A2
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.3312869518287567,-0.6828353006158897,0.9148936170212766,1.0,1.0,4/26,10.96%,FGF1;DNAAF1;CHI3L1;CCDC40
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.3473341741373056,-0.6821906719532895,0.875,1.0,1.0,5/20,20.63%,RNF8;ATXN7L3;PHC1;UHRF1;RNF20
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.3618598282696643,-0.6820801615052857,0.9523809523809523,1.0,1.0,1/24,3.74%,DNAJB13
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.2895705070989597,0.6819596663044925,0.9444444444444444,1.0,1.0,3/89,3.60%,SWSAP1;SEM1;RFWD3
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.39155061593101115,-0.6818133035206925,0.8571428571428571,1.0,1.0,1/17,1.04%,CD24
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),-0.4378383032087649,-0.6815652772214821,0.8461538461538461,1.0,1.0,2/7,16.52%,MISP;PARD3B
prerank,GO_Biological_Process_2021__response to cGMP (GO:0070305),-0.42209914848408403,-0.6814770969972547,0.7307692307692307,1.0,1.0,1/5,14.29%,PDE3A
prerank,GO_Biological_Process_2021__cellular response to cGMP (GO:0071321),-0.42209914848408403,-0.6814770969972547,0.7307692307692307,1.0,1.0,1/5,14.29%,PDE3A
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2987268280070739,0.6814403494849854,0.9787234042553191,1.0,1.0,6/63,12.35%,SIRT1;CDKN2A;ERBIN;ZNF675;TMIGD3;IRAK1
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),0.4413214553065186,0.6812187717372316,0.8947368421052632,1.0,1.0,3/7,22.19%,USH2A;CTNNB1;ERCC3
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.3283874152526278,-0.6811791767382139,0.9019607843137255,1.0,1.0,5/42,10.86%,INHA;IL11;ALAS2;ZFPM1;SPI1
prerank,GO_Biological_Process_2021__adenosine metabolic process (GO:0046085),-0.44509660212494095,-0.6810589687244548,0.7727272727272727,1.0,1.0,2/6,11.71%,XDH;ACP3
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.27251218787887344,0.6808553017093435,0.9591836734693877,1.0,1.0,21/99,20.13%,RHOBTB3;EFNA5;EPHA5;EPHA3;BICD1;DLC1;PLXNB1;CDK2AP2;GPM6B;RHOBTB1;SORBS3;RICTOR;PHLDB2;PRKAA1;RHOG;RHOD;PHLDB1;RHOB;MLST8;ABL1;IQCJ-SCHIP1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.35802535192755375,-0.6804935388120964,0.8372093023255814,1.0,1.0,4/17,19.66%,ADAMTS9;FUCA1;FBXO2;FBXO44
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.446788415593276,0.6801983960550889,0.9122807017543859,1.0,1.0,1/5,20.16%,ATP2C1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.29844278949623854,-0.6800205723258893,0.9272727272727272,1.0,1.0,15/54,26.53%,NDUFC1;UQCRC1;NDUFS5;COX6C;NDUFA10;COX7C;COX7A2L;NDUFA5;NDUFS1;UQCRH;NDUFA1;SDHC;NDUFB4;AFG1L;UQCR10
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.3813079427364049,-0.6800119869275743,0.851063829787234,1.0,1.0,1/9,1.88%,CXCL13
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.4613335309101533,0.6799324891619645,0.8771929824561403,1.0,1.0,1/5,4.31%,PRMT1
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.4075250195411981,0.6799289804936886,0.9166666666666666,1.0,1.0,2/10,6.90%,PTGS1;HPGDS
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.2941836842404776,0.6796041697886118,1.0,1.0,1.0,6/74,12.40%,NEDD4;SEC22B;ASB5;FOXO1;HECW2;TIPARP
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.40427884664039193,-0.6795198550954731,0.8809523809523809,1.0,1.0,2/7,17.97%,KIF1A;KIF1C
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.3414124827875985,-0.6794539176540274,0.9347826086956522,1.0,1.0,1/24,1.87%,MTFR2
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.35862469284681164,-0.6794216526695472,0.8148148148148148,1.0,1.0,2/13,13.03%,KIF20B;DAB2IP
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.314987456958169,-0.679163296089618,0.8461538461538461,1.0,1.0,2/30,6.14%,WTIP;RBM4
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.2890713135890378,-0.6791180101896652,0.9591836734693877,1.0,1.0,15/65,19.75%,FGF1;PLK3;ORC6;ENTR1;PLK4;ESRRB;RFPL1;CALM1;HTR2B;RAB11A;FGFR2;BLM;KIF18B;PLK2;BECN1
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.3915841581181705,0.6791094705996431,0.7857142857142857,1.0,1.0,2/12,15.19%,LMO2;THRB
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.3802094945068146,0.6790597031814711,0.8245614035087719,1.0,1.0,2/9,19.44%,ABL2;ABL1
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.3382595540923264,0.6790100657054595,0.9642857142857143,1.0,1.0,6/25,19.92%,LPIN3;CEL;LIPG;PLBD2;PLBD1;ACOX1
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),-0.35566131404631207,-0.6787101289288852,0.8928571428571429,1.0,1.0,3/22,6.14%,CTNNA1;BOC;RBM4
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.3189641390520462,0.678090015229644,0.9642857142857143,1.0,1.0,4/42,6.01%,BRINP3;ZFP36L2;WEE2;SCRIB
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.3358655045877277,0.6780010828215007,0.8979591836734694,1.0,1.0,4/30,9.52%,ABI3;FER;AUTS2;PIK3CA
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.3868920688831912,-0.6776888826562274,0.8431372549019608,1.0,1.0,6/15,23.29%,WBP4;SNRNP200;RBM22;WBP11;CWC15;CACTIN
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.36528322622910564,0.6776540321982633,0.8771929824561403,1.0,1.0,4/14,20.21%,KPTN;RNF128;CD81;LMBRD1
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.33254112808791386,0.6775522850683104,0.86,1.0,1.0,1/22,1.33%,IL17RD
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.32187034533941744,-0.6775256848911256,0.8181818181818182,1.0,1.0,4/23,18.49%,RHBDF1;PTK2B;PSME3;UBE3A
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),0.4312193940846146,0.6773247364259,0.819672131147541,1.0,1.0,2/5,11.92%,MEGF10;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),0.4408937554712341,0.6771527948998025,0.8958333333333334,1.0,1.0,2/6,9.13%,IL4;DENND1B
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),0.4408937554712341,0.6771527948998025,0.8958333333333334,1.0,1.0,2/6,9.13%,IL4;DENND1B
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.30695353129639175,0.6769899339872176,0.96,1.0,1.0,16/52,17.69%,INSIG1;CYP39A1;MSMO1;FDFT1;CYP27A1;CYP7B1;OSBPL6;HSD11B2;FDXR;CH25H;HSD17B10;STAR;SC5D;PRLR;SQLE;AKR1C3
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.3258512596508379,-0.6768100134875057,0.9111111111111111,1.0,1.0,4/22,21.59%,RPF2;DHX30;BRIX1;RPL5
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),0.420882635479258,0.6766556176998297,0.8636363636363636,1.0,1.0,2/7,18.93%,CTH;KIT
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.3305417885610671,-0.676154102909507,0.9574468085106383,1.0,1.0,13/42,15.60%,DRD4;DRD2;CYP24A1;PAQR7;SFRP1;GLDC;TRPV1;IL18;CYP1B1;ABCB4;TGFB1;FGFR4;CDKN2D
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.4046810536351981,0.6758316787448724,0.8775510204081632,1.0,1.0,1/10,6.82%,VSIR
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),-0.3885084582075443,-0.6757774628096236,0.8627450980392157,1.0,1.0,1/7,11.45%,APOA1
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.4145771211842858,0.6755156137995734,0.8771929824561403,1.0,1.0,3/6,38.68%,TRMT112;APEH;ETF1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.4158179489802503,-0.6754534783013955,0.8909090909090909,1.0,1.0,1/7,7.13%,DHX8
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.39480096305549583,-0.6753582362211693,0.8222222222222222,1.0,1.0,1/8,9.44%,NRDE2
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.3588434126167029,-0.6753527745637632,0.86,1.0,1.0,4/23,15.18%,STAC;ABCB1;ATP1B1;CTSS
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.35564169826384917,0.6751567600839641,0.9591836734693877,1.0,1.0,2/20,11.76%,FBXO5;ZNF207
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.4584889727400233,-0.6751145782027154,0.88,1.0,1.0,3/5,30.67%,PRKCH;CHRM1;PRKCI
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.3757511369476809,0.6751060948178045,0.9090909090909091,1.0,1.0,2/14,8.32%,LOC400499;CRHBP
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.40016403618277596,0.6748754150344847,0.873015873015873,1.0,1.0,2/8,27.34%,POMK;IPPK
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.34068210313413594,0.6748488230090173,0.8846153846153846,1.0,1.0,6/17,17.69%,FDX1;FDXR;HSD17B10;STAR;AKR1C1;AKR1C3
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3887135041695022,0.6746709526530376,0.8793103448275862,1.0,1.0,1/11,2.91%,PYHIN1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.3637455394567084,0.6745027242472987,0.896551724137931,1.0,1.0,3/18,16.70%,CDH2;PIEZO1;CTNNB1
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.34041599085371543,0.674462244162019,0.8301886792452831,1.0,1.0,6/27,25.70%,CHMP6;STAM2;MVB12A;VTA1;HGS;VPS37D
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.3046338632628401,-0.6744606371059664,0.94,1.0,1.0,11/35,22.45%,PER2;ENO2;GAPDHS;GOT2;G6PC3;PFKFB1;ALDOB;PCK2;ENO3;RBP4;SLC25A10
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),-0.4167230232176079,-0.6743598712212507,0.782608695652174,1.0,1.0,1/5,1.88%,CXCL13
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.3492249529450293,-0.6741528072010466,0.8571428571428571,1.0,1.0,5/26,9.99%,ALOX5;CYP21A2;HSD3B2;HSD3B1;DHRS11
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.2952335517009969,-0.674138986143344,0.9019607843137255,1.0,1.0,12/38,22.45%,PER2;ENO2;GAPDHS;GOT2;G6PC3;PFKFB1;SORD;ALDOB;PCK2;ENO3;RBP4;SLC25A10
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),0.423248197474111,0.6740856048138788,0.8867924528301887,1.0,1.0,2/6,22.48%,CARD16;CARD18
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.2943851579326525,0.6739644992502871,0.9523809523809523,1.0,1.0,2/50,3.70%,SLC16A5;SLC38A3
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.45463898986429707,0.6738276750262484,0.859375,1.0,1.0,2/6,19.96%,PLCG2;CX3CR1
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.393371537362995,0.6737684600185085,0.9454545454545454,1.0,1.0,5/15,22.80%,PCSK5;NR1H3;ANGPTL4;HDAC9;FURIN
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.38344668599378406,0.6735654402633217,0.8723404255319149,1.0,1.0,1/11,2.87%,PPARG
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.36000932614718023,0.6733376308644273,0.9347826086956522,1.0,1.0,8/24,27.68%,FGF2;VEGFA;HDAC9;AKT3;ANXA1;MEOX2;CIB1;STARD13
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.38623871488335704,-0.6732976120268894,0.813953488372093,1.0,1.0,1/10,7.88%,HFE
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.3511871307862241,0.6731140651778471,0.8333333333333334,1.0,1.0,3/19,14.02%,MID2;TRIM26;PML
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.3172636255617496,0.6729948769876487,0.9375,1.0,1.0,12/39,24.47%,ST6GALNAC3;FUT9;ST8SIA4;ST3GAL6;FUT8;ABO;B4GALNT2;ST8SIA1;NAGA;ST6GALNAC4;GAL3ST3;ST6GAL2
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.3560212371381826,0.672782104915255,0.8666666666666667,1.0,1.0,5/20,17.55%,SLC1A3;SLC7A2;SLC3A2;SLC1A6;SLC36A1
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.3156229189764179,0.6725894174105027,0.896551724137931,1.0,1.0,19/38,33.06%,PLPPR1;PTEN;MTMR9;MTMR3;MTMR11;PLPP1;INPP5J;PLPP5;PIP4P1;PLPPR5;INPP5F;OCRL;MTMR8;PIP4P2;PLPP3;SGPP2;MTM1;MTMR10;PLPP2
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.40076208502384214,0.6724545395927098,0.8461538461538461,1.0,1.0,4/10,26.67%,SPX;ACSL1;SLC27A1;CD36
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.4872147050095984,-0.6723906720509687,0.8723404255319149,1.0,1.0,1/6,12.79%,FUCA1
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.4872147050095984,-0.6723906720509687,0.8723404255319149,1.0,1.0,1/6,12.79%,FUCA1
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.37901068821647055,0.6720914189679217,0.8367346938775511,1.0,1.0,4/12,17.69%,DHRS3;EZH2;CTBP2;AKR1C3
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.38266390434429975,0.6720794184062013,0.9,1.0,1.0,5/12,24.57%,TTC21B;IFT140;DYNC2I2;CILK1;WDR35
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.33160095891667385,0.6717770648053697,0.9,1.0,1.0,6/44,12.51%,MYRF;ADGRG6;GAL3ST1;MARVELD1;ACSBG1;ABCD2
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),0.39902449854376476,0.6716171743132521,0.9166666666666666,1.0,1.0,3/8,10.69%,SAG;CNGA1;PDE6A
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.4006214986846029,0.6715971599324112,0.8363636363636363,1.0,1.0,2/11,15.19%,LMO2;THRB
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.3761195088767215,0.6714355668814961,0.9310344827586207,1.0,1.0,6/16,20.58%,NAIF1;SLC25A31;PPIF;THEM4;HEBP2;BAD
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.4060891433043769,0.6708851208906721,0.9047619047619048,1.0,1.0,1/10,3.01%,PADI2
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.32265261547104496,-0.6706306609928022,0.94,1.0,1.0,3/30,10.93%,CMTR1;GTF2F1;GTF2H2
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.32265261547104496,-0.6706306609928022,0.94,1.0,1.0,3/30,10.93%,CMTR1;GTF2F1;GTF2H2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.394572222360174,-0.6701360813349142,0.9074074074074074,1.0,1.0,1/9,4.39%,CBARP
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.4158405270134702,0.6701218762530003,0.9047619047619048,1.0,1.0,2/9,18.20%,TSPAN6;RIOK3
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),0.41708700795571446,0.6700378242452175,0.8775510204081632,1.0,1.0,1/7,2.84%,KAT2B
prerank,GO_Biological_Process_2021__regulation of thymocyte apoptotic process (GO:0070243),0.43781077296761944,0.6697017829448598,0.8679245283018868,1.0,1.0,3/5,32.83%,TP53;BMP4;ZC3H8
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.43322226266717767,0.6696934767868747,0.875,1.0,1.0,2/8,24.26%,DYRK1A;PIKFYVE
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.27566680798489646,0.6696465790220091,1.0,1.0,1.0,48/198,20.92%,LGALS9;PPARG;ROR1;FANK1;HCLS1;MID2;RELA;TLR2;ESR1;EPHA5;PLCG2;TICAM1;RPS6KA4;FER;ANXA3;CD40;NEUROD2;STING1;TAB2;NHLH2;TRIM26;IRAK1;PTEN;IL18R1;FZD1;DVL2;LRP6;FZD4;IKBKE;TRIM52;RNF25;TAB3;CTNNB1;RPS6KA5;EDA;IRAK3;VEGFA;WNT2;JMY;KIT;CX3CR1;ERC1;RIPK2;IKBKB;EDN1;DDIT3;CARD16;STK36
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.2781758352358661,-0.6696363455542245,0.9622641509433962,1.0,1.0,2/110,1.32%,TBC1D10C;STX16
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),-0.4202093106365037,-0.6693670681244834,0.8297872340425532,1.0,1.0,3/7,16.85%,VDR;MED1;FGFR2
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),0.46121956544612625,0.6693162249976814,0.9230769230769231,1.0,1.0,1/5,3.42%,SLC26A6
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.4084377917387373,0.6692477399576517,0.8823529411764706,1.0,1.0,2/10,11.95%,NPPA;PDE4B
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),-0.27791578708458176,-0.6691416676625302,0.9782608695652174,1.0,1.0,5/112,6.42%,NUPR1;ALOX5;CAMK2A;IER3;MBTPS2
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.3880686303327927,-0.6689658555349951,0.8723404255319149,1.0,1.0,1/10,7.08%,LAMB3
prerank,GO_Biological_Process_2021__proline transmembrane transport (GO:0035524),-0.44126212907821744,-0.6686625366235656,0.8048780487804879,1.0,1.0,2/5,13.86%,SLC36A2;SLC6A20
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell membrane repolarization (GO:0099624),-0.44149150372426593,-0.6682495533676543,0.8125,1.0,1.0,3/5,9.36%,KCNN2;KCNQ1;KCNA5
prerank,GO_Biological_Process_2021__membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),-0.44149150372426593,-0.6682495533676543,0.8125,1.0,1.0,3/5,9.36%,KCNN2;KCNQ1;KCNA5
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.37717471008446984,0.667731531316478,0.9,1.0,1.0,4/13,24.27%,SLC25A13;GPD2;SLC25A12;UQCRFS1
prerank,GO_Biological_Process_2021__regulation of epinephrine secretion (GO:0014060),-0.4065803351094187,-0.6672973656797826,0.8125,1.0,1.0,2/5,12.91%,CARTPT;CRH
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.35451140547123244,-0.6671839208073932,0.875,1.0,1.0,4/17,15.09%,RAB7B;FLOT1;DAB2IP;IFI35
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.4002652508865159,-0.6671247764940637,0.8,1.0,1.0,2/5,20.69%,APH1B;APH1A
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.446340243651634,0.6671107376462815,0.8703703703703703,1.0,1.0,1/6,20.06%,MINPP1
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),0.37099011350842204,0.6668639182868434,0.8163265306122449,1.0,1.0,1/12,3.42%,SLC26A6
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.29319709733458665,-0.6667723949474038,0.9615384615384616,1.0,1.0,17/82,18.56%,KIF2B;HLA-DRB1;ARF1;KIF15;CLTA;KIF26A;KIF22;DCTN2;DCTN1;HLA-DQA1;CTSS;KIF4A;DYNC1LI2;SEC24C;SEC13;AP2A2;HLA-DMA
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.29115883067887627,-0.6666357321472787,0.9565217391304348,1.0,1.0,15/51,22.45%,PER2;OAS1;ENO2;KCNJ11;GAPDHS;GOT2;G6PC3;PFKFB1;SORD;APOD;ALDOB;PCK2;ENO3;RBP4;SLC25A10
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.3316653797209055,-0.6665740110251227,0.9111111111111111,1.0,1.0,4/18,14.25%,RIN3;LRPAP1;WDR54;RAC1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.3765645579698522,0.6659495287336805,0.8333333333333334,1.0,1.0,3/11,16.06%,VSIR;IL23R;TNFRSF21
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.32332334777362354,-0.6657790795695465,0.8727272727272727,1.0,1.0,4/23,10.96%,FGF1;DNAAF1;CHI3L1;CCDC40
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.3539079438111497,0.6655194139973614,0.9310344827586207,1.0,1.0,1/17,1.53%,TSPAN12
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.3622897402194164,-0.6648675921256435,0.8703703703703703,1.0,1.0,1/13,1.90%,ENTPD2
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.3375523949201604,0.6636612718037859,0.9375,1.0,1.0,2/19,11.92%,SIX4;MEF2C
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.3204088569709469,0.6626227078271989,0.94,1.0,1.0,9/39,23.88%,NAV3;SNCA;DYRK1A;TOGARAM1;ABL1;MAP2;CAMSAP2;CLIP1;AKAP9
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),0.3706555058891386,0.6626132000168277,0.8888888888888888,1.0,1.0,1/10,7.42%,DPP4
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.34079159988520896,0.6620519094939514,0.9137931034482759,1.0,1.0,9/24,31.58%,TCN2;SLC19A1;SLC52A1;SLC19A2;SLC2A14;SLC27A1;SLC46A1;SLC35F3;CD320
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.3577561819307742,0.6620038403408304,0.9795918367346939,1.0,1.0,4/17,22.38%,NAV3;CD34;ZFP36;PTPRC
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.3551129269075602,-0.6617357043185383,0.9166666666666666,1.0,1.0,6/22,18.94%,RAC2;PARVG;RAC1;PARVB;RHOQ;NCKAP1L
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.2823533633730741,-0.6614816612208995,1.0,1.0,1.0,6/69,9.55%,KDM4D;ABRAXAS1;TICRR;RNF8;EYA1;RAD51AP1
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.36664880121974175,-0.6612555721838427,0.82,1.0,1.0,5/16,17.38%,TMIE;PAX2;USH1C;FGFR2;PAX8
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.2994474576887676,0.661038117653468,0.9122807017543859,1.0,1.0,13/60,19.92%,PPARG;ZBTB20;TLCD3B;SLC4A7;NR1D2;ABHD8;NR1H3;TENT4B;SLC4A1;PNPLA8;IRS2;WNK1;ACOX1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.35591364049993807,0.6602071311677442,0.8958333333333334,1.0,1.0,8/22,25.12%,TLR2;HMGB1;NR1H3;MFHAS1;TICAM2;TLR1;NINJ1;LBP
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.30745798741458863,-0.6601893631409022,0.9523809523809523,1.0,1.0,4/27,15.13%,PRKCD;STMN1;MYADM;TUBB4A
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),-0.44403572719437107,-0.6595513021169537,0.8918918918918919,1.0,1.0,3/5,25.71%,SLIT3;MYO9B;RHOA
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.4331230204770864,0.6591204536847638,0.8679245283018868,1.0,1.0,1/6,4.31%,PRMT1
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.4195334311266739,-0.6591087076401463,0.8695652173913043,1.0,1.0,6/6,58.06%,SRC;BDNF;FYN;STAP1;DOCK3;NTRK2
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.3139621758552963,-0.6584679915371471,0.9534883720930233,1.0,1.0,5/42,13.85%,DNASE1L1;ADAMTS9;DAB2IP;DENND3;SUPV3L1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.30499218346562207,-0.6576940423108394,1.0,1.0,1.0,1/50,0.73%,AMACR
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.2826383185913992,0.6575823882788886,0.9811320754716981,1.0,1.0,9/53,23.71%,TSR3;PUS7L;CTU1;TRDMT1;CDKAL1;NOP10;TFB1M;METTL1;TRMT9B
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.3507641873054075,0.6575315786599321,0.88,1.0,1.0,6/16,20.65%,PTGS1;HPGDS;CD74;PNPLA8;AKR1C3;EDN1
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.3506906950123293,0.6573485473591798,0.8888888888888888,1.0,1.0,4/22,15.11%,HSD17B2;FDX1;FDXR;STAR
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.3569411712577218,0.6570872079842808,0.9454545454545454,1.0,1.0,5/17,19.39%,FUT9;ST3GAL6;FUT8;ABO;B4GALNT2
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.3208036379004629,0.656753840520746,0.9347826086956522,1.0,1.0,14/30,33.21%,RACGAP1;PHLDB2;CRB2;PLCB1;PHLDB1;RPS6KA6;TDG;INSR;NIPBL;ZBED3;CLASP2;CLASP1;SEPTIN7;B4GALT5
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.28650098145431313,0.6567298388312506,0.9649122807017544,1.0,1.0,5/54,16.35%,SIRT1;ODC1;PSMD13;PSME4;PSMA1
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.3452517605744294,0.6561191828225434,0.9454545454545454,1.0,1.0,2/17,8.67%,SPR;GCH1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.27742908213897843,-0.6559663861792016,1.0,1.0,1.0,20/125,19.64%,EIF2S3B;RPF2;EIF2S2;EIF2S3;RPS27L;SRPK3;PRPF19;CELF3;SNRNP200;WDR77;RPL38;PRMT7;SRSF10;PRPF6;CRNKL1;RPS27;BRIX1;EIF4H;COIL;SNRPD2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.3821686228237819,-0.6544694394609714,0.9148936170212766,1.0,1.0,4/12,21.58%,PTK2B;CAV1;CAV3;ACTN2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.25704509436800255,0.6537957774567561,1.0,1.0,1.0,20/104,31.70%,EIF3E;SMG1;RPS5;RPL21;RPL18A;RPL7;RPS3A;NCBP1;RPL23A;RPL9;RPS29;RPS19;PABPC1;PPP2R2A;RPS15A;SMG9;RPS23;RPS12;PYM1;RPLP0
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.2712161655647715,-0.6535273060231199,1.0,1.0,1.0,15/102,15.00%,ERN2;TTC23L;RASGRF2;ERLEC1;MBTPS2;FLOT1;JUN;CREB3L1;DDRGK1;WFS1;DAB2IP;ALOX15;UFL1;ANKS4B;SEC16A
prerank,GO_Biological_Process_2021__cardiolipin biosynthetic process (GO:0032049),-0.4692451311444942,-0.6534577661112966,0.8863636363636364,1.0,1.0,2/5,17.50%,TAMM41;CRLS1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.35244097691685017,0.6530013159413471,0.8703703703703703,1.0,1.0,6/14,20.30%,MCTP2;SNCAIP;MEF2C;FMR1;MCTP1;KCNMB4
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),-0.44297265529604657,-0.6519672754450322,0.8461538461538461,1.0,1.0,4/6,18.46%,SLC14A2;UPK3A;SLC14A1;AQP1
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.3189984502792975,0.6518753941366029,0.9387755102040817,1.0,1.0,6/26,20.53%,UBE2E2;UBE2D3;UBE2E3;RNF26;FZR1;UBE2A
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.4168643698871054,0.6513774445055809,0.9411764705882353,1.0,1.0,1/7,10.93%,LIG4
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),-0.3704060079144349,-0.6513726032373697,0.8837209302325582,1.0,1.0,1/11,10.16%,VIT
prerank,GO_Biological_Process_2021__cannabinoid signaling pathway (GO:0038171),-0.416626273968926,-0.6513119447684456,0.875,1.0,1.0,1/5,19.97%,DAGLA
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.36518635049343035,0.6507688659797878,0.8653846153846154,1.0,1.0,1/12,5.96%,TET2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.3253304858820005,0.6502326848327995,0.9259259259259259,1.0,1.0,5/28,18.36%,GLRA1;RRAGC;CPEB1;VEGFA;RRAGD
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),-0.4021480017493121,-0.6499872533965607,0.9411764705882353,1.0,1.0,2/10,9.52%,CYP24A1;VDR
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.27350556640117374,-0.6499540406337554,0.9791666666666666,1.0,1.0,1/64,1.24%,RTF1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.42419747131192814,-0.6498023491261122,0.9166666666666666,1.0,1.0,1/5,16.06%,VDAC1
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.4055000487364704,-0.6492172504057354,0.9183673469387755,1.0,1.0,1/7,17.00%,STAT1
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.3656863445949266,-0.6488092515019374,0.8604651162790697,1.0,1.0,4/16,25.57%,MLYCD;NR4A3;ABCB11;TYSND1
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.37856552200377036,0.648734380856435,0.8846153846153846,1.0,1.0,1/10,4.40%,SIX4
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),0.42357182967109297,0.6485832499078046,0.9107142857142857,1.0,1.0,2/5,20.65%,BCAR1;EDN1
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.327761820162953,0.6484832269765437,0.9166666666666666,1.0,1.0,6/26,15.29%,NEO1;TF;CYBRD1;BDH2;PICALM;HJV
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.2900638780487853,0.6484412319788485,0.9444444444444444,1.0,1.0,3/43,5.58%,MLC1;GLRA1;PTGFR
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.3829930573608211,0.6483708142699296,0.9107142857142857,1.0,1.0,1/9,3.70%,SLC38A3
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.2995286653828439,-0.6483655009005656,1.0,1.0,1.0,12/61,14.25%,FBLN2;PLEKHA2;SFRP1;OLFM4;TRIOBP;VIT;MYADM;APOA1;RREB1;PTK2B;ALOX15;RAC1
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.3750154758949332,-0.6480551011313137,0.8409090909090909,1.0,1.0,4/7,31.87%,MCTS1;EIF2D;MTIF3;MRRF
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.2696186528620004,-0.6480135232368988,1.0,1.0,1.0,12/96,14.15%,CXCL13;WARS1;BIK;ERCC1;CLU;TTBK1;PARP1;GTF2H2;PSMC4;DAB2IP;TGFB1;RPA3
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.3945870659242435,-0.6475923948671977,0.8775510204081632,1.0,1.0,1/11,4.63%,SLC19A3
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.3601477055130562,-0.6474931242951,0.9245283018867925,1.0,1.0,3/16,17.93%,RECQL5;MCM2;BLM
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.3639785960603867,0.6473619661040949,0.9298245614035088,1.0,1.0,4/12,18.00%,SYK;MAPK8;DVL2;NOXO1
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.34214525646005967,-0.6473412741995739,0.8695652173913043,1.0,1.0,2/11,12.61%,CAV2;NUCKS1
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.37682303508791676,0.6470525508965469,0.8653846153846154,1.0,1.0,2/10,16.94%,GAL3ST1;DGKZ
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.41745882800351153,0.6465711748515985,0.8545454545454545,1.0,1.0,3/6,34.85%,RAB11FIP2;SELENOT;RAB11B
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.2751164709622558,-0.6463263167676615,0.9791666666666666,1.0,1.0,1/62,1.24%,RTF1
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),0.3049478039827453,0.645818527483985,0.9814814814814815,1.0,1.0,7/52,18.20%,CCL5;HLA-E;POLR3G;PLSCR1;BIRC3;IRAK3;RIOK3
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.3622569762450194,-0.6453464710141283,0.8444444444444444,1.0,1.0,4/16,17.47%,IRF5;STAT1;PTPRS;HAVCR2
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.2862031573135782,0.6450905173690239,0.9574468085106383,1.0,1.0,10/47,22.98%,NOVA1;KHDRBS2;NSRP1;PUF60;KHDRBS3;RBM5;FMR1;RBFOX1;MBNL2;HNRNPU
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.30111462431660435,0.6449298856693187,0.9803921568627451,1.0,1.0,3/23,12.92%,BMP2;DLC1;MTMR9
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),0.3543609920933316,0.6449216569077547,0.90625,1.0,1.0,2/13,9.26%,NEDD4;PTPN14
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.39062680095885616,0.6446397700039506,0.8679245283018868,1.0,1.0,1/9,3.41%,ENPP1
prerank,GO_Biological_Process_2021__mitotic spindle midzone assembly (GO:0051256),0.4215434549368233,0.6443368291961186,0.8727272727272727,1.0,1.0,1/7,13.80%,RACGAP1
prerank,GO_Biological_Process_2021__mitotic spindle elongation (GO:0000022),0.4215434549368233,0.6443368291961186,0.8727272727272727,1.0,1.0,1/7,13.80%,RACGAP1
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.344243495269781,0.6440877229260406,0.9347826086956522,1.0,1.0,8/23,16.53%,SLC10A3;ABCC2;SLC10A5;NCOA2;SLC10A1;ABCC11;SLCO1A2;AKR1C1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.297585854098702,-0.6437295406491453,0.9607843137254902,1.0,1.0,8/37,17.02%,RSPH9;CCDC40;GAS2L2;CFAP74;RSPH1;CFAP46;RSPH4A;CHP1
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),-0.3373842944517712,-0.642959709002666,0.975,1.0,1.0,5/25,16.37%,WNT7A;ARF1;SHANK1;EPHB1;SHANK3
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.37806022581247545,-0.6422201369339678,0.9636363636363636,1.0,1.0,3/10,14.29%,ATP4A;SLC4A4;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.37304945994926086,-0.641823732122904,0.9148936170212766,1.0,1.0,5/15,21.56%,WFS1;MAPK7;PAX8;PDGFB;MTPN
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),-0.3949559950790196,-0.6412595614476904,0.875,1.0,1.0,5/5,60.52%,PRKN;UBE2D4;ITCH;UBE2T;UBE2S
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.30890989061887103,-0.6410287994767642,0.9545454545454546,1.0,1.0,6/37,10.55%,DRD4;DRD2;ERLEC1;IRF5;GPRC6A;TRPV1
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.38224943088359065,0.6407468027108562,0.9245283018867925,1.0,1.0,4/11,19.74%,MID2;TRIM26;PML;TRIM28
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.33099094692080394,0.6406376906464811,0.9787234042553191,1.0,1.0,1/25,4.04%,SF3B1
prerank,GO_Biological_Process_2021__regulation of T-helper 1 type immune response (GO:0002825),-0.445548569119704,-0.6404727289210435,1.0,1.0,1.0,1/5,7.19%,SLC11A1
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.37573348476244556,-0.6402306162818505,0.8181818181818182,1.0,1.0,7/7,62.44%,MAP1LC3B;NBR1;PJVK;SQSTM1;PEX5;USP30;ATM
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.354933266492961,0.6400173889470031,0.8928571428571429,1.0,1.0,7/16,40.48%,TP53;CRYAB;MAP3K20;ATM;WRN;TMEM109;XRCC5
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.37461086212737416,0.6396199838845328,0.9122807017543859,1.0,1.0,5/11,29.16%,CD74;AXL;GAS6;DHX9;IFIH1
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3261380090388598,0.639559506584316,0.9180327868852459,1.0,1.0,2/19,14.02%,RAP1GDS1;PML
prerank,GO_Biological_Process_2021__sinoatrial node development (GO:0003163),-0.41775844712942434,-0.639485901879996,0.8837209302325582,1.0,1.0,1/6,4.62%,CACNA1G
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.3569457024770993,-0.6391685073724286,0.8666666666666667,1.0,1.0,5/19,18.30%,CBARP;UBASH3B;PTK2B;CACNB1;CAV3
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),-0.41935806076128535,-0.6385274160768626,0.8846153846153846,1.0,1.0,2/6,23.30%,FFAR4;METRNL
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.35122888119982226,0.6383695592943958,0.8985507246376812,1.0,1.0,6/16,20.28%,FGF2;EFNB2;GREM1;VEGFA;PIK3R3;EPHB4
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.3684669848199166,0.6382301016617987,0.9019607843137255,1.0,1.0,2/13,7.29%,SIRT1;IL15
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.3331703969363988,-0.6379582825418262,0.9069767441860465,1.0,1.0,2/25,10.00%,TRIM5;DHX58
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.3262149565693191,0.6377839987177226,0.9795918367346939,1.0,1.0,3/27,8.93%,TET2;WDR5B;PAXIP1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.41212756745975565,0.6373359058433699,0.9642857142857143,1.0,1.0,3/7,27.66%,NFATC3;KIT;PDCD4
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.38395071948522413,0.6368186405399887,0.9285714285714286,1.0,1.0,1/11,3.64%,KCNJ3
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.38696254693829146,0.6367543553389582,0.9411764705882353,1.0,1.0,1/12,3.52%,RNF152
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.3871792147645307,0.6366212795743196,0.9074074074074074,1.0,1.0,3/11,18.80%,KDM3A;ARID1A;PLPP1
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.3841675760668473,-0.6364199060672393,0.8333333333333334,1.0,1.0,1/6,4.64%,DHDDS
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.3841675760668473,-0.6364199060672393,0.8333333333333334,1.0,1.0,1/6,4.64%,DHDDS
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.3409592958334915,-0.6362731010372015,0.9545454545454546,1.0,1.0,6/19,18.29%,GOLGA2;TUBGCP2;TUBG1;CSNK1D;NDEL1;TUBGCP5
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.3823414526795998,0.6358968401972049,0.8873239436619719,1.0,1.0,7/12,29.14%,TLR2;OASL;ANKRD17;PUM2;PUM1;TLR5;ZCCHC3
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.3584919767092356,-0.6358170640444694,0.88,1.0,1.0,1/9,6.42%,MBTPS2
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.3661722215976465,-0.63526720944232,0.8444444444444444,1.0,1.0,3/16,15.89%,DNAAF1;CCDC40;SPA17
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.4157185988206009,0.6352385570959054,0.9,1.0,1.0,1/5,15.21%,ANO6
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.28373170259043773,0.6351400880923979,1.0,1.0,1.0,5/55,11.67%,AUP1;STING1;UBA5;RETREG1;DYNC1I2
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.4175638932394018,-0.6350168198108551,0.9347826086956522,1.0,1.0,2/11,14.16%,GOT2;GGACT
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.36959306139998677,-0.6340953883203713,0.8928571428571429,1.0,1.0,2/10,8.18%,OAS3;OAS1
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.3149890888675166,-0.6336706317112174,0.9574468085106383,1.0,1.0,4/34,14.22%,CENPH;ITGB3BP;SMARCA5;CENPF
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.3220900175189231,0.633227006194397,0.9444444444444444,1.0,1.0,10/24,21.69%,ITGAV;MEGF10;HMGB1;XKR6;NR1H3;RHOBTB1;RHOG;XKR4;ANXA1;GAS6
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.3697668136873159,0.6329857999788746,0.8275862068965517,1.0,1.0,1/8,4.00%,CNTNAP2
prerank,GO_Biological_Process_2021__skin morphogenesis (GO:0043589),-0.42342834083732744,-0.6329842503125024,0.9024390243902439,1.0,1.0,1/5,9.97%,COL1A1
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.3998187853964002,0.6329145328080488,0.9259259259259259,1.0,1.0,2/8,7.21%,CCNA2;RPS6KA4
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.3426251100412338,-0.6328641629811816,0.9642857142857143,1.0,1.0,2/23,4.09%,ZC3H12D;RNASE1
prerank,GO_Biological_Process_2021__L-ornithine transmembrane transport (GO:1903352),0.4009471950609731,0.6321867166407694,0.875,1.0,1.0,1/5,5.43%,SLC7A2
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.29362168742897343,-0.6321774121512925,0.98,1.0,1.0,9/53,18.29%,PLK3;TUBGCP2;CCDC88C;STMN3;DCTN1;TRPV4;RAB11A;CHP1;TUBGCP5
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.3896710879490185,0.6319087904604057,0.9215686274509803,1.0,1.0,4/9,12.03%,MAPKAPK2;MAPKAPK3;CARMIL1;RAB34
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.369662609036355,-0.6313220938640814,0.8913043478260869,1.0,1.0,3/16,13.11%,CBARP;MMP9;CAV1
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.31916628575253425,-0.6311536550769377,0.9523809523809523,1.0,1.0,3/30,9.16%,PRKCD;RBM3;RBM4B
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.41024084298793995,-0.6311410880084011,0.8846153846153846,1.0,1.0,2/5,14.41%,DDRGK1;UFL1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.41024084298793995,-0.6311410880084011,0.8846153846153846,1.0,1.0,2/5,14.41%,DDRGK1;UFL1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.41024084298793995,-0.6311410880084011,0.8846153846153846,1.0,1.0,2/5,14.41%,DDRGK1;UFL1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.3420072089153458,-0.6304619223055029,0.8571428571428571,1.0,1.0,1/12,6.62%,PER2
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.3420072089153458,-0.6304619223055029,0.8571428571428571,1.0,1.0,1/12,6.62%,PER2
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.4159647960632157,-0.6302319264969848,0.8723404255319149,1.0,1.0,5/5,58.42%,GPS2;PPIA;PARP10;PLAA;TRIM44
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.31568480178756003,-0.6295922960971486,0.9298245614035088,1.0,1.0,4/18,11.67%,ASS1;ASPG;GOT2;FOLH1B
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.28882785620060014,-0.6295654017271501,0.9583333333333334,1.0,1.0,8/35,27.17%,POM121C;TOMM20;NUP133;SEC13;NUP93;NUP43;RAN;NUP214
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.341775462406826,0.6295046562030672,0.9310344827586207,1.0,1.0,7/17,33.26%,RNF128;CD81;ABCA2;APOE;DACT1;CTSC;FAF1
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.3629541727600938,0.6292727127671618,0.8780487804878049,1.0,1.0,4/11,29.59%,PRICKLE1;BMP4;SOX8;NOTCH1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.3509741255467212,0.6291106365160979,0.8958333333333334,1.0,1.0,2/12,11.77%,PLXNB1;PLXNB2
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.3804430882918181,-0.6288909109671339,0.9069767441860465,1.0,1.0,3/11,13.84%,PLK3;RPS27L;CCND1
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),0.39304278567364,0.6282428557683593,0.9,1.0,1.0,2/9,12.14%,SLC26A6;SLC5A11
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.29246855789473103,0.6280221599536789,0.9777777777777777,1.0,1.0,1/26,4.48%,ZFP36L2
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.387340831423723,0.6280010924119721,0.8846153846153846,1.0,1.0,8/11,29.62%,SPX;NPPA;SLC2A5;BMPR2;ACE;GSK3A;PRCP;DDAH1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.3162518666977317,0.6279725032659496,0.9215686274509803,1.0,1.0,9/22,26.20%,HTRA2;PML;WWOX;FADD;RET;PPP2R1B;PAK2;BCL10;BID
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.2753188538752121,0.6277347990382822,0.9787234042553191,1.0,1.0,7/37,18.47%,SIRT1;RGR;LIG4;TANK;EEF1D;TP53;RHOB
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.36219409118760615,-0.6276856749128074,0.9183673469387755,1.0,1.0,2/11,10.93%,PER2;TMSB4X
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.2755285388491544,-0.62741839693126,1.0,1.0,1.0,1/67,0.60%,HK2
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.3638368058736261,-0.6273937844171139,0.8604651162790697,1.0,1.0,2/11,6.96%,PAH;DBH
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.2655630666558614,0.627129925531824,1.0,1.0,1.0,11/133,10.25%,LGALS9;F2;SSC5D;NAV3;VSIR;NLRP7;RPS6KA4;HMGB1;BTN2A2;C5AR2;IL23R
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.37605815501320194,-0.6270843839445905,0.8928571428571429,1.0,1.0,2/8,6.16%,SFRP1;MEOX1
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.34306256222635,0.6268734183759075,0.9272727272727272,1.0,1.0,1/15,3.87%,CDH2
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3394561786950126,0.6267945698519134,0.9361702127659575,1.0,1.0,1/13,11.31%,CHEK2
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2668891176909089,0.6266036695912911,1.0,1.0,1.0,12/94,14.43%,FHIT;DNAJB2;RYBP;CBFA2T3;RNF217;KEAP1;UBQLN4;ARIH1;BAG2;XPO1;PRICKLE1;EIF3H
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.40212892006286377,-0.6258485019939031,0.9137931034482759,1.0,1.0,1/7,10.86%,SPI1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.27301244936531605,-0.6254488514529423,0.9807692307692307,1.0,1.0,17/86,18.56%,KIF2B;HLA-DRB1;ARF1;KIF15;CLTA;KIF26A;KIF22;DCTN2;DCTN1;HLA-DQA1;CTSS;KIF4A;DYNC1LI2;SEC24C;SEC13;AP2A2;HLA-DMA
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.3410524613765702,0.6249654575996888,0.9787234042553191,1.0,1.0,4/16,22.23%,HNRNPD;NEK7;MAPK3;MAPK15
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.3258124377279315,0.6249277962739554,0.9074074074074074,1.0,1.0,5/18,32.79%,CPEB1;NCBP1;CPSF6;CPEB3;NUDT21
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.35632480871680633,-0.6246910966293598,0.8043478260869565,1.0,1.0,2/10,15.97%,HLA-DRB1;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of antifungal innate immune response (GO:1905034),0.39112834961996046,0.6241675759276224,0.9361702127659575,1.0,1.0,1/5,9.22%,FAM3A
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.2926015301819728,0.6240746826616806,0.9803921568627451,1.0,1.0,13/47,20.73%,SYT1;AGR2;RIMS2;DBN1;L1CAM;PLCB1;CDKL5;MACF1;SMURF1;SYT3;CPNE9;GOLGA4;SYT17
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.34026371605097216,0.6239725509072149,0.9166666666666666,1.0,1.0,5/15,21.69%,PELI3;ZNF675;CCDC3;CARD16;GAS6
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.33948121367279954,0.6233674136607724,0.9629629629629629,1.0,1.0,5/18,19.39%,FUT9;ST3GAL6;FUT8;ABO;B4GALNT2
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.3183496521307141,-0.6232255845453587,0.9,1.0,1.0,4/18,18.46%,RCSD1;ZFP36L1;TRPV4;AQP1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),0.3588819941491931,0.6230146425075017,0.9107142857142857,1.0,1.0,6/10,26.87%,TULP1;RPE65;REEP6;GNAT2;CACNA2D4;GRM6
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),0.3588819941491931,0.6230146425075017,0.9107142857142857,1.0,1.0,6/10,26.87%,TULP1;RPE65;REEP6;GNAT2;CACNA2D4;GRM6
prerank,GO_Biological_Process_2021__striated muscle hypertrophy (GO:0014897),-0.3877904224720201,-0.6220998572240511,0.9318181818181818,1.0,1.0,2/5,16.02%,TTN;HTR2B
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.3270441709039907,0.6207494992030232,0.9482758620689655,1.0,1.0,5/17,31.21%,CREB1;PRKACB;PRKAR2A;ADCY2;ADCY5
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.3487700937988358,-0.6202347917542441,1.0,1.0,1.0,4/17,16.15%,UPB1;NT5C;UPP1;TYMP
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.4015052344846235,-0.6198292757832975,0.9148936170212766,1.0,1.0,1/6,6.91%,PRKD2
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),0.39281760156090073,0.6195092438686155,0.9433962264150944,1.0,1.0,2/6,21.01%,CA2;ATP8B1
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.2790698557803306,-0.6193006601652159,1.0,1.0,1.0,1/61,1.49%,CTSO
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.2984952024173657,0.6187283651619363,0.9682539682539683,1.0,1.0,4/34,15.01%,FHIT;RYBP;EIF3H;MARCHF7
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",-0.41146966972650706,-0.6186221719141803,0.875,1.0,1.0,5/5,58.87%,PARN;TOE1;TRIR;PDE12;XRN1
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.3525947194676502,-0.6184999811892407,0.925,1.0,1.0,2/12,9.17%,PTGES;PRXL2B
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.3061436360967237,-0.6183972708682874,0.975,1.0,1.0,3/16,15.11%,FLOT1;CAV1;CGAS
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.33624215928247353,-0.6183966804468001,0.9148936170212766,1.0,1.0,10/17,33.53%,TIMM44;TOMM20;PAM16;GRPEL1;TIMM23;TIMM17B;DNAJC19;ROMO1;TOMM40;TOMM70
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.301789263889987,0.6181413063656708,0.9491525423728814,1.0,1.0,6/32,16.45%,KAT2B;SEC22B;TMEM39A;SMAD4;CCP110;LIMK2
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.41833403907076094,0.6177246443181652,0.8913043478260869,1.0,1.0,1/6,13.61%,PTX3
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.36566444701273615,0.6176878126540475,0.9591836734693877,1.0,1.0,2/14,7.00%,ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.32783952257963045,0.6176104211587047,0.9607843137254902,1.0,1.0,4/18,17.12%,PTPRD;DBN1;CAPRIN1;CDKL5
prerank,GO_Biological_Process_2021__regulation of cellular response to hypoxia (GO:1900037),0.4100911472939968,0.6172267570068666,0.9032258064516129,1.0,1.0,1/5,12.47%,CD34
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.3299078901959603,-0.6165702089667839,0.9,1.0,1.0,9/17,28.70%,CAV1;TGFB1;UBE3A;CATSPER4;YAP1;THBS1;TGFB2;SRC;TRERF1
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.26542294341333605,0.6163688223860649,0.9375,1.0,1.0,8/45,19.87%,DOCK1;CASS4;PTPRD;CARMIL1;CAPRIN1;CDKL5;ABL1;DOCK5
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.24624920680932172,0.616084627426274,1.0,1.0,1.0,23/150,21.22%,SIRT1;CDK11A;BRINP3;FBXO5;DLGAP5;SCRIB;ANAPC16;PSMD13;HECA;PSME4;NEK7;GAS1;PSMA1;PKN2;RCC1;BORA;LGMN;PIM2;FZR1;UBE2D1;UBE2E1;PSMD4;CDC25C
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.33684261329089643,-0.6160736687044204,0.9230769230769231,1.0,1.0,1/11,4.93%,DRD2
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.384416002976341,-0.615754566478476,0.9056603773584906,1.0,1.0,1/7,4.95%,KDELR1
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.38093573393104463,0.6157009949566782,0.8813559322033898,1.0,1.0,1/9,7.04%,HDAC3
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.43644818306546057,-0.6144212188408039,0.9148936170212766,1.0,1.0,1/6,8.01%,DPH6
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.43644818306546057,-0.6144212188408039,0.9148936170212766,1.0,1.0,1/6,8.01%,DPH6
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.2853301125305306,0.6143666451669904,0.9649122807017544,1.0,1.0,3/30,9.55%,SNCA;LEPR;EPB41
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.37645565392077945,0.6142106285849749,0.8846153846153846,1.0,1.0,4/8,27.67%,ANXA2;ANXA1;AKT2;C2CD5
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.379150433364605,0.6139914365750446,0.9056603773584906,1.0,1.0,2/7,20.67%,WNK1;ATP1B2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.3438535224638407,0.6124973070401422,0.9814814814814815,1.0,1.0,13/21,32.70%,TLR2;GPR108;BIRC3;IRAK3;OTUD4;CD36;APPL1;TLR5;NLRP2B;LRRC14;APPL2;LGR4;FLOT2
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.33235837027199155,0.612283252259176,0.95,1.0,1.0,1/14,8.00%,PLA2G10
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.3405988008711058,0.6121726888157683,0.9811320754716981,1.0,1.0,2/15,7.00%,ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.29733329475017795,0.6121217307009402,0.9464285714285714,1.0,1.0,7/29,16.32%,LATS1;ANKRD13A;LZTFL1;GPM6B;PICALM;MFHAS1;LEPROTL1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.3643365658628618,-0.6119166289062269,0.9534883720930233,1.0,1.0,2/8,18.77%,HFE;IRF1
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.40117154910517383,0.6118928537323691,0.9137931034482759,1.0,1.0,2/6,11.28%,SLC8A1;ATP1A2
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.3669356230836021,0.6114472708735766,0.9166666666666666,1.0,1.0,2/9,26.08%,NREP;MTR
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.29396276414626193,-0.6114431909417499,0.9512195121951219,1.0,1.0,11/49,16.85%,CRABP2;RBP2;LAMB3;HLA-DRB1;FLG2;KRTDAP;WNT10A;BNC1;EDAR;ZNF750;FGFR2
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.3259172215188495,0.6113456480314841,0.9180327868852459,1.0,1.0,3/19,13.21%,EPHA3;NR1H3;PICALM
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.35103302139900217,-0.6112785182986074,1.0,1.0,1.0,1/9,6.56%,PEX7
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.40402758066782585,0.6109859811607564,0.94,1.0,1.0,2/8,21.54%,ABHD10;NAGA
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.3725740721387034,-0.6104351216530746,0.9591836734693877,1.0,1.0,1/7,12.82%,CTPS1
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.3096605268064953,0.6103497372037867,0.9298245614035088,1.0,1.0,4/21,17.29%,LPIN3;MOGAT2;DGAT2;AGMO
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),-0.3899286286866366,-0.6100757239954345,0.9333333333333333,1.0,1.0,1/5,9.08%,WWC1
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.3653713223257812,0.6098427682501161,0.9122807017543859,1.0,1.0,3/12,17.80%,GREM1;PLCB1;WASL
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.3181218274808029,0.6090893900157606,0.8939393939393939,1.0,1.0,6/20,20.28%,FGF2;EFNB2;GREM1;VEGFA;PIK3R3;EPHB4
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.36192873417049237,0.6089458901450517,0.9183673469387755,1.0,1.0,5/9,23.43%,FER;LYN;ENPP3;ADGRE2;BLK
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.2663217571891056,0.6083358614620974,1.0,1.0,1.0,14/69,28.73%,SP1;INTS6;POU2F1;TAF5;ELL2;GTF2B;INTS11;POLR2H;NCBP1;INTS14;SNAPC1;INTS8;ICE2;GTF2F2
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.2663956784869082,0.607573713740383,0.9836065573770492,1.0,1.0,14/68,28.73%,SP1;INTS6;POU2F1;TAF5;ELL2;GTF2B;INTS11;POLR2H;NCBP1;INTS14;SNAPC1;INTS8;ICE2;GTF2F2
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.314418563588684,0.6075217453678798,0.9122807017543859,1.0,1.0,2/17,12.07%,CTNNA2;FCHSD2
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.285664916233528,0.6074103329833327,1.0,1.0,1.0,4/28,12.77%,NDE1;RANBP9;ZNF207;HDGFL3
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.29952241134771096,-0.6073598503348409,1.0,1.0,1.0,5/27,14.67%,TTC8;TMEM107;TBC1D32;DCTN1;CSNK1D
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.3450549745878673,-0.6072844214906168,0.9523809523809523,1.0,1.0,7/17,22.98%,MYO5B;MYO15A;MYO7B;MYO1H;MYO5C;ACTN4;MYO1F
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.3357788720088559,0.6071593682622861,0.9636363636363636,1.0,1.0,3/16,9.14%,MDFIC;LATS1;RAB23
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.320581570023502,0.606862858750309,1.0,1.0,1.0,2/21,7.91%,TGFBR1;CAVIN1
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.32088260590371365,0.6068000334765007,0.98,1.0,1.0,5/16,26.04%,ACTL6A;EPC1;RUVBL2;ING3;MSL3
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.2954526286626055,0.6066577934303111,1.0,1.0,1.0,9/35,22.38%,CASS4;GRM5;NCK2;GPRC5B;EFNA1;DLG3;GAS6;ACE;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.35951001419895423,-0.606639951784199,0.9318181818181818,1.0,1.0,1/11,7.86%,BTBD18
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.3685862194308491,0.6064492505310861,0.9056603773584906,1.0,1.0,2/7,26.81%,HEBP2;PRELID1
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.31827768045177285,0.6061865270912936,0.9230769230769231,1.0,1.0,2/11,14.53%,ABCA1;LIPG
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.3644749009830558,0.6056543292677854,0.9411764705882353,1.0,1.0,3/11,19.24%,TNFRSF10B;IRAK1;TNFRSF10A
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.2888534886575326,-0.605304693217607,0.96,1.0,1.0,8/32,17.00%,NR4A1;CCN3;MYH9;CYP1B1;LPXN;SCG2;EGR3;STAT1
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.342638012079171,0.6052803665614424,0.9245283018867925,1.0,1.0,3/11,21.92%,MFF;PNPT1;PID1
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.38433815029453094,0.6049016371147121,0.8958333333333334,1.0,1.0,4/7,30.35%,IL23R;CARD9;CD80;IL23A
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.38433815029453094,0.6049016371147121,0.8958333333333334,1.0,1.0,4/7,30.35%,IL23R;CARD9;CD80;IL23A
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.27962845824184673,0.604103938596113,0.9555555555555556,1.0,1.0,3/32,11.86%,DOCK1;CASS4;CARMIL1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.34445506210902366,-0.6039845992570054,0.9361702127659575,1.0,1.0,3/12,13.11%,DSG2;CTNNA3;CAV1
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.2710446703261275,-0.6039379278592901,1.0,1.0,1.0,2/51,7.07%,PIAS3;EYA1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.4177735867286051,0.6028253707986219,0.9629629629629629,1.0,1.0,2/5,21.90%,EPB41;GNAI1
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.3647228813450878,-0.6028029943935364,0.8627450980392157,1.0,1.0,1/12,3.22%,TICRR
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),-0.27249728470141044,-0.602712992245722,0.9807692307692307,1.0,1.0,5/56,8.93%,PRKCD;CAMK2A;PRKD2;TTBK1;DYRK4
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.4066002870772562,-0.6024992306019955,0.9433962264150944,1.0,1.0,3/7,13.11%,TPCN2;CAV2;CAV1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.3452483353824173,0.6024790598086825,0.9111111111111111,1.0,1.0,3/8,24.26%,WNK1;NEXMIF;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),0.3947079558744613,0.6023932816129564,0.9636363636363636,1.0,1.0,2/5,26.77%,FADD;NLRC5
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.32386273231657464,0.6020321942697262,0.9615384615384616,1.0,1.0,4/18,16.58%,ENPP1;GREM1;BCOR;HEY2
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),-0.39472495310594,-0.6016042737648407,0.8809523809523809,1.0,1.0,1/5,8.62%,P2RY12
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.3876400885006825,0.6014968740774479,0.8620689655172413,1.0,1.0,3/7,20.42%,LEPR;GREM1;SUCO
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),0.3906156191580677,0.6014536306715276,0.9523809523809523,1.0,1.0,1/6,15.21%,ANO6
prerank,GO_Biological_Process_2021__ornithine transport (GO:0015822),0.39262396945472267,0.60117274856942,0.9183673469387755,1.0,1.0,1/5,5.43%,SLC7A2
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.30302282216520565,-0.6010410174572871,0.9782608695652174,1.0,1.0,3/29,7.77%,RAC2;GULP1;ARHGAP12
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),-0.38606776614513805,-0.6006655607068316,0.9318181818181818,1.0,1.0,2/7,17.50%,TAMM41;CRLS1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.3406023590045939,-0.6006398097793209,0.86,1.0,1.0,4/11,16.15%,PUDP;TK2;UPP1;TYMP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.3406023590045939,-0.6006398097793209,0.86,1.0,1.0,4/11,16.15%,PUDP;TK2;UPP1;TYMP
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.2792202295925964,0.6002393056201808,1.0,1.0,1.0,3/24,17.47%,PHKA1;PGM1;GBE1
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.34603278384214625,0.6002249842756822,0.9433962264150944,1.0,1.0,5/11,29.79%,CANX;IL12A;JAK2;IL27RA;IL12RB2
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.38608996065215473,-0.6002150494431882,0.8536585365853658,1.0,1.0,2/6,17.27%,SMOX;SAT2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),-0.3834708950825239,-0.6000132073143546,0.8571428571428571,1.0,1.0,1/5,15.04%,PHF19
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.3370893936854368,-0.5995028821476716,0.9361702127659575,1.0,1.0,4/17,16.47%,LAS1L;FTSJ3;NSA2;RRP15
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.35657663089733366,0.5992020100180212,0.9473684210526315,1.0,1.0,1/7,20.16%,ATP2C1
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.3594788800378479,0.5976798294746944,0.9333333333333333,1.0,1.0,1/7,16.51%,UBR5
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.2676709841204338,-0.5976116234313148,1.0,1.0,1.0,17/84,18.56%,KIF2B;HLA-DRB1;ARF1;KIF15;CLTA;KIF26A;KIF22;DCTN2;DCTN1;HLA-DQA1;CTSS;KIF4A;DYNC1LI2;SEC24C;SEC13;AP2A2;HLA-DMA
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3164759442676985,0.596953737817308,0.9791666666666666,1.0,1.0,9/28,23.10%,TAP1;HLA-E;TAPBPL;HLA-F;SEC24B;CANX;HLA-B;ACE;BCAP31
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),-0.3751238019798046,-0.5964467712095697,0.9130434782608695,1.0,1.0,1/9,5.07%,ACTN3
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.3751238019798046,-0.5964467712095697,0.9130434782608695,1.0,1.0,1/9,5.07%,ACTN3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.3060896661002556,-0.596406202775241,0.9259259259259259,1.0,1.0,5/24,16.69%,SPI1;DAB2IP;DEDD2;DELE1;DAXX
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.3683153196644457,0.5962825432288544,0.8863636363636364,1.0,1.0,1/8,9.95%,GSN
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),-0.35869039791373364,-0.5957761181749821,0.9347826086956522,1.0,1.0,1/7,7.55%,HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),-0.35869039791373364,-0.5957761181749821,0.9347826086956522,1.0,1.0,1/7,7.55%,HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.35139688887276516,-0.5957601516852189,0.9038461538461539,1.0,1.0,2/8,17.10%,RAB7B;PTPRS
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),-0.3368205173737371,-0.5952379053908343,0.9361702127659575,1.0,1.0,2/7,23.29%,PTPRS;CACTIN
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.31849309170275963,0.5951058510504951,0.95,1.0,1.0,5/21,16.11%,PDGFRA;DSCAML1;RYR2;FBN1;MESP1
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.2851606770306114,0.5946600467493514,1.0,1.0,1.0,7/44,17.39%,PLA2G10;FOXO3;GRM5;METTL18;NR1H3;PM20D2;CSF1
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),0.38803003003918907,0.5943903912405669,0.9130434782608695,1.0,1.0,1/6,7.36%,SLC4A7
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.3214737152954795,0.5940281946417478,1.0,1.0,1.0,11/28,29.39%,SIRT1;NCOA2;H3-3A;HDAC1;TRIM68;FOXH1;EP300;PIAS2;KDM4C;FOXP1;PRMT2
prerank,GO_Biological_Process_2021__prepulse inhibition (GO:0060134),0.3819207264264315,0.5930573158832197,0.9811320754716981,1.0,1.0,3/6,16.69%,CTNNA2;PTEN;GRID2
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.25923530165633774,-0.5930424118959999,1.0,1.0,1.0,16/46,27.64%,PSMB4;OAZ3;PSMC4;BHMT;AZIN1;PSMD8;PSME3;PSMD12;PSMC3;PSMC2;PSMD2;PSMA5;PSMC1;PSMD3;NQO1;PSMB9
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.3576964302900002,0.5927330438175732,0.9523809523809523,1.0,1.0,3/8,27.26%,PIK3CD;KIT;MILR1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.3689391367453555,-0.5924838274119526,0.9148936170212766,1.0,1.0,1/8,5.36%,GPC1
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.37929020428093285,0.5920528382684629,0.9423076923076923,1.0,1.0,3/5,24.15%,SLC39A8;SLC30A1;SLC39A14
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.37929020428093285,0.5920528382684629,0.9423076923076923,1.0,1.0,3/5,24.15%,SLC39A8;SLC30A1;SLC39A14
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.297348407317215,0.591971054481619,0.9795918367346939,1.0,1.0,9/18,37.49%,RUVBL2;NOP10;NAF1;SHQ1;CCT3;DCP2;CCT7;DKC1;CCT4
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.2644234051839821,-0.5918745299586032,1.0,1.0,1.0,13/44,23.78%,AFG3L2;APOO;SPG7;DNAJC11;LETM1;DMAC2L;ATP5F1A;ATP5F1E;ATP5ME;SAMM50;ATP5MC3;ATP5PB;ATP5F1B
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.3923054295268684,-0.5917180482574049,0.8979591836734694,1.0,1.0,1/5,8.50%,ENTR1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.3509763894557255,-0.5916124301593187,0.8913043478260869,1.0,1.0,3/6,27.89%,ATP9A;EIPR1;PRKN
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.2294337108767296,0.5914082002073775,1.0,1.0,1.0,22/184,21.31%,GLUL;RIOK2;DDX31;PWP2;RRS1;EXOSC4;XPO1;NOC2L;RPL21;BOP1;BYSL;RPL18A;MPHOSPH6;RPL7;RIOK1;WDR36;EXOSC1;WDR18;TEX10;C1D;RPL23A;RRP1B
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.2928347485080274,0.5903308214235473,0.9833333333333333,1.0,1.0,8/23,33.76%,PLA2G10;PLSCR1;PLA2G15;SLC27A1;LPCAT3;MBOAT2;SERINC5;MBOAT1
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.3332137572537659,-0.5901501557480718,0.9361702127659575,1.0,1.0,4/14,17.73%,SLC2A8;SLC5A1;SLC2A1;HNF1A
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.26240492538585386,0.5898813861705181,1.0,1.0,1.0,6/45,18.47%,SIRT1;LIG4;TANK;EEF1D;TP53;RHOB
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.3384772584731746,-0.5897352275348607,0.926829268292683,1.0,1.0,4/18,14.78%,F11R;DAB2IP;SH3BP4;USP17L2
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.2912240306047815,0.5894973594053742,0.9803921568627451,1.0,1.0,2/24,7.04%,HCLS1;HDAC3
prerank,GO_Biological_Process_2021__cardiac atrium development (GO:0003230),0.3735554414137635,0.5892024261375982,0.9787234042553191,1.0,1.0,2/6,11.23%,ANK2;DAND5
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.26676121073683556,-0.5879018728954628,0.9814814814814815,1.0,1.0,3/42,9.16%,ATG14;RBM3;RBM4B
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.36020329745970764,0.5877873266687926,0.9464285714285714,1.0,1.0,2/8,22.18%,VEGFA;RYK
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.30845750871716243,-0.5875790068709504,0.9302325581395349,1.0,1.0,1/16,3.40%,NMUR2
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,0.26235173854269445,0.5872313147904251,1.0,1.0,1.0,11/71,16.56%,LRRC46;TTC29;TEX26;CYP2S1;C6ORF118;SPAG6;CDHR3;MORN5;CCDC181;FAM81B;PPIL6
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.328785014596815,-0.5868779940574074,0.92,1.0,1.0,1/14,5.94%,PCSK6
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.2988838804813866,0.5862734390701682,0.94,1.0,1.0,6/23,20.82%,RYBP;RNF2;BCOR;PCGF1;RAG1;UBE2E1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.3334433455070337,-0.5861454158971011,0.9777777777777777,1.0,1.0,3/13,18.22%,SMUG1;NT5C;MBD4
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.2745440826494947,-0.58583345419176,1.0,1.0,1.0,4/31,11.63%,RIN3;PAX2;LRPAP1;WDR54
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.353260047729413,0.5856230762002138,0.9322033898305084,1.0,1.0,1/8,12.54%,SMC5
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),-0.3865335478376076,-0.5856116529872031,0.875,1.0,1.0,5/5,61.36%,ALKBH1;ALKBH5;ALKBH3;JMJD6;FTO
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.35877565983743337,-0.5854898814101337,0.86,1.0,1.0,2/7,20.69%,APH1B;APH1A
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.2825743679360327,0.58511604271735,0.9827586206896551,1.0,1.0,7/29,19.82%,GRIK2;ZDHHC2;NETO1;DBN1;PPFIA3;SHISA8;MCTP1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.22351898461705502,-0.5846578068942829,1.0,1.0,1.0,50/257,21.02%,SNRNP27;DDX41;PRPF4;ZCRB1;RBM4;DHX8;WBP4;RNF113A;RBM4B;SRPK3;PRPF19;RNPC3;GTF2F1;SNRNP200;SNRPA1;CPSF4;RBMX2;CPSF3;SNIP1;WDR77;CWC25;PRMT7;SF3A3;SUGP1;ESS2;CWF19L1;FIP1L1;DNAJC8;CSTF2;HNRNPL;SRSF10;PRPF6;SYF2;MAGOHB;SNW1;DHX38;CRNKL1;MFAP1;DHX35;SF3A1;RBM22;COIL;SNRPD2;PRCC;PDCD7;WBP11;SRSF7;RBMX;SLU7;NONO
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.32192456166994343,0.5845991579683374,0.9375,1.0,1.0,2/18,12.74%,TEX15;ATF7IP
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.32192456166994343,0.5845991579683374,0.9375,1.0,1.0,2/18,12.74%,TEX15;ATF7IP
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.3666431104282737,-0.5842686402701308,0.9333333333333333,1.0,1.0,1/12,3.84%,ARPC5L
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.37943928865006654,0.583739987468999,0.9464285714285714,1.0,1.0,2/7,10.18%,GLUL;PYCR1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.2807232068180487,-0.5831401748745005,0.98,1.0,1.0,3/35,14.01%,CENPH;ITGB3BP;SMARCA5
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),-0.3371360324636511,-0.5831391306478356,0.9375,1.0,1.0,3/13,19.27%,PEX7;PAFAH1B1;TMEM86B
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.35620108583490484,-0.5828850604797445,0.8571428571428571,1.0,1.0,2/7,22.63%,SUPV3L1;TRMT10B
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.23766770714688817,-0.5824948904299792,1.0,1.0,1.0,28/154,25.45%,ERN2;SENP3;LAS1L;PDCD11;UTP11;RPL38;EMG1;DEDD2;EBNA1BP2;RPL12;UTP15;RPL37A;MRTO4;RPS27;RPL4;RPL5;MAPT;EXOSC10;SBDS;WDR55;RRP12;RPL22;UTP14A;FCF1;RPL34;RPL31;DDX49;RPL37
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),-0.3674815905015518,-0.5823970577443145,0.9302325581395349,1.0,1.0,3/6,27.89%,D2HGDH;ADAM9;PRKN
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.2881322793024678,-0.5819521717175425,0.975609756097561,1.0,1.0,4/28,10.45%,SVIP;HFE;CAMLG;DDRGK1
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.30961452116153376,0.581670058762769,0.8867924528301887,1.0,1.0,2/11,16.05%,GSN;WASHC5
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),-0.35638577626285994,-0.5813829440946084,0.9375,1.0,1.0,1/7,10.22%,SAPCD2
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.3317609415221977,-0.5812485459112218,0.9090909090909091,1.0,1.0,2/10,14.10%,PTCH1;CYP26B1
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.3391893719445455,-0.5812437224972544,0.8863636363636364,1.0,1.0,1/8,7.15%,HCK
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.32694758922994105,-0.5810420504919325,0.9285714285714286,1.0,1.0,1/13,3.41%,ALOX5
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.30422362547333964,0.580773091007797,0.9807692307692307,1.0,1.0,5/24,18.14%,WNT4;PRKCSH;PROX1;COBL;CITED2
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.269543707566069,0.5803615849463274,1.0,1.0,1.0,6/29,23.10%,CHCHD4;HSPA8;SDF2L1;DNAJB1;HSPA5;HSPA1A
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.33967964471898765,0.5797794363557607,0.9622641509433962,1.0,1.0,5/13,28.17%,LIG4;ANXA1;BRCC3;IKBIP;NIPBL
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.30922131224554295,0.5796677152848854,0.8939393939393939,1.0,1.0,7/15,21.72%,CCL5;CYP7B1;CH25H;PIK3CD;CCL25;GAS6;HSD3B7
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.3445005363427511,0.5795185138890847,0.9285714285714286,1.0,1.0,1/10,5.20%,IMMP2L
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.37800948435922466,-0.5794936147298818,0.9230769230769231,1.0,1.0,1/5,20.63%,RNF20
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.28619497922255566,0.5793361031119134,1.0,1.0,1.0,11/27,28.41%,CTNNA2;PLXNB2;NTNG2;RAPGEF2;NEXMIF;ARHGEF2;TNN;PHACTR1;SEMA6A;NIPBL;SRGAP2
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.3330769195188688,0.5792840521437865,0.9615384615384616,1.0,1.0,1/13,2.45%,CDK11A
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),0.36976614210339,0.5789938078193013,0.9444444444444444,1.0,1.0,1/8,5.13%,ODC1
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.3103365184483623,0.5786842283697555,0.92,1.0,1.0,2/20,12.74%,TEX15;ATF7IP
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.2793128050281038,0.5786812422945022,0.9642857142857143,1.0,1.0,16/43,28.65%,SNCA;GSN;NPPA;SNCAIP;GGA1;CALB1;H3-3A;ADAM10;IAPP;ITM2B;FURIN;USP9X;BACE1;CD36;B2M;APP
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.32442302386168254,0.5786688018427122,0.9344262295081968,1.0,1.0,4/14,23.64%,SMAP1;WASL;DGKD;SNAP91
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.3405365124200346,0.578648018324599,0.9411764705882353,1.0,1.0,4/10,28.77%,SPEF2;DNAAF2;ROPN1L;SPAG17
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.27550472396997056,0.5784764249785858,1.0,1.0,1.0,11/35,25.05%,DBN1;KIAA0319;L1CAM;DIP2B;CDKL5;MACF1;ABL1;MAP2;GOLGA4;NRCAM;APOE
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.3417414002449046,-0.5783723561309324,0.8717948717948718,1.0,1.0,1/9,6.42%,MBTPS2
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.35761841335242994,-0.5771448538740902,0.9622641509433962,1.0,1.0,1/9,9.00%,ERI2
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.2763907232486791,0.5764913666471501,1.0,1.0,1.0,2/33,6.65%,HES6;ELAPOR2
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.36701728029277797,0.5763532290317973,0.9555555555555556,1.0,1.0,3/8,28.65%,ABCD2;INSR;APP
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.273521947575615,-0.5763386633430649,0.9814814814814815,1.0,1.0,17/42,25.99%,SRPK3;PRPF19;CELF3;SNRNP200;SF3A3;SRSF10;PRPF6;CRNKL1;SF3A1;SNRPD2;LUC7L2;KHDC4;CELF5;SF3A2;DDX1;USP39;SMN1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),-0.3588958549615673,-0.576287724739052,0.9333333333333333,1.0,1.0,1/5,9.98%,MMP9
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),0.36733109800275743,0.5761919291721666,0.9215686274509803,1.0,1.0,2/5,24.20%,ENPP3;DCK
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.33439038243089736,-0.5758486927995742,0.9555555555555556,1.0,1.0,11/11,66.58%,GAK;EHD3;LAMP1;CLN3;RBSN;AP1G1;ANKFY1;AP4M1;SORT1;LAPTM5;CCDC91
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),0.35860080933193383,0.5754094626266089,0.9607843137254902,1.0,1.0,2/6,16.59%,HIGD1C;HIGD1B
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.2820206302259087,-0.5752719367415255,0.98,1.0,1.0,4/25,14.29%,KCNE2;KCNE1;KCNS1;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.2586394296151902,-0.5746067118630841,0.975,1.0,1.0,9/46,19.37%,PIAS3;PER2;CAMLG;CAV1;USP4;UFL1;CHP1;SH3RF2;GTPBP4
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.3643448257285278,0.5730608959941729,0.9423076923076923,1.0,1.0,2/8,16.58%,NFATC3;HEY2
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.297661057548792,0.5728812721966297,1.0,1.0,1.0,9/28,27.67%,TCAF2;MFF;ITGB2;MYO1C;AKT2;ITGAM;MIEF2;CIB1;C2CD5
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.3340263146309232,0.5728522630327028,0.9767441860465116,1.0,1.0,2/11,19.73%,FADD;LYN
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.3071022993806772,0.5727919311156224,0.9830508474576272,1.0,1.0,1/17,4.85%,GLUL
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.3403835057934234,0.5721869991497114,0.9583333333333334,1.0,1.0,1/10,9.99%,BIN1
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.3300681281397546,0.5721213977178646,0.9772727272727273,1.0,1.0,2/17,7.00%,ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.37419960633653676,-0.5718850770531535,0.9318181818181818,1.0,1.0,2/9,13.28%,CAV1;ATP6V0A2
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.2808566910585447,0.5718626984974006,0.9811320754716981,1.0,1.0,4/33,18.36%,GLRA1;RRAGC;CPEB1;RRAGD
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.376201132958878,-0.5715153000526039,0.9433962264150944,1.0,1.0,1/5,14.31%,MFSD2A
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.3297227509279469,-0.5714893055419582,0.9215686274509803,1.0,1.0,4/8,28.53%,EIF5A;MSX1;PRKN;UBB
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.3284086960008008,-0.5712528328007835,0.875,1.0,1.0,2/9,14.78%,DHX58;USP17L2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.33881245829909906,0.5708477354099368,0.9333333333333333,1.0,1.0,6/9,32.04%,EFNA1;ANXA2;FURIN;EPHA4;NELL1;ATRAID
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.34041824977854007,0.5707504203353617,0.9019607843137255,1.0,1.0,3/8,24.45%,DNM3;MX2;MIEF2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.34041824977854007,0.5707504203353617,0.9019607843137255,1.0,1.0,3/8,24.45%,DNM3;MX2;MIEF2
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.38950776032917217,0.5705399475401924,0.9090909090909091,1.0,1.0,4/6,28.30%,SLC3A2;SLC7A8;SLC38A5;SLC16A10
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.2688872645486814,0.5692119918868099,0.9807692307692307,1.0,1.0,7/47,17.80%,CORO7;GSN;MSRB1;SPIRE2;COBL;WASHC5;WASL
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),-0.35908453308861316,-0.5691221479078774,0.9215686274509803,1.0,1.0,1/7,4.55%,SLC39A4
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.31315819762925123,-0.5686964480219838,0.9767441860465116,1.0,1.0,7/19,22.98%,MYO5B;MYO15A;MYO7B;MYO1H;MYO5C;ACTN4;MYO1F
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.3609449888725931,-0.5684046528004502,0.9591836734693877,1.0,1.0,1/8,9.00%,ERI2
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.3609449888725931,-0.5684046528004502,0.9591836734693877,1.0,1.0,1/8,9.00%,ERI2
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.3086709656278103,-0.568195188206523,0.9411764705882353,1.0,1.0,3/15,14.64%,CLTA;NSG2;CLTB
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.3504026617436614,0.5680527283488126,0.9574468085106383,1.0,1.0,1/7,7.66%,SLC24A2
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.3133375454994251,0.5674491987397569,0.9629629629629629,1.0,1.0,5/13,32.47%,MFF;PNPT1;PID1;CSPG5;MTM1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),-0.3574673480976718,-0.5672127893037592,0.9574468085106383,1.0,1.0,7/7,64.27%,EIF4ENIF1;AGO2;EIF4G1;STAT3;DDX6;EIF4E2;TNRC6B
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),-0.3574673480976718,-0.5672127893037592,0.9574468085106383,1.0,1.0,7/7,64.27%,EIF4ENIF1;AGO2;EIF4G1;STAT3;DDX6;EIF4E2;TNRC6B
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.2864320451349534,0.5669266848267943,1.0,1.0,1.0,6/26,21.62%,SLC38A3;SLC7A9;SLC3A2;SLC36A1;SLC6A15;SLC7A8
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.2950427341389119,-0.5663684818046113,0.9512195121951219,1.0,1.0,2/25,8.82%,HFE;LAMP3
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.2406305466974363,-0.5663431982592588,1.0,1.0,1.0,17/117,18.27%,GINS3;RECQL5;ORC6;PSMB4;RPAIN;RFC3;PSMC4;RPA3;RFC2;PSMD8;CDC6;MCM2;PSME3;RFC1;CDC7;BLM;PNKP
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.36099058481571616,-0.5656551570569829,0.9714285714285714,1.0,1.0,2/9,16.06%,CAMKK2;VDAC1
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.32867175378907687,0.5655969223755835,0.9,1.0,1.0,2/10,10.99%,MUC13;CRACD
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.3491431303397462,0.5651216228158373,0.9322033898305084,1.0,1.0,2/7,21.95%,TAC1;TACR3
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),0.3965393133897135,0.5649558058880665,0.9591836734693877,1.0,1.0,2/5,20.77%,HTR2C;HTR2A
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),-0.37708016656747645,-0.5643006902927772,0.8947368421052632,1.0,1.0,2/6,19.09%,DHX30;MPV17L2
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.2746335430788851,0.5638479976274,0.9607843137254902,1.0,1.0,6/26,20.35%,TICAM1;GPR108;MFHAS1;IRAK3;LYN;TICAM2
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.30067348937747623,0.5637756074038488,0.96,1.0,1.0,4/14,26.61%,NLRP7;GAS1;SERPINE1;CHAC1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.2907533800590346,-0.5636970168732219,1.0,1.0,1.0,5/27,16.78%,CALB2;SHISA7;SHANK3;ADCY1;AKAP5
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.2795152690995508,-0.5632861247380928,1.0,1.0,1.0,2/31,7.08%,ACTN3;LAMB3
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.2757464825635042,-0.5632108427316226,0.9772727272727273,1.0,1.0,4/35,13.63%,TIMP4;PTPN3;DAB2IP;AZIN1
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.34176428005981296,0.5623337281834287,0.9696969696969697,1.0,1.0,1/8,6.50%,MEGF10
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.2984243731222076,-0.5616475288911823,0.9245283018867925,1.0,1.0,4/14,16.15%,PUDP;TK2;UPP1;TYMP
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.3047887464921505,0.5612045314625623,0.9649122807017544,1.0,1.0,2/18,12.08%,LLGL1;FMNL3
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.3098225599526523,0.5611891026993358,0.9818181818181818,1.0,1.0,3/13,17.39%,PLA2G10;MSR1;CSF1
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.3620911858281409,0.5611091211308072,0.94,1.0,1.0,4/8,35.18%,LIMK2;DLG1;CLASP1;TPPP
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.3666225297157666,-0.55936917817401,0.9534883720930233,1.0,1.0,4/8,22.06%,ADAMTS1;PDGFB;NR4A3;FGF9
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.30814776147275963,-0.5592292607515389,0.9583333333333334,1.0,1.0,4/13,25.00%,KCNB1;MEAK7;MTOR;SCTR
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.3275913392186415,0.5592006028940136,0.9791666666666666,1.0,1.0,5/11,26.90%,RAPGEF6;AFDN;RAPGEF2;TJP2;TJP1
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.3654815466548344,-0.5590205005854467,0.9803921568627451,1.0,1.0,2/5,25.88%,DCN;RACK1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.3400059170241744,-0.5580830815861965,0.8269230769230769,1.0,1.0,2/9,17.01%,ADCY1;AHR
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.3400059170241744,-0.5580830815861965,0.8269230769230769,1.0,1.0,2/9,17.01%,ADCY1;AHR
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.2731077276407797,0.5575929399940258,1.0,1.0,1.0,2/24,11.92%,NLGN1;MEF2C
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.316256403775207,-0.5575729313435029,0.9298245614035088,1.0,1.0,4/13,25.38%,SRSF10;SRSF7;RBMX;RNPS1
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.34821618678138755,-0.5575103258897838,0.9375,1.0,1.0,1/5,10.36%,BEX4
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.3229806917809959,-0.5571273499311903,0.9795918367346939,1.0,1.0,4/16,14.90%,RHBDF1;CEACAM1;WDR54;RHBDF2
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.216085052997279,-0.5570103193792308,1.0,1.0,1.0,46/234,21.02%,SNRNP27;DDX41;PRPF4;ZCRB1;RBM4;DHX8;WBP4;RNF113A;RBM4B;PRPF19;RNPC3;GTF2F1;SNRNP200;SNRPA1;CPSF4;RBMX2;CPSF3;SNIP1;CWC25;SF3A3;SUGP1;ESS2;CWF19L1;FIP1L1;DNAJC8;CSTF2;HNRNPL;SRSF10;PRPF6;SYF2;MAGOHB;SNW1;DHX38;CRNKL1;MFAP1;DHX35;SF3A1;RBM22;SNRPD2;PRCC;PDCD7;WBP11;SRSF7;RBMX;SLU7;NONO
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.31669613179927414,0.556924810549878,1.0,1.0,1.0,4/12,27.31%,ADGRB3;CD81;JAM2;ADAMTS5
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.262587759977561,0.5567711170222328,0.9811320754716981,1.0,1.0,4/32,13.69%,GLRA1;GLRB;RRAGC;CPEB1
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.316325919265318,0.5562901385225866,0.9464285714285714,1.0,1.0,6/12,27.24%,H6PD;ABCA2;SEC14L2;SREBF2;CLCN2;LPCAT3
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.3755790571528431,0.5562654244818491,0.896551724137931,1.0,1.0,1/5,14.02%,PML
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.27081423979010977,0.5556417769906468,0.9807692307692307,1.0,1.0,2/25,7.04%,HCLS1;HDAC3
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.3463635551985981,0.55512148090163,0.9393939393939394,1.0,1.0,4/7,18.20%,TICAM1;SLC3A2;IRAK3;RIOK3
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.32467685414694736,-0.5548717070724429,0.9090909090909091,1.0,1.0,4/13,16.78%,SHISA7;SHANK3;ADCY1;AKAP5
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),-0.35414301120603076,-0.5547933856255326,1.0,1.0,1.0,1/7,6.36%,PAX2
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),0.33059105734521743,0.5538498496732736,0.9795918367346939,1.0,1.0,5/11,25.05%,CD34;KNG1;EDN1;SERPINE1;APOE
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.326033029928306,0.5536699002257428,0.9074074074074074,1.0,1.0,3/7,26.64%,DYRK1A;ABCA7;BACE1
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),-0.31544640562014126,-0.5518635617312241,0.9512195121951219,1.0,1.0,1/8,11.20%,SEMA3F
prerank,GO_Biological_Process_2021__progesterone metabolic process (GO:0042448),0.35226115220047244,0.5517085574326558,0.9230769230769231,1.0,1.0,2/5,17.69%,AKR1C1;AKR1C3
prerank,GO_Biological_Process_2021__positive regulation of NK T cell activation (GO:0051135),0.3692293950433651,0.5516145425689509,0.9491525423728814,1.0,1.0,3/5,30.35%,IL23R;IL12A;IL23A
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.32374357762081796,0.5512233925078592,0.9821428571428571,1.0,1.0,2/8,26.81%,HEBP2;PRELID1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),0.32010662469646634,0.5510202528464133,0.9814814814814815,1.0,1.0,3/12,19.84%,TAP1;HLA-E;HLA-F
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.2333802772363527,-0.5507197160052982,1.0,1.0,1.0,11/67,16.24%,POLR1G;SSU72;GTF2H2;CPSF4;CPSF3;POLR1A;TBP;TTF2;FIP1L1;POLR1C;CSTF2
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.2100832414017294,0.5501678552866442,1.0,1.0,1.0,45/277,23.18%,U2AF1;HNRNPH1;SF3B1;THOC6;SYNCRIP;SNRPN;ELAVL2;TRA2A;NOVA1;PAPOLA;CMTR2;SNRNP48;PCF11;HNRNPD;PUF60;PRPF40B;CDC5L;HSPA8;LSM8;RBM5;CCNH;RBM41;SPEN;SRSF11;HNRNPA2B1;MNAT1;ZCCHC8;PSPC1;FUS;RBM10;RAVER2;CSTF3;RBM17;POLR2H;WDR33;NCBP1;XAB2;SNRPA;CWC27;SRSF3;ERCC3;HNRNPU;LSM2;HNRNPF;GEMIN6
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),0.34275660680468956,0.5494214013666744,0.9818181818181818,1.0,1.0,2/9,10.99%,MUC13;CRACD
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.30317109135370685,-0.5493296480864963,0.9347826086956522,1.0,1.0,3/11,26.73%,CHMP3;ATP9A;SRC
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),-0.32441984167965354,-0.549094520825896,0.9,1.0,1.0,1/9,16.57%,ADCY1
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.2577324798379989,0.5490131903985804,1.0,1.0,1.0,7/28,23.79%,CARMIL1;SNX2;ARHGEF6;RHOD;KIT;ARHGEF4;SNX1
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.3392641828214517,0.5488928755492819,0.9344262295081968,1.0,1.0,2/7,23.10%,NFE2L2;BCAP31
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.3014709791940426,0.5486175756391038,1.0,1.0,1.0,5/13,22.70%,APELA;ACVR1B;VEGFA;TIMP1;GJA1
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.2656495869382945,0.5480864320949818,0.9814814814814815,1.0,1.0,1/35,1.82%,CCL5
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.25377003409007165,0.5478735002006698,1.0,1.0,1.0,13/54,23.87%,KIAA0586;MAPK8;SLC26A4;RAB9A;PICALM;DZIP1L;AFDN;BORA;MAP2;RABGAP1L;DLG1;TRIM68;CEP290
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.35635703634003146,0.5474955611823326,0.9629629629629629,1.0,1.0,2/8,14.86%,CTCFL;PCGF5
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.31443353120771067,-0.547245495299258,0.9607843137254902,1.0,1.0,2/8,24.94%,TGFB1;THBS1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.2917581070462678,0.5470288281347099,0.9811320754716981,1.0,1.0,5/12,37.49%,GNL3L;CCT3;CCT7;DKC1;CCT4
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.3290329513525032,-0.546060420678701,0.9629629629629629,1.0,1.0,3/10,12.79%,WNT7A;AKNA;WNT3A
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.2821310175681775,-0.5459310614343248,0.9814814814814815,1.0,1.0,2/24,7.96%,PER2;JUN
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.33611742300818603,-0.5458902305027726,0.9607843137254902,1.0,1.0,2/9,13.36%,TMSB4X;XRCC1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.29782903495203245,-0.5458458947378663,1.0,1.0,1.0,4/20,17.78%,TTBK1;CCND1;RGCC;PDGFB
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.31762385190383113,0.545191283373022,0.9787234042553191,1.0,1.0,3/9,21.42%,PTGFR;AKR1C3;TNFSF4
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.2805365639265752,-0.5445624367593215,0.9772727272727273,1.0,1.0,4/20,21.42%,MBTPS2;GNB3;MBTPS1;EPHX2
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.28821283795569824,-0.5444987929146545,1.0,1.0,1.0,1/22,7.86%,BTBD18
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.3033043297500029,0.5439448045773445,0.9433962264150944,1.0,1.0,6/14,30.12%,RNF26;ZMPSTE24;DHX9;ELMOD2;PCBP2;HERC5
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.25217087552088946,-0.5439415185891109,1.0,1.0,1.0,14/37,34.49%,POM121C;NUP133;SEC13;NUP93;NUP43;RAN;NUP214;NPM1;NDC1;NUP88;TSC1;NUP37;NUP35;NUP50
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.347817734915303,0.5436340135922227,0.9464285714285714,1.0,1.0,4/7,26.89%,H6PD;AKR1C3;CLCN2;SIRT5
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.3558454855278754,-0.5433195861879957,0.96,1.0,1.0,1/6,14.35%,DCTN1
prerank,GO_Biological_Process_2021__epithelial cell differentiation involved in kidney development (GO:0035850),0.3474646050467418,0.5430660107132976,0.9649122807017544,1.0,1.0,2/6,11.92%,MTSS1;MEF2C
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),-0.34042256929572645,-0.5430213096437773,0.9302325581395349,1.0,1.0,2/5,18.30%,MYLK3;CAV3
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.2877722582742294,-0.5428645729701667,0.9824561403508771,1.0,1.0,2/21,6.36%,CRYBA4;PAX2
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.30086057005226613,-0.5424804738521947,0.8979591836734694,1.0,1.0,4/12,16.15%,PUDP;TK2;UPP1;TYMP
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.30046624324413684,-0.5421980565085319,0.9555555555555556,1.0,1.0,3/12,21.55%,PARP1;TYMP;MPV17
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.32020063136506177,-0.5420836085811611,0.8958333333333334,1.0,1.0,3/9,17.76%,SMAD3;TGFB1;RGCC
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.2766439239024582,-0.5418052670280071,1.0,1.0,1.0,4/31,14.14%,RCC1L;APOO;SPG7;DNAJC11
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.3211821600186685,0.5410262953278133,0.9782608695652174,1.0,1.0,5/12,30.68%,THEM5;PNPLA8;SLC27A1;HADHB;PLA2G6
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.3205413334595183,-0.5406554994019819,0.9473684210526315,1.0,1.0,6/6,67.96%,TRIM62;PRKN;UBE2D4;UBE2T;UBE2S;RNF6
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),-0.2993184399848542,-0.539368238535902,0.9056603773584906,1.0,1.0,11/11,70.09%,ADCY1;ADCY8;ADCY7;PTHLH;ADCY6;ADCY9;ADCY3;ADCY10;ADCY5;ADCY2;PDE4D
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.31681833225608996,0.5392262279250997,0.9795918367346939,1.0,1.0,8/12,40.92%,PTEN;SPTBN4;B4GALT5;ARHGAP35;MYCBP2;EPHB6;B4GALT6;CHRNB2
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.2542942049534001,0.538578710235554,1.0,1.0,1.0,3/36,10.28%,NDE1;MYO1E;HAP1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),0.3425480513793231,0.5384527440159008,0.9473684210526315,1.0,1.0,2/7,20.77%,HTR2C;HTR2A
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),0.3692052226307373,0.5381408008159559,0.9836065573770492,1.0,1.0,1/5,7.63%,TF
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),0.3869001336178812,0.5380967571876728,0.95,1.0,1.0,4/5,34.15%,EXOSC2;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),0.3869001336178812,0.5380967571876728,0.95,1.0,1.0,4/5,34.15%,EXOSC2;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),0.3869001336178812,0.5380967571876728,0.95,1.0,1.0,4/5,34.15%,EXOSC2;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),0.3869001336178812,0.5380967571876728,0.95,1.0,1.0,4/5,34.15%,EXOSC2;EXOSC8;EXOSC9;EXOSC7
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.2635027042712448,-0.5377517264408322,0.9761904761904762,1.0,1.0,6/25,18.30%,ANKRD53;RAC1;DCTN1;TRPV4;KATNB1;CAV3
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.3477395411314468,0.5375437151819497,0.9607843137254902,1.0,1.0,3/7,29.59%,SMAD4;RGS2;NOTCH1
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.35401501990071055,-0.5369197107741688,0.94,1.0,1.0,1/5,16.77%,RAB3A
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.2273226177112987,0.536553611786843,1.0,1.0,1.0,21/84,30.92%,FBXO5;ANAPC16;PSMD13;PSME4;PSMA1;TP53;FZR1;UBE2D1;UBE2E1;PSMD4;ERCC3;GTSE1;PSMB5;ANAPC15;PSMB1;PSMC5;BTRC;TRIM39;CDC27;CCNB1;ANAPC7
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.31907605423337265,0.5361711952417461,1.0,1.0,1.0,4/13,23.57%,ESR1;PLPP1;NR3C1;BMP4
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),-0.30872810080306223,-0.5361672837461572,0.8771929824561403,1.0,1.0,2/11,12.99%,UBASH3B;PTK2B
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.29292700293177365,0.5358214580133772,1.0,1.0,1.0,4/11,25.03%,CD81;SAR1A;BCAP31;EDEM1
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.31934168415660524,-0.5357644701469306,1.0,1.0,1.0,1/8,8.85%,PGP
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.2943914781430012,0.5357037795410475,1.0,1.0,1.0,8/17,39.29%,CNTN4;HES5;B2M;DLX1;CALR;SOX9;GSK3B;HES1
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),0.32293334246558636,0.5348157955098902,0.9508196721311475,1.0,1.0,1/8,17.28%,MTRF1
prerank,GO_Biological_Process_2021__L-phenylalanine catabolic process (GO:0006559),0.3551437343355939,0.534810349069364,0.9375,1.0,1.0,3/5,28.45%,IL4I1;FAH;QDPR
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),0.3551437343355939,0.534810349069364,0.9375,1.0,1.0,3/5,28.45%,IL4I1;FAH;QDPR
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.28758223532611393,0.5346502183095438,1.0,1.0,1.0,8/17,39.48%,SEC61A1;RYR2;EDEM1;RAB10;SRPRB;SEC61G;ZFAND2A;RAB3GAP1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),-0.3483541864386953,-0.5341420355507275,0.9361702127659575,1.0,1.0,1/8,8.01%,DPH6
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.33104857884476746,-0.5340257496342254,0.9814814814814815,1.0,1.0,1/8,9.08%,PDPR
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.33104857884476746,-0.5340257496342254,0.9814814814814815,1.0,1.0,1/8,9.08%,PDPR
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.26076835237012597,-0.5339688456791967,1.0,1.0,1.0,2/22,10.00%,RAD50;RTEL1
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.3421824720802574,-0.5339030739156368,0.9555555555555556,1.0,1.0,7/7,65.80%,SRC;BDNF;FYN;STAP1;DOCK3;NTRK2;DUSP22
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),-0.3346555527632506,-0.5335263089305867,0.9215686274509803,1.0,1.0,2/6,15.41%,CARTPT;ID2
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.2965067486990837,-0.5332140759146147,0.9736842105263158,1.0,1.0,3/13,23.88%,EPHB1;PAFAH1B1;TSKU
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.32849098566223445,-0.532994518587423,0.9285714285714286,1.0,1.0,6/6,67.16%,PRDM5;SETDB1;SUV39H1;SUV39H2;BEND3;SETDB2
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),-0.32915345667912743,-0.5327649919378156,0.9607843137254902,1.0,1.0,6/6,67.10%,MSH3;TCF7L2;MSH2;MSH6;AXIN2;RMI2
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.29645298072737436,-0.5326964145281605,1.0,1.0,1.0,2/16,8.26%,HSD3B2;HSD3B1
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.32948235824378336,0.532597817072986,0.9444444444444444,1.0,1.0,2/8,25.74%,PTPN23;RAB21
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.24043841400722402,-0.5325132170890291,1.0,1.0,1.0,15/43,27.64%,PSMB4;OAZ3;PSMC4;AZIN1;PSMD8;PSME3;PSMD12;PSMC3;PSMC2;PSMD2;PSMA5;PSMC1;PSMD3;NQO1;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),0.31891737518924346,0.5320743364108499,0.9583333333333334,1.0,1.0,2/8,12.69%,PLXNB1;GREM1
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.2749891413487536,0.5309404788268769,1.0,1.0,1.0,7/26,34.98%,DYNC1I2;ARL13B;WDR81;ACBD5;DYNC1I1;IFT88;DYNC1H1
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.2708144217293167,0.5309266711572863,0.9782608695652174,1.0,1.0,3/20,18.25%,DLC1;PTPRK;RHOD
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.24411456303458948,-0.530907242277325,0.9791666666666666,1.0,1.0,7/33,27.17%,POM121C;NUP133;SEC13;NUP93;NUP43;RAN;NUP214
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.24411456303458948,-0.530907242277325,0.9791666666666666,1.0,1.0,7/33,27.17%,POM121C;NUP133;SEC13;NUP93;NUP43;RAN;NUP214
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.22604526627535576,-0.5307601446623591,1.0,1.0,1.0,16/87,25.45%,TMA7;ZC3H15;RPL38;RPL12;RPL37A;RPS8;RPS27;RPL4;RPL5;RPL26L1;DRG1;RPS20;RPL22;RPL34;RPL31;RPL37
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.3093000655704607,-0.5307199638274126,0.9743589743589743,1.0,1.0,1/9,9.72%,ZNF703
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.341762219511223,-0.5292793345093793,0.9565217391304348,1.0,1.0,1/6,15.76%,VPS35
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.2378349105975397,0.5285429072959722,1.0,1.0,1.0,17/63,29.15%,RELA;PSMD13;TNFRSF10B;IRAK1;PSME4;PSMA1;BIRC3;TNFRSF10A;PSMD4;REL;TRAF6;PSMB5;CHUK;PSMB1;PSMC5;DICER1;BTRC
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.3003054123164845,0.5283653558478479,0.9649122807017544,1.0,1.0,1/10,15.66%,PRKAA1
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),0.30243245446445877,0.5279428802841021,0.9423076923076923,1.0,1.0,5/8,33.16%,CX3CR1;JAK2;SIRPA;CD47;NOS1AP
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),0.3399326155132762,0.5279288844317832,0.9846153846153847,1.0,1.0,3/6,32.83%,TNFSF4;BMP4;ZC3H8
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.2985025581371191,0.5276350393139673,0.9795918367346939,1.0,1.0,4/12,32.21%,PCGF5;HNRNPU;RBM15B;YTHDC1
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.3572784929839862,0.5276138709760315,0.9591836734693877,1.0,1.0,3/5,25.42%,NOTCH2;DOCK10;DOCK11
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.206939588755528,0.5275080225853277,1.0,1.0,1.0,21/165,21.31%,RIOK2;TSR3;PWP2;EXOSC4;RPL21;BOP1;BYSL;RPL18A;MPHOSPH6;RPL7;RIOK1;WDR36;ERI1;RIOK3;EXOSC1;WDR18;TEX10;C1D;TFB1M;RPL23A;RRP1B
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.3327377451889363,-0.5273546780616228,0.9111111111111111,1.0,1.0,3/6,32.18%,SKP1;CAND2;RBX1
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.2548977256857054,0.527102539179271,0.98,1.0,1.0,6/32,20.64%,PAPOLA;PCF11;MAZ;CSTF3;WDR33;NCBP1
prerank,GO_Biological_Process_2021__negative regulation of pinocytosis (GO:0048550),-0.34855290466855066,-0.5266446702104243,0.9787234042553191,1.0,1.0,4/5,25.94%,CAV1;PROM2;STX1B;NR1H2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),-0.30769840588268615,-0.5266008449954057,0.9555555555555556,1.0,1.0,2/8,17.78%,FOXO4;PDGFB
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.31560056042194284,-0.52619898914127,0.9583333333333334,1.0,1.0,2/9,13.86%,SLC36A2;SLC6A20
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.21897466378510658,0.526005743649036,1.0,1.0,1.0,37/106,34.83%,MTHFD2;CNOT4;EXOSC4;DNAJC3;H2AX;ATF6;DNAJB9;CNOT2;VEGFA;FUS;EXOSC1;BANF1;HSPA5;EIF2AK3;ATF3;EDEM1;EXOSC5;CHAC1;ALDH18A1;TATDN2;EXOSC2;EIF4E;SEC31A;SEC11A;YWHAZ;DDIT4;HYOU1;CKS1B;NOLC1;DCP2;SRPRB;CALR;EXOSC9;FKBP14;NOP56;CXXC1;YIF1A
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.33563164911420973,0.5258720601293492,0.9148936170212766,1.0,1.0,1/8,12.47%,CD34
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.33563164911420973,0.5258720601293492,0.9148936170212766,1.0,1.0,1/8,12.47%,CD34
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.26255334179939704,0.525737369274527,1.0,1.0,1.0,5/27,19.07%,RANBP17;XPO1;STRADA;STYX;SMURF1
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.31147238404832095,0.5249941630277482,0.9444444444444444,1.0,1.0,5/8,36.98%,HEY2;GAS6;NOTCH1;ROCK1;SOX9
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.2857866535671446,0.5249134118653379,0.9818181818181818,1.0,1.0,4/15,31.21%,PRKACB;PRKAR2A;ADCY2;ADCY5
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.34416997917849723,0.5244528477406326,0.9591836734693877,1.0,1.0,7/7,65.59%,SASH1;DDX3X;BIRC2;PTPN22;PLAA;PARP10;GPS2
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.3540386249615972,0.5241846269363197,0.9555555555555556,1.0,1.0,3/5,39.74%,ATP8A1;ATP11B;SCARB2
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.3099593403791798,-0.5240540355864437,0.98,1.0,1.0,1/9,14.35%,DCTN1
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.27694224219182134,-0.5239777807849548,0.975,1.0,1.0,6/25,16.81%,PCSK6;ZNF703;SMAD3;TGFB1;LATS2;TGFBR3
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.26610613881078704,-0.5236041129796787,1.0,1.0,1.0,6/29,18.28%,POLR1G;GTF2H2;POLR1A;TBP;POLR1C;TTF1
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),-0.3158279915551077,-0.5232479894854679,1.0,1.0,1.0,1/6,10.61%,CCN3
prerank,GO_Biological_Process_2021__chylomicron assembly (GO:0034378),0.3418387343250397,0.5227040419860752,0.9807692307692307,1.0,1.0,1/6,7.72%,MTTP
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.29953649664821597,-0.5223365991620194,0.9583333333333334,1.0,1.0,4/16,15.54%,RNF8;KDM2B;RING1;SKP1
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),0.29635041779417903,0.5218470348417842,0.9803921568627451,1.0,1.0,1/11,8.16%,MCM7
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),-0.32587905767041436,-0.5214722506769359,0.92,1.0,1.0,2/5,20.77%,GRN;CYBA
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),0.33576787281128906,0.5212127854126878,0.967741935483871,1.0,1.0,1/6,15.16%,IL21R
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),0.33576787281128906,0.5212127854126878,0.967741935483871,1.0,1.0,1/6,15.16%,IL21R
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.238220612929069,0.5200711941013353,1.0,1.0,1.0,12/47,25.05%,HDAC2;BAG2;TANK;ASPH;FADD;PERP;ASTL;BAD;FURIN;OGT;AURKAIP1;APOE
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.33226168801085876,-0.5192132477303807,0.9090909090909091,1.0,1.0,2/5,20.65%,SLC25A29;PDZK1
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.3283860858991799,0.5181571860706227,0.9814814814814815,1.0,1.0,3/8,25.25%,ALCAM;SLIT1;SLIT2
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.3283860858991799,0.5181571860706227,0.9814814814814815,1.0,1.0,3/8,25.25%,ALCAM;SLIT1;SLIT2
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.3359077638754698,-0.5173109831154218,0.9591836734693877,1.0,1.0,1/6,15.40%,CALM1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.31478958914038535,0.5170529202552995,1.0,1.0,1.0,4/7,30.72%,ARHGAP21;STK25;RIPOR1;YWHAZ
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.3058100345955648,-0.5163282682649063,0.9318181818181818,1.0,1.0,3/9,20.56%,TGFB1;ID2;PRKCA
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.33541773953226206,0.5163022869989241,0.9807692307692307,1.0,1.0,1/5,22.70%,SH3GL2
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.27265789376699484,0.5159939978849142,0.9807692307692307,1.0,1.0,5/21,22.26%,PDGFC;GREM1;VEGFA;RAP2A;ACE
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.2584754236444922,0.5155003823905194,1.0,1.0,1.0,9/31,24.65%,CAVIN1;TAF1A;CCNH;POLR1H;MNAT1;POLR2H;MAPK3;ERCC3;TAF1B
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.2897782227553256,-0.5154610782664804,0.9534883720930233,1.0,1.0,1/7,10.36%,BEX4
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.3288560993728602,-0.5150569785728872,0.9512195121951219,1.0,1.0,1/8,10.52%,PARP1
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.26361737480186165,0.5143300692360107,0.9818181818181818,1.0,1.0,8/19,37.03%,SLC2A5;IRS2;ZBED3;SELENOT;LPL;EIF2B5;KHK;GPLD1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.2984855655466162,-0.514251675024454,0.9583333333333334,1.0,1.0,9/9,70.17%,UBB;DIS3L2;UBA52;UBC;CHFR;TUT7;RPS27A;ISG15;TUT4
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.26512575679967376,-0.514242063652823,1.0,1.0,1.0,4/25,15.06%,P2RY12;ABLIM2;RAC1;PARVB
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.26787309241224205,0.5142412629644392,1.0,1.0,1.0,5/27,20.75%,SKA3;STMN4;ABL1;MAP2;CAMSAP2
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.28012514296129765,0.5138161951805433,1.0,1.0,1.0,3/15,21.49%,HORMAD1;FMN2;NANOS1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",0.33943089195635556,0.5132501458765121,0.9444444444444444,1.0,1.0,3/6,21.36%,HLA-E;HLA-F;HLA-B
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),0.33943089195635556,0.5132501458765121,0.9444444444444444,1.0,1.0,3/6,21.36%,HLA-E;HLA-F;HLA-B
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.2652296370831426,-0.5123556505093898,1.0,1.0,1.0,8/35,20.59%,SFRP1;AR;AKR1C2;ADCY1;AHR;AQP1;NDOR1;PCK2
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.31014873160696776,-0.5116909161496163,0.9583333333333334,1.0,1.0,2/8,23.69%,KDM1B;RIOX1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.2787780509318586,-0.5112839730039859,1.0,1.0,1.0,4/17,17.76%,FLOT1;ADAM19;BMP6;RGCC
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),-0.3344863300438388,-0.5108739357265077,0.9534883720930233,1.0,1.0,1/5,17.38%,PAX8
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.3184429424645782,0.5103383133540761,0.9615384615384616,1.0,1.0,3/9,23.21%,GRID2;FMR1;CBLN1
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.2815518064081527,0.5101801800636908,0.9811320754716981,1.0,1.0,4/11,27.11%,ATP1A2;ATP1B2;ATP12A;KCNJ2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),-0.3170727150523716,-0.509158038004403,1.0,1.0,1.0,1/8,14.31%,MFSD2A
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.2494077591133715,-0.5087143753430479,1.0,1.0,1.0,3/29,12.23%,COPG2;RAB6C;COPG1
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.32176272382191906,-0.5085928599633752,1.0,1.0,1.0,1/6,15.04%,PHF19
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by integrin (GO:0033631),0.3476978404101028,0.5075768585665282,0.9836065573770492,1.0,1.0,4/5,34.81%,NPNT;PLPP3;ITGA4;ITGB1
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.28674869853289164,-0.5067163438017199,0.9767441860465116,1.0,1.0,9/9,71.34%,SLC2A1;CYB5R3;SLC2A3;SLC23A1;SLC23A2;CYB5A;RGN;GSTO1;GSTO2
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.2966576988760477,-0.505863066703201,1.0,1.0,1.0,1/9,9.04%,MLYCD
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.29109992551591496,-0.5051106537690359,1.0,1.0,1.0,2/12,17.26%,NRDE2;AKAP8L
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.22425181711858302,-0.5050364237709626,1.0,1.0,1.0,19/56,28.62%,ORC6;PSMB4;PSMC4;PSMD8;CDC6;MCM2;PSME3;MCM3;PSMD12;PSMC3;PSMC2;PSMD2;PSMA5;PSMC1;PSMD3;MCM6;PSMB9;UBB;PSMA7
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.27991381623620837,0.5049107584614434,0.9803921568627451,1.0,1.0,4/13,25.01%,PPP1R15B;DNAJB9;HSPA5;ABCA7
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),-0.3287593451310684,-0.5044762012932645,0.9523809523809523,1.0,1.0,5/5,67.14%,YAP1;PAK1;WBP2;KMT2D;LMO3
prerank,GO_Biological_Process_2021__proline metabolic process (GO:0006560),0.3394506451215764,0.5034952679147835,1.0,1.0,1.0,3/5,26.93%,PYCR1;DAO;ALDH18A1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.2851569513465639,0.5031412171692746,0.9795918367346939,1.0,1.0,1/11,10.14%,UQCC3
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),0.31678096676045747,0.5013058231215826,0.9814814814814815,1.0,1.0,1/6,9.65%,NECTIN2
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.29124512832737154,-0.5011445480377176,1.0,1.0,1.0,2/14,14.35%,ARF1;DCTN1
prerank,GO_Biological_Process_2021__regulation of glycogen (starch) synthase activity (GO:2000465),0.3441894258403496,0.5009914740165353,0.9433962264150944,1.0,1.0,3/5,38.49%,GSK3A;EPM2AIP1;GSK3B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.24179842099771787,-0.5007978006521069,0.9433962264150944,1.0,1.0,5/24,18.30%,DSG2;CTNNA3;CAV1;CALM1;CAV3
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.27901030088580675,0.5007540249577317,1.0,1.0,1.0,3/13,17.59%,DYNC1I2;APBA1;ARHGAP21
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.32093579577356385,0.5004300035737135,1.0,1.0,1.0,4/8,23.43%,NOC2L;IRS2;LYN;BLK
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.31745193048560594,-0.5004242608710306,0.9591836734693877,1.0,1.0,2/10,16.31%,JUN;HIF1AN
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.27179720457545015,0.49982481001568574,1.0,1.0,1.0,2/17,13.78%,PROX1;CCND3
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.2748796133824937,0.4978154948823915,0.9615384615384616,1.0,1.0,1/14,9.52%,PIK3CA
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.24061500043959033,-0.49752147803316465,1.0,1.0,1.0,6/33,18.28%,POLR1G;GTF2H2;POLR1A;TBP;POLR1C;TTF1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.32798363265082814,0.4968207551195739,0.9811320754716981,1.0,1.0,1/6,7.75%,HMGB1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.2803099566850508,0.4964351163846891,1.0,1.0,1.0,2/12,16.70%,COX6A1;COX10
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),-0.3273919166642667,-0.4960669009184261,0.9821428571428571,1.0,1.0,2/6,18.53%,SORD;ALDOB
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.26059766679627794,0.49569380587139966,0.9836065573770492,1.0,1.0,5/14,32.74%,PANK1;PPCS;ACLY;SLC25A16;PANK3
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.31659678103812816,0.4955582455182904,0.9545454545454546,1.0,1.0,2/9,25.74%,NUP153;AHCTF1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell differentiation (GO:0051152),0.3258205422986973,0.49520194671331996,1.0,1.0,1.0,2/5,26.96%,KIT;SHH
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.3269580326591417,-0.49506500832074246,0.9803921568627451,1.0,1.0,1/5,18.53%,ALDOB
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),-0.30921550040949375,-0.49422556176140325,0.9433962264150944,1.0,1.0,2/8,21.58%,CAV3;ACTN2
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),0.30222863681411,0.49398667438563965,0.9666666666666667,1.0,1.0,2/6,20.22%,GPR62;RAPGEF2
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.268859550790517,0.49218544476830217,0.9811320754716981,1.0,1.0,3/16,19.41%,TLR2;KIT;ANXA2
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.259413697485236,-0.4921355001593064,0.9807692307692307,1.0,1.0,2/20,9.26%,FLOT1;CDC37
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.3080490228552501,-0.49055194163508986,0.9444444444444444,1.0,1.0,6/6,69.21%,ATPAF1;TMEM70;ATPAF2;OXA1L;ATP5F1D;ATP23
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.21276157903940177,-0.49006550647765673,1.0,1.0,1.0,17/82,21.67%,PSMB4;FBXO39;FBXL18;PSMC4;CCNF;PSMD8;SKP1;PSME3;FBXL16;CUL2;FBXO2;FBXO44;PSMD12;FBXL13;FBXL12;PSMC3;PSMC2
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.23340408144876074,-0.4878792361884563,1.0,1.0,1.0,9/26,24.56%,CELF3;SF3A3;SRSF10;SF3A1;SLU7;LUC7L2;KHDC4;CELF5;SF3A2
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.25976395213178083,0.4873271270219629,0.9824561403508771,1.0,1.0,4/14,25.08%,AGR2;DNAJB9;HSPA5;TMEM33
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.306336097957386,-0.48685767614940667,0.975,1.0,1.0,4/10,27.40%,DAB2IP;PACSIN1;ALK;VLDLR
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.2801285870206277,-0.4853045506100764,1.0,1.0,1.0,3/12,20.69%,ADAM19;APH1B;APH1A
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.3005654475194784,0.48367853726497,1.0,1.0,1.0,2/9,20.60%,NR1H3;AXL
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.2506943974970074,0.4815249473888684,1.0,1.0,1.0,5/26,23.88%,NAV3;TOGARAM1;CLIP1;HSPA1A;AKAP9
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),0.3132985290440793,0.48113051894116626,0.9795918367346939,1.0,1.0,1/5,17.29%,AGMO
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.2759117826545917,-0.48105493637244556,0.9803921568627451,1.0,1.0,1/13,6.32%,SPACA3
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.2573565296812786,-0.48079335724143535,0.9761904761904762,1.0,1.0,4/12,26.10%,PACSIN3;ADAM8;ADAM9;SNX33
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.22901010728999946,0.4806476584272959,1.0,1.0,1.0,7/43,18.12%,NPC2;BTN2A2;FASN;ACACA;ACACB;PM20D2;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.3099891165475796,-0.4806344506426149,0.94,1.0,1.0,6/6,69.01%,ADAM17;FBXW7;BTC;EGF;TGFA;ADRA2A
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.2802941941235016,0.4793584420581521,1.0,1.0,1.0,4/11,24.93%,CCP110;LIMK2;EVI5L;CDK10
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),0.3103661820265799,0.4792943376890535,0.96,1.0,1.0,3/6,31.78%,CARD9;ACE;KMT2E
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.23320694986961088,-0.47866093147957595,1.0,1.0,1.0,4/28,15.15%,WNT7A;PTCH1;CYP26B1;OSR1
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.2589576092238751,0.47840770436180424,1.0,1.0,1.0,3/18,25.74%,PTPN23;MAPK3;RAB21
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),0.31839623760911406,0.47787762012416013,0.9444444444444444,1.0,1.0,2/6,25.30%,TMEM120A;SCN1A
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.25986401032852235,-0.4765972276356245,0.9591836734693877,1.0,1.0,1/9,8.95%,PCCB
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.28527969788259394,-0.4760911555920987,0.9787234042553191,1.0,1.0,2/15,15.04%,CAMLG;EMC1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.26037164508735877,-0.47585650168764887,1.0,1.0,1.0,3/18,12.59%,AR;MISP;GBP1
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),0.2723459456013844,0.4754711910042938,0.9574468085106383,1.0,1.0,2/11,18.93%,DSP;KIT
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.30366191740809556,-0.4749343478684939,0.9019607843137255,1.0,1.0,1/6,15.00%,SEC16A
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor internalization (GO:0098884),0.31260803002767457,0.4737284095285697,1.0,1.0,1.0,2/5,22.25%,DNM3;MX2
prerank,GO_Biological_Process_2021__postsynaptic endocytosis (GO:0140239),0.31260803002767457,0.4737284095285697,1.0,1.0,1.0,2/5,22.25%,DNM3;MX2
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),0.33304556521600504,0.4730815417806164,1.0,1.0,1.0,1/5,16.45%,LIMK2
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.262813292231732,-0.472536058072215,1.0,1.0,1.0,2/21,11.50%,DNAH11;MMP21
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.2842473856054512,-0.47076651872383757,1.0,1.0,1.0,6/6,71.59%,ARFGAP3;ARFGAP2;TMED9;TMED2;GBF1;TMED10
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.2842473856054512,-0.47076651872383757,1.0,1.0,1.0,6/6,71.59%,ARFGAP3;ARFGAP2;TMED9;TMED2;GBF1;TMED10
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.2842473856054512,-0.47076651872383757,1.0,1.0,1.0,6/6,71.59%,ARFGAP3;ARFGAP2;TMED9;TMED2;GBF1;TMED10
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.2907048128416954,0.4675019734814846,0.9696969696969697,1.0,1.0,3/6,39.76%,DHX9;YBX1;DDX3X
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.2728823093672647,0.4665768246689212,0.984375,1.0,1.0,5/7,43.59%,MVB12A;VCP;CHMP2B;LYST;UBXN6
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.26637327276168843,-0.46633478354331764,0.9772727272727273,1.0,1.0,7/7,73.38%,PTPRS;RTN4RL1;CERS2;RTN4R;THY1;EPHA4;INPP5F
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.2749176339782202,-0.4649950928309668,1.0,1.0,1.0,2/13,17.00%,IRF5;STAT1
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.3176855347084516,0.4632541557154871,1.0,1.0,1.0,2/6,22.26%,DMD;ACE
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.2676168700526371,-0.4630453472772171,1.0,1.0,1.0,2/11,20.41%,CAV2;CHMP3
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.2307971524862067,-0.4627363068391612,1.0,1.0,1.0,5/33,19.59%,DHX58;TRAF3IP1;PTPRS;HAVCR2;NLRX1
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),-0.28788347750413235,-0.46257148869548825,0.926829268292683,1.0,1.0,1/5,13.89%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride lipase activity (GO:0061365),0.30906413491107,0.46198880002365583,0.9827586206896551,1.0,1.0,1/5,11.90%,NR1H3
prerank,GO_Biological_Process_2021__positive regulation of lipoprotein lipase activity (GO:0051006),0.30906413491107,0.46198880002365583,0.9827586206896551,1.0,1.0,1/5,11.90%,NR1H3
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.25938712757492133,-0.4608018565810696,1.0,1.0,1.0,3/9,26.95%,RNF20;NELFE;SUPT5H
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.2759456758677059,-0.46070964196003605,0.9743589743589743,1.0,1.0,3/12,15.69%,TMSB4X;CCDC22;NFKBIE
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.308034446862875,-0.46020174605739445,0.9807692307692307,1.0,1.0,5/5,69.21%,ATPAF1;TMEM70;OXA1L;ATP5F1D;ATP23
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.29538141207647167,-0.459726605887299,1.0,1.0,1.0,7/7,70.48%,CD63;EMP2;DMTN;LIMS2;FLNA;LIMS1;LOXL3
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.2958073064546659,-0.45939970834495253,0.9591836734693877,1.0,1.0,7/7,70.43%,HAAO;NMNAT2;NMNAT1;NADSYN1;NMNAT3;QPRT;KYNU
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.23968393075037192,0.4583588333091358,1.0,1.0,1.0,3/14,28.99%,SEC24B;SAR1A;SEC31A
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.22305050100542573,0.4562040898424305,1.0,1.0,1.0,6/22,29.96%,TAP1;SLC19A1;DISP1;SLC27A1;SLC38A5;SLC46A1
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.28987221959299575,-0.4547390233382559,0.9534883720930233,1.0,1.0,9/9,71.03%,KIF11;KIF25;CHEK1;RANBP1;NSFL1C;NEK2;UBXN2B;MAP9;CEP85
prerank,GO_Biological_Process_2021__gamma-delta T cell activation (GO:0046629),-0.2699158893282926,-0.4547250121589734,0.925,1.0,1.0,2/6,19.19%,TCF7;MICB
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.2856380447238736,0.45356681729362275,0.9803921568627451,1.0,1.0,2/8,26.08%,NREP;MTR
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.2707988396100805,0.4518786057347491,1.0,1.0,1.0,4/16,21.31%,SP1;ZNF639;CHD1;RRP1B
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.3016609094780675,-0.4517588888143505,1.0,1.0,1.0,6/6,69.85%,RHOT2;UBB;MAP1S;UXT;LRPPRC;RHOT1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.2337102950653157,0.4501275786510621,1.0,1.0,1.0,1/18,9.52%,PIK3CA
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.24907582670169154,0.44922271504932365,0.9827586206896551,1.0,1.0,4/11,32.74%,PANK1;PPCS;SLC25A16;PANK3
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.24907582670169154,0.44922271504932365,0.9827586206896551,1.0,1.0,4/11,32.74%,PANK1;PPCS;SLC25A16;PANK3
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.24907582670169154,0.44922271504932365,0.9827586206896551,1.0,1.0,4/11,32.74%,PANK1;PPCS;SLC25A16;PANK3
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),0.28215484240974986,0.44879962884970837,1.0,1.0,1.0,3/6,34.68%,TNFRSF21;EPHA4;NF1
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.2615819026861349,-0.4485203891126292,1.0,1.0,1.0,1/7,14.18%,PRKCH
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.2765407484894389,-0.4483943981457753,0.9387755102040817,1.0,1.0,1/8,10.32%,ACAN
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.26988874355379644,0.4464461091393967,1.0,1.0,1.0,4/8,25.42%,MEF2C;LYN;DOCK10;DOCK11
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.18291171464945166,0.4459409818141606,1.0,1.0,1.0,8/85,20.91%,RPS5;RPL21;SEC61A1;RPL18A;RPL7;SEC61A2;RPS3A;RPL23A
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.26975429710653903,-0.44540101719805236,0.9782608695652174,1.0,1.0,2/8,16.02%,TTN;HTR2B
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.26409119519321966,-0.4448342623598767,1.0,1.0,1.0,3/9,25.88%,BAK1;COPS5;RACK1
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.273179697636451,-0.4443627263896729,1.0,1.0,1.0,1/8,14.93%,BRCA1
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.19299001344020328,-0.44380029512280256,1.0,1.0,1.0,5/61,18.17%,C2ORF49;SARS1;CPSF4;CSTF2;DTWD2
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.24371209664293977,0.4425895580727165,1.0,1.0,1.0,6/17,29.14%,BIRC3;OASL;ANKRD17;PUM2;PUM1;ZCCHC3
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.2466603951476188,-0.44125338395329416,1.0,1.0,1.0,2/15,13.89%,PTCH1;TGFB1
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.2534257750781471,-0.44076111973968995,1.0,1.0,1.0,4/15,23.90%,P2RY12;APOD;P2RX4;RTN4RL2
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.2965122099484965,0.44034739264168754,1.0,1.0,1.0,1/5,10.93%,LIG4
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.24151479289940828,-0.43959646920191914,0.9795918367346939,1.0,1.0,14/14,75.87%,ATAD5;BRPF3;GLI2;STN1;KAT7;NPM2;PCNA;CTC1;EGF;BCAR3;FAF1;DNA2;EGFR;DHX9
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.27484383872799545,-0.43934096384643,1.0,1.0,1.0,7/7,72.53%,ADAM8;OSMR;PARK7;PTGS2;IL6ST;CREB3L3;PTGER3
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),-0.28107698859603464,-0.43816510905221695,0.9818181818181818,1.0,1.0,6/6,71.91%,DUSP3;PIK3R1;IQSEC1;ARF6;MAPRE2;MAP4K4
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),-0.28107698859603464,-0.43816510905221695,0.9818181818181818,1.0,1.0,6/6,71.91%,DUSP3;PIK3R1;IQSEC1;ARF6;MAPRE2;MAP4K4
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),-0.2635812985046375,-0.43740240587234186,1.0,1.0,1.0,7/7,73.66%,PLIN2;PLIN3;FITM2;CIDEA;PLIN5;LPL;OSBPL11
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.2663606681493399,-0.43438947527200084,1.0,1.0,1.0,6/6,73.38%,PTPRS;RTN4RL1;CERS2;RTN4R;EPHA4;INPP5F
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.2717750578315252,-0.4342059927317948,0.9818181818181818,1.0,1.0,2/8,19.84%,KIF26A;RHOXF1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.2257262280701724,0.4334599123647518,1.0,1.0,1.0,1/14,11.86%,CARMIL1
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.1999257818432042,0.4330561264494587,1.0,1.0,1.0,8/51,28.71%,RANBP2;FMR1;H3-3A;POLR2H;NUP153;PUM2;PUM1;IPO8
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.1999257818432042,0.4330561264494587,1.0,1.0,1.0,8/51,28.71%,RANBP2;FMR1;H3-3A;POLR2H;NUP153;PUM2;PUM1;IPO8
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.268288000025969,0.4323375192439134,1.0,1.0,1.0,2/7,27.34%,IMPA1;IPPK
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.2505561077192484,-0.431291780924205,1.0,1.0,1.0,10/10,74.96%,ABCB4;ABCA12;ABCA3;LRP1;DBI;TRIAP1;SPP1;CYP19A1;PRELID1;APOE
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.2761756620318252,0.43008214282092494,1.0,1.0,1.0,1/6,20.59%,IKBKB
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.24945115183396716,-0.42954855428068767,0.9565217391304348,1.0,1.0,2/8,17.93%,WFS1;ATG10
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.25033288961472056,-0.42930954703312124,0.9767441860465116,1.0,1.0,3/14,20.15%,WNT7A;OSR1;TWIST1
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),-0.2610609000141958,-0.4287748542621897,1.0,1.0,1.0,6/6,73.91%,NRP1;TAOK2;SEMA3A;CHRNA7;PTN;PHACTR1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.25454782692823713,-0.4286169084812454,0.9714285714285714,1.0,1.0,3/8,29.57%,NOD1;LDOC1;VIM
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.20729363998327352,-0.42773674601349104,1.0,1.0,1.0,6/29,24.69%,DAB2IP;DAXX;BAK1;STUB1;HSPB8;BAG3
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.21665301431808034,0.42716388401475686,1.0,1.0,1.0,3/17,22.43%,SIRT7;MAF1;EIF2AK3
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.2293456141252691,-0.42706161022688305,1.0,1.0,1.0,2/18,14.93%,PAX2;BRCA1
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),-0.28603198637266963,-0.42701449069926584,1.0,1.0,1.0,5/5,71.41%,CRY2;PER1;CRY1;LMO3;CLOCK
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.2384330175883214,-0.4256054722873378,1.0,1.0,1.0,4/14,25.38%,SRSF10;SRSF7;RBMX;RNPS1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.2197328664950105,0.4221349638664223,1.0,1.0,1.0,3/18,25.97%,PTBP2;SFSWAP;SRSF9
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.25942434960501964,0.42186304681602727,0.9591836734693877,1.0,1.0,2/7,29.12%,TRNAU1AP;SELENOT
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.25942434960501964,0.42186304681602727,0.9591836734693877,1.0,1.0,2/7,29.12%,TRNAU1AP;SELENOT
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.2814763405569485,0.4207566129311482,0.9824561403508771,1.0,1.0,2/5,37.05%,LTN1;ZNF598
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.2728291766697548,-0.4181281516098085,0.9791666666666666,1.0,1.0,2/6,21.69%,PRPS1;G6PD
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.22747335320380566,0.41774489140256704,1.0,1.0,1.0,4/16,26.64%,ACHE;ADAM10;APOE;BACE1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.24171058029883502,-0.41670859944131533,1.0,1.0,1.0,1/10,14.93%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.2498328765010356,0.41523753891103626,1.0,1.0,1.0,5/7,41.66%,FZD3;PAK2;BCL2L1;DFFA;CIDEA
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.2151687079035598,-0.4151778939219736,1.0,1.0,1.0,3/22,15.11%,FFAR4;PDE3A;CGAS
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),-0.290950964865777,-0.41398006067699356,0.9696969696969697,1.0,1.0,1/5,14.28%,LETM1
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.24735731557678065,0.41345085395091463,0.9811320754716981,1.0,1.0,2/10,18.27%,SYNE3;SUN2
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.2326644397026702,0.41293494199431896,0.9791666666666666,1.0,1.0,2/14,21.54%,HEXB;NAGA
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.25893273626286456,0.4117676248228945,1.0,1.0,1.0,1/6,18.92%,SAT1
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.21961006419048001,0.4116000704076793,1.0,1.0,1.0,6/13,30.99%,PRKAA1;CCDC3;ASXL3;PPP2R5A;SLC22A13;ADRA2A
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.20730703797930206,-0.41017324790209503,1.0,1.0,1.0,4/32,17.09%,CAMLG;OTOF;EMC1;EMD
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.26007207668492205,-0.40800597048822357,1.0,1.0,1.0,1/6,15.85%,NHP2
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.24000669464701116,0.4064426465180361,1.0,1.0,1.0,2/11,25.74%,PTPN23;RAB21
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.21880939015517176,0.40518682783440896,1.0,1.0,1.0,3/12,29.85%,ALDH6A1;DPYSL5;DPYSL3
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),0.23823899626117082,0.40413106889882655,1.0,1.0,1.0,1/7,15.96%,ME3
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.27060660546985893,0.40115330957514256,1.0,1.0,1.0,5/5,72.95%,TJP1;FERMT2;CAMSAP3;KIFC3;PLEKHA7
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.23837185595345256,0.39974706927052067,1.0,1.0,1.0,5/10,36.08%,EMC2;EMC9;EMC6;EMC10;MMGT1
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.24340190578190907,-0.39847924231653237,1.0,1.0,1.0,3/8,26.12%,MTHFD1L;HAAO;MTHFD1
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.2170619753665924,0.3973738633411598,1.0,1.0,1.0,4/15,31.21%,PRKACB;PRKAR2A;ADCY2;ADCY5
prerank,GO_Biological_Process_2021__positive regulation of podosome assembly (GO:0071803),-0.2709851424245292,-0.39492237359143073,1.0,1.0,1.0,5/5,72.91%,CAPG;ASAP1;FSCN1;LCP1;IL5
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.21783584209031526,-0.39391744435943854,1.0,1.0,1.0,13/13,78.23%,NUP133;NUP93;NDC1;RTN4;NUP35;NUP98;NUP107;SEH1L;TPR;NUP205;NUP54;AHCTF1;NUP153
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.1979506426814041,0.38943562420609634,1.0,1.0,1.0,7/22,30.63%,PKN2;LGMN;PPP1R10;USP2;EIF4E;APP;CCNB1
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.28238702179541975,0.3889761463698043,1.0,1.0,1.0,3/5,35.03%,HNRNPU;CCNB1;SIRT2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.1752359277897949,0.3873435181699518,1.0,1.0,1.0,11/48,30.63%,CHMP6;RCC1;BANF1;CCNB2;LMNA;AHCTF1;RANGAP1;LBR;REEP4;PPP2R2A;CCNB1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.1752359277897949,0.3873435181699518,1.0,1.0,1.0,11/48,30.63%,CHMP6;RCC1;BANF1;CCNB2;LMNA;AHCTF1;RANGAP1;LBR;REEP4;PPP2R2A;CCNB1
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.18596264426468972,0.38675672488113744,1.0,1.0,1.0,9/27,32.49%,MAPK8;MAP3K8;IKBKB;MAPK3;CHUK;NFKB1;BTRC;MAP3K7;CUL1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.21883667171041052,0.3814593617826679,1.0,1.0,1.0,4/10,29.59%,VEGFA;NEXMIF;EPCAM;NOTCH1
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.23901253030255104,0.37999648592990865,0.9803921568627451,1.0,1.0,2/7,26.93%,PHF14;BRPF1
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.2328472179866228,0.37846318456774175,1.0,1.0,1.0,1/10,12.35%,IRAK1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.16913718142868883,0.37789392436193053,1.0,0.9998744144300966,1.0,11/51,30.63%,CHMP6;RCC1;BANF1;CCNB2;LMNA;AHCTF1;RANGAP1;LBR;REEP4;PPP2R2A;CCNB1
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.2245394696340866,-0.3760920042467981,1.0,1.0,1.0,2/8,16.97%,MED1;ZNF385A
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.15343440297378252,-0.36843034376151346,1.0,1.0,1.0,16/88,25.45%,RPL38;SRP68;SEC62;RPL12;RPL37A;RPS8;RPS27;RPL4;SRPRA;RPL5;SRP14;RPS20;RPL22;RPL34;RPL31;RPL37
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.1799112122250832,-0.3657163247478394,1.0,1.0,1.0,5/25,24.69%,DAB2IP;DAXX;BAK1;HSPB8;BAG3
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.20020301465855572,0.35154090025395796,1.0,1.0,1.0,3/10,31.45%,PRKAA1;ADRA2A;PLIN5
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.14677313339541537,-0.34807154049677486,1.0,1.0,1.0,19/97,27.25%,RPL38;SRP68;SEC62;RPL12;RPL37A;RPS8;RPS27;RPL4;SRPRA;RPL5;SRP14;RPS20;ZFAND2B;RPL22;RPL34;RPL31;RPL37;SGTB;RPL35A
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.21128093503052098,-0.34144404936543443,1.0,0.9997796191819464,1.0,6/6,78.88%,AKAP8L;SUPT6H;IWS1;TPR;NSUN2;SETD2
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.21128093503052098,-0.34144404936543443,1.0,0.9997796191819464,1.0,6/6,78.88%,AKAP8L;SUPT6H;IWS1;TPR;NSUN2;SETD2
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.18958438278566808,0.33291118010744486,1.0,1.0,1.0,5/11,35.83%,MICALL1;FNBP1L;BIN3;EHD2;SNX9
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.20794624293355674,0.32673949135248154,1.0,0.9999532622920172,1.0,3/9,26.96%,PROX1;BMP4;SHH
